Citrus Sinensis ID: 042262
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 814 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.963 | 0.942 | 0.470 | 0.0 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.926 | 0.864 | 0.318 | 1e-101 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.871 | 0.855 | 0.324 | 1e-100 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.896 | 0.893 | 0.320 | 4e-91 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.867 | 0.852 | 0.318 | 1e-84 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.926 | 0.888 | 0.285 | 2e-78 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.382 | 0.378 | 0.474 | 1e-77 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.828 | 0.845 | 0.308 | 7e-75 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.922 | 0.881 | 0.286 | 8e-74 | |
| Q9SXB3 | 820 | G-type lectin S-receptor- | no | no | 0.898 | 0.891 | 0.304 | 3e-72 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 714 bits (1843), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/839 (47%), Positives = 527/839 (62%), Gaps = 55/839 (6%)
Query: 3 SAKLYFIFLLYQLLYYLHLAIAQNNGTVPVGATLTAGTN---SSPWVSPSGDFAFGFHQL 59
S + + L+ QL + + NG+VPVG +LTA + SS W SPSGDFAFGF ++
Sbjct: 5 SCSIIHLVLILQLQTFFVFSQNIRNGSVPVGESLTASESQQISSSWRSPSGDFAFGFRKI 64
Query: 60 DEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPA-VPRGSQVKLTADRGLVLNDPQGK 118
N F LSI+++KI +KT+VW+ + VP GS+V LTAD GLV+ DP+G+
Sbjct: 65 ----QPNDGFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQ 120
Query: 119 QVWSSKIDIGTVAIGVMNDTGNFVL----ASSSSSKLWDSFTNPSDTLLPGQMMETEQGL 174
++W + + G+V+ G D GNFVL + S LW SF NP+DTLLP Q +E + L
Sbjct: 121 ELWRA-LSGGSVSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNL 179
Query: 175 FSRKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMF 234
SR+++T+F +GRF RL +DG+L L+ N T D Y ++ + +N G +++F
Sbjct: 180 SSRRTETSFKKGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYESNTNDPNNPGIQLVF 239
Query: 235 NESGYMYILRRNSQRFDLTTGR---VVPAADFYHRATLNFDGVFAQYFYPKNGNGNWSAV 291
N+SG +Y+L+RN+ RF + R AA FY G PK V
Sbjct: 240 NQSGEIYVLQRNNSRF-VVKDRDPDFSIAAPFYIST-----GFLLSTIIPKEAR---RIV 290
Query: 292 WSQPENIC-DNISG---EFGSGACGFNSICTLDGDRRPMCECPKGYSLLDENEKYGSCKA 347
+C DN+ G+ ACG+N+IC+L ++RP CECP+ + L D + +YG C
Sbjct: 291 GGCLLGLCRDNMCSPDDALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLP 350
Query: 348 DFEL-SCNGGGQGYNKE--LFDFHELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCAVA 404
DFE+ +C Q N + L++F L+ T+WP DYE ++ YDE +CK +CLSDC CA
Sbjct: 351 DFEMQTCRPENQTANSDVNLYEFITLEKTNWPFGDYESYANYDEERCKASCLSDCLCAAV 410
Query: 405 IFGIE---SCWLVKLPLNNGRADSSVNRKAFIKYKKDDDPDPPSVPRPPDPEDKKKRKMM 461
IFG CW K PL++G + FIK + D P KK +
Sbjct: 411 IFGTNRDLKCWKKKFPLSHGERSPRGDSDTFIKVRNRSIADVPVTG-----NRAKKLDWL 465
Query: 462 NATGSVLLGSSVFVNFAMVCAFVLGFFFIYKKKWIRNNPGD-----ATI---ETNLRCFS 513
SVLLG+S FV F C++ K ++N D AT E NLR F+
Sbjct: 466 IIACSVLLGTSAFVIFDTSCSYRKT---KKSKNMMKNQARDIGRTTATTTANELNLRVFT 522
Query: 514 YKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 573
Y EL EAT +F EE+GRG+FGIVYKG ++ S VAVKKLDR+ D EKEFKNEV V
Sbjct: 523 YGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKV 582
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 633
IGQ HHKNLVRL+GFC+EGQ++++VYEFL GTLA+FLF +PSW R NIA IARG+
Sbjct: 583 IGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPSWEDRKNIAVAIARGI 642
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
LYLHE+CS QIIHCDIKPQNILLD+YY RISDFGLAKLL +NQ+ + T IRGTKGYVA
Sbjct: 643 LYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTL-TNIRGTKGYVA 701
Query: 694 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753
PEWFRNS IT+KVDVYS+GV+LLEI+ C+K+ D+ E+ IL +WA+DC+R G+L+DL
Sbjct: 702 PEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVDL---EDNVILINWAYDCFRQGRLEDLT 758
Query: 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFSGY 812
E D+EAMND++ E+ V ++IWCIQE+ +RP MR V+QMLEGV++V PPNPSP+S +
Sbjct: 759 EDDSEAMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNPSPYSTF 817
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 369 bits (947), Expect = e-101, Method: Compositional matrix adjust.
Identities = 269/845 (31%), Positives = 417/845 (49%), Gaps = 91/845 (10%)
Query: 7 YFIFLLYQLLYYLHLAIAQNNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSN 66
+F F L L H+ + G+ L A + WVS +G FA GF + +
Sbjct: 16 FFCFFLVSLATEPHIGL---------GSKLKASEPNRAWVSANGTFAIGFTRFKPTDR-- 64
Query: 67 GLFLLSIFYNKIP-EKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKI 125
FLLSI++ ++P + T+VW + ++N V + + ++L A LVL+D Q VW+S
Sbjct: 65 --FLLSIWFAQLPGDPTIVW---SPNRNSPVTKEAVLELEATGNLVLSD-QNTVVWTSNT 118
Query: 126 DIGTVAIGVMNDTGNFVLASS---SSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSDTN 182
V VM+++GNF+L + + +W SF+ PSDTLLP Q + L S S +
Sbjct: 119 SNHGVESAVMSESGNFLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSR 178
Query: 183 FSRGRFQFRLLEDGD-----LVLNVANLP-TDFAY----DAYYTSGTYDSTNSSNSGYRV 232
G + ++L+ L N+ P +++Y D +G + +++
Sbjct: 179 --HGHYSLKMLQQHTSLSLGLTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKI 236
Query: 233 MFNES--GYMYILRR---------NSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYFYP 281
++ ES G +Y+ + NS LT V+ R L +G Y +
Sbjct: 237 VYGESSIGAVYVYKNPVDDNRNYNNSSNLGLTKNPVL------RRLVLENNGNLRLYRWD 290
Query: 282 K--NGNGNWSAVWSQPENICDNISGEFGSGACGFNSICTLDGDRRPM-CECPKGYSLLDE 338
NG+ W W+ N CD +G CG N +C LD ++ C C G L +
Sbjct: 291 NDMNGSSQWVPEWAAVSNPCDI------AGICG-NGVCNLDRTKKNADCLCLPGSVKLPD 343
Query: 339 NEKYGSCKADFELSCNGGGQGYNKELFDFHELKDTDWPSSD---YEHFSPYDEV-QCKNT 394
E C + L F +++T++ S+ E+ S V +C
Sbjct: 344 QENAKLCSDNSSLVQECESNINRNGSFKISTVQETNYYFSERSVIENISDISNVRKCGEM 403
Query: 395 CLSDCFCAVAIFGIES----CWLVKLPLNNGRADSSVNRKAFIKYKKDDDPDPPSVPRPP 450
CLSDC C +++G++ CW++K G D F+K + ++ S P
Sbjct: 404 CLSDCKCVASVYGLDDEKPYCWILKSLNFGGFRDPG--STLFVKTRANE-----SYPSNS 456
Query: 451 DPEDKKKRKMMNATGSVLLGSSVFVNFAMVCAFVLGFFFIY---KKKWIRNNPGDATIET 507
+ D K RK VL+ V +V +LG Y +K+ ++ ++ I
Sbjct: 457 NNNDSKSRKSHGLRQKVLVIPIVVGMLVLVA--LLGMLLYYNLDRKRTLKRAAKNSLILC 514
Query: 508 NLRC-FSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE 566
+ F+Y++L+ T+NF + +G G FG VYKG + T VAVK+LDR GE+E
Sbjct: 515 DSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTV----AGETLVAVKRLDRALSHGERE 570
Query: 567 FKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS----WNLR 622
F EV IG HH NLVRL G+C E +RLLVYE++ NG+L ++F + + + W R
Sbjct: 571 FITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTR 630
Query: 623 TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682
IA A+G+ Y HE C +IIHCDIKP+NILLDD + ++SDFGLAK++ S +
Sbjct: 631 FEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVV- 689
Query: 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 742
T IRGT+GY+APEW N IT K DVYS+G+LLLEI+ R++ D+ E WA+
Sbjct: 690 TMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYK 749
Query: 743 CYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV-EVD 801
NG V+ + + + + K + V+ WCIQ++ S+RP+M +V ++LEG E++
Sbjct: 750 ELTNGTSLKAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEIN 809
Query: 802 VPPNP 806
+PP P
Sbjct: 810 LPPMP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 366 bits (940), Expect = e-100, Method: Compositional matrix adjust.
Identities = 266/820 (32%), Positives = 406/820 (49%), Gaps = 111/820 (13%)
Query: 29 TVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSI-FYNKIPEKTVVWYT 87
T+P+G+ + A ++ W SP+ F+ F N+ FL ++ F +P +W
Sbjct: 26 TIPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNS----FLAAVSFAGSVP----IWSA 77
Query: 88 DNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGTVAIGVMNDTGNFVLASSS 147
D RGS ++L L L + G VW SK D V G + DTG F+L ++
Sbjct: 78 GTVDS-----RGS-LRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNR 131
Query: 148 SSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDGDLVL--NVANL 205
S +W SF NP+DT++ Q + L S G + F+L G+L L N + +
Sbjct: 132 SVPVWSSFDNPTDTIVQSQNFTAGKILRS---------GLYSFQLERSGNLTLRWNTSAI 182
Query: 206 PTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDLTTGRVVPAADFYH 265
Y+ G S +S+ S R+ +G + I N L +V + D+
Sbjct: 183 --------YWNHGLNSSFSSNLSSPRLSLQTNGVVSIFESNL----LGGAEIVYSGDYGD 230
Query: 266 RATLNF-----DGVFAQYFYPKNGNGNWSAVWSQPENICDNISGEFGSGACGFNSICTLD 320
T F DG Y +G +A WS + G CG IC+ +
Sbjct: 231 SNTFRFLKLDDDGNLRIYSSASRNSGPVNAHWSAVDQC-------LVYGYCGNFGICSYN 283
Query: 321 GDRRPMCECP-KGYSLLDENEKYGSCKADFELS-CNGGGQGYNKELFDFHELK---DTDW 375
D P+C CP + + +D N++ CK ELS C+G N + D + D
Sbjct: 284 -DTNPICSCPSRNFDFVDVNDRRKGCKRKVELSDCSG-----NTTMLDLVHTRLFTYEDD 337
Query: 376 PSSD--YEHFSPYDEVQCKNTCLSDCFCAVAIF---GIESCWLVKLPLN--NGRADSSVN 428
P+S+ + SP C+ CLS C ++ G +CW K P + G SV
Sbjct: 338 PNSESFFAGSSP-----CRANCLSSVLCLASVSMSDGSGNCWQ-KHPGSFFTGYQWPSVP 391
Query: 429 RKAFIKYKKDDDPDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFAMVCAFVLGFF 488
+++K + ++ R +D + + ++ V A +LG
Sbjct: 392 STSYVKVCGPVVAN--TLERATKGDDNNSKVHL------------WIVAVAVIAGLLGLV 437
Query: 489 FIYKKKW---IRNNPGDATIETNLRC----------FSYKELEEATDNFEEEVGRGSFGI 535
+ W R NP T+ ++ F+YKEL+ T +F+E++G G FG
Sbjct: 438 AVEIGLWWCCCRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGT 497
Query: 536 VYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 595
VY+GV+ T+ T VAVK+L+ + Q GEK+F+ EV I THH NLVRL+GFC +G++R
Sbjct: 498 VYRGVL----TNRTVVAVKQLEGIEQ-GEKQFRMEVATISSTHHLNLVRLIGFCSQGRHR 552
Query: 596 LLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQ 652
LLVYEF+ NG+L +FLF +W R NIA A+G+ YLHE+C I+HCDIKP+
Sbjct: 553 LLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPE 612
Query: 653 NILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFG 712
NIL+DD + A++SDFGLAKLL ++ +++RGT+GY+APEW N IT+K DVYS+G
Sbjct: 613 NILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYG 672
Query: 713 VLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG--DTEAMNDIKCTEKLV 770
++LLE++S +++FD+ + + WA++ + G +++ + D++ ++V
Sbjct: 673 MVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMV 732
Query: 771 MVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFS 810
S WCIQE P RPTM KV QMLEG+ E+ P P S
Sbjct: 733 KTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCPKTIS 772
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 336 bits (862), Expect = 4e-91, Method: Compositional matrix adjust.
Identities = 265/828 (32%), Positives = 401/828 (48%), Gaps = 98/828 (11%)
Query: 24 AQNNGTVPVGATLTAGT-NSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPE-- 80
A + +P+G++L + SS S G F+ GF+++ F S++Y+K
Sbjct: 26 ASSRDILPLGSSLVVESYESSTLQSSDGTFSSGFYEVYTHA-----FTFSVWYSKTEAAA 80
Query: 81 ---KTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMN 136
KT+VW + N D+ P R S + L D +VL D G VW + + T V +
Sbjct: 81 ANNKTIVW-SANPDR-PVHARRSALTLQKDGNMVLTDYDGAAVWRADGNNFTGVQRARLL 138
Query: 137 DTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDG 196
DTGN V+ S + +W SF +P+DT LP Q++ L + F+F L
Sbjct: 139 DTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVPTTQSRSPGNYIFRFSDLSVL 198
Query: 197 DLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDLTTGR 256
L+ +V + +D + + D N NS M +SG + D G+
Sbjct: 199 SLIYHVPQV-SDIYWPDPDQNLYQDGRNQYNSTRLGMLTDSGVL-------ASSDFADGQ 250
Query: 257 VVPAADF----YHRATLNFDGVFAQYFYPKNGNGNWSA---VWSQPENICDNISGEFGSG 309
+ A+D R TL+ DG Y + +G+WS +QP NI G
Sbjct: 251 ALVASDVGPGVKRRLTLDPDGNLRLYSM-NDSDGSWSVSMVAMTQPCNI---------HG 300
Query: 310 ACGFNSICTLDGDRRPMCECPKGYSLLDENEKYGSCKADFELSCNGGGQGYNKELFDFHE 369
CG N IC P C CP GY+ + C A +C+ Y+K F
Sbjct: 301 LCGPNGICHYSPT--PTCSCPPGYATRNPGNWTEGCMAIVNTTCDR----YDKRSMRFVR 354
Query: 370 LKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCAVAIF--GIESCWLVKLPLNNGRA-DSS 426
L +TD+ SD +H C++ C+SDC C + G SC+ K L +GR +S
Sbjct: 355 LPNTDFWGSDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCY-PKAYLFSGRTYPTS 413
Query: 427 VNRKAFIKYKKDDDPDPPSVPRPPDPEDKKKRKM---------------MNATGSVLLGS 471
R ++K +PR D D R++ ++ TG S
Sbjct: 414 DVRTIYLKLPTGVSVSNALIPRS-DVFDSVPRRLDCDRMNKSIREPFPDVHKTGGG--ES 470
Query: 472 SVFVNFAMVCAFVL--------GFFFIYKKK------WIRNNPGDATIETNLRCFSYKEL 517
F + + AF + +FF+ K++ W + G + +N R +SY+EL
Sbjct: 471 KWFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWA-SEKGYKAMTSNFRRYSYREL 529
Query: 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 577
+AT F+ E+GRG G VYKGV++ R VAVKKL+ V Q G++ F+ E+ VIG+
Sbjct: 530 VKATRKFKVELGRGESGTVYKGVLEDDR----HVAVKKLENVRQ-GKEVFQAELSVIGRI 584
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLL 634
+H NLVR+ GFC EG +RLLV E++ NG+LA+ LF GN+ W R NIA +A+GL
Sbjct: 585 NHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALGVAKGLA 644
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694
YLH +C +IHCD+KP+NILLD + +I+DFGL KLL S + +RGT GY+AP
Sbjct: 645 YLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIAP 704
Query: 695 EWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMG--EEYAILTDWA--FDCYRNGKLD 750
EW + ITAKVDVYS+GV+LLE+++ + ++ G E +++L G+
Sbjct: 705 EWVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSMLRKLVRMLSAKLEGEEQ 764
Query: 751 DLVEG--DTEAMNDIKCTEK--LVMVSIWCIQEDPSLRPTMRKVSQML 794
++G D++ + + L+ +++ C++ED S RPTM Q L
Sbjct: 765 SWIDGYLDSKLNRPVNYVQARTLIKLAVSCLEEDRSKRPTMEHAVQTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 315 bits (806), Expect = 1e-84, Method: Compositional matrix adjust.
Identities = 253/795 (31%), Positives = 385/795 (48%), Gaps = 89/795 (11%)
Query: 46 VSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLT 105
VS G + GF + +N F + ++Y ++ + T++W N+D+ + S K++
Sbjct: 39 VSSDGTYEMGFFKPGSSSN----FYIGMWYKQLSQ-TILWVA-NRDKAVSDKNSSVFKIS 92
Query: 106 ADRGLVLNDPQGKQVWSSKIDIGTVAI----GVMNDTGNFVL----ASSSSSKLWDSFTN 157
++L+ VWS+ ++ T ++ V+ D GN VL +S S++ LW SF +
Sbjct: 93 NGNLILLDGNYQTPVWSTGLN-STSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDH 151
Query: 158 PSDTLLPGQMMETE------QGLFSRKSDTNFSRGRFQFRLLEDG--DLVLNVANLPTDF 209
P DT LPG + + Q L S KS + S G F L E ++ N +N
Sbjct: 152 PGDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTAYKILWNGSN----- 206
Query: 210 AYDAYYTSGTYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDLTTGRVVPAADFYH---- 265
Y++SG ++ + M Y+Y N F TT + +
Sbjct: 207 ---EYWSSGPWNPQSRIFDSVPEM--RLNYIY----NFSFFSNTTDSYFTYSIYNQLNVS 257
Query: 266 RATLNFDGVFAQYFYPKNGNGNWSAVWSQPENICDNISGEFGSGACGFNSICTLDGDRRP 325
R ++ G Q+ + + GN W+ WSQP C CG IC+ P
Sbjct: 258 RFVMDVSGQIKQFTWLE-GNKAWNLFWSQPRQQCQVYR------YCGSFGICS--DKSEP 308
Query: 326 MCECPKGYSLL-----DENEKYGSCKADFELSCNGGGQGYNKELFDFHELKDTDWPSSDY 380
C CP+G+ + D + C EL C+ +G + F +K D +
Sbjct: 309 FCRCPQGFRPMSQKDWDLKDYSAGCVRKTELQCS---RGDINQFFRLPNMKLAD----NS 361
Query: 381 EHFSPYDEVQCKNTCLSDCFCAVAIF--GIESCWLVKLPLNNGRADSSVNRKAFIKYKKD 438
E + C + C DC C + G C + + N + N + I Y +
Sbjct: 362 EVLTRTSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRL 421
Query: 439 DDPDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFAMVCAFVLGFFFIYKKKWIRN 498
D P+V +K +LGS +V V+ ++K +R
Sbjct: 422 AASDVPNVGASGKSNNK------GLIFGAVLGS--LGVIVLVLLVVILILRYRRRKRMRG 473
Query: 499 NPGDATIETNLRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR 558
GD T L FSY+EL+ AT NF +++G G FG V+KG + ++ +AVK+L+
Sbjct: 474 EKGDGT----LSAFSYRELQNATKNFSDKLGGGGFGSVFKGAL----PDSSDIAVKRLEG 525
Query: 559 VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---- 614
+ Q GEK+F+ EVV IG H NLVRL GFC EG +LLVY+++ NG+L S LF N
Sbjct: 526 ISQ-GEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEE 584
Query: 615 -LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673
+ W LR IA ARGL YLH++C IIHCDIKP+NILLD + +++DFGLAKL+
Sbjct: 585 KIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLV 644
Query: 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 733
+ S+ + T +RGT+GY+APEW ITAK DVYS+G++L E++S R++ + E+
Sbjct: 645 GRDFSRVL-TTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKV 703
Query: 734 AILTDWAFDCY-RNGKLDDLVEGDTEA-MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVS 791
WA ++G + LV+ E DI+ + V+ WCIQ++ S RP M +V
Sbjct: 704 RFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVV 763
Query: 792 QMLEGVVEVDVPPNP 806
Q+LEGV+EV+ PP P
Sbjct: 764 QILEGVLEVNPPPFP 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 294 bits (753), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 247/866 (28%), Positives = 384/866 (44%), Gaps = 112/866 (12%)
Query: 6 LYFIFLLYQLLYYLHLAIAQNNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNS 65
LY LY LY +A T+ G +L G N P VSP F GF +
Sbjct: 9 LYLSLFLYFFLYESSMAA----NTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHR 64
Query: 66 NGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKI 125
L I+Y I +K VVW + P + + ++ D LVL D + VWSS I
Sbjct: 65 ----FLGIWYGNIEDKAVVWVANRA--TPISDQSGVLMISNDGNLVLLDGKNITVWSSNI 118
Query: 126 DIGTV----AIGVMNDTGNFVLASSSSSK-LWDSFTNPSDTLLPGQMMETE------QGL 174
+ T + ++DTGNFVL+ + + + +W+SF +P+DT LP +
Sbjct: 119 ESSTTNNNNRVVSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAF 178
Query: 175 FSRKSDTNFSRGRFQFRLLEDG--DLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRV 232
S +S+T+ S G + + G ++VL N + SG ++S + +G
Sbjct: 179 VSWRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRK------WRSGQWNS--AIFTGIPN 230
Query: 233 MFNESGYMYILRRNSQRFDLTTGRV----VPA-ADFYHRATLNFDGVFAQYFYPKNGNGN 287
M + Y+Y + +S + TG V VP+ R + ++G + + +
Sbjct: 231 MSLLTNYLYGFKLSSPPDE--TGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLK-K 287
Query: 288 WSAVWSQPENICDNISGEFGSGACGFNSICTLDGDRRPMCECPKGYSLLDENEKYGSCKA 347
W+ S+P++ CD + CG IC + G +C C GY + C+
Sbjct: 288 WTKFQSEPDSECDQYN------RCGKFGICDMKGSN-GICSCIHGYEQVSVGNWSRGCRR 340
Query: 348 DFELSCNGGGQGYNKELFDFHELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFC-AVAIF 406
L C E +K D+ ++ P D C+ CL +C C A ++
Sbjct: 341 RTPLKCERNISVGEDEFLTLKSVKLPDFEIPEHNLVDPED---CRERCLRNCSCNAYSLV 397
Query: 407 GIESCWLVKLPLNNGRADSSVNRKAFIKYKKDDDPDPPSVPRPPDPEDKKKRKMMNATGS 466
G C + L + + + I R D E + RK
Sbjct: 398 GGIGCMIWNQDLVDLQQFEAGGSSLHI--------------RLADSEVGENRKT-----K 438
Query: 467 VLLGSSVFVNFAMVCAFVLGFFFIYKKKWIRNN--------------------------- 499
+ + +V V ++ F L + +KK +
Sbjct: 439 IAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSG 498
Query: 500 ------PGDATIETNLRCFSYKELEEATDNF--EEEVGRGSFGIVYKGVIQTTRTSTTAV 551
G A + L FS + AT++F E E+GRG FG VYKGV++ R +
Sbjct: 499 SVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGR----EI 554
Query: 552 AVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL 611
AVK+L G EFKNE+++I + H+NLVRLLG C EG+ ++LVYE++ N +L FL
Sbjct: 555 AVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFL 614
Query: 612 FGNLKPS---WNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 668
F K + W LR +I IARGLLYLH D +IIH D+K N+LLD N +ISDFG
Sbjct: 615 FDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFG 674
Query: 669 LAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIE 728
+A++ NQ++A + GT GY++PE+ + K DVYSFGVLLLEI+S +++ +
Sbjct: 675 MARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLR 734
Query: 729 MGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMR 788
E+ L +A+ Y +G+ ++LV+ + + + V++ C+Q+ + RP M
Sbjct: 735 -SSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMA 793
Query: 789 KVSQMLEGVVEVDVPPNPSPFSGYMR 814
V MLE P F+ R
Sbjct: 794 SVLLMLESDTATLAAPRQPTFTSTRR 819
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 1e-77, Method: Compositional matrix adjust.
Identities = 160/337 (47%), Positives = 217/337 (64%), Gaps = 26/337 (7%)
Query: 488 FFIYK-KKWIRNNPGDATIETNLR--------CFSYKELEEATDNFEEEVGRGSFGIVYK 538
F I+K KK I P +++ E N F+YK+L+ AT+NF ++G+G FG VY+
Sbjct: 450 FRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYE 509
Query: 539 GVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598
G T + +AVKKL+ + Q G+KEF+ EV +IG HH +LVRL GFC EG +RLL
Sbjct: 510 G----TLPDGSRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLA 564
Query: 599 YEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 654
YEFL+ G+L ++F G++ W+ R NIA A+GL YLHEDC A+I+HCDIKP+NI
Sbjct: 565 YEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENI 624
Query: 655 LLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVL 714
LLDD +NA++SDFGLAKL+T QS T +RGT+GY+APEW N I+ K DVYS+G++
Sbjct: 625 LLDDNFNAKVSDFGLAKLMTREQSHVF-TTMRGTRGYLAPEWITNYAISEKSDVYSYGMV 683
Query: 715 LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVM--- 771
LLE+I RK++D E +AF GKL D+V+G M ++ T++ V
Sbjct: 684 LLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDG---KMKNVDVTDERVQRAM 740
Query: 772 -VSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPS 807
++WCIQED RP+M KV QMLEGV V PP+ S
Sbjct: 741 KTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSS 777
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 282 bits (722), Expect = 7e-75, Method: Compositional matrix adjust.
Identities = 238/772 (30%), Positives = 350/772 (45%), Gaps = 98/772 (12%)
Query: 52 FAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLV 111
F GF N + + L I Y +P T VW N+ + + P S ++LT+ L+
Sbjct: 40 FRLGFFS---TTNGSSNWYLGISYASMPTPTHVWVA-NRIRPVSDPDSSTLELTSTGYLI 95
Query: 112 LNDPQGKQVWSSKIDIGTVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETE 171
+++ + VW + ++TGN +L + S +W SF NP+DT LPG +
Sbjct: 96 VSNLRDGVVWQTDNKQPGTDF-RFSETGNLILINDDGSPVWQSFDNPTDTWLPGMNVTGL 154
Query: 172 QGLFSRKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGT-YDSTNSSNSGY 230
+ S +S + S G + RL P+ + Y T Y ST +
Sbjct: 155 TAMTSWRSLFDPSPGFYSLRLS------------PSFNEFQLVYKGTTPYWSTGNWTGEA 202
Query: 231 RVMFNESGYMYILR---RNSQRFDLTTGRVVPAADFYH-----RATLNFDGVFAQYFYPK 282
V E YI R N + +VP D R + +G QY +
Sbjct: 203 FVGVPEMTIPYIYRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTWDP 262
Query: 283 NGNGNWSAVWSQPENICD--NISGEFGSGACGFNSICTLDGDRRPMCECPKGYSLLDENE 340
+W+ W QPE+ C N+ G+ G C+ + C C +G+ ++
Sbjct: 263 QTQ-SWNMFWLQPEDPCRVYNLCGQLG--------FCS--SELLKPCACIRGFRPRNDAA 311
Query: 341 KYGSCKADFELSCNGGGQGYNKELFDFHELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCF 400
D+ C ++ F + D + + C TCL +
Sbjct: 312 WRSD---DYSDGCRRENGDSGEKSDTFEAVGDLRYDGDVKMSRLQVSKSSCAKTCLGNSS 368
Query: 401 CAVAIFGIESCWLVKLPLNNGRADSSVNRKAFIKYKKDDDPDPPSVPRPPDPEDKKKRKM 460
C V + E L K+ L + P + K K
Sbjct: 369 C-VGFYHKEKSNLCKILLES-------------------------------PNNLKNSKG 396
Query: 461 MNATGSVLL-----GSSVFVNFAMVCAFVLGFFFIYKKKWIRNNPGDATIETNLRCFSYK 515
N + S+++ GS + F ++ +L K+K R D NL+ FS+K
Sbjct: 397 -NISKSIIILCSVVGSISVLGFTLLVPLIL-LKRSRKRKKTRKQDEDGFAVLNLKVFSFK 454
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIG 575
EL+ AT+ F ++VG G FG V+KG T S+T VAVK+L+R GE EF+ EV IG
Sbjct: 455 ELQSATNGFSDKVGHGGFGAVFKG---TLPGSSTFVAVKRLERP-GSGESEFRAEVCTIG 510
Query: 576 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIARG 632
H NLVRL GFC E +RLLVY+++ G+L+S+L P SW R IA A+G
Sbjct: 511 NIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL-SRTSPKLLSWETRFRIALGTAKG 569
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
+ YLHE C IIHCDIKP+NILLD YNA++SDFGLAKLL + S+ + T +RGT GYV
Sbjct: 570 IAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLAT-MRGTWGYV 628
Query: 693 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIE---MGEEYAILTDWAFDCYR---- 745
APEW IT K DVYSFG+ LLE+I R++ + +GE+ W F +
Sbjct: 629 APEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAREI 688
Query: 746 -NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796
G +D +V+ + + ++ V+IWCIQ++ +RP M V +MLEG
Sbjct: 689 IQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 279 bits (713), Expect = 8e-74, Method: Compositional matrix adjust.
Identities = 249/869 (28%), Positives = 400/869 (46%), Gaps = 118/869 (13%)
Query: 1 MASAKLYFIFLLYQLLYYLHLAIAQNNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLD 60
M + +++FLL+ +A+ Q++ T+ G+TL ++ VS F GF
Sbjct: 1 MILSVFFYMFLLHIRRLDCFVAV-QDSKTLFKGSTLINDSHGETLVSAGQRFELGF--FT 57
Query: 61 EENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQV 120
+S+ L I++ + TVVW + ++P + R ++ D L + D +G+
Sbjct: 58 PNGSSDERRYLGIWFYNLHPLTVVWVANR--ESPVLDRSCIFTISKDGNLEVIDSKGRVY 115
Query: 121 WSSKIDIGTVAIGVM---NDTGNFVLAS--SSSSKLWDSFTNPSDTLLPGQMMETEQGLF 175
W + + +V+ M D GN VL S + ++ +W SF NP+DT LPG M+ L
Sbjct: 116 WDTGVKPSSVSAERMVKLMDNGNLVLISDGNEANVVWQSFQNPTDTFLPGMRMDENMTLS 175
Query: 176 SRKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFN 235
S +S + S G F F++ ++ D + Y+ SG SG + +
Sbjct: 176 SWRSFNDPSHGNFTFQMDQEEDKQFIIWKRSM-----RYWKSGI--------SGKFIGSD 222
Query: 236 ESGYM--YILRRNSQRFDLTTGRVVPAADFYH---RATLNFDGVFAQYFYPKNGNGNWSA 290
E Y Y L ++ + V P + R T++ G AQYF +G W+
Sbjct: 223 EMPYAISYFLSNFTETVTVHNASVPPLFTSLYTNTRFTMSSSGQ-AQYFR-LDGERFWAQ 280
Query: 291 VWSQPENICD--NISGEFGSGACGFNSICTLDGDRRPMCECPKGYSLLDENEKYGSCKAD 348
+W++P + C N G FGS + MC+C G+ + EK+ K D
Sbjct: 281 IWAEPRDECSVYNACGNFGS----------CNSKNEEMCKCLPGFRP-NFLEKW--VKGD 327
Query: 349 FELSCNGGGQGYNKE------LFDFHELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCA 402
F C+ + K+ +F + + P S F ++E +C+ CL++C C
Sbjct: 328 FSGGCSRESRICGKDGVVVGDMFLNLSVVEVGSPDS---QFDAHNEKECRAECLNNCQCQ 384
Query: 403 VAIF-------GIESCWLVKLPLNNGRADSSVNRKAFIKYKKDDDPDPPSVPRPPDPEDK 455
+ CW+ LNN + +R FI+ PD S E
Sbjct: 385 AYSYEEVDILQSNTKCWIWLEDLNNLKEGYLGSRNVFIRVAV---PDIGS-----HVERG 436
Query: 456 KKRKMMNATGSVLLGSSVFVNFAM--VCAFVLGFFFIYKKKWIRNNPGDATIETNLRCFS 513
+ R T VL+ F + A+ V + + F+ ++K + G +L C S
Sbjct: 437 RGRYGEAKTPVVLIIVVTFTSAAILVVLSSTASYVFLQRRK-VNKELGSIPRGVHL-CDS 494
Query: 514 YKELEE---------------------------ATDNFEE--EVGRGSFGIVYKGVIQTT 544
+ ++E AT NF ++G+G FG VYKG+
Sbjct: 495 ERHIKELIESGRFKQDDSQGIDVPSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGD 554
Query: 545 RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604
+ +AVK+L R G +EFKNEVV+I + H+NLVRLLG+C G+ +LL+YE++ +
Sbjct: 555 Q----EIAVKRLSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPH 610
Query: 605 GTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 661
+L F+F + W +R NI IARGLLYLH+D +IIH D+K NILLD+ N
Sbjct: 611 KSLDFFIFDRKLCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMN 670
Query: 662 ARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISC 721
+ISDFGLA++ +++ A + GT GY++PE+ + K DV+SFGV+++E IS
Sbjct: 671 PKISDFGLARIFGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISG 730
Query: 722 RKSFDIEMGEEYAILTDWAFDCYRNGK----LDDLVEGDTEAMNDIKCTEKLVMVSIWCI 777
+++ E+ L A+D ++ + LD ++ E +KC + V + C+
Sbjct: 731 KRNTGFHEPEKSLSLLGHAWDLWKAERGIELLDQALQESCETEGFLKC----LNVGLLCV 786
Query: 778 QEDPSLRPTMRKVSQMLEGVVEVDVPPNP 806
QEDP+ RPTM V ML G E P P
Sbjct: 787 QEDPNDRPTMSNVVFML-GSSEAATLPTP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB3|Y1112_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11280 OS=Arabidopsis thaliana GN=At1g11280 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 273 bits (699), Expect = 3e-72, Method: Compositional matrix adjust.
Identities = 258/847 (30%), Positives = 381/847 (44%), Gaps = 116/847 (13%)
Query: 10 FLLYQLLYYLHLAIAQNNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLF 69
+L+ +L L ++ + + + LT G S SP G + GF NNS +
Sbjct: 10 IVLFPWFLWLSLFLSCGYAAITISSPLTLGQTLS---SPGGFYELGFF---SPNNSQNQY 63
Query: 70 LLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSK-IDIG 128
+ I++ KI + VVW + + P + + ++ + L+L D VWS++ I
Sbjct: 64 V-GIWFKKITPRVVVWVANR--EKPITTPVANLTISRNGSLILLDSSKNVVWSTRRPSIS 120
Query: 129 TVAIGVMNDTGNFVLASSSSSKL-WDSFTNPSDTLLP--GQMMETEQG----LFSRKSDT 181
+ DTGN V+ S L W SF NP DT+LP M G L S KS T
Sbjct: 121 NKCHAKLLDTGNLVIVDDVSENLLWQSFENPGDTMLPYSSLMYNLATGEKRVLSSWKSHT 180
Query: 182 NFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDSTNSS-----NSGYRVMF-- 234
+ S G F RL A + T Y SG + T + + Y F
Sbjct: 181 DPSPGDFVVRLTPQVP-----AQIVTMRGSSVYKRSGPWAKTGFTGVPLMDESYTSPFSL 235
Query: 235 -----NESGYMYILRRNSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYFYPKNGNGNWS 289
N +G L+R+S+ R + +G + Y NG G W
Sbjct: 236 SQDVGNGTGLFSYLQRSSE---------------LTRVIITSEGYLKTFRY--NGTG-WV 277
Query: 290 AVWSQPENICDNISGEFGSGACGFNSICTLDGDRRPMCECPKGY-SLLDENEKYGS---- 344
+ P N+CD GACG +C + C+C KG+ E K G+
Sbjct: 278 LDFITPANLCDLY------GACGPFGLCVTSNPTK--CKCMKGFVPKYKEEWKRGNMTSG 329
Query: 345 CKADFELSC--NGGGQGYNKELFDFHELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCA 402
C ELSC N + K + F+ L + P YE+ S D QC CLS+C C+
Sbjct: 330 CMRRTELSCQANLSTKTQGKGVDVFYRLANVK-PPDLYEYASFVDADQCHQGCLSNCSCS 388
Query: 403 V--AIFGIESCWLVKLPLNNGRADSSVNRKAFIKYKKDDDPDPPSVPRPPDPEDKKKRKM 460
I GI C L N+ D+ I+Y + R E R+
Sbjct: 389 AFAYITGI-GCLL----WNHELIDT-------IRYSVGGEFLSI---RLASSELAGSRRT 433
Query: 461 MNATGSVLLGSSVFVNFAMVCAFVLGFFFIYKKK------W-IRNNPGDA---TIE---- 506
GS+ L S+FV + AF ++ Y+ K W NN D+ +E
Sbjct: 434 KIIVGSISL--SIFV----ILAFGSYKYWRYRAKQNVGPTWAFFNNSQDSWKNGLEPQEI 487
Query: 507 TNLRCFSYKELEEATDNF--EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE 564
+ L F + AT+NF ++G+G FG VYKG + + +AVK+L G
Sbjct: 488 SGLTFFEMNTIRAATNNFNVSNKLGQGGFGPVYKGTLSDKKD----IAVKRLSSSSGQGT 543
Query: 565 KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---NLKPSWNL 621
+EF NE+ +I + H+NLVRLLG C +G+ +LL+YEFL N +L +FLF L+ W
Sbjct: 544 EEFMNEIKLISKLQHRNLVRLLGCCIDGEEKLLIYEFLVNKSLDTFLFDLTLKLQIDWPK 603
Query: 622 RTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681
R NI ++RGLLYLH D ++IH D+K NILLDD N +ISDFGLA++ Q +
Sbjct: 604 RFNIIQGVSRGLLYLHRDSCMRVIHRDLKVSNILLDDKMNPKISDFGLARMFQGTQHQDN 663
Query: 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 741
+ GT GY++PE+ + K D+Y+FGVLLLEIIS +K GEE L A+
Sbjct: 664 TRKVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEIISGKKISSFCCGEEGKTLLGHAW 723
Query: 742 DCY-RNGKLDDLVEGDTEAMNDIKC-TEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
+C+ G +D L E + + + ++ + V + + CIQ+ RP + +V M+ +
Sbjct: 724 ECWLETGGVDLLDEDISSSCSPVEVEVARCVQIGLLCIQQQAVDRPNIAQVVTMMTSATD 783
Query: 800 VDVPPNP 806
+ P P
Sbjct: 784 LPRPKQP 790
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 814 | ||||||
| 109676362 | 2037 | CCHC-type integrase [Populus trichocarpa | 0.905 | 0.361 | 0.633 | 0.0 | |
| 224099309 | 801 | predicted protein [Populus trichocarpa] | 0.957 | 0.972 | 0.571 | 0.0 | |
| 224103119 | 799 | predicted protein [Populus trichocarpa] | 0.970 | 0.988 | 0.568 | 0.0 | |
| 255544746 | 800 | ATP binding protein, putative [Ricinus c | 0.936 | 0.952 | 0.578 | 0.0 | |
| 224143661 | 691 | predicted protein [Populus trichocarpa] | 0.843 | 0.994 | 0.582 | 0.0 | |
| 356575025 | 800 | PREDICTED: G-type lectin S-receptor-like | 0.966 | 0.983 | 0.548 | 0.0 | |
| 224057535 | 775 | predicted protein [Populus trichocarpa] | 0.933 | 0.980 | 0.559 | 0.0 | |
| 224053032 | 752 | predicted protein [Populus trichocarpa] | 0.914 | 0.989 | 0.564 | 0.0 | |
| 356503095 | 807 | PREDICTED: G-type lectin S-receptor-like | 0.968 | 0.976 | 0.526 | 0.0 | |
| 356503089 | 807 | PREDICTED: G-type lectin S-receptor-like | 0.968 | 0.976 | 0.526 | 0.0 |
| >gi|109676362|gb|ABG37663.1| CCHC-type integrase [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 965 bits (2494), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/758 (63%), Positives = 585/758 (77%), Gaps = 21/758 (2%)
Query: 21 LAIAQNNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPE 80
+A+AQ NG VP GA++TA +S W S SG+FAFGF QL+ ++ FLLSI+Y KIPE
Sbjct: 51 MAVAQTNGRVPTGASITATDDSPSWPSASGEFAFGFRQLENKD----YFLLSIWYEKIPE 106
Query: 81 KTVVWYTDNKD--QNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMND 137
KTVVWY +D +PAVPRGS+++LT DRGL+L DPQG Q+WSS I G V+ GVMND
Sbjct: 107 KTVVWYAIGEDPTDDPAVPRGSKLELTDDRGLLLADPQGNQIWSSGIPPGAAVSSGVMND 166
Query: 138 TGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDGD 197
TGNFVL + +S +LW+SF NP+DTLLP Q+ME + SR+++TNFS GRFQ RLL++G+
Sbjct: 167 TGNFVLQNRNSFRLWESFNNPTDTLLPTQIMEVGGVVSSRRTETNFSLGRFQLRLLDNGN 226
Query: 198 LVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDLTTGRV 257
LVLN NLPT F YD YY+S T D++NSSNSGYR++FNESGYMYILRRN DLT
Sbjct: 227 LVLNYMNLPTKFVYDDYYSSETSDASNSSNSGYRLIFNESGYMYILRRNGLIEDLTK-TA 285
Query: 258 VPAADFYHRATLNFDGVFAQYFYPK--NGNGNWSAVWSQPENICDNISGEFGSGACGFNS 315
+P DFYHRATLNFDGVF QYFYPK +GN +WS+VWS+P++IC N+ + GSGACG+NS
Sbjct: 286 LPTIDFYHRATLNFDGVFTQYFYPKASSGNRSWSSVWSKPDDICVNMGADLGSGACGYNS 345
Query: 316 ICTLDGDRRPMCECPKGYSLLDENEKYGSCKADFELSCNGGGQGYNKELFDFHELKDTDW 375
IC L D+RP C+CP+G+SLLD+N+KYGSC DFELSC G ++ +DF EL + DW
Sbjct: 346 ICNLKADKRPECKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVELINVDW 405
Query: 376 PSSDYEHFSPYDEVQCKNTCLSDCFCAVAIFGIESCWLVKLPLNNGRADSSVNRKAFIKY 435
P+SDYE + P +E +C+ +CL+DC C+VAIF + CW KLPL+NGR D +N KAF+K+
Sbjct: 406 PTSDYERYKPINEDECRKSCLNDCLCSVAIFR-DGCWKKKLPLSNGRFDIGMNGKAFLKF 464
Query: 436 KKDDDPDPPSVPRPPD--PEDKKKRKMMNATGSVLLGSSVFVNFAMVCAFVLGFFFIYKK 493
K P + RPP P +KKK + TGSV+LG+SVFVNF +V AF L FIY+K
Sbjct: 465 PKGYVP----LDRPPPQLPGEKKKPDIKFITGSVVLGTSVFVNFVLVGAFCLTSSFIYRK 520
Query: 494 KWIRNNPGDATIETNLRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAV 553
K + G + +ETNLR F+YKEL EAT++F++EVGRG FG+VYKG IQ ST VAV
Sbjct: 521 KTEKVKEGGSGLETNLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQAG--STRVVAV 578
Query: 554 KKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG 613
KKLD+V QDGEKEFK EV VIGQTHHKNLVRLLGFCDEGQNRLLVYEFL+NGTLA+FLFG
Sbjct: 579 KKLDKVVQDGEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLFG 638
Query: 614 NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673
KP+W RT IAF IARGLLYLHE+C QIIHCDIKPQNILLD+YYNARISDFGLAKLL
Sbjct: 639 CSKPNWKQRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKLL 698
Query: 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE-E 732
++QSK +TAIRGTKGYVAPEWFRN IT KVDVYSFGV+LLEII CR++ D+E+GE E
Sbjct: 699 VMDQSKT-QTAIRGTKGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVE 757
Query: 733 YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLV 770
+LTDWA+DCY +G LD L+ DTEA NDI E+L+
Sbjct: 758 NPVLTDWAYDCYMDGSLDVLIGDDTEAKNDISTLERLL 795
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099309|ref|XP_002334494.1| predicted protein [Populus trichocarpa] gi|222872794|gb|EEF09925.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 916 bits (2368), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/801 (57%), Positives = 580/801 (72%), Gaps = 22/801 (2%)
Query: 1 MASAKLYFIFLLYQLLYYLHLAIAQNNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLD 60
MA L+ F L L+ A++Q G + VGA+L+ N+S W+SPSGDFAFGFH L
Sbjct: 1 MAFPILHLSFSL--LIMLPPFAVSQTGGNITVGASLSTSENTS-WLSPSGDFAFGFHPL- 56
Query: 61 EENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQV 120
+ LFLL+I+Y+KIPEKT+VWY N D+ PA P GS+ LTA+RG+ L DPQG+++
Sbjct: 57 --YGNKYLFLLAIWYDKIPEKTIVWYA-NGDK-PA-PTGSKAVLTANRGISLTDPQGREL 111
Query: 121 WSSKIDIGTVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSD 180
W S+ IG VA G M D GNFVL S KLW+SF NP+DTLLP Q+++ L SR+S+
Sbjct: 112 WRSETIIGVVAYGAMTDKGNFVLQDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSE 171
Query: 181 TNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYM 240
NFS GRFQ +L +DG+L L NLP+D+ + YY SGT +SS+ GY+V+FNESGY+
Sbjct: 172 NNFSMGRFQLKLTDDGNLELATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYL 231
Query: 241 YILRRNSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYFYPKNGNGN--WSAVWSQPENI 298
YILR N Q F LT DFY RATLNFDG+F QY++PK GN W+ +WSQP+NI
Sbjct: 232 YILRENDQIFSLTQRVTASTGDFYRRATLNFDGLFTQYYHPKASTGNERWTPIWSQPDNI 291
Query: 299 CDNISGEFGSGACGFNSICTLDGDRRPMCECPKGYSLLDENEKYGSCKADFELSCNGGGQ 358
C GSG CGFNS+C L+ DRRP+CECP GYSLLD +++YGSC+ ++ SC
Sbjct: 292 CQASFVSSGSGTCGFNSVCRLNSDRRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEV 351
Query: 359 GYNKELFDFHELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCAVAIF-GIESCWLVKLP 417
++L+DF EL +TDWP+SDY P+ E +C+ +CL+DC CAVAIF + CW KLP
Sbjct: 352 APVEDLYDFEELTNTDWPTSDYALLKPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLP 411
Query: 418 LNNGRADSSVNRKAFIKYKKDDDPDPPSVPRPPD-PEDKKKRKMMNATGSVLLGSSVFVN 476
L+NGR ++++ KA +K ++ + PR P P +KK R + GSV LG SVFVN
Sbjct: 412 LSNGRVQTNLDGKALLKVRRSN-----VNPRSPYFPNNKKDRDGLILVGSVFLGCSVFVN 466
Query: 477 FAMVCAFVLGFFFIYKKKWIRNNPGDATIETNLRCFSYKELEEATDNFEEEVGRGSFGIV 536
F +VCA + FFFIY+++ R D +ETNLRCF+Y+EL EAT+ F+EE+GRG+FG+V
Sbjct: 467 FLLVCAIFMCFFFIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGVV 526
Query: 537 YKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596
YKGV+ S+ VAVKKL+ V +D +EFK EV VIGQTHHKNLVRLLGFC+EG RL
Sbjct: 527 YKGVVHI--GSSIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRL 584
Query: 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 656
LVYEF++NG+L+SF+F + KP W +R IAF +ARGLLYLHE+CS QIIHCDIKPQNILL
Sbjct: 585 LVYEFMSNGSLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHEECSNQIIHCDIKPQNILL 644
Query: 657 DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLL 716
D+YYNARISDFGLAKLL L+QS+ TAIRGTKGYVAPEWFRN +T KVDVYS+GVLLL
Sbjct: 645 DEYYNARISDFGLAKLLLLDQSQT-HTAIRGTKGYVAPEWFRNLPVTVKVDVYSYGVLLL 703
Query: 717 EIISCRKSFDIEMG-EEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIW 775
EII CR++ D + EE AILTDWA+DCYR G LD LV DT A++DI+ E+ +M++ W
Sbjct: 704 EIICCRRNVDSKATIEEQAILTDWAYDCYREGTLDALVGSDTGALDDIEKLERFLMIAFW 763
Query: 776 CIQEDPSLRPTMRKVSQMLEG 796
CIQEDPSLRPTMRKV+QMLEG
Sbjct: 764 CIQEDPSLRPTMRKVTQMLEG 784
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103119|ref|XP_002334088.1| predicted protein [Populus trichocarpa] gi|222839594|gb|EEE77931.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 909 bits (2350), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/814 (56%), Positives = 588/814 (72%), Gaps = 24/814 (2%)
Query: 1 MASAKLYFIFLLYQLLYYLHLAIAQNNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLD 60
MA L+ F L L+ A++Q G + VGA+L+ N+S W+SPSGDFAFGF+QL
Sbjct: 1 MAFPILHLSFSL--LIMLPPFAVSQTGGNITVGASLSTSDNTS-WLSPSGDFAFGFYQL- 56
Query: 61 EENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQV 120
+ LFLL+I+Y+KIP+KT+VWY N D+ PA P GS+ LTA+RG+ L DPQG+++
Sbjct: 57 --YGNKDLFLLAIWYDKIPDKTIVWYA-NGDK-PA-PTGSKAVLTANRGISLTDPQGREL 111
Query: 121 WSSKIDIGTVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSD 180
W S+ IG VA G M DTGNFVL S KLW+SF NP+DTLLP Q+++ L SR+S+
Sbjct: 112 WRSETIIGDVAYGAMTDTGNFVLRDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSE 171
Query: 181 TNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYM 240
TNFS GRFQ +L +DG+LVL NLP+D+ + YY SGT +SS+ GY+V+FNESGY+
Sbjct: 172 TNFSMGRFQLKLRDDGNLVLATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYL 231
Query: 241 YILRRNSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYFYPKNGNGN--WSAVWSQPENI 298
YILR+N Q F LT DFYHRATLNFDGVF QY++PK GN W+ +WSQP+NI
Sbjct: 232 YILRKNDQIFSLTQRVTASTGDFYHRATLNFDGVFTQYYHPKASTGNERWTPIWSQPDNI 291
Query: 299 CDNISGEFGSGACGFNSICTLDGDRRPMCECPKGYSLLDENEKYGSCKADFELSCNGGGQ 358
C S GSG CGFNS+C L+ D RP+CECP GYSLLD +++YGSC+ ++ SC
Sbjct: 292 CQASSVSAGSGTCGFNSVCRLNSDGRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEV 351
Query: 359 GYNKELFDFHELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCAVAIF-GIESCWLVKLP 417
++L+DF EL +TDWP+SDY P+ E +C+ +CL+DC CAVAIF + CW KLP
Sbjct: 352 APVEDLYDFEELTNTDWPTSDYALLQPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLP 411
Query: 418 LNNGRADSSVNRKAFIKYKKDDDPDPPSVPRPPD-PEDKKKRKMMNATGSVLLGSSVFVN 476
L+NGR + V+ KA +K ++ + PR P P +KK R + GSV LG SVFVN
Sbjct: 412 LSNGRVQTIVDAKALLKVRRSN-----VNPRSPYFPNNKKDRDGLILVGSVFLGCSVFVN 466
Query: 477 FAMVCAFVLGFFFIYKKKWIRNNPGDATIETNLRCFSYKELEEATDNFEEEVGRGSFGIV 536
F +VCA +GFFFIY+++ R D +ETNLRCF+Y+EL EAT+ F+EE+GRG+FG+V
Sbjct: 467 FLLVCAICMGFFFIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGVV 526
Query: 537 YKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596
Y+GV+ S+ VAVKKL+ V +D +EFK EV VIGQTHHKNLVRLLGFC+EG RL
Sbjct: 527 YRGVVHI--GSSIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRL 584
Query: 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 656
LVYEF++NG+L+SF+F + KP W +R IAF +ARGLLYLHED +QIIHCDIKPQNILL
Sbjct: 585 LVYEFMSNGSLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHED--SQIIHCDIKPQNILL 642
Query: 657 DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLL 716
D+ NARISDFGLAKLL +Q+K TAIRGTKGYVAPEWF+N +T KVD YSFG+LLL
Sbjct: 643 DESLNARISDFGLAKLLKTDQTKT-TTAIRGTKGYVAPEWFKNLPVTTKVDTYSFGILLL 701
Query: 717 EIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIW 775
E++ CRK+F+I M E +L DWA DC + GKL+ LVE D EAM D+K E+ VMV+IW
Sbjct: 702 ELVCCRKNFEINAMQEHQIVLADWACDCLKEGKLNLLVEEDEEAMEDMKRVERFVMVAIW 761
Query: 776 CIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPF 809
CIQEDPSLRP M+KV QMLEG V+V VPP+PS F
Sbjct: 762 CIQEDPSLRPGMKKVVQMLEGGVQVSVPPDPSSF 795
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544746|ref|XP_002513434.1| ATP binding protein, putative [Ricinus communis] gi|223547342|gb|EEF48837.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 886 bits (2290), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/782 (57%), Positives = 562/782 (71%), Gaps = 20/782 (2%)
Query: 24 AQNNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTV 83
AQN T+ VG L A + W+SPSGDFAFGF QL+ +N L+LL+I YNKI +KT+
Sbjct: 23 AQNGDTIIVGDFLAAADPAESWLSPSGDFAFGFRQLENKN----LYLLAICYNKISDKTI 78
Query: 84 VWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGTVAIGVMNDTGNFVL 143
VWY + D PA P GS+V+LTADRGLVL PQGK++W S I+IG A G+MNDTGNF +
Sbjct: 79 VWYANGDD--PA-PTGSKVELTADRGLVLTSPQGKEIWKSGINIGDAARGMMNDTGNFRI 135
Query: 144 ASSSSSKLWDSFTNPSDTLLPGQMMETE-QGLFSRKSDTNFSRGRFQFRLLEDGDLVLNV 202
++ KLW +F +P DTLLPGQ +E + L SR +TNFSRGRFQFRL+ DG+ VLN
Sbjct: 136 VNTGGEKLWQTFDDPKDTLLPGQALERGGKILSSRLRETNFSRGRFQFRLIPDGNGVLNA 195
Query: 203 ANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDLTTGRVVPAAD 262
NL T AYDAYY + T D+ N SN+G R++FNESGY+Y LR +++R +T RVVP +
Sbjct: 196 NNLRTGDAYDAYYWTNTVDA-NLSNAGLRIVFNESGYLYTLRASNKRELITPERVVPTTE 254
Query: 263 FYHRATLNFDGVFAQYFYPKNG--NGNWSAVWSQPENICDNISGEFGSGACGFNSICTLD 320
+YHR TLNFDGV QY +PKN NGNWS ++S PENIC I+ + G+G CGFNS+C L+
Sbjct: 255 YYHRVTLNFDGVLTQYSHPKNSTDNGNWSIIFSAPENICFLIT-DIGTGPCGFNSVCQLN 313
Query: 321 GDRRPMCECPKGYSLLDENEKYGSCKADFELSCNGGGQGYNKELFDFHELKDTDWPSSDY 380
D+R +C CP +S +D + Y CK DF + E +DF EL +TDWP+SDY
Sbjct: 314 ADQRAICRCPPRFSSVDPGDDYAGCKPDFSTQFCEDAPSTSPEDYDFLELTNTDWPTSDY 373
Query: 381 EHFSPYDEVQCKNTCLSDCFCAVAIFGIESCWLVKLPLNNGRADSSVNRKAFIKYKKDDD 440
E + Y+ +C+ C+ DCFC V +F SCW KLPL+NGR VN +AFIK +KDD
Sbjct: 374 ERYDSYNIEECQKACIQDCFCNVVVFR-GSCWKKKLPLSNGRQSEKVNGRAFIKVRKDDY 432
Query: 441 PDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFAMVCAFVLGFFFIYKKKWIRNNP 500
PRP P K+ + + SVLLGSSVF+NF ++ F F Y KK
Sbjct: 433 MGRGLPPRP-FPNAKEDQDSLVLVISVLLGSSVFINFILIGLVTFCFLFFYHKKSTGIPQ 491
Query: 501 GDATIETNLRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF 560
G+ ++NLRCFSYKEL EAT F+EE+GRGSFGIVYKG+I+ +T VAVKKLDRV
Sbjct: 492 GE---KSNLRCFSYKELVEATKGFKEELGRGSFGIVYKGLIEMG--TTVPVAVKKLDRVV 546
Query: 561 QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN 620
+ GEKE+K EV IGQTHHKNLV+LLGFCDEGQ +LLVYE L+NGTLA+FLFG+ K SW
Sbjct: 547 EYGEKEYKAEVKAIGQTHHKNLVQLLGFCDEGQQKLLVYELLSNGTLANFLFGDTKLSWK 606
Query: 621 LRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680
RT IAF IARGL+YLHE+C+ QIIHCDIKPQNIL+D+YY+A+ISDFGLAKLL L+QS+
Sbjct: 607 QRTQIAFGIARGLVYLHEECNTQIIHCDIKPQNILVDEYYDAKISDFGLAKLLLLDQSQT 666
Query: 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 740
T IRGTKGYVAPEWFRN IT KVD YSFGVLLLEII R+S D E+ E AILTDWA
Sbjct: 667 F-TTIRGTKGYVAPEWFRNVPITVKVDAYSFGVLLLEIICSRRSVDTEISGERAILTDWA 725
Query: 741 FDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800
+DCY G++DDLVE D EA++D+K E+ +MV+IWCIQEDP+LRPTM+ V MLEG+++V
Sbjct: 726 YDCYMEGRIDDLVENDEEALSDLKKVERFLMVAIWCIQEDPTLRPTMKTVILMLEGIIQV 785
Query: 801 DV 802
V
Sbjct: 786 AV 787
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143661|ref|XP_002336066.1| predicted protein [Populus trichocarpa] gi|222869874|gb|EEF07005.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 883 bits (2282), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/785 (58%), Positives = 553/785 (70%), Gaps = 98/785 (12%)
Query: 27 NGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWY 86
NG++PVGA +TA ++ W+S SG+FAFGF L+ +++ FLLSI+Y KIPEKT+VWY
Sbjct: 1 NGSMPVGAFITATDDAPSWLSSSGEFAFGFQPLEYKDH----FLLSIWYAKIPEKTIVWY 56
Query: 87 TDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGTVAIGVMNDTGNFVLASS 146
+ NPA PR S+V+L D GLVL DPQG +WSS +GTV+ GVMNDTGNFVL +S
Sbjct: 57 ANG--DNPA-PRESKVELRGDSGLVLTDPQGNLIWSSGSLLGTVSSGVMNDTGNFVLQNS 113
Query: 147 SSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDGDLVLNVANLP 206
+S +LW+SF+NP+DTLLP Q+ME + SR+++TNFS GRFQ RLL++G+LVLN NLP
Sbjct: 114 NSFRLWESFSNPTDTLLPTQIMEVGGVVSSRRTETNFSLGRFQLRLLDNGNLVLNYMNLP 173
Query: 207 TDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDLTTGRVVPAADFYHR 266
T F YD YY+S T D++NSSNSGYR++FNESGYMYILRRN DLT +P DFYHR
Sbjct: 174 TKFVYDDYYSSETSDASNSSNSGYRLIFNESGYMYILRRNGLIEDLTK-TALPTIDFYHR 232
Query: 267 ATLNFDGVFAQYFYPKNGNGNWSAVWSQPENICDNISGEFGSGACGFNSICTLDGDRRPM 326
ATLNFD + GSGACG+NSIC L D+RP
Sbjct: 233 ATLNFDA-------------------------------DLGSGACGYNSICNLKADKRPE 261
Query: 327 CECPKGYSLLDENEKYGSCKADFELSCNGGGQGYNKELFDFHELKDTDWPSSDYEHFSPY 386
C+CP+G+SLLD+N+KYGSC DFELSC G ++ +DF EL + DWP+SDYE + P
Sbjct: 262 CKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVELINVDWPTSDYERYKPI 321
Query: 387 DEVQCKNTCLSDCFCAVAIFGIESCWLVKLPLNNGRADSSVNRKAFIKYKKDDDPDPPSV 446
+E +C+ +CL+DC C+VAIF + CW KLPL+NGR D +N KAF+K+
Sbjct: 322 NEDECRKSCLNDCLCSVAIFR-DGCWKKKLPLSNGRFDIGMNGKAFLKF----------- 369
Query: 447 PRPPDPEDKKKRKMMNATGSVLLGSSVFVNFAMVCAFVLGFFFIYKKKWIRNNPGDATIE 506
P+ K K+ G + +E
Sbjct: 370 -----PKGYKTEKV--------------------------------------KEGGSGLE 386
Query: 507 TNLRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE 566
TNLR F+YKEL EAT++F++EVGRG FG+VYKG IQ ST VAVKKLD+V QDGEKE
Sbjct: 387 TNLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQAG--STRVVAVKKLDKVVQDGEKE 444
Query: 567 FKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA 626
FK EV VIGQTHHKNLVRLLGFCDEGQNRLLVYEFL+NGTLA+FLFG KP+W RT IA
Sbjct: 445 FKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLFGCSKPNWKQRTQIA 504
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR 686
F IARGLLYLHE+C QIIHCDIKPQNILLD+YYNARISDFGLAKLL ++QSK +TAIR
Sbjct: 505 FGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQSKT-QTAIR 563
Query: 687 GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDWAFDCYR 745
GTKGYVAPEWFRN IT KVDVYSFGV+LLEII CR++ D+E+GE E +LTDWA+DCY
Sbjct: 564 GTKGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVENPVLTDWAYDCYM 623
Query: 746 NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPN 805
+G LD L+ DTEA NDI E+L+ V IWCIQEDPSLRPTMRKV+QMLEGVVEV PN
Sbjct: 624 DGSLDVLIGDDTEAKNDISTLERLLKVGIWCIQEDPSLRPTMRKVTQMLEGVVEVPAAPN 683
Query: 806 PSPFS 810
P P+S
Sbjct: 684 PFPYS 688
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575025|ref|XP_003555643.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 880 bits (2273), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/813 (54%), Positives = 575/813 (70%), Gaps = 26/813 (3%)
Query: 3 SAKLYFIFLLYQLLYYLHLAIAQNNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEE 62
+AK + + LL L L V +G TL AG W+SPS DFAFGFHQLD
Sbjct: 2 AAKTVLVCVTVILLPLLQLPYVSAT-NVSIGETLVAGNGGKRWLSPSEDFAFGFHQLD-- 58
Query: 63 NNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWS 122
N L+LL+I Y IP + +WY + NPA P+GS+++L GLVL PQG ++W+
Sbjct: 59 ---NDLYLLAISYQNIPRDSFIWYANG--DNPA-PKGSKLELNQYTGLVLKSPQGVELWT 112
Query: 123 SKIDIGTVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSDTN 182
S++ GT++ G+MNDTGNF L +S LWDSF+NP+DTL+P Q+ME + L SR+ + N
Sbjct: 113 SQLISGTISYGLMNDTGNFQLLDENSQVLWDSFSNPTDTLVPTQIMEVKGTLSSRQKEAN 172
Query: 183 FSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYMYI 242
FSRGRFQFRLL DG+ VLN NLPT++ YDA+Y S TYDSTN++NSG++V+F+ SG +YI
Sbjct: 173 FSRGRFQFRLLPDGNAVLNPINLPTNYTYDAHYISATYDSTNTTNSGFQVIFDNSG-LYI 231
Query: 243 LRRNSQRFDLTTGRVVPAAD-FYHRATLNFDGVFAQYFYPKN--GNGNWSAVWSQPENIC 299
L+R+ ++ +T + + D +Y+RAT+NFDG F YPKN N +W+ + + P+NIC
Sbjct: 232 LKRSGEKVYITNPKDALSTDSYYYRATINFDGTFTISNYPKNPASNPSWTVMKTLPDNIC 291
Query: 300 DNISGEFG-SGACGFNSICTLDGDRRPMCECPKGYSLLDENEKYGSCKADFELSCNGGGQ 358
N+ G G SG CGFNSICTL D+RP C CP+GYS LD ++YGSCK + EL C GQ
Sbjct: 292 MNLLGNTGGSGVCGFNSICTLKADQRPKCSCPEGYSPLDSRDEYGSCKPNLELGCGSSGQ 351
Query: 359 GYNKELFDFHELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCAVAIFGIESCWLVKLPL 418
+L+ E+ +TDWP SDYE + PY+ CK +CL DC CAV+IF +SC+ KLPL
Sbjct: 352 SLQGDLYFMKEMANTDWPVSDYELYKPYNSEDCKTSCLQDCLCAVSIFRDDSCYKKKLPL 411
Query: 419 NNGRADSSVNRKAFIKYKKDDDPDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFA 478
+NGR D +V AFIK K+ P P + + KK + + SVLLG SVF F
Sbjct: 412 SNGRRDRAVGASAFIKLMKNGVSLSPPNPFIEEKKYKKDQDTLITVISVLLGGSVF--FN 469
Query: 479 MVCAFVLGFFFIYKKKWIRNNPGDATIETNLRCFSYKELEEATDNFEEEVGRGSFGIVYK 538
+V A +GF+F Y KK N E+NL F++ EL +ATDNF+EE+GRGS GIVYK
Sbjct: 470 LVSAVWVGFYFYYNKKSSTNK---TATESNLCSFTFAELVQATDNFKEELGRGSCGIVYK 526
Query: 539 GVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598
G T+ +AVKKLD+V +D +KEFK EV VIGQTHHK+LVRLLG+CDE Q+R+LV
Sbjct: 527 GT-----TNLATIAVKKLDKVLKDCDKEFKTEVNVIGQTHHKSLVRLLGYCDEEQHRILV 581
Query: 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 658
YEFL+NGTLA+FLFG+ KP+WN R IAF IARGL+YLHE+C QIIHCDIKPQNILLD+
Sbjct: 582 YEFLSNGTLANFLFGDFKPNWNQRVQIAFGIARGLVYLHEECCTQIIHCDIKPQNILLDE 641
Query: 659 YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEI 718
YNARISDFGL+KLL +N+S +T IRGTKGYVAP+WFR++ IT KVDVYSFGVLLLEI
Sbjct: 642 QYNARISDFGLSKLLKINESHT-ETGIRGTKGYVAPDWFRSAPITTKVDVYSFGVLLLEI 700
Query: 719 ISCRKSFDIEMG-EEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCI 777
I CR++ D E+G EE AILTDWA+DCYR G++D L+E D EA++D E+ VMV+IWC+
Sbjct: 701 ICCRRNVDGEVGNEEKAILTDWAYDCYRAGRIDILLENDDEAIDDTNRLERFVMVAIWCL 760
Query: 778 QEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFS 810
QEDPSLRP M+KV MLEG+ V +PP+PSP++
Sbjct: 761 QEDPSLRPPMKKVMLMLEGIAPVTIPPSPSPYT 793
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224057535|ref|XP_002299255.1| predicted protein [Populus trichocarpa] gi|222846513|gb|EEE84060.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2271), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/809 (55%), Positives = 568/809 (70%), Gaps = 49/809 (6%)
Query: 6 LYFIFLLYQLLYYLHLAIAQNNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNS 65
LYF FLL+ +AQ NG VG +LTAG ++ W+SP+ DFAFGF QLD+++
Sbjct: 9 LYFFFLLFP-----SSLVAQRNGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDKKD-- 61
Query: 66 NGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKI 125
L+LL+I+YNKIP+KT+VWY N D+ PA P+ S VKLTA+ G+VLN+PQG ++W S
Sbjct: 62 --LYLLAIWYNKIPDKTIVWYA-NGDR-PA-PKKSTVKLTAELGVVLNNPQGGEIWKSGP 116
Query: 126 DIGTVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSDTNFSR 185
G A G MNDTGNF++A+++ KLW SF +DTLLP Q+ME L SR S+TNFS+
Sbjct: 117 GNGEAAYGFMNDTGNFLVANANGEKLWQSFELLTDTLLPTQIMEKGGILSSRLSETNFSQ 176
Query: 186 GRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYMYILRR 245
GRFQFRL+ DG+ VLN NLPT F Y+AY+ S T DS NSSN+GY+V+FNESGY+Y+LR
Sbjct: 177 GRFQFRLIPDGNAVLNTINLPTGFPYEAYFWSKTVDS-NSSNAGYQVVFNESGYLYVLRA 235
Query: 246 NSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYFYPKN--GNGNWSAVWSQPENICDNIS 303
N+ R LT GRVVPA + YHRATL+FDGVF Y +PKN GN NWS V + PENIC +
Sbjct: 236 NNTREALTLGRVVPATENYHRATLHFDGVFVLYSHPKNSPGNENWSVVRTMPENICTVVR 295
Query: 304 GEFGSGACGFNSICTLDGDRRPMCECPKGYSLLDENEKYGSCKADFELSCNGGGQGYNKE 363
G GSG CG+N +CT+ D+R +C CP+ +SLLD ++ YG CK DF E
Sbjct: 296 GLKGSGPCGYNGVCTISTDKRAICRCPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPE 355
Query: 364 LFDFHELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCAVAIFGIESCWLVKLPLNNGRA 423
++ L + DWP SDYE ++PY+ CK CL D FC V +FG +CW +LPL+NGR
Sbjct: 356 DYELVPLTNIDWPESDYEMYTPYNIEDCKKACLQDFFCNVIVFGEGTCWKKRLPLSNGRQ 415
Query: 424 DSSVNRKAFIKYKKDDD--PDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFAMVC 481
SVN +F+K +K + P PP +P K+ ++ SVLLG SVF NF +V
Sbjct: 416 GESVNGASFMKVRKGNYTLPGPPPIP---------KKNLLVV--SVLLGGSVFFNFVLVG 464
Query: 482 AFVLGFFFIYKKKWIRNNPGDATIETNLRCFSYKELEEATDNFEEEVGRGSFGIVYKGVI 541
FFFIY K+ R + +++NLRCFSYKEL EAT+ F+EE+GRG+FGIVYKG+
Sbjct: 465 VVSFAFFFIYHNKFTRTPQVERAVQSNLRCFSYKELMEATNGFKEELGRGAFGIVYKGLT 524
Query: 542 QTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601
Q S VA+KK+DR ++ +KEFK EV VIG FCDEGQ+R+LVYEF
Sbjct: 525 QIG--SGVPVAIKKVDRFVKESDKEFKTEVDVIG------------FCDEGQHRMLVYEF 570
Query: 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 661
L+NG LASFLFG++K SWN RT IAF IARGLLYLH++CS QIIHCDIKPQNILLD++Y+
Sbjct: 571 LSNGALASFLFGDVKLSWNQRTQIAFGIARGLLYLHDECSTQIIHCDIKPQNILLDEHYD 630
Query: 662 ARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISC 721
ARI+DFGLAKL Q K GTKGYVAPEWFRN IT KVDVY+FGVLLLEII C
Sbjct: 631 ARIADFGLAKLFRNPQHK-------GTKGYVAPEWFRNMLITVKVDVYNFGVLLLEIICC 683
Query: 722 RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDP 781
R+S D E+GEE AILTDWA+DCY+ G + LVE D EA+ND+K E+ VMV+IWCIQEDP
Sbjct: 684 RRSVDTEVGEERAILTDWAYDCYQEGMMHALVESDEEALNDMKKLERFVMVAIWCIQEDP 743
Query: 782 SLRPTMRKVSQMLEGVVEVDVPPNPSPFS 810
+LRPTM+ V MLEG+++V VPP PSPFS
Sbjct: 744 NLRPTMKMVMLMLEGIIQVPVPPCPSPFS 772
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053032|ref|XP_002297673.1| predicted protein [Populus trichocarpa] gi|222844931|gb|EEE82478.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 869 bits (2245), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/788 (56%), Positives = 558/788 (70%), Gaps = 44/788 (5%)
Query: 27 NGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWY 86
NG VG +LTAG ++ W+SP+ DFAFGF QLD+++ L+LL+I+YNKIP+KT+VWY
Sbjct: 2 NGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDKKD----LYLLAIWYNKIPDKTIVWY 57
Query: 87 TDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGTVAIGVMNDTGNFVLASS 146
N D+ PA P+ S VKLTA+ G+VLN+PQG ++W S G A G MNDTGNF++A++
Sbjct: 58 A-NGDR-PA-PKKSTVKLTAELGVVLNNPQGGEIWKSGPGNGEAAYGFMNDTGNFLVANA 114
Query: 147 SSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDGDLVLNVANLP 206
+ KLW SF +DTLLP Q+ME L SR S+TNFS+GRFQFRL+ DG+ VLN NLP
Sbjct: 115 NGEKLWQSFELLTDTLLPTQIMEKGGILSSRLSETNFSQGRFQFRLIPDGNAVLNTINLP 174
Query: 207 TDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDLTTGRVVPAADFYHR 266
T F Y+AY+ S T DS NSSN+GY+V+FNESGY+Y+LR N+ R LT GRVVPA + YHR
Sbjct: 175 TGFPYEAYFWSKTVDS-NSSNAGYQVVFNESGYLYVLRANNTREALTLGRVVPATENYHR 233
Query: 267 ATLNFDGVFAQYFYPKN--GNGNWSAVWSQPENICDNISGEFGSGACGFNSICTLDGDRR 324
ATL+FDGVF Y +PKN GN NWS V + PENIC + G GSG CG+N +CT+ D+R
Sbjct: 234 ATLHFDGVFVLYSHPKNSPGNENWSVVRTMPENICTVVRGLKGSGPCGYNGVCTISTDKR 293
Query: 325 PMCECPKGYSLLDENEKYGSCKADFELSCNGGGQGYNKELFDFHELKDTDWPSSDYEHFS 384
+C CP+ +SLLD ++ YG CK DF E ++ L + DWP SDYE ++
Sbjct: 294 AICRCPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPEDYELVPLTNIDWPESDYEMYT 353
Query: 385 PYDEVQCKNTCLSDCFCAVAIFGIESCWLVKLPLNNGRADSSVNRKAFIKYKKDDD--PD 442
PY+ CK CL D FC V +FG +CW +LPL+NGR SVN +F+K +K + P
Sbjct: 354 PYNIEDCKKACLQDFFCNVIVFGEGTCWKKRLPLSNGRQGESVNGASFMKVRKGNYTLPG 413
Query: 443 PPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFAMVCAFVLGFFFIYKKKWIRNNPGD 502
PP +P K+ ++ SVLLG SVF NF +V FFFIY K+ R +
Sbjct: 414 PPPIP---------KKNLLVV--SVLLGGSVFFNFVLVGVVSFAFFFIYHNKFTRTPQVE 462
Query: 503 ATIETNLRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD 562
+++NLRCFSYKEL EAT+ F+EE+GRG+FGIVYKG+ Q S VA+KK+DR ++
Sbjct: 463 RAVQSNLRCFSYKELMEATNGFKEELGRGAFGIVYKGLTQIG--SGVPVAIKKVDRFVKE 520
Query: 563 GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR 622
+KEFK EV VIG FCDEGQ+R+LVYEFL+NG LASFLFG++K SWN R
Sbjct: 521 SDKEFKTEVDVIG------------FCDEGQHRMLVYEFLSNGALASFLFGDVKLSWNQR 568
Query: 623 TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682
T IAF IARGLLYLH++CS QIIHCDIKPQNILLD++Y+ARI+DFGLAKL Q K
Sbjct: 569 TQIAFGIARGLLYLHDECSTQIIHCDIKPQNILLDEHYDARIADFGLAKLFRNPQHK--- 625
Query: 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 742
GTKGYVAPEWFRN IT KVDVY+FGVLLLEII CR+S D E+GEE AILTDWA+D
Sbjct: 626 ----GTKGYVAPEWFRNMLITVKVDVYNFGVLLLEIICCRRSVDTEVGEERAILTDWAYD 681
Query: 743 CYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 802
CY+ G + LVE D EA+ND+K E+ VMV+IWCIQEDP+LRPTM+ V MLEG+++V V
Sbjct: 682 CYQEGMMHALVESDEEALNDMKKLERFVMVAIWCIQEDPNLRPTMKMVMLMLEGIIQVPV 741
Query: 803 PPNPSPFS 810
PP PSPFS
Sbjct: 742 PPCPSPFS 749
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503095|ref|XP_003520347.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2152), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/816 (52%), Positives = 567/816 (69%), Gaps = 28/816 (3%)
Query: 1 MASAKLYFIFLLYQLLYYLHLAIAQNNGTVPVGATLTAGTNSSPWV--SPSGDFAFGFHQ 58
MAS+ L +F L+ + L +AQ + +G + TAG +++PW+ SPSGDFAFGF
Sbjct: 1 MASSLL--LFFLFCSVILLPFVVAQTKTNIAIGDSHTAGKSTTPWLVSSPSGDFAFGFLP 58
Query: 59 LDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGK 118
L+ + F+L I+Y I ++T+VW+ N+D PA P+GS+V+L+AD GLVL P G
Sbjct: 59 LEATPDH---FILCIWYANIQDRTIVWFA-NRDNKPA-PKGSKVELSADDGLVLTAPNGD 113
Query: 119 QVWSSKIDIGTVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRK 178
++W++ V+ GV NDTGN VL +SS W+SF + DTLLP Q ME Q L S+
Sbjct: 114 KLWNTGGFTARVSSGVFNDTGNLVLLDGASSSTWESFDDYRDTLLPSQTMERGQKLSSKL 173
Query: 179 SDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESG 238
+F+ GRF+ DG+LV++ NLP+++ YY SGT +S N+S++G +++F+ SG
Sbjct: 174 RRNDFNIGRFELFFQNDGNLVMHSINLPSEYVNANYYASGTIES-NTSSAGTQLVFDRSG 232
Query: 239 YMYILRRNSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYFYPKNGNGN--WSAVWSQPE 296
+YILR N ++++L+ G + FY RATL+FDGVF Y +PK +G+ W+ VWS P+
Sbjct: 233 DVYILRDNKEKYNLSDGGSISTTQFYLRATLDFDGVFTLYQHPKGSSGSVGWTPVWSHPD 292
Query: 297 NICDNISGEFGSGACGFNSICTLDGDRRPMCECPKGYSLLDENEKYGSCKADFELSCNGG 356
NIC + SG CG+NSIC+L +RP+C+CPK YSL+D N+ GSCK DF SC+
Sbjct: 293 NICKDYLSATSSGVCGYNSICSLGDYKRPICKCPKWYSLVDPNDPNGSCKPDFVQSCSED 352
Query: 357 GQGYNKELFDFHELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCAVAIFGI-ESCWLVK 415
++L+DF L DTDWPSSDY P+ E QC+ +C+ DC C+VAIF + +SCW K
Sbjct: 353 ELSQREDLYDFEVLIDTDWPSSDYVLQKPFTEEQCRQSCMEDCLCSVAIFRLGDSCWKKK 412
Query: 416 LPLNNGRADSSVN-RKAFIKYKKDDDPDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVF 474
LPL+NGR D+++N KAF+K +KD+ S+ PP K R + VLL S
Sbjct: 413 LPLSNGRVDATLNGAKAFMKVRKDNS----SLVVPPIIVKKNSRNTL----IVLLSGSAC 464
Query: 475 VNFAMVCAFVLGFFFIY--KKKWIRNNPGDATIETNLRCFSYKELEEATDNFEEEVGRGS 532
+N +V A L F+++ KKK R +ETNLRCF+Y+ELEEAT+ FE+ +G+G+
Sbjct: 465 LNLILVGAICLSSFYVFWCKKKLRRVGKSGTNVETNLRCFTYEELEEATNGFEKVLGKGA 524
Query: 533 FGIVYKGVIQTTRTSTTAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE 591
FGIVY+GVI S T VAVK+L+ + ++ +KEFKNE+ IG THHKNLVRLLGFC+
Sbjct: 525 FGIVYEGVINMG--SLTLVAVKRLNTFLLEEVQKEFKNELNAIGLTHHKNLVRLLGFCET 582
Query: 592 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKP 651
RLLVYE+++NGTLAS +F KPSW LR IA +ARGLLYLHE+CS QIIHCDIKP
Sbjct: 583 QDERLLVYEYMSNGTLASLVFNVEKPSWKLRLQIATGVARGLLYLHEECSTQIIHCDIKP 642
Query: 652 QNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSF 711
QNILLDDYYNARISDFGLAK+L +NQS+ TAIRGTKGYVA EWF+N ITAKVDVYS+
Sbjct: 643 QNILLDDYYNARISDFGLAKILNMNQSRT-NTAIRGTKGYVALEWFKNMPITAKVDVYSY 701
Query: 712 GVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVM 771
GVLLLEI+SCRKS + E EE AILT+WAFDCY G L DLVE D EA++D+K EKLVM
Sbjct: 702 GVLLLEIVSCRKSVEFEADEEKAILTEWAFDCYTEGVLHDLVENDKEALDDMKTLEKLVM 761
Query: 772 VSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPS 807
+++WC+QEDP LRPTMR V+QMLEGVVEV +PP PS
Sbjct: 762 IALWCVQEDPGLRPTMRNVTQMLEGVVEVQIPPCPS 797
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503089|ref|XP_003520344.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2150), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/816 (52%), Positives = 567/816 (69%), Gaps = 28/816 (3%)
Query: 1 MASAKLYFIFLLYQLLYYLHLAIAQNNGTVPVGATLTAGTNSSPWV--SPSGDFAFGFHQ 58
MAS+ L +F L+ + L +AQ + +G + TAG +++PW+ SPSGDFAFGF
Sbjct: 1 MASSLL--LFFLFCSVILLPFVVAQTKTNIAIGDSHTAGKSTTPWLVSSPSGDFAFGFLP 58
Query: 59 LDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGK 118
L+ + F+L I+Y I ++T+VW+ N+D PA P+GS+V+L+AD GLVL P G
Sbjct: 59 LEATPDH---FILCIWYANIQDRTIVWFA-NRDNKPA-PKGSKVELSADDGLVLTAPNGD 113
Query: 119 QVWSSKIDIGTVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRK 178
++W++ V+ GV NDTGN VL +SS W+SF + DTLLP Q ME Q L S+
Sbjct: 114 KLWNTGGFTARVSSGVFNDTGNLVLLDGASSSTWESFDDYRDTLLPSQTMERGQKLSSKL 173
Query: 179 SDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESG 238
+F+ GRF+ DG+LV++ NLP+++ YY SGT +S N+S++G +++F+ SG
Sbjct: 174 RRNDFNIGRFELFFQNDGNLVMHSINLPSEYVNANYYASGTIES-NTSSAGTQLVFDRSG 232
Query: 239 YMYILRRNSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYFYPKNGNGN--WSAVWSQPE 296
+YILR N ++++L+ G + FY RATL+FDGVF Y +PK +G+ W+ VWS P+
Sbjct: 233 DVYILRDNKEKYNLSDGGSISTTQFYLRATLDFDGVFTLYQHPKGSSGSVGWTPVWSHPD 292
Query: 297 NICDNISGEFGSGACGFNSICTLDGDRRPMCECPKGYSLLDENEKYGSCKADFELSCNGG 356
NIC + SG CG+NSIC+L +RP+C+CPK YSL+D N+ GSCK DF SC+
Sbjct: 293 NICKDYLSAASSGVCGYNSICSLGDYKRPICKCPKWYSLVDPNDPNGSCKPDFVQSCSED 352
Query: 357 GQGYNKELFDFHELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCAVAIFGI-ESCWLVK 415
++L+DF L DTDWP SDY P+ E QC+ +C+ DC C+VAIF + +SCW K
Sbjct: 353 ELSQREDLYDFEVLIDTDWPLSDYVLQKPFTEEQCRQSCMEDCLCSVAIFRLGDSCWKKK 412
Query: 416 LPLNNGRADSSVN-RKAFIKYKKDDDPDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVF 474
LPL+NGR D+++N KAF+K +KD+ S+ PP K R + VLL S
Sbjct: 413 LPLSNGRVDATLNGAKAFMKVRKDNS----SLVVPPIIVKKNSRNTL----IVLLSGSAC 464
Query: 475 VNFAMVCAFVLGFFFIY--KKKWIRNNPGDATIETNLRCFSYKELEEATDNFEEEVGRGS 532
+N +V A L F+++ KKK R +ETNLRCF+Y+ELEEAT+ FE+ +G+G+
Sbjct: 465 LNLILVGAICLSSFYVFWCKKKLRRVGKSGTNVETNLRCFTYEELEEATNGFEKVLGKGA 524
Query: 533 FGIVYKGVIQTTRTSTTAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE 591
FGIVY+GVI S T VAVK+L+ + ++ +KEFKNE+ VIG THHKNLVRLLGFC+
Sbjct: 525 FGIVYEGVINMG--SLTLVAVKRLNTFLLEEVQKEFKNELNVIGLTHHKNLVRLLGFCET 582
Query: 592 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKP 651
RLLVYE+++NGTLAS +F KPSW LR IA +ARGLLYLHE+CS QIIHCDIKP
Sbjct: 583 QDERLLVYEYMSNGTLASLVFNVEKPSWKLRLQIATGVARGLLYLHEECSTQIIHCDIKP 642
Query: 652 QNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSF 711
QNILLDDYYNARISDFGLAK+L +NQS+ TAIRGTKGYVA EWF+N ITAKVDVYS+
Sbjct: 643 QNILLDDYYNARISDFGLAKILNMNQSRT-NTAIRGTKGYVALEWFKNMPITAKVDVYSY 701
Query: 712 GVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVM 771
GVLLLEI+SCRKS + E EE AILT+WAFDCY G L DLVE D EA++D+K EKLVM
Sbjct: 702 GVLLLEIVSCRKSVEFEADEEKAILTEWAFDCYTEGVLHDLVENDKEALDDMKTLEKLVM 761
Query: 772 VSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPS 807
+++WC+QEDP LRPTMR V+QMLEGVVEV +PP PS
Sbjct: 762 IALWCVQEDPGLRPTMRNVTQMLEGVVEVQIPPCPS 797
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 814 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.361 | 0.354 | 0.467 | 7.1e-90 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.401 | 0.398 | 0.458 | 6.4e-85 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.379 | 0.363 | 0.394 | 2.6e-76 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.579 | 0.570 | 0.353 | 1.4e-72 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.371 | 0.355 | 0.375 | 3.9e-69 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.255 | 0.238 | 0.493 | 6.9e-69 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.362 | 0.359 | 0.376 | 5.3e-68 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.390 | 0.377 | 0.375 | 2.8e-67 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.412 | 0.412 | 0.349 | 2.1e-66 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.357 | 0.343 | 0.373 | 1.9e-64 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 729 (261.7 bits), Expect = 7.1e-90, Sum P(2) = 7.1e-90
Identities = 142/304 (46%), Positives = 206/304 (67%)
Query: 512 FSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEV 571
F+YKEL+ T +F+E++G G FG VY+GV+ T+ T VAVK+L+ + Q GEK+F+ EV
Sbjct: 474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVL----TNRTVVAVKQLEGIEQ-GEKQFRMEV 528
Query: 572 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLK-PSWNLRTNIAFQ 628
I THH NLVRL+GFC +G++RLLVYEF+ NG+L +FLF + K +W R NIA
Sbjct: 529 ATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALG 588
Query: 629 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGT 688
A+G+ YLHE+C I+HCDIKP+NIL+DD + A++SDFGLAKLL ++ +++RGT
Sbjct: 589 TAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGT 648
Query: 689 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748
+GY+APEW N IT+K DVYS+G++LLE++S +++FD+ + + WA++ + G
Sbjct: 649 RGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGN 708
Query: 749 LDDLVEG--DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNP 806
+++ + D++ ++V S WCIQE P RPTM KV QMLEG+ E+ P P
Sbjct: 709 TKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCP 768
Query: 807 SPFS 810
S
Sbjct: 769 KTIS 772
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 737 (264.5 bits), Expect = 6.4e-85, Sum P(2) = 6.4e-85
Identities = 161/351 (45%), Positives = 225/351 (64%)
Query: 473 VFVNFAMVCAFVLGFFFIYK-KKWIRNNPGDATIETN---------LRCFSYKELEEATD 522
V V ++ + F I+K KK I P +++ E N +R F+YK+L+ AT+
Sbjct: 435 VVVTVFIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIR-FAYKDLQSATN 493
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 582
NF ++G+G FG VY+G T + +AVKKL+ + Q G+KEF+ EV +IG HH +L
Sbjct: 494 NFSVKLGQGGFGSVYEG----TLPDGSRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHL 548
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHE 638
VRL GFC EG +RLL YEFL+ G+L ++F G++ W+ R NIA A+GL YLHE
Sbjct: 549 VRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHE 608
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR 698
DC A+I+HCDIKP+NILLDD +NA++SDFGLAKL+T QS T +RGT+GY+APEW
Sbjct: 609 DCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVF-TTMRGTRGYLAPEWIT 667
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758
N I+ K DVYS+G++LLE+I RK++D E +AF GKL D+V+G +
Sbjct: 668 NYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMK 727
Query: 759 AMNDI--KCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPS 807
+ D+ + ++ + ++WCIQED RP+M KV QMLEGV V PP+ S
Sbjct: 728 NV-DVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSS 777
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 2.6e-76, Sum P(2) = 2.6e-76
Identities = 126/319 (39%), Positives = 184/319 (57%)
Query: 501 GDATIETNLRCFSYKELEEATDNF--EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR 558
G A + L FS + AT++F E E+GRG FG VYKGV++ R +AVK+L
Sbjct: 506 GKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGRE----IAVKRLSG 561
Query: 559 VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS 618
G EFKNE+++I + H+NLVRLLG C EG+ ++LVYE++ N +L FLF K +
Sbjct: 562 KSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQA 621
Query: 619 ---WNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675
W LR +I IARGLLYLH D +IIH D+K N+LLD N +ISDFG+A++
Sbjct: 622 LIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGG 681
Query: 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 735
NQ++A + GT GY++PE+ + K DVYSFGVLLLEI+S +++ + E+
Sbjct: 682 NQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLR-SSEHGS 740
Query: 736 LTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
L +A+ Y +G+ ++LV+ + + + V++ C+Q+ + RP M V MLE
Sbjct: 741 LIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLE 800
Query: 796 GVVEVDVPPNPSPFSGYMR 814
P F+ R
Sbjct: 801 SDTATLAAPRQPTFTSTRR 819
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 714 (256.4 bits), Expect = 1.4e-72, Sum P(2) = 1.4e-72
Identities = 179/507 (35%), Positives = 263/507 (51%)
Query: 311 CGFNSICTLDGDRRPMCECPKGYSLLDENEKYGSCKADFELSC--NGGGQGYNKELFDFH 368
CG IC+ + P C CP+G+ + ++K K D+ C Q ++ F
Sbjct: 296 CGSFGICSDKSE--PFCRCPQGFRPM--SQKDWDLK-DYSAGCVRKTELQCSRGDINQFF 350
Query: 369 ELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCAVAIF--GIESCWLVKLPLNNGRADSS 426
L + + E + C + C DC C + G C + + N +
Sbjct: 351 RLPNMKLADNS-EVLTRTSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLED 409
Query: 427 VNRKAFIKYKKXXXXXXXXXXXXXXXXXXXXXXMMNATGSVLLGSSVFVNFAMVCAFVLG 486
N + I Y + G+VL V V +V +L
Sbjct: 410 ENSEGNIFYLRLAASDVPNVGASGKSNNKGLIF-----GAVLGSLGVIVLVLLVVILILR 464
Query: 487 FFFIYKKKWIRNNPGDATIETNLRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRT 546
+ ++K +R GD T L FSY+EL+ AT NF +++G G FG V+KG +
Sbjct: 465 Y---RRRKRMRGEKGDGT----LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALP---- 513
Query: 547 STTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT 606
++ +AVK+L+ + Q GEK+F+ EVV IG H NLVRL GFC EG +LLVY+++ NG+
Sbjct: 514 DSSDIAVKRLEGISQ-GEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGS 572
Query: 607 LASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 661
L S LF N + W LR IA ARGL YLH++C IIHCDIKP+NILLD +
Sbjct: 573 LDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFC 632
Query: 662 ARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISC 721
+++DFGLAKL+ + S+ + T +RGT+GY+APEW ITAK DVYS+G++L E++S
Sbjct: 633 PKVADFGLAKLVGRDFSRVL-TTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSG 691
Query: 722 RKSFDIEMGEEYAILTDWAFDCY-RNGKLDDLVEGDTEA-MNDIKCTEKLVMVSIWCIQE 779
R++ + E+ WA ++G + LV+ E DI+ + V+ WCIQ+
Sbjct: 692 RRNTEQSENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQD 751
Query: 780 DPSLRPTMRKVSQMLEGVVEVDVPPNP 806
+ S RP M +V Q+LEGV+EV+ PP P
Sbjct: 752 EESHRPAMSQVVQILEGVLEVNPPPFP 778
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 489 (177.2 bits), Expect = 3.9e-69, Sum P(3) = 3.9e-69
Identities = 119/317 (37%), Positives = 182/317 (57%)
Query: 504 TIETNLRCFSYKELEEATDNFEE--EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ 561
T + L ++E+ AT+NF ++G+G FGIVYKG + + +AVK+L +
Sbjct: 506 TDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQE----MAVKRLSKTSV 561
Query: 562 DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---NLKPS 618
G EFKNEV +I + H NLVRLL C + ++L+YE+L N +L S LF N K +
Sbjct: 562 QGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLN 621
Query: 619 WNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678
W +R +I IARGLLYLH+D +IIH D+K NILLD Y +ISDFG+A++ +++
Sbjct: 622 WQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDET 681
Query: 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 738
+A + GT GY++PE+ + + K DV+SFGVLLLEIIS +++ + L
Sbjct: 682 EANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLG 741
Query: 739 WAFDCYRNGKLDDLVEGD-TEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ ++ GK ++++ T++ + + E L + + + C+QE RPTM V ML
Sbjct: 742 CVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILML- 800
Query: 796 GVVEVDVPPNPSPFSGY 812
G +P +P GY
Sbjct: 801 GSESTTIPQPKAP--GY 815
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 548 (198.0 bits), Expect = 6.9e-69, Sum P(3) = 6.9e-69
Identities = 106/215 (49%), Positives = 146/215 (67%)
Query: 512 FSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEV 571
F ++ELE+AT+NF+ ++G G FG VYKG T T +AVKK+ G +EF E+
Sbjct: 505 FEFEELEQATENFKMQIGSGGFGSVYKG----TLPDETLIAVKKITNHGLHGRQEFCTEI 560
Query: 572 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQI 629
+IG H NLV+L GFC G+ LLVYE++N+G+L LF P W R +IA
Sbjct: 561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGT 620
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
ARGL YLH C +IIHCD+KP+NILL D++ +ISDFGL+KLL +S ++ T +RGT+
Sbjct: 621 ARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEES-SLFTTMRGTR 679
Query: 690 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS 724
GY+APEW N+ I+ K DVYS+G++LLE++S RK+
Sbjct: 680 GYLAPEWITNAAISEKADVYSYGMVLLELVSGRKN 714
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 524 (189.5 bits), Expect = 5.3e-68, Sum P(3) = 5.3e-68
Identities = 116/308 (37%), Positives = 183/308 (59%)
Query: 507 TNLRCFSYKELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE 564
+ L F +L+ AT+NF ++G+G FG VYKG +Q + +AVK+L G
Sbjct: 481 SGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQDGKE----IAVKRLTSSSVQGT 536
Query: 565 KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---NLKPSWNL 621
+EF NE+ +I + H+NL+RLLG C +G+ +LLVYE++ N +L F+F L+ W
Sbjct: 537 EEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDLKKKLEIDWAT 596
Query: 622 RTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681
R NI IARGLLYLH D +++H D+K NILLD+ N +ISDFGLA+L NQ +
Sbjct: 597 RFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDFGLARLFHGNQHQDS 656
Query: 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 741
++ GT GY++PE+ T + K D+YSFGVL+LEII+ ++ G++ L +A+
Sbjct: 657 TGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKEISSFSYGKDNKNLLSYAW 716
Query: 742 DCY-RNGKLDDLVEG--DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798
D + NG ++ L + D++++N ++ + V + + C+Q RP +++V ML
Sbjct: 717 DSWSENGGVNLLDQDLDDSDSVNSVEAG-RCVHIGLLCVQHQAIDRPNIKQVMSMLTSTT 775
Query: 799 EVDVPPNP 806
++ P P
Sbjct: 776 DLPKPTQP 783
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 536 (193.7 bits), Expect = 2.8e-67, Sum P(2) = 2.8e-67
Identities = 123/328 (37%), Positives = 176/328 (53%)
Query: 491 YKKKWIRNNPGDATIETNLRCFSYKELEEATDNFEEE--VGRGSFGIVYKGVIQTTRTST 548
Y I+ GD +L FS+ + AT +F EE +G+G FG VYKG R
Sbjct: 492 YSSSPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGRE-- 549
Query: 549 TAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLA 608
+AVK+L + G +EFKNE+++I + H+NLVRLLG C E ++L+YE++ N +L
Sbjct: 550 --IAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLD 607
Query: 609 SFLFGNLKPS---WNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 665
FLF K W R + IARGLLYLH D +IIH D+K NILLD N +IS
Sbjct: 608 RFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKIS 667
Query: 666 DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 725
DFG+A++ Q A + GT GY+APE+ + K DVYSFGVL+LEI+S RK+
Sbjct: 668 DFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNV 727
Query: 726 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRP 785
G ++ L +A+ + GK ++++ + D+ + + V + C Q+ RP
Sbjct: 728 SFR-GTDHGSLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRP 786
Query: 786 TMRKVSQMLEGVVEVDVPPNPSPFSGYM 813
M V MLE PP F ++
Sbjct: 787 NMGSVLLMLESQTSQLPPPRQPTFHSFL 814
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 534 (193.0 bits), Expect = 2.1e-66, Sum P(3) = 2.1e-66
Identities = 124/355 (34%), Positives = 197/355 (55%)
Query: 467 VLLGSSVFVNFAMVCAFVLGFFFIYKKKWIRNNP------GDATIET----NLRCFSYKE 516
+++ S V ++ M+ F +++ YK K +NP DA E ++ F +
Sbjct: 434 IIVASIVSISVFMILVFASYWYWRYKAKQNDSNPIPLETSQDAWREQLKPQDVNFFDMQT 493
Query: 517 LEEATDNF--EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI 574
+ T+NF E ++G+G FG VYKG +Q + +A+K+L G +EF NE+++I
Sbjct: 494 ILTITNNFSMENKLGQGGFGPVYKGNLQDGKE----IAIKRLSSTSGQGLEEFMNEIILI 549
Query: 575 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIAR 631
+ H+NLVRLLG C EG+ +LL+YEF+ N +L +F+F + K W R I IA
Sbjct: 550 SKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKRFEIIQGIAC 609
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
GLLYLH D +++H D+K NILLD+ N +ISDFGLA++ Q +A + GT GY
Sbjct: 610 GLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANTRRVVGTLGY 669
Query: 692 VAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751
++PE+ + K D+Y+FGVLLLEII+ ++ +GEE L ++A+D + D
Sbjct: 670 MSPEYAWTGMFSEKSDIYAFGVLLLEIITGKRISSFTIGEEGKTLLEFAWDSWCESGGSD 729
Query: 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNP 806
L++ D + + V + + CIQ+ RP + +V ML +++ P P
Sbjct: 730 LLDQDISSSGSESEVARCVQIGLLCIQQQAGDRPNIAQVMSMLTTTMDLPKPKQP 784
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 472 (171.2 bits), Expect = 1.9e-64, Sum P(3) = 1.9e-64
Identities = 115/308 (37%), Positives = 177/308 (57%)
Query: 509 LRCFSYKELEEATDNF--EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE 566
L +K L AT+NF + ++G+G FGIVYKG++ + +AVK+L ++ G E
Sbjct: 508 LPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKE----IAVKRLSKMSSQGTDE 563
Query: 567 FKNEVVVIGQTHHKNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPS---WNLR 622
F NEV +I + H NLVRLLG C D+G+ ++L+YE+L N +L S LF + S W R
Sbjct: 564 FMNEVRLIAKLQHINLVRLLGCCVDKGE-KMLIYEYLENLSLDSHLFDQTRSSNLNWQKR 622
Query: 623 TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682
+I IARGLLYLH+D +IIH D+K N+LLD +ISDFG+A++ +++A
Sbjct: 623 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 682
Query: 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 742
+ GT GY++PE+ + + K DV+SFGVLLLEIIS +++ L + +
Sbjct: 683 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWR 742
Query: 743 CYRNGKLDDLVEG-DTEAMNDIKCTEKL---VMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798
++ GK ++V+ + +A++ T ++ + + + C+QE RP M V ML
Sbjct: 743 HWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGS-- 800
Query: 799 EVDVPPNP 806
E P P
Sbjct: 801 ETTAIPQP 808
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4707 | 0.9631 | 0.9423 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 814 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-23 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-22 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-21 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-14 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-13 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 1e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-09 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 3e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-08 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 5e-50
Identities = 69/200 (34%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLL 586
+G G FG VY + T VA+K + + E E+ ++ + +H N+V+L
Sbjct: 1 LGEGGFGTVYLARDKKTGKK---VAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 587 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSAQII 645
G ++ + LV E+ G+L L N S + I QI GL YLH S II
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGII 114
Query: 646 HCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE-WFRNSTIT 703
H D+KP+NILLD D +++DFGL+KLLT K++ I GT Y+APE +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 704 AKVDVYSFGVLLLEIISCRK 723
K D++S GV+L E+ +
Sbjct: 173 EKSDIWSLGVILYELPELKD 192
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 3e-49
Identities = 88/282 (31%), Positives = 131/282 (46%), Gaps = 41/282 (14%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTHHKN 581
++G GSFG VYK + T VAVK L + + +K+ + E+ ++ + H N
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKI---VAVKILKKRSEKSKKDQTARREIRILRRLSHPN 59
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 641
+VRL+ ++ + LV E+ G L +L S + IA QI RGL YLH S
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH---S 116
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW-FRNS 700
IIH D+KP+NILLD+ +I+DFGLAK L + S T GT Y+APE +
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGN 174
Query: 701 TITAKVDVYSFGVLLLEIISCRKSFD----------IEMGEEYAILTDWAFDCYRNGKLD 750
KVDV+S GV+L E+++ + F I + D + +
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792
DL++ C+ +DPS RPT ++ Q
Sbjct: 235 DLIK--------------------KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 8e-48
Identities = 85/289 (29%), Positives = 135/289 (46%), Gaps = 52/289 (17%)
Query: 524 FEEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKN 581
+++G G+FG VYKG VAVK L + + +EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 639
+V+LLG C E + +V E++ G L S+L +P +L + A QIARG+ YL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA---IRGTKGYVAPEW 696
S IH D+ +N L+ + +ISDFGL++ L + + IR ++APE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPES 174
Query: 697 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEG 755
+ T+K DV+SFGVLL EI + +GE+ Y ++
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFT--------LGEQPYPGMS------------------ 208
Query: 756 DTEAMNDIK----------CTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794
+ E + +K C +L + + C EDP RPT ++ ++L
Sbjct: 209 NEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-47
Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 35/277 (12%)
Query: 524 FEEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKN 581
E++G GSFG VY +T + VA+K + + ++E E+ ++ + H N
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKL----VAIKVIKKKKIKKDRERILREIKILKKLKHPN 58
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 639
+VRL ++ LV E+ G L L G L QI L YLH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE--ARFYLRQILSALEYLH-- 114
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
S I+H D+KP+NILLD+ + +++DFGLA+ L+ + + T + GT Y+APE
Sbjct: 115 -SKGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLG 170
Query: 700 STITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDC-YRNGKLDDLVEGD 756
VD++S GV+L E+++ + F D ++ E + + +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP----- 225
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793
EA + I+ + +DP R T + Q
Sbjct: 226 -EAKDLIRK----------LLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-47
Identities = 86/290 (29%), Positives = 136/290 (46%), Gaps = 53/290 (18%)
Query: 524 FEEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKN 581
+++G G+FG VYKG VAVK L + + +EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIARGLLYLHE 638
+V+LLG C E + ++V E++ G L +L +P S + + A QIARG+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE- 120
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA---IRGTKGYVAPE 695
S IH D+ +N L+ + +ISDFGL++ L + +K IR ++APE
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPE 174
Query: 696 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE 754
+ T+K DV+SFGVLL EI + +GEE Y ++
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFT--------LGEEPYPGMS----------------- 209
Query: 755 GDTEAMNDIK----------CTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794
+ E + +K C +L + + C EDP RPT ++ ++L
Sbjct: 210 -NAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 1e-46
Identities = 84/280 (30%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKN 581
+++G G+FG VYKG ++ T T VAVK L + E+ EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHE 638
+VRLLG C +G+ +V E++ G L FL L +A QIA+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE- 119
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG---YVAPE 695
S +H D+ +N L+ + +ISDFGL++ + G K ++APE
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDI---YEDDYYRKRGGGKLPIKWMAPE 174
Query: 696 WFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754
++ T+K DV+SFGVLL EI + + + EE + + D YR + ++
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---VLELLEDGYRLPRPEN--- 228
Query: 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794
C ++L + + C DP RPT ++ + L
Sbjct: 229 ----------CPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 3e-45
Identities = 90/289 (31%), Positives = 140/289 (48%), Gaps = 46/289 (15%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVR 584
+++G G+FG VYKG ++ TT VAVK L + E K+F E V+ + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKP---SWNLRTNIAFQIARGLLY 635
LLG C E + LV E++ G L +L F + + S + A QIA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA----IRGTKGY 691
L S + +H D+ +N L+ + +ISDFGL++ + + KT IR +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 692 VAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKL 749
+APE ++ T+K DV+SFGVLL EI + +G + + + R G
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT--------LGATPYPGLSNEEVLEYLRKGYR 225
Query: 750 DDLVEGDTEAMND-IKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ C ++L +M+S W Q DP RPT ++ + LE
Sbjct: 226 ----------LPKPEYCPDELYELMLSCW--QLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 81/277 (29%), Positives = 134/277 (48%), Gaps = 33/277 (11%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
E +GRGSFG VY + + +AVK L ++ + + E+ ++ H N+V
Sbjct: 6 ELLGRGSFGSVYLA---LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV 62
Query: 584 RLLGFC-DEGQNRLLVY-EFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 639
R G DE +N L ++ E+++ G+L+S L FG L +R QI GL YLH
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-VIR-KYTRQILEGLAYLH-- 118
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
S I+H DIK NIL+D +++DFG AK L ++ ++RGT ++APE R
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 700 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759
D++S G ++E+ + + + E+G A L +G+ ++ E +E
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWS-ELGNPMAALYKIGS----SGEPPEIPEHLSEE 232
Query: 760 MND-IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
D ++ C++ DP RPT ++L+
Sbjct: 233 AKDFLRK----------CLRRDPKKRPT---ADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 16/196 (8%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
E++G+G FG VYK + + VA+K + ++ +++ NE+ ++ + H N+V+
Sbjct: 6 EKIGKGGFGEVYKA---RHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL----YLHEDCS 641
G + +V EF + G+L L + + + IA+ + + LL YLH S
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTE-SQIAY-VCKELLKGLEYLH---S 116
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
IIH DIK NILL ++ DFGL+ L+ +KA T + GT ++APE
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMV-GTPYWMAPEVINGKP 173
Query: 702 ITAKVDVYSFGVLLLE 717
K D++S G+ +E
Sbjct: 174 YDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 72/277 (25%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNL 582
+++G+GSFG VY ++ +K++D + EKE + NEV ++ + +H N+
Sbjct: 6 KQIGKGSFGKVYL--VRRKSDGKL-YVLKEID-LSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFL----FGNLKPSWNLRTNIAFQIARGLLYLHE 638
++ +E +V E+ + G L+ + + Q+ L YLH
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR 698
S +I+H DIKPQNI L ++ DFG++K+L+ A KT + GT Y++PE +
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA-KTVV-GTPYYLSPELCQ 176
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758
N K D++S G +L E+ + + F+ GE L +++G
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFE---GENLLEL------------ALKILKGQYP 221
Query: 759 AMNDIKCTE--KLVMVSIWCIQEDPSLRPTMRKVSQM 793
+ +E LV +Q+DP RP++ ++ Q
Sbjct: 222 PIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 63/199 (31%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
+G+G FG V G + + VAVK L + F E V+ H NLV
Sbjct: 10 LGATIGKGEFGDVMLGDYRGQK-----VAVKCLKDD-STAAQAFLAEASVMTTLRHPNLV 63
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCS 641
+LLG +G +V E++ G+L +L + L + A + G+ YL E
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-- 121
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+H D+ +N+L+ + A++SDFGLAK + Q K ++ T APE R
Sbjct: 122 -NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG-KLPVKWT----APEALREKK 175
Query: 702 ITAKVDVYSFGVLLLEIIS 720
+ K DV+SFG+LL EI S
Sbjct: 176 FSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 74/270 (27%), Positives = 131/270 (48%), Gaps = 34/270 (12%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKNLV 583
+ +GRG+FG+VYKG+ T VA+K++ ++ ++ K E+ ++ H N+V
Sbjct: 6 DLIGRGAFGVVYKGLNLET---GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCS 641
+ +G + + ++ E+ NG+L + FG +L +Q+ +GL YLHE
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF--PESLVAVYVYQVLQGLAYLHEQ-- 118
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+IH DIK NIL +++DFG+A LN ++ GT ++APE S
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 702 ITAKVDVYSFGVLLLEIISCRKS-FDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759
+ D++S G ++E+++ +D+ M + I+ D D L EG +
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---DHPP------LPEGISPE 226
Query: 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRK 789
+ L + C Q+DP+LRPT ++
Sbjct: 227 -----LKDFL----MQCFQKDPNLRPTAKQ 247
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (308), Expect = 3e-30
Identities = 79/287 (27%), Positives = 121/287 (42%), Gaps = 42/287 (14%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQ-TH 578
++G GSFG VY VA+K L + + KE F E+ ++ H
Sbjct: 3 RILRKLGEGSFGEVYLAR------DRKLVALKVLAKKLESKSKEVERFLREIQILASLNH 56
Query: 579 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----FGNLKPSWNLRTNIAFQIARGL 633
N+V+L F + + LV E+++ G+L L G L S L I QI L
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF--ILAQILSAL 114
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYN-ARISDFGLAKLLTLNQSKAI----KTAIRGT 688
YLH IIH DIKP+NILLD ++ DFGLAKLL S + + GT
Sbjct: 115 EYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 689 KGYVAPEWFRNST---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWA 740
GY+APE + ++ D++S G+ L E+++ F+ E I+ +
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231
Query: 741 FDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTM 787
+ E ++A +D+ + +DP R +
Sbjct: 232 TPSLASPLSPSNPELISKAASDL---------LKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 67/218 (30%), Positives = 110/218 (50%), Gaps = 30/218 (13%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTA-VAVKKLDRVFQDGE----KEFKNEVVVIGQTH 578
F +++G G FG V +T VAVK L+ GE +F+ E+ ++
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH---SGEEQHRSDFEREIEILRTLD 64
Query: 579 HKNLVRLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLL 634
H+N+V+ G C++ G++ L+ E+L +G+L +L + + NL+ + + QI +G+
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMD 123
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA-------IRG 687
YL S + IH D+ +NIL++ +ISDFGLAK+ L + K I
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKV--LPEDKDYYYVKEPGESPIF- 177
Query: 688 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKS 724
+ APE R S ++ DV+SFGV L E+ + S
Sbjct: 178 ---WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 65/228 (28%), Positives = 102/228 (44%), Gaps = 34/228 (14%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ-THH 579
F + +G GSF V + T A+K LD+ + K K E V+ + H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKE---YAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 580 KNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYL 636
+++L F DE +N V E+ NG L ++ +G+L A +I L YL
Sbjct: 62 PGIIKLYYTFQDE-ENLYFVLEYAPNGELLQYIRKYGSL--DEKCTRFYAAEILLALEYL 118
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ--------SKAIKTAIR-- 686
H S IIH D+KP+NILLD + +I+DFG AK+L N + I + I
Sbjct: 119 H---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 687 --------GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 726
GT YV+PE D+++ G ++ ++++ + F
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 75/231 (32%), Positives = 115/231 (49%), Gaps = 36/231 (15%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKL-DRVFQDGEKEFKNEVV 572
E+ + F EE+G G+FG VYKG + R S T+VA+K L + ++EF+ E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 573 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN------------------ 614
++ H N+V LLG C + Q +++E+L +G L FL N
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 615 LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674
L S L +IA QIA G+ YL S +H D+ +N L+ + +ISDFGL++ +
Sbjct: 121 LDCSDFL--HIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 675 LN-----QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
QSK++ +R ++ PE T + D++SFGV+L EI S
Sbjct: 176 SADYYRVQSKSL-LPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 70/199 (35%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 584
+E+G G+FG V KGV VAVK L G+KEF E V+ Q H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSAQ 643
L+G C +G+ +LV E G L +L + P +L +A Q+A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDL-KELAHQVAMGMAYLES---KH 115
Query: 644 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS--KAIKTAIRGTKGYVAPEWFRNST 701
+H D+ +N+LL + + A+ISDFG+++ L +A TA R + APE
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA-TTAGRWPLKWYAPECINYGK 174
Query: 702 ITAKVDVYSFGVLLLEIIS 720
++K DV+S+GV L E S
Sbjct: 175 FSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 27/270 (10%)
Query: 529 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLG 587
G+GS G+VYK + + A+KK+ + K+ E+ + +V+ G
Sbjct: 10 GQGSSGVVYKVR---HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 588 -FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIH 646
F EG+ + V E+++ G+LA L K + IA QI +GL YLH IIH
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIH 123
Query: 647 CDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKV 706
DIKP N+L++ +I+DFG++K L + GT Y++PE + + +
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPERIQGESYSYAA 181
Query: 707 DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCT 766
D++S G+ LLE + F + L + + +G ++ + +
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFEL------------MQAICDGPPPSLPAEEFS 229
Query: 767 EKLV-MVSIWCIQEDPSLRPTMRKVSQMLE 795
+ +S C+Q+DP RP+ +++L+
Sbjct: 230 PEFRDFISA-CLQKDPKKRPS---AAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 78/273 (28%), Positives = 130/273 (47%), Gaps = 36/273 (13%)
Query: 529 GRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 586
G G+FG VYKGV I VA+K L + KE +E V+ H ++VRLL
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 587 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 643
G C L+ + + G L ++ N+ + L N QIA+G+ YL E +
Sbjct: 76 GIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLL--NWCVQIAKGMSYLEE---KR 129
Query: 644 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS----KAIKTAIRGTKGYVAPEWFRN 699
++H D+ +N+L+ + +I+DFGLAKLL +++ + K I+ ++A E +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK----WMALESILH 185
Query: 700 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE-GDTE 758
T K DV+S+GV + E+++ G + ++ ++ DL+E G+
Sbjct: 186 RIYTHKSDVWSYGVTVWELMT--------FGAK-------PYEGIPAVEIPDLLEKGERL 230
Query: 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVS 791
I CT + MV + C D RPT +++
Sbjct: 231 PQPPI-CTIDVYMVLVKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 80/289 (27%), Positives = 138/289 (47%), Gaps = 45/289 (15%)
Query: 527 EVGRGSFGIVYKGVIQTTRTST--TAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 583
E+G+GSFG+VY+G+ + T VA+K ++ E+ EF NE V+ + + ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFL--------FGNLK--PSWNLRTNIAFQIARGL 633
RLLG GQ L+V E + G L S+L P+ +A +IA G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG--- 690
YL + +H D+ +N ++ + +I DFG+ + + ++ + +G KG
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRD--IYETDYYR---KGGKGLLP 184
Query: 691 --YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILT-DWAFDCYRN 746
++APE ++ T K DV+SFGV+L E+ + + E+ Y L+ + +
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT--------LAEQPYQGLSNEEVLKFVID 236
Query: 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
G DL E C +KL+ + C Q +P +RPT ++ L+
Sbjct: 237 GGHLDLPEN---------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-25
Identities = 77/275 (28%), Positives = 128/275 (46%), Gaps = 20/275 (7%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 584
E + RG G YKG + + VK+++ V E + +G+ H N+V+
Sbjct: 695 ENVISRGKKGASYKG---KSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVK 747
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQI 644
L+G C + L++E++ L+ L SW R IA IA+ L +LH CS +
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 645 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITA 704
+ ++ P+ I++D + L LL + I +A YVAPE IT
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA------YVAPETRETKDITE 857
Query: 705 KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIK 764
K D+Y FG++L+E+++ + D E G +I+ +WA CY + LD ++ +
Sbjct: 858 KSDIYGFGLILIELLTGKSPADAEFGVHGSIV-EWARYCYSDCHLDMWIDPSIRGDVSVN 916
Query: 765 CTEKL-VM-VSIWCIQEDPSLRPTMRKVSQMLEGV 797
E + VM +++ C DP+ RP V + LE
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 71/203 (34%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 584
E ++G G FG V+ G T TT VAVK L E F E ++ + H LV+
Sbjct: 11 ERKLGAGQFGEVWMG----TWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQ 65
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDC 640
L C E + +V E+++ G+L FL LR +A QIA G+ YL
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLE--- 120
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK---GYVAPEWF 697
S IH D+ +NIL+ + +I+DFGLA+L+ + TA G K + APE
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD----EYTAREGAKFPIKWTAPEAA 176
Query: 698 RNSTITAKVDVYSFGVLLLEIIS 720
T K DV+SFG+LL EI++
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 84/289 (29%), Positives = 133/289 (46%), Gaps = 39/289 (13%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVV 573
E+E + ++G G +G VY+GV + + S T VAVK L +D +EF E V
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWK--KYSLT-VAVKTLK---EDTMEVEEFLKEAAV 55
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIAR 631
+ + H NLV+LLG C ++ EF+ G L +L + N +A QI+
Sbjct: 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 115
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK-- 689
+ YL IH D+ +N L+ + + +++DFGL++L+T TA G K
Sbjct: 116 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----GDTYTAHAGAKFP 168
Query: 690 -GYVAPEWFRNSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEEYAILTDWAFDCYRN 746
+ APE + + K DV++FGVLL EI + I++ + Y +L
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------EK 220
Query: 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
G + EG C K+ + C Q +PS RP+ ++ Q E
Sbjct: 221 GYRMERPEG---------CPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 63/203 (31%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 584
E ++G G FG V++G+ + VA+K L +++F+ EV + + HK+L+
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVR----VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCS 641
L C G+ ++ E + G+L +FL G + P +L ++A Q+A G+ YL E
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-IDMACQVAEGMAYLEEQ-- 123
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLT----LNQSKAIKTAIRGTKGYVAPEWF 697
IH D+ +NIL+ + +++DFGLA+L+ L+ K I + APE
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPEAA 176
Query: 698 RNSTITAKVDVYSFGVLLLEIIS 720
+ T + K DV+SFG+LL E+ +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 74/275 (26%), Positives = 119/275 (43%), Gaps = 44/275 (16%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHHKNLV 583
+G G+FG VY V + +AVK++ QD + KE +E+ V+ H NLV
Sbjct: 8 IGGGTFGKVYTAV---NLDTGELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
+ G + + E+ + GTL L G + +R Q+ GL YLH S
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-YTLQLLEGLAYLH---SH 118
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI---RGTKGYVAPEWFRN 699
I+H DIKP NI LD ++ DFG A L N + + + GT Y+APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 700 STITAK---VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG-----KLDD 751
D++S G ++LE+ + ++ + E+ E+ I+ + G + D
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWS-ELDNEFQIM-------FHVGAGHKPPIPD 229
Query: 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT 786
++ E + + C++ DP RPT
Sbjct: 230 SLQLSPEGKDFLD----------RCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 522 DNFEEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK 580
N E+ +G G+ G VYK T + VA+KK+ R+ + ++ NE++++ H
Sbjct: 22 KNLEK-IGEGASGEVYKATDRATGKE----VAIKKM-RLRKQNKELIINEILIMKDCKHP 75
Query: 581 NLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN---IAF---QIARGL 633
N+V + L +V E+++ G+L + N +R N IA+ ++ +GL
Sbjct: 76 NIVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQGL 129
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
YLH S +IH DIK NILL + +++DFG A LT +SK + ++ GT ++A
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RNSVVGTPYWMA 184
Query: 694 PEWFRNSTITAKVDVYSFGVLLLEII 719
PE + KVD++S G++ +E+
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 77/285 (27%), Positives = 133/285 (46%), Gaps = 32/285 (11%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIG 575
E++ + ++G G FG V++G+ +TT VAVK L D K+F E ++
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN----NTTPVAVKTLKPGTMD-PKDFLAEAQIMK 56
Query: 576 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGL 633
+ H L++L C + +V E + G+L +L G + L ++A Q+A G+
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK---G 690
YL + IH D+ +N+L+ + +++DFGLA+++ + I A G K
Sbjct: 117 AYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKED----IYEAREGAKFPIK 169
Query: 691 YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750
+ APE + + K DV+SFG+LL EI++ + Y +T N ++
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRM-------PYPGMT--------NAEVL 214
Query: 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
V+ C ++L + + C +EDP RPT + LE
Sbjct: 215 QQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 78/278 (28%), Positives = 131/278 (47%), Gaps = 30/278 (10%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 583
E+ +G G FG V +G ++ VA+K L D ++ +F E ++GQ H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSA 642
RL G + + +++ E++ NG+L FL N K + + IA G+ YL E
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS----KAIKTAIRGTKGYVAPEWFR 698
+H D+ +NIL++ ++SDFGL++ L +++ K K IR T APE
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIA 181
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDT 757
T+ DV+SFG+++ E++S GE Y D + N + VE
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMS--------YGERPYW---DMS-----NQDVIKAVEDGY 225
Query: 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ C L + + C Q+D + RPT ++ L+
Sbjct: 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 76/284 (26%), Positives = 129/284 (45%), Gaps = 49/284 (17%)
Query: 524 FEEEVGRGSFGIV----YKGVIQTTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQ 576
F +E+G G FG+V ++G I VA+K + ++G E +F E V+ +
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID--------VAIKMI----REGAMSEDDFIEEAKVMMK 55
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGL 633
H NLV+L G C + + +V E++ NG L ++L G L W L ++ + +
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL--DMCSDVCEAM 113
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK---G 690
YL + IH D+ +N L+ + ++SDFGLA+ + +Q T+ +GTK
Sbjct: 114 EYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY----TSSQGTKFPVK 166
Query: 691 YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750
+ PE F S ++K DV+SFGVL+ E+ S K ++ + N ++
Sbjct: 167 WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM---------------PYERFSNSEVV 211
Query: 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794
+ V ++ + C E P RP +K+ L
Sbjct: 212 ESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
+E+G G FG+V+ G R VA+K + E++F E V+ + H LV
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRK----VAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLV 62
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 641
+L G C E LV+EF+ +G L+ +L + ++ T + + G+ YL
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN- 120
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK---GYVAPEWFR 698
+IH D+ +N L+ + ++SDFG+ + + +Q T+ GTK + +PE F
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY----TSSTGTKFPVKWSSPEVFS 174
Query: 699 NSTITAKVDVYSFGVLLLEIIS 720
S ++K DV+SFGVL+ E+ S
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 78/285 (27%), Positives = 122/285 (42%), Gaps = 44/285 (15%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAV-KKLD-RVFQDGEKE-FKNEVVVIGQTHHKNL 582
E +G+GSFG V K V R S + V K++D + EK+ +EV ++ + H N+
Sbjct: 6 ETIGKGSFGTVRK-VR---RKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 583 VRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRT--------NIAFQIARG 632
VR D L +V E+ G LA + + R I Q+
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI----QKCKKERKYIEEEFIWRILTQLLLA 117
Query: 633 LLYLH--EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690
L H D ++H D+KP NI LD N ++ DFGLAK+L + S A KT + GT
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA-KTYV-GTPY 175
Query: 691 YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750
Y++PE + + K D++S G L+ E+ + F L + GK
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKI----KEGKFR 228
Query: 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ + +N V+ S + DP RP+ ++L+
Sbjct: 229 RIPYRYSSELN-------EVIKS--MLNVDPDKRPS---TEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 79/275 (28%), Positives = 129/275 (46%), Gaps = 39/275 (14%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
E +G G FG V +G + VAVK K D Q F E V+ + HHKNLV
Sbjct: 12 EIIGEGEFGAVLQGEYTGQK-----VAVKNIKCDVTAQ----AFLEETAVMTKLHHKNLV 62
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCS 641
RLLG +V E ++ G L +FL + ++ + F +A G+ YL S
Sbjct: 63 RLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---S 118
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+++H D+ +NIL+ + A++SDFGLA++ S + + K + APE ++
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVK-WTAPEALKHKK 173
Query: 702 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-DWAFDCYRNGKLDDLVEGDTEAM 760
++K DV+S+GVLL E+ S ++ Y ++ +C G + EG
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRA-------PYPKMSLKEVKECVEKGYRMEPPEG----- 221
Query: 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
C + ++ C + +P RP+ K+ + LE
Sbjct: 222 ----CPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 76/283 (26%), Positives = 120/283 (42%), Gaps = 58/283 (20%)
Query: 529 GRGSFGIVYKGVIQTTRTSTTAV-AVKKLD-RVFQDGEKEFK-NEVVVIGQTHHKNLVR- 584
G+GS+G VYK R S A+K++D E+E NE+ ++ +H N++
Sbjct: 9 GKGSYGSVYK----VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY 64
Query: 585 ----LLGFCDEGQNRL-LVYEFLNNGTLASFL-----FGNLKPS---WNLRTNIAFQIAR 631
L G N+L +V E+ G L+ + L P W I Q+ R
Sbjct: 65 KEAFLDG------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLR 114
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
GL LHE +I+H D+K NILL +I D G++K+L KT I GT Y
Sbjct: 115 GLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQI-GTPHY 167
Query: 692 VAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKL 749
+APE ++ + K D++S G LL E+ + F+ ++ Y + GK
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR---------GKY 218
Query: 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792
+ ++ + + +Q P LRP K+
Sbjct: 219 PPIPPIYSQDLQ------NFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 79/270 (29%), Positives = 131/270 (48%), Gaps = 28/270 (10%)
Query: 528 VGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
+G G FG V+KG+ I + VA+K + DR + +E + ++ +G H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
LG C G + LV + G+L + +L P N QIA+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQIAKGMYYLEEHR-- 129
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI 702
++H ++ +NILL +I+DFG+A LL + K + + ++A E
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 703 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE-GDTEAMN 761
T + DV+S+GV + E++S E YA + R ++ DL+E G+ A
Sbjct: 189 THQSDVWSYGVTVWEMMSYG-------AEPYAGM--------RPHEVPDLLEKGERLAQP 233
Query: 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVS 791
I CT + MV + C D ++RPT ++++
Sbjct: 234 QI-CTIDVYMVMVKCWMIDENVRPTFKELA 262
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 8e-23
Identities = 83/298 (27%), Positives = 131/298 (43%), Gaps = 52/298 (17%)
Query: 528 VGRGSFGIVYKGVIQTT--RTSTTAVAVKKL--DRVFQDGEKEFKNEVV------VIGQT 577
+G G+FG V K T+ VAVK L D EK+ + V +IG+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT----EKDLSDLVSEMEMMKMIGK- 74
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------------FGNLKPSWNLR--- 622
HKN++ LLG C + +V E+ +G L FL P L
Sbjct: 75 -HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 623 -TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681
+ A+Q+ARG+ +L S + IH D+ +N+L+ + + +I+DFGLA+ +
Sbjct: 134 LVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWA 740
T R ++APE + T + DV+SFGVLL EI + G Y I +
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG-------GSPYPGIPVEEL 243
Query: 741 FDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798
F + G + CT++L + C E PS RPT +++ + L+ ++
Sbjct: 244 FKLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-22
Identities = 77/291 (26%), Positives = 135/291 (46%), Gaps = 41/291 (14%)
Query: 523 NFEEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHH 579
E+G+GSFG+VY+G + + T VAVK ++ E+ EF NE V+
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQI 629
++VRLLG +GQ L+V E + +G L S+L G P+ +A +I
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
A G+ YL+ + + +H D+ +N ++ + +I DFG+ + + ++ + +G K
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR---KGGK 180
Query: 690 G-----YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 744
G ++APE ++ T D++SFGV+L EI S L + +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGL 225
Query: 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
N ++ V C E++ + C Q +P +RPT ++ +L+
Sbjct: 226 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 23/204 (11%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 584
E++G+G+FG VYKGV++ T VAVK + D +++F E ++ Q H N+V+
Sbjct: 1 EKIGKGNFGDVYKGVLKGN----TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI----ARGLLYLHEDC 640
L+G C + Q +V E + G+L +FL K L Q+ A G+ YL
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK----GYVAPEW 696
IH D+ +N L+ + +ISDFG+++ + I T G K + APE
Sbjct: 114 C---IHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 697 FRNSTITAKVDVYSFGVLLLEIIS 720
T++ DV+S+G+LL E S
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 14/200 (7%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV----VIGQTHHKNL 582
E+G G+FG V KG+ + ++ T VAVK L + + K+E++ V+ Q + +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKT-VAVKILKN--DNNDPALKDELLREANVMQQLDNPYI 58
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
VR++G C E ++ +LV E G L FL N + T + Q++ G+ YL E
Sbjct: 59 VRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET--- 114
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS--KAIKTAIRGTKGYVAPEWFRNS 700
+H D+ +N+LL + A+ISDFGL+K L +++ KA K Y APE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APECMNYY 173
Query: 701 TITAKVDVYSFGVLLLEIIS 720
++K DV+SFGVL+ E S
Sbjct: 174 KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKN 581
E +G+GSFG VYK + + + VA+K +D ++ E E + E+ + Q
Sbjct: 6 LECIGKGSFGEVYKAID---KRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHE 638
+ + G +G ++ E+ G+ L KP T IAF ++ GL YLHE
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHE 116
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR 698
+ IH DIK NILL + + +++DFG++ LT SK GT ++APE +
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV--GTPFWMAPEVIK 171
Query: 699 NSTITAKVDVYSFGVLLLEII 719
S K D++S G+ +E+
Sbjct: 172 QSGYDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 4e-22
Identities = 75/286 (26%), Positives = 134/286 (46%), Gaps = 37/286 (12%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLV 583
EE +G G FG V +G ++ VA+K L + + + ++F +E ++GQ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLH 637
L G + + +++ EF+ NG L SFL F ++ LR IA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG-----IAAGMKYLS 123
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK---GYVAP 694
E +H D+ +NIL++ ++SDFGL++ L + S T+ G K + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 695 EWFRNSTITAKVDVYSFGVLLLEIISC--RKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752
E T+ DV+S+G+++ E++S R +D+ N + +
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----------------NQDVINA 223
Query: 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798
+E D + C L + + C Q+D + RP ++ L+ ++
Sbjct: 224 IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 79/283 (27%), Positives = 129/283 (45%), Gaps = 47/283 (16%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-----KEFKNEVVVIGQTHHK 580
E +G GSFG VY+G+ AVK++ K+ + E+ ++ + H
Sbjct: 6 ELLGSGSFGSVYEGL---NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHE 638
N+V+ LG E N + E + G+LA L +G+ + QI GL YLH
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP--VIRLYTRQILLGLEYLH- 119
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAK-LLTLNQSKAIKTAIRGTKGYVAPEWF 697
+H DIK NIL+D +++DFG+AK ++ + +K+ K G+ ++APE
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK----GSPYWMAPEVI 173
Query: 698 -RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL----DDL 752
+ D++S G +LE+ + + + E A + F R+ +L D L
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQL--EGVAAV----FKIGRSKELPPIPDHL 227
Query: 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
EA + I + C+Q DPSLRPT +++LE
Sbjct: 228 ---SDEAKDFI----------LKCLQRDPSLRPT---AAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 12/207 (5%)
Query: 526 EEVGRGSFGIVYKGVIQTTRT--STTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
++G+GSFG+V+K V + + + + + K++R ++ E +E V+ + ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE---EAIDEARVLAKLDSSYII 62
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARGLLYLHEDCS 641
R + +V E+ NG L L + QI GL +LH S
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---S 119
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+I+H DIK N+ LD Y N +I D G+AKLL+ N + A I GT Y++PE +
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDKP 177
Query: 702 ITAKVDVYSFGVLLLEIISCRKSFDIE 728
K DV++ GV+L E + + FD
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (240), Expect = 7e-22
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 526 EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEKE--FKN---EVVVIGQTHH 579
E++G G++G+VYK +T VA+KK + D E+E E+ ++ + H
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEI----VALKK---IRLDNEEEGIPSTALREISLLKELKH 57
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLH 637
N+V+LL + LV+E+ + L +L + +I +Q+ RGL Y H
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
S +I+H D+KPQNIL++ +++DFGLA+ + + T Y APE
Sbjct: 116 ---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEIL 170
Query: 698 RNSTI-TAKVDVYSFGVLLLEII 719
S + VD++S G + E+I
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-22
Identities = 72/215 (33%), Positives = 103/215 (47%), Gaps = 34/215 (15%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTT--AVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVR 584
+G G+FG VY+G+ + VAVK L + E +F E +++ + +H+N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN----LKPSWNLRT----NIAFQIARGLLYL 636
L+G E R ++ E + G L SFL N +PS +L A +A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPS-SLTMKDLLFCARDVAKGCKYL 132
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNAR---ISDFGLAKLLTLNQSKAIKTAIRGTKG--- 690
E IH DI +N LL R I+DFG+A + I A KG
Sbjct: 133 EE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMA--------RDIYRASYYRKGGRA 181
Query: 691 -----YVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
++ PE F + T+K DV+SFGVLL EI S
Sbjct: 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 77/292 (26%), Positives = 125/292 (42%), Gaps = 53/292 (18%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL---DRVFQDGEKE-------FKNEVVVIG 575
E +G G+FG VYK ++ +A+K++ + F ++E +EV +I
Sbjct: 6 EHLGSGAFGCVYK--VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIK 63
Query: 576 -QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS---------WNLRTNI 625
Q H N+VR E +V + + L F +LK WN I
Sbjct: 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWN----I 118
Query: 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI 685
Q+ L YLH++ +I+H D+ P NI+L + I+DFGLAK Q ++ T++
Sbjct: 119 FVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSV 173
Query: 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 745
GT Y PE +N K DV++FG +L ++ + + F Y
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF------------------YS 215
Query: 746 NGKLD---DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794
L +VE E + + +E + V C+ D RP + +VS M+
Sbjct: 216 TNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 66/203 (32%), Positives = 96/203 (47%), Gaps = 25/203 (12%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--RVFQDGEKEF-KNEVVVIGQTHHKNLVR 584
+G+GSFG V + T A+K L ++ + E E E ++ + +H +V+
Sbjct: 1 LGKGSFGKVLLVRKKDTGK---LYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 585 LL-GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAF---QIARGLLYLH 637
L F E +L LV E+ G L S L G F +I L YLH
Sbjct: 58 LHYAFQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEER-----ARFYAAEIVLALEYLH 110
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
S II+ D+KP+NILLD + +++DFGLAK L ++ T GT Y+APE
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFC-GTPEYLAPEVL 165
Query: 698 RNSTITAKVDVYSFGVLLLEIIS 720
VD +S GVLL E+++
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 16/202 (7%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVRLL 586
+G+G FG VY G + + AVK L+R+ E ++F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 587 GFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAF--QIARGLLYLHEDC 640
G C EG L+V ++ +G L +F+ + N ++ I F Q+A+G+ YL
Sbjct: 63 GICLPSEGSP-LVVLPYMKHGDLRNFI---RSETHNPTVKDLIGFGLQVAKGMEYL---A 115
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI--KTAIRGTKGYVAPEWFR 698
S + +H D+ +N +LD+ + +++DFGLA+ + + ++ T + ++A E +
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 699 NSTITAKVDVYSFGVLLLEIIS 720
T K DV+SFGVLL E+++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 26/209 (12%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 583
++ +G G FG V++G+++ AVA+K L + + ++ +F +E ++GQ H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLH 637
RL G + + +++ E++ NG L +L F + + LR IA G+ YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG-----IAAGMKYLS 124
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL------TLNQSKAIKTAIRGTKGY 691
+ +H D+ +NIL++ ++SDFGL+++L T S K IR T
Sbjct: 125 D---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG-KIPIRWT--- 177
Query: 692 VAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
APE T+ DV+SFG+++ E++S
Sbjct: 178 -APEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 70/228 (30%), Positives = 109/228 (47%), Gaps = 19/228 (8%)
Query: 516 ELEEATDNFEEEV--GRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 573
E E D E V G+G++GIVY +T+ +A+K++ + E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVR---IAIKEIPERDSRYVQPLHEEIAL 58
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIA 630
H+N+V+ LG E + E + G+L++ L P + I F QI
Sbjct: 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA-RISDFGLAKLLT-LNQSKAIKTAIRGT 688
GL YLH++ QI+H DIK N+L++ Y +ISDFG +K L +N T GT
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GT 172
Query: 689 KGYVAPEWFRNST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 734
Y+APE A D++S G ++E+ + + F IE+GE A
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF-IELGEPQA 219
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 14/206 (6%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
VGRG+FGIV+ + + V +K++ +++ +D +NE V+ H N++
Sbjct: 8 VGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSAQ 643
E + ++V E+ GTLA ++ + T + F QI LL LH +
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI---LLALHHVHTKL 121
Query: 644 IIHCDIKPQNILLDDYYNA-RISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI 702
I+H D+K QNILLD + +I DFG++K+L+ SK+ + GT Y++PE
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKPY 178
Query: 703 TAKVDVYSFGVLLLEIISCRKSFDIE 728
K D+++ G +L E+ S +++F+
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 65/214 (30%), Positives = 116/214 (54%), Gaps = 25/214 (11%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKK--LDRVFQDGEKE-------FKNEVVVIGQTH 578
+G GSFG VY G+ +S +AVK+ L V + E+ ++ +
Sbjct: 8 IGSGSFGSVYLGM---NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 579 HKNLVRLLGFCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLY 635
H+N+V+ LG + L ++ E++ G++A+ L +G + + L N QI +GL Y
Sbjct: 65 HENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEET--LVRNFVRQILKGLNY 121
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----QSKAIKTAIRGTKGY 691
LH + IIH DIK NIL+D+ +ISDFG++K L N ++ + +++G+ +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 692 VAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 725
+APE + ++ T K D++S G L++E+++ + F
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 18/210 (8%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIG 575
E+ T +++G G FG V+ G T VA+K L + E F E ++
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYN----GHTKVAIKSLKQGSMSPEA-FLAEANLMK 56
Query: 576 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGL 633
Q H LVRL + + ++ E++ NG+L FL +K + N ++A QIA G+
Sbjct: 57 QLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGM 115
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK---G 690
++ IH D++ NIL+ + +I+DFGLA+L+ N+ TA G K
Sbjct: 116 AFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY----TAREGAKFPIK 168
Query: 691 YVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
+ APE T T K DV+SFG+LL EI++
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 76/283 (26%), Positives = 136/283 (48%), Gaps = 43/283 (15%)
Query: 527 EVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 583
E+G+GSFG+VY+G+ + T VA+K ++ E+ EF NE V+ + + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 633
RLLG +GQ L++ E + G L S+L PS +A +IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG--- 690
YL+ + + +H D+ +N ++ + + +I DFG+ + + ++ + +G KG
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 184
Query: 691 --YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748
+++PE ++ T DV+SFGV+L EI A L + + N +
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGMSNEQ 229
Query: 749 -LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
L ++EG D C + L + C Q +P +RP+ ++
Sbjct: 230 VLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 76/286 (26%), Positives = 127/286 (44%), Gaps = 40/286 (13%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
+G G FG V +G + S VAVK KLD +EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 586 LGFCDEGQNR------LLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAF--QIARGL 633
+G C E + +++ F+ +G L SFL G L L+T + F IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL----TLNQSKAIKTAIRGTK 689
YL + IH D+ +N +L + ++DFGL+K + Q + K ++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK--- 180
Query: 690 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 749
++A E + T+K DV++FGV + EI + G+ + N ++
Sbjct: 181 -WIAIESLADRVYTSKSDVWAFGVTMWEIAT--------RGQT-------PYPGVENHEI 224
Query: 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
D + C ++L + C + DP RPT K+ ++LE
Sbjct: 225 YDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-21
Identities = 81/296 (27%), Positives = 136/296 (45%), Gaps = 47/296 (15%)
Query: 528 VGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVR 584
+G G FG V K R T VAVK L E ++ +E ++ Q +H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFL-------------FGNLKPSW---------NLR 622
L G C + LL+ E+ G+L SFL GN S+ +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 623 TNIAF--QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680
I+F QI+RG+ YL E +++H D+ +N+L+ + +ISDFGL++ + S
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDW 739
++ R ++A E + T + DV+SFGVLL EI++ G Y I +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG-------GNPYPGIAPER 237
Query: 740 AFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
F+ + G + E C+E++ + + C +++P RPT +S+ LE
Sbjct: 238 LFNLLKTGYRMERPE---------NCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 8/199 (4%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 584
+++G GSFG+V +G T+ VAVK L D +F E ++ H+NL+R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCSA 642
L G ++V E G+L L + + + T + A QIA G+ YL S
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SK 116
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK-GYVAPEWFRNST 701
+ IH D+ +NILL +I DFGL + L N+ + + APE R T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 702 ITAKVDVYSFGVLLLEIIS 720
+ DV+ FGV L E+ +
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-20
Identities = 44/111 (39%), Positives = 58/111 (52%), Gaps = 8/111 (7%)
Query: 80 EKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSS-KIDIGTVAIGVMNDT 138
+TVVW N+ NP + L +D LVL D G+ VWSS G+ + V+ D
Sbjct: 1 NQTVVWVA-NRL-NPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDD 58
Query: 139 GNFVLASSSSSKLWDSFTNPSDTLLPGQMMET-----EQGLFSRKSDTNFS 184
GN VL +S LW SF +P+DTLLPGQ + L S KS+T+ S
Sbjct: 59 GNLVLYDNSGKVLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 75/276 (27%), Positives = 120/276 (43%), Gaps = 33/276 (11%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 584
E +GRG+FG V+ G + R T VAVK + + D + +F E ++ Q H N+VR
Sbjct: 1 ERIGRGNFGEVFSGRL---RADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 57
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSA 642
L+G C + Q +V E + G +FL P ++ I A G+ YL
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKHC- 115
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK----GYVAPEWFR 698
IH D+ +N L+ + +ISDFG+++ + + + G K + APE
Sbjct: 116 --IHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758
+++ DV+SFG+LL E S YA L+ N + + +E
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAV-------PYANLS--------NQQTREAIEQGVR 214
Query: 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794
C + + + C + DP RP+ V Q L
Sbjct: 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLVR 584
+G+G+FG V ++Q T A+K +++ + +N E ++ + +H LV
Sbjct: 8 IGKGAFGKVC--IVQKRDTKKM-FAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 585 L-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQ----------IARGL 633
L F DE +N LV + L G L ++L + F I L
Sbjct: 65 LWYSFQDE-ENMYLVVDLLLGGDL----------RYHLSQKVKFSEEQVKFWICEIVLAL 113
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
YLH S IIH DIKP NILLD+ + I+DF +A +T + + T+ GT GY+A
Sbjct: 114 EYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMA 167
Query: 694 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDI 727
PE + VD +S GV E + ++ +
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 73/293 (24%), Positives = 126/293 (43%), Gaps = 43/293 (14%)
Query: 524 FEEEVGRGSFGIVYKG--VIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHK 580
+ E+G G+FG V+ G VAVK L + D K+F+ E ++ H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN--------------IA 626
N+V+ G C EG ++V+E++ +G L FL + + L++ IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA-- 684
QIA G++YL S +H D+ +N L+ +I DFG+++ + +
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 685 --IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 742
IR ++ PE T + DV+SFGV+L EI + K + E I +
Sbjct: 186 LPIR----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI------E 235
Query: 743 CYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
C G+L C ++ + + C + DP R ++ + + L+
Sbjct: 236 CITQGRLLQRPRT---------CPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 78/291 (26%), Positives = 136/291 (46%), Gaps = 24/291 (8%)
Query: 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTA-VAVKKLDRVFQDGEKEFKNEVVVIGQ 576
EE F +++G+G+FG V + +T VAVKKL + ++F+ E+ ++
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61
Query: 577 THHKNLVRLLGFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARG 632
H N+V+ G C G+ L LV E+L G+L +L + + + R + + QI +G
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKG 120
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS-KAIKTAIRGTKGY 691
+ YL S + +H D+ +NIL++ +I DFGL K+L ++ ++ +
Sbjct: 121 MEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 692 VAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKS------FDIEMGEEYAILTDWAFDCY 744
APE S + DV+SFGV+L E+ + KS F MG + Y
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND----KQGQMIVY 233
Query: 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
L +L++ + C ++ + C DPS RP+ +++ +E
Sbjct: 234 H---LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 13/204 (6%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK-NEVVVIGQ-THHKNLV 583
+++G G+FG VY + + VA+KK+ + F E+ EV + + H N+V
Sbjct: 5 KQLGDGTFGSVYLAR---NKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIV 61
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSA 642
+L E V+E++ KP S ++ +I +QI +GL ++H
Sbjct: 62 KLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KH 118
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF-RNST 701
H D+KP+N+L+ +I+DFGLA+ + +S+ T T+ Y APE R+++
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTRWYRAPEILLRSTS 175
Query: 702 ITAKVDVYSFGVLLLEIISCRKSF 725
++ VD+++ G ++ E+ + R F
Sbjct: 176 YSSPVDIWALGCIMAELYTLRPLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 53/204 (25%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN--EVVVIGQTHHKNLV 583
++G G++G+VYK + + VA+KK+ F+ E+ ++ + +H N++
Sbjct: 5 GKIGEGTYGVVYKA---RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSA 642
+LL + LV+EF++ L + + +L + +Q+ +GL + H S
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SH 117
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI 702
I+H D+KP+N+L++ +++DFGLA+ + T T+ Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 703 -TAKVDVYSFGVLLLEIISCRKSF 725
+ VD++S G + E++S R F
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-20
Identities = 80/282 (28%), Positives = 129/282 (45%), Gaps = 27/282 (9%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIG 575
E+ + E ++G+G FG V+ G T TT VA+K L E F E V+
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMK 56
Query: 576 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGL 633
+ H+ LV+L E + +V E+++ G+L FL G + L ++A QIA G+
Sbjct: 57 KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 115
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
Y+ +H D++ NIL+ + +++DFGLA+L+ N+ A + A K + A
Sbjct: 116 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTA 171
Query: 694 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753
PE T K DV+SFG+LL E+ + + + N ++ D V
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQV 216
Query: 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
E +C E L + C +++P RPT + LE
Sbjct: 217 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 63/218 (28%), Positives = 113/218 (51%), Gaps = 34/218 (15%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL----------DRVFQDGEKEFKNEVVVIG 575
E +G+G++G VY + TT +AVK++ D +D K ++E+ +
Sbjct: 7 ELIGKGTYGRVYLALNVTT---GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK 63
Query: 576 QTHHKNLVRLLGFCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARG 632
H N+V+ LGF + + L ++ E++ G++ S L +G + L Q+ G
Sbjct: 64 DLDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ--LVRFFTEQVLEG 120
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI-----KTAIRG 687
L YLH S I+H D+K N+L+D +ISDFG++K +S I +++G
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK-----KSDDIYDNDQNMSMQG 172
Query: 688 TKGYVAPEWFRNST--ITAKVDVYSFGVLLLEIISCRK 723
+ ++APE + + +AKVD++S G ++LE+ + R+
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 71/228 (31%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 514 YKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 573
Y LE F++ +G G+FG V K I+ A + + +D ++F E+ V
Sbjct: 1 YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 574 IGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA-- 630
+ + HH N++ LLG C+ L E+ +G L FL + S L T+ AF IA
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANS 116
Query: 631 ------------------RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672
RG+ YL + Q IH D+ +NIL+ + Y A+I+DFGL++
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR- 172
Query: 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
+ KT R ++A E S T DV+S+GVLL EI+S
Sbjct: 173 --GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 20/199 (10%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNL 582
E +G+GSFG VYKG+ T+ VA+K +D ++ E E ++ E+ V+ Q +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKE---VVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHED 639
R G +G ++ E+L G+ L KP T IA +I +GL YLH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLH-- 118
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
S + IH DIK N+LL + + +++DFG+A LT Q K + GT ++APE +
Sbjct: 119 -SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQ 175
Query: 700 STITAKVDVYSFGVLLLEI 718
S K D++S G+ +E+
Sbjct: 176 SAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 69/204 (33%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVR 584
+G+G FG V ++ T A KKLD+ + GE+ NE ++ + + +V
Sbjct: 1 LGKGGFGEVCACQVKAT---GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS 57
Query: 585 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCS 641
L + E ++ L LV +N G L ++ +P + I A QI GL +LH+
Sbjct: 58 L-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-- 114
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+I++ D+KP+N+LLDD+ N RISD GLA + L K IK GT GY+APE +
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRA-GTPGYMAPEVLQGEV 170
Query: 702 ITAKVDVYSFGVLLLEIISCRKSF 725
VD ++ G L E+I+ R F
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 80/305 (26%), Positives = 131/305 (42%), Gaps = 53/305 (17%)
Query: 512 FSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTST--TAVAVKKLDRV-FQDGEKEFK 568
F L+E T +GRG FG V+ + T V VK L + ++ + EF+
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 569 NEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN------LKP---SW 619
E+ + + HKN+VRLLG C E + ++ E+ + G L FL LKP S
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 620 NLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK------LL 673
+ + QIA G+ +L +A+ +H D+ +N L+ ++S L+K
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE- 732
L + +R ++APE + + K DV+SFGVL+ E+ + GE
Sbjct: 174 KLRNALI---PLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT--------QGELP 218
Query: 733 YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKV 790
+ L+D L+ L G E C +L +M W + +P RP+ ++
Sbjct: 219 FYGLSDEEV-------LNRLQAGKLELPVPEGCPSRLYKLMTRCWAV--NPKDRPSFSEL 269
Query: 791 SQMLE 795
L
Sbjct: 270 VSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 14/196 (7%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNL 582
E +G+GSFG V+KG+ T+ VA+K +D ++ E E ++ E+ V+ Q +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQ---VVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
+ G +G ++ E+L G+ L + + T + +I +GL YLH S
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLH---SE 120
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI 702
+ IH DIK N+LL + + +++DFG+A LT Q K + GT ++APE + S
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAY 178
Query: 703 TAKVDVYSFGVLLLEI 718
+K D++S G+ +E+
Sbjct: 179 DSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 3e-19
Identities = 74/269 (27%), Positives = 129/269 (47%), Gaps = 26/269 (9%)
Query: 528 VGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEK---EFKNEVVVIGQTHHKNLV 583
+G G+FG VYKG+ + T VA+K L+ G K EF +E +++ H +LV
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TGPKANVEFMDEALIMASMDHPHLV 72
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSA 642
RLLG C +L V + + +G L ++ + L N QIA+G++YL E
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---R 128
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI 702
+++H D+ +N+L+ + +I+DFGLA+LL ++ + + ++A E
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 703 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762
T + DV+S+GV + E+++ G+ Y D ++ DL+E
Sbjct: 189 THQSDVWSYGVTIWELMTFG-------GKPY--------DGIPTREIPDLLEKGERLPQP 233
Query: 763 IKCTEKLVMVSIWCIQEDPSLRPTMRKVS 791
CT + MV + C D RP ++++
Sbjct: 234 PICTIDVYMVMVKCWMIDADSRPKFKELA 262
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 31/271 (11%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
F +E+G G FG+V G + VA+K + + E EF E V+ + H+ LV
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYD----VAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLV 62
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSA 642
+L G C + + +V E+++NG L ++L + K + + + G+ YL S
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SK 119
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV---APEWFRN 699
Q IH D+ +N L+DD ++SDFGL++ + ++ T+ G+K V PE
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY----TSSVGSKFPVRWSPPEVLLY 175
Query: 700 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759
S ++K DV++FGVL+ E+ S L ++ + N + + V
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYS---------------LGKMPYERFNNSETVEKVSQGLRL 220
Query: 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+EK+ + C E RPT +++
Sbjct: 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 73/292 (25%), Positives = 136/292 (46%), Gaps = 35/292 (11%)
Query: 517 LEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIG 575
++ + E+ +G G FG V G ++ VA+K L + + ++ +F +E ++G
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 576 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQI 629
Q H N++ L G + + ++V E++ NG+L +FL F ++ LR I
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRG-----I 115
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
A G+ YL D +H D+ +NIL++ ++SDFGL+++L + A T RG K
Sbjct: 116 ASGMKYL-SDMGY--VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT--RGGK 170
Query: 690 ---GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746
+ APE T+ DV+S+G+++ E++S + EM + I
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA--------- 221
Query: 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798
+E + C L + + C Q+D + RP ++ +L+ ++
Sbjct: 222 ------IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 82/274 (29%), Positives = 126/274 (45%), Gaps = 46/274 (16%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
+G G FG VY+GV + AVAVK K EK F E ++ Q H ++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHIV 70
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCS 641
+L+G E +V E G L S+L N K S +L + I ++Q++ L YL S
Sbjct: 71 KLIGVITE-NPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLE---S 125
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS--KAIKTA--IRGTKGYVAPEWF 697
+ +H DI +N+L+ ++ DFGL++ L ++S KA K I+ ++APE
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIK----WMAPESI 180
Query: 698 RNSTITAKVDVYSFGVLLLEIISC-RKSFD----------IEMGEE-----------YAI 735
T+ DV+ FGV + EI+ K F IE GE Y++
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 240
Query: 736 LTD-WAFDCYRNGKLDDLVEGDTEAMNDIKCTEK 768
+T WA+D + + +L ++DI EK
Sbjct: 241 MTKCWAYDPSKRPRFTELK----AQLSDILQEEK 270
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 37/298 (12%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTS-TTAVAVKKLDRVFQDGE-KEFKNEVVV 573
EL + F EE+G +FG +YKG + VA+K L + + EF+ E +
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---------------GNLKPS 618
+ + HH N+V LLG + Q +++E+LN G L FL G +K S
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 619 WNLRT--NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676
+ +IA QIA G+ YL S +H D+ +NIL+ + + +ISD GL++ +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 736
++ ++ PE ++ D++SFGV+L EI F + Y
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI------FSFGLQPYYGFS 231
Query: 737 TDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794
+ R +L E C ++ + C QE PS RP + + L
Sbjct: 232 NQEVIEMVRKRQLLPCSE---------DCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 78/285 (27%), Positives = 133/285 (46%), Gaps = 36/285 (12%)
Query: 528 VGRGSFGIVYKGV---IQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 583
+G G+FG VY+G I + VAVK L + D EK EF E ++ +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRT-----NIAFQIARGLLYL 636
+LLG C + + ++ E + G L S+L + L T +I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 637 HEDCSAQIIHCDIKPQNILLD--DYYNAR---ISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
+ IH D+ +N L+ Y R I DFGLA+ + + + +
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 692 VAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLD 750
+APE + T + DV+SFGVL+ EI++ +G++ Y L + + ++
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILT--------LGQQPYPALNN--QEVLQHVT-- 227
Query: 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
G + + C +K+ + C +DPS RPT ++ ++L+
Sbjct: 228 --AGGRLQKPEN--CPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 7e-19
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 581
DNF + +G GS GIV I T +++ VAVKK+D Q + NEVV++ H N
Sbjct: 22 DNFVK-IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 641
+V + G +V EFL G L + + T + + + L +LH +
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLAVLKALSFLH---A 133
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+IH DIK +ILL ++SDFG ++ + + ++ GT ++APE
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLP 191
Query: 702 ITAKVDVYSFGVLLLEII 719
+VD++S G++++E++
Sbjct: 192 YGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 579
+++E + +G G++G VYK T A+ V KL+ D + + E+ ++ + H
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELV-AIKVIKLEP--GDDFEIIQQEISMLKECRH 59
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLA---SFLFGNLKPSWNLRTNIAF---QIARGL 633
N+V G +V E+ G+L G L IA+ + +GL
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS-----ELQIAYVCRETLKGL 114
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
YLHE IH DIK NILL + + +++DFG++ LT +K K+ I GT ++A
Sbjct: 115 AYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR-KSFI-GTPYWMA 169
Query: 694 PEWF---RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 731
PE R K D+++ G I+ IE+ E
Sbjct: 170 PEVAAVERKGGYDGKCDIWALG------ITA-----IELAE 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 578
E D+F + +G GS GIV I T + + VAVKK+D Q + NEVV++ H
Sbjct: 22 EYLDSFIK-IGEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77
Query: 579 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 638
H+N+V + G +V EFL G L + + T + + R L YLH
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLSVLRALSYLH- 135
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR 698
+ +IH DIK +ILL ++SDFG ++ K + ++ GT ++APE
Sbjct: 136 --NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVIS 191
Query: 699 NSTITAKVDVYSFGVLLLEII 719
+VD++S G++++E+I
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 78/282 (27%), Positives = 125/282 (44%), Gaps = 27/282 (9%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIG 575
E+ + +++G G FG V+ G T T VAVK L E F E ++
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMG----TWNGNTKVAVKTLKPGTMSPES-FLEEAQIMK 56
Query: 576 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGL 633
+ H LV+L E + +V E+++ G+L FL + L ++A Q+A G+
Sbjct: 57 KLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM 115
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
Y+ IH D++ NIL+ D +I+DFGLA+L+ N+ A + A K + A
Sbjct: 116 AYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK-WTA 171
Query: 694 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753
PE T K DV+SFG+LL E+++ + + N ++ + V
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRV---------------PYPGMNNREVLEQV 216
Query: 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
E C L + + C ++DP RPT + LE
Sbjct: 217 ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 76/283 (26%), Positives = 129/283 (45%), Gaps = 29/283 (10%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIG 575
E+ + E+++G G FG V+ T T VAVK + E F E V+
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVW----MATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMK 56
Query: 576 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARG 632
H LV+L + + ++ EF+ G+L FL G+ +P L + + QIA G
Sbjct: 57 TLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEG 114
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
+ ++ + IH D++ NIL+ +I+DFGLA+++ N+ A + A K +
Sbjct: 115 MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WT 170
Query: 693 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752
APE + T K DV+SFG+LL+EI++ + Y ++ N ++
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRI-------PYPGMS--------NPEVIRA 215
Query: 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+E C E+L + + C + P RPT + +L+
Sbjct: 216 LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 20/203 (9%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK----NL 582
E+G G+FG V KGV + R VA+K L + EK ++E++ + H+ +
Sbjct: 2 ELGSGNFGCVKKGVYKM-RKKQIDVAIKVLK---NENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---FQIARGLLYLHED 639
VR++G C E + +LV E + G L FL G K +N+ Q++ G+ YL
Sbjct: 58 VRMIGVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEG- 113
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS--KAIKTAIRGTKGYVAPEWF 697
+H D+ +N+LL + + A+ISDFGL+K L + S KA ++A + + APE
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA-RSAGKWPLKWYAPECI 170
Query: 698 RNSTITAKVDVYSFGVLLLEIIS 720
+++ DV+S+G+ + E S
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 75/278 (26%), Positives = 127/278 (45%), Gaps = 37/278 (13%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
F +E+G G FG+V+ G + + VA+K + E++F E V+ + H LV
Sbjct: 8 FMKELGSGQFGVVHLGKWR----AQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDC 640
+L G C + + +V EF+ NG L ++L G L L ++ + G+ YL +
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL--SMCQDVCEGMEYLERN- 119
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIKTAIRGTKGYVAPEWF 697
IH D+ +N L+ ++SDFG+ + + ++ S K ++ + PE F
Sbjct: 120 --SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK----WSPPEVF 173
Query: 698 RNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756
S ++K DV+SFGVL+ E+ + + F+ + E + F YR KL
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP-KL------- 225
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794
A + VM S W E P RPT ++ + +
Sbjct: 226 --ASMTV----YEVMYSCW--HEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQ 576
D+FE + +G GSFG V + + S A+K L + V + NE ++
Sbjct: 1 DDFEFIKTLGTGSFGRVM---LVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 636
H LV L G + N LV E++ G L S L + + + A Q+ L YL
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
H S I++ D+KP+N+LLD +I+DFG AK + T + GT Y+APE
Sbjct: 118 H---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYT-LCGTPEYLAPEI 169
Query: 697 FRNSTITAKVDVYSFGVLLLEII 719
+ VD ++ G+L+ E++
Sbjct: 170 ILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTA--VAVKKLDRVFQDGEKEFKN----EVVV 573
+ +E VG G++G+V K R T VA+KK + +++ K EV V
Sbjct: 1 NKYEVLGVVGEGAYGVVLK-----CRNKATGEIVAIKKFKES--EDDEDVKKTALREVKV 53
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIA 630
+ Q H+N+V L LV+E++ TL L G L P +Q+
Sbjct: 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRS--YIWQLL 110
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690
+ + Y H S IIH DIKP+NIL+ + ++ DFG A+ L + + T T+
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRW 166
Query: 691 YVAPEWFRNSTITAK-VDVYSFGVLLLEIISCRKSF 725
Y APE T K VDV++ G ++ E++ F
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 20/199 (10%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNL 582
E++G+GSFG V+KG+ T+ VA+K +D ++ E E ++ E+ V+ Q +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQK---VVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHED 639
+ G + ++ E+L G+ L +P T IA +I +GL YLH
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH-- 118
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
S + IH DIK N+LL ++ +++DFG+A LT Q K + GT ++APE +
Sbjct: 119 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQ 175
Query: 700 STITAKVDVYSFGVLLLEI 718
S +K D++S G+ +E+
Sbjct: 176 SAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 21/201 (10%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKN----EVVVIGQTHHKN 581
VG GS+G+V K + + VA+KK F + E K K E+ ++ Q H+N
Sbjct: 9 VGEGSYGMVMKC---KHKETGQIVAIKK----FLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASF-LFGNLKPSWNLRTNIAFQIARGLLYLHEDC 640
LV L+ + LV+EF+++ L + N +R + FQI RG+ + H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL-FQILRGIEFCH--- 117
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS 700
S IIH DIKP+NIL+ ++ DFG A+ TL + T T+ Y APE
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAPELLVGD 175
Query: 701 TITAK-VDVYSFGVLLLEIIS 720
T + VD+++ G L+ E+++
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 66/274 (24%), Positives = 123/274 (44%), Gaps = 34/274 (12%)
Query: 528 VGRGSFG--IVYKGVIQTTRTSTTAVAVKK---LDRVFQDGEKEFKNEVVVIGQTHHKNL 582
+G+G+FG +Y+ RT ++ V K L R+ + ++ NE+V++ H N+
Sbjct: 8 LGKGAFGEATLYR------RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--FQIARGLLYLHEDC 640
+ + L+ E+ N GTL + + + FQI + Y+H+
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK-- 119
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS 700
A I+H DIK NI L ++ DFG++K+L S A +T + GT Y++PE +
Sbjct: 120 -AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA-ETVV-GTPYYMSPELCQGV 176
Query: 701 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760
K D+++ G +L E+++ +++FD + +V+G+
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV---------------KIVQGN-YTP 220
Query: 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794
+ +L+ + +Q+DP RPT +V
Sbjct: 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 526 EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHH---K 580
E +GRG++G VY+G + T R VA+K ++ D + + + EV ++ Q
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRV----VALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL----YL 636
N+ + G +G ++ E+ G++ + + K I+ I R +L Y+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISV-IIREVLVALKYI 117
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
H +IH DIK NIL+ + N ++ DFG+A LL N SK ++ GT ++APE
Sbjct: 118 H---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEV 172
Query: 697 FRN-STITAKVDVYSFGVLLLEIIS 720
K D++S G+ + E+ +
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMAT 197
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 581
DNF + +G GS GIV I T ++S VAVKK+D Q + NEVV++ H+N
Sbjct: 23 DNFIK-IGEGSTGIV---CIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 641
+V + G +V EFL G L + + + + + L LH +
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLKALSVLH---A 134
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+IH DIK +ILL ++SDFG +++ + ++ GT ++APE
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 702 ITAKVDVYSFGVLLLEII 719
+VD++S G++++E++
Sbjct: 193 YGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 4e-18
Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 42/222 (18%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHK 580
VG G++G V T VA+KKL R FQ K E+ ++ H+
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRK---VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 581 NLVRLLG-FC-----DEGQNRLLVYEF----LNNGTLASFLFGNLKPSWNLRTNIAFQIA 630
N++ LL F ++ Q+ LV LNN + K S + + +QI
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNN------IVKCQKLSDDHIQFLVYQIL 128
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690
RGL Y+H SA IIH D+KP NI +++ +I DFGLA+ + T G
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMT------G 174
Query: 691 YVAPEWFRNSTI-------TAKVDVYSFGVLLLEIISCRKSF 725
YVA W+R I VD++S G ++ E+++ + F
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 29/273 (10%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 583
E+G G+ G+V K + R + +AVK + R+ + E K E+ ++ + + +V
Sbjct: 8 ELGAGNSGVVSKVLH---RPTGKIMAVKTI-RLEIN-EAIQKQILRELDILHKCNSPYIV 62
Query: 584 RLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 640
G F + G + + E+++ G+L L R IA + +GL YLHE
Sbjct: 63 GFYGAFYNNGDISICM-EYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHEK- 119
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS 700
+IIH D+KP NIL++ ++ DFG++ L S A KT + GT Y+APE + +
Sbjct: 120 -HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLA-KTFV-GTSSYMAPERIQGN 174
Query: 701 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760
+ K D++S G+ L+E+ + R + E I L +V +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE----------LLQYIVNEPPPRL 224
Query: 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793
K + C+ +DP RP+ +++ +
Sbjct: 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 5e-18
Identities = 55/185 (29%), Positives = 85/185 (45%), Gaps = 25/185 (13%)
Query: 550 AVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKNLVRLLGFCDEGQ---NRLL-VYEFL 602
VA+K L + E + F+ E + + +H N+V LL D G+ L V+E++
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALL---DSGEAPPGLLFAVFEYV 61
Query: 603 NNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---D 657
TL L G L R + Q+ L H I+H D+KPQNI++
Sbjct: 62 PGRTLREVLAADGALPAGETGR--LMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTG 116
Query: 658 DYYNARISDFGLAKLLTLNQSKAIKTAIR-----GTKGYVAPEWFRNSTITAKVDVYSFG 712
+A++ DFG+ LL + + T R GT Y APE R +T D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 713 VLLLE 717
++ LE
Sbjct: 177 LIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 75/306 (24%), Positives = 134/306 (43%), Gaps = 61/306 (19%)
Query: 524 FEEEVGRGSFGIVYK----GVIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTH 578
+ ++G+G+FG V++ G++ T VAVK L + D + +F+ E ++ +
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYE--PFTMVAVKMLKEEASADMQADFQREAALMAEFD 66
Query: 579 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN------------------ 620
H N+V+LLG C G+ L++E++ G L FL P
Sbjct: 67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHR-SPRAQCSLSHSTSSARKCGLNPL 125
Query: 621 -----LRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL------ 669
+ IA Q+A G+ YL E + +H D+ +N L+ + +I+DFGL
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEM 729
A +++ AI IR ++ PE + T + DV+++GV+L EI F M
Sbjct: 183 ADYYKASENDAI--PIR----WMPPESIFYNRYTTESDVWAYGVVLWEI------FSYGM 230
Query: 730 GEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRK 789
Y + + R+G + + C +L + C + PS RP+
Sbjct: 231 QPYYGMAHEEVIYYVRDGNVLSCPDN---------CPLELYNLMRLCWSKLPSDRPSFAS 281
Query: 790 VSQMLE 795
++++L+
Sbjct: 282 INRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIGQT---H 578
E+G G++G VYK + VA+KK+ E+ E+ ++ Q
Sbjct: 5 AEIGEGAYGTVYKA---RDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 579 HKNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIA 630
H N+VRLL C D LV+E ++ LA++L KP ++ ++ Q+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-DLMRQLL 117
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690
RG+ +LH S +I+H D+KPQNIL+ +I+DFGLA++ + + T++ T
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLW 171
Query: 691 YVAPEWFRNSTITAKVDVYSFGVLLLEI 718
Y APE S+ VD++S G + E+
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKK--LDRVFQDG-EKEFKN---EVVVIGQTHH 579
E +G+G++G VY G+ + +AVK+ LD EKE++ EV ++ H
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQL----IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPSWNLRTNIAFQIARGLLYL 636
N+V+ LG C + + EF+ G+++S L FG L +P + T QI G+ YL
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK---QILDGVAYL 118
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL---TLNQSKA-IKTAIRGTKGYV 692
H +C ++H DIK N++L ++ DFG A+ L L+ + + + ++ GT ++
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 693 APEWFRNSTITAKVDVYSFGVLLLEI 718
APE S K D++S G + E+
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 41/211 (19%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
E++G GS+G VYK + + VA+K + V +D + E E+ ++ Q +V
Sbjct: 7 ILEKLGEGSYGSVYKA---IHKETGQVVAIKVV-PVEEDLQ-EIIKEISILKQCDSPYIV 61
Query: 584 RLLGFCDEGQNRLLVYEF----------------LNNGTLASFLFGNLKPSWNLRTNIAF 627
+ G + + +V E+ L +A+ L+ LK
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLK----------- 110
Query: 628 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRG 687
GL YLH S + IH DIK NILL++ A+++DFG++ LT +K T I G
Sbjct: 111 ----GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR-NTVI-G 161
Query: 688 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEI 718
T ++APE + K D++S G+ +E+
Sbjct: 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 528 VGRGSFGIVYKGVIQTTRT-STTAV-AVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
+ +G++G V+ + + T A+ +KK D + ++ + E ++ Q +V+L
Sbjct: 1 ISKGAYGRVF--LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 586 L-GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
F + +N LV E+L G LAS L G+L +I L YLH S
Sbjct: 59 YYSFQGK-KNLYLVMEYLPGGDLASLLENVGSLDEDV--ARIYIAEIVLALEYLH---SN 112
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKL------LTLNQSKAIKTAIRGTKGYVAPEW 696
IIH D+KP NIL+D + +++DFGL+K+ + LN + I GT Y+APE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 697 FRNSTITAKVDVYSFGVLLLEIIS 720
+ VD +S G +L E +
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 34/211 (16%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTA-VAVKKLDRVFQDGEKE-----FKNEVVVIGQTHH 579
++G G++G VYK T VA+KK+ + EKE E+ ++ + H
Sbjct: 5 AQIGEGTYGQVYKA----RNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRH 57
Query: 580 KNLVRLLGFC-DEGQNRL-LVYEFLN---NGTLAS----FLFGNLKPSWNLRTNIAFQIA 630
N+VRL +G+ + +V+E+++ G L S F +K Q+
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK-------CYMKQLL 110
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690
GL YLH S I+H DIK NIL+++ +++DFGLA+ T ++ A T T
Sbjct: 111 EGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYT-KRNSADYTNRVITLW 166
Query: 691 YVAPEWFRNSTI-TAKVDVYSFGVLLLEIIS 720
Y PE +T +VD++S G +L E+
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 67/231 (29%), Positives = 115/231 (49%), Gaps = 33/231 (14%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQ 576
D +E E++G G++G+VYK R + +A+KK+ R+ Q+ E E+ ++ +
Sbjct: 2 DQYEKVEKIGEGTYGVVYKA---RDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKE 57
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLL 634
H N+VRL + LV+E+L+ L + + + N R +QI RG+
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNA-RISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
Y H S +++H D+KPQN+L+D NA +++DFGLA +A +R V
Sbjct: 117 YCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLA--------RAFGIPVRTFTHEVV 165
Query: 694 PEWFRNSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 735
W+R I + VD++S G + E+++ + F D E+ E + I
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216
|
Length = 294 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
+++G G FG V+ G ++T VAVK L + + F E ++ H LVRL
Sbjct: 12 KKLGAGQFGEVWMGYYN----NSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRL 66
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSAQ 643
+ + ++ E++ G+L FL + L I F QIA G+ Y+
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---N 123
Query: 644 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTIT 703
IH D++ N+L+ + +I+DFGLA+++ N+ A + A K + APE + T
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFT 182
Query: 704 AKVDVYSFGVLLLEIIS 720
K DV+SFG+LL EI++
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 70/288 (24%), Positives = 118/288 (40%), Gaps = 39/288 (13%)
Query: 527 EVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 584
E+G G+FG V+ VAVK L + ++F+ E ++ H+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFL-----------------FGNLKPSWNLRTNIAF 627
G C EG+ L+V+E++ +G L FL G L L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA--IAS 129
Query: 628 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRG 687
QIA G++YL S +H D+ +N L+ +I DFG+++ + +
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 688 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 747
++ PE T + D++SFGV+L EI + K Y + A +C G
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ------PWYQLSNTEAIECITQG 240
Query: 748 KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ E C ++ + C Q +P R ++ + L+
Sbjct: 241 R---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 71/242 (29%), Positives = 108/242 (44%), Gaps = 29/242 (11%)
Query: 564 EKEFKNEVVVIGQTHHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNL 621
+K+ E+ + +V+ G F DE + + + E+ G+L S ++ +K
Sbjct: 43 QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVK-KRGG 100
Query: 622 RTN------IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675
R IA + +GL YLH S +IIH DIKP NILL ++ DFG++ L
Sbjct: 101 RIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157
Query: 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 735
+ + GT Y+APE + + DV+S G+ LLE+ R F E GE
Sbjct: 158 SLAGTFT----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE-GEPPLG 212
Query: 736 LTDWAFDCYR--NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793
+ N +L D E N IK +E+ C+++DP+ RPT M
Sbjct: 213 PIELLSYIVNMPNPELKD------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPW---DM 263
Query: 794 LE 795
LE
Sbjct: 264 LE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN----EVVVIGQTHHKN 581
+ + +G+FG VY + R++ A+K L + + + N +++ Q
Sbjct: 2 KPISKGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 639
+ +L LV E+LN G AS + G L W + IA ++ G+ LH+
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLHQR 116
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
IIH DIKP+N+L+D + +++DFGL++ N+ GT Y+APE
Sbjct: 117 ---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILG 167
Query: 700 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732
D +S G ++ E + F E +
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 66/291 (22%), Positives = 125/291 (42%), Gaps = 33/291 (11%)
Query: 524 FEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 581
+ E+G G+FG V+ VAVK L + K+F E ++ H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPSWNLRT--------NIAFQ 628
+V+ G C EG ++V+E++ +G L FL + L N +IA Q
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 629 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGT 688
IA G++YL S +H D+ +N L+ + +I DFG+++ + +
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 689 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748
++ PE T + DV+S GV+L EI + K Y + + +C G+
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ------PWYQLSNNEVIECITQGR 239
Query: 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
+ C +++ + + C Q +P +R ++++ +L+ + +
Sbjct: 240 V---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 64/220 (29%), Positives = 112/220 (50%), Gaps = 36/220 (16%)
Query: 523 NFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIG 575
NF+ E++G G++G+VYK + + VA+KK+ R+ D E E E+ ++
Sbjct: 1 NFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKI-RL--DTETEGVPSTAIREISLLK 54
Query: 576 QTHHKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARG 632
+ +H N+V+LL +N+L LV+EFL+ L F+ + L + FQ+ +G
Sbjct: 55 ELNHPNIVKLLDVI-HTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
L + H S +++H D+KPQN+L++ +++DFGLA +A +R V
Sbjct: 113 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEV 161
Query: 693 APEWFRNSTI-------TAKVDVYSFGVLLLEIISCRKSF 725
W+R I + VD++S G + E+++ R F
Sbjct: 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 528 VGRGSFGIVYKGV-IQTTRTSTTAVAVKKL--DRVFQDGEKE---FKNEVVVIGQTHHKN 581
+G+G+FG VY + T R +AVK++ D + +KE + E+ ++ H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRE----LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 639
+V+ G + + + E++ G++ L +G L + + QI G+ YLH
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGAL--TETVTRKYTRQILEGVEYLH-- 121
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAK-LLTLNQSKAIKTAIRGTKGYVAPEWFR 698
S I+H DIK NIL D N ++ DFG +K L T+ S ++ GT +++PE
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 699 NSTITAKVDVYSFGVLLLEIIS 720
K DV+S G ++E+++
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 523 NFEEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHK 580
E +G G+ +VY + + VA+K++D Q E + EV + Q +H
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEK----VAIKRIDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLH 637
N+V+ G LV +L+ G+L + + IA ++ +GL YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL---TLNQSKAIKTAIRGTKGYVAP 694
S IH DIK NILL + + +I+DFG++ L K KT + GT ++AP
Sbjct: 120 ---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAP 175
Query: 695 EWFRNST-ITAKVDVYSFGVLLLEII 719
E K D++SFG+ +E+
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELA 201
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKN 581
+ +G+G FG V G + + VAVK K D Q F E V+ Q H N
Sbjct: 10 LLQTIGKGEFGDVMLGDYRGNK-----VAVKCIKNDATAQ----AFLAEASVMTQLRHSN 60
Query: 582 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHE 638
LV+LLG E + L +V E++ G+L +L G + + + + YL
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 119
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR 698
+ +H D+ +N+L+ + A++SDFGL K + Q K ++ T APE R
Sbjct: 120 --ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVKWT----APEALR 172
Query: 699 NSTITAKVDVYSFGVLLLEIIS 720
+ K DV+SFG+LL EI S
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 3e-17
Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 31/214 (14%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQ-THHKNLV 583
+G+G++GIV+K + + T+ VA+KK+ F+ D ++ F+ E++ + + H N+V
Sbjct: 15 LGKGAYGIVWKAIDRRTKE---VVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIV 70
Query: 584 RLLGF--CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 641
+LL + ++ LV+E++ A L+ + I +Q+ + L Y+H S
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH--KRYIMYQLLKALKYIH---S 125
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLT---LNQSKAIKTAIRGTKGYVAPEWFR 698
+IH D+KP NILL+ +++DFGLA+ L+ N + T YVA W+R
Sbjct: 126 GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD------YVATRWYR 179
Query: 699 NSTI-------TAKVDVYSFGVLLLEIISCRKSF 725
I T VD++S G +L E++ + F
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 84/311 (27%), Positives = 132/311 (42%), Gaps = 48/311 (15%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYK----GVIQTTRTSTTAVAVKKL-----DRVFQDGEKE 566
EL + +G G FG V G+ + VAVK L D+ D E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 567 FKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR---- 622
+ + +IG+ HKN++ LLG C + ++ E+ + G L +L P +
Sbjct: 68 ME-MMKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 623 ------------TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670
+ A+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 730
+ + T R ++APE + T + DV+SFGVLL EI + G
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG-------G 234
Query: 731 EEY-AILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRK 789
Y I + F + G D CT +L M+ C PS RPT ++
Sbjct: 235 SPYPGIPVEELFKLLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQ 285
Query: 790 VSQMLEGVVEV 800
+ + L+ V+ V
Sbjct: 286 LVEDLDRVLTV 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 81/282 (28%), Positives = 124/282 (43%), Gaps = 27/282 (9%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIG 575
E+ + + ++G+G FG V+ G T TT VA+K L E F E ++
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMG----TWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMK 56
Query: 576 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGL 633
+ H LV L E + +V EF+ G+L FL L ++A QIA G+
Sbjct: 57 KLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGM 115
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
Y+ IH D++ NIL+ D +I+DFGLA+L+ N+ A + A K + A
Sbjct: 116 AYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK-WTA 171
Query: 694 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753
PE T K DV+SFG+LL E+++ + + N ++ + V
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRV---------------PYPGMVNREVLEQV 216
Query: 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
E C E L + C ++DP RPT + LE
Sbjct: 217 ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 24/204 (11%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 584
E +G+G+FG V+KG ++ T VAVK + + Q+ + +F +E ++ Q H N+V+
Sbjct: 1 ELLGKGNFGEVFKGTLK----DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVK 56
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDC 640
L+G C + Q +V E + G SFL K L+T A A G+ YL
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFL---RKKKDELKTKQLVKFALDAAAGMAYLE--- 110
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK----GYVAPEW 696
S IH D+ +N L+ + +ISDFG+++ + I ++ G K + APE
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSR----QEDDGIYSS-SGLKQIPIKWTAPEA 165
Query: 697 FRNSTITAKVDVYSFGVLLLEIIS 720
+++ DV+S+G+LL E S
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 28/288 (9%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLV 583
+G G FG V T VAVK L R Q +K E+ ++ +H+N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 584 RLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHED 639
+ G C E G+ L+ E++ G+L +L K NL + F QI G+ YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLH-- 124
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL-TLNQSKAIKTAIRGTKGYVAPEWFR 698
S IH D+ +N+LLD+ +I DFGLAK + ++ ++ + A E +
Sbjct: 125 -SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 699 NSTITAKVDVYSFGVLLLEII-------SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751
+ + DV+SFGV L E++ S K F+ +G + +T +L +
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV--------RLIE 235
Query: 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
L+E C +++ ++ C + + RPT R + +L+ +
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 69/221 (31%), Positives = 110/221 (49%), Gaps = 31/221 (14%)
Query: 517 LEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI 574
L + T FE E +G G++G VYK + T VA+K +D + +D E+E K E ++
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQ---LVAIKIMD-IIEDEEEEIKEEYNIL 56
Query: 575 GQ-THHKNLVRLLG-------FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN- 624
+ ++H N+ G ++ Q L LV E G++ + G K L+
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQ--LWLVMELCGGGSVTDLVKGLRKKGKRLKEEW 114
Query: 625 IAF---QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681
IA+ + RGL YLHE+ ++IH DIK QNILL ++ DFG++ L +
Sbjct: 115 IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR- 170
Query: 682 KTAIRGTKGYVAPEWF-----RNSTITAKVDVYSFGVLLLE 717
T I GT ++APE +++ A+ DV+S G+ +E
Sbjct: 171 NTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-17
Identities = 82/310 (26%), Positives = 142/310 (45%), Gaps = 50/310 (16%)
Query: 528 VGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
+G G+FG VYKG+ I VA+K+L + KE +E V+ + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
LG C +L + + + G L ++ N+ + L N QIA+G+ YL E
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEE---R 128
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----QSKAIKTAIRGTKGYVAPEWFR 698
+++H D+ +N+L+ + +I+DFGLAKLL + ++ K I+ ++A E
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK----WMALESIL 184
Query: 699 NSTITAKVDVYSFGVLLLEIISC-RKSFD-IEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756
+ T + DV+S+GV + E+++ K +D I E +IL +G+
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------------KGE 228
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV----SQMLEG-----VVEVDVP---P 804
I CT + M+ + C D RP R++ S+M V++ D P
Sbjct: 229 RLPQPPI-CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 287
Query: 805 NPSPFSGYMR 814
+P+ + Y
Sbjct: 288 SPTDSNFYRA 297
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 71/267 (26%), Positives = 124/267 (46%), Gaps = 24/267 (8%)
Query: 528 VGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
+G G+FG VYKG+ I VA+K L + KE +E V+ + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARGLLYLHEDCSAQ 643
LG C +L V + + G L ++ N S +L N QIA+G+ YL E +
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQIAKGMSYLEE---VR 129
Query: 644 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTIT 703
++H D+ +N+L+ + +I+DFGLA+LL +++++ + ++A E + T
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 704 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDI 763
+ DV+S+GV + E++ +F + +D ++ DL+E
Sbjct: 190 HQSDVWSYGVTVWELM----TFGAK-----------PYDGIPAREIPDLLEKGERLPQPP 234
Query: 764 KCTEKLVMVSIWCIQEDPSLRPTMRKV 790
CT + M+ + C D RP R++
Sbjct: 235 ICTIDVYMIMVKCWMIDSECRPRFREL 261
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 59/204 (28%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV------FQDGEKEFKNEVVVIGQTHH 579
+++G G+F Y+ + +T T +AVK++ V ++ + + E+ ++ + +H
Sbjct: 6 QQLGTGAFSSCYQA--RDVKTGTL-MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLH 637
+++R+LG E + L E++ G+++ L +G K + N Q+ RGL YLH
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE--AVIINYTEQLLRGLSYLH 120
Query: 638 EDCSAQIIHCDIKPQNILLDDY-YNARISDFGLAKLLTLNQSKA--IKTAIRGTKGYVAP 694
E+ QIIH D+K N+L+D RI+DFG A L + A + + GT ++AP
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 695 EWFRNSTITAKVDVYSFGVLLLEI 718
E R DV+S G +++E+
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEM 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 71/289 (24%), Positives = 124/289 (42%), Gaps = 29/289 (10%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVI 574
EL+ + E +G G FG + +G ++ VA+ L D ++ F E + +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 575 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIAR 631
GQ H N+VRL G G ++V E+++NG L SFL G L + + +A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLM--GMLPGLAS 118
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG- 690
G+ YL E +H + +L++ +IS F L ++S+AI T + G
Sbjct: 119 GMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPV 172
Query: 691 -YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 749
+ APE + ++ DV+SFG+++ E++S + +M + I
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI-------------- 218
Query: 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798
VE C L + + C Q++ RP ++ +L +V
Sbjct: 219 -KAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 69/257 (26%), Positives = 125/257 (48%), Gaps = 40/257 (15%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNL 582
E++G G++G+VYKG + + VA+KK+ R+ + E E+ ++ + H N+
Sbjct: 6 EKIGEGTYGVVYKGR---NKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 583 VRLLGFCDEGQNRL-LVYEFLN---NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 638
V L + ++RL L++EFL+ L S G + +++ + +QI +G+L+ H
Sbjct: 62 VCLQDVLMQ-ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYL-YQILQGILFCH- 118
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRG------TKGYV 692
S +++H D+KPQN+L+D+ +++DFGLA +A +R T Y
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLA--------RAFGIPVRVYTHEVVTLWYR 168
Query: 693 APEWFRNST-ITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNGKL 749
APE S + VD++S G + E+ + + F D E+ + + I G
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRIL-------GTP 221
Query: 750 DDLVEGDTEAMNDIKCT 766
+ V ++ D K T
Sbjct: 222 TEDVWPGVTSLPDYKNT 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 33/219 (15%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKN 581
FE+ +G G+FG V + +I+ A A+K L + ++ ++F E+ V+ + HH N
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNA-AIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF-------------- 627
++ LLG C+ + E+ G L FL + S L T+ AF
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFL----RKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 628 ------QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681
+A G+ YL E Q IH D+ +N+L+ + ++I+DFGL++ +
Sbjct: 121 LLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRG---EEVYVK 174
Query: 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
KT R ++A E S T K DV+SFGVLL EI+S
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV---VIGQTHHKNLVR 584
+G+G FG V R + A KKL++ K ++ +V ++ + H + +V
Sbjct: 1 LGKGGFGEVSAC---QMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS 57
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNL---KPSWNLRTNIAF--QIARGLLYLHED 639
L + LV +N G L ++ N+ P + + QI GL +LH+
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
+II+ D+KP+N+LLD+ N RISD GLA L QSK A GT G++APE +
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA--GTPGFMAPELLQG 171
Query: 700 STITAKVDVYSFGVLLLEIISCRKSF 725
VD ++ GV L E+I+ R F
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 2e-16
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 40/213 (18%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVR 584
+G G++G+V V RT VA+KK+ VF D ++ + E+ ++ H+N++
Sbjct: 8 IGSGAYGVVCSAV--DKRTGRK-VAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIG 63
Query: 585 LLG-FCDEGQNRL----LVYEFLNNGT-LASFLFGNLKPSWNLRTN----IAFQIARGLL 634
LL +V E + T L + K L + +QI RGL
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELM--ETDLHKVI----KSPQPLTDDHIQYFLYQILRGLK 117
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA-IKTAIRGTKGYVA 693
YLH SA +IH D+KP NIL++ + +I DFGLA+ + ++ + T YV
Sbjct: 118 YLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT------EYVV 168
Query: 694 PEWFR-------NSTITAKVDVYSFGVLLLEII 719
W+R +S T +D++S G + E++
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 523 NFEE--EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIG 575
FE+ +G G++GIVY+ TS VA+KK V D E++ E+ ++
Sbjct: 8 EFEKLNRIGEGTYGIVYRA---RDTTSGEIVALKK---VRMDNERDGIPISSLREITLLL 61
Query: 576 QTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARG 632
H N+V L + LV E+ LAS L P S + + Q+ RG
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
L YLHE+ IIH D+K N+LL D +I+DFGLA+ L + T Y
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYR 175
Query: 693 APE-WFRNSTITAKVDVYSFGVLLLEII 719
APE +T T +D+++ G +L E++
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVR 584
+G+G FG V ++ T A KKLD+ + GEK E ++ + + +V
Sbjct: 1 LGKGGFGEVCAVQVKNT---GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSA 642
L + + LV +N G L ++ + + I + QI G+L+LH S
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SM 114
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI 702
I++ D+KP+N+LLDD N R+SD GLA + L K I T GT GY+APE +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTI-TQRAGTNGYMAPEILKEEPY 171
Query: 703 TAKVDVYSFGVLLLEIISCRKSF 725
+ VD ++ G + E+++ R F
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 31/282 (10%)
Query: 524 FEEEVGRGSFGIVYK----GVIQTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQT- 577
F + +G G+FG V + G+ ++ + VAVK L E+E +E+ ++
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSD--AVMKVAVKMLKPTAHSSEREALMSELKIMSHLG 96
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLY 635
+H+N+V LLG C G L++ E+ G L +FL + L ++F Q+A+G+ +
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE 695
L S IH D+ +N+LL +I DFGLA+ + + + +K R ++APE
Sbjct: 157 L---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 696 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF-DCYRNGKLDDLV 753
N T + DV+S+G+LL EI S Y + D F + G
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFSLG-------SNPYPGMPVDSKFYKLIKEGYRMAQP 266
Query: 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
E + DI M + W DP RPT +++ Q++
Sbjct: 267 EHAPAEIYDI-------MKTCW--DADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 65/293 (22%)
Query: 531 GSFGIVYKGV-IQTTRTSTTAVAVK---------KLDRVFQDGEKEFKNEVVVIGQTHHK 580
G+FG ++ G+ I V VK ++ + Q+ + G H+
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCL-------LYG-LSHQ 68
Query: 581 NLVRLLGFCDEGQNRLLV-YEFLNNGTLASFL----FGNLKPSWNLRT----NIAFQIAR 631
N++ +L C E V Y ++N G L FL G L T ++A QIA
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK--------LLTLNQSKAIKT 683
G+ YLH +IH DI +N ++D+ +I+D L++ L N+++ +K
Sbjct: 129 GMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK- 184
Query: 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAF 741
++A E N ++ DV+SFGVLL E+++ ++ +I+ E A L D
Sbjct: 185 -------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-- 235
Query: 742 DCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794
YR + I C ++L V C DP RP+ ++ Q L
Sbjct: 236 --YRLAQ-------------PINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
+G G+ GIV+K R + VA+KK L R+ + E+ + H +V+L
Sbjct: 8 IGEGAHGIVFKAKD---RETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN-IAFQIARGLLYLHEDCSAQI 644
L G +LV E++ L+ L +P + + +G+ Y+H I
Sbjct: 65 LDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGI 120
Query: 645 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS-TIT 703
+H D+KP N+L+ +I+DFGLA+L + + + + T+ Y APE +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYD 179
Query: 704 AKVDVYSFGVLLLEIISCRKSF----DIE 728
VD+++ G + E+++ F DIE
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGENDIE 208
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 62/225 (27%), Positives = 111/225 (49%), Gaps = 24/225 (10%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVI--QTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVV 572
E+ +T F EE+G FG VYKG + T AVA+K L D+ +EFK+E +
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 573 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--------GNLKPSWNLRT- 623
+ + H N+V LLG + Q +++ + ++ L FL G+ +++
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 624 -------NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK-LLTL 675
+I QIA G+ +L S ++H D+ +N+L+ D N +ISD GL + +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
+ K + ++ + +++PE + D++S+GV+L E+ S
Sbjct: 178 DYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 70/293 (23%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTA----VAVKKLDRVFQDGEKEFKNEVVVIGQTHH 579
+ E+G G+FG V+ + + S T VAVK L K+F+ E ++ H
Sbjct: 9 LKRELGEGAFGKVF--LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 66
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF------------------GNLKPSWNL 621
+++V+ G C +G ++V+E++ +G L FL G L S L
Sbjct: 67 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 622 RTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681
+IA QIA G++YL S +H D+ +N L+ +I DFG+++ + +
Sbjct: 127 --HIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 741
++ PE T + DV+SFGV+L EI + K ++ I
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI------ 235
Query: 742 DCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794
+C G++ + C +++ + + C Q +P R ++++ ++L
Sbjct: 236 ECITQGRVLERPR---------VCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-16
Identities = 82/298 (27%), Positives = 132/298 (44%), Gaps = 50/298 (16%)
Query: 528 VGRGSFGIVYK----GVIQTTRTSTTAVAVKKL-----DRVFQDGEKEFKNEVV-VIGQT 577
+G G FG V + G+ ++ T VAVK L D+ D E E++ +IG+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM--ELMKLIGK- 76
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------ 625
HKN++ LLG C + ++ E+ G L FL P + +I
Sbjct: 77 -HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 626 ----AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681
A+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWA 740
+ R ++APE + T + DV+SFG+L+ EI + G Y I +
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG-------GSPYPGIPVEEL 245
Query: 741 FDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798
F R G D CT +L M+ C P+ RPT +++ + L+ V+
Sbjct: 246 FKLLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 80/298 (26%), Positives = 127/298 (42%), Gaps = 50/298 (16%)
Query: 528 VGRGSFGIVYK----GVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV------VIGQT 577
+G G FG V G+ + T VAVK L EK+ + + +IG+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGK- 82
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------------- 624
HKN++ LLG C + ++ E+ + G L +L P N
Sbjct: 83 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 625 ---IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681
A+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWA 740
T R ++APE + T + DV+SFGVLL EI + G Y + +
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEEL 251
Query: 741 FDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798
F + G D CT +L M+ C PS RPT +++ + L+ ++
Sbjct: 252 FKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 65/228 (28%), Positives = 113/228 (49%), Gaps = 38/228 (16%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHK 580
E++G G++G+VYK + + VA+KK+ R+ + E E E+ ++ + +H
Sbjct: 5 EKIGEGTYGVVYKA---RDKLTGEIVALKKI-RL--ETEDEGVPSTAIREISLLKELNHP 58
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----AFQIARGLLYL 636
N+VRLL LV+EFL+ L ++ + P L + +Q+ +G+ Y
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRG------TKG 690
H S +++H D+KPQN+L+D +++DFGLA +A +R T
Sbjct: 116 H---SHRVLHRDLKPQNLLIDREGALKLADFGLA--------RAFGVPVRTYTHEVVTLW 164
Query: 691 YVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 735
Y APE S + VD++S G + E+++ R F D E+ + + I
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLD-RVFQDGEKEF-KNEVVVIGQTHHKNLVRL 585
+G GSFG +Y + ++ + +K++D EKE K EV+++ + H N+V
Sbjct: 8 IGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGLLY 635
E +V E+ + G L + N + + F QI+ GL +
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRI--------NRQRGVLFSEDQILSWFVQISLGLKH 116
Query: 636 LHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694
+H+ +I+H DIK QNI L + A++ DFG+A+ LN S + GT Y++P
Sbjct: 117 IHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSP 171
Query: 695 EWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 726
E +N K D++S G +L E+ + + F+
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 14/178 (7%)
Query: 551 VAVKKLDRVFQDGEK---EFKNEVVVIGQTHHKNLVRLLGFCDEGQNR--LLVYEFLNNG 605
VAVK L + G + K E+ ++ +H+N+V+ G C E L+ EFL +G
Sbjct: 36 VAVKSLKP--ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 93
Query: 606 TLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR 663
+L +L N K NL+ A QI +G+ YL S Q +H D+ +N+L++ + +
Sbjct: 94 SLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVK 149
Query: 664 ISDFGLAKLLTLNQS-KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
I DFGL K + ++ +K + + APE S DV+SFGV L E+++
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 77/294 (26%), Positives = 126/294 (42%), Gaps = 42/294 (14%)
Query: 528 VGRGSFGIVYK----GVIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKN 581
+G G FG V G+ + VAVK L D + + +E+ ++ HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------------- 626
++ LLG C + ++ E+ + G L +L P +IA
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 627 -FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI 685
+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ + T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 744
R ++APE + T + DV+SFGVL+ EI + G Y I + F
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLL 252
Query: 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798
+ G D CT +L M+ C PS RPT +++ + L+ ++
Sbjct: 253 KEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 56/194 (28%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
E++G+G+ G VY + T VA+K+++ Q ++ NE++V+ + H N+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQE---VAIKQMNLQQQPKKELIINEILVMRENKHPNIVNY 81
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 645
L G +V E+L G+L + + + + + L +LH S Q+I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 137
Query: 646 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAK 705
H DIK NILL + +++DFG +T QSK ++ + GT ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 706 VDVYSFGVLLLEII 719
VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVR 584
+G+G FG V R + A KKL++ + GE NE ++ + + + +V
Sbjct: 8 LGKGGFGEV---CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 585 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCS 641
L + E ++ L LV +N G L ++ P ++ + A +I GL LH
Sbjct: 65 L-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---R 120
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+I++ D+KP+NILLDDY + RISD GLA + + + + I+ + GT GY+APE +N
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV-GTVGYMAPEVVKNER 177
Query: 702 ITAKVDVYSFGVLLLEIISCRKSF 725
T D + G L+ E+I + F
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 55/193 (28%), Positives = 96/193 (49%), Gaps = 9/193 (4%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 586
++G GS GIV I + S VAVK +D Q + NEVV++ H+N+V +
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 587 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIH 646
G+ ++ EFL G L + + + + + + L YLH S +IH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLH---SQGVIH 140
Query: 647 CDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKV 706
DIK +ILL ++SDFG ++ + K + ++ GT ++APE + +V
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 707 DVYSFGVLLLEII 719
D++S G++++E++
Sbjct: 199 DIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 74/290 (25%), Positives = 123/290 (42%), Gaps = 44/290 (15%)
Query: 513 SYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG-EKEFKNEV 571
S ELE +G G+ G VYK VI R + A+K + +D ++ E+
Sbjct: 72 SLSELERV-----NRIGSGAGGTVYK-VIH--RPTGRLYALKVIYGNHEDTVRRQICREI 123
Query: 572 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 631
++ +H N+V+ D ++ EF++ G+L G ++A QI
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE----GTHIADEQFLADVARQILS 179
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
G+ YLH I+H DIKP N+L++ N +I+DFG++++ L Q+ + GT Y
Sbjct: 180 GIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAY 234
Query: 692 VAPEWFRNSTITAKV-----DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA----FD 742
++PE D++S GV +LE R F +G + DWA
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR--FPFGVGRQ----GDWASLMCAI 288
Query: 743 CYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792
C + E + I C C+Q +P+ R + ++ Q
Sbjct: 289 CMSQPP-EAPATASREFRHFISC----------CLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 76/310 (24%), Positives = 131/310 (42%), Gaps = 64/310 (20%)
Query: 524 FEEEVGRGSFGIVY----KGVIQTTRTSTTA-------VAVKKL-DRVFQDGEKEFKNEV 571
+E++G G FG V+ +G+ + VAVK L V + +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 572 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL----------FGNLKPSWNL 621
++ + + N++RLLG C ++ E++ NG L FL N PS ++
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 622 RT--NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN--- 676
+A QIA G+ YL S +H D+ +N L+ ++Y +I+DFG+++ L
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 677 --QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 734
Q +A+ IR ++A E T DV++FGV L E+ + K + Y+
Sbjct: 186 RIQGRAV-LPIR----WMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE------QPYS 234
Query: 735 ILTDWAFDCYRNGKLDDLVEGDTEAMNDIK----------CTEKLVMVSIWCIQEDPSLR 784
+L+D + ++E E + C + + + C D R
Sbjct: 235 LLSD-----------EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDR 283
Query: 785 PTMRKVSQML 794
PT K+ L
Sbjct: 284 PTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVR 584
+G+G FG V + R + A KKL++ + GE NE ++ + + + +V
Sbjct: 8 LGKGGFGEVCACQV---RATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 585 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCS 641
L + E ++ L LV +N G L ++ + + + A +I GL LH++
Sbjct: 65 L-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-- 121
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+I++ D+KP+NILLDD+ + RISD GLA + + + + IK + GT GY+APE +N
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGYMAPEVVKNER 177
Query: 702 ITAKVDVYSFGVLLLEIISCRKSF 725
T D ++ G LL E+I+ + F
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
E++G+G+ G VY + T VA+K+++ Q ++ NE++V+ + + N+V
Sbjct: 25 EKIGQGASGTVYTAIDIAT---GQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNY 81
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 645
L G +V E+L G+L + + + + + L +LH S Q+I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALDFLH---SNQVI 137
Query: 646 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAK 705
H DIK NILL + +++DFG +T QSK ++ + GT ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 706 VDVYSFGVLLLEII 719
VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 80/313 (25%), Positives = 130/313 (41%), Gaps = 67/313 (21%)
Query: 523 NFEEEVGRGSFGIVY----KGVIQTTR---------TSTTAVAVKKL-DRVFQDGEKEFK 568
NF E++G G FG V+ G+ + + VAVK L + ++F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 569 NEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----------FGNLKP 617
EV ++ + N+ RLLG C ++ E++ NG L FL +
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 618 SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN- 676
S++ +A QIA G+ YL S +H D+ +N L+ Y +I+DFG+++ L +
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 677 ----QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGE 731
Q +A IR ++A E T K DV++FGV L EI++ CR+ +
Sbjct: 185 YYRVQGRAP-LPIR----WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE-------Q 232
Query: 732 EYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIK----------CTEKLVMVSIWCIQEDP 781
Y LTD ++E D C + + + + C + D
Sbjct: 233 PYEHLTD-----------QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDE 281
Query: 782 SLRPTMRKVSQML 794
RPT R++ L
Sbjct: 282 EDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 4e-15
Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
E++G+G+ G VY + T VA+++++ Q ++ NE++V+ + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVAT---GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 645
L G +V E+L G+L + + + + + L +LH S Q+I
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 138
Query: 646 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAK 705
H DIK NILL + +++DFG +T QSK ++ + GT ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 706 VDVYSFGVLLLEII 719
VD++S G++ +E+I
Sbjct: 197 VDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 25/213 (11%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIGQTH---H 579
E+G G++G V+K + + VA+K++ RV Q GE+ EV V+ H
Sbjct: 8 EIGEGAYGKVFKA--RDLKNGGRFVALKRV-RV-QTGEEGMPLSTIREVAVLRHLETFEH 63
Query: 580 KNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARG 632
N+VRL C D LV+E ++ L ++L +P T ++ FQ+ RG
Sbjct: 64 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
L +LH S +++H D+KPQNIL+ +++DFGLA++ + + T++ T Y
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYR 176
Query: 693 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 725
APE S+ VD++S G + E+ + F
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 68/223 (30%), Positives = 100/223 (44%), Gaps = 19/223 (8%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTHHKNLVRL 585
+G+GSFG V ++ T A+KK D V +D + E V+ H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 586 LGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 643
FC ++ V E+LN G L + + + A +I GL +LH
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKG 116
Query: 644 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTIT 703
II+ D+K N+LLD + +I+DFG+ K + KA + GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAPEILKGQKYN 174
Query: 704 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746
VD +SFGVLL E++ + F E +E FD N
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-------FDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-15
Identities = 67/225 (29%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 515 KELEEATDNFEE--EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG--EKEFKNE 570
K + E D + + +VG G++G V + RT VA+KKL R FQ K E
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSAL--DRRTGAK-VAIKKLYRPFQSELFAKRAYRE 64
Query: 571 VVVIGQTHHKNLVRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN 624
+ ++ H+N++ LL D + LV F+ GT L + K S +
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQF 122
Query: 625 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA 684
+ +Q+ +GL Y+H +A IIH D+KP N+ +++ +I DFGLA+ Q+ + T
Sbjct: 123 LVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTG 174
Query: 685 IRGTKGYVAPE----WFRNSTITAKVDVYSFGVLLLEIISCRKSF 725
T+ Y APE W T VD++S G ++ E+++ + F
Sbjct: 175 YVVTRWYRAPEVILNWMH---YTQTVDIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 68/216 (31%), Positives = 104/216 (48%), Gaps = 16/216 (7%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDRVFQDGEKEFK-NEVVVIGQTHH 579
NF +G+GSFG K ++ + + A+K K D + QD + E E V+
Sbjct: 3 NFLMVLGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 580 KNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYL 636
+ L C + +RL V E++N G L + G K A +IA GL +L
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP--HAVFYAAEIAIGLFFL 117
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
H S II+ D+K N++LD + +I+DFG+ K + K +T GT Y+APE
Sbjct: 118 H---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTFC-GTPDYIAPEI 172
Query: 697 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732
VD ++FGVLL E+++ + FD E +E
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 77/297 (25%), Positives = 126/297 (42%), Gaps = 62/297 (20%)
Query: 521 TDNF--EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN----EVVVI 574
NF E+++G+G F +VYK VA+KK+ ++F+ + + + E+ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA---ICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLL 56
Query: 575 GQTHHKNLVRLL-GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRT--NIAFQ 628
Q H N+++ L F + N L +V E + G L+ + F K RT Q
Sbjct: 57 KQLDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 629 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT-AIRG 687
+ L ++H S +I+H DIKP N+ + ++ D GL + + SK ++ G
Sbjct: 115 LCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVG 168
Query: 688 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF------------DIEMGEEYAI 735
T Y++PE + K D++S G LL E+ + + F IE +Y
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-DYPP 227
Query: 736 LTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792
L D Y + +L DLV CI DP RP + V Q
Sbjct: 228 LPA---DHY-SEELRDLVSR--------------------CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVR 584
+G+G FG V + R + A K+L++ + GE NE ++ + + + +V
Sbjct: 8 LGKGGFGEVCACQV---RATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 585 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCS 641
L + E ++ L LV +N G L ++ P + + A +I GL LH +
Sbjct: 65 L-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-- 121
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
++ D+KP+NILLDDY + RISD GLA + + + ++I+ + GT GY+APE N
Sbjct: 122 -NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRV-GTVGYMAPEVLNNQR 177
Query: 702 ITAKVDVYSFGVLLLEIISCRKSF 725
T D + G L+ E+I + F
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 7e-15
Identities = 51/194 (26%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
E++G+G+ G V+ + VA+K+++ Q ++ NE++V+ + + N+V
Sbjct: 25 EKIGQGASGTVFTA---IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNF 81
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 645
L G +V E+L G+L + + + + + L +LH + Q+I
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA-VCRECLQALEFLHAN---QVI 137
Query: 646 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAK 705
H DIK N+LL + +++DFG +T QSK ++ + GT ++APE K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 706 VDVYSFGVLLLEII 719
VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 14/217 (6%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEF-KNEVVVIGQT-HHKNLVRL 585
+G+GSFG V ++ T AV V K D + QD + E E V+ H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTD-ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 586 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQI 644
C + ++RL V E++N G L + + + A +I GL +LHE I
Sbjct: 62 HS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GI 117
Query: 645 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITA 704
I+ D+K N+LLD + +I+DFG+ K L + GT Y+APE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFCGTPDYIAPEILSYQPYGP 175
Query: 705 KVDVYSFGVLLLEIISCRKSFDIEMGEEY---AILTD 738
VD ++ GVLL E+++ + F+ + E+ +IL D
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSILED 211
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 33/215 (15%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNLVRL 585
+G G+FG V K I+ A A+K++ + +D ++F E+ V+ + HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF------------------ 627
LG C+ L E+ +G L FL + S L T+ AF
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 628 --QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI 685
+ARG+ YL + Q IH D+ +NIL+ + Y A+I+DFGL++ + KT
Sbjct: 118 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMG 171
Query: 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
R ++A E S T DV+S+GVLL EI+S
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 30/223 (13%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTHHK 580
E+G+G++GIV + VA+KK+ VF +E K ++ HK
Sbjct: 7 ELGQGAYGIVCS-ARNAETSEEETVAIKKITNVFSKKILAKRALRELK---LLRHFRGHK 62
Query: 581 NLVRL--LGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637
N+ L + G N L +YE L L + + + +QI GL Y+H
Sbjct: 63 NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
SA ++H D+KP N+L++ +I DFGLA+ + N + YVA W+
Sbjct: 123 ---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF----MTEYVATRWY 175
Query: 698 R-------NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 733
R + T +DV+S G +L E++ + F G++Y
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF---KGKDY 215
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
+G G FG V +G + S VAVK K+ + ++F +E V + + H N++RL
Sbjct: 7 LGEGEFGSVMEGQL-NQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRL 65
Query: 586 LGFCDEGQNR------LLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAF--QIARGL 633
+G C + +++ F+ +G L SFL G+ + + F IA G+
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL----TLNQSKAIKTAIRGTK 689
YL S IH D+ +N +L++ N ++DFGL+K + Q + K ++
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK--- 179
Query: 690 GYVAPEWFRNSTITAKVDVYSFGVLLLEI 718
++A E + T K DV+SFGV + EI
Sbjct: 180 -WIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 70/240 (29%), Positives = 110/240 (45%), Gaps = 36/240 (15%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIG---QTHH 579
E+G G++G VYK S VA+K + RV Q E EV ++ H
Sbjct: 7 EIGVGAYGTVYKA---RDPHSGHFVALKSV-RV-QTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 580 KNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARG 632
N+VRL+ C D LV+E ++ L ++L P T ++ Q RG
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
L +LH +C I+H D+KP+NIL+ +++DFGLA++ + + T + T Y
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYR 174
Query: 693 APEWFRNSTITAKVDVYSFGVLLLEIIS-----CRKSFDIEMGEEYAIL-----TDWAFD 742
APE ST VD++S G + E+ C S ++G+ + ++ DW D
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 27/209 (12%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVR 584
E VG G++G VYKG + +T A A+K +D V D E+E K E+ ++ + +HH+N+
Sbjct: 12 ELVGNGTYGQVYKG--RHVKTGQLA-AIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 585 LLG-FCDEGQNRL-----LVYEFLNNGTLASFLF---GN-LKPSWNLRTNIAFQIARGLL 634
G F + + LV EF G++ + GN LK W I +I RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICREILRGLS 125
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694
+LH+ ++IH DIK QN+LL + ++ DFG++ L+++ + GT ++AP
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAP 180
Query: 695 EWFR-----NSTITAKVDVYSFGVLLLEI 718
E ++T K D++S G+ +E+
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKN 581
E +G G++G+V + + VA+KK+ F ++ + E+ ++ H N
Sbjct: 10 IENIGSGAYGVVCSAIDTRSGKK---VAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDN 65
Query: 582 LVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637
++ + + ++ +V + L L + + + +Q+ RGL Y+H
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS--KAIKTAIRGTKGYVAPE 695
SA +IH D+KP N+L+++ RI DFG+A+ L+ + + K T T+ Y APE
Sbjct: 125 ---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 696 -WFRNSTITAKVDVYSFGVLLLEIISCRKSF 725
T +D++S G + E++ R+ F
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 29/212 (13%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 584
+E+G G FG V G S V VK+L D + F EV + +H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHED 639
LG C E LLV EF G L ++L N ++ +A ++A GLL+LH+
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA------IRGTKGYVA 693
A IH D+ +N L + +I D+GLA L T +R ++A
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLR----WLA 170
Query: 694 PEW-------FRNSTITAKVDVYSFGVLLLEI 718
PE T K +++S GV + E+
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-14
Identities = 39/119 (32%), Positives = 51/119 (42%), Gaps = 10/119 (8%)
Query: 40 TNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRG 99
++ VS + F GF L N I Y +TVVW N+D NP V
Sbjct: 5 SSGQTLVSGNSLFELGFFTL---IMQN--DYNLILYKSSS-RTVVWVA-NRD-NP-VSDS 55
Query: 100 SQVKLTADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSFTN 157
+ L +D LVL D G+ VWSS + V+ D GN V+ S + LW SF
Sbjct: 56 CTLTLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 53/213 (24%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKNLV 583
+++G GSFG K ++ ++ +K+++ ++ +E + EV V+ H N+V
Sbjct: 6 KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGL 633
+ +E N +V ++ G L + N + + F QI L
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKI--------NAQRGVLFPEDQILDWFVQICLAL 114
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
++H+ +I+H DIK QNI L ++ DFG+A++L + + +T I GT Y++
Sbjct: 115 KHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCI-GTPYYLS 169
Query: 694 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 726
PE N K D+++ G +L E+ + + +F+
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 69/230 (30%), Positives = 106/230 (46%), Gaps = 40/230 (17%)
Query: 515 KELEEATDNFEE--EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNE 570
K + E + ++ VG G++G V T+T VAVKKL R FQ K E
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRE 66
Query: 571 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN-- 624
+ ++ H+N++ LL ++ E N+ L + L G N+ L +
Sbjct: 67 LRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 122
Query: 625 --IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682
+ +QI RGL Y+H SA IIH D+KP N+ +++ +I DFGLA+
Sbjct: 123 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----------H 169
Query: 683 TAIRGTKGYVAPEWFRNSTI-------TAKVDVYSFGVLLLEIISCRKSF 725
T T GYVA W+R I VD++S G ++ E+++ R F
Sbjct: 170 TDDEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 515 KELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV 572
+ L + TD +E E +G+G++G VYK T + + AVK LD + D ++E + E
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYK---VTNKKDGSLAAVKILDPI-SDVDEEIEAEYN 70
Query: 573 VIGQ-THHKNLVRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--- 622
++ +H N+V+ G GQ LV E N G++ + G L L
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQ-LWLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 623 -TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681
+ I + GL +LH + +IIH D+K NILL ++ DFG++ LT ++
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLR 184
Query: 682 KTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEI 718
+ GT ++APE + + A+ DV+S G+ +E+
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-14
Identities = 59/188 (31%), Positives = 86/188 (45%), Gaps = 24/188 (12%)
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
LL +H S +IH DIK NILL ++ DFG +K+ S + GT YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 693 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752
APE +R + K D++S GVLL E+++ ++ FD E EE T G+ D L
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT-------LAGRYDPL 265
Query: 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM------LEGVVEVDVPPNP 806
+ M +I + DP RP+ K+ M + G++E+ V P
Sbjct: 266 PPSISPEMQEIVTA---------LLSSDPKRRPSSSKLLNMPICKLFISGLLEI-VQTQP 315
Query: 807 SPFSGYMR 814
FSG +R
Sbjct: 316 G-FSGPLR 322
|
Length = 496 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 37/215 (17%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN--------EVVVIGQTHH 579
+G G++ +VYK + T VA+KK + KE K+ E+ ++ + H
Sbjct: 8 LGEGTYAVVYKA--RDKETGRI-VAIKK---IKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 580 KNLVRLLGFCDEGQNRLLVYEFL--------NNGTLASFLFGNLKPSWNLRTNIAFQIAR 631
N++ LL N LV+EF+ + ++ ++K S+ L R
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI-VLTPADIK-SYML------MTLR 113
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
GL YLH S I+H D+KP N+L+ +++DFGLA+ + T T+ Y
Sbjct: 114 GLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPNRKMTHQVVTRWY 168
Query: 692 VAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSF 725
APE + VD++S G + E++ R F
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 27/209 (12%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVR 584
E VG G++G VYKG + +T A A+K +D V +D E+E K E+ ++ + +HH+N+
Sbjct: 22 EVVGNGTYGQVYKG--RHVKTGQLA-AIKVMD-VTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 585 LLG-FCDE---GQNR--LLVYEFLNNGTLASFLF---GN-LKPSWNLRTNIAFQIARGLL 634
G F + G + LV EF G++ + GN LK W I +I RGL
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLA 135
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694
+LH + ++IH DIK QN+LL + ++ DFG++ L+++ + GT ++AP
Sbjct: 136 HLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAP 190
Query: 695 EWFR-----NSTITAKVDVYSFGVLLLEI 718
E ++T + D++S G+ +E+
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRL 585
+G G+FG+V+ T VA+KK+ VFQ+ K E+ ++ H N++
Sbjct: 8 IGYGAFGVVWS---VTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 586 LGFCDEGQ----NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 641
L + V L L + S + +QI RGL YLH S
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---S 121
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
A I+H DIKP N+L++ +I DFGLA++ ++SK T T+ Y APE S
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSR 180
Query: 702 -ITAKVDVYSFGVLLLEIISCRKSF 725
T+ VD++S G + E++ R F
Sbjct: 181 HYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 58/220 (26%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 513 SYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK-NEV 571
++K+LE+ +G G++ VYKG RT+ VA+K++ ++G E+
Sbjct: 1 NFKQLEK--------LGEGTYATVYKG---RNRTTGEIVALKEIHLDAEEGTPSTAIREI 49
Query: 572 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----FGNLKPSWNLRTNIA 626
++ + H+N+VRL +LV+E+++ L ++ G L P N +
Sbjct: 50 SLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDP--NTVKSFT 106
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR 686
+Q+ +G+ + HE+ +++H D+KPQN+L++ +++DFGLA+ + + +
Sbjct: 107 YQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV- 162
Query: 687 GTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSF 725
T Y AP+ S T + +D++S G ++ E+I+ R F
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 56/210 (26%), Positives = 108/210 (51%), Gaps = 26/210 (12%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVR 584
+++G G++ V+KG ++ + VA+K++ ++G EV ++ H N+V
Sbjct: 11 DKLGEGTYATVFKG---RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVT 67
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
L + LV+E+L++ L +L GNL N++ FQ+ RGL Y H+
Sbjct: 68 LHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHK---R 122
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR---- 698
+I+H D+KPQN+L+++ +++DFGLA+ +K++ T + V W+R
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLAR------AKSVPTKTYSNE--VVTLWYRPPDV 174
Query: 699 ---NSTITAKVDVYSFGVLLLEIISCRKSF 725
++ + +D++ G +L E+ + R F
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
+G+G FG V + +++ S VAVK K D +EF E + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 586 LGFC--DEGQNRL----LVYEFLNNGTLASFLF----GNLKPSWNLRTNIAF--QIARGL 633
+G + RL ++ F+ +G L +FL G + L+T + F IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL----TLNQSKAIKTAIRGTK 689
YL S IH D+ +N +L++ ++DFGL+K + Q A K ++
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK--- 180
Query: 690 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNG 747
++A E ++ T DV++FGV + EI++ ++ +E E Y L
Sbjct: 181 -WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI---------- 229
Query: 748 KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797
C E + + C +P RP+ + + LE +
Sbjct: 230 -------KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 27/201 (13%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLVRL 585
VG G+FG+V Q T VA+KK+ + F K E+ ++ H+N++ L
Sbjct: 18 VGMGAFGLVCSARDQLT---GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 586 LG-FCDEGQNRLLVYEFLNNGT-LASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
F ++ V E L GT L L L+ + +QI RGL Y+H SA
Sbjct: 75 SDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQF--IQYFLYQILRGLKYVH---SA 127
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE----WFR 698
++H D+KP NIL+++ + +I DFGLA++ Q + T T+ Y APE W +
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARI----QDPQM-TGYVSTRYYRAPEIMLTWQK 182
Query: 699 NSTITAKVDVYSFGVLLLEII 719
+VD++S G + E++
Sbjct: 183 YDV---EVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 25/203 (12%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNL 582
E++G G++G V+K R + VA+K++ R+ D E + E+ ++ + HKN+
Sbjct: 6 EKIGEGTYGTVFKAK---NRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
VRL + LV+E+ + F N + + FQ+ +GL + H S
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SH 118
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI 702
++H D+KPQN+L++ +++DFGLA +A +R V W+R +
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLA--------RAFGIPVRCYSAEVVTLWYRPPDV 170
Query: 703 -------TAKVDVYSFGVLLLEI 718
+ +D++S G + E+
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 55/210 (26%), Positives = 108/210 (51%), Gaps = 26/210 (12%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVR 584
E++G G++ V+KG ++ + VA+K++ ++G EV ++ H N+V
Sbjct: 12 EKLGEGTYATVFKG---RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
L ++ LV+E+L+ L ++ GN+ N++ + +QI RGL Y H
Sbjct: 69 LHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCHR---R 123
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR---- 698
+++H D+KPQN+L+++ +++DFGLA+ +K++ T + V W+R
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR------AKSVPTKTYSNE--VVTLWYRPPDV 175
Query: 699 ---NSTITAKVDVYSFGVLLLEIISCRKSF 725
+S + ++D++ G + E+ S R F
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL---DRVFQDGEKEFKNEVVVIGQ 576
D+ E + VG G+FG V+ R S A+K + + + E+ NE V+ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLV---RDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKE 57
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 636
H ++RL + + ++ E++ G L S+L + + S + A +I L YL
Sbjct: 58 VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT-AIRGTKGYVAPE 695
H S +I++ D+KP+NILLD + +++DFG AK L +T + GT Y+APE
Sbjct: 118 H---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR------DRTWTLCGTPEYLAPE 168
Query: 696 WFRNSTITAKVDVYSFGVLLLEIIS 720
++ VD ++ G+L+ E++
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLV 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVR 584
+G+G FG V + R + A KKL++ + GE NE ++ + + + +V
Sbjct: 8 LGKGGFGEVCACQV---RATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 585 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCS 641
L + E ++ L LV +N G L ++ P ++ + I A ++ GL L +
Sbjct: 65 L-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+I++ D+KP+NILLDD + RISD GLA + + + + ++ + GT GY+APE N
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRV-GTVGYMAPEVINNEK 177
Query: 702 ITAKVDVYSFGVLLLEIISCRKSF 725
T D + G L+ E+I + F
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 39/101 (38%), Positives = 57/101 (56%), Gaps = 5/101 (4%)
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK-TAI 685
+QI RGL Y+H SA ++H D+KP N+LL+ + +I DFGLA++ T
Sbjct: 113 YQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 686 RGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSF 725
T+ Y APE NS T +D++S G +L E++S R F
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-13
Identities = 38/114 (33%), Positives = 47/114 (41%), Gaps = 9/114 (7%)
Query: 46 VSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLT 105
VS F GF +L I Y +TVVW N+D NP + L
Sbjct: 11 VSSGSLFELGFFKL----IMQSRDYNLILYKGSS-RTVVWVA-NRD-NP-SGSSCTLTLQ 62
Query: 106 ADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSFTNP 158
+D LV+ D G VWSS + V+ D GN VL S + LW SF P
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV--AVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
+G G FG V ++ + T VKK V ++ +E ++ + +H +V+L
Sbjct: 1 LGVGGFGRVEL--VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 586 L-GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
F D+ + ++ E+ G L + L G + R IA + YLH +
Sbjct: 59 YRTFKDK-KYIYMLMEYCLGGELWTILRDRGLF-DEYTARFYIA-CVVLAFEYLH---NR 112
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI 702
II+ D+KP+N+LLD ++ DFG AK L +S GT YVAPE N
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKGY 169
Query: 703 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 738
VD +S G+LL E+++ R F + + I D
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND 205
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 58/217 (26%), Positives = 108/217 (49%), Gaps = 26/217 (11%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVR 584
+++G G++ VYKG ++ + VA+K++ ++G EV ++ H N+V
Sbjct: 12 DKLGEGTYATVYKG---RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
L ++ LV+E+L+ L +L GN N++ + FQ+ RGL Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHRR--- 123
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI 702
+++H D+KPQN+L+++ +++DFGLA+ +K+I T + V W+R I
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNE--VVTLWYRPPDI 175
Query: 703 -------TAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732
+ ++D++ G + E+ + R F EE
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 77/282 (27%), Positives = 134/282 (47%), Gaps = 50/282 (17%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHK 580
+E+G+G++G VYK + + T + +A+K++ R+ D E +F E+ ++ +
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVT---MAMKEI-RLELD-ESKFNQIIMELDILHKAVSP 59
Query: 581 NLVRLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNL----KPSWNLRTNIAFQIARG 632
+V G F EG VY E+++ G+L G + P LR I + + +G
Sbjct: 60 YIVDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKG 114
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
L +L E+ IIH D+KP N+L++ ++ DFG++ L + + KT I G + Y+
Sbjct: 115 LKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA---KTNI-GCQSYM 168
Query: 693 APEWFR------NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746
APE + N T T + DV+S G+ +LE+ R + E Y N
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET--------------YAN 214
Query: 747 --GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT 786
+L +V+GD + + V+ C+ + P+ RPT
Sbjct: 215 IFAQLSAIVDGDPPTLPSGYSDDAQDFVAK-CLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 26/204 (12%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLVR 584
E+G G+FG VYK + + A K + + E+ +F E+ ++ + H N+V
Sbjct: 12 ELGDGAFGKVYKAQ---HKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNIVG 66
Query: 585 LL-GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDC 640
L + E + +L+ EF + G L S + + I + Q+ L +LH
Sbjct: 67 LYEAYFYENKLWILI-EFCDGGALDSIMLELERGL--TEPQIRYVCRQMLEALNFLHSH- 122
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGL-AKLLTLNQSKAIKTAIRGTKGYVAP----- 694
++IH D+K NILL + +++DFG+ AK + Q + T I GT ++AP
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFI-GTPYWMAPEVVAC 177
Query: 695 EWFRNSTITAKVDVYSFGVLLLEI 718
E F+++ K D++S G+ L+E+
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 25/265 (9%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
++E +G G+ G VYK TR AV V LD + + +K+ +E+ ++ + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTR-RILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYII 62
Query: 584 RLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 641
G F E NR+ + EF++ G+L + K ++ IA + +GL YL S
Sbjct: 63 GFYGAFFVE--NRISICTEFMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYL---WS 113
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+I+H D+KP N+L++ ++ DFG++ L +I GT Y+APE
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQ 169
Query: 702 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761
DV+S G+ +E+ R + + +++ C +V+ D +
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC--------IVDEDPPVLP 221
Query: 762 DIKCTEKLVMVSIWCIQEDPSLRPT 786
+ +EK V C+++ P RP
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 65/200 (32%), Positives = 92/200 (46%), Gaps = 8/200 (4%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTHHKNLVRL 585
+G+GSFG V+ ++ T A+KK D V D + E + V+ H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 645
+N V E+LN G L + K T A +I GL +LH S I+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIV 118
Query: 646 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAK 705
+ D+K NILLD + +I+DFG+ K L +K GT Y+APE
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT--CTFCGTPDYIAPEILLGQKYNTS 176
Query: 706 VDVYSFGVLLLEIISCRKSF 725
VD +SFGVLL E++ + F
Sbjct: 177 VDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 45/220 (20%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE------KEFKNEVVV 573
+ +E ++G GS+G+V+K R + VA+KK F + E K E+ +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKC---RNRETGQIVAIKK----FVESEDDPVIKKIALREIRM 53
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIAR 631
+ Q H NLV L+ + LV+E+ ++ T+ + L N + P ++ I +Q +
Sbjct: 54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIK-KIIWQTLQ 111
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG- 690
+ + H IH D+KP+NIL+ ++ DFG A++LT G
Sbjct: 112 AVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILT------------GPGDD 156
Query: 691 ---YVAPEWFR-------NSTITAKVDVYSFGVLLLEIIS 720
YVA W+R ++ VDV++ G + E+++
Sbjct: 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 40/225 (17%)
Query: 512 FSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG--EKEFKN 569
F+ ++L++ E+GRG+FG V K + + S T +AVK++ R D +K
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNKML---HKPSGTIMAVKRI-RSTVDEKEQKRLLM 51
Query: 570 EV-VVIGQTHHKNLVRLLG---------FCDEGQNRLLVYEFLNNGTLASFLFGNLK--- 616
++ VV+ + +V+ G C E L+ L+ +++ LK
Sbjct: 52 DLDVVMRSSDCPYIVKFYGALFREGDCWICME-----LMDISLDK--FYKYVYEVLKSVI 104
Query: 617 PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676
P + IA + L YL E+ +IIH D+KP NILLD N ++ DFG++ L
Sbjct: 105 PE-EILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--- 158
Query: 677 QSKAIKTAIRGTKGYVAPEWFRNSTITA---KVDVYSFGVLLLEI 718
KT G + Y+APE S + DV+S G+ L E+
Sbjct: 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKNLVR- 584
VG+GS+G V + RT +KKL+ + K + E ++ Q H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 585 -------------LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 631
++GFC+ G +Y L G L P N QIA
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGD----LYHKLKEQK------GKLLPE-NQVVEWFVQIAM 113
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
L YLHE I+H D+K QN+ L ++ D G+A++L NQ T I GT Y
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLI-GTPYY 168
Query: 692 VAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 726
++PE F N K DV++ G + E+ + + +F+
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 20/218 (9%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTT---AVAVKKLDRVFQDGEKEFKN-EVVVIGQTH 578
NF +G+GSFG V+ R T A+ + K D V QD + E E V+ +
Sbjct: 3 NFLMVLGKGSFG----KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG 58
Query: 579 HKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLY 635
+ L C + +RL V E++N G L + G K + A +IA GL +
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF--YAAEIAIGLFF 116
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT-AIRGTKGYVAP 694
LH S II+ D+K N++LD + +I+DFG+ K N + T GT Y+AP
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NMWDGVTTKTFCGTPDYIAP 170
Query: 695 EWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732
E VD ++FGVLL E+++ + F+ E +E
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVR 584
+GRG++GIV + VA+KK+ F D ++ + E+ ++ H+N++
Sbjct: 13 IGRGAYGIVCSAK---NSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIA 68
Query: 585 LLGFCDEGQNR-----LLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLY 635
+ +VYE ++ L ++ S L + +Q+ RGL Y
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE 695
+H SA ++H D+KP N+LL+ + +I DFGLA+ T ++ T T+ Y APE
Sbjct: 124 IH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPE 178
Query: 696 WFRNST-ITAKVDVYSFGVLLLEII 719
N + T +DV+S G + E++
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 67/241 (27%), Positives = 97/241 (40%), Gaps = 46/241 (19%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKK-LDRVFQDGEKEFK----NEVVVIGQT 577
++G G+FG VYK T VA+KK L +DG F E+ ++ +
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGR---VVALKKILMHNEKDG---FPITALREIKILKKL 64
Query: 578 HHKNLVRLLGFC-----DEGQNRLLVY--EFLNNGTLASFLFGNLKPSWNLR----TNIA 626
H N+V L+ + R VY + L+ L N PS L
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-EN--PSVKLTESQIKCYM 121
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN---------Q 677
Q+ G+ YLHE I+H DIK NIL+D+ +I+DFGLA+
Sbjct: 122 LQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 678 SKAIKTAIRGTKGYVAPEWF---RNSTITAKVDVYSFGVLLLEIISCRKSF----DIEMG 730
T + T+ Y PE R T TA VD++ G + E+ + R DI+
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYT-TA-VDIWGIGCVFAEMFTRRPILQGKSDIDQL 236
Query: 731 E 731
Sbjct: 237 H 237
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 76/320 (23%), Positives = 129/320 (40%), Gaps = 75/320 (23%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTA-------------VAVKKL-DRVFQDGEKEFKN 569
F+E++G G FG V+ + + T VAVK L ++ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 570 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--------------- 614
EV ++ + N++RLLG C + ++ E++ NG L FL +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 615 ----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670
S++ ++A QIA G+ YL S +H D+ +N L+ + +I+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 671 KLLTLN-----QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKS 724
+ L Q +A+ IR ++A E T DV++FGV L EI+ C++
Sbjct: 186 RNLYAGDYYRIQGRAV-LPIR----WMAWECILMGKFTTASDVWAFGVTLWEILMLCKE- 239
Query: 725 FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIK----------CTEKLVMVSI 774
+ Y LTD + ++E E D C + L + +
Sbjct: 240 ------QPYGELTD-----------EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELML 282
Query: 775 WCIQEDPSLRPTMRKVSQML 794
C D RP+ + L
Sbjct: 283 QCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 65/285 (22%), Positives = 117/285 (41%), Gaps = 47/285 (16%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHH-KNLV 583
EE+GRG++G+V K + T +AVK++ E K ++ + ++ V
Sbjct: 7 EELGRGAYGVVDK---MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 584 RLLG---------FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 634
G C E + L +F + G P ++ IA I + L
Sbjct: 64 TFYGALFREGDVWICMEVMDTSL-DKFYKK----VYDKGLTIPE-DILGKIAVSIVKALE 117
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694
YLH S +IH D+KP N+L++ ++ DFG++ L + +K I G K Y+AP
Sbjct: 118 YLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA---GCKPYMAP 172
Query: 695 EWFRNSTITA----KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN--GK 748
E K DV+S G+ ++E+ A + +D ++ +
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIEL---------------ATGR-FPYDSWKTPFQQ 216
Query: 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793
L +VE + + K + + C++++ RP ++ Q
Sbjct: 217 LKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 27/205 (13%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKL--------DRVFQDGEKEFKNEVVVIGQTHH 579
+G+GSFG V+ T + A+K L DRV K E ++ + +H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV------RTKMERDILAEVNH 57
Query: 580 KNLVRL-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLY 635
+V+L F EG+ L+ +FL G L + L K ++ F ++A L +
Sbjct: 58 PFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDH 113
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE 695
LH S II+ D+KP+NILLD+ + +++DFGL+K ++ KA + GT Y+APE
Sbjct: 114 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFCGTVEYMAPE 168
Query: 696 WFRNSTITAKVDVYSFGVLLLEIIS 720
T D +SFGVL+ E+++
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 73/267 (27%), Positives = 112/267 (41%), Gaps = 35/267 (13%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 583
E+G GSFG VY T + VAVKK+ + +++++ EV + Q H N +
Sbjct: 28 EIGHGSFGAVY---FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSA 642
G + LV E+ G+ + L + KP + I +GL YLH
Sbjct: 85 EYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE---WFRN 699
+IH DIK NILL + +++DFG A + S GT ++APE
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDE 194
Query: 700 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759
KVDV+S G I+C IE+ E L F+ L + + D+
Sbjct: 195 GQYDGKVDVWSLG------ITC-----IELAERKPPL----FNMNAMSALYHIAQNDSPT 239
Query: 760 MNDIKCTEKLVMVSIWCIQEDPSLRPT 786
+ + T+ +C+Q+ P RP
Sbjct: 240 LQSNEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRL 585
+G G+ GIV + VAVKKL R FQ+ K E+V++ +HKN++ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGIN---VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 586 LGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 639
L +E Q+ LV E ++ L + L + + +Q+ G+ +LH
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMEL--DHERMSYLLYQMLCGIKHLH-- 140
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
SA IIH D+KP NI++ +I DFGLA+ N + T T+ Y APE
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILG 196
Query: 700 STITAKVDVYSFGVLLLEII 719
VD++S G ++ E++
Sbjct: 197 MGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 22/273 (8%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 584
E+++GRG F VY+ R V+ + + ++ E+ ++ Q +H N+++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAF--QIARGLLYLHEDC 640
L E +V E + G L+ + F K RT + Q+ + ++H
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--- 123
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS 700
S +++H DIKP N+ + ++ D GL + + + A ++ GT Y++PE +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHEN 181
Query: 701 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760
K D++S G LL E+ + + F G++ + + C + + + D +
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLFS----LCQK------IEQCDYPPL 228
Query: 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793
+EKL + CI DP RP + V Q+
Sbjct: 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 90/337 (26%), Positives = 135/337 (40%), Gaps = 90/337 (26%)
Query: 528 VGRGSFGIVYKGVI--QTTRTSTTAVAVKKLDRVFQDGE-KEFKNEV-VVIGQTHHKNLV 583
+G G+FG V + ++S VAVK L E K +E+ ++I +H N+V
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVV 74
Query: 584 RLLGFCDEGQNRLLV-YEFLNNGTL----------------------------------- 607
LLG C + L+V EF G L
Sbjct: 75 NLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD 134
Query: 608 -------ASFLFGNLKPSWNLRTN--------------------IAFQIARGLLYLHEDC 640
AS LF +PS + TN +FQ+ARG+ +L
Sbjct: 135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---A 191
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS 700
S + IH D+ +NILL + +I DFGLA+ + + K + R ++APE +
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK 251
Query: 701 TITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758
T + DV+SFGVLL EI S S +++ EE+ C R L +G
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF---------CQR------LKDGTRM 296
Query: 759 AMNDIKCTE-KLVMVSIWCIQEDPSLRPTMRKVSQML 794
+ E +M++ W Q DP RPT + ++L
Sbjct: 297 RAPENATPEIYRIMLACW--QGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 38/215 (17%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRL 585
VG G++G V R VAVKKL R FQ + E+ ++ H+N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK---VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH 637
L + E N L + L G N+ L + +Q+ RGL Y+H
Sbjct: 80 LDVFTPATS----IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
SA IIH D+KP N+ +++ RI DFGLA+ Q+ T GYVA W+
Sbjct: 136 ---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMT------GYVATRWY 181
Query: 698 RNSTI-------TAKVDVYSFGVLLLEIISCRKSF 725
R I VD++S G ++ E++ + F
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 21/176 (11%)
Query: 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI 685
+FQ+ARG+ +L S + IH D+ +NILL + +I DFGLA+ + + K
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 743
R ++APE + T + DV+SFGVLL EI S S +++ EE+ C
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF---------C 286
Query: 744 YRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
R L EG T T ++ + + C +P RPT ++ ++L +++
Sbjct: 287 RR------LKEG-TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 12/216 (5%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK-NEVVVIGQTHHKNLVRLL 586
+G+GSFG V ++ + AV V K D + QD + E E ++ + + L
Sbjct: 3 LGKGSFGKVMLARLKESG-RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 587 GFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 645
C + +RL V EF+N G L + + + A +I L++LH+ II
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD---KGII 118
Query: 646 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR-GTKGYVAPEWFRNSTITA 704
+ D+K N+LLD + +++DFG+ K N T+ GT Y+APE +
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCKEGIFN---GKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 705 KVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 738
VD ++ GVLL E++ F+ E ++ AIL D
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHH 579
NF +G+GSFG V + T A+ + K D V QD + E E V+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGT-DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK 59
Query: 580 KNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYL 636
+ L C + +RL V E++N G L + G K + A +I+ GL +L
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF--YAAEISVGLFFL 117
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT-AIRGTKGYVAPE 695
H II+ D+K N++LD + +I+DFG+ K + + T GT Y+APE
Sbjct: 118 HR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---HMVDGVTTRTFCGTPDYIAPE 171
Query: 696 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732
VD +++GVLL E+++ + FD E +E
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 48/154 (31%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQTHHKNLV 583
+E+G G FG V G + + + V VK+L Q+ + +F E H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSG-YTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLL 58
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFG-----NLKPSWNLRTNIAFQIARGLLYLHE 638
+ LG C E LLV EF G L +L + P +A +IA GLL+LH+
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672
+ IH D+ +N LL +I D+GL+
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 69/220 (31%), Positives = 101/220 (45%), Gaps = 21/220 (9%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 583
+G+GSFG V+Q + T + A+K + + E + E V+ Q + +V
Sbjct: 1 IGKGSFG----KVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIV 56
Query: 584 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCS 641
L F + +L LV F+N G L F +L+ + A F A L L
Sbjct: 57 PL-KFSFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAELLCALENLHK 111
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT-AIRGTKGYVAPEWFRNS 700
+I+ D+KP+NILLD + + DFGL K LN KT GT Y+APE
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCK---LNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 701 TITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEY-AILTD 738
T VD ++ GVLL E+++ F D + E Y IL +
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 31/230 (13%)
Query: 501 GDATIETNLRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF 560
G TI+ +LE E+G G+ G VYK + + +AVK++ R
Sbjct: 1 GYLTIDGQKYPADLNDLE-----NLGEIGSGTCGQVYK---MRFKKTGHVMAVKQMRRT- 51
Query: 561 QDGEKEFKNEVV----VIGQTHH-KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNL 615
G KE ++ V+ ++H +V+ G+ + + E + T L +
Sbjct: 52 --GNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRI 107
Query: 616 K---PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672
+ P ++ + I + L YL E +IH D+KP NILLD N ++ DFG++
Sbjct: 108 QGPIPE-DILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGR 164
Query: 673 LTLNQSKAIKTAIRGTKGYVAPEWF----RNSTITAKVDVYSFGVLLLEI 718
L SKA KT G Y+APE N + DV+S G+ L+E+
Sbjct: 165 LV--DSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 526 EEVGRGSFGIVYKG----VIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 581
E +G+G+F ++KG V T V +K LD+ ++ + F ++ Q HK+
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHE 638
LV G C G ++V E++ G+L ++L N + SW L +A Q+A L +L +
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE--VAKQLAWALHFLED 118
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI--KTAIRGTKGYVAPEW 696
+ H ++ +N+LL + + + KL S + K + +V PE
Sbjct: 119 K---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPEC 175
Query: 697 FRNS-TITAKVDVYSFGVLLLEIIS 720
N ++ D +SFG L EI S
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLVRL 585
VG G++G V + + T VA+KKL R FQ K E+ ++ H+N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEK---VAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------IAFQIARGLLYLHED 639
L D + + EF + + ++ +L+ + + +Q+ GL Y+H
Sbjct: 80 L---DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH-- 134
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
SA IIH D+KP N+ +++ +I DFGLA+ + A T T+ Y APE N
Sbjct: 135 -SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILN 188
Query: 700 -STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 733
VD++S G ++ E+++ + F G++Y
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFK---GKDY 220
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 58/207 (28%), Positives = 106/207 (51%), Gaps = 32/207 (15%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 586
E+G G+FG VYK + T A A K ++ ++ +++ E+ ++ +H +V+LL
Sbjct: 19 ELGDGAFGKVYKA--KNKETGALAAA-KVIETKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 587 G-FCDEGQNRLLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCS 641
G F +G+ +++ EF G + + + G +P + I Q+ L YLH S
Sbjct: 76 GAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLH---S 128
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR-----GTKGYVAP-- 694
+IIH D+K N+LL + +++DFG++ +K +KT R GT ++AP
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVS-------AKNVKTLQRRDSFIGTPYWMAPEV 181
Query: 695 ---EWFRNSTITAKVDVYSFGVLLLEI 718
E +++ K D++S G+ L+E+
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 66/280 (23%), Positives = 122/280 (43%), Gaps = 30/280 (10%)
Query: 523 NF--EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL---DRVFQDGEKEFKNEVVVIGQT 577
NF E+++GRG F VY+ T VA+KK+ D + + E+ ++ Q
Sbjct: 3 NFRIEKKIGRGQFSEVYRA---TCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 59
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAF--QIARGL 633
+H N+++ E +V E + G L+ + F K +T + Q+ L
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
++H S +++H DIKP N+ + ++ D GL + + + A ++ GT Y++
Sbjct: 120 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMS 174
Query: 694 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753
PE + K D++S G LL E+ + + F + Y++ C + +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-------CKK------IE 221
Query: 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793
+ D + +E+L + CI DP RP + V +
Sbjct: 222 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 586
E+G G+FG VYK Q T A A K +D ++ +++ E+ ++ H N+V+LL
Sbjct: 12 ELGDGAFGKVYKA--QNKETGVLAAA-KVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 587 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF-QIARGLLYLHEDCSAQII 645
N ++ EF G + + + +P + + Q L YLHE+ +II
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 646 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF-----RNS 700
H D+K NIL + +++DFG++ T + + + GT ++APE ++
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDR 183
Query: 701 TITAKVDVYSFGVLLLEI 718
K DV+S G+ L+E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 30/212 (14%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK--NEVVVIGQTHHKNLV 583
E++G GS+ VYKG+ +R + VA+K + ++G F E ++ H N+V
Sbjct: 11 EKLGEGSYATVYKGI---SRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIV 66
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDC 640
L + V+E+++ LA ++ G L P +N+R FQ+ RGL Y+H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHP-YNVRL-FMFQLLRGLAYIHGQ- 122
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR-- 698
I+H D+KPQN+L+ +++DFGLA+ +K+I + ++ V W+R
Sbjct: 123 --HILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSE--VVTLWYRPP 172
Query: 699 -----NSTITAKVDVYSFGVLLLEIISCRKSF 725
+ ++ +D++ G + +E++ + +F
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 9e-12
Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 8/200 (4%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTHHKNLVRL 585
+G+GSFG V ++ A+KK D V D + E + V+ + L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKK-DVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 645
++ V EFLN G L + + T A +I GL +LH S II
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGII 118
Query: 646 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAK 705
+ D+K N++LD + +I+DFG+ K ++A + GT Y+APE + T
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKYTFS 176
Query: 706 VDVYSFGVLLLEIISCRKSF 725
VD +SFGVLL E++ + F
Sbjct: 177 VDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 514 YKELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEV 571
+ + +D +E E +G+G++G V+K + + + + AVK LD + D ++E + E
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVL---NKKNGSKAAVKILDPI-HDIDEEIEAEY 65
Query: 572 VVI-GQTHHKNLVRLLGF-----CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI 625
++ + H N+V+ G G LV E N G++ + G LK + I
Sbjct: 66 NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125
Query: 626 AFQIAR----GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681
I GL +LH + + IH D+K NILL ++ DFG++ LT ++
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLR 180
Query: 682 KTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEI 718
+ GT ++APE +ST A+ DV+S G+ +E+
Sbjct: 181 RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 59/212 (27%), Positives = 108/212 (50%), Gaps = 20/212 (9%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK--NEVVVIGQT 577
D++E E++G GS+ VYKG ++ + VA+K + R+ ++ F E ++
Sbjct: 5 DSYEKLEKLGEGSYATVYKG---KSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGL 60
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLL 634
H N+V L + LV+E+++ L ++ G L P N++ + FQ+ RGL
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPE-NVKLFL-FQLLRGLS 117
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694
Y+H+ I+H D+KPQN+L+ D +++DFGLA+ ++ + T Y P
Sbjct: 118 YIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPP 172
Query: 695 EWFRNST-ITAKVDVYSFGVLLLEIISCRKSF 725
+ ST + +D++ G + +E+I +F
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 72/321 (22%), Positives = 133/321 (41%), Gaps = 82/321 (25%)
Query: 524 FEEEVGRGSFGIVY----KGV---------IQTTRTSTTAVAVKKL-DRVFQDGEKEFKN 569
F+E++G G FG V+ +G+ + + VAVK L + ++ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 570 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------------------ 611
E+ ++ + N++RLL C ++ E++ NG L FL
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 612 FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671
+ L +A QIA G+ YL S +H D+ +N L+ Y +I+DFG+++
Sbjct: 129 YSTLI-------FMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 672 LLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI-----TAKVDVYSFGVLLLEIIS-CRKSF 725
N I+G + + W +I T DV++FGV L EI++ C++
Sbjct: 179 ----NLYSGDYYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE-- 231
Query: 726 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIK----------CTEKLVMVSIW 775
+ Y+ L+D + ++E E D C + L + +
Sbjct: 232 -----QPYSQLSD-----------EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLS 275
Query: 776 CIQEDPSLRPTMRKV-SQMLE 795
C + + RP+ +++ + +LE
Sbjct: 276 CWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 53/172 (30%), Positives = 86/172 (50%), Gaps = 21/172 (12%)
Query: 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI 685
+ Q+A+G+ +L S IH D+ +N+LL D A+I DFGLA+ + + + +K
Sbjct: 218 SSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274
Query: 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 744
R ++APE + T + DV+S+G+LL EI S KS Y IL + F Y
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS-------PYPGILVNSKF--Y 325
Query: 745 RNGKLDDLVEGDTEAMNDIKCTE-KLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ K G + D E +M W + +P+ RPT ++SQ+++
Sbjct: 326 KMVK-----RGYQMSRPDFAPPEIYSIMKMCWNL--EPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 44/212 (20%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRL 585
+G G+ GIV + VA+KKL R FQ+ K E+V++ +HKN++ L
Sbjct: 24 IGSGAQGIV---CAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 586 LG-FC-----DEGQNRLLVYEF------------LNNGTLASFLFGNLKPSWNLRTNIAF 627
L F +E Q+ LV E L++ ++ L +
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLL---------------Y 125
Query: 628 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRG 687
Q+ G+ +LH SA IIH D+KP NI++ +I DFGLA+ T S + T
Sbjct: 126 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMM-TPYVV 179
Query: 688 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 719
T+ Y APE VD++S G ++ E+I
Sbjct: 180 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
VG GSFG + ++ S A+K +L + E K E V++ + H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK-EAVLLAKMKHPNIVAF 63
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
+ + +V E+ + G L + G L P + Q+ G+ ++HE
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE-DTILQWFVQMCLGVQHIHEK--- 119
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI 702
+++H DIK +NI L ++ DFG A+LLT + A GT YV PE + N
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--GTPYYVPPEIWENMPY 177
Query: 703 TAKVDVYSFGVLLLEIISCRKSF 725
K D++S G +L E+ + + F
Sbjct: 178 NNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 56/234 (23%), Positives = 101/234 (43%), Gaps = 51/234 (21%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN--------EVVVI 574
E +GRG++G VYK + + A+KK G+KE E+ ++
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKD-GKEYAIKKF-----KGDKEQYTGISQSACREIALL 56
Query: 575 GQTHHKNLVRLLGFCDEGQNRL--LVYEFLNNGTLASF-LFGNLK----------PSWNL 621
+ H+N+V L+ E ++ L++++ A L+ +K P +
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 622 RTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR----ISDFGLAKLLTLNQ 677
+ ++ +QI G+ YLH + ++H D+KP NIL+ R I D GLA+L
Sbjct: 111 K-SLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF---- 162
Query: 678 SKAIKTAIRG-----TKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSF 725
+ +K T Y APE + T +D+++ G + E+++ F
Sbjct: 163 NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV----VIGQTHHKNL 582
++G G+ G V K T V KK+ V + + +++ ++ + +
Sbjct: 12 DLGAGNGGSVSK----VKHIPTGTVMAKKV--VHIGAKSSVRKQILRELQIMHECRSPYI 65
Query: 583 VRLLG-FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 639
V G F +E N + EF++ G+L G + + IA + GL YL+
Sbjct: 66 VSFYGAFLNEN-NICMCMEFMDCGSLDRIYKKGGPIPV--EILGKIAVAVVEGLTYLYN- 121
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
+I+H DIKP NIL++ ++ DFG++ L +I GT Y++PE +
Sbjct: 122 -VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI----NSIADTFVGTSTYMSPERIQG 176
Query: 700 STITAKVDVYSFGVLLLEIISCRKSFD 726
T K DV+S G+ ++E+ + F
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 28/216 (12%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQ 576
D +E E++G G++G VYK + + VA+KK R+ D E E+ ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKA---RDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQM 56
Query: 577 THHKN-LVRLLGF----CDEGQNRL-LVYEFLNNGTLASFLFGNLK-PSWNLRTNIA--- 626
+VRLL G+ L LV+E+L++ L F+ N + P L
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 627 -FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA-RISDFGLAKLLTLNQSKAIKTA 684
+Q+ +G+ + H ++H D+KPQN+L+D +I+D GL + ++
Sbjct: 116 MYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 685 IRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEII 719
+ T Y APE ST + VD++S G + E+
Sbjct: 173 V--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 16/199 (8%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKLDRVFQDGEKEFKNEV----VVIGQTHHKNL 582
+G+GSFG V + AVK L + +KE K+ + V++ H L
Sbjct: 3 IGKGSFGKVL----LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 583 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 641
V L + + ++L V +++N G L L A +IA L YLH S
Sbjct: 59 VGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH---S 114
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
II+ D+KP+NILLD + ++DFGL K + SK T GT Y+APE R
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFC-GTPEYLAPEVLRKQP 172
Query: 702 ITAKVDVYSFGVLLLEIIS 720
VD + G +L E++
Sbjct: 173 YDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 26/203 (12%)
Query: 528 VGRGSFGIV---YKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNL 582
+G G+ GIV Y V+ VA+KKL R FQ+ K E+V++ +HKN+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 583 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 636
+ LL +E Q+ LV E ++ L + ++ + + +Q+ G+ +L
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 135
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
H SA IIH D+KP NI++ +I DFGLA+ + + T T+ Y APE
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 189
Query: 697 FRNSTITAKVDVYSFGVLLLEII 719
VD++S G ++ E++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 21/178 (11%)
Query: 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI 685
+FQ+A+G+ +L S + IH D+ +NILL + +I DFGLA+ + + K
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 743
R ++APE + T + DV+SFGVLL EI S S +++ EE+ C
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 292
Query: 744 YRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801
R L EG D E + + C +PS RPT ++ + L +++ +
Sbjct: 293 RR------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-11
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKNLVR 584
+G+G+FG VY T A V+ D + KE + E+ ++ H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQ-FDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 585 LLG-FCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDC 640
G D + L ++ E++ G++ L +G L S + QI G+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTES--VTRKYTRQILEGMSYLH--- 123
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAK-LLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
S I+H DIK NIL D N ++ DFG +K L T+ S ++ GT +++PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 700 STITAKVDVYSFGVLLLEIIS 720
K DV+S G ++E+++
Sbjct: 184 EGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 51/208 (24%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 518 EEATDNFEE--EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV--- 572
E D+FE E+G G+ G+V K + + +KL + + + +N+++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTK----VQHKPSGLIMARKL--IHLEIKPAIRNQIIREL 54
Query: 573 -VIGQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 630
V+ + + +V G F +G+ + + E ++ G+L L + + ++ +
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVL 113
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690
RGL YL E QI+H D+KP NIL++ ++ DFG++ L ++ + GT+
Sbjct: 114 RGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRS 167
Query: 691 YVAPEWFRNSTITAKVDVYSFGVLLLEI 718
Y++PE + + + + D++S G+ L+E+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 80/286 (27%), Positives = 121/286 (42%), Gaps = 37/286 (12%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEK--EFKNEVVVIGQTHHKNLV 583
E+G GSFG VY + RT+ VA+KK+ Q EK + EV + Q H N +
Sbjct: 22 EIGHGSFGAVYFA--RDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTI 78
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSA 642
G LV E+ G+ + L + KP + I +GL YLH S
Sbjct: 79 EYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SH 134
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE---WFRN 699
+ IH DIK NILL + +++DFG A L++ S GT ++APE
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVILAMDE 188
Query: 700 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759
KVDV+S G I+C IE+ E L F+ L + + D+
Sbjct: 189 GQYDGKVDVWSLG------ITC-----IELAERKPPL----FNMNAMSALYHIAQNDSPT 233
Query: 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPN 805
++ ++ C+Q+ P RP+ ++ + V + PP
Sbjct: 234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR--FVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 67/239 (28%), Positives = 111/239 (46%), Gaps = 40/239 (16%)
Query: 518 EEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE-FK----NE 570
+ D F+ ++G G++G VYK + T VA+KK V D EKE F E
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDT---GELVALKK---VRLDNEKEGFPITAIRE 56
Query: 571 VVVIGQTHHKNLVRL----------LGFCDEGQNRLLVYEFLNN---GTLASFLFGNLKP 617
+ ++ Q +H+N+V L L F + LV+E++++ G L S L
Sbjct: 57 IKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV----- 111
Query: 618 SWNLRTNIAF--QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675
++ +F Q+ GL Y H+ +H DIK NILL++ +++DFGLA+L
Sbjct: 112 HFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 676 NQSKAIKTAIRGTKGYVAPEWFR-NSTITAKVDVYSFGVLLLEIISCRKSF--DIEMGE 731
+S+ + T Y PE +DV+S G +L E+ + + F + E+ +
Sbjct: 169 EESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DRVFQDGEKE---FKNEVVVIGQTHHKNL 582
+GRG+FG VY + + +AVK++ D Q+ KE + E+ ++ H +
Sbjct: 10 LGRGAFGEVY---LCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 583 VRLLGFC--DEGQNRLLVY-EFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLH 637
V+ G C D + +L ++ E++ G++ L +G L + N+ QI +G+ YLH
Sbjct: 67 VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGAL--TENVTRRYTRQILQGVSYLH 123
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK-LLTLNQSKAIKTAIRGTKGYVAPEW 696
S I+H DIK NIL D N ++ DFG +K + T+ S ++ GT +++PE
Sbjct: 124 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 697 FRNSTITAKVDVYSFGVLLLEIIS 720
K DV+S ++E+++
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 26/203 (12%)
Query: 528 VGRGSFGIV---YKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNL 582
+G G+ GIV Y +++ VA+KKL R FQ+ K E+V++ +HKN+
Sbjct: 32 IGSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 583 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 636
+ LL +E Q+ +V E ++ L + ++ + + +Q+ G+ +L
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 142
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
H SA IIH D+KP NI++ +I DFGLA+ T S + + T+ Y APE
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV-TRYYRAPEV 196
Query: 697 FRNSTITAKVDVYSFGVLLLEII 719
VD++S G ++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 624 NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT 683
+ ++Q+A+G+ +L S IH D+ +NILL +I DFGLA+ + + + +K
Sbjct: 218 SFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274
Query: 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 743
R ++APE N T + DV+S+G+LL EI S S M + +
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF-----YKM 329
Query: 744 YRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ G E M DI M S W DP RPT +++ Q++E
Sbjct: 330 IKEGYRMLSPECAPSEMYDI-------MKSCW--DADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 37/221 (16%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKN 581
+E +G+GS+G+V + T VA+KK++ VF+ D + + E+ ++ H +
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEK---VAIKKINDVFEHVSDATRILR-EIKLLRLLRHPD 60
Query: 582 LVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARG 632
+V + E ++ +V+E + S L +K + +L +Q+ R
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELME-----SDLHQVIKANDDLTPEHHQFFLYQLLRA 115
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
L Y+H +A + H D+KP+NIL + +I DFGLA++ + TAI T YV
Sbjct: 116 LKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP----TAIFWTD-YV 167
Query: 693 APEWFRN--------STITAKVDVYSFGVLLLEIISCRKSF 725
A W+R S T +D++S G + E+++ + F
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 46/213 (21%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN---- 581
E +G GSFG V I + + A+K L K E++ + Q H
Sbjct: 24 ETLGTGSFGRVR---IAKHKGTGEYYAIKCLK----------KREILKMKQVQHVAQEKS 70
Query: 582 ---------LVRLL-GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQI 629
+V ++ F DE NR+ + EF+ G L F +L+ + ++A F
Sbjct: 71 ILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYH 124
Query: 630 ARGLL---YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR 686
A +L YLH S II+ D+KP+N+LLD+ + +++DFG AK + +
Sbjct: 125 AELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLC 176
Query: 687 GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 719
GT Y+APE ++ VD ++ GVLL E I
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 528 VGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKNLV 583
+G+G+FG VY T R AV + D + KE + E+ ++ H+ +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRE--LAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 584 RLLGFCDEGQNRLL--VYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 639
+ G + R L E + G++ L +G L + N+ QI G+ YLH
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGAL--TENVTRKYTRQILEGVSYLH-- 123
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAK-LLTLNQSKAIKTAIRGTKGYVAPEWFR 698
S I+H DIK NIL D N ++ DFG +K L T+ S ++ GT +++PE
Sbjct: 124 -SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 699 NSTITAKVDVYSFGVLLLEIISCR 722
K D++S G ++E+++ +
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 48/216 (22%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL- 585
+G GSFG+VY+ + T + VA+KK V QD ++KN E++++ +H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDT---SEKVAIKK---VLQD--PQYKNRELLIMKNLNHINIIFLK 125
Query: 586 --------------------LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI 625
+ F + ++ + + NN L FL
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV----------KLY 175
Query: 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTA 684
++Q+ R L Y+H S I H D+KPQN+L+D + + ++ DFG AK L Q
Sbjct: 176 SYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232
Query: 685 IRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEII 719
R Y APE +T T +D++S G ++ E+I
Sbjct: 233 SR---FYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 44/228 (19%)
Query: 513 SYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK--NE 570
+YK+L++ +G GS+ VYKG + T VA+K++ R+ + F E
Sbjct: 6 TYKKLDK--------LGEGSYATVYKGRSKLTGQ---LVALKEI-RLEHEEGAPFTAIRE 53
Query: 571 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAF 627
++ H N+V L + LV+E+L+ L ++ G L N+R F
Sbjct: 54 ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH-NVRL-FLF 110
Query: 628 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRG 687
Q+ RGL Y H +++H D+KPQN+L+ + +++DFGLA+ +K++
Sbjct: 111 QLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR------AKSVP----- 156
Query: 688 TKGY---VAPEWFR------NST-ITAKVDVYSFGVLLLEIISCRKSF 725
+K Y V W+R ST + +D++ G + E+ + R F
Sbjct: 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 61/234 (26%), Positives = 96/234 (41%), Gaps = 46/234 (19%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAV-AVKKL---DRVFQDGEKEFKNEVVVIG 575
D+FE + +GRG+FG V+ T V A+K L D + ++ + E ++
Sbjct: 1 DDFEVIKVIGRGAFGEVW----LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILA 56
Query: 576 QTHHKNLVRLL-GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARG 632
+V+L F DE ++ LV E++ G L + L F IA
Sbjct: 57 DADSPWIVKLYYSFQDE-EHLYLVMEYMPGGDLMNLLIRKDVFPEET-----ARFYIAEL 110
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL------------------- 673
+L L IH DIKP NIL+D + +++DFGL K +
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 674 --------TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 719
Q + + GT Y+APE R + + D +S GV+L E++
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 12/204 (5%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTT-AVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRL 585
+GRGS+ V +++ +T A+ V K + V D + ++ + E V Q + +
Sbjct: 3 IGRGSYAKVL--LVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 586 LGFCDEGQNRLL-VYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSAQ 643
L C + ++RL V E++N G L + K P + R A +I+ L YLHE
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RG 116
Query: 644 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTIT 703
II+ D+K N+LLD + +++D+G+ K + + GT Y+APE R
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 704 AKVDVYSFGVLLLEIISCRKSFDI 727
VD ++ GVL+ E+++ R FDI
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 49/208 (23%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 518 EEATDNFEE--EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV--- 572
E D+FE+ E+G G+ G+V+K + + + +KL + + + +N+++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFK----VSHKPSGLIMARKL--IHLEIKPAIRNQIIREL 54
Query: 573 -VIGQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 630
V+ + + +V G F +G+ + + E ++ G+L L + + ++ +
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 113
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690
+GL YL E +I+H D+KP NIL++ ++ DFG++ L ++ + GT+
Sbjct: 114 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRS 167
Query: 691 YVAPEWFRNSTITAKVDVYSFGVLLLEI 718
Y++PE + + + + D++S G+ L+E+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 529 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK-NEVVVIGQ-THHKNLVRLL 586
G G+F V K Q+ +T A+K + + F+ E+ E+ + + + H N++RL+
Sbjct: 8 GEGTFSEVLK--AQSRKTGKY-YAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 587 GFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRT-NIAFQIARGLLYLHEDCSAQ 643
D RL LV+E L + L + G +P R + +Q+ + L ++H +
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---G 120
Query: 644 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE-WFRNSTI 702
I H DIKP+NIL+ D +++DFG + + SK T T+ Y APE +
Sbjct: 121 IFHRDIKPENILIKD-DILKLADFGSCRGI---YSKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 703 TAKVDVYSFGVLLLEIIS 720
K+D+++ G + EI+S
Sbjct: 177 GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 14/217 (6%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKNLVR 584
+G+GSFG V ++ T A+ V K D + QD + + + ++ + H +
Sbjct: 3 LGKGSFGKVMLAELKGT-DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH--PFLT 59
Query: 585 LLGFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 643
L C + ++RL V E++N G L + + K A ++ L++LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---G 116
Query: 644 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTIT 703
+I+ D+K NILLD + +++DFG+ K LN T GT Y+APE +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTTTFCGTPDYIAPEILQELEYG 174
Query: 704 AKVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 738
VD ++ GVL+ E+++ + F+ + ++ +IL D
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 583
E+G GSFG VY + RT+ VA+KK+ + +++++ EV + + H N +
Sbjct: 32 EIGHGSFGAVY--FARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSI 88
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSA 642
G LV E+ G+ + L + KP + I +GL YLH S
Sbjct: 89 EYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SH 144
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE---WFRN 699
+IH DIK NILL + +++DFG A + + S GT ++APE
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDE 198
Query: 700 STITAKVDVYSFGVLLLEI 718
KVDV+S G+ +E+
Sbjct: 199 GQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTA--VAVKKLDRV---FQDGEKEFKNEVVVIG--QTHHK 580
+GRG FG VY R + T A+K LD+ + GE NE +++ T
Sbjct: 2 IGRGGFGEVYG-----CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 581 NLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 639
+ + + ++L + + +N G L L + S A +I GL ++H
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH-- 114
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
+ +++ D+KP NILLD++ + RISD GLA + SK A GT GY+APE +
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQK 169
Query: 700 STI-TAKVDVYSFGVLLLEIISCRKSF 725
T + D +S G +L +++ F
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 20/200 (10%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEV----VVIGQTHHKNLV 583
+G+GSFG K ++ ++ + AVK L + +KE + + V++ H LV
Sbjct: 3 IGKGSFG---KVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLHED 639
L + V +++N G L F +L+ A ++A + YLH
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARFYAAEVASAIGYLH-- 113
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
S II+ D+KP+NILLD + ++DFGL K + + + GT Y+APE R
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV--EPEETTSTFCGTPEYLAPEVLRK 170
Query: 700 STITAKVDVYSFGVLLLEII 719
VD + G +L E++
Sbjct: 171 EPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQ-THHKNLVR 584
+GRGS+ V ++ TR +KK + D E + E V ++H LV
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKK--ELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 585 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSA 642
L C + ++RL V EF++ G L + K P + R A +I+ L +LHE
Sbjct: 61 LHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHE---R 115
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK-----TAIRGTKGYVAPEWF 697
II+ D+K N+LLD + +++D+G+ K + I+ + GT Y+APE
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-------EGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFDI 727
R VD ++ GVL+ E+++ R FDI
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEV----VVIGQTHHKNLV 583
+G+GSFG K ++ + AVK L + KE K+ + V++ H LV
Sbjct: 3 IGKGSFG---KVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----PSWNLRTNIAFQIARGLLYLHE 638
L + V +F+N G L F +L+ P R A +IA L YLH
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYAA-EIASALGYLH- 113
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR 698
S I++ D+KP+NILLD + ++DFGL K + QS T GT Y+APE R
Sbjct: 114 --SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDT-TTTFCGTPEYLAPEVIR 169
Query: 699 NSTITAKVDVYSFGVLLLEII 719
VD + G +L E++
Sbjct: 170 KQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 8/202 (3%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRLL 586
+GRGS+ V V A+ V K + V D + ++ + E V Q + L
Sbjct: 3 IGRGSYAKVLL-VRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 587 GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 645
C + +RL LV E++N G L + K A +I L +LHE II
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGII 118
Query: 646 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAK 705
+ D+K N+LLD + +++D+G+ K L T GT Y+APE R
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFC-GTPNYIAPEILRGEEYGFS 176
Query: 706 VDVYSFGVLLLEIISCRKSFDI 727
VD ++ GVL+ E+++ R FDI
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-09
Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 40/230 (17%)
Query: 528 VGRGSFGIVYKG--VIQTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNL 582
+G+G G VY + + R VA+KK+ + K F E + H +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRR-----VALKKIREDLSENPLLKKRFLREAKIAADLIHPGI 64
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-----NLKPSWNLRTNI-AF-----QIAR 631
V + C +G ++ TL S L +L +T++ AF +I
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ-------------- 677
+ Y+H S ++H D+KP NILL + I D+G A L +
Sbjct: 125 TIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 678 --SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 725
S I I GT Y+APE + D+Y+ GV+L ++++ +
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 11/170 (6%)
Query: 570 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQ 628
E +++ +H +++R+ G +V ++ L ++L +P + I Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 629 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGT 688
I GL YLH + +IIH D+K +NI ++D I D G A+ + GT
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ---FPVVAPAFLGLAGT 219
Query: 689 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS-FDIE--MGEEYAI 735
APE +K D++S G++L E+++ + F+ EEY
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269
|
Length = 357 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 47/226 (20%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRL 585
+G GS G+V+ V VAVKK+ V D + K E+ +I + H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKR---VAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKV 67
Query: 586 LGFCDEGQNRL--------------LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 631
+ L +V E++ LA+ L + R +Q+ R
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARL-FMYQLLR 125
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690
GL Y+H SA ++H D+KP N+ ++ + +I DFGLA+++ + S KG
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH---------KG 173
Query: 691 Y----VAPEWFRNSTI-------TAKVDVYSFGVLLLEIISCRKSF 725
Y + +W+R+ + T +D+++ G + E+++ + F
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 39/156 (25%), Positives = 64/156 (41%), Gaps = 10/156 (6%)
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637
+ N ++L + +L+ +++ +G L L K S I Q+ L LH
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 638 EDCSAQIIHCDIKPQNILLDDY-YNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
IIH DIK +N+L D + D+GL K + GT Y +PE
Sbjct: 127 ---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSCYDGTLDYFSPEK 177
Query: 697 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732
+ D ++ GVL E+++ + F + EE
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 67/273 (24%), Positives = 124/273 (45%), Gaps = 33/273 (12%)
Query: 526 EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 584
+ VG G++G VYK + T + AV + KL+ D + E+ ++ + H N+V
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELA--AVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVA 70
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDCS 641
G + + E+ G+L ++ P L+ IA+ + +GL YLH S
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQ--IAYVCRETLQGLAYLH---S 124
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF---R 698
+H DIK NILL D + +++DFG+A +T +K + + GT ++APE +
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--RKSFIGTPYWMAPEVAAVEK 182
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKS-FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757
N D+++ G+ +E+ + FD+ +++ F + KL D + +
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF---QPPKLKDKTKWSS 239
Query: 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
N +K + + ++P RPT ++
Sbjct: 240 TFHNFVKIS----------LTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-09
Identities = 23/88 (26%), Positives = 35/88 (39%), Gaps = 8/88 (9%)
Query: 349 FELSCNGGGQGYNKELFDFHELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCAVAIF-- 406
L+C G G F +L D P + + +C+ CLS+C C +
Sbjct: 1 TPLNCGGDGST-----DGFLKLPDVKLPDNASA-ITAISLEECREACLSNCSCTAYAYNN 54
Query: 407 GIESCWLVKLPLNNGRADSSVNRKAFIK 434
G C L LNN R+ SS +++
Sbjct: 55 GSGGCLLWNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVR 584
+G+G+FG K ++ + S A+K L + + +D E V+ T H L
Sbjct: 3 LGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 585 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 643
L + + ++RL V E++N G L L S + +I L YLH S +
Sbjct: 60 L-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGK 115
Query: 644 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTIT 703
I++ D+K +N++LD + +I+DFGL K + + +KT GT Y+APE ++
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 704 AKVDVYSFGVLLLEIISCRKSF 725
VD + GV++ E++ R F
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 26/159 (16%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE-FK----NEVVVIGQTHHKNL 582
+G+G+FG V+K + + VA+KK V + EKE F E+ ++ H+N+
Sbjct: 20 IGQGTFGEVFKA---RHKKTKQIVALKK---VLMENEKEGFPITALREIKILQLLKHENV 73
Query: 583 VRLLGFCD---EGQNR-----LLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARG 632
V L+ C NR LV+EF + LA L N + L + + G
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-SNKNVKFTLSEIKKVMKMLLNG 131
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671
L Y+H +I+H D+K NIL+ +++DFGLA+
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 30/94 (31%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 625 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA 684
I+ + RGL YL E +I+H D+KP NIL++ ++ DFG++ L ++ +
Sbjct: 104 ISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANS 157
Query: 685 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEI 718
GT+ Y++PE + + T + D++S G+ L+E+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 70/267 (26%), Positives = 113/267 (42%), Gaps = 35/267 (13%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 583
E+G GSFG VY ++ VA+KK+ + +++++ EV + + H N +
Sbjct: 22 EIGHGSFGAVY---FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 78
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSA 642
+ G LV E+ G+ + L + KP + + +GL YLH S
Sbjct: 79 QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE---WFRN 699
+IH D+K NILL + ++ DFG A ++ A GT ++APE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDE 188
Query: 700 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759
KVDV+S G I+C IE+ E L F+ L + + ++ A
Sbjct: 189 GQYDGKVDVWSLG------ITC-----IELAERKPPL----FNMNAMSALYHIAQNESPA 233
Query: 760 MNDIKCTEKLVMVSIWCIQEDPSLRPT 786
+ +E C+Q+ P RPT
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDR---VFQDGEKEFKNEVVVIGQTH 578
NF +G GSFG V ++ T + VA+K+ ++ + Q +E ++ +
Sbjct: 33 NFIRTLGTGSFGRV---ILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 579 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 638
H V L G + LV EF+ G +FL N + ++ A QI YL
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ- 148
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR 698
S I++ D+KP+N+LLD +++DFG AK++ + GT Y+APE
Sbjct: 149 --SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILL 201
Query: 699 NSTITAKVDVYSFGVLLLEII 719
N D ++ G+ + EI+
Sbjct: 202 NVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDGE-KEFKNEVVVIGQTHHKNL 582
+VG+G +G V+ + + + VA+K++ + +F+ E + E ++ T + L
Sbjct: 7 TQVGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWL 63
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCS 641
V+LL + + L E++ G + L NL L + A F +A +
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLL-NNLG---VLSEDHARFYMAEMFEAVDALHE 119
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAK-LLTLNQSKAIKTAIRGTKGYVAPEWFRNS 700
IH D+KP+N L+D + +++DFGL+K ++T S + G+ Y+APE R
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS------VVGSPDYMAPEVLRGK 173
Query: 701 TITAKVDVYSFGVLLLEIIS 720
VD +S G +L E +
Sbjct: 174 GYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 32/214 (14%)
Query: 526 EEVGRGSFGIVYKGVIQ-------TTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 578
E +G+G+F +YKGV++ +V +K L +D F ++ Q
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLS 59
Query: 579 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLY 635
HK+LV+L G C +N ++V E++ G L FL N+ W L ++A Q+A L Y
Sbjct: 60 HKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKL--DVAKQLASALHY 116
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYN-------ARISDFGLAKLLTLNQSKAIKTAIRGT 688
L + +++H ++ +NIL+ Y ++SD G+ + L++ + ++
Sbjct: 117 LEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV-LSREERVERI---- 168
Query: 689 KGYVAPEWFRN--STITAKVDVYSFGVLLLEIIS 720
++APE RN +++T D +SFG LLEI S
Sbjct: 169 -PWIAPECIRNGQASLTIAADKWSFGTTLLEICS 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 69/276 (25%), Positives = 121/276 (43%), Gaps = 44/276 (15%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK-NEVV-------VIGQ 576
++ +G+GSFG VY AVA ++L + + E NE V ++ +
Sbjct: 5 QQRLGKGSFGTVY------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSK 58
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-----SWNLRTNIAFQIAR 631
H +V+ E ++ E+ L LK S N Q+
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDL-DCKLEELKHTGKTLSENQVCEWFIQLLL 117
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
G+ Y+H+ +I+H D+K +NI L + +I DFG+++LL S + T GT Y
Sbjct: 118 GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLATTFTGTPYY 171
Query: 692 VAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751
++PE ++ +K D++S G +L E+ +F E L+ +
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-----EGQNFLS----------VVLR 216
Query: 752 LVEGDTEAMNDIKCTE-KLVMVSIWCIQEDPSLRPT 786
+VEG T ++ + + +M S+ + +DPSLRP+
Sbjct: 217 IVEGPTPSLPETYSRQLNSIMQSM--LNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTA--VAVKKLDRV---FQDGEKEFKNEVVVIG--QTHHK 580
+GRG FG VY R + T A+K LD+ + GE NE +++ T
Sbjct: 2 IGRGGFGEVYG-----CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 581 NLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 639
+ + + ++L + + +N G L L + S A +I GL ++H
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH-- 114
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
+ +++ D+KP NILLD++ + RISD GLA + SK A GT GY+APE +
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQK 169
Query: 700 STI-TAKVDVYSFGVLLLEII 719
+ D +S G +L +++
Sbjct: 170 GVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEV----VVIGQTHHKNLV 583
+G+GSFG K ++ + AVK L + +KE K+ + V++ H LV
Sbjct: 3 IGKGSFG---KVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 584 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHED 639
L F + ++L V +++N G L L L+P A +IA L YLH
Sbjct: 60 GL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF---YAAEIASALGYLH-- 113
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
S I++ D+KP+NILLD + ++DFGL K + + GT Y+APE
Sbjct: 114 -SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI--EHNGTTSTFCGTPEYLAPEVLHK 170
Query: 700 STITAKVDVYSFGVLLLEII 719
VD + G +L E++
Sbjct: 171 QPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 62/250 (24%), Positives = 104/250 (41%), Gaps = 69/250 (27%)
Query: 522 DNFE--EEVGRGSFG---IVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE----FKNEVV 572
D+FE + +GRG+FG +V K + + A+KKL + + EKE + E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQK------KDTGHIYAMKKLRKS-EMLEKEQVAHVRAERD 53
Query: 573 VIGQTHHKNLVRLL-GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------ 625
++ + + +V+L F DE L+ E+L G + + L ++ +
Sbjct: 54 ILAEADNPWVVKLYYSFQDE-NYLYLIMEYLPGGDMMTLL---------MKKDTFTEEET 103
Query: 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL------------ 673
F IA +L + IH DIKP N+LLD + ++SDFGL L
Sbjct: 104 RFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163
Query: 674 --------------TLNQSKAIKTAIR----------GTKGYVAPEWFRNSTITAKVDVY 709
++ + +T R GT Y+APE F + + D +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223
Query: 710 SFGVLLLEII 719
S GV++ E++
Sbjct: 224 SLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 587
VGRG FG V + T +KK + Q+ F+ E ++ ++ + +L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 588 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSAQIIH 646
+ N LV E+ G L S L ++A F +A +L +H +H
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQFYLAELVLAIHSVHQMGYVH 125
Query: 647 CDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR------NS 700
DIKP+N+L+D + +++DFG A LT N+ K + GT Y+APE
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDGKG 184
Query: 701 TITAKVDVYSFGVLLLEIISCRKSF 725
T + D +S GV+ E+I R F
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 66/279 (23%), Positives = 123/279 (44%), Gaps = 31/279 (11%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQT 577
++FE + +G G++G VYK +T +A K+ ++ + GE + E++++
Sbjct: 9 EDFELIQRIGSGTYGDVYKA----RNVNTGELAAIKVIKL-EPGEDFAVVQQEIIMMKDC 63
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637
H N+V G + EF G+L S + ++ + +GL YLH
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
S +H DIK NILL D + +++DFG++ +T +K + + GT ++APE
Sbjct: 124 ---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK--RKSFIGTPYWMAPEVA 178
Query: 698 ---RNSTITAKVDVYSFGVLLLEIISCRKS-FDIEMGEEYAILTDWAFDCYRNGKLDDLV 753
R D+++ G+ +E+ + FD+ ++T F + KL D +
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF---QPPKLKDKM 235
Query: 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792
+ + +K + ++P RPT K+ Q
Sbjct: 236 KWSNSFHHFVKMA----------LTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 19/198 (9%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKN----EVVVIGQTHHKN 581
VG G++G+V K + T+ VA+KK F+D E +E K E+ ++ +N
Sbjct: 9 VGEGAYGVVLKCRHKETKE---IVAIKK----FKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDC 640
+V L LV+E++ L N P +R+ I +Q+ + + + H++
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN- 119
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS 700
I+H DIKP+N+L+ ++ DFG A+ L+ S A T T+ Y +PE +
Sbjct: 120 --DIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGA 176
Query: 701 TITAKVDVYSFGVLLLEI 718
VD++S G +L E+
Sbjct: 177 PYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 43/136 (31%), Positives = 70/136 (51%), Gaps = 10/136 (7%)
Query: 597 LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 654
L+ +++N G L + L+ + S +R IA +I L +LH+ II+ DIK +NI
Sbjct: 82 LILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLHQ---LGIIYRDIKLENI 136
Query: 655 LLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI--TAKVDVYSFG 712
LLD + ++DFGL+K + + GT Y+APE R + VD +S G
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 713 VLLLEIISCRKSFDIE 728
VL E+++ F ++
Sbjct: 196 VLTFELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 59/246 (23%), Positives = 98/246 (39%), Gaps = 37/246 (15%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 587
+GRG+FG V + T ++K D + ++ + E ++ + +V++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 588 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHC 647
+ N L+ EFL G + + L +K F IA +L + IH
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR 125
Query: 648 DIKPQNILLDDYYNARISDFGLAKLL-----------------------TLNQSKAIKTA 684
DIKP N+LLD + ++SDFGL L +N + +T
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETW 185
Query: 685 IR----------GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-Y 733
R GT Y+APE F + D +S GV++ E++ F E +E Y
Sbjct: 186 KRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 734 AILTDW 739
+ +W
Sbjct: 246 KKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 33/226 (14%)
Query: 529 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNE---VVVIGQTHHKNLVRL 585
GRG FG V + T A+KK D + +D + E H LV L
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNL 67
Query: 586 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI---------AFQIARGLLY 635
C + ++ + V E+ G L ++ T++ A + GL Y
Sbjct: 68 FA-CFQTEDHVCFVMEYAAGGDLM----------MHIHTDVFSEPRAVFYAACVVLGLQY 116
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR-GTKGYVAP 694
LHE+ +I++ D+K N+LLD +I+DFGL K +T+ GT ++AP
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAP 170
Query: 695 EWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 738
E ++ T VD + GVL+ E++ F + EE +I+ D
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 61/254 (24%), Positives = 104/254 (40%), Gaps = 39/254 (15%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 579
D+FE + +GRG+FG V + T ++K D + ++ + E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 639
+V++ + +N L+ EFL G + + L +K F IA +L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLAIDAI 117
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL-----------------------TLN 676
IH DIKP N+LLD + ++SDFGL L +N
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 677 QSKAIKT----------AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 726
+ +T + GT Y+APE F + D +S GV++ E++ F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 727 IEMGEE-YAILTDW 739
E +E Y + +W
Sbjct: 238 SETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 38/105 (36%), Positives = 59/105 (56%), Gaps = 6/105 (5%)
Query: 628 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRG 687
+I L +LH+ I++ DIK +NILLD + ++DFGL+K L++ K + G
Sbjct: 113 EIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCG 168
Query: 688 TKGYVAPEWFRNSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGE 731
T Y+APE R K VD +S G+L+ E+++ F +E GE
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE-GE 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 35/106 (33%), Positives = 47/106 (44%), Gaps = 7/106 (6%)
Query: 624 NIAFQIARGLL----YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679
A I R LL YLH IIH D+K +NI LD+ NA + DFG A L +
Sbjct: 185 EQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 725
GT +PE AK D++S G++L E+ +
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 28/99 (28%), Positives = 39/99 (39%), Gaps = 25/99 (25%)
Query: 235 NESGYM-YILRRNSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYFYPKNGNGNWSAVWS 293
NE Y Y + NS Y R TL+ +G ++ + N +W+ WS
Sbjct: 31 NEEVYYTYRMTNNS---------------IYSRLTLSSEGSLERFTWIPNSQ-DWNLFWS 74
Query: 294 QPENICDNISGEFGSGACGFNSICTLDGDRRPMCECPKG 332
P++ CD G CG C D + P C C KG
Sbjct: 75 APKDQCDVY------GRCGPYGYC--DVNTSPKCNCIKG 105
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 526 EEVGRGSFGIVYKGVIQ---------TTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ 576
E +GRG+ +Y G++ + V +K LD +D F ++ Q
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGL 633
HK++V L G C ++V EF+ G L F+ L W +A Q+A L
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF--KVAKQLASAL 118
Query: 634 LYLHEDCSAQIIHCDIKPQNILL-----DDYYNA--RISDFGLAKLLTLNQSKAIKTAIR 686
YL ED ++H ++ +NILL D ++SD G+ + L++ + ++
Sbjct: 119 SYL-ED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQECVERI-- 172
Query: 687 GTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEI 718
++APE +S ++ D +SFG L EI
Sbjct: 173 ---PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVR 584
+G+G+FG K ++ + + A+K L + + +D E V+ T H L
Sbjct: 3 LGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 585 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGL 633
L + + +RL V E+ N G L ++L F +I L
Sbjct: 60 L-KYSFQTHDRLCFVMEYANGGELF----------FHLSRERVFSEDRARFYGAEIVSAL 108
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
YLH S +++ D+K +N++LD + +I+DFGL K ++ +KT GT Y+A
Sbjct: 109 GYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTPEYLA 163
Query: 694 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 725
PE ++ VD + GV++ E++ R F
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 29/181 (16%)
Query: 624 NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT 683
+ +Q+ARG+ +L S +H D+ +N+LL +I DFGLA+ + + + K
Sbjct: 241 SFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF- 741
+ ++APE ++ T DV+S+G+LL EI S G Y ++ D F
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG-------GTPYPGMIVDSTFY 350
Query: 742 ----DCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797
YR K D A ++ +MV W +P RP+ +S ++E +
Sbjct: 351 NKIKSGYRMAKPD-------HATQEV----YDIMVKCW--NSEPEKRPSFLHLSDIVESL 397
Query: 798 V 798
+
Sbjct: 398 L 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVR 584
+G+G+FG K ++ + + A+K L + + +D E V+ T H L
Sbjct: 3 LGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 585 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 643
L + + +RL V E+ N G L L + +I L YLH S
Sbjct: 60 L-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRD 115
Query: 644 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTIT 703
+++ DIK +N++LD + +I+DFGL K + A GT Y+APE ++
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 704 AKVDVYSFGVLLLEIISCRKSF 725
VD + GV++ E++ R F
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 41/139 (29%), Positives = 70/139 (50%), Gaps = 9/139 (6%)
Query: 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 656
L+ +++N G L + L + + +I L +LH+ II+ DIK +NILL
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILL 138
Query: 657 DDYYNARISDFGLAK-LLTLNQSKAIKTAIRGTKGYVAPEWFR--NSTITAKVDVYSFGV 713
D + ++DFGL+K +A + GT Y+AP+ R + VD +S GV
Sbjct: 139 DSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGV 196
Query: 714 LLLEIISCRKSFDIEMGEE 732
L+ E+++ F ++ GE+
Sbjct: 197 LMYELLTGASPFTVD-GEK 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 38/222 (17%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT---------- 577
+G G++G V K T T VA+KK+ + + + + ++G
Sbjct: 17 LGEGTYGKVEKAY--DTLTGKI-VAIKKVKII--EISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 578 ------HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 631
H+N++ L+ EG LV + + L + ++ + + I QI
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILN 130
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK-----LLTLNQSKAIKTAIR 686
GL LH +H D+ P NI ++ +I+DFGLA+ + SK R
Sbjct: 131 GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 687 G-------TKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIIS 720
T Y APE + VD++S G + E+++
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 29/204 (14%)
Query: 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQ-IARGLLY------LHEDCSAQIIHCD 648
LL+ E+ + G L N + L+ ++ FQ GLL+ L E S +++H D
Sbjct: 141 LLIMEYGSGGDL------NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRD 194
Query: 649 IKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDV 708
+K NI L ++ DFG +K + + S + ++ GT Y+APE + + K D+
Sbjct: 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADM 254
Query: 709 YSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEK 768
+S GV+L E+++ + F E I+ + GK D + M K
Sbjct: 255 WSLGVILYELLTLHRPFKGPSQRE--IMQQVLY-----GKYDPFPCPVSSGM-------K 300
Query: 769 LVMVSIWCIQEDPSLRPTMRKVSQ 792
++ + + ++P+LRPT +++
Sbjct: 301 ALLDPL--LSKNPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 48/199 (24%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 587
+GRG+FG V ++++ + K + + + F E ++ + +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 588 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSAQIIH 646
+ + +V E++ G L NL ++++ A F A +L L S +IH
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLV-----NLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH 165
Query: 647 CDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK--TAIRGTKGYVAPEWFR----NS 700
D+KP N+LLD + + +++DFG + ++++ ++ TA+ GT Y++PE + +
Sbjct: 166 RDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 701 TITAKVDVYSFGVLLLEII 719
+ D +S GV L E++
Sbjct: 223 YYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKLDRVFQDGEKEF-----KNEVVVIGQTHHKN 581
+G+G+FG VY Q + T + A+K L + +KE + ++V
Sbjct: 1 IGKGTFGQVY----QVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESP 56
Query: 582 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHED 639
+ L F + + L LV ++++ G L F +L+ + A F IA +L L
Sbjct: 57 FIVGLKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFSEDRAKFYIAELVLALEHL 112
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKL-LTLNQSKAIKTAIRGTKGYVAPE-WF 697
I++ D+KP+NILLD + + DFGL+K LT N GT Y+APE
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---KTTNTFCGTTEYLAPEVLL 169
Query: 698 RNSTITAKVDVYSFGVLLLEI 718
T VD +S GVL+ E+
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH----HKN 581
+E+G G FG V I T T V VK+L KE +NE + G + H N
Sbjct: 1 QEIGNGWFGKVLLSEIYTD-TGVARVVVKELKA--NASSKE-QNEFLQQGDPYRILQHPN 56
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLY 635
+++ LG C E LLV+E+ G L S+L N + L +A +IA G+ +
Sbjct: 57 ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL--LLQRMACEIAAGVTH 114
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT------AIRGTK 689
+H+ +H D+ +N L ++ D+G+ + + I+T +R
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLR--- 166
Query: 690 GYVAPEW---FRNSTITAK----VDVYSFGVLLLEIISCRK 723
++APE F ITA+ +V++ GV L E+
Sbjct: 167 -WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA 206
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVR 584
+G+G+FG K ++ + + A+K L + V +D E V+ + H L
Sbjct: 3 LGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 585 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 643
L + + +RL V E+ N G L L S + +I L YLH +
Sbjct: 60 L-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KN 116
Query: 644 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTIT 703
+++ D+K +N++LD + +I+DFGL K + +KT GT Y+APE ++
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEYLAPEVLEDNDYG 174
Query: 704 AKVDVYSFGVLLLEIISCRKSF 725
VD + GV++ E++ R F
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 8e-07
Identities = 61/246 (24%), Positives = 113/246 (45%), Gaps = 41/246 (16%)
Query: 514 YKELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNE 570
Y + E + +E +++G G FG V+ +++ RT R ++ EK + E
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIE 62
Query: 571 VVVIGQTHHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASF------LFGNLKPSWNLR 622
V V+ + HKN+VR + F ++ +L ++ EF + G L+ +FG ++ +
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE--HAI 120
Query: 623 TNIAFQIARGLLYLHE----DCSAQIIHCDIKPQNILLDDYYN----------------- 661
+I Q+ L Y H +++H D+KPQNI L
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 662 ARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTIT--AKVDVYSFGVLLLEII 719
A+I DFGL+K + + +++ + GT Y +PE + T + K D+++ G ++ E+
Sbjct: 181 AKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 720 SCRKSF 725
S + F
Sbjct: 238 SGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 22/220 (10%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNE--VVVIGQT 577
D+FE + +GRG+FG V ++ T + K + + + F+ E V+V G
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 578 HHKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLL 634
+ L + + +N L LV ++ G L + L F + P R F IA +L
Sbjct: 61 Q---WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYIAEMVL 113
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR-GTKGYVA 693
+H +H DIKP N+LLD + R++DFG L +NQ +++++ GT Y++
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYIS 171
Query: 694 PEWFRN-----STITAKVDVYSFGVLLLEIISCRKSFDIE 728
PE + + D +S GV + E++ F E
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 44/230 (19%), Positives = 94/230 (40%), Gaps = 28/230 (12%)
Query: 567 FKNEVVVIGQTHHKNLVRLLGF----CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR 622
+NE+ + + N++++ GF D+ L+ E+ G L L S+ +
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTK 124
Query: 623 TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682
++A +GL L++ + + ++ + L+ + Y +I GL K+L+ K +
Sbjct: 125 LDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182
Query: 683 TAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 740
+ Y + + + S T K D+YS GV+L EI + + F+
Sbjct: 183 FMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE---NLTTK------ 228
Query: 741 FDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+ Y D ++ + + C ++ + C D RP ++++
Sbjct: 229 -EIY-----DLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 3/95 (3%)
Query: 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI 685
++Q+A G+ +L S +H D+ +N+L+ + +I DFGLA+ + + + K +
Sbjct: 245 SYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
++APE N+ T DV+SFG+LL EI +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 53/185 (28%), Positives = 84/185 (45%), Gaps = 34/185 (18%)
Query: 551 VAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 610
V +K LD +D F ++ Q H +L + G C G ++V EF+ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 611 LF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDF 667
L G + +W + +A Q+A L YL ED + ++H ++ +NILL AR+
Sbjct: 107 LRKEKGRVPVAWKI--TVAQQLASALSYL-EDKN--LVHGNVCAKNILL-----ARL--- 153
Query: 668 GLAKLLTLNQSKAIKTAIRGTK-------------GYVAPEWFRN-STITAKVDVYSFGV 713
GLA+ S IK + G ++APE ++++ D +SFG
Sbjct: 154 GLAE----GTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGT 209
Query: 714 LLLEI 718
LLEI
Sbjct: 210 TLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 53/214 (24%), Positives = 102/214 (47%), Gaps = 17/214 (7%)
Query: 515 KELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV 572
++L +++E + +GRG+FG V ++TR + K + + + F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 573 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIAR 631
++ + +V+L + + +V E++ G L NL ++++ A F A
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFYTAE 150
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK--TAIRGTK 689
+L L S IH D+KP N+LLD + +++DFG + +N+ ++ TA+ GT
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTP 207
Query: 690 GYVAPEWFR----NSTITAKVDVYSFGVLLLEII 719
Y++PE + + + D +S GV L E++
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 6/102 (5%)
Query: 625 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL-LTLNQSKAIKT 683
I + R + YLHE+ +IIH DIK +NI ++ + + DFG A + +N +K
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 725
A GT APE VD++S G++L E+ +C S
Sbjct: 244 A--GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 11/206 (5%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHHKNLV 583
+G+G +G V++ T + A+K L + Q K E ++ H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSA 642
L+ G L+ E+L+ G L F +L+ + A F ++ L L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI 702
II+ D+KP+NILLD + +++DFGL K + GT Y+APE S
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESI--HEGTVTHTFCGTIEYMAPEILMRSGH 177
Query: 703 TAKVDVYSFGVLLLEIISCRKSFDIE 728
VD +S G L+ ++++ F E
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 53/220 (24%), Positives = 98/220 (44%), Gaps = 43/220 (19%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE-FK----NEVVVI 574
D +E + G++G+VY+ + T VA+KKL + EKE F E+ ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKT---GEIVALKKLK---MEKEKEGFPITSLREINIL 58
Query: 575 GQTHHKNLVRL----LGFCDEGQNRL-LVYEF--------LNNGTLASFLFGNLKPSWNL 621
+ H N+V + +G +++ +V E+ + FL +K
Sbjct: 59 LKLQHPNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVK----- 109
Query: 622 RTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681
+ Q+ G+ +LH++ I+H D+K N+LL++ +I DFGLA+
Sbjct: 110 --CLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY- 163
Query: 682 KTAIRGTKGYVAPE-WFRNSTITAKVDVYSFGVLLLEIIS 720
T + T Y APE + +D++S G + E+++
Sbjct: 164 -TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 21/202 (10%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 584
+GRG+FG V + ++S A+K K + + + F E ++ + + +V+
Sbjct: 51 IGRGAFGEVQ---LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 585 L-LGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCS 641
L F D+ + +V E++ G L + L N + W F A +L L S
Sbjct: 108 LHYAFQDD-KYLYMVMEYMPGGDLVN-LMSNYDIPEKW-----ARFYTAEVVLALDAIHS 160
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
IH D+KP N+LLD + +++DFG + N TA+ GT Y++PE ++
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 702 ITA----KVDVYSFGVLLLEII 719
+ D +S GV L E++
Sbjct: 220 GDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVR 584
+GRG+FG V + + + A+K L++ + + E F+ E V+ ++ +
Sbjct: 9 IGRGAFGEV---AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITT 65
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
L + N LV ++ G L + L F + P R F +A ++ +
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVIAIDSVHQL 121
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR-GTKGYVAPEWFR--- 698
+H DIKP NIL+D + R++DFG L L + +++++ GT Y++PE +
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 699 --NSTITAKVDVYSFGVLLLEIISCRKSFDIE 728
+ D +S GV + E++ F E
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 3/95 (3%)
Query: 623 TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682
T +A Q+ + Y+H + IIH DIK +N+L++ + + DFG A + S
Sbjct: 263 TAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319
Query: 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLE 717
I GT APE T VD++S G+++ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 16/100 (16%)
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL----LTLNQSKA-IKTAIR- 686
L YLH + I+H D+KP N+L+ + +++DFGL+K+ LT N + I+ R
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 687 -------GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 719
GT Y+APE VD ++ G++L E +
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQ 576
D+FE + +GRG+FG V V++ + + A+K L++ + + E F+ E V+
Sbjct: 1 DDFEILKVIGRGAFGEV--AVVKM-KNTGQVYAMKILNKWEMLKRAETACFREERDVLVN 57
Query: 577 THHKNLVRL-LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGL 633
+ + L F DE N LV ++ G L + L F + P R F +A +
Sbjct: 58 GDRRWITNLHYAFQDE-NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMV 112
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR-GTKGYV 692
L + +H DIKP N+LLD + R++DFG L L +++ + GT Y+
Sbjct: 113 LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYI 170
Query: 693 APEWFR-----NSTITAKVDVYSFGVLLLEII 719
+PE + + D +S GV + E++
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 8/102 (7%)
Query: 621 LRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN---- 676
L NI + L Y+HE I H DIKP+NI++D I D+G+A ++
Sbjct: 127 LIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183
Query: 677 -QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLE 717
SK K RGT Y + + +T + D+ S G +L+
Sbjct: 184 EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 587
+ RG+FG VY G + VKK D + ++ + + E + + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 588 FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 645
N LV E+L G + S L +G ++ I+ ++A L YLH II
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY-IS-EVALALDYLHRH---GII 126
Query: 646 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677
H D+KP N+L+ + + +++DFGL+K +TLN+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSK-VTLNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 56/230 (24%), Positives = 87/230 (37%), Gaps = 46/230 (20%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAV--AVKKLDRVFQDGEKEFKN---EVVVIGQTHHK 580
+ +G+G G V+ R T A+K LD+ + K E ++ H
Sbjct: 7 KLLGKGDVGRVF-----LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLL---YL 636
L L LV ++ G L L +P L +A F A LL YL
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR---------- 686
H I++ D+KP+NILL + + +SDF L+K + K +
Sbjct: 120 H---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 687 -----------------GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 719
GT+ Y+APE + VD ++ G+LL E++
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 25/215 (11%)
Query: 527 EVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
E+GRG + + + T T T V + L+ ++ K +NEVV+ H N++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIARGLLYLHEDCSA 642
G ++ F+ G+ A+ L P S L NI F RGL YLH++
Sbjct: 65 WTVFTTGSWLWVISPFMAYGS-ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN--- 120
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTL----NQSKAI------KTAIRGTKGYV 692
IH +IK +IL+ + +S GL+ L +L ++K + T++ ++
Sbjct: 121 GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWL 175
Query: 693 APEWFRN--STITAKVDVYSFGVLLLEIISCRKSF 725
+PE R K D+YS G+ E+ + R F
Sbjct: 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 55/244 (22%), Positives = 92/244 (37%), Gaps = 50/244 (20%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 587
+G G+FG V T ++K D + ++ K E ++ + ++ +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 588 FCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIH 646
+ N V +++ G + S L + P R F IA L + IH
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLAR----FYIAELTLAIESVHKMGFIH 124
Query: 647 CDIKPQNILLDDYYNARISDFGLA------------------------------------ 670
DIKP NIL+D + +++DFGL
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184
Query: 671 ---KLLTLNQ------SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISC 721
+L TL Q + + ++ GT Y+APE T D +S GV+L E++
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244
Query: 722 RKSF 725
+ F
Sbjct: 245 QPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 57/235 (24%), Positives = 104/235 (44%), Gaps = 32/235 (13%)
Query: 524 FEEE---VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK 580
FE E VGRG++G VYK + + A+K+++ E+ ++ + H
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDDRD-YALKQIEGT--GISMSACREIALLRELKHP 58
Query: 581 NLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLF-----GNLKPSWNLR---TNIAFQIA 630
N++ L F ++ L++++ + F N KP R ++ +QI
Sbjct: 59 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLN-QSKAIKTAI 685
G+ YLH + ++H D+KP NIL+ + +I+D G A+L + A +
Sbjct: 119 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 686 RGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIIS------CRKSFDIEMGEEY 733
T Y APE + T +D+++ G + E+++ CR+ DI+ Y
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-DIKTSNPY 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 524 FEEE---VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK 580
FE E VGRG++G VYK + + A+K+++ E+ ++ + H
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGT--GISMSACREIALLRELKHP 58
Query: 581 NLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLF-----GNLKPSWNLRT---NIAFQIA 630
N++ L F ++ L++++ + F N KP R+ ++ +QI
Sbjct: 59 NVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLN-QSKAIKTAI 685
G+ YLH + ++H D+KP NIL+ + +I+D G A+L + A +
Sbjct: 119 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 686 RGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSF 725
T Y APE + T +D+++ G + E+++ F
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 40/164 (24%), Positives = 76/164 (46%), Gaps = 18/164 (10%)
Query: 566 EFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV---YEFLNNGTLASFLFG---NLKPS- 618
+ +NE++ +G+ +H+N++++ N ++ Y+F L SF++ + K
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264
Query: 619 --WNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676
R I Q+ + Y+H ++IH DIK +NI L+ + DFG A
Sbjct: 265 LLKQTRA-IMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE-K 319
Query: 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
+ +A GT +PE D++S G++LL+++S
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 55/250 (22%), Positives = 95/250 (38%), Gaps = 62/250 (24%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 587
+G G+FG V T+ ++K D + ++ K E ++ + ++ +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 588 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE-DCSAQ--- 643
+ N V +++ G + S L +R I F Y+ E C+ +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL---------IRMGI-FPEDLARFYIAELTCAVESVH 118
Query: 644 ---IIHCDIKPQNILLDDYYNARISDFGLA------------------------------ 670
IH DIKP NIL+D + +++DFGL
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 671 ---------KLLTLNQSKA------IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 715
+L L + A + ++ GT Y+APE + T D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 716 LEIISCRKSF 725
E++ + F
Sbjct: 239 YEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 12/96 (12%)
Query: 524 FEEEVGRGSFGIVYKGVIQTT------RTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQ 576
F + +G G+FG V++ T + VAVK L E+E +E+ ++
Sbjct: 42 FGKTLGAGAFG----KVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 577 T-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL 611
HKN+V LLG C G L++ E+ G L +FL
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 60/240 (25%), Positives = 94/240 (39%), Gaps = 58/240 (24%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DRVFQ-DGEKEFKNEVVVIGQTHHKNLVR 584
+G+G+FG V ++Q T A+K L +F+ D K E V+ ++ +V
Sbjct: 9 IGKGAFGEVR--LVQKKDTGKI-YAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN--IAFQIARGLLYLHEDCSA 642
L + Q L+ EFL G L + L ++ + F +A +L +
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTMLI-----KYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLA-------------KL----------------- 672
IH DIKP NIL+D + ++SDFGL+ KL
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 673 -----LTLNQSKAIKTAIR----------GTKGYVAPEWFRNSTITAKVDVYSFGVLLLE 717
LT++ I T + GT Y+APE F + D +S G ++ E
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 814 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.98 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.75 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.73 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.71 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.65 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.65 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.65 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.64 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.59 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.58 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.55 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.55 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.55 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.47 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.44 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.42 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.36 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.22 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.2 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.2 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.03 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.02 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.88 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.87 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.87 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.82 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.81 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.75 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.66 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.6 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.53 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.52 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.42 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.39 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.27 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.2 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.1 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.04 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.04 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.97 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.94 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.81 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.65 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.52 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.51 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.4 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.35 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.25 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.21 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.07 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.87 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.82 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.73 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.55 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.41 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.26 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.22 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.05 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.01 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.61 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.36 | |
| PLN02236 | 344 | choline kinase | 94.0 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 93.99 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 93.57 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.09 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.02 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 92.22 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 92.17 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 91.3 | |
| smart00223 | 79 | APPLE APPLE domain. Four-fold repeat in plasma kal | 91.19 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 89.74 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 89.36 | |
| PF14295 | 51 | PAN_4: PAN domain; PDB: 2YIL_E 2YIP_C 2YIO_A. | 88.69 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-55 Score=474.16 Aligned_cols=287 Identities=46% Similarity=0.764 Sum_probs=253.9
Q ss_pred CccccCHHHHHHHHhhhh--ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeee
Q 042262 508 NLRCFSYKELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585 (814)
Q Consensus 508 ~~~~f~~~el~~~~~~~~--~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l 585 (814)
..+.|++.+|.+||++|+ +.||+|+||.||+|.+. ++..||||++........++|.+|++++.+++|||||+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~----~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~L 136 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS----DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKL 136 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC----CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccE
Confidence 577899999999999998 58999999999999997 458899998876543215679999999999999999999
Q ss_pred eeeeccCC-ceehhhhhccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCe
Q 042262 586 LGFCDEGQ-NRLLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA 662 (814)
Q Consensus 586 ~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ 662 (814)
+|||.+.+ +++||||||++|+|.++|+... .++|.+|++||.++|+||+|||+.+.+.||||||||+|||||+++++
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99999998 5999999999999999999865 89999999999999999999999988899999999999999999999
Q ss_pred EEeecCCcccccccccccccccc-cCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHH
Q 042262 663 RISDFGLAKLLTLNQSKAIKTAI-RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 741 (814)
Q Consensus 663 kl~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 741 (814)
||+|||+++........ .... .||.+|+|||++..+..++|+|||||||+|+||+||+++.+.........+.+|++
T Consensus 217 KlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99999999765531111 1112 79999999999999999999999999999999999999998766555556889999
Q ss_pred HHHhcCCccccccCccc-ccCCh-hHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 742 DCYRNGKLDDLVEGDTE-AMNDI-KCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 742 ~~~~~~~~~~l~~~~~~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
..+.++++.+++|+.+. ...+. +....+.+++.+|++.+|.+||+|.||+++|+.+...
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999999999986 44443 6788899999999999999999999999999665544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=391.34 Aligned_cols=251 Identities=34% Similarity=0.534 Sum_probs=210.2
Q ss_pred hhccccccceeEEEEEEEeccCCcceE-EEEEeeccccccc--hhhhhceeeEEeeccccceeeeeeeeccCC-ceehhh
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTA-VAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-NRLLVY 599 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~-vaVK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~ 599 (814)
+.+.||+|+||+||+|.+. ++. ||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..+|||
T Consensus 45 ~~~~iG~G~~g~V~~~~~~-----g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWR-----GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hhhhcccCCceeEEEEEeC-----CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 3455999999999999996 444 9999997643332 458999999999999999999999999988 799999
Q ss_pred hhccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eeecCCCCCcEEECCCC-CeEEeecCCcccccc
Q 042262 600 EFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQ-IIHCDIKPQNILLDDYY-NARISDFGLAKLLTL 675 (814)
Q Consensus 600 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~ 675 (814)
|||++|+|.++++. ...+++..+++|+.|||+||.|||++ + ||||||||+||||+.++ ++||+|||+++....
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999988 57899999999999999999999964 5 99999999999999997 999999999998765
Q ss_pred cccccccccccCCCCccCccccc--CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFR--NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
.. ...+...||..|||||.+. ...++.|+|||||||+||||+||+.||..... .+.+......+...
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp--- 265 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRP--- 265 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCC---
Confidence 42 1133467999999999999 56999999999999999999999999975543 12222232233222
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
..+..++..+..++.+||+.||.+||++.|++.+|+.+..
T Consensus 266 ------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 266 ------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 2233478899999999999999999999999999986543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=370.10 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=211.8
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCCc-eehhhhhc
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN-RLLVYEFL 602 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~e~~ 602 (814)
.+.||+|..|+|||+.++. .++.+|+|.+... .....+++.+|++++++.+||+||.++|.|..+.. ..|+||||
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~---t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKP---TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhcccCCCcEEEEEEEcC---CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 4679999999999999985 5789999999543 33446889999999999999999999999999884 99999999
Q ss_pred cCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccc
Q 042262 603 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682 (814)
Q Consensus 603 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (814)
.+|||++++...+++++...-+|+.+|++||.|||+ ..+||||||||+|||++..+++||+|||.++.+... ..
T Consensus 161 DgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a 234 (364)
T KOG0581|consen 161 DGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA 234 (364)
T ss_pred CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence 999999999988889999999999999999999996 379999999999999999999999999999987655 24
Q ss_pred ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCc--chhhHHHHHHHHHhcCCccccccCccccc
Q 042262 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE--EYAILTDWAFDCYRNGKLDDLVEGDTEAM 760 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~l~~~~~~~~ 760 (814)
..++||..|||||.+++..|+.++||||||+.++|+.+|+.|+...... ....+. ..+++.+.+..
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll------------~~Iv~~ppP~l 302 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL------------CAIVDEPPPRL 302 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH------------HHHhcCCCCCC
Confidence 5678999999999999999999999999999999999999999875321 122221 11223222222
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 761 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
....++.+++.++..||+.||.+|||++|+++.
T Consensus 303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222588999999999999999999999998873
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=381.84 Aligned_cols=263 Identities=30% Similarity=0.452 Sum_probs=221.8
Q ss_pred HHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCc
Q 042262 515 KELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 515 ~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 594 (814)
.++......+.++||+|-||.||.|.+. ....||||.++.. ....++|.+|+.+|++|+|+|||+++|+|..++.
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~----~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWN----GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEc----CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 4556666778899999999999999997 3457999998765 3445789999999999999999999999999889
Q ss_pred eehhhhhccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 595 RLLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
++||+|||+.|+|.++|.. ...+...+.+.++.|||+|++||+ +.++|||||.++||||+++..+||+|||||+.
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccc
Confidence 9999999999999999986 467899999999999999999999 56999999999999999999999999999996
Q ss_pred ccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
...+.... .....-...|.|||.+..+.++.|||||||||+||||+| |+.|+......+ +.+
T Consensus 353 ~~d~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------------v~~ 415 (468)
T KOG0197|consen 353 IGDDEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------------VLE 415 (468)
T ss_pred cCCCceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----------------HHH
Confidence 65554433 233334678999999999999999999999999999999 777765332211 122
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCC
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 802 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~ 802 (814)
.++...+...+..|+.++.+|+..||+.+|++|||++.+...|+++.....
T Consensus 416 ~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 416 LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 333444555677899999999999999999999999999999988766543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=361.92 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=210.9
Q ss_pred HHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccc-------hhhhhceeeEEeeccccceeeeeeeec
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG-------EKEFKNEVVVIGQTHHKNLVRLLGFCD 590 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~ 590 (814)
....+-+.+.||+|+||.|-+|...+ +++.||||++.+..... ....++|+++|++++|||||++.+++.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~---tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK---TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc---cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 45566778899999999999999875 67899999997532221 223579999999999999999999999
Q ss_pred cCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC---CCeEEeec
Q 042262 591 EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY---YNARISDF 667 (814)
Q Consensus 591 ~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~---~~~kl~Df 667 (814)
+.+..|||+||+++|.|.+++-.+..+.+..-..+++|++.|+.||| +.+|+||||||+|||+..+ ..+||+||
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999999999988888889999999999999999 4699999999999999765 78999999
Q ss_pred CCcccccccccccccccccCCCCccCcccccCCCC--C-CccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHH
Q 042262 668 GLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI--T-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 744 (814)
Q Consensus 668 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--t-~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 744 (814)
|+|+..+... ...+.+||+.|.|||++.+... . .|.|+||+||+||-+++|.+||....++. . ..+.+
T Consensus 324 GlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s----l~eQI 394 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S----LKEQI 394 (475)
T ss_pred chhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c----HHHHH
Confidence 9999876332 3567899999999999987653 3 37899999999999999999998654432 0 22334
Q ss_pred hcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 745 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..|+.... .....+.+++..+++.++|+.||++|||+.|+++
T Consensus 395 ~~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 LKGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hcCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 44443221 1223467899999999999999999999999876
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=392.55 Aligned_cols=267 Identities=28% Similarity=0.484 Sum_probs=226.2
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEeccC--CcceEEEEEeecccccc-chhhhhceeeEEeeccccceeeeeeeeccC
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 592 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 592 (814)
++......+.++||+|+||+||+|...... .....||||.+++..+. ..++|++|++++..++|||||+|+|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 444555567789999999999999987533 45679999999887665 678999999999999999999999999999
Q ss_pred CceehhhhhccCCchhhhhcCC----------CC----CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 042262 593 QNRLLVYEFLNNGTLASFLFGN----------LK----PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 658 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~----------~~----l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~ 658 (814)
+..+||+|||..|+|.+||... .. |+..+.+.||.|||.|++||- +..+|||||.++|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceecc
Confidence 9999999999999999999521 23 788999999999999999999 569999999999999999
Q ss_pred CCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHH
Q 042262 659 YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILT 737 (814)
Q Consensus 659 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~ 737 (814)
+..+||+||||+|..-..+.........-..+|||||.|..+++|.+||||||||+|||++| |+.|+.....
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------- 711 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------- 711 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------
Confidence 99999999999997655443332222223579999999999999999999999999999999 8899875543
Q ss_pred HHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCC
Q 042262 738 DWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801 (814)
Q Consensus 738 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~ 801 (814)
+.+.+.+++|++. ..+.+++.++..|+..||+.+|.+||+++||..+|+...+..
T Consensus 712 ~EVIe~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 712 QEVIECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 2355667777653 346689999999999999999999999999999998765443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=354.32 Aligned_cols=200 Identities=32% Similarity=0.511 Sum_probs=180.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.++||+|.|++||+|++.. .+..||||.+... ..+..+.+..|+.+|+.++|||||+++++++..+..+|||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~---~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKK---SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred ceehhhccCcceEEEEEeEecc---CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4455679999999999999986 4689999999765 4455667899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC------CCeEEeecCCcccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY------YNARISDFGLAKLL 673 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~------~~~kl~DfGla~~~ 673 (814)
|||.+|+|.++|+....+++...+.++.|||.||++||+ .+||||||||+||||+.. -.+||+|||+|+.+
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999994 699999999999999764 45899999999998
Q ss_pred cccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCC
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 730 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~ 730 (814)
.... ...+.+|++-|||||+++.++|+.|+|+||+|++|||+++|+.||+....
T Consensus 166 ~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 166 QPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred Cchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 8543 24567899999999999999999999999999999999999999986544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=369.11 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=213.8
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
.+|...+.||+|||+.||+++... .+..+|+|++.+. .....+.+.+||++.+.|+|||||+++++|++.++.|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 445666789999999999999843 5789999999763 2334567899999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
||.|+|.+++|..+++....+++.+++.++.||+.||.||| +.+|||||||..|++|+++.++||+|||||..+..+
T Consensus 95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 99999999999999998899999999999999999999999 569999999999999999999999999999988765
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
..+ ..+.+||+.|+|||++....++..+||||+|||||-||.|++||+...-. ..+..++..+
T Consensus 172 ~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-------ety~~Ik~~~-------- 234 (592)
T KOG0575|consen 172 GER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-------ETYNKIKLNE-------- 234 (592)
T ss_pred ccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-------HHHHHHHhcC--------
Confidence 443 45688999999999999999999999999999999999999999754321 1223333221
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
...+...+.+..+|+..+|+.+|.+|||+.+|+.
T Consensus 235 --Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 --YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1123356788999999999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.06 Aligned_cols=256 Identities=26% Similarity=0.354 Sum_probs=212.6
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecc--ccccchhhhhceeeEEeeccccceeeeee-eeccCCc-
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDGEKEFKNEVVVIGQTHHKNLVRLLG-FCDEGQN- 594 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g-~~~~~~~- 594 (814)
.+.+.+.++||+|.||.|||+.... ++..+|.|.++- .+.+..+++..|+.+|++++|||||+.++ -+.++++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~---~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLL---DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeecc---CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 3456778899999999999999875 678999999863 34445567999999999999999999999 4555555
Q ss_pred eehhhhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEECCCCCeEEeecC
Q 042262 595 RLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQ--IIHCDIKPQNILLDDYYNARISDFG 668 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~Dikp~NIll~~~~~~kl~DfG 668 (814)
..|||||+..|+|...++. .+.++++.+++++.|+++||.++|.. -+. |+||||||.||+|++++.+||+|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccch
Confidence 8899999999999999863 46689999999999999999999963 134 9999999999999999999999999
Q ss_pred CcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC
Q 042262 669 LAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748 (814)
Q Consensus 669 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 748 (814)
+++.+..+... ....+||+-||+||.+...+|+.|+||||+||+++||+.-..||.... + ......+.+|+
T Consensus 174 L~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~-~~L~~KI~qgd 244 (375)
T KOG0591|consen 174 LGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------L-LSLCKKIEQGD 244 (375)
T ss_pred hHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------H-HHHHHHHHcCC
Confidence 99998765543 355789999999999999999999999999999999999999998652 1 11345556665
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
...+. ..-++..+.+|+..|+..||+.||+...+++.+.
T Consensus 245 ~~~~p--------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 245 YPPLP--------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred CCCCc--------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 44332 2467899999999999999999998655555443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=376.18 Aligned_cols=272 Identities=25% Similarity=0.457 Sum_probs=229.9
Q ss_pred ccccCHHHHHHHHhhh-----------hccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEee
Q 042262 509 LRCFSYKELEEATDNF-----------EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQ 576 (814)
Q Consensus 509 ~~~f~~~el~~~~~~~-----------~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~ 576 (814)
.+.++|++-.+|..+| +++||.|.||.|++|.++..++....||||.|+.. .++...+|..|..||.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 4567887666665554 45799999999999999987777889999999875 34556789999999999
Q ss_pred ccccceeeeeeeeccCCceehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 042262 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNIL 655 (814)
Q Consensus 577 l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIl 655 (814)
+.||||++|.|+....+..+||.|||+||+|+.||..+ .++.+.+..-++++||.|++||. +.++|||||.++|||
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNIL 763 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNIL 763 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhee
Confidence 99999999999999999999999999999999999764 56899999999999999999999 579999999999999
Q ss_pred ECCCCCeEEeecCCcccccccccccccccccC--CCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcc
Q 042262 656 LDDYYNARISDFGLAKLLTLNQSKAIKTAIRG--TKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 732 (814)
Q Consensus 656 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~ 732 (814)
|+.+..+|++|||++|.+..+.... .+...| ..+|.|||.|...++|.++||||||+||||+++ |.+|+-.....+
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 842 (996)
T ss_pred eccceEEEeccccceeecccCCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence 9999999999999999886655322 333333 468999999999999999999999999999998 888874221111
Q ss_pred hhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 733 YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 733 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
+...++.......+++++..|.+|++.|||.|-.+||.+.+|+.+|++++..
T Consensus 843 ----------------VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 843 ----------------VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ----------------HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 1112333445566889999999999999999999999999999999877644
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.08 Aligned_cols=264 Identities=29% Similarity=0.448 Sum_probs=212.7
Q ss_pred CHHHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeec
Q 042262 513 SYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD 590 (814)
Q Consensus 513 ~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 590 (814)
.+.|+.-....+.+.||+|.||+||+|.+.. .||||++... ..+..+.|++|+..+++.+|.||+-+.|+|.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 4455656666777899999999999999973 4999999654 3345678999999999999999999999999
Q ss_pred cCCceehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCC
Q 042262 591 EGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 669 (814)
Q Consensus 591 ~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl 669 (814)
+... .||..++++.+|+.+|+-. .+++....+.|++|||+|+.||| .++|||||||..||+|.+++.+||+|||+
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccc
Confidence 9887 9999999999999999864 57888899999999999999999 57999999999999999999999999999
Q ss_pred cccccccccccccccccCCCCccCcccccCC---CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS---TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 670 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
+.....-..........|...|||||+++.+ +|++.+||||||+|+|||++|..||.....+... +.+ ..
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi------fmV-Gr 607 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII------FMV-GR 607 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE------EEe-cc
Confidence 9765432222212334578899999999643 7999999999999999999999999843322111 111 11
Q ss_pred CC-ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 747 GK-LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 747 ~~-~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
|- ..++. ....+++.++.+|+..||..++++||.+.+|+.+|+.++.
T Consensus 608 G~l~pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 608 GYLMPDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cccCccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11 11111 1234678899999999999999999999999998887665
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.40 Aligned_cols=268 Identities=24% Similarity=0.401 Sum_probs=219.8
Q ss_pred HHHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccch-hhhhceeeEEeeccccceeeeeeeeccC
Q 042262 514 YKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVRLLGFCDEG 592 (814)
Q Consensus 514 ~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~-~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 592 (814)
.+|+.+..-.|.++||+|-||.|.++... .+..||||+++....... ++|..|+++|.+++||||++|+|+|..+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeve----g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVE----GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEec----CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 44666666678899999999999999987 468999999987655544 8899999999999999999999999999
Q ss_pred CceehhhhhccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 593 QNRLLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
+..++|+|||++|+|..++..+. .+....-.+|+.|||.||+||. +.++|||||.++|+|+|.++++||+|||++
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccc
Confidence 99999999999999999998763 3455666789999999999999 679999999999999999999999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh--CCcCCcccCCcchhhHHHHHHHHHhcCC
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEEYAILTDWAFDCYRNGK 748 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 748 (814)
+-+...+........+-..+|||||.+..+++|.++|||+||++|||+++ ...||.....+. ..+-....++.+.
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~ 761 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQG 761 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCC
Confidence 97776666555556667889999999999999999999999999999876 556765322111 1122222222222
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
.... ...+.-++..+.+++..||..|-++||+++++...|++.
T Consensus 762 ~~~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2211 223557889999999999999999999999999998753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.96 Aligned_cols=266 Identities=29% Similarity=0.420 Sum_probs=205.6
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEee--ccccceeeeeeeeccCC----cee
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ--THHKNLVRLLGFCDEGQ----NRL 596 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~ 596 (814)
.+.+.||+|+||.||||.+. ++.||||++... ..+.|++|-++.+. ++|+||+++++.-+.+. +.+
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-----~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-----NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred hhHHHhhcCccceeehhhcc-----CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 45678999999999999995 589999998653 34566666666554 68999999999987766 889
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC------SAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
||+||.+.|+|.++|..+ .++|....+|+..+++||+|||++. +++|+|||||++||||.+|++..|+|||+|
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999999766 5799999999999999999999863 578999999999999999999999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCC-CCC-----CccchhhHHHHHHHHHhCCcCCcccCCcchhh---------
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNS-TIT-----AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI--------- 735 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t-----~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~--------- 735 (814)
..+............+||.+|||||++.+. .+. .+.||||+|.|||||++.-.-++.....++..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 998877665445557899999999999765 233 36999999999999999776654322111111
Q ss_pred --HHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCC
Q 042262 736 --LTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801 (814)
Q Consensus 736 --l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~ 801 (814)
+.+...-+++....+.+.+.... .....-+++.+..||..||+.|.|+.=|-+++.++....
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 11111122222222333222221 245678899999999999999999998888876655443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=351.21 Aligned_cols=263 Identities=28% Similarity=0.404 Sum_probs=205.2
Q ss_pred HHHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccccc-cchhhhhceeeEEeec-cccceeeeeeeeccCC-
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ- 593 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~- 593 (814)
...+.+.++||+|+||.||+|.+.. ....+..||||+++.... ...+.+.+|+.++..+ +||||++++++|.+.+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 3456677899999999999998642 122456799999875322 2345789999999999 8999999999987644
Q ss_pred ceehhhhhccCCchhhhhcCC-----------------------------------------------------------
Q 042262 594 NRLLVYEFLNNGTLASFLFGN----------------------------------------------------------- 614 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~----------------------------------------------------------- 614 (814)
..++||||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999988642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCCc
Q 042262 615 ---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691 (814)
Q Consensus 615 ---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 691 (814)
..+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++....+..........++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 236778889999999999999994 69999999999999999999999999999876433222212233466789
Q ss_pred cCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHH
Q 042262 692 VAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLV 770 (814)
Q Consensus 692 ~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~ 770 (814)
+|||.+.+..++.++||||||++||||++ |..||......+. ....+..+... ..+...+..+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRM---------RAPENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCC---------CCCCCCCHHHH
Confidence 99999999999999999999999999997 9999865332211 11222222211 11224567899
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 771 MVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 771 ~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
+++.+||+.||.+|||+.||+++|+.++.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.39 Aligned_cols=277 Identities=24% Similarity=0.286 Sum_probs=211.5
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccC--Cceehh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLV 598 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 598 (814)
+..++||+|.||.||||+... .++.||+|+++... .....-..+||.+|++|+||||++|.+...+. ...|||
T Consensus 120 eki~kIGeGTyg~VYkAr~~~---tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 120 EKIEKIGEGTYGQVYKARDLE---TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHhcCcchhheeEeeecc---cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 334689999999999999875 67899999997543 33344568999999999999999999998765 689999
Q ss_pred hhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
+|||++ +|.-++.. ..+++..++..+++|++.||.|+| +.+|+|||||.+|||||++|.+||+|||||+++....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999977 66666655 568999999999999999999999 5699999999999999999999999999999887766
Q ss_pred cccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHH--------hcCC
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY--------RNGK 748 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--------~~~~ 748 (814)
... .+..+-|++|+|||.+.+. .|+.++|+||.||||.||+.|++.+.....-++. +.++... ...+
T Consensus 273 ~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl---~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 273 SAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL---HKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred Ccc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH---HHHHHHhCCCChhcccccc
Confidence 554 5667789999999999886 6999999999999999999999999765332211 1122111 1111
Q ss_pred ccc--cccCccc-----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCCCCCCCCCc
Q 042262 749 LDD--LVEGDTE-----AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFSG 811 (814)
Q Consensus 749 ~~~--l~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~pp~p~~~~~ 811 (814)
++. .+.+... .+.-...++..++|+..+|..||.+|.|+.++++- +-....+.|..|+.+..
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s-eyF~t~p~~~~p~~Lp~ 417 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS-EYFTTEPLPCDPSSLPK 417 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC-cccccCCCCCCcccCCC
Confidence 111 1111000 00012345678889999999999999999998863 12234455555555544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=336.75 Aligned_cols=262 Identities=23% Similarity=0.313 Sum_probs=208.4
Q ss_pred HHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchh-hhhceeeEEeecc-ccceeeeeeeeccCC-c
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTH-HKNLVRLLGFCDEGQ-N 594 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~-~~~~Ei~~l~~l~-H~niv~l~g~~~~~~-~ 594 (814)
...+|...++||.|.||.||+|+-.. .+..||||+++......++ -=.+|+..|++|+ |||||+|.+++.+.+ .
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~---~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE---TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC---CCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 34567788999999999999999875 5678999999876544332 2478999999998 999999999998888 8
Q ss_pred eehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 595 RLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
.++|||||+. +|.+++++. ..+++..+..|+.||++||+|+|. .|++|||+||+|||+.....+||+|||+||..
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccc
Confidence 9999999955 899988765 568999999999999999999995 59999999999999999999999999999987
Q ss_pred cccccccccccccCCCCccCccccc-CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC-----
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFR-NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG----- 747 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----- 747 (814)
.... -.+.++.|.+|+|||++. .+-|+.+.|+||+|||++||.+-++.|.....-++.. -+.+.+...
T Consensus 161 ~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~---KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 161 RSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY---KICEVLGTPDKDSW 234 (538)
T ss_pred ccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH---HHHHHhCCCccccc
Confidence 6433 256788999999999985 5579999999999999999999999987553321111 011111111
Q ss_pred ------------CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 748 ------------KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 748 ------------~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+++......+....+ ..+.+..+++.+|++-||.+|||++|.+++
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 112222222222222 377899999999999999999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=334.65 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=203.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCC--ceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ--NRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 599 (814)
....+.||+|.||.||++...+ .+...|||..........+.+++|+.+|.+++|||||+.+|...... ...+.|
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~---~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKK---TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhccccCccceEEEEEEecC---CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 4455789999999999999875 37789999986543333566899999999999999999999854444 688999
Q ss_pred hhccCCchhhhhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~ 677 (814)
||+++|+|.+++.... .+++..+.++..||++||+||| +.+|+||||||+||||+. ++.+||+|||+++......
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998765 7999999999999999999999 569999999999999999 7999999999998776411
Q ss_pred -cccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 678 -SKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 678 -~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.........||+.|||||++.++ ....++||||+||+++||+||+.||.... ....+.......+..+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig~~~~~P----- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIGREDSLP----- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHhccCCCC-----
Confidence 11113346799999999999964 33459999999999999999999997431 1112222222222222
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L 794 (814)
..+...+.+..+++..|++.||++|||+.|+++.-
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 22445778999999999999999999999999854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=317.36 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=207.5
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeecccccc--chhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
..++|+|+||+|||++.+. .++.||||++.+..++ -.+-.++|+++|++++|+|+|.|+.+|......+||+||+
T Consensus 7 LgkvGEGSYGvV~KCrnk~---TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKD---TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred hhccccCcceEEEEeccCC---cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 3579999999999999875 6899999999654332 2344689999999999999999999999999999999999
Q ss_pred cCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccc
Q 042262 603 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682 (814)
Q Consensus 603 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (814)
+..-|+++-.....++.+....++.|+++|+.|+| +.++|||||||+||||+.++.+||+|||+|+.+... ....
T Consensus 84 dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~Y 158 (396)
T KOG0593|consen 84 DHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDNY 158 (396)
T ss_pred chHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC--cchh
Confidence 99888777666677889999999999999999999 569999999999999999999999999999988742 1225
Q ss_pred ccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHH--------HHHHHh-cCCcccc
Q 042262 683 TAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW--------AFDCYR-NGKLDDL 752 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~-~~~~~~l 752 (814)
+.++.|.+|+|||.+-+ .+|....||||+||++.||++|.+.|....+-+...+... -.+.+. +..+..+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 66788999999999987 5899999999999999999999999876654333222111 112222 2223333
Q ss_pred ccCcccccC-----ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 753 VEGDTEAMN-----DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 753 ~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.-+..+... -...+.-+++++..|++.||.+|++-+|++.
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 333222222 2344568899999999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=371.58 Aligned_cols=265 Identities=29% Similarity=0.469 Sum_probs=216.7
Q ss_pred HHHHHhhhhccccccceeEEEEEEEeccCCc--ceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCC
Q 042262 517 LEEATDNFEEEVGRGSFGIVYKGVIQTTRTS--TTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 593 (814)
Q Consensus 517 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~--~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 593 (814)
+....-++.+.||+|+||.||.|........ ...||||.+++. +.+...+|.+|..+|+.++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 3344556667899999999999999864433 456999999775 3455678999999999999999999999999999
Q ss_pred ceehhhhhccCCchhhhhcCC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEee
Q 042262 594 NRLLVYEFLNNGTLASFLFGN-------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISD 666 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 666 (814)
..+|++|||++|+|..+|... ..+.....+.|+.|||+|+.||+ +.++|||||..+|+||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999764 45789999999999999999999 56999999999999999999999999
Q ss_pred cCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHh
Q 042262 667 FGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 745 (814)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 745 (814)
||||+.+...+.........-..+|||||.++.+.+|.|+|||||||+||||+| |..||......+ ......+
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------v~~~~~~ 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------VLLDVLE 919 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------HHHHHHh
Confidence 999995544332221111123468999999999999999999999999999999 888886433211 1112233
Q ss_pred cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 746 NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 746 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
.|+ ...+..|++.+.+|+..||+.+|++||++..|++.++.+..-
T Consensus 920 ggR----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 920 GGR----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CCc----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 332 234678999999999999999999999999999998776543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.82 Aligned_cols=249 Identities=27% Similarity=0.351 Sum_probs=211.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeec-cccceeeeeeeeccCCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 597 (814)
+.|.+.||+|.|++|++|+... .++.+|||++.+. .+...+-+..|-.+|.+| .||.|++|+-.|.+....|+
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~---t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKA---TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred cchhheeccccceeEEEeeecC---CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 4677889999999999999875 6789999999753 233345577888888888 89999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|+||+++|+|.++|+.-..+++...+.++.+|+.||+||| +.+||||||||+|||||+++++||+|||.|+.+...+
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999999999999999999999999999999999 6799999999999999999999999999999986543
Q ss_pred cc---------ccc--ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 678 SK---------AIK--TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 678 ~~---------~~~--~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
.. ... ..++||..|.+||.+..+..+..+|+|+|||+||+|+.|++||.... ++..+..
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--eyliFqk-------- 298 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--EYLIFQK-------- 298 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--HHHHHHH--------
Confidence 22 112 45889999999999999999999999999999999999999997543 2222211
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
++ .+....+...++.+.+|+.+.|..||.+|+|.+||.+.
T Consensus 299 -----I~--~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 -----IQ--ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----HH--HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 11223455667899999999999999999999999885
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=326.72 Aligned_cols=240 Identities=28% Similarity=0.352 Sum_probs=203.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.++.+.||+|+||+|++++... .++.+|+|++++. .....+..++|..+|.+++||.||++.-.|.++++.|||
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~d---t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKD---TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcc---cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4556899999999999999874 6789999999753 223456789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
+||+.||.|..+|.++..+++.....++..|+.||.||| +.+||||||||+|||||++|+++|+|||+++....+..
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999999999999999999999999999999999999999 56999999999999999999999999999996543322
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. ..+++||..|||||++.+..++..+|-||+|+++|||++|.+||....... ..+.+..+++.
T Consensus 181 ~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~~~k~~-------- 243 (357)
T KOG0598|consen 181 A--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKILKGKLP-------- 243 (357)
T ss_pred c--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHhcCcCC--------
Confidence 2 455889999999999999999999999999999999999999998654221 22333333311
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCC
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRP 785 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP 785 (814)
..+.-.+.+..+++...|+.||++|.
T Consensus 244 -~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 -LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 11223567889999999999999996
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=334.35 Aligned_cols=246 Identities=19% Similarity=0.278 Sum_probs=200.6
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccc---hhhhhceeeEEeeccccceeeeeeeecc----CCceehh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNRLLV 598 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV 598 (814)
..||+|+++.||+|.+ ++..||||+++...... .+.|.+|+.++.+++||||++++|++.+ ....++|
T Consensus 26 ~~i~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv 100 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI 100 (283)
T ss_pred eEEeeCCceEEEEEEE-----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEE
Confidence 3689999999999998 36789999997643322 3567899999999999999999999866 3467899
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+++.....+++..+.+++.++++||+|||. ..+++||||||+||++++++.+||+|||+++.+....
T Consensus 101 ~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 101 LEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred EEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999999999888889999999999999999999995 2478899999999999999999999999998654321
Q ss_pred ccccccccCCCCccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ........+.
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------~~~~i~~~~~-------- 239 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------IYDLIINKNN-------- 239 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcCC--------
Confidence 22347889999999976 689999999999999999999999997442211 1111111111
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
....+..++..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 240 -~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 -SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11122346788999999999999999999999999997653
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=349.45 Aligned_cols=267 Identities=31% Similarity=0.405 Sum_probs=215.1
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEeccCCcc-eEEEEEeecc---ccccchhhhhceeeEEeeccccceeeeeeeecc
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE 591 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~-~~vaVK~l~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 591 (814)
+|......+.++||+|+||.||+|.+....... ..||||..+. ......++|++|.++++.++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 444444556689999999999999998643312 2399999975 335567889999999999999999999999999
Q ss_pred CCceehhhhhccCCchhhhhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 592 GQNRLLVYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 592 ~~~~~lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
....+||||++.||+|.++|.... .++..++++++.+.|+||+||| +.++|||||.++|+|++.+..+||+|||++
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999998876 5999999999999999999999 569999999999999999999999999998
Q ss_pred ccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHH-hcCC
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY-RNGK 748 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~-~~~~ 748 (814)
+....-... .....-..+|+|||.+..+.++.++|||||||++||+++ |..|+...... .+...+ .++
T Consensus 310 ~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------~v~~kI~~~~- 379 (474)
T KOG0194|consen 310 RAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------EVKAKIVKNG- 379 (474)
T ss_pred cCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------HHHHHHHhcC-
Confidence 865411111 111234679999999999999999999999999999999 88888644321 111111 222
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCC
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 803 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~p 803 (814)
.....+...+.++..++..|++.+|++||+|.+|.+.|+.+.....+
T Consensus 380 --------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 380 --------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred --------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 12222336678888999999999999999999999999876555443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.77 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=207.2
Q ss_pred cccCHHHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeee
Q 042262 510 RCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFC 589 (814)
Q Consensus 510 ~~f~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 589 (814)
-...+++|.+. +=||.|+-|.||+|++. ++.||||+++... +.+|+-|++|+|+||+.+.|+|
T Consensus 119 WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~-----netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 119 WEIPFEEISEL-----EWLGSGAQGAVFLGRLH-----NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred ccCCHHHhhhh-----hhhccCcccceeeeecc-----CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeee
Confidence 33445555433 34999999999999996 6789999986543 3356678899999999999999
Q ss_pred ccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCC
Q 042262 590 DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 669 (814)
Q Consensus 590 ~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl 669 (814)
...--.+||||||..|-|...|+....+.......+..+||.|+.|||. ..|||||||.-||||..+..+||+|||.
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccc
Confidence 9999999999999999999999999999999999999999999999995 5999999999999999999999999999
Q ss_pred cccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCc
Q 042262 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 749 (814)
Q Consensus 670 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 749 (814)
++...... ....+.||..|||||+|++.+.++|.|||||||||||||||..|+..-.... . +|
T Consensus 259 S~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----I--Iw-------- 321 (904)
T KOG4721|consen 259 SKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----I--IW-------- 321 (904)
T ss_pred hHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----e--EE--------
Confidence 98765431 1345789999999999999999999999999999999999999986322110 0 00
Q ss_pred cccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 750 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
.+-...+....+..+++.+.-|+++||+..|..||++++|+..|+
T Consensus 322 -GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 322 -GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred -eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 111123334456788999999999999999999999999999985
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=332.06 Aligned_cols=260 Identities=22% Similarity=0.370 Sum_probs=209.1
Q ss_pred HHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
....+.+.+.||+|+||.||+|.+.........+|+|.++.... .....+.+|+.++.+++||||+++++++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 34556778899999999999999875555677999999876432 33457899999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 597 LVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
|||||+++|+|.+++... ..+++..++.++.||++||+|||+ .+++||||||+||+++.++.+|++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999998764 578999999999999999999995 5999999999999999999999999998765432
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
..... .....++..|+|||.+.+..++.++||||||++++|+++ |+.||......+ ....+..+..
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~----- 226 (266)
T cd05064 160 EAIYT-TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGFR----- 226 (266)
T ss_pred cchhc-ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCC-----
Confidence 21111 112234678999999999999999999999999999875 999986443221 1112222211
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
...+..++..+.+++..||+.+|.+||++.||.+.|+.+
T Consensus 227 ----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 112335677899999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.22 Aligned_cols=261 Identities=27% Similarity=0.400 Sum_probs=204.7
Q ss_pred HHHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeeeccCCc
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 594 (814)
...+.+.+.||+|+||.||+|.... .......||||+++... ....+.+.+|+.++..+ +||||++++++|.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 3446677899999999999998642 12345689999986432 23345688999999999 89999999999999999
Q ss_pred eehhhhhccCCchhhhhcCC------------------------------------------------------------
Q 042262 595 RLLVYEFLNNGTLASFLFGN------------------------------------------------------------ 614 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~------------------------------------------------------------ 614 (814)
.++||||+++|+|.+++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999888532
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 615 ---------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 615 ---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
..+++..+..++.||++||+|||+ .+|+||||||+|||++++..+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 146788899999999999999994 69999999999999999999999999999876543322
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.......++..|+|||.+.+..++.++||||||++++||++ |..||....... . ....+..+...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~----~~~~~~~~~~~-------- 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--K----FYKMIKEGYRM-------- 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--H----HHHHHHhCccC--------
Confidence 21222345678999999999999999999999999999998 888886432211 1 11222222111
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
..+...+.++.+++.+||+.||++||||.||+++|+..
T Consensus 337 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 -LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11123356889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=303.95 Aligned_cols=259 Identities=22% Similarity=0.291 Sum_probs=204.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc--chhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
|.-.++||+|.||.||+|.+.. .++.||||+++..... -.....+||+.|+.++|+||+.|++++.+.+...||+
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~---t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTE---TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecC---CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 4455789999999999999875 6789999999754222 2345789999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+. +|+..++.. ..++..++..++.++++||+||| ...|+||||||.|+|+++++.+||+|||+++.+.....
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 99965 899988876 56789999999999999999999 56999999999999999999999999999998875543
Q ss_pred ccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc---CCccc---
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---GKLDD--- 751 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~--- 751 (814)
. .+..+-|.+|+|||.+.+. .|+...||||.|||+.||+-|.+-|....+-++. ..+...+-. ...++
T Consensus 157 ~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL---~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 157 I--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL---SKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred c--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH---HHHHHHcCCCCcccCccccc
Confidence 3 2334689999999999876 6999999999999999999998887655432221 222222221 11111
Q ss_pred ccc---------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 752 LVE---------GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 752 l~~---------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+.| +.... .-..++..+.+++..++..||.+|.|+.|++++
T Consensus 232 lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111 11111 112445677999999999999999999999875
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=333.02 Aligned_cols=252 Identities=33% Similarity=0.538 Sum_probs=199.2
Q ss_pred hhccccccceeEEEEEEEe-ccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 524 FEEEVGRGSFGIVYKGVIQ-TTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~-~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.||.|.||.||+|.+. ........|+||.++.... ...++|.+|++.+++++||||++++|+|.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999999 4455678999999965332 3367899999999999999999999999988889999999
Q ss_pred ccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 602 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 602 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
+++|+|.++|... ..+++..+..|+.||++||+|||+ .+++|++|+++||++++++.+||+|||+++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 778999999999999999999995 58999999999999999999999999999877332222
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
...........|+|||.+.+..++.++||||||+++|||++ |+.|+...... + ....+.++..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------~-~~~~~~~~~~--------- 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------E-IIEKLKQGQR--------- 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------H-HHHHHHTTEE---------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc------c-cccccccccc---------
Confidence 22233446778999999999899999999999999999999 67887543211 1 1122222222
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L 794 (814)
...+..++..+.+++..||+.+|++||||+||++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112334678899999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.47 Aligned_cols=261 Identities=22% Similarity=0.301 Sum_probs=210.3
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
..|++.++||.|.-++||+|.... .++.||||++.-.. ....+.+++|+..++.++||||++.+..|..+...++|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p---~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIP---TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecc---cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 346677899999999999999875 46899999996422 22357899999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 599 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|.||.+||+.++++.. ..+++..+..|++++++||.|||+ .+.||||||+.||||+++|.+||+|||.+-.+...
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999999764 458899999999999999999995 59999999999999999999999999987655432
Q ss_pred ccc-ccc-ccccCCCCccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 677 QSK-AIK-TAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 677 ~~~-~~~-~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
..+ ... ..++||+.|||||+++. ..|+.|+||||||++.+||.+|..||....+-. +.-.-.++..+.+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-------vLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-------VLLLTLQNDPPTL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-------HHHHHhcCCCCCc
Confidence 222 112 56789999999999643 369999999999999999999999996432210 0111123444333
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
....+..+........+.+++..||+.||.+|||++++++.
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 33333444455667799999999999999999999998863
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.43 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=204.0
Q ss_pred HHhhhhccccccceeEEEEEEEeccC-------------CcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeee
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTR-------------TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRL 585 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~-------------~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l 585 (814)
..+.+.++||+|+||.||++.+.... ..+..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 34566788999999999999875321 234579999987542 2334678999999999999999999
Q ss_pred eeeeccCCceehhhhhccCCchhhhhcCC-------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 042262 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGN-------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIH 646 (814)
Q Consensus 586 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 646 (814)
++++.+.+..+|||||+++++|.+++... ..+++..+.+++.||++||+|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 99999999999999999999999988532 236788899999999999999995 58999
Q ss_pred cCCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh--CCcC
Q 042262 647 CDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS--CRKS 724 (814)
Q Consensus 647 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt--G~~p 724 (814)
|||||+|||+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||++++||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999987644332222233446789999999998899999999999999999997 4556
Q ss_pred CcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 725 FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 725 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
+...... .....+...++....... ...+..++..+.+++.+||+.||.+||||.||+++|++
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6533221 111222222222111100 11123456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.24 Aligned_cols=263 Identities=26% Similarity=0.412 Sum_probs=205.9
Q ss_pred HHHHhhhhccccccceeEEEEEEEecc--CCcceEEEEEeeccccc-cchhhhhceeeEEeec-cccceeeeeeeeccCC
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ 593 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 593 (814)
....+.+.+.||+|+||.||+|..... ......||||+++.... .....+.+|+++++.+ +|+||++++++|.+..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 344566778999999999999986532 22445799999975432 2345688999999999 8999999999999999
Q ss_pred ceehhhhhccCCchhhhhcCC-----------------------------------------------------------
Q 042262 594 NRLLVYEFLNNGTLASFLFGN----------------------------------------------------------- 614 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~----------------------------------------------------------- 614 (814)
..+|||||+++|+|.+++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 999999999999999987431
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccc
Q 042262 615 -----------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT 683 (814)
Q Consensus 615 -----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 683 (814)
..+++....+|+.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 136788889999999999999994 699999999999999999999999999998654332222122
Q ss_pred cccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 684 ~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
...++..|+|||++.+..++.++||||||++++||++ |+.||........ .......+. ....+
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~---------~~~~~ 337 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGY---------QMSRP 337 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHccc---------CccCC
Confidence 2345678999999999999999999999999999997 9999865432211 111111111 11112
Q ss_pred hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
...+.++.+++.+||+.||.+|||+.||+++|++++
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 234578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=378.28 Aligned_cols=269 Identities=27% Similarity=0.498 Sum_probs=214.3
Q ss_pred cCHHHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeecc
Q 042262 512 FSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE 591 (814)
Q Consensus 512 f~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 591 (814)
++++++... ....+.||+|+||.||+|.... .+..||||+++..... ..+|++.+++++|||||+++|+|.+
T Consensus 683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 683 ITINDILSS-LKEENVISRGKKGASYKGKSIK---NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred hhHHHHHhh-CCcccEEccCCCeeEEEEEECC---CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence 444444432 2334579999999999999854 5678999998654321 2345778889999999999999999
Q ss_pred CCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 592 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 592 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
.+..++||||+++|+|.++++ .++|..+.+|+.|||+||+|||+.++.+|+||||||+||++++++.+++. ||...
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 999999999999999999995 38999999999999999999998878899999999999999999998886 66654
Q ss_pred cccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
....+ ....++..|+|||++.+..++.|+|||||||++|||++|+.|++...+. ......|+...........
T Consensus 831 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 831 LLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDM 903 (968)
T ss_pred ccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhh
Confidence 43221 2235789999999999999999999999999999999999999654432 2334566655555555555
Q ss_pred cccCcccc--cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 752 LVEGDTEA--MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 752 l~~~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.+++.... ..+.++..++.+++.+||+.||++||||+||+++|+++..
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 55554422 2344667788999999999999999999999999988755
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=335.98 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=206.4
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc----cc-cchhhhhceeeEEeecc-ccceeeeeeeeccCC
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV----FQ-DGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQ 593 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~----~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 593 (814)
..+.+.+.||+|.||+|+.|.... .+..||||.+... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~---t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRL---TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeecc---CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345667889999999999999875 4588999977553 11 23456778999999998 999999999999999
Q ss_pred ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CCeEEeecCCccc
Q 042262 594 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-YNARISDFGLAKL 672 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGla~~ 672 (814)
+.++||||+.+|.|.+++....++.+....+++.|++.|++||| +.+|+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999999999888999999999999999999999 5699999999999999999 9999999999998
Q ss_pred ccccccccccccccCCCCccCcccccCCC-CC-CccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNST-IT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
.. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..... -....+..+...
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-------~l~~ki~~~~~~ 241 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-------NLYRKIRKGEFK 241 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-------HHHHHHhcCCcc
Confidence 74 1222255678999999999999987 86 6899999999999999999999853211 112223333221
Q ss_pred ccccCcccccCChhH-HHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 751 DLVEGDTEAMNDIKC-TEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 751 ~l~~~~~~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+... +.++..++.+|++.||.+|+|+.||++
T Consensus 242 ----------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 242 ----------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ----------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 12223 788999999999999999999999993
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=328.03 Aligned_cols=258 Identities=29% Similarity=0.472 Sum_probs=208.2
Q ss_pred HhhhhccccccceeEEEEEEEeccC--CcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.+.||+|+||.||+|.+.... .....+++|.+.... .....+|.+|+.++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 4456788999999999999986532 234679999986432 2234568999999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC
Q 042262 598 VYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 661 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~ 661 (814)
+|||+++++|.+++... ..+++...+.++.|+++||+|||+ .+++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 99999999999998643 457888999999999999999995 59999999999999999999
Q ss_pred eEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHH
Q 042262 662 ARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 740 (814)
Q Consensus 662 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 740 (814)
+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||......+ .
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------~ 235 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------V 235 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------H
Confidence 99999999987644332222333446788999999998899999999999999999998 999987543221 1
Q ss_pred HHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 741 FDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 741 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
...+..+... ..+..++.++.+|+.+||+.||.+||++.||++.|+.+
T Consensus 236 ~~~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 IEMIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 2222332221 12335678999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=331.73 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=210.1
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 605 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 605 (814)
++||+|+-|.||.+.... .+..||||++........+-+.+|+.+|+..+|+|||+++.-+..+++.++|||||++|
T Consensus 279 ~kigqgaSG~vy~A~~~~---~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~gg 355 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKIS---TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGG 355 (550)
T ss_pred hhhccccccceeeeeecc---CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCC
Confidence 579999999999998775 56789999998776666677899999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccc
Q 042262 606 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI 685 (814)
Q Consensus 606 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 685 (814)
+|.+.+... .+++.++..|++++++||+||| ..+|+|||||.+|||++.++.+||+|||++..+...+.+ ..+.
T Consensus 356 sLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R~Tm 429 (550)
T KOG0578|consen 356 SLTDVVTKT-RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--RSTM 429 (550)
T ss_pred chhhhhhcc-cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--cccc
Confidence 999988654 3889999999999999999999 569999999999999999999999999999988776653 4567
Q ss_pred cCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhH
Q 042262 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKC 765 (814)
Q Consensus 686 ~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 765 (814)
+||+.|||||++....|.+|.||||||++.+||+-|.+||-.+.+-. +...+...- ..+...+...
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-------AlyLIa~ng-------~P~lk~~~kl 495 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNG-------TPKLKNPEKL 495 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-------HHHHHhhcC-------CCCcCCcccc
Confidence 89999999999999999999999999999999999999997643311 111122211 1222335567
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 766 TEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 766 ~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+..+.+++.+||+.|+++||++.|+++.
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 8899999999999999999999999873
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=333.72 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=214.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+++.+.||.|+-|.|.+|++.. .|+..|||++.+.. +.....+.+||.+|+.+.|||+++++++.++.++.|||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~---TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAE---TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred eeccccccCCCCceehhhhccc---ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 3456789999999999999875 68899999996642 22345689999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
.||+++|.|.+++.....+++.+..+++.||+.|+.|+| ..+|+||||||+|+|||+..++||+|||||.+-..+.
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk- 166 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK- 166 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence 999999999999999999999999999999999999999 5699999999999999999999999999998755432
Q ss_pred ccccccccCCCCccCcccccCCCCCC-ccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITA-KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~-k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
...+.+|++.|.|||++++.+|.- ++||||.||||+.||+|+.||+.+.- .. ....+..|.++
T Consensus 167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~----LLlKV~~G~f~------- 230 (786)
T KOG0588|consen 167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RV----LLLKVQRGVFE------- 230 (786)
T ss_pred --cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HH----HHHHHHcCccc-------
Confidence 245678999999999999999865 89999999999999999999983321 11 23344444432
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HcCCcCC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEGVVEV 800 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~--L~~~~~~ 800 (814)
.+.+.+.++.+|+.+|+..||++|-|++||.+. |.+-..+
T Consensus 231 ---MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 231 ---MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred ---CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 245778899999999999999999999999984 4444433
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=294.68 Aligned_cols=244 Identities=25% Similarity=0.359 Sum_probs=207.9
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
++.+.||+|.||.||.|..++ ..-.||+|++.+. ..+.++++.+|+++-..++||||+++++++.+....||++
T Consensus 25 eigr~LgkgkFG~vYlarekk---s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKK---SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred cccccccCCccccEeEeeecc---CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 456789999999999999875 5668999999642 2344678999999999999999999999999999999999
Q ss_pred hhccCCchhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||.++|+|...|+ ...+++......++.|+|.||.|+| .++||||||||+|+|++.++..||+|||-+..-..+.
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k 178 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK 178 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCC
Confidence 9999999999998 5577899999999999999999999 6799999999999999999999999999987644221
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
..+.+||..|.+||...+...+.++|+|++|++.+|++.|.+||.....++ .+..++.-+
T Consensus 179 ----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-------tYkrI~k~~--------- 238 (281)
T KOG0580|consen 179 ----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-------TYKRIRKVD--------- 238 (281)
T ss_pred ----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-------HHHHHHHcc---------
Confidence 456789999999999999999999999999999999999999998654322 122222211
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
...+...+..+.+++.+|+..+|.+|.+..||+..
T Consensus 239 -~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 -LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 12235677889999999999999999999998863
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=322.64 Aligned_cols=259 Identities=25% Similarity=0.428 Sum_probs=208.5
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.+.||+|+||.||+|.+...+.....++||.++... .....+|.+|+.++..++|+||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 4566789999999999999987544456689999986543 233457889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++.......
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 85 EYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999999998664 468999999999999999999994 6999999999999999999999999999998753222
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
........++..|+|||.+.+..++.++||||||++++||++ |..||....... .......+...
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~------- 227 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRL------- 227 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC-------
Confidence 211222335678999999999899999999999999999998 999885332111 11222221110
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
..+..+++.+.+++.+||+.+|++||++.||+++|++++
T Consensus 228 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 228 --PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 112345678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.50 Aligned_cols=259 Identities=26% Similarity=0.480 Sum_probs=208.9
Q ss_pred HHHhhhhccccccceeEEEEEEEecc--CCcceEEEEEeecccccc-chhhhhceeeEEeeccccceeeeeeeeccCCce
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 595 (814)
..++.+.+.||+|+||.||+|..... +.....+|||.++..... ..+.+.+|+++++.++|+||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 45667788999999999999987643 234578999998765433 456899999999999999999999999999999
Q ss_pred ehhhhhccCCchhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC
Q 042262 596 LLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 661 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~ 661 (814)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 9999999999999998643 346888999999999999999994 59999999999999999999
Q ss_pred eEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHH
Q 042262 662 ARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 740 (814)
Q Consensus 662 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 740 (814)
+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||......+ .
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~ 233 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------V 233 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------H
Confidence 99999999986543322111223345778999999999999999999999999999999 999986433221 1
Q ss_pred HHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 741 FDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 741 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
......+.... .+...+..+.+++.+||+.||++||++.||+++|++
T Consensus 234 ~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IECITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 12222332211 122456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=333.59 Aligned_cols=262 Identities=22% Similarity=0.316 Sum_probs=204.3
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
..+.+.+.||+|+||.||++.... .+..+|+|.+.... .....++.+|++++++++|+||+++++++..++..++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKP---SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECC---CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 345556789999999999999864 46789999886532 22345789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++++|.+++.....+++..+..++.|+++||+|||+. .+|+||||||+|||+++++.+||+|||+++.+....
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 99999999999998878899999999999999999999952 469999999999999999999999999998654321
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC----------
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---------- 748 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------- 748 (814)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||......+ +..........+.
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 233468999999999999999999999999999999999999996433211 1000000000000
Q ss_pred ------------------------ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 749 ------------------------LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 749 ------------------------~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
...+.............+.++.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000111122356789999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.50 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=206.2
Q ss_pred HHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 517 LEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 517 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
+....+.+.+.||+|++|.||+|... ....+|+|.++... ...+++.+|+.++++++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN----NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec----CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 34455677789999999999999875 34679999986532 34567899999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 597 LVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+|+||||+||++++++.+||+|||+++...
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 999999999999998764 368999999999999999999995 599999999999999999999999999998765
Q ss_pred ccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
...... ......+..|+|||.+.+..++.++||||||++++||++ |+.||....... ....+..+.
T Consensus 155 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~----- 221 (261)
T cd05068 155 EDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGY----- 221 (261)
T ss_pred CCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC-----
Confidence 322111 111223458999999999999999999999999999999 999986432111 111111111
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
....+...+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 222 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 ----RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ----CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0111234567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=298.63 Aligned_cols=261 Identities=25% Similarity=0.283 Sum_probs=209.8
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCC-----c
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----N 594 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~ 594 (814)
.++.+.+.||+|||+-||.++.-. ++..+|+|++.....++.+..++|++.-++++|||++++++++..+. +
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s---~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLS---TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccC---cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 456677899999999999998543 56789999998766677888999999999999999999999985433 4
Q ss_pred eehhhhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 595 RLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
.||+++|...|+|.+.+.. +..+++.+.++|+.+|++||++||+. .++++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999998853 34689999999999999999999975 456999999999999999999999999998
Q ss_pred ccccccccc---c--c--cccccCCCCccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHH
Q 042262 671 KLLTLNQSK---A--I--KTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 740 (814)
Q Consensus 671 ~~~~~~~~~---~--~--~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 740 (814)
......... + . ......|..|+|||.+. +..+++++|||||||+||+|+.|..||+......
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-------- 248 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-------- 248 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC--------
Confidence 765422111 0 0 12245789999999984 5678999999999999999999999997543311
Q ss_pred HHHHhcCCcccc-ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 741 FDCYRNGKLDDL-VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 741 ~~~~~~~~~~~l-~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
|.+.-. ............+++.+.+++.+|+|.||.+||++.|++..+++++
T Consensus 249 ------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 ------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 112111 1222222233348899999999999999999999999999998764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=319.55 Aligned_cols=246 Identities=25% Similarity=0.374 Sum_probs=210.6
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
-.+.||+|.||.||||.+.. ..+.||+|++.-. ......++++|+.++..++|+||.+.+|.+..+...+++|||+
T Consensus 17 ~~~~IgrGsfG~Vyk~~d~~---t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 17 KLELIGRGSFGEVYKAIDNK---TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred cchhccccccceeeeeeecc---ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 34789999999999999875 5678999999754 3344578899999999999999999999999999999999999
Q ss_pred cCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccc
Q 042262 603 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682 (814)
Q Consensus 603 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (814)
.+|++.+.+.....+++..+..|+++++.||.|||. .+.+|||||+.|||+..++.+|++|||.+..+.....+.
T Consensus 94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-- 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-- 168 (467)
T ss_pred cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc--
Confidence 999999999988888888889999999999999995 599999999999999999999999999999887665543
Q ss_pred ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
.+++||+-|||||+++...|+.|+||||||++.+||.+|.+|+....+-. +..++-........
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP~L~ 232 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPPRLD 232 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCCccc
Confidence 56789999999999998899999999999999999999999986433211 11122222222233
Q ss_pred hhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..++..+.+++..||..+|+.||+++++++.
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3778889999999999999999999998863
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.65 Aligned_cols=272 Identities=25% Similarity=0.333 Sum_probs=210.3
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeecc-----CCceeh
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-----GQNRLL 597 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~~~l 597 (814)
.+.||+|++|.|.++.... +++.||||++... .....++..+|+++|++++|+||+.+++.+.. -+..|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~~---t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi 103 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKR---TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL 103 (359)
T ss_pred cccccCcceeeEEEEEEcC---CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence 4679999999999999875 5689999999743 33345778899999999999999999998854 457899
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|+|+| ..+|...++.++.++......++.||++||+|+| +.+|+||||||+|++++.+...||+|||+|+......
T Consensus 104 V~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 104 VFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred ehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99999 6699999999988999999999999999999999 6799999999999999999999999999999886543
Q ss_pred cccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHH--------HHHHHHhcCC
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD--------WAFDCYRNGK 748 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~~~ 748 (814)
.....+..+.|.+|.|||.+.+ ..||..+||||.|||+.||++|++.|.....-.+..+.- .....+....
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 3333577889999999999865 479999999999999999999999997653322111110 0011111111
Q ss_pred cccccc-------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHcCCcCCCCCC
Q 042262 749 LDDLVE-------GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEGVVEVDVPP 804 (814)
Q Consensus 749 ~~~l~~-------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~--~L~~~~~~~~pp 804 (814)
....+. ....... .......++|+.+||..||.+|+|++|.++ .|...-+.+..|
T Consensus 260 ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 111111 1111111 245678899999999999999999999987 355554444444
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.09 Aligned_cols=242 Identities=23% Similarity=0.279 Sum_probs=198.9
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
+.||+|+||.||++.... .++.+|||+++... ......+.+|+.++.+++||||+++++++.+++..+|||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence 368999999999999864 56789999987532 223356788999999999999999999999999999999999
Q ss_pred cCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccc
Q 042262 603 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682 (814)
Q Consensus 603 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (814)
++++|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~ 152 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence 999999999888889999999999999999999994 6999999999999999999999999999875322211 12
Q ss_pred ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
....||..|+|||.+.+..++.++|||||||+++||++|+.||....... .......+.. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~~~~~~~----------~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI----------RFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCCC----------CCC
Confidence 34568999999999999999999999999999999999999996432211 1111111111 112
Q ss_pred hhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 792 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~ 792 (814)
...+.++.+++.+||+.||++|| ++.|+++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 34567889999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.62 Aligned_cols=254 Identities=28% Similarity=0.432 Sum_probs=206.0
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
..+.+.++||+|++|.||+|.... .+..+++|.++.. ....+++.+|++++++++|+||+++++++......++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---CCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 345567789999999999999874 4678999998653 334567899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++++|.+++... ..+++..++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||+++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999998653 458999999999999999999994 599999999999999999999999999998765432
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
... ......+..|+|||.+.+..++.++||||||++++||++ |..|+.....++ .......+.
T Consensus 159 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~-------- 222 (263)
T cd05052 159 YTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKGY-------- 222 (263)
T ss_pred eec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCC--------
Confidence 211 112234568999999999999999999999999999998 899986432211 112222211
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
....+...+.++.+++.+||+.+|++||++.|++++|+.+
T Consensus 223 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 -RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1112334568899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.30 Aligned_cols=260 Identities=24% Similarity=0.448 Sum_probs=209.9
Q ss_pred HhhhhccccccceeEEEEEEEecc--CCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.+.+.+.||+|+||.||+|..... ......+++|.++.......+.+.+|+.++++++|+||+++++++.+....++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 345567899999999999986532 224567999998765555567799999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCe
Q 042262 599 YEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA 662 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ 662 (814)
|||+++++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||++++++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 9999999999998643 247899999999999999999994 599999999999999999999
Q ss_pred EEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHH
Q 042262 663 RISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF 741 (814)
Q Consensus 663 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 741 (814)
||+|||++................++..|+|||.+.+..++.++||||||++++||++ |+.||....... ..
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~ 235 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VI 235 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HH
Confidence 9999999976543322222233446788999999999999999999999999999999 999986443221 12
Q ss_pred HHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 742 DCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 742 ~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
+....+..... +...+..+.+++.+||+.+|++|||+++|+++|+++..
T Consensus 236 ~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 236 ECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 22333332211 22346789999999999999999999999999988744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.49 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=204.5
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCC-cceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRT-STTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~-~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
...+...+.||+|+||.||+|.+...+. ....+|||.++... ....+++.+|+.+++.++|+||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3445666789999999999999764322 23458999986532 33456788999999999999999999999775 567
Q ss_pred hhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 597 LVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
+|+||+++|+|.+++... ..+++..+++++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.+..
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999998764 468899999999999999999994 6999999999999999999999999999997754
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
...........++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+ + ......+..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~----- 229 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGER----- 229 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHhCCCC-----
Confidence 433221222234678999999999999999999999999999998 999986432211 1 111222111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
...+..++..+.+++..||+.+|.+||++.+++..|..+..
T Consensus 230 ----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 230 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 11122345678999999999999999999999999875543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=337.42 Aligned_cols=261 Identities=24% Similarity=0.368 Sum_probs=205.3
Q ss_pred HhhhhccccccceeEEEEEEEeccC--CcceEEEEEeeccccc-cchhhhhceeeEEeecc-ccceeeeeeeeccCCcee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 596 (814)
.+.+.+.||+|+||.||+|+..... .....||||+++.... ...+.+.+|++++.++. ||||++++++|.+....+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 4556688999999999999875321 2345799999975432 23457899999999996 999999999999999999
Q ss_pred hhhhhccCCchhhhhcCC--------------------------------------------------------------
Q 042262 597 LVYEFLNNGTLASFLFGN-------------------------------------------------------------- 614 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~-------------------------------------------------------------- 614 (814)
|||||+++|+|.++|...
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 999999999999887532
Q ss_pred ----------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC
Q 042262 615 ----------------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY 660 (814)
Q Consensus 615 ----------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~ 660 (814)
..+++..+..++.||++||+|||+ .+|+|+||||+|||+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCC
Confidence 236778889999999999999994 6999999999999999999
Q ss_pred CeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHH
Q 042262 661 NARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW 739 (814)
Q Consensus 661 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 739 (814)
.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||....... .
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~------~ 348 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS------T 348 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH------H
Confidence 999999999987644332221223346788999999999899999999999999999997 889886432211 1
Q ss_pred HHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 740 AFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 740 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.......+.. ...+...+..+.+++.+||+.||++||++.+|+++|+.+.+
T Consensus 349 ~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 FYNKIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1122222211 11123456789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.24 Aligned_cols=242 Identities=24% Similarity=0.272 Sum_probs=196.4
Q ss_pred ccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
||+|+||.||++.... .+..+|+|+++.. .......+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 7999999999999864 4678999998643 223345678899999999999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccccc
Q 042262 605 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA 684 (814)
Q Consensus 605 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 684 (814)
|+|.+++.....+++..+..++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 152 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT 152 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence 9999999888889999999999999999999994 6999999999999999999999999999986432221 1234
Q ss_pred ccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChh
Q 042262 685 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIK 764 (814)
Q Consensus 685 ~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 764 (814)
..||..|+|||.+.+..++.++|||||||+++||++|+.||...... ... .....+.. ..+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~-~~~~~~~~----------~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMY-RKILQEPL----------RFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHH-HHHHcCCC----------CCCCc
Confidence 56899999999999999999999999999999999999999643221 111 11111111 11234
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042262 765 CTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794 (814)
Q Consensus 765 ~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L 794 (814)
.+.++.+++..||+.||.+||++..+.+.|
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 567889999999999999998654444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=322.25 Aligned_cols=248 Identities=25% Similarity=0.315 Sum_probs=199.5
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
...+.||+|+||.||++.... +++.+|||.+.... ......+.+|+.++.+++|+||+++++++.+++..++|+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred eEEEEEecCCCEEEEEEEEec---CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 345789999999999999875 56789999986432 223345788999999999999999999999999999999
Q ss_pred hhccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++|+|..++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999999988754 346889999999999999999999 4699999999999999999999999999998754322
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
. .....||..|+|||.+.+..++.++|||||||+++||++|+.||......... ...........
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------- 221 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ--------- 221 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc---------
Confidence 1 23446899999999999999999999999999999999999999754332110 11111111111
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~eV~~ 792 (814)
...+...+.++.+|+..||+.||.+||+ ++|+++
T Consensus 222 -~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 -EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1123345678999999999999999997 788877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=324.01 Aligned_cols=245 Identities=28% Similarity=0.415 Sum_probs=209.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
|.+.+.||+|.||.||||+-+. +.+.||+|.+.+. .++..+.+.+|++++++++|||||.+++.++...+.++|.
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~---t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKY---TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred hhHHHHhcCCccceeeeccccc---ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 5567889999999999999764 5789999999754 3334567899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+.+ +|..+|.....++++....|+.++..||.||| +.+|+|||+||+|||++..+.+|++|||+|+.+..+.
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-- 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-- 154 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc--
Confidence 99977 99999999999999999999999999999999 5699999999999999999999999999999877533
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.+.+.+.||+-|||||.+.+++|+..+|.||+||+|||+.+|++||.... +.+.+.... ..+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~---------~d~v-- 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSIL---------KDPV-- 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHh---------cCCC--
Confidence 34567889999999999999999999999999999999999999996431 111111111 1111
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+.+.+..+..++...|+.||.+|.|--+++.
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 123467788999999999999999999988876
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=326.71 Aligned_cols=263 Identities=28% Similarity=0.425 Sum_probs=221.7
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEecc-CCcceEEEEEeecc-ccccchhhhhceeeEEeeccccceeeeeeeeccCC
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTT-RTSTTAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 593 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~~-~~~~~~vaVK~l~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 593 (814)
+|.++...+.+.||.|-||.||+|+.... ++....||||..+. ...+..+.|.+|..+|+.+.|||||+|+|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 45566667788999999999999998765 44556799999987 445556789999999999999999999999977 4
Q ss_pred ceehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 594 NRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
..+||||.++-|.|..+|+.+ ..++......++.||+.+|+||| +..+|||||..+|||+....-+||+|||+++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 679999999999999999876 46788888899999999999999 67999999999999999999999999999999
Q ss_pred ccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
+..+.... .+...-...|||||.+.-..+|.++|||-|||.+||+++ |..||..-. +.++-.
T Consensus 541 ~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk----------------NsDVI~ 603 (974)
T KOG4257|consen 541 LEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK----------------NSDVIG 603 (974)
T ss_pred ccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc----------------ccceEE
Confidence 87655433 223335678999999999999999999999999999998 899986432 233333
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.++...+...+.+|+..+.-|+.+||..||.+||++.|+...|+++.+
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 444555556788999999999999999999999999999988865544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=300.08 Aligned_cols=234 Identities=29% Similarity=0.329 Sum_probs=204.2
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
++.+.||.|.||.|.+++.+. .+..+|+|++++.. .+..+...+|..+|+.+.||.++++++.+.+.+..+|||
T Consensus 47 e~~~tlGtGSFGrV~LVr~k~---~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 47 ERLKTLGTGSFGRVHLVREKH---SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hheeeeccCccceEEEEEEcc---CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 345789999999999999875 57799999997643 233455788999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++|.|..+++..++++.+..+.++.||+.||+||| +.+|++|||||+|||||.+|.+||+|||.|+.....
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 99999999999999999999999999999999999999 679999999999999999999999999999987543
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.-+.+||+.|+|||+++..++..++|-|||||++|||+.|.+||..... .-.++.+-++++.
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~KI~~~~v~--------- 259 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEKILEGKVK--------- 259 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHHHHhCccc---------
Confidence 4567899999999999999999999999999999999999999986543 1234555555432
Q ss_pred cCChhHHHHHHHHHHHccccCCCCC
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLR 784 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~R 784 (814)
.+.-....+.+|+...||.|-.+|
T Consensus 260 -fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 -FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -CCcccCHHHHHHHHHHHhhhhHhh
Confidence 344566788899999999999999
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=323.94 Aligned_cols=262 Identities=24% Similarity=0.462 Sum_probs=209.8
Q ss_pred HHhhhhccccccceeEEEEEEEecc--CCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
..+.+.+.||+|+||.||++..... ......+++|.+........+.+.+|+.++.+++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 3455678899999999999986431 22456799999876655556789999999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEE
Q 042262 598 VYEFLNNGTLASFLFGN-------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 664 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl 664 (814)
||||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 99999999999998643 248999999999999999999995 59999999999999999999999
Q ss_pred eecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHH
Q 042262 665 SDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 743 (814)
Q Consensus 665 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 743 (814)
+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....... ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 99999986643322211223335778999999999899999999999999999998 899886443211 1222
Q ss_pred HhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 744 YRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 744 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
+..+..... +...+..+.+++.+||+.+|.+|||+.||++.|+++...
T Consensus 235 i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 333322111 123456799999999999999999999999999876643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=317.73 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=202.9
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCc------
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN------ 594 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------ 594 (814)
.+.+.||+|+||.||+|.+..+......+|||+++... .....++.+|+..++.++|+||+++++++.+...
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 35678999999999999987654455789999987432 2234578999999999999999999999866554
Q ss_pred eehhhhhccCCchhhhhcCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecC
Q 042262 595 RLLVYEFLNNGTLASFLFGN------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 668 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfG 668 (814)
.++|+||+++++|..++... ..+++.....++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 78999999999999988432 357899999999999999999995 599999999999999999999999999
Q ss_pred CcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcC
Q 042262 669 LAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG 747 (814)
Q Consensus 669 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 747 (814)
+++.+.............++..|+|||.+.+..++.++||||||++++||++ |..||......+ ..+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-------IYDYLRHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC
Confidence 9987654332211222335678999999998899999999999999999999 888885432211 11222222
Q ss_pred CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 748 KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 748 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
... ..+..++..+.+++.+||+.||.+|||+.||++.|+++
T Consensus 232 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 11234667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=323.25 Aligned_cols=264 Identities=20% Similarity=0.233 Sum_probs=201.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||.||++.... .+..+|||+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred ceEEEEecccCCEEEEEEEECC---CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 4566789999999999999864 46789999986532 223456788999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||++++.|..+......+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.+......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 999998887766555678999999999999999999994 69999999999999999999999999999876433222
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHH---------HHHHHhcCCcc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW---------AFDCYRNGKLD 750 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~---------~~~~~~~~~~~ 750 (814)
. .....|+..|+|||.+.+..++.++|||||||+++||++|+.||......+....... ...........
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 N-YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred c-ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 1 2345689999999999998999999999999999999999999975432111100000 00000010000
Q ss_pred ccccCcc------cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 751 DLVEGDT------EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 751 ~l~~~~~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....+.. ........+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00011124567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.29 Aligned_cols=244 Identities=25% Similarity=0.261 Sum_probs=201.5
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||+|.... .++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRI---SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 3456789999999999999864 46789999986432 22345688999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++++|.+++.....+++.....++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 9999999999999888889999999999999999999994 69999999999999999999999999999865432
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||....... ....+..+..
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~--------- 215 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGKL--------- 215 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCc---------
Confidence 223458999999999999999999999999999999999999997543211 1122222221
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPT-----MRKVSQM 793 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~eV~~~ 793 (814)
..+......+.+++.+||+.||.+||+ ++|+++.
T Consensus 216 -~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 -EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 112234568899999999999999995 7887764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=321.46 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=204.9
Q ss_pred HHhhhhccccccceeEEEEEEEec-cCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
....+.++||+|+||.||+|.... .......+++|.+.... .....++.+|++++++++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 345667889999999999998643 22345789999987432 2234678899999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC
Q 042262 598 VYEFLNNGTLASFLFGN-----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY 660 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~ 660 (814)
||||+++++|.+++... ..+++...+.++.|+++||+|||+ .+|+|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 99999999999988421 246788899999999999999995 5999999999999999999
Q ss_pred CeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHH
Q 042262 661 NARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW 739 (814)
Q Consensus 661 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 739 (814)
.+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..||.......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999987654332222333445778999999998889999999999999999998 888886432211
Q ss_pred HHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 740 AFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 740 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
+.+....+... ..+..++..+.+++.+||+.+|.+||++.+|.++|.+
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11222222211 1223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=317.12 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=204.1
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
..+.+.++||+|+||.||+|... .+..+++|.+... ....+.+.+|+.+++.++|+||+++++.+.+.+..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~----~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN----NSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec----CCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 34566789999999999999875 3457999988643 223567899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999865 3567899999999999999999995 599999999999999999999999999998765332
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
... .....++..|+|||.+.+..++.++||||||++++||++ |+.||....... ....+..+..
T Consensus 158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~------- 222 (261)
T cd05072 158 YTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGYR------- 222 (261)
T ss_pred eec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence 211 223345678999999998899999999999999999998 999986432211 1111111111
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
.......+..+.+++.+|++.+|++||+++++.+.|+++
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 --MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 011123567889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=319.46 Aligned_cols=258 Identities=26% Similarity=0.362 Sum_probs=202.0
Q ss_pred hhhhccccccceeEEEEEEEeccCC-cceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRT-STTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~-~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||+||+|.+...+. ....+++|.+..... ....++..|+..+.+++||||+++++++.. ...++++
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~ 87 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVT 87 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEE
Confidence 3455789999999999999864321 123588888764322 223567888888899999999999999864 4567899
Q ss_pred hhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++|+|.+++.. ...+++..+..++.||++||+|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 88 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 88 QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 99999999999975 4568999999999999999999995 5899999999999999999999999999987654433
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
........++..|+|||.+.+..++.++||||||+++||+++ |+.||....... ..+.+..+....
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~------ 231 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLA------ 231 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCC------
Confidence 222334557789999999998899999999999999999998 999986432211 112222322111
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.+..++..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 232 ---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 ---QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 112245678889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=328.85 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=204.7
Q ss_pred HHhhhhccccccceeEEEEEEEecc--CCcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeeecc-CCc
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE-GQN 594 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~-~~~ 594 (814)
..+.+.+.||+|+||.||+|..... ...++.||+|+++... ....+.+..|+.++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4567788999999999999976432 2245789999986532 22335677899999999 89999999998865 456
Q ss_pred eehhhhhccCCchhhhhcCC------------------------------------------------------------
Q 042262 595 RLLVYEFLNNGTLASFLFGN------------------------------------------------------------ 614 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~------------------------------------------------------------ 614 (814)
.++++||+++++|.+++...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 78999999999999987531
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCCccC
Q 042262 615 -LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693 (814)
Q Consensus 615 -~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 693 (814)
..+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 257899999999999999999994 5999999999999999999999999999987643332221223446778999
Q ss_pred cccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHH
Q 042262 694 PEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMV 772 (814)
Q Consensus 694 PE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l 772 (814)
||++.+..++.++|||||||+|+||++ |..||......+. ....+..+... ..+.....++.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRM---------RAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCC---------CCCccCCHHHHHH
Confidence 999999999999999999999999998 9999864322211 11122222111 1122445788999
Q ss_pred HHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 773 SIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 773 ~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
+.+||+.+|++||++.||+++|+++++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=314.79 Aligned_cols=249 Identities=26% Similarity=0.432 Sum_probs=199.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
..+.+.||+|+||.||++.+. ....+|+|.+... ....+++.+|+.++++++||||+++++++.+....++||||
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~----~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWR----AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred cEEeeEecCCcCceEEEEEec----cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 455678999999999999875 3457999987643 23356788999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 602 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 602 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
+++|+|.+++... ..+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999998753 468999999999999999999995 599999999999999999999999999988654322211
Q ss_pred ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....++..|+|||.+.+..++.++||||||++++||++ |+.||......+ . ...+..+...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~----~~~i~~~~~~--------- 220 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---V----VEMISRGFRL--------- 220 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCCC---------
Confidence 122235668999999998899999999999999999999 899986443211 1 1112222111
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
..+...+..+.+++.+||+.+|.+||+|.|+++.|.
T Consensus 221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011223567899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=329.89 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=204.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||+|.... .++.||||+++... ....+.+..|+.++..++||||+++++++.+++..+||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 4456789999999999999874 46789999987532 22345688899999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++++|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999999888889999999999999999999995 5999999999999999999999999999986543
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
......||..|+|||.+.+..++.++|||||||++|||++|+.||......+. ...+... .........
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~--~~~~~~~~~ 222 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------WENLKYW--KETLQRPVY 222 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------HHHHHhc--cccccCCCC
Confidence 12345689999999999999999999999999999999999999975433211 1111110 011111111
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.......+.++.+++.+||+.+|.+||+++|+++.
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11112456788999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=314.26 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=198.2
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
+.||+|+||.||+|.+.. +++.+|+|...... .+....+.+|++++++++|+||+++++++......++|+||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEec---CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 469999999999999864 46789999876432 23346789999999999999999999999999999999999999
Q ss_pred CchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccc
Q 042262 605 GTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT 683 (814)
Q Consensus 605 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 683 (814)
++|.+++... ..+++..++.++.|+++||+|||+ .+|+|+||||+||+++.++.+||+|||+++............
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999998654 468999999999999999999994 599999999999999999999999999988654321111111
Q ss_pred cccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 684 ~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
....+..|+|||.+.++.++.++||||||++++|+++ |..|+....... .......+. ....+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~---------~~~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGV---------RLPCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCC---------CCCCc
Confidence 1123457999999999899999999999999999998 888886432211 111111111 11122
Q ss_pred hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
...+..+.+++.+|++.+|++|||+.||.++|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 345678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.79 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=213.0
Q ss_pred HHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccch---hhhhceeeEEeeccccceeeeeeeeccCCc
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~---~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 594 (814)
.+.++++.+.||+|.||.|-++.... .++.||||.+++..-+++ -.+.+||++|..++||||+.++.+|++.+.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~---sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHK---SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhcc---CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 45678889999999999999998754 678999999976533333 457899999999999999999999999999
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
++|||||..+|.|++++...+.|++.+..++++||..|+.|+|. .+++|||||.+|||||+++++||+|||++.++.
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999999999999999999999999999999999995 599999999999999999999999999998876
Q ss_pred ccccccccccccCCCCccCcccccCCCCC-CccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRNSTIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
.+. ...+++|++-|.+||++.+.+|. +..|-||+||+||-|+-|..||+...- ..+ ...+..|.-.
T Consensus 205 ~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~l----vrQIs~GaYr--- 271 (668)
T KOG0611|consen 205 DKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRL----VRQISRGAYR--- 271 (668)
T ss_pred ccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHH----HHHhhccccc---
Confidence 443 35678999999999999999885 579999999999999999999985432 111 1222333221
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L 794 (814)
..+-+....-|++|||-.+|++|.|+.+|....
T Consensus 272 --------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 --------EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 123345677899999999999999999998864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=328.94 Aligned_cols=262 Identities=20% Similarity=0.343 Sum_probs=203.6
Q ss_pred HHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
....+.+.++||+|+||.||++.+.. .+..+|+|.++... .....++.+|+++++.++|+||+++++++.+++..+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKP---SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECC---CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34556777899999999999999864 46678999886532 223456899999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||||+++++|.+++.....+++.....++.|+++||.|||+ ..+|+|+||||+|||+++++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999999887788999999999999999999995 247999999999999999999999999998765332
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc-----
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD----- 751 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~----- 751 (814)
. .....|+..|+|||.+.+..++.++|||||||+++||++|+.||.......... .......+....
T Consensus 158 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 229 (333)
T cd06650 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL----MFGCPVEGDPAESETSP 229 (333)
T ss_pred c----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH----HhcCcccCCccccccCc
Confidence 1 233468999999999999899999999999999999999999997543211100 000000000000
Q ss_pred ----------------------------cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 752 ----------------------------LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 752 ----------------------------l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+.............+.++.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 00000000011124567899999999999999999999965
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=319.32 Aligned_cols=259 Identities=27% Similarity=0.467 Sum_probs=202.8
Q ss_pred HHHhhhhccccccceeEEEEEEEecc--CCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCce
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 595 (814)
...+.+.+.||+|+||.||+|.+... ......+|||++.... .....++.+|+.+++.++|+||+++++++.++...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 34566778999999999999987531 1245679999986432 22345688999999999999999999999999999
Q ss_pred ehhhhhccCCchhhhhcCC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEe
Q 042262 596 LLVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 665 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 665 (814)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999998642 235788899999999999999995 599999999999999999999999
Q ss_pred ecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHH
Q 042262 666 DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY 744 (814)
Q Consensus 666 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 744 (814)
|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||....... .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~~ 234 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRFV 234 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHH
Confidence 9999886543322111122335678999999999899999999999999999999 688886432211 11112
Q ss_pred hcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 745 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
..+.... .+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 2222111 122456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=329.10 Aligned_cols=244 Identities=23% Similarity=0.286 Sum_probs=201.6
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.+.||+|+||.||+|.... .++.+|||.+.... ....+.+.+|+.++.+++||||+++++++.+++..++
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 34667889999999999999864 46789999986532 2234568899999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+++++|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 99999999999999888888999999999999999999995 59999999999999999999999999999876432
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||...... .....+.++...
T Consensus 172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~------- 233 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIYEKILAGRLK------- 233 (329)
T ss_pred ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHHHHHhcCCcC-------
Confidence 22346899999999999999999999999999999999999999643221 112222333211
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~eV~~ 792 (814)
.+...+.++.+++..||+.||.+||+ +++++.
T Consensus 234 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 ---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 12234567889999999999999997 677664
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=320.11 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=205.4
Q ss_pred HHhhhhccccccceeEEEEEEEecc--CCcceEEEEEeecccccc-chhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
..+.+.++||+|+||.||+|..... ......+|+|+++..... ....+.+|+.++..++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4466778999999999999987642 224578999999754322 2356889999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC
Q 042262 597 LVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY 660 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~ 660 (814)
+++||+++++|.+++... ..+++..+.+++.|+++||+|||+ .+|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 999999999999988421 247888899999999999999994 5999999999999999999
Q ss_pred CeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHH
Q 042262 661 NARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW 739 (814)
Q Consensus 661 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 739 (814)
.+||+|||+++.+.............++..|+|||.+.++.++.++||||||++++||++ |..|+......+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------- 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999887643322221223345778999999988889999999999999999998 888876432211
Q ss_pred HHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 740 AFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 740 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
..+.+..+... ..+..++..+.+++..||+.+|.+||++.||++.|+.
T Consensus 235 ~~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 12222232221 1233567889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=326.59 Aligned_cols=245 Identities=26% Similarity=0.307 Sum_probs=200.2
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc----ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||.||++........++.+|||.++... ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999876544567899999986532 12234578899999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++++|.+++.....+.+..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 156 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV-- 156 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc--
Confidence 9999999999888888899999999999999999994 69999999999999999999999999998754322221
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||..|+|||++.+..++.++||||||++++||++|+.||....... ....+..+.. ..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-------~~~~~~~~~~----------~~ 219 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-------TIDKILKGKL----------NL 219 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC----------CC
Confidence 234568999999999999889999999999999999999999997543211 1111222211 11
Q ss_pred ChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 792 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~ 792 (814)
+...+..+.+++.+||+.+|++|| ++.++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 223457889999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=316.88 Aligned_cols=259 Identities=24% Similarity=0.455 Sum_probs=206.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.++..+.||+|+||.||+|.+.........+++|.++... ....+++..|++++.+++|+||+++++++.+.+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 3455678999999999999997654445689999986542 233467889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 86 EYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999999998753 568999999999999999999995 5999999999999999999999999999987653322
Q ss_pred cccc-ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 679 KAIK-TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 679 ~~~~-~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.... .....+..|+|||.+.+..++.++||||||+++||+++ |+.||......+ ....+..+.
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~-------- 227 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGF-------- 227 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCC--------
Confidence 1111 11123457999999998889999999999999999998 999986433211 111122211
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
........+..+.+++.+||+.+|++||+|.+|++.|++++
T Consensus 228 -~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 228 -RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11112245678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=327.39 Aligned_cols=243 Identities=24% Similarity=0.284 Sum_probs=199.0
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
+.||+|+||.||++.... .+..+|||++.... ......+.+|+.+++.++||||+++++++.+.+..+|||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence 368999999999999864 56789999996532 223456788999999999999999999999999999999999
Q ss_pred cCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccc
Q 042262 603 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682 (814)
Q Consensus 603 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (814)
++|+|..++.....+++..+..++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++........ .
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~ 152 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT--M 152 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc--c
Confidence 99999999988888999999999999999999999 469999999999999999999999999998754322111 2
Q ss_pred ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
....||..|+|||.+.+..++.++|||||||+++||++|+.||....... .......+.. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-------~~~~~~~~~~----------~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEDI----------KFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-------HHHHhccCCc----------cCC
Confidence 34568999999999999999999999999999999999999996432211 1111111110 112
Q ss_pred hhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQM 793 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~~ 793 (814)
...+.++.+++.+||+.||.+|| ++.|+++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 34567889999999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=313.77 Aligned_cols=249 Identities=30% Similarity=0.434 Sum_probs=200.5
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
+||+|+||.||+|.+...+ .+..+|+|+++... ....+++.+|+.+++.++|+||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKK-SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCC-CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 6899999999999875432 46789999986432 223467899999999999999999999985 4567899999999
Q ss_pred CchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc-cc
Q 042262 605 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI-KT 683 (814)
Q Consensus 605 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~ 683 (814)
++|.+++.....+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++.+........ ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999999877788999999999999999999994 5999999999999999999999999999987654332110 11
Q ss_pred cccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 684 ~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
...++..|+|||.+.+..++.++||||||++++||++ |+.||......+ ....++.+... ..+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i~~~~~~---------~~~ 220 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGERM---------ECP 220 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCC---------CCC
Confidence 2234578999999988889999999999999999998 999997543221 11222222211 122
Q ss_pred hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
...+.++.+++.+||+.||++||++.+|++.|++
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 3466789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=326.74 Aligned_cols=242 Identities=24% Similarity=0.278 Sum_probs=197.7
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
+.||+|+||.||++.... .+..+|+|+++... ......+.+|+.+++.++||||+++++.+...+..+|||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence 468999999999999764 56789999987532 223345778999999999999999999999999999999999
Q ss_pred cCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccc
Q 042262 603 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682 (814)
Q Consensus 603 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (814)
++|+|..++.....+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++........ .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~ 152 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 152 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc--c
Confidence 999999999888889999999999999999999994 59999999999999999999999999998753222111 2
Q ss_pred ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
....||..|+|||.+.+..++.++|||||||++|||++|+.||....... .......+.. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~~~~~~~----------~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI----------RFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCC----------CCC
Confidence 34568999999999999999999999999999999999999996433211 1111111111 112
Q ss_pred hhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 792 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~ 792 (814)
...+.++.+++.+||+.||.+|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 34567889999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=326.56 Aligned_cols=262 Identities=28% Similarity=0.422 Sum_probs=221.4
Q ss_pred CHHHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccC
Q 042262 513 SYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 592 (814)
Q Consensus 513 ~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 592 (814)
.-.|+++.......+||-|.||.||.|.+++ -...||||.+++... ..++|..|..+|+.++|||+|+|+|+|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKk---yslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeec---cceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 4456666666777899999999999999986 456899999987543 457899999999999999999999999999
Q ss_pred CceehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 593 QNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
...|||.|||.+|+|.++|.+. ..++.-..+.++.||+.|++||. ..++|||||..+|.|+.++..+||+|||++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchh
Confidence 9999999999999999999864 34566677899999999999999 569999999999999999999999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCc
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKL 749 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 749 (814)
+++..+...+ .....-.+.|.|||-+.-..++.|+|||+|||+||||.| |..|+.... + ..++.
T Consensus 413 RlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------l-SqVY~------- 477 (1157)
T KOG4278|consen 413 RLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------L-SQVYG------- 477 (1157)
T ss_pred hhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------H-HHHHH-------
Confidence 9998765443 223334678999999999999999999999999999999 777775322 1 12333
Q ss_pred cccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 750 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
++....+...+..|++.+.+|++.||+-.|.+||++.|+.+.+|.+.
T Consensus 478 --LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 478 --LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred --HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 33444555667899999999999999999999999999999987654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=298.42 Aligned_cols=274 Identities=23% Similarity=0.269 Sum_probs=205.5
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeecccccc--chhhhhceeeEEeeccccceeeeeeee--ccCCceehhhh
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFC--DEGQNRLLVYE 600 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~--~~~~~~~lV~e 600 (814)
.+.|++|.||.||+|++.. +++.||+|+++...+. -.---.+||++|.+++|||||.+-.+. .+-+..|||||
T Consensus 81 lnrI~EGtyGiVYRakdk~---t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKK---TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HhhcccCcceeEEEeccCC---cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 4679999999999999875 6789999999753211 112357899999999999999998876 44567999999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|++. +|..++..- +++...+..-+..|+++||+|||. ..|+|||||++|+|+...|.+||+|||+|+.+......
T Consensus 158 ~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP 233 (419)
T ss_pred HHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence 9976 788888664 578999999999999999999994 59999999999999999999999999999987654322
Q ss_pred cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc---CCcccccc-
Q 042262 680 AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---GKLDDLVE- 754 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~l~~- 754 (814)
.+..+.|.+|+|||.+.+. .|++.+|+||+|||+.|++++++.|.....-++. +.+...+.. ...+.+..
T Consensus 234 --~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl---~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 234 --YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL---DKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred --CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH---HHHHHHhCCCccccCCCcccc
Confidence 4567789999999999876 5999999999999999999999998765432211 112222211 11111110
Q ss_pred -------------CcccccCCh-hHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCCCCCCCCCc
Q 042262 755 -------------GDTEAMNDI-KCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFSG 811 (814)
Q Consensus 755 -------------~~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~pp~p~~~~~ 811 (814)
..+...+.. ...+.-.+++...+..||.+|-|+.|.++. +=..+.+.|..|..+..
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h-~~F~e~P~p~~P~~~Pt 378 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH-EYFRETPLPIDPSMFPT 378 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc-cccccCCCCCChhhcCC
Confidence 011111111 145777889999999999999999998763 22445555555554443
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=338.23 Aligned_cols=258 Identities=21% Similarity=0.291 Sum_probs=209.5
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-ccceeeeeeee-cc------CCc
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFC-DE------GQN 594 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~-~~------~~~ 594 (814)
.+.+.|.+|||+.||.|.+.. .+..+|+|++-..++...+.+++||.+|++|+ |+|||.+++.. .. .-+
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~---~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVK---GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEccCCcEEEEEEEecC---CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 455789999999999999985 23789999997767778889999999999996 99999999932 11 236
Q ss_pred eehhhhhccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 595 RLLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
.+|.||||++|.|-+++.. ...|++.++++|+.++++|+++||.. .++|||||||-+||||+++++.||||||.+.-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 7899999999999999974 35599999999999999999999975 88999999999999999999999999999865
Q ss_pred cccccccccc-------ccccCCCCccCcccc---cCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHH
Q 042262 673 LTLNQSKAIK-------TAIRGTKGYVAPEWF---RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 742 (814)
Q Consensus 673 ~~~~~~~~~~-------~~~~gt~~y~aPE~~---~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 742 (814)
.......... -...-|+.|+|||.+ .+.++++|+|||+|||+||-|+-...||+....
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------------ 263 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------------ 263 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------------
Confidence 4332211100 112358999999987 577999999999999999999999999974311
Q ss_pred HHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCC
Q 042262 743 CYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 803 (814)
Q Consensus 743 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~p 803 (814)
..+++..........++..+.+||..||+++|++||++-+|++.+-.+...+.|
T Consensus 264 -------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 264 -------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred -------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 112333333333458899999999999999999999999999988776655444
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=318.67 Aligned_cols=256 Identities=25% Similarity=0.446 Sum_probs=204.9
Q ss_pred hhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
..+.++||+|+||.||++.... .......+++|.+..........+.+|+++++.++|+||+++++++.++...++|+
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence 4456789999999999997643 22345689999987765556678999999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEE
Q 042262 600 EFLNNGTLASFLFGN---------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 664 (814)
Q Consensus 600 e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl 664 (814)
||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEE
Confidence 999999999998653 247899999999999999999994 69999999999999999999999
Q ss_pred eecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHH
Q 042262 665 SDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 743 (814)
Q Consensus 665 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 743 (814)
+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||......+. ...
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~ 236 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------IEC 236 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------HHH
Confidence 99999976543322111222335678999999999999999999999999999998 8998854322111 111
Q ss_pred HhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 744 YRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 744 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
...+.. ...+..++..+.+++.+||+.||.+||++.||.+.|++
T Consensus 237 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 ITQGRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHcCcc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 112111 11122456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=321.42 Aligned_cols=260 Identities=28% Similarity=0.415 Sum_probs=206.6
Q ss_pred HHhhhhccccccceeEEEEEEEeccC--CcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeeeccCCce
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 595 (814)
..+.+.+.||+|+||.||++...... .....+|+|.+.... .+...++.+|+.++.++ +|+||+++++++.+++..
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 34556678999999999999986432 344689999987532 23345688899999999 799999999999999999
Q ss_pred ehhhhhccCCchhhhhcC----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC
Q 042262 596 LLVYEFLNNGTLASFLFG----------------NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY 659 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~ 659 (814)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+|+||||+||+++++
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTED 168 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCC
Confidence 999999999999999853 2467899999999999999999994 599999999999999999
Q ss_pred CCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHH
Q 042262 660 YNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTD 738 (814)
Q Consensus 660 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~ 738 (814)
+.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+......+
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------ 242 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------ 242 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH------
Confidence 9999999999987654332221222335678999999999899999999999999999998 888885432211
Q ss_pred HHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 739 WAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 739 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.......+.. ...+...+..+.+++.+|++.+|++||||.||++.|++++
T Consensus 243 -~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -LFKLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1122222211 1123345678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=331.46 Aligned_cols=265 Identities=24% Similarity=0.394 Sum_probs=206.2
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeecccccc-chhhhhceeeEEeecc-ccceeeeeeeecc
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTH-HKNLVRLLGFCDE 591 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~ 591 (814)
++......+.+.||+|+||.||+|.+.. .......||||+++..... ..+.++.|++++.++. ||||++++++|.+
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 3444455567899999999999999753 1224568999999754222 2346889999999997 9999999999999
Q ss_pred CCceehhhhhccCCchhhhhcCC---------------------------------------------------------
Q 042262 592 GQNRLLVYEFLNNGTLASFLFGN--------------------------------------------------------- 614 (814)
Q Consensus 592 ~~~~~lV~e~~~~gsL~~~l~~~--------------------------------------------------------- 614 (814)
.+..++|+||+++|+|.++++..
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 99999999999999999988542
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 042262 615 -----------------------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 653 (814)
Q Consensus 615 -----------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~N 653 (814)
..+++...+.|+.||++||+||| ..+|+||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcce
Confidence 12566778899999999999999 4699999999999
Q ss_pred EEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcc
Q 042262 654 ILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 732 (814)
Q Consensus 654 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~ 732 (814)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986543222111222346788999999998899999999999999999998 888886432211
Q ss_pred hhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 733 YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 733 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.....+..+. ....+...+.++.+++..||+.+|.+||+++||++.|++++
T Consensus 350 ------~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 ------QFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ------HHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111112221 11122345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=328.18 Aligned_cols=281 Identities=23% Similarity=0.351 Sum_probs=205.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccC-----Cc
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QN 594 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 594 (814)
+.+.+.||+|+||.||+|.... .+..||||++.... .....++.+|++++++++||||+++++++... ..
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECC---CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 4566889999999999999864 56789999986432 22345688999999999999999999988543 24
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
.++||||+. ++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 799999995 6899998887789999999999999999999995 599999999999999999999999999998654
Q ss_pred ccccc-cccccccCCCCccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHH--------HHHHHH
Q 042262 675 LNQSK-AIKTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT--------DWAFDC 743 (814)
Q Consensus 675 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~--------~~~~~~ 743 (814)
..... .......||..|+|||.+.+ ..++.++|||||||+++||++|+.||............ ......
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 32221 11234568999999999876 67899999999999999999999999654321110000 000000
Q ss_pred HhcCCcccccc---Cccc---ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HcCCcCCCCCCCCCCC
Q 042262 744 YRNGKLDDLVE---GDTE---AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEGVVEVDVPPNPSPF 809 (814)
Q Consensus 744 ~~~~~~~~l~~---~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~--L~~~~~~~~pp~p~~~ 809 (814)
+........+. .... .......+..+.+++.+||+.||++|||++|+++. ++++.....++.-.++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~ 308 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPI 308 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCcc
Confidence 11111000000 0000 00011345678899999999999999999999974 5665555544443333
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=342.69 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=202.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.+.||+|+||.||+|....+ .+..|++|.+..........+.+|+.+++.++||||+++++++.+++..+|||||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~--~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSD--PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCC--CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 56678899999999999987642 2467888877544444455678899999999999999999999999999999999
Q ss_pred ccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 602 LNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 602 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999987753 3467889999999999999999994 699999999999999999999999999998765433
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.........||..|+|||++.+..++.++|||||||+++||++|+.||...... . .......+....
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~-~~~~~~~~~~~~------ 290 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------E-IMQQVLYGKYDP------ 290 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCCCC------
Confidence 322234566999999999999999999999999999999999999999643221 1 111111222111
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+...+.++.+++..||+.||++||++.++++
T Consensus 291 ---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 ---FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 12245578999999999999999999998864
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.76 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=203.6
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
++||+|+||.||+|...........+++|.+..... ...+++.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998865443457899999875433 24567899999999999999999999876 4568999999999
Q ss_pred CchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc-cc
Q 042262 605 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI-KT 683 (814)
Q Consensus 605 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~ 683 (814)
++|.+++.....+++..+..++.|++.||+|||. .+++|+||||+||++++++.+||+|||+++.+........ ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 9999999887789999999999999999999995 5899999999999999999999999999987654332110 11
Q ss_pred cccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 684 ~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
...++..|+|||.+.+..++.++||||||++++|+++ |+.||....... + ...+..+.. ...+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~----~~~~~~~~~---------~~~~ 220 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---V----IAMLESGER---------LPRP 220 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---H----HHHHHcCCc---------CCCC
Confidence 1223568999999999999999999999999999998 999986543211 1 111222211 1122
Q ss_pred hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
..++..+.+++.+|++.+|++||++.+|++.|+++.
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 345678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=316.01 Aligned_cols=258 Identities=25% Similarity=0.439 Sum_probs=206.3
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.+.||+|+||.||+|.+...+.....++||.++.. .....++|..|+.+++.++||||+++++++.++...++|+
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 456778999999999999999865545568999998754 2334567999999999999999999999999999999999
Q ss_pred hhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 99999999999875 3568999999999999999999995 5999999999999999999999999999886654322
Q ss_pred cccccc-cc--CCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 679 KAIKTA-IR--GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 679 ~~~~~~-~~--gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
...... .. .+..|+|||.+.+..++.++||||||++++|+++ |..||......+ . ...+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~----~~~i~~~------- 227 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---V----INAIEQD------- 227 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---H----HHHHHcC-------
Confidence 211111 11 2357999999999999999999999999999886 999986432211 1 1111111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
.....+..++..+.+++..||+.+|.+||+|.+|+++|+.+
T Consensus 228 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 --YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01111234567889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=313.85 Aligned_cols=253 Identities=26% Similarity=0.474 Sum_probs=207.8
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
..+.+.++||+|+||.||+|.... +..+++|.+.........++.+|+.+++.++|+||+++++++.+....++||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~----~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN----RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC----CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 346677899999999999999873 5679999987665545667899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+|+||||+||++++++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999999753 468999999999999999999995 589999999999999999999999999998764332
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.. .....++..|+|||.+.+..++.++||||||+++++|++ |+.||......+ . ......+
T Consensus 159 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~----~~~~~~~--------- 220 (261)
T cd05148 159 YL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---V----YDQITAG--------- 220 (261)
T ss_pred cc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---H----HHHHHhC---------
Confidence 21 123345678999999998899999999999999999998 899986443211 1 1111111
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
.....+..+++.+.+++.+||+.||.+|||++++++.|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11112335667899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.40 Aligned_cols=265 Identities=26% Similarity=0.406 Sum_probs=206.5
Q ss_pred HHhhhhccccccceeEEEEEEEeccCC-------------cceEEEEEeecccc-ccchhhhhceeeEEeeccccceeee
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRT-------------STTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRL 585 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~-------------~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l 585 (814)
..+.+.++||+|+||.||++.+..... ....+|+|.+.... ....+++.+|++++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 345677899999999999998764221 23568999987543 2345678999999999999999999
Q ss_pred eeeeccCCceehhhhhccCCchhhhhcCCC-----------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 042262 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNL-----------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 654 (814)
Q Consensus 586 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NI 654 (814)
++++..+...++|+||+++++|.+++.... .+++..++.++.|+++||+|||+ .+|+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 999999999999999999999999987654 68999999999999999999995 5999999999999
Q ss_pred EECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh--CCcCCcccCCcc
Q 042262 655 LLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEE 732 (814)
Q Consensus 655 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt--G~~p~~~~~~~~ 732 (814)
++++++.++|+|||+++.+.............++..|+|||.+.+..++.++||||||++++||++ +..|+......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ- 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence 999999999999999986644332222334456788999999998889999999999999999998 66676532211
Q ss_pred hhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 733 YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 733 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
.........++....... ...+..++.++.+++.+||+.||.+|||+.||++.|+.
T Consensus 241 --~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 --QVIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111111111111 11123456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.42 Aligned_cols=271 Identities=25% Similarity=0.356 Sum_probs=203.9
Q ss_pred hhhccccccceeEEEEEEEec-cCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccC--Cceehh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLV 598 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 598 (814)
.+.+.||+|+||+||++.... ....+..+|+|.++... ......+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 566789999999999876542 22356789999987542 23456788999999999999999999998653 457899
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++++|.+++... .+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.+||+|||+++.......
T Consensus 87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999998654 58999999999999999999995 5999999999999999999999999999987654322
Q ss_pred cc-ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KA-IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.. ......++..|+|||.+.+..++.++||||||++++||++|+.|+........ ..............+.++++...
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhcCC
Confidence 11 11222356679999999988999999999999999999999999854321100 00000000000011111122212
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
....+...+..+.+++..||+.+|++|||+++|+++|+.+.
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22223456789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.59 Aligned_cols=259 Identities=28% Similarity=0.452 Sum_probs=206.1
Q ss_pred HHHhhhhccccccceeEEEEEEEeccC--CcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCce
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 595 (814)
...+.+.+.||+|+||.||+|...... .....+++|.+.... .....++.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 345566788999999999999987432 345789999986542 23345788999999999999999999999999999
Q ss_pred ehhhhhccCCchhhhhcCC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEe
Q 042262 596 LLVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 665 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 665 (814)
++||||+++++|.+++... ..+++..+..++.|++.||.||| ..+++|+||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 9999999999999998642 23688899999999999999999 4699999999999999999999999
Q ss_pred ecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHH
Q 042262 666 DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY 744 (814)
Q Consensus 666 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 744 (814)
|||+++.+.............++..|+|||.+.+..++.++||||||++++|+++ |+.||....... + ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~----~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---V----LKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---H----HHHH
Confidence 9999987654332211233346789999999998899999999999999999998 888886432211 1 1111
Q ss_pred hcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 745 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
..+... ..+..++..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 222111 1122346889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.22 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=201.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||+||+|... ....+|||.++.. .....++.+|+.++.+++||||+++++++.+....++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~----~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HeEEeeEecCcccceEEEEEec----CCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 3456788999999999999875 2346999988643 2335678999999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++++|.+++... ..+++..++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||+++........
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999998753 468999999999999999999994 59999999999999999999999999998866433221
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. .....++..|+|||.+.+..++.++||||||++++||++ |+.||....... .......+...
T Consensus 157 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~-------- 220 (256)
T cd05113 157 S-SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLRL-------- 220 (256)
T ss_pred e-cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCCC--------
Confidence 1 122335678999999998889999999999999999999 999986433211 11122222111
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
..+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111234578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=327.21 Aligned_cols=247 Identities=24% Similarity=0.301 Sum_probs=203.3
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
..+.+.+.||+|+||.||+|.+... ....+|+|++.... ....+.+.+|+.++..++||||+++++++.+++..+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECC--CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3466778999999999999987642 34689999986432 223456888999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
+||||+++|+|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 999999999999999888889999999999999999999994 69999999999999999999999999999875432
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..+...
T Consensus 185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~~------ 246 (340)
T PTZ00426 185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGIIY------ 246 (340)
T ss_pred -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCCC------
Confidence 23456899999999999988999999999999999999999999744221 112222222211
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQM 793 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~~ 793 (814)
.+...+..+.+++.+|++.||.+|+ +++|+++.
T Consensus 247 ----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 ----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1223456788999999999999995 89888764
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.79 Aligned_cols=258 Identities=28% Similarity=0.449 Sum_probs=203.4
Q ss_pred hhhccccccceeEEEEEEEeccC--CcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.||+|+||.||+|...... .....+++|.+..... ....++.+|+.+++.++||||+++++.+...+..++|+
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 35578999999999999875321 2335788998865332 23457889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 042262 600 EFLNNGTLASFLFGN------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNIL 655 (814)
Q Consensus 600 e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIl 655 (814)
||+.+++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEE
Confidence 999999999987532 246788999999999999999994 59999999999999
Q ss_pred ECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchh
Q 042262 656 LDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA 734 (814)
Q Consensus 656 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 734 (814)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||.......
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-- 237 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-- 237 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence 99999999999999986543322111222345678999999988899999999999999999998 999986433221
Q ss_pred hHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 735 ILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 735 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.+.....+. ....+...+.++.+++..||+.+|++||++.|+++.|+++..
T Consensus 238 -----~~~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 -----LFNLLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -----HHHHHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 112222211 111123456789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=316.30 Aligned_cols=266 Identities=24% Similarity=0.381 Sum_probs=202.6
Q ss_pred HHHhhhhccccccceeEEEEEEEeccC-----------CcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeee
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTR-----------TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLL 586 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~-----------~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~ 586 (814)
...+.+.+.||+|+||.||++...... .....+|+|.++... ......+.+|++++.+++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 445667789999999999998875321 123468999986532 22345689999999999999999999
Q ss_pred eeeccCCceehhhhhccCCchhhhhcCC------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 042262 587 GFCDEGQNRLLVYEFLNNGTLASFLFGN------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 654 (814)
Q Consensus 587 g~~~~~~~~~lV~e~~~~gsL~~~l~~~------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NI 654 (814)
+++...+..++||||+++++|.+++... ..+++..++.++.|+++||+|||+ .+++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 9999999999999999999999988542 136788999999999999999994 5999999999999
Q ss_pred EECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh--CCcCCcccCCcc
Q 042262 655 LLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEE 732 (814)
Q Consensus 655 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt--G~~p~~~~~~~~ 732 (814)
++++++.+||+|||++..+.............++..|+|||.+.++.++.++||||||++++||++ +..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999986643322221223345678999999998899999999999999999998 556665432211
Q ss_pred hhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 733 YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 733 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
................. ...+...+..+.+++.+||+.+|++||+|.+|++.|+.
T Consensus 241 ---~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 ---VIENTGEFFRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHhhhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111111111000 11122356789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.24 Aligned_cols=244 Identities=25% Similarity=0.328 Sum_probs=194.5
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||.||++.... .++.+|+|.++... ....+.+..|+.++.++ +||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 368999999999999874 46789999987532 22334577788877766 899999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++|+|..++.....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~-- 152 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-- 152 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc--
Confidence 9999999998888889999999999999999999995 59999999999999999999999999998753322111
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCc--chhhHHHHHHHHHhcCCccccccCcccc
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE--EYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....||..|+|||.+.+..++.++||||||++++||++|+.||...... .......+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 23456899999999999999999999999999999999999999642211 111122233333322221
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTM 787 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 787 (814)
..+...+..+.+++.+||+.||.+||+.
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1123456778899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=321.52 Aligned_cols=268 Identities=25% Similarity=0.401 Sum_probs=210.7
Q ss_pred HHHHHhhhhccccccceeEEEEEEEec----cCCcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeeec
Q 042262 517 LEEATDNFEEEVGRGSFGIVYKGVIQT----TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCD 590 (814)
Q Consensus 517 l~~~~~~~~~~LG~G~fG~Vykg~~~~----~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 590 (814)
+....+.+.+.||+|+||.||++.... .......+++|.+.... ....+++.+|+.++..+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 344556677899999999999998632 12234579999986532 23346789999999999 8999999999999
Q ss_pred cCCceehhhhhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 042262 591 EGQNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 654 (814)
Q Consensus 591 ~~~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NI 654 (814)
.....++||||+++++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence 999999999999999999998642 246788899999999999999995 5999999999999
Q ss_pred EECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcch
Q 042262 655 LLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY 733 (814)
Q Consensus 655 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~ 733 (814)
++++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||++++||++ |..|+......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-- 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence 999999999999999987654332221223345678999999998899999999999999999998 77877533211
Q ss_pred hhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCC
Q 042262 734 AILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 803 (814)
Q Consensus 734 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~p 803 (814)
+ ....+..+... ..+..++..+.+++.+||+.+|.+||||.||++.|+++..+..+
T Consensus 247 ----~-~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 247 ----E-LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred ----H-HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 1 12222222111 11235668899999999999999999999999999988766543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.94 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=198.8
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||.||++.... .+..+|||+++... ....+.+..|..++..+ +||||+++++++.+.+..+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 368999999999999874 46789999997532 22334577888888888 799999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++|+|..++.....+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++....... .
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--T 152 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--c
Confidence 9999999998887889999999999999999999994 6999999999999999999999999999875322111 1
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcc--hhhHHHHHHHHHhcCCccccccCcccc
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....||..|+|||.+.+..++.++||||||+++|||++|+.||+...... ......+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 223 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--------- 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC---------
Confidence 234568999999999999999999999999999999999999997432211 111222333333332211
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPT------MRKVSQ 792 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt------m~eV~~ 792 (814)
.+...+.++.+++.+||+.||.+||+ ++++++
T Consensus 224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12245677899999999999999997 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.00 Aligned_cols=249 Identities=27% Similarity=0.430 Sum_probs=199.5
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
..+.+.||+|+||.||+|... ....+++|.+.... ....++.+|+++++.++|+||+++++++.+.+..++|+||
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR----GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred cchhhhhccCCCceEEEeEec----CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 456788999999999999875 34578999886432 2345688899999999999999999999999999999999
Q ss_pred ccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 602 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 602 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999998653 468999999999999999999995 589999999999999999999999999998654322111
Q ss_pred ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .......+. ..
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~ 220 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-------VVESVSAGY---------RL 220 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-------HHHHHHcCC---------cC
Confidence 112224457999999999999999999999999999999 889886432211 111111111 11
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
..+...+.++.+++.+||+.+|++||||.||++.|.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 112346778999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=305.27 Aligned_cols=252 Identities=26% Similarity=0.337 Sum_probs=193.5
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCC-----ceehhh
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----NRLLVY 599 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lV~ 599 (814)
.+.+|+|.||.||+|++.. ....||||+.-.. .+.--.|+.+|+++.|||||+|+-++.... ...||+
T Consensus 29 ~~liG~GsFg~Vyq~~~~e---~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRE---TEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred eEEEeecccceEEEEEEcC---CCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 3679999999999999986 3678999997432 223356888888999999999998884432 235899
Q ss_pred hhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CCeEEeecCCccccc
Q 042262 600 EFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-YNARISDFGLAKLLT 674 (814)
Q Consensus 600 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGla~~~~ 674 (814)
|||+. +|.+.++. +++++...++-+..||.+||+||| +.+|+||||||+|+|+|.+ +.+||+|||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99987 77777763 567788888889999999999999 4699999999999999965 999999999999987
Q ss_pred ccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHh--------
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR-------- 745 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-------- 745 (814)
.++.. .....|.-|+|||.+.+. .|+.++||||.|||+.||+-|++.|..+.+.++. ...+ ..+.
T Consensus 178 ~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL--~eIi-k~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 178 KGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL--VEII-KVLGTPTREDIK 251 (364)
T ss_pred cCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH--HHHH-HHhCCCCHHHHh
Confidence 65543 344568889999999876 6999999999999999999999999876543322 2211 1111
Q ss_pred c-------CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 746 N-------GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 746 ~-------~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
. -....+.............+.+.++++.++++.+|.+|.++.|++..
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1 11111111111122334567899999999999999999999998864
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=325.53 Aligned_cols=244 Identities=23% Similarity=0.274 Sum_probs=198.4
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
+.||+|+||.||++.... .+..+|+|.++... .....++..|++++..++||||+++++++.+.+..+|||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 468999999999998764 56789999987532 223356778899999999999999999999999999999999
Q ss_pred cCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccc
Q 042262 603 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682 (814)
Q Consensus 603 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (814)
++|+|..++.....+++..+..++.||+.||+|||+ ..+|+||||||+|||+++++.+||+|||+++........ .
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~ 153 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--M 153 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--c
Confidence 999999999888889999999999999999999994 258999999999999999999999999998754322111 2
Q ss_pred ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
....||..|+|||.+.+..++.++||||||++++||++|+.||.....+.. ......+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-------~~~i~~~~~----------~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEEI----------RFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-------HHHHhcCCC----------CCC
Confidence 335689999999999999999999999999999999999999964432111 111111111 112
Q ss_pred hhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQM 793 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~~ 793 (814)
...+.++.+++.+||+.||.+|+ ++.|+++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 24567889999999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=326.07 Aligned_cols=242 Identities=25% Similarity=0.277 Sum_probs=197.7
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhcc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 603 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 603 (814)
+.||+|+||.||++........+..+|+|++..... .....+..|++++.+++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 569999999999998765445678999999975322 223457789999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccc
Q 042262 604 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT 683 (814)
Q Consensus 604 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 683 (814)
+++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++........ ..
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~~ 156 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AY 156 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc--ee
Confidence 99999999887889999999999999999999994 69999999999999999999999999999865433221 23
Q ss_pred cccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCCh
Q 042262 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDI 763 (814)
Q Consensus 684 ~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~ 763 (814)
...|+..|+|||.+.+..++.++||||||++++||++|+.||....... ....+..... ..+.
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-------~~~~i~~~~~----------~~p~ 219 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-------TMTMILKAKL----------GMPQ 219 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-------HHHHHHcCCC----------CCCC
Confidence 4568999999999998889999999999999999999999997543211 1111111111 1122
Q ss_pred hHHHHHHHHHHHccccCCCCCCCHHH
Q 042262 764 KCTEKLVMVSIWCIQEDPSLRPTMRK 789 (814)
Q Consensus 764 ~~~~~l~~l~~~Cl~~dP~~RPtm~e 789 (814)
..+..+.+++.+||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 45678889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.06 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=198.7
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccC------Cce
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------QNR 595 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~ 595 (814)
+.+.||+|+||.||+|.+.... ....+|+|.++.. .....+.+.+|+++++.++|+||+++++++... ...
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDD-SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred cccccCcccCceEEEeEEccCC-CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4578999999999999986532 2346899988643 223346788899999999999999999987432 246
Q ss_pred ehhhhhccCCchhhhhcC------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCC
Q 042262 596 LLVYEFLNNGTLASFLFG------NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 669 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl 669 (814)
++|+||+++|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999988732 2347899999999999999999995 5999999999999999999999999999
Q ss_pred cccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCC
Q 042262 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK 748 (814)
Q Consensus 670 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 748 (814)
++.+.............++..|+|||.+.+..++.++||||||++++||++ |+.||...... ...+.+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCC
Confidence 987654322111222345678999999999999999999999999999999 78888643221 1122233332
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
... .+...+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 1224567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=318.56 Aligned_cols=266 Identities=26% Similarity=0.435 Sum_probs=202.4
Q ss_pred HhhhhccccccceeEEEEEEEec-cCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeecc--CCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 597 (814)
.+.+.+.||+|+||.||++.... ....+..+++|++........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 34566789999999999998642 223567899999876655556788999999999999999999998744 346789
Q ss_pred hhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|+||+++++|.+++... ..+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.+||+|||+++.+...
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999998754 468999999999999999999995 59999999999999999999999999999876543
Q ss_pred cccc-ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC-------
Q 042262 677 QSKA-IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK------- 748 (814)
Q Consensus 677 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------- 748 (814)
.... ......++..|+|||.+.+..++.++||||||++++||++|..++...... + ........
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~-~~~~~~~~~~~~~~~ 233 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------F-MRMMGNDKQGQMIVY 233 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------h-hhhcccccccccchH
Confidence 2211 011122344699999999889999999999999999999987765322110 0 00000000
Q ss_pred -ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 749 -LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 749 -~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
+.+.+........+...+.++.+++.+||+.+|++||||.||++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0001111111112334567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.06 Aligned_cols=259 Identities=28% Similarity=0.444 Sum_probs=203.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||.||+|.+...+ ....+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+....++|+
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDG-LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCC-CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 456678999999999999986532 2235788887643 223346788999999999 7999999999999999999999
Q ss_pred hhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeE
Q 042262 600 EFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR 663 (814)
Q Consensus 600 e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~k 663 (814)
||+++++|.+++... ..+++..++.|+.|++.||+|||+ .+|+||||||+||++++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence 999999999998643 247888999999999999999995 5999999999999999999999
Q ss_pred EeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHH
Q 042262 664 ISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD 742 (814)
Q Consensus 664 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 742 (814)
|+|||++........ ......+..|+|||.+.+..++.++||||||++++||++ |..||....... ...
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~ 229 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYE 229 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH
Confidence 999999864321111 111223557999999998899999999999999999998 999986443211 111
Q ss_pred HHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCC
Q 042262 743 CYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 803 (814)
Q Consensus 743 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~p 803 (814)
....+. ....+..++..+.+++.+||+.+|.+||++.+|++.|+++.+...+
T Consensus 230 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 230 KLPQGY---------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111111 1112234567889999999999999999999999999887765544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=324.07 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=193.0
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
++.++||+|+||.||+|.+.. .++.||||++.... ....+.+.+|+++++.++|+||+++++++.+++..++||||
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRP---TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred hhhhhccCCCCeEEEEEEECC---CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 345789999999999998864 46789999986432 22346789999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++++|.... ...+..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.+......
T Consensus 154 ~~~~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~-- 224 (353)
T PLN00034 154 MDGGSLEGTH----IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP-- 224 (353)
T ss_pred CCCCcccccc----cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--
Confidence 9999987542 34667788999999999999995 59999999999999999999999999999876533211
Q ss_pred cccccCCCCccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 682 KTAIRGTKGYVAPEWFRN-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.....||..|+|||.+.. ...+.++|||||||++|||++|+.||......+...+ .. ......
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~-~~~~~~-------- 292 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL---MC-AICMSQ-------- 292 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HH-HHhccC--------
Confidence 233568999999998843 2345689999999999999999999974332221111 00 000000
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
........+.++.+++.+||+.||++|||+.||++.
T Consensus 293 -~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 -PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223456789999999999999999999999985
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=323.23 Aligned_cols=254 Identities=21% Similarity=0.231 Sum_probs=201.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc----ccchhhhhceeeEEeec-cccceeeeeeeeccCCcee
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 596 (814)
+.+.+.||+|+||.||++........+..+|+|++.... ....+.+..|+.++.++ +|+||+++++++.+.+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 345678999999999999876554567899999986432 12234578899999999 5999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
+||||+++|+|.+++.....+++.....++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 999999999999999888889999999999999999999994 59999999999999999999999999999865433
Q ss_pred ccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.... .....||..|+|||.+.+. .++.++||||||++++||++|+.||......... ......+... ++
T Consensus 159 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~------~~ 228 (332)
T cd05614 159 EKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKC------DP 228 (332)
T ss_pred CCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcC------CC
Confidence 2221 2345689999999999875 4789999999999999999999999754322111 1111111111 11
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 792 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~ 792 (814)
..+...+..+.+++.+||+.||++|| +++++++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 229 ----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11224567888999999999999999 6667765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.13 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=200.4
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc---------c-----hhhhhceeeEEeeccccceeeee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD---------G-----EKEFKNEVVVIGQTHHKNLVRLL 586 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~---------~-----~~~~~~Ei~~l~~l~H~niv~l~ 586 (814)
.+.+.+.||+|.||.|-+|.... +++.+|||++.+.... . .+...+||.+|++++|+|||+|+
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~---~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEV---DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred heehhhhhcCCccceEEEEeecC---CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 35566789999999999999875 6789999999642110 1 13678999999999999999999
Q ss_pred eeecc--CCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEE
Q 042262 587 GFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 664 (814)
Q Consensus 587 g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl 664 (814)
.+..+ .++.|||+||+..|.+...--....++..+.++++.++..||+|||. .+||||||||+|+||++++.+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEe
Confidence 99866 46899999999998876654444448999999999999999999995 59999999999999999999999
Q ss_pred eecCCcccccccc---cccccccccCCCCccCcccccCCC----CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHH
Q 042262 665 SDFGLAKLLTLNQ---SKAIKTAIRGTKGYVAPEWFRNST----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 737 (814)
Q Consensus 665 ~DfGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 737 (814)
+|||.+....... ........+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||..+..-+
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~----- 326 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE----- 326 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-----
Confidence 9999998763321 112233467999999999987642 4568999999999999999999997443211
Q ss_pred HHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042262 738 DWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794 (814)
Q Consensus 738 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L 794 (814)
.++. ++...+......+..+++.+|++++|+.||+.|.+..+|....
T Consensus 327 --l~~K--------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 327 --LFDK--------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred --HHHH--------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1222 2333333333446778999999999999999999999998764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=327.04 Aligned_cols=257 Identities=20% Similarity=0.239 Sum_probs=195.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||++.+.. .++.||+|+.. ...+.+|++++++++||||+++++++..+...++|+|
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~---~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNK---TCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECC---CCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 35667889999999999999865 56789999753 2356789999999999999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
++. ++|..++.....+++..++.|+.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 164 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 164 RYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 985 6888888777788999999999999999999995 599999999999999999999999999997543221111
Q ss_pred ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCc-----chhhHHHHHHHHHhc--C------
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE-----EYAILTDWAFDCYRN--G------ 747 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~-----~~~~l~~~~~~~~~~--~------ 747 (814)
.....||..|+|||++.+..++.++|||||||++|||++|+.|+...... ....+.. ....... .
T Consensus 240 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~-i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 240 -YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL-IIRRSGTHPNEFPIDA 317 (391)
T ss_pred -cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH-HHHHhcCChhhcCcch
Confidence 23456999999999999999999999999999999999999886533211 0011100 0000000 0
Q ss_pred --Cccccc---------cCccc--ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 748 --KLDDLV---------EGDTE--AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 748 --~~~~l~---------~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+.... .+... .......+.++.+++.+||+.||.+|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 00000 0001234668899999999999999999999986
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=308.13 Aligned_cols=251 Identities=33% Similarity=0.510 Sum_probs=206.8
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccc-hhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
+.||+|+||.||+|...........+++|.+....... .+++.+|++.+..++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46899999999999997532346789999997654333 57889999999999999999999999999999999999999
Q ss_pred CchhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 605 GTLASFLFGN---------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 605 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 678999999999999999999994 6999999999999999999999999999988765
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
...........++..|+|||.+.+..++.++||||+|++++||++ |+.||....... ..+....+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC-----
Confidence 432222334457889999999998899999999999999999999 689987542211 1222222111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
...+...+.++.+++.+||+.+|.+|||+.|+++.|+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1123345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=316.52 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=205.4
Q ss_pred HHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccccc-cchhhhhceeeEEeec-cccceeeeeeeeccCCce
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 595 (814)
..+.+.+.||+|+||.||++.... .......+|||+++.... ...+.+.+|+++++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 345667899999999999998642 123456799999875432 2345688999999999 799999999999999999
Q ss_pred ehhhhhccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 596 LLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
++||||+++++|.+++.... .+++.++..++.|++.||+|||+ .+|+|+||||+||+++++..+||+|||+++.+
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999987543 37999999999999999999995 59999999999999999999999999999866
Q ss_pred cccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
.............++..|+|||.+.+..++.++||||||++++||++ |+.||......+. .......+..
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~~~~~--- 262 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEGYR--- 262 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHHcCCc---
Confidence 43322111222345778999999999999999999999999999998 9999864332111 1111222211
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
...+...+.++.+++.+|++.+|++|||+.||++.|+++
T Consensus 263 ------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 ------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111223457899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.47 Aligned_cols=252 Identities=29% Similarity=0.449 Sum_probs=201.4
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
...+.+.++||+|+||.||+|... .+..+++|.++.... ..+++.+|+.++++++|+|++++++++.+ ...++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~----~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN----GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec----CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEE
Confidence 345677789999999999999875 345699999875332 35678999999999999999999998854 568899
Q ss_pred hhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 599 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++..+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999998753 458999999999999999999995 58999999999999999999999999999876543
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.... .....++..|+|||.+.+..++.++||||||++++||++ |+.||......+ ..+.+..+.
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~------- 220 (260)
T cd05070 156 EYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLEQVERGY------- 220 (260)
T ss_pred cccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC-------
Confidence 2211 122235668999999988899999999999999999999 888886432211 111111111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
....+...+..+.+++.+|++.+|.+|||+.++.+.|++
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 --RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111223456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.45 Aligned_cols=262 Identities=24% Similarity=0.385 Sum_probs=207.3
Q ss_pred HHHhhhhccccccceeEEEEEEEeccC-CcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeecc-CCce
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTR-TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNR 595 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~-~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 595 (814)
...+.+.+.||+|+||.||+|.+.... .....|++|++.... ....+.+.+|+.++++++|+||+++++++.+ +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 345567789999999999999987422 235789999886532 2334668889999999999999999998866 5678
Q ss_pred ehhhhhccCCchhhhhcCC--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeec
Q 042262 596 LLVYEFLNNGTLASFLFGN--------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDF 667 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df 667 (814)
++++||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998643 457899999999999999999995 59999999999999999999999999
Q ss_pred CCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 668 GLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 668 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
|+++.+.............++..|+|||.+.+..++.++||||||++++|+++ |+.||......+ + ...+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---M----AAYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---H----HHHHHc
Confidence 99987654433222233346778999999998899999999999999999999 999986442211 1 111122
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
+. .......+++++.+++.+||+.+|++|||+.||++.|+++..
T Consensus 235 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11 001122356789999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.15 Aligned_cols=262 Identities=26% Similarity=0.395 Sum_probs=204.3
Q ss_pred HHhhhhccccccceeEEEEEEEeccCC-cceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRT-STTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~-~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
....+.+.||+|+||+||+|.....+. ....||+|+++... ....+++.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 344566889999999999999764322 12358999986532 3345678899999999999999999999975 45778
Q ss_pred hhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
++||+++|+|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++.+...
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999999764 568999999999999999999994 59999999999999999999999999999876543
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
..........++..|+|||.+.+..++.++||||||+++|||++ |..||+...... + ...+..+...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~----- 230 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---I----PDLLEKGERL----- 230 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCcC-----
Confidence 22211122234678999999999999999999999999999998 889986432211 1 1112222111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCC
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~ 801 (814)
..+..++..+.+++..||+.||++||++.|+++.|+.+...+
T Consensus 231 ----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 ----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 112245678899999999999999999999999998765544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.45 Aligned_cols=259 Identities=24% Similarity=0.441 Sum_probs=206.5
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
..+.+.+.||+|+||.||+|.+...+.....+|+|.++... ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 34556789999999999999986544445689999986532 23346789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||+++++|.+++... ..+++.++..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999764 467999999999999999999994 699999999999999999999999999998765432
Q ss_pred ccccc-ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 678 SKAIK-TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 678 ~~~~~-~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
..... ....++..|+|||.+.+..++.++||||||++++|+++ |+.||......+ . ...+.++.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~----~~~~~~~~------- 226 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V----IKAIEEGY------- 226 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H----HHHHhCCC-------
Confidence 21111 11223567999999998899999999999999999887 999986443221 1 11112111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
........+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 --RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111234567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=319.04 Aligned_cols=241 Identities=27% Similarity=0.344 Sum_probs=191.9
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEee-ccccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||.||+|.... .+..||||.++... ....+.+..|..++.. .+||||+++++++..++..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 369999999999999864 46789999986532 1223344555555554 4899999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++|+|..++.....++......++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~ 152 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--K 152 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--c
Confidence 9999999999887789999999999999999999995 6999999999999999999999999999986533221 1
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||..|+|||.+.+..++.++|||||||+++||++|+.||....... ....+.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~----------~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSILNDR----------PHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC----------CCC
Confidence 334568999999999999999999999999999999999999997543211 111111111 111
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMR-KVS 791 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~-eV~ 791 (814)
+...+.++.+++..||+.||.+||++. +++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 234567788999999999999999876 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.60 Aligned_cols=237 Identities=25% Similarity=0.376 Sum_probs=192.8
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||.||+|.... .++.+|||+++... ....+.+..|+.++..+ +||||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 368999999999999864 46789999986432 22334566777777766 799999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~-- 152 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT-- 152 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc--
Confidence 9999999999888889999999999999999999994 69999999999999999999999999998754322111
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||..|+|||.+.+..++.++||||||++++||++|+.||....... ....+..+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~----------~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV----------VY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCC----------CC
Confidence 234568999999999999999999999999999999999999997543211 1122222211 11
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTM 787 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm 787 (814)
+...+.++.+++.+||+.||.+||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 22356788999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=308.61 Aligned_cols=254 Identities=30% Similarity=0.472 Sum_probs=204.3
Q ss_pred HHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 517 LEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 517 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
+....+++.++||+|+||.||+|... ++..+|+|.+.... ....++.+|+.++++++|+||+++++++. .+..+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~----~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN----GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC----CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45667788899999999999999865 45679999987543 33467899999999999999999999874 45789
Q ss_pred hhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 597 LVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
+||||+++++|.+++... ..+++.++..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 999999999999998653 46789999999999999999999 4699999999999999999999999999998765
Q ss_pred ccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
...... .....++..|+|||.+.+..++.++||||||++++|+++ |+.||....... ....+..+..
T Consensus 154 ~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~---- 221 (260)
T cd05067 154 DNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQNLERGYR---- 221 (260)
T ss_pred CCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHHcCCC----
Confidence 332211 223345678999999998889999999999999999999 999996433211 1111111111
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
...+...+.++.+++.+|++.+|++||+++++.++|+.
T Consensus 222 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 -----MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11122345789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=313.93 Aligned_cols=261 Identities=28% Similarity=0.457 Sum_probs=203.2
Q ss_pred HHHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCce
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 595 (814)
...+.+.+.||+|+||.||+|.... .......+|+|.+..... ....++.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 4456677899999999999998653 222356899998864322 2234678899999999999999999999999999
Q ss_pred ehhhhhccCCchhhhhcCC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEe
Q 042262 596 LLVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 665 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 665 (814)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999998642 234677888999999999999994 699999999999999999999999
Q ss_pred ecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHH
Q 042262 666 DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY 744 (814)
Q Consensus 666 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 744 (814)
|||+++...............++..|+|||.+.++.++.++||||||++++||++ |..||.....++ .....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~ 234 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFV 234 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence 9999986543322111222235678999999999899999999999999999999 788886432211 11111
Q ss_pred hcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 745 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
..+.... .+...+..+.+++.+||+.+|++||||.|+++.|++.+
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1121111 12234578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=307.66 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=198.8
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCC
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 605 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 605 (814)
.||+|+||.||+|.+...+ .+..+|+|++..... ...+++.+|+.++++++|+||+++++++.. ...++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~-~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCC-CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 4899999999999876432 355799999865432 234568999999999999999999999854 5789999999999
Q ss_pred chhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc-cc
Q 042262 606 TLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI-KT 683 (814)
Q Consensus 606 sL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~ 683 (814)
+|.+++.. ...+++..+++++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||+++....+..... ..
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999875 4568999999999999999999995 5999999999999999999999999999986544322111 11
Q ss_pred cccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 684 ~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
...++..|+|||.+.+..++.++||||||++++|+++ |..||......+ +...+..+.. ...+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKR---------LDCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCC---------CCCC
Confidence 1223568999999998889999999999999999996 999986443211 1122222221 1123
Q ss_pred hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
..+++++.+++..||+.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 35578899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.00 Aligned_cols=253 Identities=29% Similarity=0.458 Sum_probs=202.0
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
...+.+.++||+|+||.||+|.+.. ...+++|+++... ...+++.+|+.+++.++|+||+++++++.+ ...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----CceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 3457788899999999999998753 3459999987532 234678999999999999999999998754 567899
Q ss_pred hhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 599 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||.++.+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999999753 457899999999999999999994 69999999999999999999999999999876543
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.... .....++..|+|||.+.+..++.++||||||++++||++ |+.||....... .......+.
T Consensus 156 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~------- 220 (262)
T cd05071 156 EYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGY------- 220 (262)
T ss_pred cccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhcCC-------
Confidence 2211 122345678999999998899999999999999999999 888886432211 111111111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
........+..+.+++.+|++.+|++||++.++++.|++.
T Consensus 221 --~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0111235667889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.65 Aligned_cols=243 Identities=23% Similarity=0.351 Sum_probs=196.3
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||.||+|.... .++.+|||+++... ....+.+..|.+++..+ +||||+++++++.+++..+|||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 369999999999999864 46789999986532 22334567787777765 799999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++++|...+.....+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++....... .
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 9999999999888889999999999999999999995 5999999999999999999999999999875432221 1
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||..|+|||++.+..++.++||||||+++|||++|+.||....... ....+..+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-------~~~~i~~~~~----------~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-------LFESILHDDV----------LY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC----------CC
Confidence 234568999999999999999999999999999999999999997543211 1111222211 11
Q ss_pred ChhHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRP-------TMRKVSQM 793 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RP-------tm~eV~~~ 793 (814)
+...+.++.+++..||+.||++|| ++.++++.
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 223457889999999999999999 77777653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=307.18 Aligned_cols=252 Identities=28% Similarity=0.422 Sum_probs=203.7
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
+.||+|++|.||+|.+.........+|||.++.... ...+++..|+.++++++|+||+++++++.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999876443455799999976544 456789999999999999999999999988 889999999999
Q ss_pred CchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc-cc
Q 042262 605 GTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK-AI 681 (814)
Q Consensus 605 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~ 681 (814)
++|.+++.... .+++.....++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||+++.+...... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999987653 68999999999999999999994 69999999999999999999999999999876543221 11
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccccc
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~ 760 (814)
.....++..|+|||.+.+..++.++||||||++++||++ |+.|+......+ ........+.. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~---------~~ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGER---------LE 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCc---------CC
Confidence 223446789999999999899999999999999999999 999986432221 11111111110 01
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 761 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
.+...+..+.+++.+|++.+|.+||++.||++.|.+
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 122456789999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=327.26 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=197.4
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.||+|+||+||+|.... .++.+|||++.... ......+.+|+.++.+++|+||+++++++.+.+..++||
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVD---THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred eEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 455789999999999999864 56789999996532 223456889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc-
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS- 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~- 678 (814)
||+++|+|.+++.....+++.....++.||+.||+|||. .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999999888888999999999999999999994 6999999999999999999999999999764321100
Q ss_pred --------------------------------------------ccccccccCCCCccCcccccCCCCCCccchhhHHHH
Q 042262 679 --------------------------------------------KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVL 714 (814)
Q Consensus 679 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvv 714 (814)
........||..|+|||.+.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000123469999999999999899999999999999
Q ss_pred HHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHH--ccccCCCCCCCHHHHHH
Q 042262 715 LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIW--CIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 715 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPtm~eV~~ 792 (814)
++||++|+.||......... ........ ..........+.++.+++.+ |+..+|..||++.|+++
T Consensus 238 l~elltG~~Pf~~~~~~~~~------~~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQ------LKVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHH------HHHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 99999999999754322110 11111000 01111122345677778776 66677777999999987
Q ss_pred H
Q 042262 793 M 793 (814)
Q Consensus 793 ~ 793 (814)
.
T Consensus 305 h 305 (381)
T cd05626 305 H 305 (381)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=311.17 Aligned_cols=251 Identities=29% Similarity=0.467 Sum_probs=197.2
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhhhcc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN 603 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 603 (814)
+.||+|+||.||+|.+..++ ....+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 46899999999999987532 23457888886532 33446788999999999 89999999999999999999999999
Q ss_pred CCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeec
Q 042262 604 NGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDF 667 (814)
Q Consensus 604 ~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df 667 (814)
+++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence 99999998643 247889999999999999999995 59999999999999999999999999
Q ss_pred CCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 668 GLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 668 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
|+++....... ......+..|+|||++.+..++.++||||||++++||++ |..||......+ .......
T Consensus 157 gl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~ 226 (270)
T cd05047 157 GLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQ 226 (270)
T ss_pred CCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHHhC
Confidence 99863221111 111223567999999988899999999999999999997 999985432111 1111111
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
+.. ...+...+.++.+++.+|++.+|.+|||+.|+++.|+++++
T Consensus 227 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 227 GYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred CCC---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 111 11122345678999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=311.85 Aligned_cols=263 Identities=20% Similarity=0.302 Sum_probs=208.9
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
.+.||+|+||.||+++-+. .+..+|+|++++..- ...+.++.|-.+|....++.||+|+-.|.+.+..||||||
T Consensus 146 Lk~IgkGAfGeVrLarKk~---Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKD---TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred heeeccccceeEEEEEEcc---CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 4689999999999999875 678999999986432 3345678899999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc-----
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----- 676 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~----- 676 (814)
++||++..+|.....|++.....++.+++-||.-||+ .++|||||||+|+|||..|++||+||||+.-+...
T Consensus 223 lPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 223 LPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred cCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence 9999999999999999999999999999999999995 69999999999999999999999999998543210
Q ss_pred -----------------cccc----c-------------------cccccCCCCccCcccccCCCCCCccchhhHHHHHH
Q 042262 677 -----------------QSKA----I-------------------KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLL 716 (814)
Q Consensus 677 -----------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ 716 (814)
+... . ....+||+.|||||++.+..++..+|.||+|||+|
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Imy 379 (550)
T KOG0605|consen 300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMY 379 (550)
T ss_pred hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHH
Confidence 0000 0 01146999999999999999999999999999999
Q ss_pred HHHhCCcCCcccCCcc-hhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 042262 717 EIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT---MRKVSQ 792 (814)
Q Consensus 717 elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---m~eV~~ 792 (814)
|||.|.+||..+...+ ...+..|.. .+........+.+..+||.+|+. ||++|.- ++||.+
T Consensus 380 EmLvGyPPF~s~tp~~T~rkI~nwr~--------------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 380 EMLVGYPPFCSETPQETYRKIVNWRE--------------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhh--------------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 9999999998776532 222222211 01111223445889999999999 9999975 566655
Q ss_pred H-------HcCCcCCCCCCCCCC
Q 042262 793 M-------LEGVVEVDVPPNPSP 808 (814)
Q Consensus 793 ~-------L~~~~~~~~pp~p~~ 808 (814)
. .+.+.+.+.|=.|..
T Consensus 445 HPfF~~v~W~~l~~~~apfvP~v 467 (550)
T KOG0605|consen 445 HPFFKGVDWDHLREMPAPFVPQV 467 (550)
T ss_pred CCccccCCcchhhcCCCCCCCCC
Confidence 3 245556665544443
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=308.27 Aligned_cols=254 Identities=26% Similarity=0.381 Sum_probs=193.3
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
+.||+|+||.||+|..... .....+++|+++.... .....+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG-YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCC-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 3689999999999987642 2456799998865432 2345788899999999999999999999999999999999999
Q ss_pred CchhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 605 GTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 605 gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999998642 245677888999999999999994 59999999999999999999999999999764433221
Q ss_pred cccccccCCCCccCcccccCC-------CCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNS-------TITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~-------~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
.......++..|+|||++.+. .++.++||||||++++||++ |+.||......+.. . .... +....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~---~~~~-~~~~~ 229 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---T---YTVR-EQQLK 229 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---H---HHhh-cccCC
Confidence 112234567889999998642 35789999999999999996 99999644322110 0 1111 11111
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
...+.. ....++.+.+++..|+ .+|++|||+.||++.|+
T Consensus 230 ~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111 1134566888999999 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=314.68 Aligned_cols=259 Identities=21% Similarity=0.290 Sum_probs=196.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.++||+|+||.||+|.... .+..||+|+++... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECC---CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 4556789999999999998864 46789999986432 2234467889999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++ +|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 9975 888887643 457889999999999999999994 69999999999999999999999999999765432211
Q ss_pred cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc------------
Q 042262 680 AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN------------ 746 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------------ 746 (814)
.....++..|+|||.+.+ ..++.++||||+|++++||++|+.||......+... ........
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 160 --YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH---LIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred --ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHHhhccccc
Confidence 223457899999999865 568999999999999999999999997543322111 11111100
Q ss_pred CCccccccCcccc----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 747 GKLDDLVEGDTEA----MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 747 ~~~~~l~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........+.... ........++.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 001134567889999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.74 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=212.2
Q ss_pred hhhccccccceeEEEEEEEeccC-CcceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTR-TSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~-~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.-.++||+|+||+||||.+...+ .-..+||+|++... ..+...++.+|.-+|.++.||||++|+|+|.... ..||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 33468999999999999987533 22358999998654 3445678999999999999999999999998876 889999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+.|+|.++++.+ ..+..+..+.+..|||+||.|||+ .+++||||.++||||.+-..+||.|||+++.+..+...
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999765 567888899999999999999995 59999999999999999999999999999998876554
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
-......-.+.|||-|.+....++.++|||||||++|||+| |..|++....++ +.+++....+
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~geR 918 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEKGER 918 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhcccc
Confidence 32333334568999999999999999999999999999999 899987554332 2233333334
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
...+..++.++..++..||..|+..||+++|+...+..+
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 556778999999999999999999999999988876543
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.39 Aligned_cols=257 Identities=29% Similarity=0.464 Sum_probs=200.8
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 598 (814)
.+.+.+.||+|+||.||+|.+...+ ....+++|+++... ....+++.+|++++.++ +|+||+++++++.+.+..++|
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCC-ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 3466788999999999999986432 23457888876432 33446788999999999 899999999999999999999
Q ss_pred hhhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCe
Q 042262 599 YEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA 662 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ 662 (814)
+||+++++|.+++... ..+++..++.++.||++||+|||+ .+++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 9999999999998643 247889999999999999999994 699999999999999999999
Q ss_pred EEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHH
Q 042262 663 RISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF 741 (814)
Q Consensus 663 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 741 (814)
||+|||+++....... ......+..|+|||.+.+..++.++||||||++++||++ |..||......+ ..
T Consensus 164 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~ 233 (303)
T cd05088 164 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY 233 (303)
T ss_pred EeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------HH
Confidence 9999999864321111 111224567999999988889999999999999999998 999986432211 11
Q ss_pred HHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 742 DCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 742 ~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
.....+. ....+...+..+.+++.+||+.+|++||++.++++.|+.+.+-
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 234 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHHhcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111 0111223556789999999999999999999999998765543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=312.15 Aligned_cols=256 Identities=29% Similarity=0.413 Sum_probs=199.9
Q ss_pred HhhhhccccccceeEEEEEEEeccC--CcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.+.||+|++|.||+|.+.... .....+++|...... ......+..|+.++++++|+||+++++++.+....++
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence 3455678999999999999986411 135678999886433 2334568999999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCCC-------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC---CeEEeec
Q 042262 598 VYEFLNNGTLASFLFGNL-------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---NARISDF 667 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~Df 667 (814)
||||+++++|.+++.... .+++..+++++.||++||+|||+ .+++|+||||+||++++++ .+||+||
T Consensus 87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999986542 57899999999999999999995 5899999999999998654 5999999
Q ss_pred CCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 668 GLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 668 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
|+++................+..|+|||.+.+..++.++|||||||+++||++ |..||........ ...+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-------~~~~~~ 236 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-------MEFVTG 236 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHc
Confidence 99987633221111112223567999999999999999999999999999997 9999874432211 111111
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
+. ....+...+..+.+++.+|++.+|++||++.||++.|+
T Consensus 237 ~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 GG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11 11123345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=326.72 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=203.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||+||+|.... .++.+|||+++... ......+.+|+.++..++|+||+++++++.+++..++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 4556789999999999999874 46789999986532 23345688999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc-
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ- 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~- 677 (814)
|||+++++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 9999999999999888889999999999999999999994 699999999999999999999999999998765432
Q ss_pred --------------------------cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCc
Q 042262 678 --------------------------SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 731 (814)
Q Consensus 678 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~ 731 (814)
.........||..|+|||.+.+..++.++|||||||+++||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001123356899999999999999999999999999999999999999754321
Q ss_pred chhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 042262 732 EYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT-MRKVSQM 793 (814)
Q Consensus 732 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-m~eV~~~ 793 (814)
. ....+.... ...........+.++.+++..|++ ||.+||+ +.|+++.
T Consensus 237 ~-------~~~~i~~~~------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 E-------TYNKIINWK------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H-------HHHHHhccC------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 111111100 001111111256888999999998 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=319.35 Aligned_cols=244 Identities=25% Similarity=0.306 Sum_probs=196.0
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||.||++.... .+..+|+|+++... ....+.+..|+.++.++ +|+||+++++++.+.+..+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 369999999999999864 46789999997532 22335577888888887 699999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++++|..++.....+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T 152 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence 9999999998877889999999999999999999995 5999999999999999999999999999875322111 1
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||..|+|||.+.+..++.++||||||++++||++|+.||.............+.......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CC
Confidence 23456899999999999999999999999999999999999999754332222222233333322211 11
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTM 787 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm 787 (814)
+...+..+.+++.+||+.||.+||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 22345778899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=308.92 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=204.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||+|.... .+..+|||.++.. .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLL---DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeC---CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 4566889999999999999865 4678999987542 223345688999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 599 YEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
+||+++++|.+++.. ...++......++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999988742 3457889999999999999999995 599999999999999999999999999988765
Q ss_pred ccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
..... .....++..|+|||.+.+..++.++||||||++++||++|+.|+....... ..+. ..+.......
T Consensus 158 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~-~~~~~~~~~~--- 227 (267)
T cd08228 158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLC-QKIEQCDYPP--- 227 (267)
T ss_pred chhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHH-HHHhcCCCCC---
Confidence 33221 123457889999999998889999999999999999999999986433211 1111 1122211111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
......+..+.+++.+||+.+|++||++.||++.|+++
T Consensus 228 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 -----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11224567899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=309.21 Aligned_cols=255 Identities=22% Similarity=0.285 Sum_probs=202.1
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
..+.+.+.||+|+||.||+|.... ++..+|+|++..........+++|+.++.+++|+||+++++.+..++..++|+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLH---TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECC---CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 345667889999999999999864 46789999987554444566888999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++++|.+++.....+++..+..++.|+++||.|||+ .+|+|+||||+||++++++.+||+|||++..+......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 999999999999877788999999999999999999995 59999999999999999999999999999876432211
Q ss_pred cccccccCCCCccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 680 AIKTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.....++..|+|||.+. ...++.++||||||++++||++|+.|+.......... .+.... ...+.
T Consensus 163 --~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~---~~~~~ 230 (267)
T cd06646 163 --RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSN---FQPPK 230 (267)
T ss_pred --cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCC---CCCCC
Confidence 22345788999999984 4457889999999999999999999985332111000 000000 00000
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L 794 (814)
. ......+..+.+++.+||+.+|++|||+++|++.|
T Consensus 231 ~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 L--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1 11224567899999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=318.30 Aligned_cols=242 Identities=29% Similarity=0.365 Sum_probs=193.6
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEee-ccccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||.||+|.... .+..+|||+++... ......+..|..++.. ++||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 368999999999999864 46789999987532 2233445666667665 4899999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++|+|..++.....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-- 152 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc--
Confidence 9999999999887788999999999999999999995 59999999999999999999999999998753322111
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||....... ....+..+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~~----------~~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSIRMDNP----------CY 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC----------CC
Confidence 234568999999999999999999999999999999999999997543211 1111111110 11
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMR-KVSQ 792 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~-eV~~ 792 (814)
+.....++.+++.+||+.||.+||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 223456788999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=313.15 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=190.5
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEee---ccccceeeeeeeec-----c
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQ---THHKNLVRLLGFCD-----E 591 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~---l~H~niv~l~g~~~-----~ 591 (814)
+.+.+.||+|+||.||+|..... .+..+|||+++.... .....+.+|+.+++. ++||||++++++|. .
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCC--CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 45668899999999999987532 357899998864322 222345556665554 47999999999884 3
Q ss_pred CCceehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCC
Q 042262 592 GQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 669 (814)
Q Consensus 592 ~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl 669 (814)
....++|+||+. ++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 5888888643 457899999999999999999995 5999999999999999999999999999
Q ss_pred cccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc---
Q 042262 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN--- 746 (814)
Q Consensus 670 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--- 746 (814)
++...... ......|+..|+|||.+.+..++.++||||||++++||++|+.||......+. + ....+....
T Consensus 157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~--~-~~i~~~~~~~~~ 230 (290)
T cd07862 157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--L-GKILDVIGLPGE 230 (290)
T ss_pred eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH--H-HHHHHHhCCCCh
Confidence 98754331 13345689999999999988999999999999999999999999975433211 1 111111100
Q ss_pred CCccc-------cccCccc---ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 747 GKLDD-------LVEGDTE---AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 747 ~~~~~-------l~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..... ....... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 0000000 0001134567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=319.26 Aligned_cols=242 Identities=24% Similarity=0.331 Sum_probs=196.4
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||+||+|.+.. .+..+|||+++... ......+..|++++..+ +||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 368999999999999864 46789999987532 22334567787888777 799999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++++|..++.....+++..+..++.||++||+||| +.+|+||||||+||++++++.+||+|||+++........
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-- 152 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--
Confidence 999999999988888999999999999999999999 469999999999999999999999999998753222211
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....|+..|+|||.+.+..++.++|||||||+++||++|+.||....... ....+..+.. ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~~----------~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDEV----------RY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCC----------CC
Confidence 233468999999999999999999999999999999999999996443211 1111112111 11
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTM-----RKVSQ 792 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm-----~eV~~ 792 (814)
+...+..+.+++.+||+.||.+||++ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 22456788999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=318.98 Aligned_cols=264 Identities=28% Similarity=0.410 Sum_probs=206.5
Q ss_pred HHHHHhhhhccccccceeEEEEEEEeccC----CcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeeec
Q 042262 517 LEEATDNFEEEVGRGSFGIVYKGVIQTTR----TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCD 590 (814)
Q Consensus 517 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~----~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 590 (814)
+....+.+.+.||+|+||.||++...... .....+|+|.++... .....++.+|++++..+ +|+||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 33456778889999999999999875321 123579999987532 23345688899999999 7999999999999
Q ss_pred cCCceehhhhhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 042262 591 EGQNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 654 (814)
Q Consensus 591 ~~~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NI 654 (814)
+.+..++||||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+++|+||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHhe
Confidence 999999999999999999998643 247889999999999999999994 5999999999999
Q ss_pred EECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcch
Q 042262 655 LLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY 733 (814)
Q Consensus 655 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~ 733 (814)
++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||.....++
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~- 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-
Confidence 999999999999999986543221111122224568999999999899999999999999999998 888885432111
Q ss_pred hhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 734 AILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 734 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.......+.. ...+...+.++.+++.+|++.+|.+||||.||++.|+.++.
T Consensus 251 ------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 251 ------LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred ------HHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 1122222211 11223456788999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=336.26 Aligned_cols=251 Identities=25% Similarity=0.315 Sum_probs=201.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCC-----
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----- 593 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 593 (814)
.+.+.+.||+|+||+||++.... +++.+|||+++.. .......+.+|+.++..++|+||+++...+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVS---DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcC---CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 55677899999999999998764 5678999998643 2333456888999999999999999988764332
Q ss_pred ---ceehhhhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEee
Q 042262 594 ---NRLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISD 666 (814)
Q Consensus 594 ---~~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 666 (814)
..++||||+++|+|.+++.. ...+++.....|+.|+++||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 25799999999999998864 246789999999999999999999 46999999999999999999999999
Q ss_pred cCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 667 FGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
||+++.+.............||..|+|||.+.+..++.++||||||+++|||++|+.||...... . .......
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~-~~~~~~~ 259 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------E-VMHKTLA 259 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHhc
Confidence 99998765433333234567999999999999999999999999999999999999999644221 1 1111222
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+.... .+...+.++.+++..||+.||.+||++.++++.
T Consensus 260 ~~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 22111 123456789999999999999999999999763
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=321.28 Aligned_cols=263 Identities=27% Similarity=0.382 Sum_probs=202.3
Q ss_pred HHHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeeeccC-C
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG-Q 593 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 593 (814)
...+.+.+.||+|+||.||+|.... ....++.||||+++... ......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 4567788999999999999998642 12356789999997532 22345688899999999 789999999988654 4
Q ss_pred ceehhhhhccCCchhhhhcCC-----------------------------------------------------------
Q 042262 594 NRLLVYEFLNNGTLASFLFGN----------------------------------------------------------- 614 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~----------------------------------------------------------- 614 (814)
..++|+||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999987532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccccccc
Q 042262 615 --------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR 686 (814)
Q Consensus 615 --------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 686 (814)
..+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 135778888999999999999994 699999999999999999999999999998754332211122234
Q ss_pred CCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhH
Q 042262 687 GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKC 765 (814)
Q Consensus 687 gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 765 (814)
++..|+|||.+.+..++.++||||||++++||++ |..|+........ .......+.... .+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~~---------~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMR---------APDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCCC---------CCCCC
Confidence 5678999999998899999999999999999997 8888864322111 111222222111 11123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 766 TEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 766 ~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
+.++.+++..||+.+|.+|||+.||++.|+.+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4678999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.78 Aligned_cols=265 Identities=25% Similarity=0.431 Sum_probs=207.2
Q ss_pred HhhhhccccccceeEEEEEEEecc-CCcceEEEEEeecccccc-chhhhhceeeEEeeccccceeeeeeeecc--CCcee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTT-RTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRL 596 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~-~~~~~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 596 (814)
...+.+.||+|+||.||+|.+... ...+..+|||.++..... ..+++.+|+++++.++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 445668899999999999997632 335678999999765332 46789999999999999999999999877 56789
Q ss_pred hhhhhccCCchhhhhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 597 LVYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999997654 68999999999999999999995 5999999999999999999999999999987763
Q ss_pred cccc-cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchh--------hHHHHHHHHHhc
Q 042262 676 NQSK-AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--------ILTDWAFDCYRN 746 (814)
Q Consensus 676 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~--------~l~~~~~~~~~~ 746 (814)
.... .......++..|+|||.+.+..++.++||||||++++||++|+.|+......... .......+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 3221 1111223456799999999889999999999999999999999998643221100 000111111111
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
+ .....+..++.++.+++.+||+.+|.+||||.||+++|+.+
T Consensus 242 ~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 G---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred C---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1 11112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=317.74 Aligned_cols=241 Identities=27% Similarity=0.334 Sum_probs=193.1
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEee-ccccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||.||+|.... .+..+|+|.++... ......+..|..++.. .+|+||+++++++.+.+..+|||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 469999999999999874 56789999987532 2233455667767665 4899999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++|+|..++.....+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R 152 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence 9999999999887788999999999999999999994 6999999999999999999999999999875322211 1
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||..|+|||.+.+..++.++||||||++++||++|+.||....... ..+.+..+. + ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-------~~~~~~~~~------~----~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-------LFESIRVDT------P----HY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC------C----CC
Confidence 234568999999999999999999999999999999999999996443211 111221111 0 11
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMR-KVS 791 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~-eV~ 791 (814)
+...+.++.+++..||+.||.+||++. ++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 223457788999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=320.70 Aligned_cols=267 Identities=28% Similarity=0.417 Sum_probs=208.5
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEeccC----CcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeee
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTR----TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFC 589 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~----~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 589 (814)
++...++.+.+.||+|+||.||++...... .....+|+|.++... ....+++.+|++++.++ +|+||++++++|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 344556778899999999999999864321 123478999886432 23346789999999999 799999999999
Q ss_pred ccCCceehhhhhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 042262 590 DEGQNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 653 (814)
Q Consensus 590 ~~~~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~N 653 (814)
.+++..++|+||+++|+|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccce
Confidence 9999999999999999999998642 347888999999999999999995 699999999999
Q ss_pred EEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcc
Q 042262 654 ILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 732 (814)
Q Consensus 654 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~ 732 (814)
|++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||.....++
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986643322111222334567999999999999999999999999999998 888885432211
Q ss_pred hhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCC
Q 042262 733 YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801 (814)
Q Consensus 733 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~ 801 (814)
....+..+... ..+...+.++.+++.+|++.+|.+||+|.|+++.|+.+....
T Consensus 245 -------~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 -------LFKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -------HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11222222111 112245678999999999999999999999999998877443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=313.53 Aligned_cols=260 Identities=22% Similarity=0.278 Sum_probs=193.5
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.+.||+|+||.||+|.... .++.+|||+++.... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKV---NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECC---CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4566889999999999999864 467899999865432 223457789999999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+. ++|.+++.. ...++...+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 996 566666654 3568889999999999999999994 69999999999999999999999999998754322211
Q ss_pred cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC---------c
Q 042262 680 AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---------L 749 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------~ 749 (814)
.....++..|+|||.+.+ ..++.++||||+||+++||++|+.||....... ..+ ......+.... .
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 160 --YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-DQL-ERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred --CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHH-HHHHHHhCCCChhhccchhhc
Confidence 233457899999999865 458899999999999999999999997543211 011 11111110000 0
Q ss_pred cccccCcccc---------cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 750 DDLVEGDTEA---------MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 750 ~~l~~~~~~~---------~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.......... ......+..+.+++..||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000 001123357889999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=304.52 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=197.6
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
+.||+|+||.||+|.+. ++..+|+|.+..... .....+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~----~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec----CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 46899999999999865 456899999865432 2234688999999999999999999999999999999999999
Q ss_pred CchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccc
Q 042262 605 GTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT 683 (814)
Q Consensus 605 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 683 (814)
++|.+++... ..+++..+..++.|++.+|.|||+ .+++|+||||+||++++++.+||+|||++.......... ..
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SG 152 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-CC
Confidence 9999988653 457899999999999999999994 599999999999999999999999999987644322111 11
Q ss_pred cccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 684 ~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
...++..|+|||++.+..++.++||||||++++|+++ |..||....... .......+. ....+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~~~ 216 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGY---------RMSCP 216 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCC---------CCCCC
Confidence 2234568999999998899999999999999999998 999986432211 111111111 11112
Q ss_pred hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 345688999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=323.30 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=194.4
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.||+|+||+||++.... .+..+|||+++... ......+.+|+.++.+++|+||+++++.+.+....+|||
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKD---TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 456789999999999998764 46789999986532 223356788999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++|+|.+++.....+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 99999999999988888999999999999999999999 469999999999999999999999999998765321100
Q ss_pred ---------------------------------cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCc
Q 042262 680 ---------------------------------AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 726 (814)
Q Consensus 680 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~ 726 (814)
.......||..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123469999999999999999999999999999999999999997
Q ss_pred ccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHcc--ccCCCCCCCHHHHHHH
Q 042262 727 IEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCI--QEDPSLRPTMRKVSQM 793 (814)
Q Consensus 727 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl--~~dP~~RPtm~eV~~~ 793 (814)
.....+ ....+..... .+..+ ......+++.+++.+++ ..++..||+++||++.
T Consensus 238 ~~~~~~-------~~~~i~~~~~-~~~~p-----~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQE-------TYKKVMNWKE-TLIFP-----PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHH-------HHHHHHcCcC-cccCC-----CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 543211 1111111110 01001 01123456666666533 3344467999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=306.79 Aligned_cols=254 Identities=26% Similarity=0.481 Sum_probs=196.2
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeec-cCCceehhhhhcc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCD-EGQNRLLVYEFLN 603 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~~~ 603 (814)
+.||+|+||.||+|.+.........+|+|++.... ....+.+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999986544456789999985432 233467888999999999999999999875 4556889999999
Q ss_pred CCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc--
Q 042262 604 NGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA-- 680 (814)
Q Consensus 604 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-- 680 (814)
+++|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999998754 456788889999999999999995 599999999999999999999999999998654321111
Q ss_pred ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCC-cCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
......++..|+|||.+.+..++.++||||||++++||++|. .|+...... .+ .. ....+.. .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~---~~-~~~~~~~---------~ 221 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DI---TV-YLLQGRR---------L 221 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HH---HH-HHhcCCC---------C
Confidence 012234567899999999889999999999999999999964 555432111 11 11 1111111 0
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
..+...+..+.+++..||+.+|++||++.||++.|+.+.
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 112234568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=307.75 Aligned_cols=255 Identities=21% Similarity=0.335 Sum_probs=204.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||++.... ++..++||.+.... .....++.+|+.+++.++|+||+++++++.+++..+++
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecC---CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 4566889999999999999764 46789999875422 22345788999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 599 YEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
|||+++++|.+++.. ...+++..+..++.||++||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999999999998853 3567999999999999999999994 599999999999999999999999999988664
Q ss_pred ccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
..... .....++..|+|||.+.+..++.++||||||++++||++|..||.....+. . .. .........
T Consensus 158 ~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~---~~-~~~~~~~~~----- 225 (267)
T cd08229 158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-Y---SL-CKKIEQCDY----- 225 (267)
T ss_pred cCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-H---HH-hhhhhcCCC-----
Confidence 33211 223458889999999999899999999999999999999999986432211 0 11 111111110
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
........++.+.+++.+||+.+|++||||.+|+++++++
T Consensus 226 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 226 ---PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1111224667899999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=313.17 Aligned_cols=265 Identities=23% Similarity=0.385 Sum_probs=201.9
Q ss_pred HHhhhhccccccceeEEEEEEEec-------------cCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeee
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQT-------------TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRL 585 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~-------------~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l 585 (814)
..+.+.+.||+|+||.||++.... .......+|+|++.... .....++.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 345677889999999999986432 11234579999987542 3345678999999999999999999
Q ss_pred eeeeccCCceehhhhhccCCchhhhhcCC-----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 042262 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGN-----------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 654 (814)
Q Consensus 586 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NI 654 (814)
++++...+..++||||+++++|.+++... ..+++.....++.|++.||+|||+ .+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 99999999999999999999999998643 236778899999999999999995 5999999999999
Q ss_pred EECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh--CCcCCcccCCcc
Q 042262 655 LLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEE 732 (814)
Q Consensus 655 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt--G~~p~~~~~~~~ 732 (814)
++++++.+||+|||+++.+.............++..|+|||...++.++.++||||||+++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986643322211222334678999999888899999999999999999998 667775432211
Q ss_pred hhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 733 YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 733 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
. ................ ...+..++..+.+++.+||+.||.+||+|.||++.|++
T Consensus 242 ~---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 V---IENTGEFFRDQGRQVY------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHhhcccccc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 0111111111110000 11123456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.35 Aligned_cols=242 Identities=23% Similarity=0.365 Sum_probs=189.5
Q ss_pred cccccceeEEEEEEEeccC---------------------CcceEEEEEeeccccccchhhhhceeeEEeeccccceeee
Q 042262 527 EVGRGSFGIVYKGVIQTTR---------------------TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~---------------------~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l 585 (814)
.||+|+||.||+|.+.... .....|++|++.........++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5899999999999874311 1234689999876544445678889999999999999999
Q ss_pred eeeeccCCceehhhhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC----
Q 042262 586 LGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---- 660 (814)
Q Consensus 586 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~---- 660 (814)
+++|.+....+|||||+++|+|..++.. ...+++..+..++.||++||+|||+ .+|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999865 4568999999999999999999994 5999999999999997643
Q ss_pred ---CeEEeecCCcccccccccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHH-hCCcCCcccCCcchhh
Q 042262 661 ---NARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEII-SCRKSFDIEMGEEYAI 735 (814)
Q Consensus 661 ---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~ell-tG~~p~~~~~~~~~~~ 735 (814)
.+||+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......+..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~- 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE- 231 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-
Confidence 3799999987643221 12246788999999875 56899999999999999995 689988644322111
Q ss_pred HHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 736 LTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 736 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
. ...... .. +......+.+++.+||+.+|++||||.+|++.|.
T Consensus 232 --~----~~~~~~-------~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 --R----FYEKKH-------RL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --H----HHHhcc-------CC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 111000 00 1112356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.22 Aligned_cols=242 Identities=24% Similarity=0.377 Sum_probs=191.0
Q ss_pred ccccccceeEEEEEEEeccC---------CcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 526 EEVGRGSFGIVYKGVIQTTR---------TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~---------~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
+.||+|+||.||+|.+.... .....+++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 46899999999999875321 123468999887654445567888999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC-------eEEeecC
Q 042262 597 LVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN-------ARISDFG 668 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~-------~kl~DfG 668 (814)
+||||+++++|..++.. ...+++..++.++.||++||+||| +.+|+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999998875 356899999999999999999999 469999999999999987654 8999999
Q ss_pred CcccccccccccccccccCCCCccCccccc-CCCCCCccchhhHHHHHHHHH-hCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 669 LAKLLTLNQSKAIKTAIRGTKGYVAPEWFR-NSTITAKVDVYSFGVLLLEII-SCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 669 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~S~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
++...... ....++..|+|||.+. +..++.++||||||+++|||+ .|+.|+......+. .....
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--------~~~~~ 223 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--------ERFYE 223 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--------HHHHh
Confidence 98765322 2234788999999987 467899999999999999998 58888754321110 01111
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L 794 (814)
+... . ......++.+++.+||+.||.+||++.||++.|
T Consensus 224 ~~~~-~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQCM-L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCcc-C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1110 0 112346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.31 Aligned_cols=247 Identities=27% Similarity=0.377 Sum_probs=202.6
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.||+|++|.||+|.... .+..+++|.+... .....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcC---CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 456789999999999999864 4678999988532 23445678899999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 601 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 601 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||||+||++++++.+||+|||+++.+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999998764 568899999999999999999994 5999999999999999999999999999887654322
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. .....|+..|+|||++.+..++.++||||||++++||++|+.||....... .......+....
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~------- 220 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-------LILKIIRGVFPP------- 220 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCC-------
Confidence 1 233457889999999999999999999999999999999999997543211 111122222111
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.+...+..+.+++.+||+.+|++||+|.|+++.
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 --VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 112456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=305.95 Aligned_cols=247 Identities=29% Similarity=0.435 Sum_probs=203.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||+|... +..+++|.++.... ..+++.+|+.+++.++|+||+++++++.+....++|||
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~-----~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR-----GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hccceeeeecCCCceEEEEEec-----CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 4566788999999999999864 56799999976543 46788999999999999999999999999999999999
Q ss_pred hccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 601 FLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999999997654 68999999999999999999994 5999999999999999999999999999987643221
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
....+..|+|||.+.+..++.++||||||++++|+++ |+.||....... .......+..
T Consensus 158 -----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~-------- 217 (256)
T cd05039 158 -----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYR-------- 217 (256)
T ss_pred -----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCC--------
Confidence 2234668999999998899999999999999999998 999986442211 1111111111
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
...+...++.+.+++.+||+.+|++||+++|++++|+.+
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 -MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 111224568899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.00 Aligned_cols=251 Identities=30% Similarity=0.454 Sum_probs=199.7
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
..+.+.+.||+|++|.||+|.+.. ...+++|.+.... ...+.+.+|+.++++++|+|++++++++.. +..++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG----TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC----CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEE
Confidence 446677889999999999998763 3468999876432 334678899999999999999999998854 5688999
Q ss_pred hhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||+++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999753 357899999999999999999995 589999999999999999999999999998764332
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
... .....++..|+|||.+.+..++.++||||||++++||++ |+.||......+ .......+..
T Consensus 157 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~------- 221 (260)
T cd05069 157 YTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQVERGYR------- 221 (260)
T ss_pred ccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence 211 122345678999999998899999999999999999999 899886432211 1111111110
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
...+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 --MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01123456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=288.64 Aligned_cols=246 Identities=26% Similarity=0.387 Sum_probs=203.0
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeecccccc--------chhhhhceeeEEeec-cccceeeeeeeeccCCce
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--------GEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--------~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 595 (814)
.+.||+|..++|.+..++. .+...|+|++...... -.++-..|+.+|+++ .||+|+++.++++.+.-.
T Consensus 22 keilgrgvss~vrRci~k~---t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKE---TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred HHHhcccchhhhhhhhhcc---cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 4679999999999998875 4667888888643211 123457789999997 699999999999999999
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
++|+|.|+.|.|.++|.+...++++...+|++|+.+|+.||| ..+|+||||||+|||+|++.++||+|||.+..+.+
T Consensus 99 FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 999999999999999999999999999999999999999999 56999999999999999999999999999998876
Q ss_pred cccccccccccCCCCccCccccc------CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCc
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFR------NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 749 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 749 (814)
+.. ....+||++|+|||.+. ...|+...|+|+.||++|.|+.|.+||-... + -.....+.+|..
T Consensus 176 Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk----Q---mlMLR~ImeGky 245 (411)
T KOG0599|consen 176 GEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK----Q---MLMLRMIMEGKY 245 (411)
T ss_pred chh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH----H---HHHHHHHHhccc
Confidence 654 45678999999999984 3358889999999999999999999995321 0 112233334432
Q ss_pred cccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 750 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
. .....-.+.++...+|+.+|||.||.+|-|++|+++
T Consensus 246 q------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 246 Q------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred c------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 2 112223466788999999999999999999999876
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=317.64 Aligned_cols=241 Identities=26% Similarity=0.318 Sum_probs=193.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccc-cceeeeeeeeccCCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~l 597 (814)
+.+.+.||+|+||.||+|.... .+..+|||+++... ....+.+..|++++..++| ++|+++++++.+.+..++
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 3456789999999999999764 45789999986532 2334567788888888866 568889999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+++|+|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 99999999999999888888999999999999999999995 599999999999999999999999999987532221
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.. .....||..|+|||++.+..++.++||||||++++||++|+.||......+ ....+.....
T Consensus 156 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~~-------- 218 (324)
T cd05587 156 KT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHNV-------- 218 (324)
T ss_pred Cc--eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC--------
Confidence 11 234568999999999999999999999999999999999999997543211 1111111111
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTM 787 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 787 (814)
..+...+.++.+++.+||+.||.+||+.
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 --SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1122456788999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.87 Aligned_cols=245 Identities=27% Similarity=0.324 Sum_probs=195.2
Q ss_pred ccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
||+|+||+||++.... .++.+|+|.+..... ...+.+..|+++++.++|+||+++.+++..+...++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEcc---CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 7999999999998864 467899999864322 1234577899999999999999999999999999999999999
Q ss_pred CchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 605 GTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 605 gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
|+|..++.. ...+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||++..+......
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~- 153 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK- 153 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-
Confidence 999887742 3568999999999999999999995 59999999999999999999999999999866543221
Q ss_pred ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~ 760 (814)
.....||..|+|||.+.+..++.++||||||++++||++|+.||........ ... ...... ... ..
T Consensus 154 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~~--------~~~--~~ 219 (280)
T cd05608 154 -TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKE-LKQRIL--------NDS--VT 219 (280)
T ss_pred -ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHH-HHHhhc--------ccC--CC
Confidence 2345689999999999999999999999999999999999999975432110 000 011110 110 01
Q ss_pred CChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042262 761 NDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQM 793 (814)
Q Consensus 761 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~~ 793 (814)
.+...+..+.+++..||+.||++|| +++|+++.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 2234667899999999999999999 77777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.65 Aligned_cols=250 Identities=26% Similarity=0.331 Sum_probs=199.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
++..+.||+|+||.||++.... .+..+|||++.... ......+.+|+.++++++|+||+++++.+.+++..++|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcC---CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 3455789999999999999764 46789999986432 12234577899999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 599 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||+++++|.+++... ..+++..+..++.|+++||.|||+ .+|+|+||||+||++++++.++|+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999999887543 468999999999999999999995 59999999999999999999999999999875432
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.. .....|+..|+|||.+.+..++.++||||||++++|+++|+.||......... ......+..+.
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~-------- 221 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ-------- 221 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc--------
Confidence 21 22346899999999999889999999999999999999999999754321110 11111111111
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQM 793 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~~ 793 (814)
...+...+..+.+++..||+.||.+|| +++++++.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 112234667889999999999999999 88888663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=316.62 Aligned_cols=244 Identities=25% Similarity=0.312 Sum_probs=192.7
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceee---EEeeccccceeeeeeeeccCCcee
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVV---VIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
.+.+.||+|+||.||+|.... .++.+|||+++... ....+.+..|++ .++.++||||+++++++.+++..+
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred eEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 356789999999999998864 56789999996532 122344555544 456778999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
+||||+++++|..++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 99999999999988765 468999999999999999999994 69999999999999999999999999998754322
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ....+..+..
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~~------- 218 (324)
T cd05589 155 GDR--TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-------VFDSIVNDEV------- 218 (324)
T ss_pred CCc--ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC-------
Confidence 111 234568999999999999999999999999999999999999997543211 1111111111
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~ 792 (814)
..+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 12234567889999999999999999 4666555
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=316.50 Aligned_cols=261 Identities=28% Similarity=0.417 Sum_probs=203.7
Q ss_pred HHHhhhhccccccceeEEEEEEEec----cCCcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeeeccC
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQT----TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG 592 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~----~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 592 (814)
...+.+.++||+|+||.||++.... .......+|+|.++... .....++.+|++++.++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 3455677899999999999998642 11234579999887532 22345688899999998 699999999999999
Q ss_pred CceehhhhhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 042262 593 QNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 656 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll 656 (814)
...++|+||+++|+|.+++... ..+++..+.+++.||+.||.|||+ .+++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 9999999999999999998542 347889999999999999999994 599999999999999
Q ss_pred CCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhh
Q 042262 657 DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI 735 (814)
Q Consensus 657 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 735 (814)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999987643222111112224467999999999899999999999999999999 888885432211
Q ss_pred HHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 736 LTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 736 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.......+... ..+..++.++.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 245 ----~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 ----LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ----HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 12222222111 112345678889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=324.29 Aligned_cols=251 Identities=21% Similarity=0.271 Sum_probs=198.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||+||++.... .++.+|||++.... ......+.+|+.++..++|+||+++++++.+++..+||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 3456789999999999999874 46789999996532 22345678899999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999999888889999999999999999999994 5999999999999999999999999999876532211
Q ss_pred cc------------------------------------ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCC
Q 042262 679 KA------------------------------------IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCR 722 (814)
Q Consensus 679 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~ 722 (814)
.. ......||..|+|||++.+..++.++|||||||+++||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 011245899999999999999999999999999999999999
Q ss_pred cCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 042262 723 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT---MRKVSQ 792 (814)
Q Consensus 723 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---m~eV~~ 792 (814)
.||....... ....+.... ...........++++.+++.+|+. +|.+|++ +.|+++
T Consensus 237 ~Pf~~~~~~~-------~~~~i~~~~------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQE-------TYRKIINWK------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHH-------HHHHHHcCC------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9997543211 011111111 001111112345778889999996 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=312.18 Aligned_cols=257 Identities=27% Similarity=0.436 Sum_probs=202.4
Q ss_pred HhhhhccccccceeEEEEEEEecc--CCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.+.||+|+||.||++..... +.....+|+|.+.... ....+++.+|+.++++++||||+++++++.++...++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 345567899999999999987531 2246789999986542 2334678999999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 042262 598 VYEFLNNGTLASFLFGN----------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNIL 655 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIl 655 (814)
|+||+++++|.+++... ..+++..++.++.|+++||+|||+ .+++||||||+||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheE
Confidence 99999999999998532 246788899999999999999995 59999999999999
Q ss_pred ECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchh
Q 042262 656 LDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA 734 (814)
Q Consensus 656 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 734 (814)
+++++.+||+|||+++................+..|+|||.+.+..++.++||||||++++||++ |..||......+
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~-- 240 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE-- 240 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999876543221111122234667999999998899999999999999999998 888875332211
Q ss_pred hHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 735 ILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 735 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
....+..+.... .+...+.++.+++.+||+.+|.+|||+.|+++.|+.
T Consensus 241 -----~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -----VIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 112222332211 122456789999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.60 Aligned_cols=254 Identities=31% Similarity=0.489 Sum_probs=204.4
Q ss_pred HHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
....+.+.++||+|+||.||+|.+. ....++||.+.... ...+++.+|+.++++++|+||+++++++.+....++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~----~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN----GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc----CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 3445667789999999999999875 34679999987532 345679999999999999999999999999899999
Q ss_pred hhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 598 VYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.+..
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999999764 468999999999999999999995 5899999999999999999999999999987653
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
..... ......+..|+|||.+.+..++.++||||||++++|+++ |+.||....... .......+.
T Consensus 156 ~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~------ 221 (261)
T cd05034 156 DEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-------VLEQVERGY------ 221 (261)
T ss_pred hhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC------
Confidence 22111 122234568999999998899999999999999999999 999985432211 111111110
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
....+...+.++.+++.+|++.+|++||+++|+.+.|+.
T Consensus 222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 ---RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011122346789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=321.37 Aligned_cols=250 Identities=22% Similarity=0.251 Sum_probs=200.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||+||++.... .+..+|+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..+||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 4556789999999999999864 56789999997532 22345688999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||+++++|.+++... ..+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999999775 678999999999999999999994 699999999999999999999999999998765433
Q ss_pred cccccccccCCCCccCccccc------CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFR------NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~------~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
.. ......||..|+|||.+. ...++.++||||||++++||++|+.||....... ............
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~- 228 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFL- 228 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCcc-
Confidence 22 123346899999999986 4567899999999999999999999997543211 111111111111
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........+..+.+++..|++ +|.+|||+.++++
T Consensus 229 ------~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 ------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 111122456788899999998 9999999999886
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.85 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=196.8
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
.+.+.||+|+||.||+|.... .+..+|+|.+... .....+++.+|++++.+++||||+++++++...+..++|+||
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLL---TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred hheeeeccCCCeEEEEEEEcC---CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 456789999999999998764 4678999998643 233346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++++|..+ ..+++.....++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---- 149 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---- 149 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----
Confidence 999999765 346788889999999999999994 699999999999999999999999999998654321
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....++..|+|||.+.+..++.++||||||++++||++|+.||........................ ....
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 221 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--------PVLP 221 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--------CCCC
Confidence 23456899999999999989999999999999999999999999654322111110011111111111 1111
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
....+.++.+++.+|++.+|++||+++|+++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 22345678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=323.22 Aligned_cols=264 Identities=20% Similarity=0.223 Sum_probs=201.4
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
...+.+.+.||+|+||.||++..... .....|+||.+... +...+|+++++.++|+||+++++++......++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~-~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCC-ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 34567778999999999999976532 24678999987542 3456799999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||++. ++|.+++.....+++..++.|+.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99985 6888888767789999999999999999999995 5999999999999999999999999999987654433
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcc-hhhHHHHHHHHHhcCCccc------
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDD------ 751 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~------ 751 (814)
........||..|+|||++.+..++.++|||||||++|||++|+.||....... ...+.. +...+.......
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~-i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS-IIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH-HHHHhccCccccCCccch
Confidence 222334569999999999999999999999999999999999999996543221 111111 111111000000
Q ss_pred --------c---ccCcc---cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 752 --------L---VEGDT---EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 752 --------l---~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
. ..+.. ..........++.+++.+||+.||++|||+.|++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00000 000011335678889999999999999999999875
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.11 Aligned_cols=263 Identities=21% Similarity=0.321 Sum_probs=201.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.+.||+|+||.||++.... .+..+++|.+.... .....++.+|++++.+++||||+++++++.+++..++|+|
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRP---SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcC---CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 3456789999999999998764 45678999886432 2234568899999999999999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
|+++++|.+++.....+++..+..++.|+++||+|||+ ..+++|+||||+||++++++.+||+|||++.......
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 99999999999887888999999999999999999995 2489999999999999999999999999987654321
Q ss_pred ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC-C-----------
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG-K----------- 748 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~----------- 748 (814)
.....++..|+|||.+.+..++.++||||||++++||++|+.||...................... .
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 233468899999999988889999999999999999999999986432211000000000000000 0
Q ss_pred ---------ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 749 ---------LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 749 ---------~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
...+............++.++.+++.+||+.+|++|||++||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000111245679999999999999999999999885
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=316.45 Aligned_cols=240 Identities=26% Similarity=0.328 Sum_probs=193.1
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeec-cccceeeeeeeeccCCceehh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 598 (814)
.+.+.||+|+||.||+|.... .+..+|||.++... ....+.+..|..++..+ +|++|+++++++.+.+..++|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 456789999999999999864 46789999987532 12233456677777666 689999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+.+.....+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 9999999999999887889999999999999999999994 5999999999999999999999999999975432221
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. .....||..|+|||.+.+..++.++|||||||++|||++|+.||....... + ...+.....
T Consensus 157 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~----~~~i~~~~~--------- 218 (323)
T cd05616 157 T--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L----FQSIMEHNV--------- 218 (323)
T ss_pred c--cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---H----HHHHHhCCC---------
Confidence 1 234568999999999999999999999999999999999999997543211 1 111111111
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTM 787 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 787 (814)
..+...+.++.+++.+|++.||.+|++.
T Consensus 219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1123456788999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=311.29 Aligned_cols=266 Identities=26% Similarity=0.385 Sum_probs=205.7
Q ss_pred HHHhhhhccccccceeEEEEEEEec-cCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccC--Cc
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QN 594 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~ 594 (814)
+.++...+.||+|+||.||++.... ....+..+|+|.++... ......+.+|+.+++.++|+||+++++++.+. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3455667889999999999998653 23356789999987542 33346789999999999999999999998775 56
Q ss_pred eehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 595 RLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.+
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 88999999999999998654 458999999999999999999995 59999999999999999999999999999876
Q ss_pred cccccc-cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCc---------chhhHHHHHHHH
Q 042262 674 TLNQSK-AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE---------EYAILTDWAFDC 743 (814)
Q Consensus 674 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~~~~~ 743 (814)
...... .......++..|+|||.+.+..++.++||||||++++||++++.|....... ..... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV-TRLVRV 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH-HHHHHH
Confidence 543221 1122345677899999999889999999999999999999987765322110 00000 111111
Q ss_pred HhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 744 YRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 744 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
...+.. ...+..++..+.+++.+||+.+|.+|||+.+|++.|+++
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111 111234668899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.56 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=199.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccc-eeeeeeeeccCC-----
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKN-LVRLLGFCDEGQ----- 593 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~----- 593 (814)
+...++||+|.||+||+|+... .+..||+|+++-..+ .......+|+.++++++|+| |++|++++...+
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~---~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKR---TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEec---CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3444679999999999999986 568999999975433 23455689999999999999 999999998877
Q ss_pred -ceehhhhhccCCchhhhhcCCC----CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecC
Q 042262 594 -NRLLVYEFLNNGTLASFLFGNL----KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 668 (814)
Q Consensus 594 -~~~lV~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfG 668 (814)
..+||+||+. -+|..++.... .++...++.++.||++||+||| +.+|+||||||+||||++++.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 7889999984 48888876533 4677889999999999999999 5699999999999999999999999999
Q ss_pred CcccccccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc-
Q 042262 669 LAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN- 746 (814)
Q Consensus 669 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~- 746 (814)
+|+........ .+..++|..|+|||++.+. .|+...||||+||++.||++++..|......+. + ..+.+.+..
T Consensus 166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l-~~If~~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--L-FRIFRLLGTP 240 (323)
T ss_pred hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--H-HHHHHHcCCC
Confidence 99976533322 3456789999999999887 799999999999999999999998876654221 1 222333221
Q ss_pred --CCccccc---cCcc--cccC-C-------hhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 747 --GKLDDLV---EGDT--EAMN-D-------IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 747 --~~~~~l~---~~~~--~~~~-~-------~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
...+.+. +... .... + ........+++.+||+.+|.+|.|++..+++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111111 1111 0000 1 1112478899999999999999999999885
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=322.05 Aligned_cols=260 Identities=26% Similarity=0.343 Sum_probs=197.9
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCC-----ce
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----NR 595 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~ 595 (814)
.+.+.||+|+||.||++.... .++.||||++.... ....+++.+|+++++.++|+||+++++++.... ..
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPR---DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred cccceeeeCCCEEEEEEEECC---CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 345789999999999999754 56789999986532 223467889999999999999999999998776 78
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
++|+||+. ++|.+.+.....+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99999986 5788888777889999999999999999999994 6999999999999999999999999999987654
Q ss_pred cccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc---
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD--- 751 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~--- 751 (814)
..... .....++..|+|||.+.+. .++.++|||||||+++||++|+.||......... ..+.+........+
T Consensus 156 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 156 DESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL---DLITDLLGTPSLEAMRS 231 (372)
T ss_pred Ccccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCHHHHHH
Confidence 33222 2334578899999999875 4799999999999999999999999754322111 00111000000000
Q ss_pred --------cc----cCc-cc--ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 752 --------LV----EGD-TE--AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 752 --------l~----~~~-~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+. .+. .. .......++++.+++.+||+.||.+|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 000 00 00112346788999999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.74 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=206.1
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
...+.+.+.||+|+||.||+|.+.........++||...... ....+.+.+|+.+++.++|+||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 344567789999999999999986543344579999886543 3345678999999999999999999999876 45789
Q ss_pred hhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
||||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999999764 458999999999999999999994 59999999999999999999999999999876543
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.... .+...++..|+|||.+....++.++||||||++++|+++ |..||......+. ...+..+...
T Consensus 161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~~~~----- 227 (270)
T cd05056 161 SYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-------IGRIENGERL----- 227 (270)
T ss_pred ccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHcCCcC-----
Confidence 2211 122234568999999988889999999999999999996 9999864432211 1112222111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
..+..++..+.+++.+|+..+|.+|||+.|+++.|+++..
T Consensus 228 ----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 ----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1123456789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=316.79 Aligned_cols=238 Identities=24% Similarity=0.277 Sum_probs=190.0
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceee-EEeeccccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVV-VIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||.||+|.... .+..+|+|++.... .....++..|.. +++.++||||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence 469999999999999864 56789999986432 122334555544 56788999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++++|..++.....++......++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T 152 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence 9999999998877788899999999999999999994 6999999999999999999999999999875322211 1
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||...... . ..+.+..+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~-~~~~i~~~~~----------~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------Q-MYDNILHKPL----------QL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------H-HHHHHhcCCC----------CC
Confidence 23456899999999999999999999999999999999999999654211 1 1111111111 11
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMR 788 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~ 788 (814)
+......+.+++.+||+.||.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 224567889999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.19 Aligned_cols=258 Identities=23% Similarity=0.309 Sum_probs=206.7
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
...+++.+.||+|+||+||++.... .+..+|+|++.... ....+++.+|++++..++|+||+++++++......+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP---TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC---CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3456677899999999999999864 46789999876432 3345678999999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+++++|.+++.....+++.....++.+++++|.|||+ ..+++|+||||+||++++++.++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999999998877788999999999999999999995 3489999999999999999999999999987543221
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcc-----hhhHHHHHHHHHhcCCcccc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~l 752 (814)
.....|+..|+|||.+.+..++.++||||||++++|+++|+.||......+ ...+..+.......
T Consensus 159 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 228 (284)
T cd06620 159 ----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------ 228 (284)
T ss_pred ----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------
Confidence 223468999999999988899999999999999999999999997543321 11111111111111
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L 794 (814)
..........+.++.+++.+|++.||.+|||+.||+++.
T Consensus 229 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 229 ---PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111111223567899999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=317.93 Aligned_cols=238 Identities=26% Similarity=0.300 Sum_probs=190.6
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceee-EEeeccccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVV-VIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||+||+|.... .++.+|+|++.... ....+++..|.. +++.++||||+++++.+.+.+..++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence 468999999999999864 56789999986432 112234444544 45778999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++|+|..++.....+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--T 152 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--c
Confidence 9999999999888889999999999999999999995 5999999999999999999999999999875432211 1
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||..|+|||.+.+..++.++|||||||+++||++|+.||...... + ..+.+..+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~-~~~~i~~~~~----------~~ 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------E-MYDNILNKPL----------RL 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------H-HHHHHHcCCC----------CC
Confidence 33456899999999999999999999999999999999999999643221 1 1111111111 01
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMR 788 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~ 788 (814)
....+..+.+++.+||+.||.+||+++
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 223467889999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=322.66 Aligned_cols=253 Identities=19% Similarity=0.261 Sum_probs=199.7
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
..+.+.+.||+|+||.||++.... .+..+|+|++.... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 345667889999999999999864 56789999986421 223345788999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
+||||+++|+|.+++... .++......++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999988654 57888889999999999999994 69999999999999999999999999999876433
Q ss_pred ccccccccccCCCCccCcccccCC----CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNS----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~----~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
.... .....||..|+|||.+.+. .++.++|||||||++|||++|+.||....... ....+..+..
T Consensus 196 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~--- 264 (370)
T cd05596 196 GMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMDHKN--- 264 (370)
T ss_pred Cccc-CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-------HHHHHHcCCC---
Confidence 2211 2345689999999998653 47889999999999999999999997543211 1111111110
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSL--RPTMRKVSQM 793 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPtm~eV~~~ 793 (814)
..........+.++.+++..||+.+|.+ ||++.|+++.
T Consensus 265 ---~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 ---SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111112245688899999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.22 Aligned_cols=251 Identities=27% Similarity=0.472 Sum_probs=198.5
Q ss_pred cccccceeEEEEEEEeccC---CcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 527 EVGRGSFGIVYKGVIQTTR---TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~---~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
.||+|+||.||+|...... ..+..++||.+.... .....++.+|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 5899999999999986421 233679999886532 234567889999999999999999999999999999999999
Q ss_pred cCCchhhhhcCC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-----CeEEeecCCc
Q 042262 603 NNGTLASFLFGN-------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-----NARISDFGLA 670 (814)
Q Consensus 603 ~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-----~~kl~DfGla 670 (814)
++++|.+++... ..+++..++.++.|+++||+|||+ .+++|+||||+||+++.+. .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999998632 347889999999999999999994 5899999999999999877 8999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCc
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKL 749 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 749 (814)
+...............++..|+|||.+.+..++.++||||||++++||++ |+.||....... . ......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~----~~~~~~~~~ 231 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---V----LQHVTAGGR 231 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---H----HHHHhcCCc
Confidence 86543322211222345678999999999999999999999999999998 999986432211 1 111111111
Q ss_pred cccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 750 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
...+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus 232 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 232 ---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11123456788999999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.70 Aligned_cols=244 Identities=26% Similarity=0.354 Sum_probs=193.1
Q ss_pred ccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
||+|+||.||++.... .+..+|+|.+.... ....+.+..|++++++++||||+++++++.++...++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEcc---CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 7999999999999874 46789999986421 12234456789999999999999999999999999999999999
Q ss_pred CchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccc
Q 042262 605 GTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682 (814)
Q Consensus 605 gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (814)
++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++........ .
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~ 151 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---I 151 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---e
Confidence 9999888543 457899999999999999999994 6999999999999999999999999999887643221 2
Q ss_pred ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
....|+..|+|||++.+..++.++||||+||++|||++|+.||........ .... .......... ...
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~-~~~~~~~~~~---------~~~ 219 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEEL-KRRTLEDEVK---------FEH 219 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHH-HHHhhccccc---------ccc
Confidence 334589999999999998999999999999999999999999864332111 0011 1111111110 011
Q ss_pred hhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
...+.++.+++..||+.||++||+++|+++
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 235678899999999999999999977664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.23 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=198.7
Q ss_pred hhhccccccceeEEEEEEEeccCC-cceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRT-STTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~-~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
...+.||+|+||.||+|.+...+. ....+|+|.+..... ....++.+|+.+++.++|+||++++++|... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e 88 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ 88 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence 445689999999999999865321 123688898865432 2234688999999999999999999999764 4678999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++.+......
T Consensus 89 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 165 (303)
T cd05110 89 LMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165 (303)
T ss_pred hcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence 99999999998764 368899999999999999999995 59999999999999999999999999999876543322
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... . ......+...
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~-------- 230 (303)
T cd05110 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---I----PDLLEKGERL-------- 230 (303)
T ss_pred cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHCCCCC--------
Confidence 11222345678999999999999999999999999999998 888886432111 1 1122222111
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
..+..++..+.+++..||..+|++||+|+|+++.|+.+.
T Consensus 231 -~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 231 -PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111234567889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=315.12 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=211.5
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc-chhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
....+.|+||+|.||+|++|.+....++...||||.++..... ...+|.+|+.+|.+|+|+|+++|+|+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 3445668899999999999999987777889999999765433 56789999999999999999999999988 788999
Q ss_pred hhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 599 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
+|.++.|+|.+.|+.. ..+-......++.|||+||.||. +.++|||||..+|+||-....+||+||||.+.+..+
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999999873 34667777889999999999999 679999999999999999999999999999988765
Q ss_pred cccccc-ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 677 QSKAIK-TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 677 ~~~~~~-~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
+..-.. ....-...|.|||.+....++.++|||+|||+||||+| |..||-.-.+.. +.+.+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhcc
Confidence 543211 22334668999999999999999999999999999999 677875433211 112233
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.......+..+++++.++++.||..+|.+|||+..|.+.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 333344577899999999999999999999999999743
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.44 Aligned_cols=250 Identities=25% Similarity=0.352 Sum_probs=202.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
++.+.+.||+|+||.||+|.... .+..+++|.+..........+.+|+.+++.++|+||+++++.+..+.+.++|||
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECC---CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 34455789999999999998754 467899999876544555678899999999999999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
|+++++|.+++.. ..+++.++..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++.........
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 172 (296)
T cd06654 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (296)
T ss_pred ccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence 9999999999864 357899999999999999999994 59999999999999999999999999998865433221
Q ss_pred ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~ 760 (814)
.....++..|+|||.+.+..++.++||||||++++||++|+.||........ .......+. . ...
T Consensus 173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~~-~-------~~~ 237 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGT-P-------ELQ 237 (296)
T ss_pred -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCCC-C-------CCC
Confidence 2234578899999999988899999999999999999999999965432111 111111111 0 011
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 761 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.+...+..+.+++.+||+.+|++||++.||++.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 123456788999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.85 Aligned_cols=254 Identities=27% Similarity=0.455 Sum_probs=203.2
Q ss_pred HHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 517 LEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 517 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
+..+.+.+.++||+|+||.||++.+. ....+++|.+... ....+.+.+|+.+++.++|+||+++.+++.+ ...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~----~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec----CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 34556677889999999999999865 3456999988653 2234678899999999999999999999987 7789
Q ss_pred hhhhhccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 597 LVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
++|||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++..+.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 99999999999999865 3467889999999999999999995 599999999999999999999999999998664
Q ss_pred ccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
...... .....++..|+|||.+....++.++||||||++++|+++ |+.||....... + ...+..+...
T Consensus 154 ~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~----~~~~~~~~~~--- 222 (260)
T cd05073 154 DNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V----IRALERGYRM--- 222 (260)
T ss_pred CCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHhCCCCC---
Confidence 332211 222345678999999998889999999999999999999 899986432211 1 1122222111
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
......+.++.+++.+|++.+|++||++.++.++|+.
T Consensus 223 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=302.63 Aligned_cols=251 Identities=21% Similarity=0.275 Sum_probs=201.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-----cchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-----DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
+...+.||+|++|.||++.... .+..+++|.+..... ...+.+.+|++++++++||||+++++++.++...+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~---~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVD---TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred ccccceecCCCceEEEEEEEcC---CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 3456789999999999998764 467899998764321 12346888999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
+|+||+++++|.+++.....++...+..++.|++.||+|||+ .+|+|+||+|+||++++++.++|+|||+++.....
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999999877788999999999999999999995 59999999999999999999999999999765432
Q ss_pred ccccc-cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 677 QSKAI-KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 677 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~-------- 223 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQP-------- 223 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHhccC--------
Confidence 21110 1234578899999999998999999999999999999999999864322110 11111111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.....+...+..+.+++..||+.+|.+|||+.|+++.
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 -TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111233456788999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=318.00 Aligned_cols=241 Identities=26% Similarity=0.287 Sum_probs=192.1
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceee-EEeeccccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVV-VIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||+||++.... ++..+|+|++.... ....+++..|.. +++.++||||+++++.+...+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence 468999999999999764 56789999986432 222344555544 46678999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++|+|..++.....+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 152 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T 152 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence 9999999999888889999999999999999999994 6999999999999999999999999999875432211 1
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||..|+|||.+.+..++.++|||||||+++||++|+.||......+ ....+..+.+. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~~~~~~~~----------~ 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-------MYDNILHKPLV----------L 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-------HHHHHHcCCcc----------C
Confidence 234568999999999999999999999999999999999999996432211 11111121110 1
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVS 791 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~ 791 (814)
....+..+.+++..|++.+|.+||++++.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 123457788999999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=317.15 Aligned_cols=241 Identities=26% Similarity=0.291 Sum_probs=191.2
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceee-EEeeccccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVV-VIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||+||++.... .+..+|+|++.... .....++..|.. +++.++|+||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence 369999999999999864 46789999986432 122233444433 46778999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++++|.+++.....+.......++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~ 152 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T 152 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence 9999999999887788888999999999999999994 6999999999999999999999999999975432211 1
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||..|+|||.+.+..++.++|||||||+++||++|+.||......+ ....+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~~----------~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNKPL----------QL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCCc----------CC
Confidence 334568999999999999999999999999999999999999997432211 1111111111 11
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVS 791 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~ 791 (814)
....+..+.+++..||+.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 224567889999999999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=302.40 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=205.5
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||+|.... .+..+++|.++.. .....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLL---DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcC---CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 4567889999999999999874 4678999988532 222356788999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 599 YEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
|||+++++|.+++.. ...+++.++..++.++++||+|||+ .+|+|+||||+||++++++.++|+|||+++.+.
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999998853 3457899999999999999999994 599999999999999999999999999988654
Q ss_pred ccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
..... .....++..|+|||.+.+..++.++||||||++++||++|+.||...... ... ..+.+..+....
T Consensus 158 ~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~~~--- 227 (267)
T cd08224 158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEKCDYPP--- 227 (267)
T ss_pred CCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH-HHhhhhcCCCCC---
Confidence 33211 22345788999999999889999999999999999999999998644321 111 111222222111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
......+..+.+++.+||+.+|++|||+.+|+++|+++
T Consensus 228 -----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 -----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11225567899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=303.66 Aligned_cols=254 Identities=29% Similarity=0.417 Sum_probs=191.5
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
++||+|+||.||+|..... .....+++|.+.... .....++.+|+.+++.++|+||+++++.+.+....++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecC-CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 3689999999999986543 245678999876432 22345688899999999999999999999999999999999999
Q ss_pred CchhhhhcCCC-----CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 605 GTLASFLFGNL-----KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 605 gsL~~~l~~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+|.+++.... ..++.....++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999986532 34677888999999999999995 59999999999999999999999999998754332211
Q ss_pred cccccccCCCCccCccccc-------CCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFR-------NSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~-------~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
.......++..|+|||++. ...++.++||||||++++||++ |..||......+ ........+.. .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~~-~ 229 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQDI-K 229 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccCc-c
Confidence 1122234567899999874 3457889999999999999999 778875432211 11112222211 1
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
+..+. .+...+..+.+++..|+ .||++|||++||+++|.
T Consensus 230 ~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 12345677788888998 49999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=323.27 Aligned_cols=252 Identities=23% Similarity=0.262 Sum_probs=196.5
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||++.... .++.+|||++.... ....+.+++|++++.+++||||+++++++.+.+..+||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKD---TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 3456789999999999998865 56789999986431 22345688899999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+++.....+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999999988888899999999999999999999 46999999999999999999999999999964321100
Q ss_pred c---------------------------------------------cccccccCCCCccCcccccCCCCCCccchhhHHH
Q 042262 679 K---------------------------------------------AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGV 713 (814)
Q Consensus 679 ~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gv 713 (814)
. .......||..|+|||.+.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0001245899999999999999999999999999
Q ss_pred HHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCC---CCHHHH
Q 042262 714 LLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLR---PTMRKV 790 (814)
Q Consensus 714 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ptm~eV 790 (814)
+++||++|+.||......+. ...+.... . ..........+.++.+++..|++ +|.+| |++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~~-------~~~i~~~~--~----~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENSHET-------YRKIINWR--E----TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHH-------HHHHHccC--C----ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 99999999999965432111 11111100 0 00001112345678899999997 66665 599888
Q ss_pred HHH
Q 042262 791 SQM 793 (814)
Q Consensus 791 ~~~ 793 (814)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=306.69 Aligned_cols=243 Identities=24% Similarity=0.403 Sum_probs=191.5
Q ss_pred ccccccceeEEEEEEEeccCC----cceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRT----STTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~----~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||.||+|.....+. ....+++|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998764321 2345888887655444556788999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC--------eEEeecCCccc
Q 042262 602 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN--------ARISDFGLAKL 672 (814)
Q Consensus 602 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~--------~kl~DfGla~~ 672 (814)
+++|+|..++... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++. +|++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999764 458999999999999999999994 69999999999999987765 59999998875
Q ss_pred ccccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCC-cCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
.... ....++..|+|||.+.+. .++.++||||||++++||++|. .|+......... ..... .
T Consensus 158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-------~~~~~-~-- 221 (258)
T cd05078 158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-------QFYED-R-- 221 (258)
T ss_pred cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-------HHHHc-c--
Confidence 4321 234578899999999874 5799999999999999999995 554322211100 01111 0
Q ss_pred ccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 751 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
...+.....++.+++..||+.+|++|||++|+++.|+
T Consensus 222 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 --------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111223467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.51 Aligned_cols=240 Identities=26% Similarity=0.330 Sum_probs=201.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeec-cccceeeeeeeeccCCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 597 (814)
..|.++||+|.||+|+++.++. +++.+|||.+++.. .+..+..+.|.+++... +||.|++|+..+.+.++.+.
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~---~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKG---TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcC---CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 3566899999999999999986 56799999998642 33445677888887776 59999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+.+|++..+ .....+++.....++..|+.||.|||+ .+||+||||.+|||||.+|.+||+||||++......
T Consensus 447 vmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 9999999994443 445678999999999999999999995 599999999999999999999999999998654222
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
. ...+++||+.|||||++.+..|+..+|-|||||+|||||.|..||..+..++ +.+.+...
T Consensus 523 ~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------~FdsI~~d---------- 583 (694)
T KOG0694|consen 523 D--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------VFDSIVND---------- 583 (694)
T ss_pred C--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcC----------
Confidence 2 2577999999999999999999999999999999999999999998665433 12222221
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTM 787 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 787 (814)
+..++...+.+.+.|+.+.+..+|++|.-+
T Consensus 584 ~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 223567788999999999999999999977
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.22 Aligned_cols=250 Identities=21% Similarity=0.272 Sum_probs=193.6
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.++||+|+||.||+|.... .++.+|+|++.... ......+.+|+.++++++|+||+++++.+.+++..+|||
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVD---TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 455789999999999999864 56789999986532 223456889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc-
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS- 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~- 678 (814)
||+++|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999999887788999999999999999999994 5999999999999999999999999999754321000
Q ss_pred --------------------------------------------ccccccccCCCCccCcccccCCCCCCccchhhHHHH
Q 042262 679 --------------------------------------------KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVL 714 (814)
Q Consensus 679 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvv 714 (814)
........||..|+|||.+.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000123468999999999999999999999999999
Q ss_pred HHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 042262 715 LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT---MRKVS 791 (814)
Q Consensus 715 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---m~eV~ 791 (814)
|+||++|+.||......+. ........ ...........+.++.+++.+++ .+|.+|++ +.|++
T Consensus 238 l~elltG~~Pf~~~~~~~~------~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLET------QMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHHhCCCCCCCCCHHHH------HHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 9999999999975432111 11111100 00111111234566677776665 49999997 77766
Q ss_pred H
Q 042262 792 Q 792 (814)
Q Consensus 792 ~ 792 (814)
+
T Consensus 304 ~ 304 (382)
T cd05625 304 A 304 (382)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.47 Aligned_cols=259 Identities=21% Similarity=0.317 Sum_probs=195.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.++||+|+||.||+|.... .+..+|+|.++... ......+.+|+.++++++|+||+++++++..++..++|||
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred eEEEEEecccCCEEEEEEEecC---CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 4556789999999999998764 45689999986432 2233467789999999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++ +|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 9975 77777654 3457899999999999999999995 59999999999999999999999999999765432211
Q ss_pred cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC---cc-----
Q 042262 680 AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---LD----- 750 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~----- 750 (814)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||......+.... ....+.... ..
T Consensus 161 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 161 --YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSN 235 (309)
T ss_pred --cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcch
Confidence 223457889999999865 4689999999999999999999999975433221111 111100000 00
Q ss_pred -cccc---Cccc----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 751 -DLVE---GDTE----AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 751 -~l~~---~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
...+ +... .......+.++.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000 0000 0011234667889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=324.01 Aligned_cols=252 Identities=20% Similarity=0.260 Sum_probs=196.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||++.... .++.+|||.+.... ......+.+|+.++.+++|+||+++++.+.+++..+||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVD---TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 3456789999999999999864 46789999986432 22345678899999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+++.....++......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999999888888999999999999999999995 6999999999999999999999999999753321000
Q ss_pred -----------------------------------------ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHH
Q 042262 679 -----------------------------------------KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLE 717 (814)
Q Consensus 679 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~e 717 (814)
........||..|+|||++.+..++.++|||||||+++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000123469999999999999999999999999999999
Q ss_pred HHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 042262 718 IISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRP---TMRKVSQM 793 (814)
Q Consensus 718 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---tm~eV~~~ 793 (814)
|++|+.||......+. ... +..... ..........+.++.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 237 ll~G~~Pf~~~~~~~~------~~~-i~~~~~------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAET------QLK-VINWET------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHH------HHH-HhccCc------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999975433211 111 111100 0011112234567777888765 5999999 88888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=302.29 Aligned_cols=246 Identities=27% Similarity=0.398 Sum_probs=197.6
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeee-ccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFC-DEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 599 (814)
.+.+.+.||+|+||.||++... +..+++|.++.. ...+.+.+|+.++++++|+|++++++++ .+++..++|+
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-----CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 4566788999999999999764 567899988643 2345788999999999999999999976 4556789999
Q ss_pred hhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999998754 347899999999999999999994 599999999999999999999999999988654322
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
....++..|+|||++.+..++.++||||||++++||++ |+.||...... +. ...+..+...
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~------~~-~~~~~~~~~~------ 218 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DV-VPRVEKGYKM------ 218 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HH-HHHHhcCCCC------
Confidence 12234568999999999899999999999999999998 99988633211 11 1111111111
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
.....++..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 ---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11224567899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=319.70 Aligned_cols=253 Identities=19% Similarity=0.253 Sum_probs=197.4
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
..+.+.+.||+|+||.||++.... .+..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 345666789999999999999864 4678999998642 1223445788999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
+||||+++|+|.+++... .++......++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+...
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 999999999999998654 57888999999999999999994 69999999999999999999999999999876432
Q ss_pred ccccccccccCCCCccCcccccCC----CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNS----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~----~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
.... .....||..|+|||.+.+. .++.++||||+||+++||++|+.||....... ..........
T Consensus 196 ~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~~~---- 264 (370)
T cd05621 196 GMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDHKN---- 264 (370)
T ss_pred Ccee-cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCc----
Confidence 2111 2345699999999999754 37889999999999999999999997543211 1111111111
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSL--RPTMRKVSQM 793 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPtm~eV~~~ 793 (814)
..........+..+.+++..|++.++.+ ||++.|+++.
T Consensus 265 ---~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 ---SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111112345677888999999865544 8899998885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=299.82 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=198.6
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccccc-chhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
++||+|+||.||++.+. .+..+++|.++..... ..+.+.+|++++++++|+||+++++++.+....++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~----~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK----GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEe----CCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 46899999999999986 3678999988764333 456789999999999999999999999999999999999999
Q ss_pred CchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccc
Q 042262 605 GTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT 683 (814)
Q Consensus 605 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 683 (814)
++|.+++.. ...+++..+..++.+++.+|+|||+ .+++||||||+||++++++.+||+|||+++............
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999999865 3567899999999999999999995 599999999999999999999999999998654222111111
Q ss_pred cccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 684 ~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
....+..|+|||.+.++.++.++||||||++++||++ |..||....... ....+..+. ....+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~~---------~~~~~ 217 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGY---------RMPAP 217 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcCC---------CCCCC
Confidence 2234567999999998899999999999999999999 788875432211 111111111 11112
Q ss_pred hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
...+.++.+++.+|++.+|.+|||+.||++.|++
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 3456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=303.68 Aligned_cols=245 Identities=24% Similarity=0.337 Sum_probs=195.2
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 605 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 605 (814)
..||+|+||.||+|.+.. .+..+++|.+........+.+.+|+.++++++|+||+++++++..++..++|+||++++
T Consensus 14 ~~lg~g~~g~v~~~~~~~---~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 14 VVLGKGTYGIVYAARDLS---TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred EEEecCCceEEEEeEecC---CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 479999999999998764 46789999987655555678999999999999999999999999999999999999999
Q ss_pred chhhhhcCC-CCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCCeEEeecCCcccccccccccc
Q 042262 606 TLASFLFGN-LKP--SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 606 sL~~~l~~~-~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+|.+++... ..+ ++..+..++.||++||+|||+ .+|+|+||||+||+++. ++.+||+|||++.........
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-- 165 (268)
T cd06624 91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-- 165 (268)
T ss_pred CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--
Confidence 999998754 334 788889999999999999994 69999999999999986 678999999998765432221
Q ss_pred cccccCCCCccCcccccCCC--CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 682 KTAIRGTKGYVAPEWFRNST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~--~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....++..|+|||++.+.. ++.++||||||++++||++|+.|+......... .+. .+.. ....
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~-----~~~~------~~~~ 231 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFK-----VGMF------KIHP 231 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhh-----hhhh------ccCC
Confidence 22345788999999986643 788999999999999999999998643221110 000 0000 0011
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+....+++.+++.+||+.+|.+|||+.||++
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 123345678999999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=289.21 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=205.5
Q ss_pred HHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecc--ccccchhhhhceeeEEeeccccceeeeeeeeccCCce
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 595 (814)
....+.+.++||+|.|+.||+..... .++.+|+|.+.. ....+.+++.+|+.+-+.++||||++|.....+....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~---tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhcc---chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 34556777899999999999988764 566677777642 3344667899999999999999999999999999999
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCCeEEeecCCccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARISDFGLAKL 672 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DfGla~~ 672 (814)
+||+|+|.++.|..-|-.....++...-+.++||+++|.|+|. .+|||||+||+|++|-. .-.+||+|||++..
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999999987766555566778888999999999999994 59999999999999953 34589999999998
Q ss_pred ccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
+. +.. .-...+||++|||||+++..+++..+|||+.||+|+-|+.|..||..+.... .++.+..|...
T Consensus 163 l~-~g~--~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------lye~I~~g~yd-- 230 (355)
T KOG0033|consen 163 VN-DGE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYEQIKAGAYD-- 230 (355)
T ss_pred eC-Ccc--ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HHHHHhccccC--
Confidence 87 222 2456789999999999999999999999999999999999999997543321 33444444322
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+..+-....++..+|+.+||..||.+|-|+.|.+.
T Consensus 231 ----~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 ----YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 122233456788999999999999999999988764
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.70 Aligned_cols=260 Identities=27% Similarity=0.407 Sum_probs=205.3
Q ss_pred HHhhhhccccccceeEEEEEEEeccCC-cceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRT-STTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~-~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
..+.+.+.||+|+||.||+|....++. ....+++|.+..... ....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 345666889999999999999865332 234689998865432 334678899999999999999999999987 78899
Q ss_pred hhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|+||+++|+|.+++... ..+++..+..++.||++||+|||+ .+++|+||||+||++++++.+||+|||+++.+...
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999998764 468999999999999999999995 69999999999999999999999999999876543
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
..........++..|+|||.+....++.++||||||++++|+++ |+.||......+ . ...+..+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~-~~~~~~~~~------ 229 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------I-PDLLEKGER------ 229 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------H-HHHHhCCCC------
Confidence 32211112223568999999988899999999999999999999 999986543211 1 112222211
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
...+..++..+.+++..||..+|.+||++.++++.|+.+..
T Consensus 230 ---~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 ---LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11122345678899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=300.66 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=189.9
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCC
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 605 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 605 (814)
+||+|+||.||+|...... ....+++|.++... ....+.+.+|+.+++.++||||+++++.|.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDT-GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCC-CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 6999999999999875432 34567778776432 234567899999999999999999999999999999999999999
Q ss_pred chhhhhcCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 606 TLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 606 sL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+|.+++... ...++.....++.||++||+|||+ .+++|+||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999998753 345667788999999999999995 5899999999999999999999999999864322211111
Q ss_pred cccccCCCCccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 682 KTAIRGTKGYVAPEWFRN-------STITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~-------~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
.....++..|+|||++.. ..++.++||||||++++||++ |..||...... +.....+.. ....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~-~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIKD-QQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhh-cccccC
Confidence 233457889999999843 245789999999999999997 46677532211 111112222 222222
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
++... ....+.+.+++..|| .+|++||+++||++.|.
T Consensus 231 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22222 234567888999999 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=304.82 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=199.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+++.++||+|+||.||+|.... .+..+++|.+........+.+.+|+++++.++|+||+++++++..++..++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECC---CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 4566889999999999999864 4668899998765555566788999999999999999999999999999999999
Q ss_pred ccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 602 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 602 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
+++++|..++.. ...+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~- 159 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR- 159 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccccc-
Confidence 999999998765 4568999999999999999999995 59999999999999999999999999998765432111
Q ss_pred ccccccCCCCccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 681 IKTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.....++..|+|||.+. +..++.++|||||||+++||++|+.||......+ . ..... .......
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~----~~~~~-~~~~~~~--- 228 (282)
T cd06643 160 -RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--V----LLKIA-KSEPPTL--- 228 (282)
T ss_pred -cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--H----HHHHh-hcCCCCC---
Confidence 22345889999999984 4457889999999999999999999986433211 0 11111 1111111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..+...+.++.+++.+||+.+|.+||++.++++.
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 ----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1123456789999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=301.31 Aligned_cols=250 Identities=27% Similarity=0.464 Sum_probs=199.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
...+.+.||+|+||.||++.+. .+..+++|.++... ....++.+|++++++++||||+++++++......++|+|
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~----~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL----EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe----CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 3456688999999999999875 24579999886432 234678999999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++++|.+++... ..+++..+..++.|++.+|+|||+ .+++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999998754 457899999999999999999995 58999999999999999999999999998765432211
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. .....++.+|+|||.+.+..++.++||||||++++||++ |+.||....... ..+....+.. .
T Consensus 157 ~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~--~------ 220 (256)
T cd05112 157 S-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAGFR--L------ 220 (256)
T ss_pred c-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhCCCC--C------
Confidence 1 112234678999999998899999999999999999998 999986433211 1111122110 0
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
..+...++.+.+++.+||+.+|++|||+.||++.|.
T Consensus 221 -~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 -YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 011224578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=304.42 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=200.6
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+...+.||+|+||.||+|.+.. .+..+|+|.++... ....+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNR---TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcC---CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 44556789999999999998864 46789999886432 333457899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++++|.+++.. ..+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||++..+......
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 99999999998864 467899999999999999999994 69999999999999999999999999999876533211
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+........ ......+.. .
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~---------~ 219 (277)
T cd06642 158 --RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-------LFLIPKNSP---------P 219 (277)
T ss_pred --hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-------HhhhhcCCC---------C
Confidence 2234578899999999998999999999999999999999999864322110 001111111 1
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
......+..+.+++.+||+.+|++||+|.||++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1122456788999999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.74 Aligned_cols=256 Identities=23% Similarity=0.400 Sum_probs=199.9
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCC------c
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------N 594 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~ 594 (814)
.+.+.||+|+||.||+|.+......+..+|||++.... ....+++.+|+.++++++||||+++++++...+ .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 34578999999999999987655567899999986532 233567889999999999999999999885532 2
Q ss_pred eehhhhhccCCchhhhhcCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecC
Q 042262 595 RLLVYEFLNNGTLASFLFGN------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 668 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfG 668 (814)
.++++||+++|+|..++... ..+++.....++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 36888999999998887432 247888999999999999999995 599999999999999999999999999
Q ss_pred CcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcC
Q 042262 669 LAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG 747 (814)
Q Consensus 669 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 747 (814)
+++...............++..|++||.+.+..++.++||||||++++||++ |+.||...... .+ ...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~----~~~~~~~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EI----YNYLIKG 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HH----HHHHHcC
Confidence 9987654332211223345678999999998899999999999999999999 88888643221 11 1111111
Q ss_pred CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 748 KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 748 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
... ..+...+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 11224557899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=301.74 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=200.9
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||+|.... .+..+++|.++.........+.+|+.+++.++||||+++++.+...+..++|+|
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVN---TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcC---CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 55677889999999999998864 467899999875544444567889999999999999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
|+++++|.+++.....+++.+...++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++..+......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~- 162 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK- 162 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc-
Confidence 99999999999888889999999999999999999995 59999999999999999999999999998765432211
Q ss_pred ccccccCCCCccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 681 IKTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.....|+..|+|||.+. ...++.++|||||||+++||++|+.|+........ + .. ....... .+..
T Consensus 163 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~----~~-~~~~~~~---~~~~ 231 (267)
T cd06645 163 -RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L----FL-MTKSNFQ---PPKL 231 (267)
T ss_pred -cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H----Hh-hhccCCC---CCcc
Confidence 23446889999999984 45688999999999999999999999854322110 0 00 0111110 0000
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.....++..+.+++.+|++.+|++||++.+|++
T Consensus 232 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 --KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 111234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=338.02 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=200.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.++||+|+||.||+|.... .++.||||+++.... ...+++.+|++++++++||||+++++++.+++..++|
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~---tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPV---CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECC---CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 4556789999999999999764 467899999865322 2245788999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC-----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeec
Q 042262 599 YEFLNNGTLASFLFGN-----------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDF 667 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df 667 (814)
|||+++++|.+++... ...++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEec
Confidence 9999999999988531 234677788999999999999995 59999999999999999999999999
Q ss_pred CCcccccccccc----------------cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCc
Q 042262 668 GLAKLLTLNQSK----------------AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 731 (814)
Q Consensus 668 Gla~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~ 731 (814)
|+++........ .......||..|+|||.+.+..++.++|||||||+++||++|+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 999876221100 0011246899999999999999999999999999999999999999753321
Q ss_pred chhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCC-CHHHHHHHHcCCcC
Q 042262 732 EYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRP-TMRKVSQMLEGVVE 799 (814)
Q Consensus 732 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-tm~eV~~~L~~~~~ 799 (814)
... .. .. .............+..+.+++.+|++.||++|| +++++.+.|+..++
T Consensus 238 ki~------~~----~~----i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 KIS------YR----DV----ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh------hh----hh----ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 100 00 00 000001111124567788999999999999995 67778777766543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=296.08 Aligned_cols=264 Identities=22% Similarity=0.336 Sum_probs=198.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEee--ccccceeeeeeeeccCC----ce
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ--THHKNLVRLLGFCDEGQ----NR 595 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~ 595 (814)
..+.+.||+|+||.||+|.+. |+.||||++.. ..++.+.+|.++.+. |+|+||+.+++.-..++ +.
T Consensus 213 I~L~e~IGkGRyGEVwrG~wr-----Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRWR-----GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred eEEEEEecCccccceeecccc-----CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 345678999999999999996 77899999854 345677788777776 59999999998875543 57
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED-----CSAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
+||.+|.++|||.|+|.. ..++....++++..+|.||+|||.+ .++.|.|||||+.||||..++...|+|+|||
T Consensus 285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 899999999999999988 6788999999999999999999985 4789999999999999999999999999999
Q ss_pred cccccccc--ccccccccCCCCccCcccccCCC----CC--CccchhhHHHHHHHHHhC----------CcCCcccCCcc
Q 042262 671 KLLTLNQS--KAIKTAIRGTKGYVAPEWFRNST----IT--AKVDVYSFGVLLLEIISC----------RKSFDIEMGEE 732 (814)
Q Consensus 671 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~t--~k~DV~S~Gvvl~elltG----------~~p~~~~~~~~ 732 (814)
.....+.. .......+||.+|||||++...- +. ..+||||||.|+||+... +.||..-.+.+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 87654421 12234567999999999996432 21 259999999999999753 23333222211
Q ss_pred hhhHHHHHHHHHhcCCccccccCc-ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 733 YAILTDWAFDCYRNGKLDDLVEGD-TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 733 ~~~l~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
.. +.+ ++.---.+-+.+. .+.-...+....+.+|++.||..+|..|.|+--|.+.|.++.+.
T Consensus 444 Ps-~ee-----MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 444 PS-FEE-----MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CC-HHH-----HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 11 101 1110000001111 12223456778899999999999999999999999998877754
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=303.24 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=202.6
Q ss_pred hhhhccccccceeEEEEEEEeccC--CcceEEEEEeecccccc-chhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+...+.||+|+||.||+|...... .....+++|.+...... ..+++.+|++++++++|+||+++++++.+....++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (275)
T cd05046 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI 86 (275)
T ss_pred ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEE
Confidence 344567999999999999976432 23467999988654333 346789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCC---------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCC
Q 042262 599 YEFLNNGTLASFLFGNL---------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 669 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~---------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl 669 (814)
|||+++++|.+++.... .+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.++|+|||+
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccccc
Confidence 99999999999997654 68999999999999999999994 5899999999999999999999999999
Q ss_pred cccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCC
Q 042262 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK 748 (814)
Q Consensus 670 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 748 (814)
++......... .....++..|+|||.+.+...+.++||||||++++||++ |..||....... .......+.
T Consensus 164 ~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~~~ 235 (275)
T cd05046 164 SKDVYNSEYYK-LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAGK 235 (275)
T ss_pred ccccCcccccc-cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHcCC
Confidence 87543222111 222345678999999998889999999999999999999 778885332211 111222222
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
... ......+..+.+++.+||+.+|.+||++.|+++.|+
T Consensus 236 ~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 211 112245678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=314.22 Aligned_cols=244 Identities=26% Similarity=0.377 Sum_probs=203.7
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCCc
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT 606 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 606 (814)
+||+|.||+||.|++.. ....+|||-+........+-+++||.+-++++|.|||+.+|.|.+++..-|.||.++||+
T Consensus 582 VLGKGTYG~VYA~RD~~---tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeecccc---ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 59999999999999875 456899999988777777889999999999999999999999999999999999999999
Q ss_pred hhhhhcCC-CCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCCeEEeecCCccccccccccccc
Q 042262 607 LASFLFGN-LKP--SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLNQSKAIK 682 (814)
Q Consensus 607 L~~~l~~~-~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~ 682 (814)
|.++|... .++ ++...-.+.+||++||.|||+ ..|||||||-.|||++- .|.+||+|||.++.+..- ....
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~T 733 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCT 733 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC--Cccc
Confidence 99999764 333 777888899999999999996 59999999999999975 688999999999877532 2235
Q ss_pred ccccCCCCccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccccc
Q 042262 683 TAIRGTKGYVAPEWFRNS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~~--~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~ 760 (814)
.++-||..|||||++..+ .|..++|||||||++.||.||++||..-.. ... .+++-|.. .....
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs-pqA-------AMFkVGmy------KvHP~ 799 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS-PQA-------AMFKVGMY------KVHPP 799 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC-hhH-------hhhhhcce------ecCCC
Confidence 667799999999999766 488999999999999999999999963321 111 11122211 12233
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 761 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+.+.+++...++++|..+||.+||+++++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 46688899999999999999999999999886
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.71 Aligned_cols=241 Identities=26% Similarity=0.318 Sum_probs=193.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeecc-ccceeeeeeeeccCCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l 597 (814)
+++.+.||+|+||.||++.... .+..+|+|++.... ....+.+..|..++..+. |++|+++.+++.+.+..++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 3566789999999999998764 56789999986532 223345777888887775 5778889999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999999999999888889999999999999999999995 599999999999999999999999999987543221
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
. ......||..|+|||.+.+..++.++||||||++++||++|+.||....... ....+..+..
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~~-------- 218 (323)
T cd05615 156 V--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHNV-------- 218 (323)
T ss_pred c--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC--------
Confidence 1 1234568999999999999999999999999999999999999997543211 1111111111
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTM 787 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 787 (814)
..+...+.++.+++.+||+.+|.+|++.
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1122445788899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=321.14 Aligned_cols=259 Identities=21% Similarity=0.214 Sum_probs=193.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.+.||+|+||.||++.+.. .+..||||... ...+.+|++++++++|+||+++++++..++..+||||+
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~---~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPD---YPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECC---CCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4556789999999999999875 46789999632 23467899999999999999999999999999999999
Q ss_pred ccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 602 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 602 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
+. ++|.+++... ..+++.+++.|+.||++||.|||+ .+|+||||||+||||+.++.+||+|||+++.........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 85 6888877553 568999999999999999999994 599999999999999999999999999998765433322
Q ss_pred ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccC-CcchhhHHHHHHHHHhcCCc-----ccccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEM-GEEYAILTDWAFDCYRNGKL-----DDLVE 754 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~~-----~~l~~ 754 (814)
......||..|+|||++.+..++.++|||||||+||||++|..++.... ..........+...++.... .....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 2334569999999999999999999999999999999999886653221 11101111111112221111 00000
Q ss_pred ----------------Ccccc---cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 755 ----------------GDTEA---MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 755 ----------------~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..... .........+.+|+.+||+.||.+|||+.|+++.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0001223478899999999999999999999874
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=306.92 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=202.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.+.||.|++|.||+|.... .+..+++|.+........+.+.+|+++++.++|+||+++++++..++..++|+||
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVA---TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcC---CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 3445689999999999998754 5678999998765555566788999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++++|..++... .+++.++..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.........
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-- 171 (296)
T cd06655 98 LAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-- 171 (296)
T ss_pred cCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--
Confidence 9999999988654 58999999999999999999994 69999999999999999999999999998876543321
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....++..|+|||.+.+..++.++|||||||+++||++|+.||......... ... ....... ...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~-~~~~~~~-------~~~ 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLI-ATNGTPE-------LQN 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH-HhcCCcc-------cCC
Confidence 22345788999999999988999999999999999999999999755432111 111 1111111 111
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+...+..+.+++.+||+.||.+||++.+|++.
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 23456788899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=302.02 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=194.9
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccC------C
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG------Q 593 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~------~ 593 (814)
.+.+.+.||+|+||.||+|.... .++.+|+|++... .....++..|+.++.++ +|+||+++++++... .
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcC---CCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 34556789999999999998864 4678999998654 23446788899999888 799999999998653 3
Q ss_pred ceehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 594 NRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 578999999999999998753 468899999999999999999995 599999999999999999999999999998
Q ss_pred cccccccccccccccCCCCccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
........ .....|+..|+|||++. +..++.++|||||||++|||++|+.||......... ... ..
T Consensus 160 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~------~~~-~~ 230 (272)
T cd06637 160 QLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLI-PR 230 (272)
T ss_pred eccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH------HHH-hc
Confidence 65432211 23456889999999986 345788999999999999999999999643221100 011 11
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
... ........+..+.+++.+||+.+|.+|||+.||++
T Consensus 231 ~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCC--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 110 11112234568899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=306.97 Aligned_cols=245 Identities=27% Similarity=0.397 Sum_probs=198.0
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 605 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 605 (814)
..||+|+||.||++.... .+..+|||++........+.+.+|+.+++.++|+||+++++.+..++..++||||++++
T Consensus 28 ~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 28 IKIGEGSTGIVCIATEKH---TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hcccCCCCeEEEEEEECC---CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 569999999999998764 46789999987655555667899999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccc
Q 042262 606 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI 685 (814)
Q Consensus 606 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 685 (814)
+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++......... ....
T Consensus 105 ~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~ 178 (292)
T cd06658 105 ALTDIVTH-TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSL 178 (292)
T ss_pred cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Ccee
Confidence 99998854 458899999999999999999995 59999999999999999999999999998765432221 2334
Q ss_pred cCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhH
Q 042262 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKC 765 (814)
Q Consensus 686 ~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 765 (814)
.++..|+|||.+.+..++.++||||||++++||++|+.||........ ...+... . .+... .....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~~-~----~~~~~--~~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-------MRRIRDN-L----PPRVK--DSHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhc-C----CCccc--ccccc
Confidence 588999999999988999999999999999999999999864322110 1111111 1 11111 11234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 766 TEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 766 ~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+..+.+++.+|++.||.+|||++|+++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 5678899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=298.50 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=202.1
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||+|.... .+..+++|.++.... .+++.+|+.++++++|+||+++++++.+....++++|
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKE---TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcC---CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 35566789999999999999874 357899999865432 6789999999999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 9999999999865 4578999999999999999999995 59999999999999999999999999999876543221
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+......... ........ ...
T Consensus 156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~-------~~~ 219 (256)
T cd06612 156 --RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNKPP-------PTL 219 (256)
T ss_pred --cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccCCC-------CCC
Confidence 22344788999999999989999999999999999999999998743221100 00000000 011
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+.....++.+++.+||+.+|++|||+.||++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 122345678999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=300.99 Aligned_cols=248 Identities=27% Similarity=0.382 Sum_probs=199.8
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc---------chhhhhceeeEEeeccccceeeeeeeeccCC
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD---------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 593 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 593 (814)
.+.+.||+|++|.||+|.... .+..+++|.+...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNAS---SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD 79 (267)
T ss_pred cccceeecCCCeEEEEEEecC---CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence 456789999999999999764 4678999988643221 1246888999999999999999999999999
Q ss_pred ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 594 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
..++|+||+++++|.+++.....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999999887788999999999999999999995 59999999999999999999999999999876
Q ss_pred ccccccc----ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCc
Q 042262 674 TLNQSKA----IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 749 (814)
Q Consensus 674 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 749 (814)
....... ......|+..|+|||.+.+..++.++||||||++++||++|+.||....... .... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~- 228 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFK-IGENA- 228 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHH-HhccC-
Confidence 5321110 1123457889999999999889999999999999999999999997432111 0111 11111
Q ss_pred cccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 750 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....+...++.+.+++.+||+.||.+||++.||++
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 --------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11122345688899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=309.87 Aligned_cols=252 Identities=29% Similarity=0.356 Sum_probs=212.5
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccc---hhhhhceeeEEeecc-ccceeeeeeeeccCCc
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQN 594 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~---~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 594 (814)
...+.+.++||+|.||.||+++... .+..+|+|.+.+..... ...+.+|+.+|+++. |||||.+.+.+++...
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~---tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKS---TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecC---CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 4456667899999999999999885 47889999997654433 358999999999998 9999999999999999
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC----CCeEEeecCCc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY----YNARISDFGLA 670 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~----~~~kl~DfGla 670 (814)
.++|||++.+|.|.+.+... .+++.....++.||+.+++||| +.+|+||||||+|+|+... +.+|++|||++
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999998766 4899999999999999999999 5799999999999999643 47999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
...... ......+||+.|+|||.+....++..+||||+||++|.|++|.+||......... ..+..++.
T Consensus 187 ~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------~~i~~~~~- 255 (382)
T KOG0032|consen 187 KFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------LAILRGDF- 255 (382)
T ss_pred eEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-------HHHHcCCC-
Confidence 987762 2255678999999999999999999999999999999999999999866543221 13333433
Q ss_pred ccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 751 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
......-...++.+.+++..++..||.+|+|+.++++.
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22223334668899999999999999999999999983
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=315.36 Aligned_cols=254 Identities=19% Similarity=0.253 Sum_probs=197.0
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCce
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 595 (814)
...+.+.+.||+|+||.||++.... .+..+|+|.+... .....+.+.+|+.+++.++||||+++++.+.+++..
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECC---CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 3455667889999999999999875 5678999998642 122334578899999999999999999999999999
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
++||||+++|+|.+++... .++...+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 9999999999999988654 5788888999999999999999 46999999999999999999999999999987643
Q ss_pred cccccccccccCCCCccCcccccCC----CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNS----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
..... .....||..|+|||.+.+. .++.++|||||||++|||++|+.||....... ....+....-
T Consensus 195 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~-- 264 (371)
T cd05622 195 EGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMNHKN-- 264 (371)
T ss_pred CCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC--
Confidence 32211 2345699999999999754 37899999999999999999999997543211 1111111110
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSL--RPTMRKVSQM 793 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPtm~eV~~~ 793 (814)
..........+..+.+++..|++.++.+ ||++.|+++.
T Consensus 265 ----~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 265 ----SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ----cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0111112345678889999999844443 7789888874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=311.65 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=209.6
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCc-eeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN-RLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~l 597 (814)
.|...+.+|+|+||.++...++. +...+++|++.-. .....+..++|+.++++++|||||...+.+.+++. .+|
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~---~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKS---DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred hhhhhhhcCccccchhhhhhhcc---CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 45667899999999999988875 4568999988542 33334467899999999999999999999999888 999
Q ss_pred hhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 598 VYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
||+|++||+|.+.|... ..++++.+..++.|++.|+.|||+ .+|+|||||+.||++..+..+||.|||+|+.+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999999765 457888999999999999999994 5999999999999999999999999999999987
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
+... .....||+.|+.||.+.+.+|..|+||||+||+++||++-+++|....... + +....+ + .
T Consensus 159 ~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---L---i~ki~~-~----~--- 222 (426)
T KOG0589|consen 159 EDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---L---ILKINR-G----L--- 222 (426)
T ss_pred chhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---H---HHHHhh-c----c---
Confidence 6533 456789999999999999999999999999999999999999998654322 1 111111 1 1
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
-...+..++.++..++..|++.+|..||++.+++.+
T Consensus 223 --~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 --YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 112345678899999999999999999999999875
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=305.28 Aligned_cols=250 Identities=25% Similarity=0.347 Sum_probs=202.3
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
..+.+.+.||+|+||.||++.... .+..+|+|.+........+.+.+|+.+++.++|+||+++++++..++..++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIA---TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECC---CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 345566789999999999999754 46789999987654455567889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++++|.+++.. ..+++.++..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++.........
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999999854 457889999999999999999995 59999999999999999999999999998865443221
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....++..|+|||.+.+..++.++||||||++++++++|+.||.......... .....+ ....
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~--------~~~~ 235 (297)
T cd06656 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG--------TPEL 235 (297)
T ss_pred --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC--------CCCC
Confidence 223457889999999999899999999999999999999999996543211100 000000 0111
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...+..+.+++.+||+.+|++||++++|++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 123345677889999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=323.25 Aligned_cols=254 Identities=23% Similarity=0.338 Sum_probs=187.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccC--------C
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--------Q 593 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~ 593 (814)
+.+.+.||+|+||.||+|.... .+..||||++... .....+|+.+++.++|+||+++++++... .
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICID---TSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 5566889999999999999864 4678999988542 22345688999999999999999876321 2
Q ss_pred ceehhhhhccCCchhhhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-CeEEeecC
Q 042262 594 NRLLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFG 668 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfG 668 (814)
..++||||+++ +|.+++. ....+++.....++.||++||+|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999985 5665553 34678999999999999999999994 6999999999999999664 69999999
Q ss_pred CcccccccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC
Q 042262 669 LAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 747 (814)
Q Consensus 669 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 747 (814)
+++.+..... .....||..|+|||.+.+. .++.++|||||||+++||++|+.||......+. +... ...+...
T Consensus 217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i-~~~~~~p 290 (440)
T PTZ00036 217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRI-IQVLGTP 290 (440)
T ss_pred cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHH-HHHhCCC
Confidence 9987653322 2234679999999998764 689999999999999999999999975433211 1111 1111000
Q ss_pred ---------------CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 748 ---------------KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 748 ---------------~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+.......+....+...+.++.+++.+||+.||.+|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000011111111122335678999999999999999999999885
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=298.81 Aligned_cols=241 Identities=28% Similarity=0.461 Sum_probs=191.1
Q ss_pred ccccccceeEEEEEEEeccC-------CcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 526 EEVGRGSFGIVYKGVIQTTR-------TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~-------~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.||+|+||.||+|.+.... .....+++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999997532 11245788877654332 6788999999999999999999999988 778999
Q ss_pred hhhccCCchhhhhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-------CeEEeecCCc
Q 042262 599 YEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-------NARISDFGLA 670 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-------~~kl~DfGla 670 (814)
+||+++++|.+++.... .+++..+..++.||+.||+||| +.+|+|+||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998665 7899999999999999999999 46999999999999999887 7999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCC--CCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcC
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNS--TITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG 747 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 747 (814)
..... .....++..|+|||.+.+. .++.++||||||++++||++ |..|+......+.. ..+...
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-------~~~~~~ 222 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFYQDQ 222 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-------HHHhcC
Confidence 86543 1223467789999999876 78999999999999999999 56666543221110 011100
Q ss_pred CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 748 KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 748 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
. .. +......+.+++.+||+.+|.+|||+.||++.|+
T Consensus 223 ~-------~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H-------RL----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C-------CC----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 0111278889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.50 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=199.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc----------ccchhhhhceeeEEee-ccccceeeeeeeec
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF----------QDGEKEFKNEVVVIGQ-THHKNLVRLLGFCD 590 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~----------~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~ 590 (814)
+.+.+.||+|+||.||+|.+... .+..+++|.+.... .....++.+|+.++.+ ++|+||+++++++.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 79 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNN--GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL 79 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCC--CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence 34567899999999999998742 35689999875321 1122446678877764 79999999999999
Q ss_pred cCCceehhhhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEee
Q 042262 591 EGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISD 666 (814)
Q Consensus 591 ~~~~~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 666 (814)
+++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ ..+++|+||+|+||++++++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988742 3568899999999999999999995 25799999999999999999999999
Q ss_pred cCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 667 FGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... . .....+
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~-~~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------L-ATKIVE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------H-HHHHhh
Confidence 99998765433 1334568899999999998889999999999999999999999986432111 1 111111
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
+.... ......+..+.+++.+||+.||++||++.||.++|++
T Consensus 228 ~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVYEP--------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccCCc--------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11111 1112345788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.37 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=201.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.+.||.|++|.||+|.... .+..+++|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECC---CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 4556789999999999999864 56789999986532 3334678899999999999999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
|+++++|.+++... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++.+......
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 154 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK- 154 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccccc-
Confidence 99999999998765 78999999999999999999994 58999999999999999999999999999877543221
Q ss_pred ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~ 760 (814)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||....... .......+....+.
T Consensus 155 -~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~------- 219 (274)
T cd06609 155 -RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPKNNPPSLE------- 219 (274)
T ss_pred -cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HHHHhhhcCCCCCc-------
Confidence 233457889999999999889999999999999999999999996443211 11111111111111
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 761 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....+..+.+++.+||+.+|++|||++++++
T Consensus 220 -~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 -GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1115678899999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=302.48 Aligned_cols=252 Identities=28% Similarity=0.438 Sum_probs=199.7
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccch--hhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~--~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.||+|+||+||++.... .+..+|+|++........ .....|+.++++++|+||+++++++.+....++|||
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKK---NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETT---TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECC---CCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccc
Confidence 456789999999999999875 566899999976533222 234559999999999999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
|+.+++|.+++.....+++..+..++.||++||+|||+ .+|+|+||||+||++++++.++|+|||.+..... ...
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~ 153 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE 153 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred cccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccc
Confidence 99999999999877788999999999999999999996 5999999999999999999999999999976411 111
Q ss_pred ccccccCCCCccCccccc-CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 681 IKTAIRGTKGYVAPEWFR-NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
......++..|+|||.+. +...+.++||||+|+++++|++|+.|+........... ..... ....... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~---~~~~~-~~~~~~~------~ 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI---IEKIL-KRPLPSS------S 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH---HHHHH-HTHHHHH------T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh---hhhcc-ccccccc------c
Confidence 234456889999999998 88899999999999999999999999975521111111 11000 0000000 0
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.........+.+++..||+.||++||++.|+++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001112389999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.97 Aligned_cols=258 Identities=25% Similarity=0.304 Sum_probs=190.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc--chhhhhceeeEEeec---cccceeeeeeeecc-----
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQT---HHKNLVRLLGFCDE----- 591 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~----- 591 (814)
+.+.+.||+|+||.||+|.... .+..+|+|.++..... ....+.+|+.+++.+ +||||+++++++..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 3456789999999999999874 5678999988653221 223455666666555 79999999998854
Q ss_pred CCceehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCC
Q 042262 592 GQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 669 (814)
Q Consensus 592 ~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl 669 (814)
....++||||+.+ +|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 3457899999975 788877653 458999999999999999999995 5999999999999999999999999999
Q ss_pred cccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc---
Q 042262 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN--- 746 (814)
Q Consensus 670 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--- 746 (814)
++....... .....++..|+|||.+.+..++.++|||||||+++||++|++||........ +.. .......
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~-~~~~~~~~~~ 228 (288)
T cd07863 155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGK-IFDLIGLPPE 228 (288)
T ss_pred cccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHH-HHHHhCCCCh
Confidence 987643221 2334578999999999998999999999999999999999999865432211 101 1111100
Q ss_pred CCcccc-------ccCcc---cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 747 GKLDDL-------VEGDT---EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 747 ~~~~~l-------~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
...... ..+.. ........++.+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 00000 00011245677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.00 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=203.5
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||.|+||.||+|.... .+..+++|.+........+.+.+|+.++++++||||+++++++.++...+++||
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIA---TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecC---CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 34566789999999999999864 356799999876555556789999999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++++|.+++... ..++...+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 99999999998776 678999999999999999999995 59999999999999999999999999998765432211
Q ss_pred cccccccCCCCccCcccccCC---CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNS---TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~---~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.....++..|+|||.+.+. .++.++||||||++++||++|+.|+......... .. ....... .
T Consensus 158 --~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~------~~-~~~~~~~-----~ 223 (262)
T cd06613 158 --RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL------FL-ISKSNFP-----P 223 (262)
T ss_pred --cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhccCC-----C
Confidence 2334578899999999776 8899999999999999999999998643321110 00 1111100 0
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.........+.++.+++.+||+.+|.+|||+.+|+.
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011123355678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.15 Aligned_cols=256 Identities=17% Similarity=0.211 Sum_probs=193.8
Q ss_pred hhcccccc--ceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 524 FEEEVGRG--SFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 524 ~~~~LG~G--~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.++||+| +|++||++.... +++.||+|+++... ....+.+++|+.+++.++||||+++++++..++..++|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecc---cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 45789999 789999999875 57889999986532 223456788999999999999999999999999999999
Q ss_pred hhccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc-
Q 042262 600 EFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN- 676 (814)
Q Consensus 600 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~- 676 (814)
||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++++||+........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999999864 3458999999999999999999994 59999999999999999999999999865433211
Q ss_pred ccc----cccccccCCCCccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 677 QSK----AIKTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 677 ~~~----~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
... .......++..|+|||++.+ ..++.++|||||||+++||++|+.||....... .. ... ..+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~----~~~-~~~~~~ 228 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--ML----LEK-LNGTVP 228 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HH----HHH-hcCCcc
Confidence 100 00122346778999999976 468999999999999999999999996432111 00 000 011111
Q ss_pred ccccC------------------------------------cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 751 DLVEG------------------------------------DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 751 ~l~~~------------------------------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+.+. .............+.+++.+||+.||++|||++||++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 11000 0000112234568899999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.75 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=201.6
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+...+.||.|+||.||+|.... .+..+|+|.+.... ......+.+|+.++++++|+||+++++++.++...++||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEcc---CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 34455789999999999998864 46789999886432 334567889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++++|.+++.. ..+++.....++.|+++||+|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 99999999998865 467888999999999999999994 69999999999999999999999999999876433211
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+......... .....+. ..
T Consensus 158 --~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~---------~~ 219 (277)
T cd06640 158 --RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------FLIPKNN---------PP 219 (277)
T ss_pred --cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-------hhhhcCC---------CC
Confidence 22345788999999999889999999999999999999999998644321110 1111111 11
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
......+..+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2233567889999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.08 Aligned_cols=196 Identities=23% Similarity=0.404 Sum_probs=158.2
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeecc--CCceehhhhhcc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLLVYEFLN 603 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~ 603 (814)
++||+|+||.||+|..... .....+|+|.++.. .....+.+|+.++++++||||+++++++.. +...++|+||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~-~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDG-KDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred cccccCCCeEEEEEEEccC-CCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 5799999999999987532 24578999998643 223457889999999999999999998854 456789999986
Q ss_pred CCchhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----CCCCCeEEeecCCc
Q 042262 604 NGTLASFLFG---------NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLA 670 (814)
Q Consensus 604 ~gsL~~~l~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DfGla 670 (814)
+ +|.+++.. ...+++..+..|+.||++||+|||+ .+|+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 77766532 1247888999999999999999994 599999999999999 45678999999999
Q ss_pred ccccccccc-cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCccc
Q 042262 671 KLLTLNQSK-AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIE 728 (814)
Q Consensus 671 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~ 728 (814)
+........ .......||..|+|||++.+. .++.++||||+||+++||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876533211 112345689999999999774 5899999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.63 Aligned_cols=251 Identities=31% Similarity=0.519 Sum_probs=202.8
Q ss_pred hhccccccceeEEEEEEEeccC-CcceEEEEEeecccccc-chhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTR-TSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~-~~~~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.||+|+||.||++...... .....+|+|.+...... ..+.+.+|+.++..++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 4578999999999999987532 22478999999765433 467899999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCC--CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 602 LNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
+++++|.+++..... +++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999976543 8999999999999999999994 59999999999999999999999999999876544222
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. .....++..|+|||.+.+..++.++||||+|++++||++ |+.||....... ..+....+...
T Consensus 160 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~-------- 223 (258)
T smart00219 160 K-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-------VLEYLKKGYRL-------- 223 (258)
T ss_pred c-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCCC--------
Confidence 1 112336789999999988889999999999999999998 788876432211 11122222211
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L 794 (814)
..+...+.++.+++.+|++.+|++|||+.|+++.|
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11223567899999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.15 Aligned_cols=250 Identities=21% Similarity=0.307 Sum_probs=199.9
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.++||+|+||.||+|.... .+..+++|.+........+++.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKE---TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECC---CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 45677889999999999998864 467899999876555556778899999999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++++|..++.. ...+++..+..++.|++++|+|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 9999999988754 4568999999999999999999994 69999999999999999999999999998754322111
Q ss_pred cccccccCCCCccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 680 AIKTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.....++..|+|||.+. ...++.++||||||+++|||++|+.||....... ....+........
T Consensus 167 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~-- 235 (292)
T cd06644 167 --RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSEPPTL-- 235 (292)
T ss_pred --cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-------HHHHHhcCCCccC--
Confidence 22345788999999984 3457889999999999999999999986433211 1111111111111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...+.++.+++.+||+.+|++||++.||++
T Consensus 236 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 -----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 112345678899999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=311.12 Aligned_cols=256 Identities=19% Similarity=0.251 Sum_probs=188.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||+|.... .+..||+|..... ....|+.++++++|+||+++++++.++...++|+|
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPG---QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECC---CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 45667899999999999999864 4568999975332 33568888999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+. ++|.+++.. ...+++..+..|+.||++||.|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 212 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA- 212 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc-
Confidence 985 577777754 4678999999999999999999995 5999999999999999999999999999975432211
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCC-cccCCcchhhH---HHHHHHHHhc-CCccc-cc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAIL---TDWAFDCYRN-GKLDD-LV 753 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~-~~~~~~~~~~l---~~~~~~~~~~-~~~~~-l~ 753 (814)
.....||..|+|||.+.+..++.++|||||||++|||+++..++ ........... .......+.. +.... +.
T Consensus 213 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 213 --FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred --cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 23456899999999999999999999999999999999866554 32211100000 0011111110 00000 00
Q ss_pred ------------cC---------cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 754 ------------EG---------DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 754 ------------~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+. ..........+..+.+++..||+.||.+|||+.||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 00 0000011233456677999999999999999999986
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.95 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=198.6
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeecccccc----------chhhhhceeeEEeeccccceeeeeeeeccCC
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD----------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 593 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~----------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 593 (814)
..+.||+|+||.||+|.... .+..+|+|.++..... ..+.+.+|+.+++.++|+||+++++++...+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVT---TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ecceecccCceEEEEEeecC---CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 45689999999999998764 4678999987532111 1235788999999999999999999999999
Q ss_pred ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 594 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
..++|+||+++++|.+++.....+++..+..++.||+.||.|||+ .+++|+||+|+||++++++.++|+|||+++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999999887788999999999999999999995 59999999999999999999999999999865
Q ss_pred cccccccccccccCCCCccCcccccCCC--CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
.............++..|+|||.+.... ++.++||||||++++|+++|+.|+...... ....+..... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~ 231 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKR-SAP 231 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccc-cCC
Confidence 4322222123445888999999987654 889999999999999999999998532211 1111111111 111
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..........+..+.+++..||+.+|.+||++.+|++.
T Consensus 232 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 232 ----PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ----cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111122456889999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=315.85 Aligned_cols=250 Identities=23% Similarity=0.294 Sum_probs=194.7
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
++.+.||+|+||.||++.... .+..+|+|+++... ......+.+|+.++..++|+||+++++.+.+++..+|||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKD---TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 445789999999999999874 46789999986432 223456788999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc-
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS- 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~- 678 (814)
||+++|+|.+++.....+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999999999988888999999999999999999999 56999999999999999999999999999875432110
Q ss_pred --------------------------------ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCc
Q 042262 679 --------------------------------KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 726 (814)
Q Consensus 679 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~ 726 (814)
........||..|+|||++.+..++.++|||||||+++||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 000123468999999999999999999999999999999999999997
Q ss_pred ccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 042262 727 IEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT---MRKVSQ 792 (814)
Q Consensus 727 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---m~eV~~ 792 (814)
...... ....+..... ..........++++.+++.+++. ||.+|++ +.|+++
T Consensus 238 ~~~~~~-------~~~~i~~~~~------~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 238 SETPQE-------TYRKVMNWKE------TLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCHHH-------HHHHHHcCCC------ceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 543221 1111111110 00000111245677788877664 9999996 455554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.33 Aligned_cols=241 Identities=23% Similarity=0.281 Sum_probs=188.1
Q ss_pred ccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeec---cccceeeeeeeeccCCceehhhhh
Q 042262 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQT---HHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
||+|+||+||+|.... .+..+|||++..... .....+..|..++.+. +||||+++++.+.+.+..++||||
T Consensus 1 lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 7999999999999864 467899999864321 1122344455555544 699999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++|+|..++.....+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-- 152 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-- 152 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence 9999999999888889999999999999999999995 59999999999999999999999999998764322211
Q ss_pred cccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccccc
Q 042262 682 KTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~ 760 (814)
.....||..|+|||.+.+. .++.++|||||||+++||++|+.||....... ....+..+... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~------~--- 216 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKVR------F--- 216 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCCC------C---
Confidence 2345689999999998765 48999999999999999999999996543211 11222222211 0
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 042262 761 NDIKCTEKLVMVSIWCIQEDPSLRPT----MRKVSQ 792 (814)
Q Consensus 761 ~~~~~~~~l~~l~~~Cl~~dP~~RPt----m~eV~~ 792 (814)
.....+.++.+++.+||+.||.+||+ +.|+++
T Consensus 217 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11134577889999999999999995 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=304.06 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=199.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.++||+|+||.||+|.... .+..+|+|++..... ...+.+.+|+++++.++|+||+++++++..+...++|+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECC---CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4456889999999999999864 467899998864322 23456888999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++++|..+......+++..++.++.||++||+|||+ .+++|+||+|+||++++++.+||+|||++..+......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 999999999888776678999999999999999999995 59999999999999999999999999999876443321
Q ss_pred cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhh-HHHH-------HHHHHhcCCc-
Q 042262 680 AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDW-------AFDCYRNGKL- 749 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~-------~~~~~~~~~~- 749 (814)
.....++..|+|||++.+ ..++.++||||||++++||++|++||......+... .... ..........
T Consensus 157 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 157 --YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred --cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 233457889999999875 457889999999999999999999986443211000 0000 0000000000
Q ss_pred cccccCccc-----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 750 DDLVEGDTE-----AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 750 ~~l~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.....+... .......+..+.+++.+||+.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 0011245678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.33 Aligned_cols=248 Identities=27% Similarity=0.314 Sum_probs=197.4
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
...+.||+|+||.||++.... .++.+|||.+..... .....+.+|+.++++++|+||+++++.+.+.+..++||
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcC---CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 345679999999999999875 467899999865322 12345778999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+|+||||+||++++++.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999988543 45889999999999999999999 4699999999999999999999999999987654322
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
. .....|+..|+|||.+.+..++.++||||||++++||++|+.||......... ..........
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~---------- 220 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEV---------- 220 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhh----------
Confidence 1 12346899999999999999999999999999999999999999754321100 0001110000
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~eV~~ 792 (814)
........+.++.+++..||+.||++||| ++|+++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00112245567899999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=296.83 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=192.9
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-----cchhhhhceeeEEeeccccceeeeeeeecc--CCce
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-----DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNR 595 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 595 (814)
...+.||+|+||.||+|.... .+..+++|++..... +..+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVD---TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred cccceecCCCCEEEEEEEEcC---CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 445789999999999998764 467899998854321 223468889999999999999999998865 3567
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
++++||+++++|.+++.....+++..+..++.|+++||+||| +.+|+|+||||+||++++++.+||+|||+++.+..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 899999999999999987777899999999999999999999 46999999999999999999999999999986543
Q ss_pred cccc-cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 676 NQSK-AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 676 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.... .......++..|+|||.+.+..++.++||||||++++||++|+.||....... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~~~~~~~------ 226 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFKIATQPT------ 226 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHHHhcCCC------
Confidence 2111 11223457889999999999889999999999999999999999996432111 1111111111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....+....+.+.+++ .||..+|++||+|+||++
T Consensus 227 ---~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 ---NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111223445566666 688889999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=300.85 Aligned_cols=247 Identities=26% Similarity=0.315 Sum_probs=196.4
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
..+.||+|+||+||+|.... .++.+|+|.+..... .....+.+|+++++.++|+||+++.+.+..++..++|||
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred EEEEEecCCCeEEEEEEECC---CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 44679999999999999875 467899999864321 223457789999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 601 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 601 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999999888643 46899999999999999999999 46999999999999999999999999999876542211
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||........ . .........+.
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~-~~~~~~~~~~~---------- 221 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--R-EEVDRRVLETE---------- 221 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHhhhccc----------
Confidence 2234689999999999998999999999999999999999999974422111 0 11111111111
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~eV~~ 792 (814)
.......+..+.+++..|++.||++||+ +.|+++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0112345677889999999999999999 666666
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=324.74 Aligned_cols=260 Identities=21% Similarity=0.283 Sum_probs=187.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec------cccceeeeeeeeccC-C
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT------HHKNLVRLLGFCDEG-Q 593 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~-~ 593 (814)
.+.+.++||+|+||+||+|.+.. .+..||||+++... ...+++..|+.+++.+ +|.+++++++++..+ .
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcC---CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 45666889999999999999864 46789999986432 1223344455554444 456699999988654 5
Q ss_pred ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-------------
Q 042262 594 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY------------- 660 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~------------- 660 (814)
+.+||||++ +++|.+++.....+++..+..|+.||+.||+|||+ ..+||||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 688999987 77888888877789999999999999999999995 25999999999999998765
Q ss_pred ---CeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHH
Q 042262 661 ---NARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 737 (814)
Q Consensus 661 ---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 737 (814)
.+||+|||.+...... .....||..|+|||++.+..++.++|||||||++|||++|+.||+.....+...+.
T Consensus 283 ~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4999999987643211 33467899999999999999999999999999999999999999754432211111
Q ss_pred H---------HHH--------HHHhc-CCccccccCc----c---cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 738 D---------WAF--------DCYRN-GKLDDLVEGD----T---EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 738 ~---------~~~--------~~~~~-~~~~~l~~~~----~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
. |.. ..+.. +.+....++. . ...........+++|+.+||+.||.+|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0 000 00000 0000000000 0 00001112456789999999999999999999987
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=309.79 Aligned_cols=253 Identities=19% Similarity=0.216 Sum_probs=194.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||++.... .+..+|+|.+.... ......+.+|+.++..++|+||+++++++.+.+..+||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKH---TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 4556789999999999998864 46789999986421 22234578889999999999999999999999999999
Q ss_pred hhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999976 467899999999999999999999 4699999999999999999999999999998765432
Q ss_pred cccccccccCCCCccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRN-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
... .....||..|+|||.+.+ +.++.++||||||++||||++|+.||......+ .............
T Consensus 157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~- 228 (331)
T cd05624 157 TVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQ- 228 (331)
T ss_pred cee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCccc-
Confidence 211 233568999999999875 567889999999999999999999996443211 1111111110000
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSL--RPTMRKVSQM 793 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPtm~eV~~~ 793 (814)
.. ......++++.+++.+|++.++.+ |++++++++.
T Consensus 229 ----~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 ----FP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----CC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 011234678889999988865544 4678887753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=296.72 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=198.3
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc------cchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
...+.||+|+||.||+|... .+..+|||.++.... .....+.+|+.++++++|+||+++++++.+.+..+
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTN----QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred cccceEeccCCeEEEEEEEc----CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEE
Confidence 34578999999999999864 467899998864321 12245888999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
+|+||+++++|.+++.....+++..+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 999999999999999877778999999999999999999995 58999999999999999999999999998765321
Q ss_pred cc----ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 677 QS----KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 677 ~~----~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
.. ........++..|+|||.+.+..++.++||||||++++||++|+.||....... .........+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~-- 228 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFYIGAHRGLMP-- 228 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHHhhhccCCCC--
Confidence 11 111223458899999999999899999999999999999999999996432211 0000000001111
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...+.++.+++.+||+.+|.+||++.|+++
T Consensus 229 -------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 -------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 112245678899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.51 Aligned_cols=253 Identities=20% Similarity=0.231 Sum_probs=193.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||++.... .++.+|+|++... .....+.+.+|+.++..++|+||+++++++.+++..++|
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 4566889999999999999874 4678999998642 122335588899999999999999999999999999999
Q ss_pred hhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999975 4578899999999999999999994 699999999999999999999999999987654332
Q ss_pred cccccccccCCCCccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRN-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
... .....||..|+|||.+.. ..++.++|||||||++|||++|+.||......+ .............+
T Consensus 157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~ 229 (331)
T cd05597 157 TVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHFQF 229 (331)
T ss_pred Ccc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCcccC
Confidence 211 223458999999999863 457889999999999999999999996432211 11111111111110
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccC--CCCCCCHHHHHHH
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQED--PSLRPTMRKVSQM 793 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~d--P~~RPtm~eV~~~ 793 (814)
. ......++.+.+++.+|+..+ +..||+++++++.
T Consensus 230 -----~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 -----P-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----C-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 011235667788888877543 3347899888875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.53 Aligned_cols=263 Identities=22% Similarity=0.312 Sum_probs=199.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+++.+.||+|+||.||+|.+.. .+..+|+|++.... ....+.+.+|+.+++.++|+||+++++++..+...++||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRE---TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred eeeeeeecccCCeEEEEEEECC---CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 4456789999999999999864 46789999886432 223356788999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||++++.|..++.....+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 999999999888777789999999999999999999995 69999999999999999999999999999876543211
Q ss_pred cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHH--------HHHHhcCCc-
Q 042262 680 AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCYRNGKL- 749 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~~- 749 (814)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||......+......-. ...+.....
T Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 157 --YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred --ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 223447789999999876 45789999999999999999999999754332111100000 000000000
Q ss_pred cccccCcccccC-----ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 750 DDLVEGDTEAMN-----DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 750 ~~l~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.....+...... ....+..+.+++.+||+.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000001100000 1134678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=298.35 Aligned_cols=247 Identities=21% Similarity=0.345 Sum_probs=209.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
-|.+.+.||+|.|.+|-++.+.- .++.||||++.+.. ......+.+|++.|+.++|||||+||.+.....+.|||
T Consensus 19 LYDLekTlG~GHFAVVKLArHVF---TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhc---ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 45667889999999999888764 67899999997642 33345789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC-CCCCeEEeecCCccccccc
Q 042262 599 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DfGla~~~~~~ 676 (814)
.|.=.+|+|.++|.. ...+.+....+++.||+.||.|+| ..++|||||||+||.+- .-|-+||.|||++..+.++
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999999854 467899999999999999999999 46999999999999775 5688999999999887766
Q ss_pred ccccccccccCCCCccCcccccCCCCC-CccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
+. .++.+|++.|-|||++.+..|+ ++.||||+|||||.|++|+.||+...+.+...+ ++|=
T Consensus 173 ~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImDC 234 (864)
T KOG4717|consen 173 KK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMDC 234 (864)
T ss_pred ch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhcc
Confidence 54 4567899999999999999887 579999999999999999999987665443221 1111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
....+.-.+.++.+|+..||+.||.+|.+.+||+..
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 122355678899999999999999999999999863
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.92 Aligned_cols=247 Identities=23% Similarity=0.305 Sum_probs=200.0
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
.+.+.||+|+||.||++.... .+..+++|.++.. .....+.+.+|+.+++.++|+||+++++.+.+++..++||||
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVN---SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcC---CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 456789999999999998764 4678999988542 233446788899999999999999999999999999999999
Q ss_pred ccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 602 LNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 602 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
+++++|.+++.. ...++......++.|+++||.|||+ .+|+|+||||+||++++++.++|+|||++..+......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999998754 3457889999999999999999994 59999999999999999999999999999866432211
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....++..|+|||.+.+..++.++||||||+++++|++|+.||....... . ......+....
T Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~-~~~~~~~~~~~-------- 219 (255)
T cd08219 157 --ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------L-ILKVCQGSYKP-------- 219 (255)
T ss_pred --cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------H-HHHHhcCCCCC--------
Confidence 233568889999999999899999999999999999999999997432211 1 11122222211
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.+...+..+.+++.+||+.||++|||+.||+..
T Consensus 220 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 -LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.38 Aligned_cols=253 Identities=20% Similarity=0.226 Sum_probs=194.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.++||+|+||.||++.+.. .+..+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..+||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 4456789999999999999864 4678999998642 122234578889999999999999999999999999999
Q ss_pred hhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999976 4678999999999999999999994 699999999999999999999999999987654322
Q ss_pred cccccccccCCCCccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
... .....||..|+|||++. ...++.++|||||||++|||++|+.||....... .............
T Consensus 157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~- 228 (332)
T cd05623 157 TVQ-SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKERFQ- 228 (332)
T ss_pred cce-ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCcccc-
Confidence 211 23356899999999986 3468899999999999999999999997543211 1111111110000
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPS--LRPTMRKVSQM 793 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~--~RPtm~eV~~~ 793 (814)
. .......+.++.+++.+|++.++. .||++.|+++.
T Consensus 229 ----~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 ----F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 001124567788888888755444 46899988775
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=308.93 Aligned_cols=262 Identities=25% Similarity=0.300 Sum_probs=192.8
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCC----
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ---- 593 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 593 (814)
..+.+.+.||+|+||.||++.... .+..+|||++... ......++.+|+.+++.++||||+++++++...+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTV---LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcC---CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 345566889999999999998764 5678999998643 2233456788999999999999999999985443
Q ss_pred --ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 594 --NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 594 --~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
..++||||+.+ +|...+. ..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 46899999976 4555553 347888899999999999999995 599999999999999999999999999997
Q ss_pred cccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchh------------hHHH-
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA------------ILTD- 738 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~------------~l~~- 738 (814)
....... .....||..|+|||.+.+..++.++||||||+++|||++|+.||......... .+..
T Consensus 172 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 172 TACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 6543221 23356899999999999999999999999999999999999999754321100 0000
Q ss_pred ---HHHHHHhc-CCc-----cccccC---cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 739 ---WAFDCYRN-GKL-----DDLVEG---DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 739 ---~~~~~~~~-~~~-----~~l~~~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
........ ... .++... .............+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 000 000000 00001111235678999999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.26 Aligned_cols=244 Identities=30% Similarity=0.480 Sum_probs=196.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||++.. .+..+++|.++... ....+.+|+.++.+++|+||+++++++..+ ..++|||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-----~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-----TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HceeeeeeccCCCCceEeccc-----CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 456778899999999999874 35679999986432 345788999999999999999999998664 4789999
Q ss_pred hccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 601 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 601 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|+++++|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 99999999998754 357899999999999999999994 699999999999999999999999999987643221
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.....+..|+|||.+.+..++.++||||||++++||++ |+.||......+ .......+...
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~------- 216 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRM------- 216 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCCCC-------
Confidence 12234568999999998899999999999999999998 999986433211 11222222111
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
......+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 217 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 --EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1122456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=295.19 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=202.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||.||.+.... .+..+++|.+... .....+++.+|+.++++++|+||+++++++.+.+..+++|
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTE---DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred ceEeeEecccCCceEEEEEEcC---CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 3456789999999999988764 5678999987543 2344567889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999999764 568899999999999999999995 589999999999999999999999999998765433
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.. .....++..|+|||.+.+..++.++||||||++++||++|+.||......+ .... +..+....
T Consensus 156 ~~--~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~-~~~~~~~~------ 220 (256)
T cd08221 156 SM--AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVK-IVQGNYTP------ 220 (256)
T ss_pred cc--ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHH-HHcCCCCC------
Confidence 21 234458899999999998889999999999999999999999986543211 1111 12222211
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.....+.++.+++.+||+.+|.+||++.|+++.
T Consensus 221 ---~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 ---VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ---CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 113456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=298.25 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=201.6
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||+|.... .+..+++|.++.......+.+.+|++++++++|+||+++++++.++...++|||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKE---TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcC---CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 35667889999999999999864 467899999876544555678899999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++++|.+++... ..+++.....++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 99999999998663 568999999999999999999995 59999999999999999999999999998765432211
Q ss_pred cccccccCCCCccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 680 AIKTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.....++..|+|||.+. +..++.++||||||+++|||++|+.||....... . ...+..+....+
T Consensus 160 --~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~-----~~~~~~~~~~~~-- 228 (280)
T cd06611 160 --RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--V-----LLKILKSEPPTL-- 228 (280)
T ss_pred --cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--H-----HHHHhcCCCCCc--
Confidence 23345888999999974 3457889999999999999999999986442211 0 111111211111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..+...+.++.+++..||+.+|.+||++.+|++.
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 -----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1122456788999999999999999999999774
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=300.39 Aligned_cols=260 Identities=23% Similarity=0.280 Sum_probs=198.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc-----chhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD-----GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
+.+.+.||+|++|.||+|.... .++.++||+++..... ....+..|++++++++|+||+++++++.+++..+
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNIN 78 (298)
T ss_pred ceeeeeeeeccccEEEEEEECC---CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEE
Confidence 3456789999999999999864 4678999999754322 2345678999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 597 LVYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
+||||+ +++|.+++.... .+++..+..++.||++||+|||+ .+|+|+||||+||+++.++.+||+|||+++....
T Consensus 79 lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999999 999999997765 78999999999999999999995 5999999999999999999999999999987654
Q ss_pred cccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc--------
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-------- 746 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-------- 746 (814)
.... .....++..|+|||.+.+ ..++.++||||||++++||++|..+|......+. + .........
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--L-GKIFEALGTPTEENWPG 229 (298)
T ss_pred CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--H-HHHHHHcCCCchhhhhh
Confidence 3211 222346778999999865 4678999999999999999999887764432111 1 111111000
Q ss_pred -CCccccccCccc-----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 747 -GKLDDLVEGDTE-----AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 747 -~~~~~l~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
............ .......+..+.+++.+||+.+|.+|||+.||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 00112346789999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=309.14 Aligned_cols=261 Identities=25% Similarity=0.281 Sum_probs=192.4
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccC------
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------ 592 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 592 (814)
.+.+.+.||+|+||.||++.... .+..+|||++.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecC---CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45556789999999999998754 46789999986532 22345677899999999999999999987543
Q ss_pred CceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 593 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
...++||||+++ +|...+.. .+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357899999975 56555543 47888899999999999999994 6999999999999999999999999999986
Q ss_pred ccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhh-HH--------------
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LT-------------- 737 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~-------------- 737 (814)
...... .....||..|+|||.+.+..++.++||||||++++||++|+.||.......... ..
T Consensus 169 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 169 AGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred CCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 543221 233568999999999999999999999999999999999999996543111000 00
Q ss_pred -HHHHHHHhc-CCccccc------cCcc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 738 -DWAFDCYRN-GKLDDLV------EGDT--EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 738 -~~~~~~~~~-~~~~~l~------~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
......... .....+. +... ..........++.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 0000000 0000 011122345678999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=299.01 Aligned_cols=249 Identities=21% Similarity=0.360 Sum_probs=198.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+++.+.||+|+||.||++.... .+..+|+|.++.. ......++.+|+.++++++|+||+++++.+...+..++|+|
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRP---TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcC---CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4567889999999999999864 4678999988643 22234578899999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 601 FLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 601 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|+++++|..++... ..+++..+..++.|++.||.|||+ ..+|+|+||||+||+++.++.+||+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999988763 368999999999999999999995 3589999999999999999999999999987654322
Q ss_pred cccccccccCCCCccCcccccCCC------CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNST------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~------~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
.....++..|+|||.+.+.. ++.++|||||||+++||++|+.||......... . .......+...
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~-~~~~~~~~~~~- 228 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---A-QLSAIVDGDPP- 228 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---H-HHHHHhhcCCC-
Confidence 22345788999999985543 588999999999999999999999654321110 0 01111111111
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+..++.++.+++.+||+.+|.+||++.++++
T Consensus 229 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 --------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred --------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 122346788999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.46 Aligned_cols=259 Identities=21% Similarity=0.308 Sum_probs=195.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.++||+|+||.||+|.... .+..||+|.++... ......+.+|+.+++.++|+||+++++++.+++..++|+|
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKL---TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcC---CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 4556789999999999998764 46789999986432 2233467789999999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|++ ++|.+++.. ...+++.....++.||++||+||| +.+|+|+||||+||++++++.+||+|||++.........
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 997 588887765 356789999999999999999999 469999999999999999999999999999765432211
Q ss_pred cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc---CCcccccc-
Q 042262 680 AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---GKLDDLVE- 754 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~l~~- 754 (814)
.....++..|+|||.+.+. .++.++||||||++++||++|+.||......+.. ......+.. ........
T Consensus 161 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 161 --YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred --ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCChhhchhhhcc
Confidence 1223468899999998654 5788999999999999999999999754332111 111111000 00000000
Q ss_pred --------Cccc----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 755 --------GDTE----AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 755 --------~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+... .......+..+.+++.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 0011234667889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.64 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=201.3
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeecc--CCceehh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLLV 598 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 598 (814)
++.+.||.|+||.||++.... .+..+++|.+... .....+++.+|+.+++.++|+||+++++++.. +...+++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred eeeeeeccCCCeEEEEeeecC---CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 455789999999999998875 4578999988642 23334568889999999999999999997753 4567899
Q ss_pred hhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 599 YEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDC--SAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
|||+++++|.+++.. ...+++..++.++.||++||+|||..+ +.+++|+||||+||++++++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999864 357899999999999999999999543 56999999999999999999999999999987
Q ss_pred ccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
....... .....++..|+|||.+.+..++.++||||||+++++|++|+.|+...... . ..+....+...
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~~-- 228 (265)
T cd08217 160 LGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---Q----LASKIKEGKFR-- 228 (265)
T ss_pred ccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---H----HHHHHhcCCCC--
Confidence 6543321 22345889999999999988999999999999999999999999754311 1 11222222221
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..+...+..+.+++.+|++.+|.+||+++||++.
T Consensus 229 -------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 -------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1223556789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=295.52 Aligned_cols=246 Identities=28% Similarity=0.401 Sum_probs=200.4
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-----ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
...+.||+|++|.||+|.... ++..+++|.+.... .+..+.+.+|+.+++.++|+||+++++++.++...++
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLD---DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred cccceeeecCCceEEEEEEcC---CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence 345789999999999999864 46789999886432 2234678999999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|+||+++++|.+++.....+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999999877778999999999999999999994 599999999999999999999999999988764433
Q ss_pred cccccccccCCCCccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
......++..|+|||.+.... ++.++|+||||+++++|++|+.||...... .............
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~------ 221 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELP------ 221 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCC------
Confidence 123455888999999998776 899999999999999999999998654311 1111111111111
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+......+.+++.+||+.+|.+||++.++++
T Consensus 222 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 ---PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 112245678899999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.94 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=198.7
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 605 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 605 (814)
..||+|+||.||++.... .+..+++|.+........+.+.+|+.++..++||||+++++++..++..++|+||++++
T Consensus 27 ~~ig~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 27 IKIGEGSTGIVCIAREKH---SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhcCCCCceeEEEEEEcC---CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 469999999999998764 46789999986554455567889999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccc
Q 042262 606 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI 685 (814)
Q Consensus 606 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 685 (814)
+|..++.. ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++......... ....
T Consensus 104 ~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~ 177 (297)
T cd06659 104 ALTDIVSQ-TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSL 177 (297)
T ss_pred CHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccce
Confidence 99987754 468899999999999999999994 59999999999999999999999999998765433221 2334
Q ss_pred cCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhH
Q 042262 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKC 765 (814)
Q Consensus 686 ~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 765 (814)
.++..|+|||++.+..++.++||||||++++||++|+.||........ ...+....... .......
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~-------~~~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-------MKRLRDSPPPK-------LKNAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhccCCCC-------ccccCCC
Confidence 588999999999988999999999999999999999999974432111 01111111110 0112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 766 TEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 766 ~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+..+.+++..||+.+|.+||++.||++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 5678899999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.18 Aligned_cols=264 Identities=24% Similarity=0.327 Sum_probs=202.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+++.+.||+|+||.||+|.... .+..++||+++... ....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKA---TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCC---CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 4566789999999999999864 46789999986532 233467899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||++++.|..++.....+++..+..++.||++||+|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 999998888777666778999999999999999999995 59999999999999999999999999999876654321
Q ss_pred cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHH--------HHH-hcCCc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DCY-RNGKL 749 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~-~~~~~ 749 (814)
. .....++..|+|||++.+. .++.++||||||++++||++|+.||......+......... ..+ .....
T Consensus 157 ~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 157 P-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred c-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 1 2335578899999999888 88999999999999999999999987543221100000000 000 00000
Q ss_pred -----cccccCc-ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 750 -----DDLVEGD-TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 750 -----~~l~~~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....+.. .....+..++.++.+++.+||+.+|++|||+++|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000 001112234788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=294.10 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=199.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeecc-CCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV 598 (814)
+.+.+.||+|++|.||++.... .+..+++|++.... ....+.+.+|++++++++|+|++++++.+.. ....++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRT---DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcC---CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 4567889999999999999864 45689999986432 2334568889999999999999999998764 4457899
Q ss_pred hhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 599 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||+++++|.+++... ..+++.++..++.+++.||+|||+ .+++|+||||+||++++++.++|+|||++..+...
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999998753 458999999999999999999994 59999999999999999999999999999876432
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.. ......++..|+|||.+.+..++.++||||||++++||++|+.||...... .... ....+.+..
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~-~~~~~~~~~----- 221 (257)
T cd08223 156 CD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVY-RIIEGKLPP----- 221 (257)
T ss_pred CC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHH-HHHhcCCCC-----
Confidence 22 123445788999999999999999999999999999999999998643211 1111 112222211
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.+...+..+.+++.+|++.+|++||++.|+++.
T Consensus 222 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 ----MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 123456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.88 Aligned_cols=257 Identities=24% Similarity=0.333 Sum_probs=193.7
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.||+|++|.||+|.... .+..+|||+++... ....+.+.+|+.++++++||||+++++++.++...++|+|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred eEeeEecccCceEEEEEEECC---CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 455789999999999999864 46789999986432 2234568889999999999999999999999999999999
Q ss_pred hccCCchhhhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 601 FLNNGTLASFLFG---NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 601 ~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|++ ++|.+++.. ...+++..+..++.||++||+|||+ .+|+|+||||+||++++++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 997 678877753 2568999999999999999999994 699999999999999999999999999998654332
Q ss_pred cccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHh---cC------
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---NG------ 747 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~------ 747 (814)
.. .....++..|+|||.+.+. .++.++||||||++++||++|+.||........ +.... ..+. +.
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 RV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIF-RILGTPTEDVWPGVT 230 (285)
T ss_pred cc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-HHhCCCChhhhhcch
Confidence 11 2233468899999988654 578999999999999999999999975432110 00000 0000 00
Q ss_pred -------CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 748 -------KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 748 -------~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.......... .......+.++.+++.+||+.||.+|||+.||++
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 231 SLPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0011235678889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=294.51 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=201.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc--chhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+...+.||+|+||.||+|.... .+..+++|.++..... ..+++.+|+.++++++|+||+++++++.+.+..++|+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLD---TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECC---CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 3456789999999999998764 4678999998754432 5678999999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++++|.+++.....+++..+..|+.|+++||+|||+ .+|+|+||+|+||++++++.+||+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 999999999999887778999999999999999999994 59999999999999999999999999999876543322
Q ss_pred cc--cccccCCCCccCcccccCCC---CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 680 AI--KTAIRGTKGYVAPEWFRNST---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 680 ~~--~~~~~gt~~y~aPE~~~~~~---~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.. .....++..|+|||.+.+.. .+.++||||||++++|+++|+.||....... ..... ...+....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~-~~~~~~~~--- 226 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFH-VGAGHKPP--- 226 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHH-HhcCCCCC---
Confidence 11 11345788999999998766 8899999999999999999999996432111 01111 11111111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.......+..+.+++.+||+.+|.+|||+.|++.
T Consensus 227 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 ----IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111234677889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=303.02 Aligned_cols=196 Identities=23% Similarity=0.402 Sum_probs=158.0
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeec--cCCceehhhhhcc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD--EGQNRLLVYEFLN 603 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~lV~e~~~ 603 (814)
.+||+|+||.||+|...... ....+|+|.++... ....+.+|++++++++||||+++++++. .+...++|+||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~-~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCC-ccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 47999999999999975432 45789999886532 2346788999999999999999999884 3557789999987
Q ss_pred CCchhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----CCCCCeEEeecCCc
Q 042262 604 NGTLASFLFG---------NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLA 670 (814)
Q Consensus 604 ~gsL~~~l~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DfGla 670 (814)
+ +|.+++.. ...+++..+..++.||++||.|||+ .+|+||||||+||++ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 66665531 1347888999999999999999994 699999999999999 56678999999999
Q ss_pred ccccccccc-cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCccc
Q 042262 671 KLLTLNQSK-AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIE 728 (814)
Q Consensus 671 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~ 728 (814)
+........ .......+|..|+|||.+.+. .++.++||||||++++||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 112335689999999998764 5899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=308.29 Aligned_cols=261 Identities=25% Similarity=0.276 Sum_probs=192.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccC------
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------ 592 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 592 (814)
.+.+.+.||+|+||.||++.... .+..+|||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECC---CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 45566889999999999998764 46789999986532 23345678899999999999999999987543
Q ss_pred CceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 593 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
...++||||+.+ +|...+.. .+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 357999999975 66666543 47888899999999999999994 6999999999999999999999999999986
Q ss_pred ccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhh-H-----------HH--
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-L-----------TD-- 738 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-l-----------~~-- 738 (814)
...... .....+|..|+|||.+.+..++.++|||||||+++||++|+.||......+... . ..
T Consensus 176 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 176 AGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 543221 234568999999999999999999999999999999999999996543211000 0 00
Q ss_pred --HHHHHHhcC-Cc-----cccccC---cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 739 --WAFDCYRNG-KL-----DDLVEG---DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 739 --~~~~~~~~~-~~-----~~l~~~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.......+. .. ..+... .............+.+++.+||+.||.+|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 00 000000 00001111234678899999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=299.09 Aligned_cols=260 Identities=20% Similarity=0.282 Sum_probs=194.5
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||.||+|.... .+..+++|+++... ......+.+|+.++++++|+||+++++++.+....++|+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~---~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred ceeEEEecccCCeEEEEEEECC---CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 3456789999999999999875 46789999886432 223356788999999999999999999999999999999
Q ss_pred hhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++ +|.+++.. ...+++.....++.||++||.|||+ .+|+|+||||+||+++.++.+||+|||+++.+.....
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 99974 67776654 4668999999999999999999995 5999999999999999999999999999986543322
Q ss_pred ccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC------ccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK------LDD 751 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~ 751 (814)
. .....++..|+|||.+.+. .++.++||||||++++||++|+.|+........ .+ ........... +..
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHHhHHhhh
Confidence 1 2234578899999998765 478999999999999999999998654322111 00 11111100000 000
Q ss_pred cccC----ccc-----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 752 LVEG----DTE-----AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 752 l~~~----~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+. ... .......+.++.+++.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 000 0111235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=300.89 Aligned_cols=255 Identities=19% Similarity=0.265 Sum_probs=201.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||++.... .+..|++|.+.... ....+.+.+|+++++.++|+||+++++.+.+++..++|
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKE---TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECC---CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 3456789999999999999864 46789999886542 22345678899999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++++|.+++.....+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999999887788999999999999999999995 5999999999999999999999999999874211110
Q ss_pred -------------ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHh
Q 042262 679 -------------KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 745 (814)
Q Consensus 679 -------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 745 (814)
........++..|+|||.+.+..++.++||||||++++|+++|+.||......+ ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-------~~~~~~ 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LFGQVI 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHH
Confidence 001122457889999999998899999999999999999999999986432211 111111
Q ss_pred cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 746 NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 746 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
.+.... +. .....+.++.+++.+||+.+|++||++.++.++|+.
T Consensus 230 ~~~~~~---~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SDDIEW---PE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hcccCC---CC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111110 00 111456788999999999999999997777777755
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=293.75 Aligned_cols=247 Identities=21% Similarity=0.319 Sum_probs=201.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||.||++.... .+..+++|++... .....+++.+|+.++++++|+||+++++++.+.+..++|+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcC---CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 3456789999999999999864 4678999988642 2233457899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999988653 357889999999999999999995 599999999999999999999999999998664332
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.. .....|+..|+|||.+.+...+.++||||||++++||++|+.|+...... +..... ..+...
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~-~~~~~~------- 219 (256)
T cd08218 156 EL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKI-IRGSYP------- 219 (256)
T ss_pred hh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHH-hcCCCC-------
Confidence 21 12345788999999999989999999999999999999999998643221 111111 122211
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...+.++.+++.+||+.+|.+||+|.||++
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 --PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 112345678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=295.24 Aligned_cols=244 Identities=25% Similarity=0.378 Sum_probs=198.7
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 605 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 605 (814)
+.||+|++|.||++.... .+..+++|++........+.+.+|+.+++.++|+||+++++++..+++.++|+||++++
T Consensus 25 ~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~ 101 (285)
T cd06648 25 VKIGEGSTGIVCIATDKS---TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG 101 (285)
T ss_pred eEeccCCCeEEEEEEECC---CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCC
Confidence 589999999999998764 45789999886554445567889999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccc
Q 042262 606 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI 685 (814)
Q Consensus 606 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 685 (814)
+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.++|+|||++......... ....
T Consensus 102 ~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~ 175 (285)
T cd06648 102 ALTDIVTH-TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSL 175 (285)
T ss_pred CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--cccc
Confidence 99999877 568999999999999999999995 59999999999999999999999999988765432211 2234
Q ss_pred cCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhH
Q 042262 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKC 765 (814)
Q Consensus 686 ~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 765 (814)
.|+..|+|||.+.+..++.++||||||++++||++|+.||....... . ......+..... ......
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~-~~~~~~~~~~~~-------~~~~~~ 241 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------A-MKRIRDNLPPKL-------KNLHKV 241 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------H-HHHHHhcCCCCC-------cccccC
Confidence 58889999999998889999999999999999999999986432211 1 111222211111 112235
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 766 TEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 766 ~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+..+.+++.+||+.+|++||++.|+++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 678999999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.90 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=194.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+...+.||+|+||.||+|.... .+..+++|.+..... ...+++.+|+++++.++||||+++++++.+++..++
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 35566789999999999999864 467899998854322 233568899999999999999999999999999999
Q ss_pred hhhhccCCchhhhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|+||+. |+|.+++. ....+++..+..++.|++.||.|||+ .+|+|+||+|+||++++++.+||+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 999997 56666554 34568999999999999999999994 59999999999999999999999999998765432
Q ss_pred ccccccccccCCCCccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+....... ..... ..+..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~~-~~~~~---- 231 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHI-AQNDS---- 231 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHHH-hcCCC----
Confidence 2345788999999884 4568899999999999999999999986432111 01111 11111
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
........+..+.+++.+||+.+|++||+|.+|++.
T Consensus 232 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 ----PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111123456789999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=295.34 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=202.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+++.+.||+|++|.||++.+.. .+..+++|++.... ....+++.+|++++++++|+||+++++.+......++|+|
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRP---TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcC---CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 3456789999999999999864 46789999986543 3345678899999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++++|.+++... ..++......++.|+++||+|||. ..+++|+||||+||++++++.+||+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 99999999999765 778899999999999999999994 169999999999999999999999999998766432211
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
...++..|+|||.+.+..++.++||||||+++++|++|+.|+......... ..+.... ...+... .
T Consensus 158 ----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~-~~~~~~~--------~ 223 (265)
T cd06605 158 ----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQY-IVNEPPP--------R 223 (265)
T ss_pred ----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHH-HhcCCCC--------C
Confidence 255788999999999999999999999999999999999998654321111 1111111 1111111 1
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
......+.++.+++..||+.+|.+|||+.|++.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111126678999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=294.00 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=199.9
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeeccccc------cchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
..+.||+|++|.||+|.... .+..+|+|.+..... ...+.+++|++++++++|+||+++++++.+++..++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~---~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVK---TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred ccceecCcCceEEEEEEEcC---CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 44679999999999998754 467899998864321 124678999999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-CeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~ 676 (814)
|+||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999877788999999999999999999995 5999999999999998775 5999999999876543
Q ss_pred ccc--cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 677 QSK--AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 677 ~~~--~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
... .......++..|+|||.+.+..++.++||||+|+++++|++|+.||......... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~------ 228 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASATT------ 228 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhccCC------
Confidence 211 1122345788999999998888999999999999999999999998643321111 11111111110
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....+...+.++.+++.+|++.+|.+||++.|+++
T Consensus 229 ---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ---APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11223356688999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=330.09 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=197.2
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeecc--
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-- 591 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-- 591 (814)
+.....+.+.+.||+|+||+||++.+.. .+..+|+|.+... .......|..|+.++..++|||||++++++.+
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~---tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKR---TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECC---CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 3334456777899999999999999874 4678999988642 22334678899999999999999999998744
Q ss_pred CCceehhhhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcC----CCCeeecCCCCCcEEECCC----
Q 042262 592 GQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDC----SAQIIHCDIKPQNILLDDY---- 659 (814)
Q Consensus 592 ~~~~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~iiH~Dikp~NIll~~~---- 659 (814)
....+|||||+++++|.++|.. ...+++..++.|+.||+.||+|||... ..+||||||||+||||+.+
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 4568999999999999998864 256899999999999999999999642 1469999999999999642
Q ss_pred -------------CCeEEeecCCcccccccccccccccccCCCCccCcccccC--CCCCCccchhhHHHHHHHHHhCCcC
Q 042262 660 -------------YNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKS 724 (814)
Q Consensus 660 -------------~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~Gvvl~elltG~~p 724 (814)
..+||+|||+++.+..... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.|
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred ccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 3489999999987643221 234568999999999854 4589999999999999999999999
Q ss_pred CcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 725 FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 725 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
|....... . ....+..+. .+ .....+.++.+|+..||+.+|.+||++.|+++
T Consensus 243 F~~~~~~~-----q-li~~lk~~p-------~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 243 FHKANNFS-----Q-LISELKRGP-------DL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcCCcHH-----H-HHHHHhcCC-------CC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 96432211 1 111111111 00 11134578899999999999999999999984
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=293.97 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=200.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.+.||+|+||.||+|.... .+..+|+|.+.... ....+.+.+|+.++.+++|+||+++++++.++...++||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECC---CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 44566789999999999998754 46789999876432 233467889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++++|.+++.. ..+++..+..++.|++.+|.|||+ .+++|+||||+||++++++.++|+|||++..+......
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 99999999998864 457899999999999999999995 69999999999999999999999999998766432211
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....++..|+|||.+.+..++.++||||||++++||++|..|+....... .......+...
T Consensus 158 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~--------- 219 (277)
T cd06641 158 --RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNNPP--------- 219 (277)
T ss_pred --hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcCCCC---------
Confidence 223457889999999998889999999999999999999999986432211 11111111111
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
......+.++.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1122456788899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=291.96 Aligned_cols=251 Identities=26% Similarity=0.355 Sum_probs=205.8
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
++.+.||+|++|.||++.... .+..++||++..... ...+++.+|+..+.+++|+||+++++++...+..++|+||
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~---~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 455789999999999999875 467899999876433 3457899999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++++|.+++.....+++..+..++.|+++||+|||+ ..+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 156 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-- 156 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence 9999999999887889999999999999999999994 169999999999999999999999999999876543322
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+..........+ .. .+...... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~-~~~~~~~~---------~~ 223 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQ-AICDGPPP---------SL 223 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH---HH-HHhcCCCC---------CC
Confidence 1234578899999999999999999999999999999999999865432111111 11 11111111 11
Q ss_pred Chh-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 762 DIK-CTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 762 ~~~-~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+.. .++.+.+++..||+.+|++||++.|+++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 222 66889999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=296.04 Aligned_cols=249 Identities=26% Similarity=0.359 Sum_probs=192.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeec-----cCCce
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCD-----EGQNR 595 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~-----~~~~~ 595 (814)
+.+.+.||+|+||.||++.... .+..+++|.++.. .....++.+|+.++.++ +|+||+++++++. .+...
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECC---CCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 4455789999999999999865 4678999987643 22345688899999998 6999999999883 34568
Q ss_pred ehhhhhccCCchhhhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 596 LLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
++||||+++++|.+++. ....+++..+..++.|+++||.|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 99999999999998874 23567888999999999999999994 699999999999999999999999999998
Q ss_pred cccccccccccccccCCCCccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
.+...... .....|+..|+|||.+. +..++.++|||||||+++||++|+.|+....... .+ . ....
T Consensus 173 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~----~-~~~~ 243 (286)
T cd06638 173 QLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--AL----F-KIPR 243 (286)
T ss_pred ecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HH----h-hccc
Confidence 76432211 22345899999999985 3457889999999999999999999986432211 00 0 0011
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+...... .+...+..+.+++.+||+.+|++|||+.||++.
T Consensus 244 ~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 244 NPPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cCCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1111111 122345678999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=292.32 Aligned_cols=248 Identities=21% Similarity=0.290 Sum_probs=194.5
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-----ccchhhhhceeeEEeeccccceeeeeeeeccC--Cce
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNR 595 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 595 (814)
.+.+.||+|+||.||+|.... .+..++||.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDAD---TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred eEeeEEecCCceEEEEEEEcC---CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 445789999999999999864 46789999875321 11234678899999999999999999988664 457
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
++|+||+++++|.+++.....+++....+++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.+..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 7999999999999999877778899999999999999999995 5899999999999999999999999999986543
Q ss_pred cccc-cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 676 NQSK-AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 676 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.... .......++..|+|||.+.+..++.++||||||++++||++|+.||....... . ........
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~------- 225 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIATQP------- 225 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H-HHHHhcCC-------
Confidence 2111 11223458889999999998889999999999999999999999986432111 0 11111111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.....+......+.+++..|+. +|.+||+++||++
T Consensus 226 --~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 --TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1111234556778889999985 8999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=298.71 Aligned_cols=240 Identities=26% Similarity=0.341 Sum_probs=197.3
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
..||.|.||.||-+.+.. ....||||++.-.. .....++..|+..|..++|||+|..-|++..+...+||||||
T Consensus 32 rEIGHGSFGAVYfArd~~---n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC 108 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC 108 (948)
T ss_pred HHhcCCccceeEEeeccC---ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH
Confidence 469999999999999875 56799999996432 223467899999999999999999999999999999999999
Q ss_pred cCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 603 NNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 603 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
- ||-.+++.- .+++....+..|..+.+.||+||| +.+.||||||+.||||++.+.+||+|||.+..+.+.
T Consensus 109 l-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 109 L-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred h-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 4 577777653 456788899999999999999999 569999999999999999999999999999887653
Q ss_pred cccccCCCCccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 682 KTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
..++||+-|||||++. .+.|+-|+||||+|++..||.-.++|...... ...+ -.+..+ ..+
T Consensus 180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--MSAL-----YHIAQN--------esP 243 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSAL-----YHIAQN--------ESP 243 (948)
T ss_pred -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--HHHH-----HHHHhc--------CCC
Confidence 4567999999999984 57899999999999999999999998753221 1111 111112 222
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.....+.+..++.++..||+.-|.+|||..+++..
T Consensus 244 tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 244 TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 22355889999999999999999999999988763
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=306.88 Aligned_cols=256 Identities=25% Similarity=0.303 Sum_probs=191.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccC------
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------ 592 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 592 (814)
.+...+.||+|+||.||+|.... .+..||||++..... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTR---LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhheecccCCCeEEEEEEECC---CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 45556789999999999998764 467899999865321 2345677899999999999999999987543
Q ss_pred CceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 593 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
...++++|++ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++.
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 3568999987 7788887753 468999999999999999999995 5999999999999999999999999999986
Q ss_pred ccccccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHH-------
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY------- 744 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~------- 744 (814)
.... .....||..|+|||.+.+ ..++.++||||||++++||++|+.||....... .+..+ ....
T Consensus 168 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~-~~~~~~~~~~~ 239 (343)
T cd07878 168 ADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRI-MEVVGTPSPEV 239 (343)
T ss_pred cCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHH-HHHhCCCCHHH
Confidence 5432 233468999999999977 468999999999999999999999996432211 00000 0000
Q ss_pred ----hcCC-------ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 745 ----RNGK-------LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 745 ----~~~~-------~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.... +.......... ........+.+++.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00000000000 001223467899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=297.24 Aligned_cols=247 Identities=24% Similarity=0.298 Sum_probs=195.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+...+.||+|+||.||+|.... .+..+++|++..... +..+++.+|+++++.++|+|++++++++.++...+||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcC---CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 4456789999999999999864 467899999864322 2235688899999999999999999999999999999
Q ss_pred hhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||+.+ +|.+.+.. ...+++..+..++.|++.||.|||+ .+|+|+||+|+||++++++.+||+|||++......
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 999975 67666643 4568999999999999999999995 59999999999999999999999999998754322
Q ss_pred cccccccccCCCCccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
....++..|+|||++. ++.++.++||||||++++||++|+.||....... ........+.
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~------ 241 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNES------ 241 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhccC------
Confidence 2345788999999973 4568999999999999999999999986432111 0111111111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
........+..+.+++.+||+.+|.+||++.+|++.+--
T Consensus 242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 111122456778999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.59 Aligned_cols=243 Identities=25% Similarity=0.283 Sum_probs=189.4
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeE---EeeccccceeeeeeeeccCCceehhhh
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVV---IGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~---l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.||+|+||.||++.... .+..+|+|.+..... .....+.+|..+ +...+|+||+.+++++..++..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECC---CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 48999999999999864 567899998864321 112233444333 333479999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
|+++++|.+++.....+++.....|+.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++.......
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999999999887889999999999999999999994 689999999999999999999999999987553221
Q ss_pred ccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 681 IKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....|+..|+|||.+.+ ..++.++||||||++++||++|+.||..........+ ...... ...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~----------~~~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT----------VNV 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHHhhc----------CCc
Confidence 223458999999999864 5689999999999999999999999975433221111 111000 011
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQM 793 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~~ 793 (814)
..+...+.++.+++..||+.||.+|| |++|+++.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 12334567899999999999999999 69999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-33 Score=290.03 Aligned_cols=246 Identities=25% Similarity=0.371 Sum_probs=198.5
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|++|.||++.... .+..++||.+... .....+.+.+|+.++++++|+||+++++.+..++..++|+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKA---DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred ceEEEEecccCceEEEEEEEcC---CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 3456789999999999999864 5678999988643 2233567899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CCeEEeecCCccccccc
Q 042262 600 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-YNARISDFGLAKLLTLN 676 (814)
Q Consensus 600 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGla~~~~~~ 676 (814)
||+++++|.+++... ..+++..+..++.+++++|+|||+ .+++|+||||+||+++++ ..+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999999753 457899999999999999999995 599999999999999865 45899999999876543
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.. .....++..|+|||.+.+..++.++||||||+++++|++|+.||....... ..... ..+....
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~-~~~~~~~----- 220 (256)
T cd08220 156 SK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKI-MSGTFAP----- 220 (256)
T ss_pred cc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHH-HhcCCCC-----
Confidence 22 223457889999999998889999999999999999999999986543211 11111 1111111
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+...+..+.+++.+||+.+|.+|||+.|+++
T Consensus 221 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ----ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 12235678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=292.48 Aligned_cols=247 Identities=24% Similarity=0.376 Sum_probs=197.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeecc---ccceeeeeeeeccCCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~l 597 (814)
+.+.+.||+|+||.||+|.+.. .+..+++|.+.... ....+++.+|+.++++++ |+|++++++++.++...++
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVP---TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhheeccCCceEEEEEEcC---CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 3456789999999999999864 46789999886432 233456888988888886 9999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+++++|.+++... .+++.....++.|+++||.|||+ .+|+|+||+|+||++++++.++|+|||++..+....
T Consensus 80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999999999998654 78899999999999999999994 599999999999999999999999999998765443
Q ss_pred cccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.. .....|+..|+|||.+.++ .++.++||||||+++++|++|+.||........ . ......... .
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~-~~~~~~~~~-----~ 221 (277)
T cd06917 156 SK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M-MLIPKSKPP-----R 221 (277)
T ss_pred cc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h-hccccCCCC-----C
Confidence 22 2334588899999998754 578999999999999999999999974432110 0 011111111 1
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
. .....+.++.+++.+||+.||.+||++.|+++
T Consensus 222 ~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 L---EDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred C---CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1 11125678899999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=298.81 Aligned_cols=250 Identities=22% Similarity=0.249 Sum_probs=198.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc---chhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|++|.||++.... .+..+|+|.+...... ..+.+.+|++++..++|+||+++++.+.+++..++|
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcC---CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 3455789999999999998864 4678999998653222 345688999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 599 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||+.+++|.+++... ..+++..+..++.|+++||+|||. .+++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999998753 568999999999999999999994 69999999999999999999999999998755322
Q ss_pred cccc---------------------------ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccC
Q 042262 677 QSKA---------------------------IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEM 729 (814)
Q Consensus 677 ~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~ 729 (814)
.... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1100 0112357889999999999889999999999999999999999996443
Q ss_pred CcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 042262 730 GEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT----MRKVSQ 792 (814)
Q Consensus 730 ~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt----m~eV~~ 792 (814)
.... + ... ... ..........+..+.+++.+||+.+|++||| +.|+++
T Consensus 237 ~~~~--~----~~~-~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET--F----SNI-LKK--------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH--H----HHH-hcC--------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2211 1 111 111 1111111225788999999999999999999 666666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=294.75 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=199.5
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|++|.||+|.... .+..++||++.... ....+.+.+|+.++++++|+||+++++++..+...++|+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred ceEEeecccCCCcEEEEEEECC---CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 4566789999999999999864 46789999986543 333567899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+ +++|.+++.. ...+++.++..++.||++||+|||+ .+++|+||||+||++++++.++|+|||++........
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 999 9999998864 4568999999999999999999994 5999999999999999999999999999987654332
Q ss_pred ccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC------Cccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG------KLDD 751 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~ 751 (814)
.. .....++..|+|||.+.+. .++.++||||+|++++||++|+++|....... ........+... ...+
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 RL-YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred Cc-cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccC
Confidence 11 2334588999999998654 46899999999999999999988775433211 111111111000 0000
Q ss_pred ccc------Cccc----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 752 LVE------GDTE----AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 752 l~~------~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+.+ .... .....+.+..+.+++.+||+.+|++|||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0000 00112345889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=295.41 Aligned_cols=243 Identities=26% Similarity=0.296 Sum_probs=200.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||++.... .++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 3556789999999999999875 46789999986432 22345688899999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++++|.+++.....++...+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999999888889999999999999999999995 69999999999999999999999999999876543
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.....++..|+|||.+.+...+.++||||||++++||++|+.||...... ........+..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~--------- 215 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGKV--------- 215 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCc---------
Confidence 22345788999999998888999999999999999999999998644311 11111112211
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~ 792 (814)
..+...+..+.+++.+||+.+|.+|| +++|+++
T Consensus 216 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 -RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11223467889999999999999999 6777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=289.45 Aligned_cols=243 Identities=23% Similarity=0.303 Sum_probs=197.9
Q ss_pred ccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
||.|++|.||++.... .+..+++|.+.... ....+.+.+|+.+++.++|+||+++++++.++...++|+||+++
T Consensus 1 lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKS---KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 6999999999999864 46789999986432 23446789999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccccc
Q 042262 605 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA 684 (814)
Q Consensus 605 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 684 (814)
++|.+++.....+++..+..++.||+.||+|||+ .+++|+||+|+||+++.++.+||+|||+++....... ...
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~~ 151 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWT 151 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---ccc
Confidence 9999999887788999999999999999999994 6999999999999999999999999999987654321 223
Q ss_pred ccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChh
Q 042262 685 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIK 764 (814)
Q Consensus 685 ~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 764 (814)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||.....+.. ........ + ......+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~-~--------~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EIYNDILK-G--------NGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HHHHHHhc-c--------CCCCCCCcc
Confidence 4578899999999888899999999999999999999999975542111 11111111 0 011112223
Q ss_pred HHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042262 765 CTEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 792 (814)
Q Consensus 765 ~~~~l~~l~~~Cl~~dP~~RPt-----m~eV~~ 792 (814)
.+.++.+++..||+.+|++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 3678999999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=294.67 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=201.1
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||++.... .+..+++|.+........+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVA---TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcC---CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 45566789999999999998754 456799999865444455678899999999999999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
|+++++|.+++... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 97 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~- 171 (293)
T cd06647 97 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (293)
T ss_pred cCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-
Confidence 99999999998654 57889999999999999999994 59999999999999999999999999998765433221
Q ss_pred ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~ 760 (814)
.....++..|+|||.+.+..++.++||||||++++|+++|+.||.......... .....+ .....
T Consensus 172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~--------~~~~~ 236 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG--------TPELQ 236 (293)
T ss_pred -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCC--------CCCCC
Confidence 223457889999999988889999999999999999999999997543221100 000001 00111
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 761 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.....+..+.+++..||+.+|++||++.+++..
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122345678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=292.98 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=201.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.+.||+|++|.||+|.+.. .+..+++|.+..... ..+.+.+|+++++.++|+||+++++.+......++|+||
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred chHhHhccCCCCeEEEEEEEcc---CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 3445789999999999999874 467899999875433 456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 602 LNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 602 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 172 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK- 172 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh-
Confidence 99999999998766 89999999999999999999994 69999999999999999999999999988765432211
Q ss_pred ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~ 760 (814)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+........ ... ........ ..
T Consensus 173 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~~-------~~ 237 (286)
T cd06614 173 -RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFL-ITTKGIPP-------LK 237 (286)
T ss_pred -hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhcCCCC-------Cc
Confidence 2233478899999999988899999999999999999999999864432110 011 11111111 11
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 761 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.....+..+.+++.+|++.+|.+||++.+|++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 12235678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=293.74 Aligned_cols=259 Identities=23% Similarity=0.282 Sum_probs=197.1
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccC--Cceehh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLV 598 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 598 (814)
++.+.||+|++|.||+|.... .+..+++|++.... ......+.+|+.++++++|+|++++++++.+. +..++|
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKK---TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred eeeEEeccCCCeEEEEEEECC---CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 355789999999999999874 46789999997653 23345688899999999999999999999887 889999
Q ss_pred hhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
+||+++ +|.+++... ..+++..++.++.||++||+|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 999975 888888665 578999999999999999999995 599999999999999999999999999998765443
Q ss_pred cccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc---CCcccc-
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---GKLDDL- 752 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~l- 752 (814)
... .+...++..|+|||.+.+ ..++.++||||||++++||++|+.||......... ......... ......
T Consensus 155 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 SAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL---EKIFELCGSPTDENWPGVS 230 (287)
T ss_pred ccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchhhccccc
Confidence 211 223346788999998765 46789999999999999999999999754432111 111111000 000000
Q ss_pred -------------ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 753 -------------VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 753 -------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
............++..+.+++.+||+.+|.+||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000111113678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=291.43 Aligned_cols=253 Identities=26% Similarity=0.340 Sum_probs=198.1
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeecc--CCceehhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLLVY 599 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 599 (814)
...+.||.|++|.||++.+.. .+..+|+|.+..... ....++.+|++++++++|+||+++++++.+ .+..++||
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKN---TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred EEEEEeccCCceEEEEEEECC---CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 345789999999999999874 467899999864322 345678999999999999999999998854 34689999
Q ss_pred hhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 600 EFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 600 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
||+++++|.+++.. ...++......|+.||++||+|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999987643 3557889999999999999999995 6999999999999999999999999999876543
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCc--chhhHHHHHHHHHhcCCccccc
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE--EYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....+..+ ........+.
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 229 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY----IVNMPNPELK 229 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH----HhcCCchhhc
Confidence 221 2334788999999999999999999999999999999999999765321 11111111 1111111111
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+. .......++.+.+++.+||+.+|.+||||.||++
T Consensus 230 ~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11 1111235678999999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-33 Score=304.77 Aligned_cols=246 Identities=24% Similarity=0.399 Sum_probs=200.3
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEee--cccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCc--ee
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN--RL 596 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l--~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--~~ 596 (814)
.|.++||+|+|-+||||.+.. .+..||=-.+ ++.. ....++|..|+++|+.|+|+|||+++....+... .-
T Consensus 43 k~~evLGrGafKtVYka~De~---~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE---EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccc---cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 456789999999999999865 3444443222 2222 2334789999999999999999999998866554 77
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCCeEEeecCCcccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTL 675 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~~ 675 (814)
+|.|.|..|+|..+++..++.+.+....+++||++||.|||.+ .++|||||||-+||+|+. .|.+||+|+|||..+..
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 8999999999999999999999999999999999999999998 899999999999999974 58999999999998765
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
... ..+.||+.|||||.+. ..|++.+||||||+.++||+|+..|+..=.. . ..++..+..|.-+.-+..
T Consensus 199 s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~-AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 199 SHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----P-AQIYKKVTSGIKPAALSK 267 (632)
T ss_pred ccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----H-HHHHHHHHcCCCHHHhhc
Confidence 432 3367999999999998 7899999999999999999999999963221 1 224555556654443322
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
-...++.++|.+||.. ..+|||+.|+++
T Consensus 268 --------V~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 --------VKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --------cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1135788999999998 999999999987
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=302.01 Aligned_cols=196 Identities=30% Similarity=0.409 Sum_probs=168.6
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-c-----cceeeeeeeeccCCc
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-H-----KNLVRLLGFCDEGQN 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~ 594 (814)
+|.+.+.||+|.||.|-|+.+.. .++.||||++++.. ....+-..|+.+|..++ | -|+|++++++...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~---T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHK---TGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecC---CCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 66778999999999999999875 57899999998642 23456678999999986 4 479999999999999
Q ss_pred eehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC--CCeEEeecCCc
Q 042262 595 RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY--YNARISDFGLA 670 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~--~~~kl~DfGla 670 (814)
.|||+|.+ ..+|.++|+.+ ..++....+.|+.||+.||..||+ .+|||+||||+||||.+- ..+||+|||.+
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 99999998 45999999876 468899999999999999999994 699999999999999754 46999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccC
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEM 729 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~ 729 (814)
......- .....+.-|+|||++.+.+|+.++||||||||+.||++|.+.|..+.
T Consensus 339 c~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 339 CFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 8754321 24556778999999999999999999999999999999988886554
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=289.06 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=201.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+++.+.||.|+||+||+|.... .+..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcC---CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4556789999999999999764 46689999986432 2345678999999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 601 FLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 601 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
++++++|.+++... ..+++.....++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999998653 458999999999999999999994 699999999999999999999999999988765433
Q ss_pred ccc--ccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 678 SKA--IKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 678 ~~~--~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
... ......++..|+|||.+... .++.++||||||++++||++|+.||....... .+ ..... .....+ .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~----~~~~~-~~~~~~-~ 228 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VL----MLTLQ-NDPPSL-E 228 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hH----HHHhc-CCCCCc-C
Confidence 221 22344588999999999877 78999999999999999999999996443211 11 11111 111100 0
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
. .......++.+.+++..||+.||++||++.||++
T Consensus 229 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 229 T---GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred C---ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 0011355688999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-33 Score=291.57 Aligned_cols=248 Identities=26% Similarity=0.376 Sum_probs=200.4
Q ss_pred ccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
||+|+||.||++.... .+..+++|.+..... ...+.+.+|++++++++|+||+++++.+.++...++|+||+++
T Consensus 1 lg~g~~~~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 6899999999999864 467899999865432 3456788999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc-----
Q 042262 605 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK----- 679 (814)
Q Consensus 605 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~----- 679 (814)
++|.+++.....+++..+..++.||++||+|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9999999877788999999999999999999995 59999999999999999999999999998765433211
Q ss_pred -cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 -AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 -~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.......++..|+|||.+.+...+.++||||||++++||++|+.||......+ .......+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~-------- 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-------IFQNILNGKIE-------- 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCcC--------
Confidence 11233457889999999988889999999999999999999999997543221 11111111111
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
.......+..+.+++..||+.+|.+|||+.+|.+.|+.
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 11111236888999999999999999999888887764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=292.02 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=189.2
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeE-EeeccccceeeeeeeeccCCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVV-IGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.||+|+||.||++.... .+..||+|+++... .....++..|+.. ++.++|+||+++++++..++..++|+|
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVP---TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred eEEEEecccCCeEEEEEEEcC---CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 455789999999999999874 57899999986542 2233455556554 555689999999999999999999999
Q ss_pred hccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 601 FLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 601 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|++ ++|.+++.. ...+++..+..++.||+.||+|||+. .+++||||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 677776643 34689999999999999999999952 38999999999999999999999999999865432
Q ss_pred ccccccccccCCCCccCcccccC----CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRN----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~----~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
.. .+...++..|+|||.+.+ ..++.++||||||++++||++|+.||....... .. ..... .+....
T Consensus 158 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~----~~~~~-~~~~~~- 227 (283)
T cd06617 158 VA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQ----LKQVV-EEPSPQ- 227 (283)
T ss_pred cc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HH----HHHHH-hcCCCC-
Confidence 11 223457889999998865 456889999999999999999999986322110 01 11111 111111
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
......++++.+++..||+.+|.+||++.+|++
T Consensus 228 -------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 -------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111235678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=293.18 Aligned_cols=260 Identities=20% Similarity=0.257 Sum_probs=191.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.+.||+|+||.||+|.... .+..+++|++..... .....+.+|+.+++.++|+||+++.+++.++...++|+|
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRI---NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcC---CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 4456789999999999999864 456899999865432 223467789999999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+. ++|.+.+.. ...+.+..+..++.|+++||+|||+ .+|+|+||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 996 566665543 4567888889999999999999995 59999999999999999999999999999764332211
Q ss_pred cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc------------
Q 042262 680 AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN------------ 746 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------------ 746 (814)
.....++..|+|||.+.+. .++.++||||||++++||++|+.||+........ + ...+..+..
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 160 --YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ-L-EKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred --CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH-H-HHHHHHcCCCChhhhhhhhhc
Confidence 1223468899999998764 5788999999999999999999999754332111 1 001110000
Q ss_pred -CCccccccCccc-----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 747 -GKLDDLVEGDTE-----AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 747 -~~~~~l~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
...++....... ..........+.+++.+|++.||.+|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 0001123567889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=293.39 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=193.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccC-----Cce
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG-----QNR 595 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-----~~~ 595 (814)
+.+.+.||+|+||.||++.... .++.+|+|.+.... ....++.+|+.++.++ +|+||+++++++... ...
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~---~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECC---CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 3445789999999999999864 56789999986432 2345677888888888 899999999998653 357
Q ss_pred ehhhhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 596 LLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 999999999999998753 4568999999999999999999995 599999999999999999999999999988
Q ss_pred cccccccccccccccCCCCccCcccccCC-----CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFRNS-----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
........ .....++..|+|||.+... .++.++||||||++++||++|+.||....... .+ ..+..
T Consensus 177 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~-----~~~~~ 247 (291)
T cd06639 177 QLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TL-----FKIPR 247 (291)
T ss_pred hccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HH-----HHHhc
Confidence 75432211 1234578899999998643 36889999999999999999999986432211 11 11111
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+....+. .+......+.+++.+||+.+|++||++.|+++
T Consensus 248 ~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 248 NPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2111111 12234567999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=282.69 Aligned_cols=268 Identities=24% Similarity=0.331 Sum_probs=213.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.++.+.||.|.-|+||++.+.. .+...|+|++.+.. .+...+.+.|-+||+.+.||.|..|+..++..+..+||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~---t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRG---TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecC---CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3455789999999999999985 45899999997643 23345678899999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc-
Q 042262 599 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL- 675 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~- 675 (814)
||||+||+|..+++.+ ..+++..++.++..|+-||+||| -.|||.|||||+||||-++|++-|+||.|+.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999998764 57899999999999999999999 57999999999999999999999999998643210
Q ss_pred --------------------------------ccc---------------------ccccccccCCCCccCcccccCCCC
Q 042262 676 --------------------------------NQS---------------------KAIKTAIRGTKGYVAPEWFRNSTI 702 (814)
Q Consensus 676 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 702 (814)
... ......++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 011123679999999999999999
Q ss_pred CCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCC
Q 042262 703 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPS 782 (814)
Q Consensus 703 t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 782 (814)
+.++|-|+|||+||||+.|+.||......+. + ..++.+++......+.+..+.+||++.|..||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l-------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--L-------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh--H-------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 9999999999999999999999987654331 1 112333333333446778999999999999999
Q ss_pred CCCC----HHHHHHH--HcCC----cCCCCCCC-CCCCC
Q 042262 783 LRPT----MRKVSQM--LEGV----VEVDVPPN-PSPFS 810 (814)
Q Consensus 783 ~RPt----m~eV~~~--L~~~----~~~~~pp~-p~~~~ 810 (814)
+|.. +.||.+. .+++ +....||. |.+..
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d 416 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVD 416 (459)
T ss_pred hhhccccchHHhhcCccccCCChhheeccCCCcCCCccc
Confidence 9998 8888763 4443 44455554 55443
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=284.47 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=202.8
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
...+.||+|++|.||++.... ++..+++|++........+++.+|++.++.++|+|++++++++......++++||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred eeeeeeccCCceEEEEEEECC---CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 345789999999999999874 46789999997655445678999999999999999999999999999999999999
Q ss_pred cCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 603 NNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 603 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
++++|.+++... ..+++..+..++.|++++|+|||+ .+++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999998776 678999999999999999999994 6999999999999999999999999999987654432
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....++..|+|||.+.+...+.++||||||+++++|++|+.|+........ .. .........+ ..
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~-~~~~~~~~~~-------~~ 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------LF-KIATNGPPGL-------RN 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------HH-HHHhcCCCCc-------Cc
Confidence 2334578899999999988899999999999999999999999864421110 00 1111111111 11
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....+..+.+++.+||+.||++|||+.|+++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1223678999999999999999999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=290.33 Aligned_cols=247 Identities=25% Similarity=0.313 Sum_probs=201.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||.|+||.||++.... .+..+++|.+.... ....+.+.+|++++++++||||+++++++.++...++|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred ceEEEEeccCCCceEEEEEEcc---CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 3456789999999999999764 46789999986532 23456789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
+||+++++|.+++.....+++.....++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 9999999999999877788999999999999999999995 5899999999999999999999999999887654321
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.....|+..|+|||.+.+..++.++||||||+++++|++|+.|+........ ......... ..
T Consensus 156 ---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~----------~~ 218 (258)
T cd05578 156 ---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQET----------AD 218 (258)
T ss_pred ---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhcc----------cc
Confidence 2334578899999999988899999999999999999999999976543211 111111111 01
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTM--RKVS 791 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm--~eV~ 791 (814)
...+...+..+.+++.+||+.||.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11233456889999999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=292.57 Aligned_cols=258 Identities=24% Similarity=0.318 Sum_probs=195.5
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.++||.|++|.||+|.... ++..+++|++.... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKL---TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred chheEecCCCCeEEEEEEEcC---CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 345789999999999999864 46789999986432 2223568889999999999999999999999999999999
Q ss_pred hccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 601 FLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|+. ++|.+++.... .+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.++|+|||+++.+.....
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 995 68999887654 78999999999999999999995 5999999999999999999999999999976543321
Q ss_pred ccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC----------
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---------- 747 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------- 747 (814)
. .....++..|+|||.+.+. .++.++||||||++++||++|+.||....... .+...........
T Consensus 155 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 T--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred c--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhc
Confidence 1 1223468899999988664 57899999999999999999999986543211 1101000000000
Q ss_pred -----CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 748 -----KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 748 -----~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........ .........+..+.+++.+|++.+|.+|||++|+++
T Consensus 231 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQ-DLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhccccccc-chhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 001112344578899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=291.69 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=193.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeecc------CC
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE------GQ 593 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~------~~ 593 (814)
.+.+.+.||+|+||.||+|.... .+..+|+|.+.... ....++..|+.++.++ +|+||+++++++.. ..
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcC---CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 45566789999999999999864 46789999885432 2345678888888888 79999999999853 45
Q ss_pred ceehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 594 NRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
..++||||+++|+|.+++... ..+++..+..++.||++||+|||+ .+|+|+||||+||++++++.++|+|||++.
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 789999999999999988653 457888899999999999999995 599999999999999999999999999987
Q ss_pred cccccccccccccccCCCCccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
........ .....|+..|+|||.+. +..++.++||||||++++||++|+.||......... ....+
T Consensus 170 ~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~------~~~~~- 240 (282)
T cd06636 170 QLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL------FLIPR- 240 (282)
T ss_pred hhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh------hhHhh-
Confidence 65422211 23345888999999986 346788999999999999999999999643221100 00000
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
. .........++..+.+++..||+.||.+||++.|+++
T Consensus 241 ~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 N--------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C--------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0011112245678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=292.58 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=193.2
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeecc-ccceeeeeeeeccCCceehhhhh
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.++||+|+||.||++.... .+..+|+|++.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKP---SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HHHHhCCCCceEEEEEEECC---CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 44679999999999999864 46789999986432 234557888999999986 99999999999999999999999
Q ss_pred ccCCchhhh---hc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 602 LNNGTLASF---LF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 602 ~~~gsL~~~---l~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
+.. +|.++ +. ....+++.....++.|+++||+|||+ ..+++||||||+||++++++.+||+|||+++.+...
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 44443 22 23568999999999999999999996 358999999999999999999999999999765433
Q ss_pred ccccccccccCCCCccCcccccCC---CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNS---TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~---~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
.. .....|+..|+|||.+.+. .++.++||||||++++||++|+.||..... ......... .+...
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~-~~~~~--- 229 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVV-KGDPP--- 229 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhc-CCCCC---
Confidence 21 1233578899999999776 689999999999999999999999864321 111111111 11111
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.........++.++.+++.+||+.+|++|||+.||++.
T Consensus 230 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 --ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111223567889999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=293.21 Aligned_cols=262 Identities=18% Similarity=0.203 Sum_probs=185.5
Q ss_pred HHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccch-----------hhhhceeeEEeeccccceeeee
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-----------KEFKNEVVVIGQTHHKNLVRLL 586 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~l~ 586 (814)
....+.+.+.||+|+||+||+|....+......+++|.......... .....+...+..+.|+||++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 33456677899999999999999875432245566665432211110 0112223345567899999999
Q ss_pred eeeccCC----ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCe
Q 042262 587 GFCDEGQ----NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA 662 (814)
Q Consensus 587 g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ 662 (814)
+++.... ..++++|++.. ++.+.+......++..+..|+.|+++||+|||+ .+|+||||||+|||++.++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcE
Confidence 9765443 34567776543 555555544456788889999999999999994 599999999999999999999
Q ss_pred EEeecCCcccccccccc-----cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhH-
Q 042262 663 RISDFGLAKLLTLNQSK-----AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL- 736 (814)
Q Consensus 663 kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l- 736 (814)
||+|||+++.+..+... .......||..|+|||.+.+..++.++||||||++++||++|+.||...........
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999876432211 112334699999999999999999999999999999999999999975532211000
Q ss_pred --HHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 737 --TDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 737 --~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
.++ ...+..+.. .....+..+.+++..|++.+|++||++.++++.|+
T Consensus 246 ~~~~~-~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AKCDF-IKRLHEGKI-----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHH-HHHhhhhhh-----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 001 111111111 11234678999999999999999999999999874
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=285.87 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=204.5
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccC--Cceehh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLV 598 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 598 (814)
...+.||+|++|.||+|.... .+..+++|++..... ...+.+.+|+.++++++|+||+++++.+.+. ...++|
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKD---TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred eeeeEeeecCceEEEEEEECC---CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 345789999999999999874 467899999865432 3467789999999999999999999999888 889999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
+||+++++|.+++.....+++..+..++.|++++|+|||+ .+++|+||+|+||++++++.+||+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999999877789999999999999999999995 6999999999999999999999999999987765433
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
........++..|+|||.+.+...+.++||||||+++++|++|+.||....... .........+. .
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~---------~ 222 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIGSSGE---------P 222 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhccccCC---------C
Confidence 111233458889999999998889999999999999999999999997554111 11111111011 1
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
...+...+..+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1122344688999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=291.72 Aligned_cols=257 Identities=24% Similarity=0.330 Sum_probs=193.1
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
...+.||.|++|.||+|+... .+..++||++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred eeeeeecCCCceEEEEEEECC---CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 345789999999999999864 46789999886432 2223568899999999999999999999999999999999
Q ss_pred hccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 601 FLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 601 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|+. ++|.+++.. ...+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 996 688888754 3568899999999999999999994 5999999999999999999999999999876543221
Q ss_pred ccccccccCCCCccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC----------
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---------- 747 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------- 747 (814)
. .....++..|+|||.+.+.. ++.++||||||++++||++|+.||....... .+.... ......
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIF-RTLGTPDEVVWPGVTS 230 (284)
T ss_pred c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCCChhhhhhhhH
Confidence 1 22234678999999887644 6889999999999999999999986543211 111100 000000
Q ss_pred ------CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 748 ------KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 748 ------~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
............ .......++.+++.+||+.||.+|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 01124567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=291.11 Aligned_cols=263 Identities=18% Similarity=0.220 Sum_probs=195.1
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccC--Ccee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRL 596 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 596 (814)
.+.+.+.||+|+||.||+|.... .++.+++|.++.... .....+.+|+.++.+++||||+++++++... ...+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKK---TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECC---CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35566789999999999999864 467899999864322 2233567899999999999999999998776 8899
Q ss_pred hhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 597 LVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
+|+||+.+ +|.+++... ..+++..+..++.||+.||+|||+ .+++|+||||+||++++++.+||+|||+++....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99999974 888887654 458999999999999999999995 5899999999999999999999999999987654
Q ss_pred cccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhh-HHH-------HHHHHHh-
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTD-------WAFDCYR- 745 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~-------~~~~~~~- 745 (814)
.... .....++..|+|||.+.+. .++.++||||||++++||++|+.||.......... +.. ..+..+.
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 3211 2233468899999998764 46899999999999999999999997543211000 000 0000000
Q ss_pred -----cCCccccccCcccccCChh-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 746 -----NGKLDDLVEGDTEAMNDIK-CTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 746 -----~~~~~~l~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
................+.. .++.+.+++..||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000001001111111111 4677899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=289.11 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=195.8
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccCC------
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ------ 593 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~------ 593 (814)
.+.+.+.||+|++|.||+|.... .+..+++|.+..... ..+++.+|+.+++++ +|+||+++++++.+..
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred heeheeeecCCCCeEEEEEEECC---CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45567889999999999999864 456899998865432 346789999999998 7999999999996544
Q ss_pred ceehhhhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCC
Q 042262 594 NRLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 669 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl 669 (814)
..++||||+++++|.+++.. ...+++..+..++.|+++||.||| +.+++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999998864 357899999999999999999999 46999999999999999999999999999
Q ss_pred cccccccccccccccccCCCCccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHH
Q 042262 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRN-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 744 (814)
Q Consensus 670 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 744 (814)
+......... .....++..|+|||.+.. ..++.++||||||++++|+++|+.||....... . ... .
T Consensus 160 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~----~~~-~ 230 (275)
T cd06608 160 SAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--A----LFK-I 230 (275)
T ss_pred ceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--H----HHH-h
Confidence 8765432221 233458889999998753 347789999999999999999999996432111 0 111 1
Q ss_pred hcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 745 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+... ....+...++++.+++.+||..||++|||+.||++
T Consensus 231 ~~~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNPPP-------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccCCC-------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 11122346678999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=299.41 Aligned_cols=267 Identities=22% Similarity=0.319 Sum_probs=197.1
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeec-cccceeeeeeeeccC--C
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG--Q 593 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~--~ 593 (814)
...+.+.+.||+|+||.||+|.+.. .+..++||++... .......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcC---CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 3456677899999999999999864 4678999988542 222345677899999999 999999999998653 4
Q ss_pred ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 594 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
..++||||+. ++|..++... .+++..+..++.||+.||+|||+ .+|+|+||||+||++++++.+||+|||+++..
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 6799999997 5898888766 78899999999999999999994 69999999999999999999999999999876
Q ss_pred cccccc---cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHH--------H
Q 042262 674 TLNQSK---AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------F 741 (814)
Q Consensus 674 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~ 741 (814)
...... .......|+..|+|||.+.+ ..++.++||||||++++||++|+.||............... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 543221 11234568899999998865 46789999999999999999999998644322110000000 0
Q ss_pred HHHhcCCcccccc----Ccc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 742 DCYRNGKLDDLVE----GDT--EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 742 ~~~~~~~~~~l~~----~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..+.......+++ ... ........+.++.+++.+||+.+|.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000 000 000111256789999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=292.26 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=193.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.+.||+|++|.||+|.... .++.+|||.+..... .....+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKL---TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcC---CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 4456789999999999999764 467899999865322 223456789999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+.+ +|.+++... ..+++.....++.|+++||.|||+ .+|+|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 9985 898887653 467899999999999999999994 59999999999999999999999999998764322111
Q ss_pred cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC---Cc------
Q 042262 680 AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KL------ 749 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~------ 749 (814)
.....++..|+|||.+.+ ..++.++||||+|++++||++|+.||......... ....+..+... ..
T Consensus 160 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 160 --YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHhcCCCChhhhhhhhhc
Confidence 122346788999999875 45889999999999999999999999644321110 01111111100 00
Q ss_pred ---cccc-----cCccc-ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 750 ---DDLV-----EGDTE-AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 750 ---~~l~-----~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.... ..... ..........+.+++.+||+.+|.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00000 0001122367889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=286.27 Aligned_cols=246 Identities=23% Similarity=0.295 Sum_probs=193.5
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeE-EeeccccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVV-IGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.||+|+||.||+|.... .++.+|||.++.... .....+..|..+ ....+|+||+++++++.+++..++|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecC---CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 468999999999999864 467899999864321 112233444333 3445899999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++++|.+++.....+++..+..++.|++.||.|||. .+++|+||+|+||++++++.+||+|||+++....
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999999999887788999999999999999999994 5999999999999999999999999999876432
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....++..|+|||.+.+..++.++||||||++++||++|..||....... .......+... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRIN------WPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccC------CCCcc
Confidence 223457889999999988889999999999999999999999996543211 11111222111 01111
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
...++.++.+++.+||+.+|++||++.++.++|..
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 22456889999999999999999998877777643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=266.79 Aligned_cols=248 Identities=22% Similarity=0.362 Sum_probs=193.9
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeecc-ccceeeeeeeeccCCceehhhhh
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+...||.|..|+|++..... .+..+|||.+.... .+..+++...+.++..-+ +|.||+.+|+|..+....+-||.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs---~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRS---TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred hHHhhcCCCccceEEEEEcc---cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 34569999999999999975 57899999997643 334466777777776654 89999999999999999999999
Q ss_pred ccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 602 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 602 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
|.- .++.++.. ...+++...-++...+.+||.||.+ ..+|||||+||+|||+|+.|++|++|||++..+..+..
T Consensus 173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 853 44555543 2456777778899999999999998 57999999999999999999999999999988765443
Q ss_pred ccccccCCCCccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 681 IKTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.+...|...|||||.+. ...|+.++||||||+.|+||.||+.||..-..+- .. ...+.+... ..+
T Consensus 248 -htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~----ltkvln~eP-P~L---- 315 (391)
T KOG0983|consen 248 -HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EV----LTKVLNEEP-PLL---- 315 (391)
T ss_pred -cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HH----HHHHHhcCC-CCC----
Confidence 34556899999999995 4468899999999999999999999997643321 11 111111111 111
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.....++..+++++..||+.|+.+||...++++.
T Consensus 316 --~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 --PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1223478899999999999999999999988763
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=300.03 Aligned_cols=263 Identities=24% Similarity=0.323 Sum_probs=198.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccC-----Cc
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QN 594 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 594 (814)
+...+.||+|+||+||++.... .+..||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSE---TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecC---CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4456789999999999999764 5678999998653 222345677899999999999999999988654 35
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
.+||+||+. ++|.+++.....+++.....++.|+++||.|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 799999996 6898888877889999999999999999999994 599999999999999999999999999998764
Q ss_pred ccccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHH---------
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY--------- 744 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--------- 744 (814)
.... ......++..|+|||.+.+ ..++.++||||||+++++|++|+.||.......... ...+..
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~ 234 (337)
T cd07858 160 EKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK---LITELLGSPSEEDLG 234 (337)
T ss_pred CCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH---HHHHHhCCCChHHhh
Confidence 3321 1233457889999998865 468999999999999999999999996543211110 011100
Q ss_pred --hcCCccccc-------cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HcCC
Q 042262 745 --RNGKLDDLV-------EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEGV 797 (814)
Q Consensus 745 --~~~~~~~l~-------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~--L~~~ 797 (814)
..+.....+ ..... ......+.++.+++.+||+.+|++|||++|+++. ++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000 00000 0112456788999999999999999999999886 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=291.45 Aligned_cols=261 Identities=24% Similarity=0.289 Sum_probs=193.9
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCC----
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ---- 593 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 593 (814)
..+.+.+.||+|+||.||+|.... .++.+++|+++... ......+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKD---TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECC---CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 445667889999999999999874 46789999986532 223346778999999999999999999987654
Q ss_pred ------ceehhhhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEee
Q 042262 594 ------NRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISD 666 (814)
Q Consensus 594 ------~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 666 (814)
..+||+||+++ +|...+.. ...+++..+..++.||+.||+|||+ .+|+|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999986 56665554 3568999999999999999999995 5999999999999999999999999
Q ss_pred cCCcccccccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHh
Q 042262 667 FGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 745 (814)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 745 (814)
||++.......... .....++..|+|||.+.+. .++.++||||||++++||++|+.||....... .+ ........
T Consensus 160 fg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~-~~~~~~~~ 235 (302)
T cd07864 160 FGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QL-ELISRLCG 235 (302)
T ss_pred ccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HH-HHHHHHhC
Confidence 99998765433211 1223457789999988654 57899999999999999999999997543211 11 11111110
Q ss_pred cC---Cccccc--------cC------cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 746 NG---KLDDLV--------EG------DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 746 ~~---~~~~l~--------~~------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.. ....+. +. ... ......+..+.+++..||+.+|.+||++.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 000000 00 000 011134678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=290.74 Aligned_cols=258 Identities=21% Similarity=0.256 Sum_probs=203.8
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc----ccchhhhhceeeEEeec-cccceeeeeeeeccCCceeh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.||+|++|.||++........+..+|||.++... ....+.+.+|+.++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 45678999999999999876544467789999986432 22335678899999999 59999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+++++|.+++.....+++.....++.|++++|+|||+ .+++|+||||+||+++.++.++|+|||+++.+....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 83 ILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 99999999999999877778999999999999999999994 699999999999999999999999999988765432
Q ss_pred cccccccccCCCCccCcccccCCC--CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
... .....|+..|+|||.+.+.. .+.++||||||++++||++|+.||....... ............ .
T Consensus 160 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~-~------- 228 (288)
T cd05583 160 EER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS-K------- 228 (288)
T ss_pred ccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc-C-------
Confidence 221 22345788999999987665 7889999999999999999999986432211 111111111111 0
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
...+...+..+.+++.+||+.+|++|||+.+|.+.|+..
T Consensus 229 ---~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 ---PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 111223456788999999999999999999998888653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=297.11 Aligned_cols=266 Identities=22% Similarity=0.333 Sum_probs=197.8
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeecc----CCc
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQN 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~ 594 (814)
.+.+.+.||+|+||.||+|.... .+..+++|++.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcC---CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 34556789999999999999874 46789999986532 2334567889999999999999999998753 356
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
.++|+||+. ++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 899999995 6899999877789999999999999999999995 599999999999999999999999999998664
Q ss_pred ccccc--cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHH--------HHHH
Q 042262 675 LNQSK--AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW--------AFDC 743 (814)
Q Consensus 675 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~~ 743 (814)
..... .......++..|+|||.+.+ ..++.++||||||++++||++|+.||.............. ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 33221 11123468889999999865 4689999999999999999999999965432111000000 0000
Q ss_pred HhcCCccccccC-ccccc-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 744 YRNGKLDDLVEG-DTEAM-----NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 744 ~~~~~~~~l~~~-~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.....+....+. ..... .....++.+.+++.+||+.+|.+||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000111111100 00000 012346889999999999999999999998884
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=287.50 Aligned_cols=256 Identities=21% Similarity=0.270 Sum_probs=190.7
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeecc-ccceeeeeeeeccC--Cceehh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEG--QNRLLV 598 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV 598 (814)
.+.++||+|+||.||+|.... .+..+|+|+++... .........|+.++.++. |+||+++++++.++ +..++|
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRK---TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred ceEeeccccccceEEEEEEcC---CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 456789999999999999864 46789999986532 222234456888888885 99999999999887 889999
Q ss_pred hhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
+||++ ++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||++++ +.+||+|||+++.+....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 99997 477777765 3568999999999999999999995 59999999999999999 999999999998764332
Q ss_pred cccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHH-----------Hh
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC-----------YR 745 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-----------~~ 745 (814)
. .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+ ........ ..
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 2 123457889999997654 567899999999999999999999996543211 11111111 11
Q ss_pred cCCccccccCccc----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 746 NGKLDDLVEGDTE----AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 746 ~~~~~~l~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.........+... .......+..+.+++.+||+.+|++||++.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1100000000000 0001245789999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=285.96 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=198.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||.||+|.... .+..+++|.+.... ....+.+.+|+.+++.++|+||+++++.+.+....++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcC---CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 3456789999999999999875 45679999986431 233457889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-CeEEeecCCccccccc
Q 042262 600 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLTLN 676 (814)
Q Consensus 600 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~ 676 (814)
||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++ .+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999998654 357899999999999999999994 5999999999999999885 4699999999876533
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
... .....|+..|+|||.+.+..++.++||||||++++|+++|+.|+...... ....... .+....
T Consensus 156 ~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~----- 221 (257)
T cd08225 156 MEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKIC-QGYFAP----- 221 (257)
T ss_pred ccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh-cccCCC-----
Confidence 211 22345888999999998888999999999999999999999998643211 1122211 111111
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.....+..+.+++.+|++.+|++|||+.||++
T Consensus 222 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 ----ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 12244578999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=289.34 Aligned_cols=244 Identities=25% Similarity=0.374 Sum_probs=197.0
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 605 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 605 (814)
.+||+|+||.||++.... .+..++||++..........+.+|+.+++.++|+||+++++++..++..++||||++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 26 IKIGEGSTGIVCIATVKS---SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHcCCCCCeEEEEEEEcC---CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 579999999999998864 57789999986554445567889999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccc
Q 042262 606 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI 685 (814)
Q Consensus 606 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 685 (814)
+|.+++.. ..+++.....++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++......... ....
T Consensus 103 ~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 176 (292)
T cd06657 103 ALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSL 176 (292)
T ss_pred cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--cccc
Confidence 99998754 457899999999999999999995 59999999999999999999999999998765432211 2234
Q ss_pred cCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhH
Q 042262 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKC 765 (814)
Q Consensus 686 ~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 765 (814)
.++..|+|||.+.+..++.++||||||++++||++|+.||........ ......+. . .... .....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~~~-~----~~~~--~~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNL-P----PKLK--NLHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhhC-C----cccC--CcccC
Confidence 578899999999888899999999999999999999999864322111 11111111 0 0010 11234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 766 TEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 766 ~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+..+.+++.+||+.+|.+||++.+|++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 567889999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=318.32 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=211.8
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEeccCCc----ceEEEEEeeccccc-cchhhhhceeeEEeec-cccceeeeeeee
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTS----TTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFC 589 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~----~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 589 (814)
|+......+.+.||+|.||.|++|........ ...||||.++.... ...+.+..|+++++.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 34444445667999999999999998753322 56899999986543 3457899999999998 699999999999
Q ss_pred ccCCceehhhhhccCCchhhhhcCCC----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 042262 590 DEGQNRLLVYEFLNNGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 653 (814)
Q Consensus 590 ~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~N 653 (814)
.+.+..++|.||++.|+|.+++...+ .+.....+.++.|||.|++||+ +.++|||||..+|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhh
Confidence 99999999999999999999997654 3788899999999999999999 5689999999999
Q ss_pred EEECCCCCeEEeecCCccccccccccccccccc--CCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCC
Q 042262 654 ILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR--GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMG 730 (814)
Q Consensus 654 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~ 730 (814)
||+.++..+||+|||+++.......... ..-. -...|||||.+....++.|+|||||||+||||+| |..|+.....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999996554332221 1111 2346999999999999999999999999999999 7788754211
Q ss_pred cchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 731 EEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 731 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
.. +. .+.+++|.. ...+..+..++.++++.||+.+|++||++.|+++.++..
T Consensus 528 ~~-----~l-~~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 TE-----EL-LEFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HH-----HH-HHHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11 11 334445442 234557789999999999999999999999999999773
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=313.10 Aligned_cols=266 Identities=19% Similarity=0.281 Sum_probs=185.3
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEE------------------EeeccccccchhhhhceeeEEeecccc
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAV------------------KKLDRVFQDGEKEFKNEVVVIGQTHHK 580 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaV------------------K~l~~~~~~~~~~~~~Ei~~l~~l~H~ 580 (814)
...+.+.++||+|+||+||++.+.... +...++ |++.. .......+++|+.++.+++|+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRAST--EEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccc--hhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence 345777789999999999998875321 111111 11111 122345688999999999999
Q ss_pred ceeeeeeeeccCCceehhhhhccCCchhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 042262 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNIL 655 (814)
Q Consensus 581 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIl 655 (814)
||+++++++.+.+..++|+|++. ++|.+++... ..........|+.||+.||+|||+ .+|+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence 99999999999999999999885 4666655432 223456677899999999999994 69999999999999
Q ss_pred ECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccC-Ccchh
Q 042262 656 LDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEM-GEEYA 734 (814)
Q Consensus 656 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~-~~~~~ 734 (814)
++.++.+||+|||+++.+....... .....||..|+|||.+.+..++.++|||||||++|||++|..++.... .....
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 9999999999999998765432211 234568999999999999999999999999999999999885443222 22111
Q ss_pred hHHHHHHHHHh--cCCccc-------cccC--------cc-cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 735 ILTDWAFDCYR--NGKLDD-------LVEG--------DT-EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 735 ~l~~~~~~~~~--~~~~~~-------l~~~--------~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.+..... .+. ...+.+ .++. .. ........+..+.+++.+||+.||.+|||+.|+++.
T Consensus 379 ~~~~~~~-~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIID-SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHH-hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111110 000 000000 0000 00 000011234567788999999999999999999873
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=292.66 Aligned_cols=265 Identities=22% Similarity=0.314 Sum_probs=193.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccC--Ccee
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRL 596 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 596 (814)
+.+.+.||+|+||.||+|..... ..+..+|+|.+.... ......+.+|+.++..++||||+++++++.+. ...+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 34567899999999999998642 146789999997632 33345678899999999999999999999887 7899
Q ss_pred hhhhhccCCchhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC----CCCeEEeec
Q 042262 597 LVYEFLNNGTLASFLFG-----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD----YYNARISDF 667 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~----~~~~kl~Df 667 (814)
+||||+++ +|.+++.. ...++......++.||+.||.||| +.+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 56555532 136788999999999999999999 469999999999999999 999999999
Q ss_pred CCcccccccccc-cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcch-------hhHHH
Q 042262 668 GLAKLLTLNQSK-AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-------AILTD 738 (814)
Q Consensus 668 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~-------~~l~~ 738 (814)
|+++........ .......++..|+|||.+.+. .++.++||||||++++||++|+.||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 999876433221 112234578899999988764 588999999999999999999999975443220 00000
Q ss_pred HHHHHHhc------------CCccccccC---------cccccCC--hhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 739 WAFDCYRN------------GKLDDLVEG---------DTEAMND--IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 739 ~~~~~~~~------------~~~~~l~~~---------~~~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....+.. .......+. .+..... .....++.+++.+||+.||++|||+.|+++
T Consensus 237 -~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 -IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred -HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 000000000 0000000 134567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=291.49 Aligned_cols=248 Identities=24% Similarity=0.305 Sum_probs=194.9
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCce
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 595 (814)
..++...+.||+|+||.||+|.... .+..+++|.+... .....+++.+|+++++.++|+|++++++++......
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 90 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcC---CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence 3445556789999999999999864 4678999988532 222345678899999999999999999999999999
Q ss_pred ehhhhhccCCchhhhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 596 LLVYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
++|+||+. |+|.+.+. ....+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++....
T Consensus 91 ~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 91 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99999996 57777664 34568899999999999999999995 599999999999999999999999999987654
Q ss_pred ccccccccccccCCCCccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
.. ....++..|+|||.+. ...++.++||||||++++||++|+.|+....... .... +..+...
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~-~~~~~~~- 232 (308)
T cd06634 167 PA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IAQNESP- 232 (308)
T ss_pred Cc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHH-HhhcCCC-
Confidence 32 2345788999999974 3567889999999999999999999986432211 1111 1111111
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L 794 (814)
.......+..+.+++.+||+.+|++||++.+|++..
T Consensus 233 -------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 233 -------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 111224567889999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=285.97 Aligned_cols=243 Identities=28% Similarity=0.356 Sum_probs=193.1
Q ss_pred ccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
||+|+||+||++.... .++.+++|.+.... ......+.+|+++++.++||||+++++.+...+..++|+||+++
T Consensus 1 lg~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKA---TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcC---CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 6899999999998764 46789999886432 22344567899999999999999999999999999999999999
Q ss_pred CchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccc
Q 042262 605 GTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682 (814)
Q Consensus 605 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (814)
++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++........ .
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~ 151 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---I 151 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---c
Confidence 99999987654 68999999999999999999995 5999999999999999999999999999886543211 2
Q ss_pred ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
....++..|+|||.+.+..++.++||||||+++++|++|+.||......... ..+...... .....+
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~------~~~~~~ 218 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-------EELKRRTLE------MAVEYP 218 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-------HHHHhcccc------ccccCC
Confidence 2345788999999998888999999999999999999999999654321100 000111000 011122
Q ss_pred hhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 792 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~ 792 (814)
...+..+.+++..||+.+|.+|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 34567889999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=287.86 Aligned_cols=257 Identities=23% Similarity=0.355 Sum_probs=194.4
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
.+.++||+|++|.||+|.... .+..++||.++.... .....+.+|+.++++++|+||+++++++.+.+..+|||||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRT---TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred eEeeeeccCCceEEEEEEECC---CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 456789999999999999864 467899999875432 2345677899999999999999999999999999999999
Q ss_pred ccCCchhhhhcCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 602 LNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 602 ~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
+++ +|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||+++.+.....
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 985 788877543 458999999999999999999994 5999999999999999999999999999976543221
Q ss_pred ccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc---C------C
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---G------K 748 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~------~ 748 (814)
. .....++..|++||.+.+. .++.++||||||++++||++|+.||......+... ...+.... . .
T Consensus 156 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 T--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL---KIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhCCCChhhHHHHhc
Confidence 1 2233468899999998664 57889999999999999999999987543321100 00000000 0 0
Q ss_pred ccccccCccc-------ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 749 LDDLVEGDTE-------AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 749 ~~~l~~~~~~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..... .... .......+..+.+++.+|++.||.+||++.||++
T Consensus 231 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYK-PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred Cchhc-ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0000 0011234577889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=283.71 Aligned_cols=246 Identities=26% Similarity=0.341 Sum_probs=201.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|++|.||++.... .+..+++|.+.... .....++.+|+.+++.++|+||+++++++.+....++|+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLS---DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred ceEeeeecCCCceeEEEEEECC---CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 3456789999999999998764 46789999986432 233456788999999999999999999999999999999
Q ss_pred hhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 600 EFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 600 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
||+++++|.+++.. ...+++..+..++.|+++||+||| +.+++|+||+|+||++++++.+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 99999999998865 356889999999999999999999 56999999999999999999999999999987654
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.. .....++..|+|||.+.+..++.++|+||||++++||++|+.||......+ .......+....
T Consensus 156 ~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~---- 220 (256)
T cd08530 156 NM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKYPP---- 220 (256)
T ss_pred CC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCCCC----
Confidence 41 223457889999999999999999999999999999999999996543211 111112222221
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.+...+.++.+++.+|++.+|++||++.|+++.
T Consensus 221 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 -----IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 122566789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-33 Score=278.18 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=209.8
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
....+.++||+|.||.|||+.++. .+..+|||++.. +.+.+++..|+.++++...+++|+.+|.+......++||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~E---sG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRE---SGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhc---cCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 344566889999999999999875 688999999864 345678999999999999999999999999999999999
Q ss_pred hhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||..|+..+++.- ++++++.++..+++..++||+|||. ..=||||||+.||||+.++.+||+|||.+..+.....
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 99999999999864 5789999999999999999999994 5779999999999999999999999999988764332
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc-ccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL-VEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l-~~~~~ 757 (814)
+ ..++.||+-|||||+++.-.|+.++||||+|+.-.||.-|++|+....+-. .+..+ ..++.
T Consensus 185 K--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------------AIFMIPT~PPP 247 (502)
T KOG0574|consen 185 K--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------------AIFMIPTKPPP 247 (502)
T ss_pred h--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------------eeEeccCCCCC
Confidence 2 455779999999999999999999999999999999999999986332210 01111 12222
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
....+...+.++.++++.||-..|++|-|+-++++.
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 334567889999999999999999999999887763
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=293.12 Aligned_cols=259 Identities=24% Similarity=0.298 Sum_probs=191.3
Q ss_pred cccccc--ceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 526 EEVGRG--SFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G--~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
++||+| +||+||++.+.. .+..||||.+.... ....+.+++|+.+++.++||||+++++++..++..++|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP---TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcC---CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 456766 899999998864 56799999986432 22346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 602 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 602 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
+.+++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|++||+.+.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 9999999988753 45888999999999999999999 469999999999999999999999999865433211110
Q ss_pred c-----ccccccCCCCccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHH-----------
Q 042262 680 A-----IKTAIRGTKGYVAPEWFRNS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF----------- 741 (814)
Q Consensus 680 ~-----~~~~~~gt~~y~aPE~~~~~--~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~----------- 741 (814)
. ......++..|+|||++.+. .++.++||||||++++||++|+.||........ ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccc
Confidence 0 01112346679999999764 478999999999999999999999964422110 000000
Q ss_pred -----HHH----------------hcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 742 -----DCY----------------RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 742 -----~~~----------------~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
... ..+....+............++..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 000000111111122223456788999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=282.10 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=202.5
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|++|.||++.... .+..+++|.+..... ....++.+|++++.+++|+|++++++++.+++..++|+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLE---TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcC---CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 3456789999999999998864 456899999876533 34567899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++++|.+++.....+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999999988788999999999999999999999 469999999999999999999999999999876543321
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....++..|+|||.+.+...+.++||||+|+++++|++|+.|+....... . .+.. ..... .
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~--~----~~~~-~~~~~---------~ 217 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--A----LFRI-VQDDH---------P 217 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH--H----HHHH-hccCC---------C
Confidence 223457889999999988888999999999999999999999986432110 0 1111 11111 1
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...++.+.+++.+||+.+|++|||+.|++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112245678899999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=295.19 Aligned_cols=261 Identities=24% Similarity=0.275 Sum_probs=193.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccC------
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------ 592 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 592 (814)
.+...+.||+|+||.||+|.... .+..+|+|.+... .....+++.+|+.++++++|+||+++++++...
T Consensus 17 ~y~~~~~lg~g~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 17 RYQNLKPIGSGAQGIVCAAYDTV---TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred ceEEEEEeccCCCEEEEEEEECC---CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 45556789999999999999864 4678999998642 222345677899999999999999999988543
Q ss_pred CceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 593 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
...++|+||+. ++|.+.+... ++...+..++.|+++||+|||. .+|+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 35799999996 4777777544 7888999999999999999994 5999999999999999999999999999987
Q ss_pred ccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchh------------hHHHH-
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA------------ILTDW- 739 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~------------~l~~~- 739 (814)
...... .....++..|+|||.+.+..++.++||||||+++++|++|+.||......... .+...
T Consensus 168 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 168 AGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred CCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 643221 22345788999999999999999999999999999999999999644321100 00000
Q ss_pred ---HHHHHhcCC------ccccccC----cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 740 ---AFDCYRNGK------LDDLVEG----DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 740 ---~~~~~~~~~------~~~l~~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
......... +.++... ..........+..+.+++.+||+.||.+|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0000000 00011122456778999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=290.86 Aligned_cols=264 Identities=21% Similarity=0.286 Sum_probs=190.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccCC------
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------ 593 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 593 (814)
+.+.++||+|+||.||+|.... .+..+|||.+..... .....+.+|++++++++||||+++++++....
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECC---CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 5566789999999999999764 567899998854322 22334577999999999999999999986644
Q ss_pred --ceehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 594 --NRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 594 --~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
..++||||+.+ +|.+.+... ..+++.....++.||++||+|||+ .+++|+||||+||++++++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 34999999975 677766543 468999999999999999999995 59999999999999999999999999999
Q ss_pred ccccccccc--cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC
Q 042262 671 KLLTLNQSK--AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 747 (814)
Q Consensus 671 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 747 (814)
......... .......++..|+|||.+.+. .++.++||||||++++||++|+.||......................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 876433221 112234578899999988664 47889999999999999999999987544322111111100000000
Q ss_pred Cccc-----ccc------Cc---c-cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 748 KLDD-----LVE------GD---T-EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 748 ~~~~-----l~~------~~---~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.... ..+ .. . ...........+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 000 00 0 00001112356779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=297.05 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=194.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccC-----Cce
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QNR 595 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 595 (814)
+.+.+.||+|+||.||+|.... .+..||||++.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKP---TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcC---CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4556889999999999999864 46789999986432 22345678899999999999999999987543 357
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
++|+||+.+ +|...+. ...+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 84 ~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 999999975 7777664 3468999999999999999999994 5999999999999999999999999999986543
Q ss_pred ccccc-ccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCc---c
Q 042262 676 NQSKA-IKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL---D 750 (814)
Q Consensus 676 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~ 750 (814)
..... ......|+..|+|||.+.+ ..++.++||||||++++||++|+.||....... ......+.+..... .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHH
Confidence 22111 1223467899999998754 568999999999999999999999996432111 00111111111000 0
Q ss_pred --------cccc-----Cccc-ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HcCCc
Q 042262 751 --------DLVE-----GDTE-AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEGVV 798 (814)
Q Consensus 751 --------~l~~-----~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~--L~~~~ 798 (814)
+... .... .......+.++.+++.+||+.+|++|||+.|+++. ++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000 0000 00011345778999999999999999999999986 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=284.41 Aligned_cols=243 Identities=24% Similarity=0.270 Sum_probs=189.2
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceee---EEeeccccceeeeeeeeccCCceehhhh
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVV---VIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.||+|+||.||++.... .++.+|+|.+..... .....+..|.. .++...|+||+++++++.+.+..++|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEec---CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence 48999999999998764 467899998864321 11222333333 3344579999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
|+++++|..++.....+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.+||+|||++..+....
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 99999999999877789999999999999999999995 589999999999999999999999999987654322
Q ss_pred ccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....|+..|+|||.+.++ .++.++||||+|++++||++|+.||........... ....... ..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~----------~~ 216 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTM----------AV 216 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhcc----------CC
Confidence 2234589999999999754 689999999999999999999999975432211110 1110000 01
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQM 793 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~~ 793 (814)
..+...+.++.+++.+|++.+|.+|| ++.|+++.
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11223467899999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=294.25 Aligned_cols=260 Identities=20% Similarity=0.245 Sum_probs=196.0
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeeccccccc--------------hhhhhceeeEEeeccccceeeeeeee
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG--------------EKEFKNEVVVIGQTHHKNLVRLLGFC 589 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~--------------~~~~~~Ei~~l~~l~H~niv~l~g~~ 589 (814)
+.+.||+|+||+||+|.... .++.+|||.++...... ...+.+|+++++.++|+||+++++++
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTL---TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVY 89 (335)
T ss_pred hhhcccCCCceeEEEEEECC---CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEE
Confidence 45679999999999999764 56789999886432211 12467899999999999999999999
Q ss_pred ccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCC
Q 042262 590 DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 669 (814)
Q Consensus 590 ~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl 669 (814)
..++..++||||+. ++|.+++.....+++.....++.|+++||+|||+ .+|+|+||+|+||+++.++.+||+|||+
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 90 VEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred ecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999999996 6899998877789999999999999999999994 6999999999999999999999999999
Q ss_pred ccccccccc------------ccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhH
Q 042262 670 AKLLTLNQS------------KAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 736 (814)
Q Consensus 670 a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l 736 (814)
++....+.. ........++..|+|||.+.+. .++.++||||||++++||++|+.||......+ .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~ 242 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---Q 242 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 986651110 0111223467889999999765 47899999999999999999999997554321 1
Q ss_pred HHHHHHHHhcCC---cccccc-----------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 737 TDWAFDCYRNGK---LDDLVE-----------GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 737 ~~~~~~~~~~~~---~~~l~~-----------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
...+........ ...... +..........+..+.+++..||+.+|++|||+.|++..
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 111111111110 000000 000000112346788999999999999999999999984
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=273.58 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=210.5
Q ss_pred CHHHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeecc
Q 042262 513 SYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE 591 (814)
Q Consensus 513 ~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 591 (814)
+++++.+.|. +.||+|+++.|--++... .+..+|||++++.......++.+|++++..- .|+||+.|+.||++
T Consensus 74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~---t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQ---TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhHH---HHhcCccceeeeeeeeec---cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 4566655554 579999999998887664 5778999999988778888999999999988 49999999999999
Q ss_pred CCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC---CeEEeecC
Q 042262 592 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---NARISDFG 668 (814)
Q Consensus 592 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DfG 668 (814)
+...|||||-|.+|+|..+|+....+++.+..++.++|+.||.+|| ..+|.|||+||+|||..+-. .+||+||.
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence 9999999999999999999999999999999999999999999999 56999999999999997543 48999999
Q ss_pred Cccccccccc-----ccccccccCCCCccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchh----
Q 042262 669 LAKLLTLNQS-----KAIKTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA---- 734 (814)
Q Consensus 669 la~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~---- 734 (814)
+..-++.... .....+.+|+..|||||+.. ...|+.++|.||+|||||-||+|.+||....+.+-.
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 8865543221 11233467899999999872 346899999999999999999999999876553211
Q ss_pred ----hHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 735 ----ILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 735 ----~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.-....++.+.+|..+ .+...-...+.+..+++...+..|+.+|.++.++++
T Consensus 305 e~Cr~CQ~~LFesIQEGkYe------FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGKYE------FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhccCCc------CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111122333344321 111112345678889999999999999999999887
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=288.74 Aligned_cols=259 Identities=21% Similarity=0.267 Sum_probs=190.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeec-cccceeeeeeeeccCCc----
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN---- 594 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~---- 594 (814)
+.+.+.||+|+||.||+|.... ++..||||.++.... .....+.+|+.+++.+ +|+||+++++++.....
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~---~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKN---TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred ceEeeEecccCCeEEEEEEECC---CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 3455789999999999999864 467899998765322 2235678899999999 46999999999877665
Q ss_pred -eehhhhhccCCchhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCCeEEeec
Q 042262 595 -RLLVYEFLNNGTLASFLFG-----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDF 667 (814)
Q Consensus 595 -~~lV~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~Df 667 (814)
.++||||+++ +|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeec
Confidence 7999999986 78887753 2357999999999999999999994 69999999999999998 889999999
Q ss_pred CCcccccccccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 668 GLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 668 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
|+++........ .....++..|+|||++.+ ..++.++||||||++++||++|..||....... .+.. ....+..
T Consensus 156 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~ 230 (295)
T cd07837 156 GLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLH-IFKLLGT 230 (295)
T ss_pred ccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-HHHHhCC
Confidence 998865432211 122346788999998865 457999999999999999999999986532211 1100 0111100
Q ss_pred CCc---ccc---cc--------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 747 GKL---DDL---VE--------GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 747 ~~~---~~l---~~--------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
... ... .. +..........+.++.+++.+||+.+|.+||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 000 00 00000011235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=289.66 Aligned_cols=260 Identities=27% Similarity=0.289 Sum_probs=191.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccC--Cceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 597 (814)
+.+.+.||+|+||.||+|.... .+..||+|+++.... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTT---SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECC---CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4556789999999999999864 467899999864322 2233466799999999999999999998654 46899
Q ss_pred hhhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
||||+.+ +|.+++.. ...+++..+..++.||++||+|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999965 78777764 3668999999999999999999995 58999999999999999999999999999876543
Q ss_pred ccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC--C-cc--
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG--K-LD-- 750 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~-~~-- 750 (814)
... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||........ + .......... . ..
T Consensus 162 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~--~-~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 162 AKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ--L-DLIIQLLGTPNESIWPGF 236 (309)
T ss_pred cCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHhcCCCChhhchhh
Confidence 211 122335778999999865 4688999999999999999999999975432211 1 1111110000 0 00
Q ss_pred ------cccc---Ccccc--cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 751 ------DLVE---GDTEA--MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 751 ------~l~~---~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.... ..... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 00000 0001235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=287.50 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=197.6
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc--chhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
...+.||+|++|.||++.... ++..+++|++...... ....+.+|+.++++++|+||+++++++..+...++|+|
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKL---TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred ccceeeecCCCceEEEEEcCC---CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 345679999999999999864 5678999998654322 34678889999999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++ +|.+++.. ...+++..+..++.|+++||.|||+ .+|+|+||||+||++++++.+||+|||.+.........
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 9975 77777755 4678999999999999999999995 59999999999999999999999999999877654311
Q ss_pred cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC---Ccccccc-
Q 042262 680 AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLDDLVE- 754 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~l~~- 754 (814)
.....++..|+|||.+.+. .++.++||||||+++++|++|+.||......+... .....+... ......+
T Consensus 155 --~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 155 --YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF---KIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred --ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCchHhcccchhh
Confidence 2234477889999999877 78999999999999999999999986543211110 011110000 0000000
Q ss_pred ----------Cc--ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 755 ----------GD--TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 755 ----------~~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.. .........+.++.+++..||+.||.+||+++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 000112245788999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=285.66 Aligned_cols=259 Identities=25% Similarity=0.363 Sum_probs=193.8
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeecc-ccceeeeeeeeccCCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.||+|++|+||+|+... .+..++||++..... .......+|+..+.+++ |+||+++++++.+++..++|||
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKE---TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred eeheeeccCCceEEEEEEECC---CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 456789999999999999864 457899999865432 22234456888888998 9999999999999999999999
Q ss_pred hccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 601 FLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|+ +++|.+++.... .+++..+..++.|++++|.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 99 889998887654 78999999999999999999995 5999999999999999999999999999986643221
Q ss_pred ccccccccCCCCccCccccc-CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhh-HH---------HHHHHHHhcC
Q 042262 679 KAIKTAIRGTKGYVAPEWFR-NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LT---------DWAFDCYRNG 747 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~---------~~~~~~~~~~ 747 (814)
.....++..|+|||.+. +..++.++||||||++++||++|+.||......+... .. .|........
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 22345788999999885 4468999999999999999999999986543211100 00 0000000000
Q ss_pred Ccccccc----CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 748 KLDDLVE----GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 748 ~~~~l~~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.....+. ...... .......+.+++.+||+.+|++|||++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQL-IPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHH-cccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 1110000 000000 1122578999999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=279.37 Aligned_cols=235 Identities=21% Similarity=0.242 Sum_probs=184.1
Q ss_pred ccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhhhccCCc
Q 042262 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGT 606 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 606 (814)
||+|+||.||++.... .+..+++|.+........ |+.....+ +|+||+++++.+...+..++||||+++++
T Consensus 24 lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 95 (267)
T PHA03390 24 LIDGKFGKVSVLKHKP---TQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD 95 (267)
T ss_pred ecCCCceEEEEEEEcC---CCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence 5999999999998764 467789998764321111 11111112 69999999999999999999999999999
Q ss_pred hhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-CeEEeecCCcccccccccccccccc
Q 042262 607 LASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLTLNQSKAIKTAI 685 (814)
Q Consensus 607 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~~ 685 (814)
|.+++.....+++..+..++.||++||.|||+ .+++|+||||+||+++.++ .++|+|||+++..... ...
T Consensus 96 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~ 166 (267)
T PHA03390 96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCY 166 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccC
Confidence 99999887789999999999999999999995 5899999999999999988 9999999998765432 223
Q ss_pred cCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhH
Q 042262 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKC 765 (814)
Q Consensus 686 ~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 765 (814)
.++..|+|||.+.+..++.++||||||++++||++|+.||.....+. .....+.... .. .. ......
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~~--------~~--~~~~~~ 233 (267)
T PHA03390 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--QK--------KL--PFIKNV 233 (267)
T ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh--cc--------cC--Cccccc
Confidence 57889999999999899999999999999999999999997443221 1111111110 00 00 112246
Q ss_pred HHHHHHHHHHccccCCCCCCC-HHHHHH
Q 042262 766 TEKLVMVSIWCIQEDPSLRPT-MRKVSQ 792 (814)
Q Consensus 766 ~~~l~~l~~~Cl~~dP~~RPt-m~eV~~ 792 (814)
+..+.+++..||+.+|.+||+ ++|+++
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 234 SKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 678999999999999999995 688874
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=295.22 Aligned_cols=267 Identities=24% Similarity=0.342 Sum_probs=194.8
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCC------ce
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------NR 595 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~ 595 (814)
..+.||+|+||.||+|.... .+..+|||++.... ......+.+|+.+++.++|+||+++++++.... ..
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred EEEEeeecCCeEEEEEEeCC---CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 34689999999999999764 46789999986432 222356788999999999999999999986543 45
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
++|+||+.. +|..++ ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 96 ~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 96 YLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred EEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 899999864 666654 2357899999999999999999995 5899999999999999999999999999876532
Q ss_pred cccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHH-----------
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC----------- 743 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~----------- 743 (814)
. .....++..|+|||.+.+ ..++.++||||||++++||++|+.||....... .+.. ....
T Consensus 170 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~ 241 (342)
T cd07879 170 E-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQ-ILKVTGVPGPEFVQK 241 (342)
T ss_pred C-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHhcCCCCHHHHHH
Confidence 2 223456889999999876 468899999999999999999999997542211 0100 0000
Q ss_pred HhcCCcccccc-------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HcCCcCCCCCCCCCC
Q 042262 744 YRNGKLDDLVE-------GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEGVVEVDVPPNPSP 808 (814)
Q Consensus 744 ~~~~~~~~l~~-------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~--L~~~~~~~~pp~p~~ 808 (814)
+.......... ..... .....+..+.+++.+||+.||.+||++.|+++. +++..+.+..+.|.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~ 314 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP 314 (342)
T ss_pred hcccchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc
Confidence 00000000000 00000 001245678899999999999999999999954 777666554444443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=285.00 Aligned_cols=254 Identities=21% Similarity=0.259 Sum_probs=198.8
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc----cchhhhhceeeEEeec-cccceeeeeeeeccCCceeh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ----DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.||+|+||.||++........+..+|+|++..... ...+.+.+|+.++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 456789999999999998865444678899999865321 2235678899999999 69999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|+||+++++|.+++.....+++.....++.|+++||.|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 83 ILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 99999999999999887788999999999999999999994 699999999999999999999999999998764432
Q ss_pred cccccccccCCCCccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
... .....|+..|+|||.+.+. .++.++||||||++++||++|+.|+....... .............
T Consensus 160 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~-------- 228 (290)
T cd05613 160 VER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE-------- 228 (290)
T ss_pred ccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC--------
Confidence 221 2234588899999998753 47889999999999999999999986432211 1111111111110
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQM 793 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~~ 793 (814)
...+......+.+++.+||+.+|.+|| ++.+++..
T Consensus 229 ---~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ---PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 011224567888999999999999997 66776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=287.59 Aligned_cols=242 Identities=25% Similarity=0.329 Sum_probs=190.3
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
..++||+|+||.||+|+... .+..+++|++..... ...+.+.+|+++++.++|+|++++++++.+....++|||
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSH---TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred cceeeccCCCeEEEEEEECC---CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 34679999999999998754 467899999864322 223567889999999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+. ++|.+++.. ...+++..+..++.||+.+|+|||+ .+++|+||+|+||++++++.+||+|||++.....
T Consensus 102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 996 466666643 4568999999999999999999994 5999999999999999999999999998864322
Q ss_pred cccccccCCCCccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 680 AIKTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.....|+..|+|||++. ...++.++||||||++++||++|..|+....... ....... .....
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~-~~~~~----- 239 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQ-NDSPT----- 239 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHh-cCCCC-----
Confidence 22345888999999984 4568899999999999999999999986443211 1111111 11111
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
......+..+.+++.+||+.+|.+||++.++++.
T Consensus 240 ---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 ---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122345678899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=293.99 Aligned_cols=268 Identities=23% Similarity=0.332 Sum_probs=204.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCC-----c
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----N 594 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~ 594 (814)
+.+.+.||+|++|.||+|.... .+..++||++.... ....+.+.+|+.+++.++|+||+++++++.... .
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCC---CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 4556789999999999999764 46789999987643 334567899999999999999999999997775 7
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
.++||||+. ++|.+++.....+++..+..++.||++||+|||+ .+|+|+||||+||++++++.++|+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 899999998 4899988877789999999999999999999994 699999999999999999999999999998765
Q ss_pred ccccc-cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHh-------
Q 042262 675 LNQSK-AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR------- 745 (814)
Q Consensus 675 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~------- 745 (814)
..... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN---LIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHhcCCCChhHh
Confidence 44310 112334578899999999888 89999999999999999999999996543221100 0000000
Q ss_pred ----cCCccccccC-cc-----cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HcCCcC
Q 042262 746 ----NGKLDDLVEG-DT-----EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEGVVE 799 (814)
Q Consensus 746 ----~~~~~~l~~~-~~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~--L~~~~~ 799 (814)
.......+.. .. ........+..+.+++.+||+.+|.+||++.++++. +++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000000000 00 000112356788999999999999999999999984 554433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=286.91 Aligned_cols=259 Identities=25% Similarity=0.346 Sum_probs=191.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|++|.||+|.... .++.+++|++.... ....+.+.+|++++++++|+||+++++++.++...++||
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRV---TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecC---CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 4456789999999999999864 46789999886432 223456888999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCCeEEeecCCccccccc
Q 042262 600 EFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLN 676 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~ 676 (814)
||++ ++|.+++.... .+++.....++.||+.||+|||+ .+++|+||+|+||++++ +..+||+|||++......
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9996 57777765433 35778888999999999999995 59999999999999985 567999999999765432
Q ss_pred ccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC-------
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK------- 748 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------- 748 (814)
... .....++..|+|||.+.+. .++.++||||||+++++|++|+.||......+. ... .........
T Consensus 157 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 VRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFK-IFRILGTPNEETWPGV 231 (294)
T ss_pred ccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChhhcccc
Confidence 211 1233568899999998664 578999999999999999999999965432110 000 011110000
Q ss_pred --cccccc------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 749 --LDDLVE------GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 749 --~~~l~~------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+..... ...........+.++.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 00000112245677899999999999999999999987
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=287.44 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=190.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||.||+|.... .+..+|||+++... .....++..|+.++.+. .|+||+++++++.+....++||
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred heeeeEeeccCCeEEEEEEECC---CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4566889999999999999864 36789999986532 22334556676666666 4999999999999999999999
Q ss_pred hhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+.+ +|.+++.. ...+++..+..++.||++||+|||+ ..+|+||||+|+||++++++.+||+|||++..+.....
T Consensus 94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 99854 66666544 4578999999999999999999995 24899999999999999999999999999986643322
Q ss_pred ccccccccCCCCccCcccccCCC----CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNST----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~----~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.....++..|+|||.+.+.. ++.++||||||++++||++|+.||....... +........ .....
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~-~~~~~-- 239 (296)
T cd06618 171 ---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQE-EPPSL-- 239 (296)
T ss_pred ---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHhcC-CCCCC--
Confidence 12234778999999997553 7889999999999999999999986432211 111111111 11110
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.....+++++.+++.+||+.||.+||++.++++.
T Consensus 240 -----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 -----PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111356789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=283.87 Aligned_cols=257 Identities=26% Similarity=0.338 Sum_probs=191.1
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeec---cccceeeeeeeeccCCc---
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT---HHKNLVRLLGFCDEGQN--- 594 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~--- 594 (814)
.+.+.||+|+||.||+|.... .+..+|+|+++.... .....+.+|+.++.++ +|+||+++++++.....
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred eEEEEecccCceEEEEEEECC---CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 345789999999999999864 467899999964322 1233456676666555 69999999999987776
Q ss_pred --eehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 595 --RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 595 --~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
.+++|||+.+ +|.+++... ..+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999974 788887653 358999999999999999999995 59999999999999999999999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc-CCc
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-GKL 749 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~ 749 (814)
........ .....++..|+|||.+.+..++.++||||||++++||++|+.||......+. +.. ..+.... +..
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~ 228 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDK-IFDVIGLPSEE 228 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHH-HHHHcCCCChH
Confidence 87644322 1233478899999999999999999999999999999999999875433211 111 1111000 000
Q ss_pred --c-------ccccCcc---cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 750 --D-------DLVEGDT---EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 750 --~-------~l~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
. ....... ...........+.+++.+||+.||.+||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0000000 01111244578889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=280.48 Aligned_cols=249 Identities=21% Similarity=0.266 Sum_probs=196.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc-----cccchhhhhceeeEEeeccccceeeeeeeeccC--Cc
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-----FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QN 594 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~ 594 (814)
+.+.+.||+|+||.||+|.... .+..+++|.+... .....+.+++|++++++++|+||+++++++.+. ..
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDAD---TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcC---CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 3456789999999999999764 4678999987421 122335788999999999999999999998654 45
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
.++|+||+++++|.+++.....+++.....++.|++.||.|||+ .+++|+||||+||++++++.++|+|||+++...
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 78999999999999999877778899999999999999999994 599999999999999999999999999998654
Q ss_pred ccccc-cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 675 LNQSK-AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 675 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
..... .......++..|+|||.+.+..++.++||||||++++||++|+.||....... -+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~------ 225 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIFKIATQP------ 225 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHHHHHcCC------
Confidence 32111 11223458889999999998889999999999999999999999986432111 011111111
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.....+....+.+.+++..|++ +|.+||+..+++.
T Consensus 226 ---~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 ---TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1112234566889999999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=290.44 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=203.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
..++...||.|+||.|||++... .+...|-|.+.........+++-||++|....||+||+|++.+..++..+|..|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nke---t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKE---TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhccc---chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 35566789999999999998763 455677788876666677889999999999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||.||-++.++.. ...|...++.-+++|++.||.||| +..|||||||+.|||+.-+|.++|+|||.+-......
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-- 184 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-- 184 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHH--
Confidence 9999999998765 567899999999999999999999 5699999999999999999999999999875432211
Q ss_pred cccccccCCCCccCcccc-----cCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 680 AIKTAIRGTKGYVAPEWF-----RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~-----~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.....+.||+.|||||+. ...+|+.++||||||++|.||.-+.+|...-.. ...+ -.+...+.+.++
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--MRVl-----lKiaKSePPTLl- 256 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVL-----LKIAKSEPPTLL- 256 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--HHHH-----HHHhhcCCCccc-
Confidence 113457799999999987 466899999999999999999999999753221 0111 111112222222
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+......+.+++..||..+|..||++.++++
T Consensus 257 ------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 ------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 34567889999999999999999999999876
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=279.85 Aligned_cols=246 Identities=25% Similarity=0.397 Sum_probs=201.7
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.||+|+||.||++.... ++..+++|++..... ...+++.+|+++++.++|+|++++++.+..+...++|+|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcC---CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 455789999999999999864 467899999865432 445678899999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 601 FLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 601 ~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|+++++|.+++... ..+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999998763 678999999999999999999995 59999999999999999999999999999876543
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.. ......++..|+|||.+.+..++.++||||+|+++++|++|+.|+...... ..... ...+....
T Consensus 157 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~----- 222 (258)
T cd08215 157 VD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALK-ILKGQYPP----- 222 (258)
T ss_pred cc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHH-HhcCCCCC-----
Confidence 21 123345788999999999889999999999999999999999998644311 11111 11111111
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+...+..+.+++.+||+.+|++|||+.|+++
T Consensus 223 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 ----IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 12245678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=287.31 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=197.4
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecc--ccccchhhhhceeeEEeec-cccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~--~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 597 (814)
.|++.++||+||-+.||++.-. +...+|+|++.. .+.+....|.+|++.|.++ .|.+||+|++|-..++..||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s----~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNS----DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecC----CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 4566788999999999999865 456778877643 3444557799999999999 49999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
||||= +.+|..+|..... +....++.+..|++.++.+.|++ +|||.||||.|+|+.. |.+||+|||+|..+..+
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 99984 6689999976533 33237788999999999999965 9999999999999875 58999999999999888
Q ss_pred ccccccccccCCCCccCcccccCC-----------CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHh
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNS-----------TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 745 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 745 (814)
...-.....+||..||+||.+... .++.++||||+|||||+|+-|+.||... ..+ |+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~--~a----- 580 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQ--IA----- 580 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHH--HH-----
Confidence 776666778899999999998421 2567999999999999999999999521 111 11
Q ss_pred cCCccccccCcccccCC-hhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 746 NGKLDDLVEGDTEAMND-IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 746 ~~~~~~l~~~~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
++..+.++..+.+++ .....+++++++.||+.||.+|||+.|+++.
T Consensus 581 --Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 --KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 133344443322221 1222349999999999999999999999884
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=285.37 Aligned_cols=258 Identities=17% Similarity=0.185 Sum_probs=189.7
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhcc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 603 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 603 (814)
+.+|.|+++.||++.. .+..+|||++... .....+.+..|+++++.++|+||+++++++.+.+..+++|||++
T Consensus 8 ~~~~~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-----TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred HhhcCCceEEEEEecC-----CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 3445555555555443 4678999998653 33445679999999999999999999999999999999999999
Q ss_pred CCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc---
Q 042262 604 NGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS--- 678 (814)
Q Consensus 604 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~--- 678 (814)
+++|.+++... ..+++.....++.|+++||+|||+ .+|+|+||||+||++++++.+||+|||.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999998753 457888999999999999999995 5999999999999999999999999998875532211
Q ss_pred --ccccccccCCCCccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHH----Hh-----
Q 042262 679 --KAIKTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC----YR----- 745 (814)
Q Consensus 679 --~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~----~~----- 745 (814)
........++..|+|||.+.. ..++.++||||||++++||++|+.||....... .+.+..... +.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchh
Confidence 111223456788999999876 358899999999999999999999997432111 010000000 00
Q ss_pred --cCCccc--------cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 746 --NGKLDD--------LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 746 --~~~~~~--------l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
...+.. ................++.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 000011112233556788999999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=315.48 Aligned_cols=246 Identities=27% Similarity=0.369 Sum_probs=200.8
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhcc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 603 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 603 (814)
..||.|.||.||-+.... .+...|||-++-. .....+...+|+.++..|+|||+|+.+|+--+.++.+|.||||+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~---tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLD---TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCE 1317 (1509)
T ss_pred cccCCcceeeeEEeecCC---ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhc
Confidence 469999999999999875 5778999987543 23445778999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc--cc
Q 042262 604 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK--AI 681 (814)
Q Consensus 604 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~--~~ 681 (814)
+|+|.+.+......++.....+..|++.|++|||+ .+||||||||.||+|+.++.+|++|||.|..+...... ..
T Consensus 1318 ~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1318 GGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred cCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 99999999988888888888899999999999995 59999999999999999999999999999887654211 11
Q ss_pred cccccCCCCccCcccccCCC---CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHH-HHHhcCCccccccCcc
Q 042262 682 KTAIRGTKGYVAPEWFRNST---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-DCYRNGKLDDLVEGDT 757 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~---~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-~~~~~~~~~~l~~~~~ 757 (814)
.....||+.|||||.+.+.. ...++||||+|||++||+||++|+..... +|+. -.+..|..+
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh~P------- 1460 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGHKP------- 1460 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccCCC-------
Confidence 22456999999999997643 55689999999999999999999974332 2222 112223322
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..+...+.+-.+++..||+.||.+|=++.|+++.
T Consensus 1461 --q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 --QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2244577888899999999999999777776664
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=288.48 Aligned_cols=262 Identities=23% Similarity=0.264 Sum_probs=189.9
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc--chhhhhceeeEEeeccccceeeeeeeeccCC-----
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----- 593 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 593 (814)
.+.+.++||+|+||.||+|.... .+..++||++...... ....+.+|++++++++|+||+++++++.+..
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 34556789999999999999764 4678999988643222 2345778999999999999999999875433
Q ss_pred ---ceehhhhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCC
Q 042262 594 ---NRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 669 (814)
Q Consensus 594 ---~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl 669 (814)
..++|+||+.. +|...+.. ...+++..+..++.|+++||+||| +.+|+|+||||+||++++++.+||+|||+
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46899999875 56555543 457899999999999999999999 46999999999999999999999999999
Q ss_pred ccccccccccc---------ccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHH
Q 042262 670 AKLLTLNQSKA---------IKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 739 (814)
Q Consensus 670 a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 739 (814)
++......... ..+...++..|+|||.+.+. .++.++||||||++++||++|+.||.......... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~---~ 238 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH---L 238 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH---H
Confidence 98654322111 11234568889999988654 58999999999999999999999986543321111 1
Q ss_pred HHHHHhc---------CCccccc----cCccc---ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 740 AFDCYRN---------GKLDDLV----EGDTE---AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 740 ~~~~~~~---------~~~~~l~----~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....... ..+.... ..... ........+.+.+++.+||+.+|.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1111000 0000000 00000 0001123367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=280.80 Aligned_cols=249 Identities=22% Similarity=0.311 Sum_probs=191.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.++||+|+||.||++...........+++|.+... ......++..|+.+++.++||||+++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 45668899999999999988653222223333433221 1122345667888999999999999999999999999999
Q ss_pred hhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 600 EFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 600 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
||+++++|.+++.. ...+++..++.++.|+++||.|||+ .+++|+||||+||++++ +.+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999988753 3568999999999999999999994 69999999999999976 4699999999987643
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.... .....++..|+|||.+.+..++.++||||||+++++|++|..||..... .... .....+...
T Consensus 158 ~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~-~~~~~~~~~----- 223 (260)
T cd08222 158 SCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVV-LRIVEGPTP----- 223 (260)
T ss_pred Cccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHH-HHHHcCCCC-----
Confidence 3221 2234578899999999888899999999999999999999999863321 1111 111112111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...+.++.+++.+||+.+|++||++.|+++
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 ----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 113356678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=283.12 Aligned_cols=248 Identities=25% Similarity=0.313 Sum_probs=200.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeecc-ccceeeeeeeeccCCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l 597 (814)
+.+.+.||+|+||.||++.... .+..+++|.+... .....+.+.+|++++.+++ |+||+++++++.+++..++
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKE---TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcC---CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 4456789999999999999864 5678999988652 2233467888999999998 9999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+++++|.+++.....+++..+..|+.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999999888789999999999999999999995 599999999999999999999999999988664432
Q ss_pred cc------------------cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHH
Q 042262 678 SK------------------AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 739 (814)
Q Consensus 678 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 739 (814)
.. .......++..|+|||.+.+..++.++||||||++++++++|+.|+...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~---- 230 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--LT---- 230 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--HH----
Confidence 11 1122345788999999999888999999999999999999999999754311 10
Q ss_pred HHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 042262 740 AFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTM----RKVSQ 792 (814)
Q Consensus 740 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm----~eV~~ 792 (814)
....... ....+...++.+.+++.+||+.+|.+||++ +++++
T Consensus 231 -~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 -FQKILKL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -HHHHHhc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111111 111223446789999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=275.45 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=209.2
Q ss_pred hhccccccceeEEEEEEEeccC--CcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeecc-CCceehhh
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLVY 599 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~--~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~ 599 (814)
.+..+-+|.||.||+|.+...+ .+.+.|-||.++.... -....+..|-..+..+.|||+..+.+++.+ ....+++|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 3456889999999999887533 1234577787765433 234567888888999999999999999955 56788999
Q ss_pred hhccCCchhhhhc-----C---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 600 EFLNNGTLASFLF-----G---NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 600 e~~~~gsL~~~l~-----~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
.++.-|+|..+|. + .+.++..+...++.|++.|++||| +.+|||.||..+|.+||+..++||+|-.++|
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhcc
Confidence 9999999999996 1 245677778899999999999999 5699999999999999999999999999999
Q ss_pred cccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
.+.+.+.+...........||+||.+.+..++.++|||||||+||||+| |+.|+....+.+ + +
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE---m-------------~ 508 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE---M-------------E 508 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---H-------------H
Confidence 9988888777766777889999999999999999999999999999999 889986443322 1 1
Q ss_pred ccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 751 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
..+....+...+.++++++..++..||..+|++||+.+|++.-|.+
T Consensus 509 ~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1222233444577999999999999999999999999999998864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-33 Score=270.21 Aligned_cols=261 Identities=24% Similarity=0.336 Sum_probs=202.3
Q ss_pred ccccCHHHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEee-ccccceeeee
Q 042262 509 LRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQ-THHKNLVRLL 586 (814)
Q Consensus 509 ~~~f~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~-l~H~niv~l~ 586 (814)
...|+-..|+.. ..||.|+||+|+|-.++. .++.+|||+++... +...+++..|.+...+ -+.||||+++
T Consensus 58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~---sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKP---SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred ccccccchHHHH-----HHhcCCcchhhhhhhcCc---cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 445655555432 469999999999998874 68899999997643 3556778888776555 4799999999
Q ss_pred eeeccCCceehhhhhccCCchhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC
Q 042262 587 GFCDEGQNRLLVYEFLNNGTLASFLF-----GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 661 (814)
Q Consensus 587 g~~~~~~~~~lV~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~ 661 (814)
|.+..++..+|-||.|. .||+.+-+ ....+++...-+|.....+||.||.+ ...|||||+||+||||+..|.
T Consensus 130 Ga~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 130 GALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCC
Confidence 99999999999999994 46655432 23567888888999999999999998 479999999999999999999
Q ss_pred eEEeecCCcccccccccccccccccCCCCccCccccc--CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHH
Q 042262 662 ARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR--NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 739 (814)
Q Consensus 662 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 739 (814)
+||+|||+...+..+.. .+...|...|||||.+. +..++.++||||+|++|+|+.||+.|+..-+. +.+.
T Consensus 207 vKLCDFGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeq 278 (361)
T KOG1006|consen 207 VKLCDFGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQ 278 (361)
T ss_pred EeeecccchHhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHH
Confidence 99999999987764432 34456889999999995 34589999999999999999999999974332 1111
Q ss_pred HHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 740 AFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 740 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
. ..+-.|+.+.+.... ...+....++.++..|+..|..+||...++.++
T Consensus 279 l-~~Vv~gdpp~l~~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 279 L-CQVVIGDPPILLFDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred H-HHHHcCCCCeecCcc----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 122334444443221 233577889999999999999999999887763
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=280.25 Aligned_cols=256 Identities=25% Similarity=0.333 Sum_probs=197.0
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.||+|++|.||+|+... .++.+++|.+.... ....+.+..|+.++++++|+||+++++++.+....++|+||
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred eehcccccCcceEEEeeecC---CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 45679999999999999875 46789999987643 23345678899999999999999999999999999999999
Q ss_pred ccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 602 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 602 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
++ ++|.+++... ..+++..+..++.|+++||+|||+ .+|+|+||+|+||++++++.+||+|||+++........
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 154 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT- 154 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-
Confidence 98 5899999776 578999999999999999999995 59999999999999999999999999999876543221
Q ss_pred ccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHh--------------
Q 042262 681 IKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR-------------- 745 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-------------- 745 (814)
.....++..|+|||.+.+. .++.++||||||++++||++|+.||......+.. ........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 155 -YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL---FKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred -cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHHHHhCCCcHHHHHhhcccc
Confidence 2223457789999999776 7899999999999999999999998654321110 00111000
Q ss_pred --cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 746 --NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 746 --~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....+....... .......+..+.+++..||+.+|++||++.+|+.
T Consensus 231 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 231 DYKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000 0011123678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=269.50 Aligned_cols=280 Identities=23% Similarity=0.293 Sum_probs=197.9
Q ss_pred hhhhccccccceeEEEEEEEeccCC-cceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeecc-CCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRT-STTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~-~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~l 597 (814)
++....||+|.+|.||||.-.++.. ....+|+|+++.... .-.....+|+.+++.++|+||+.|..++.+ ....+|
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 4556789999999999997654331 134799999875422 112446789999999999999999999977 778899
Q ss_pred hhhhccCCchhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC----CCeEEeecC
Q 042262 598 VYEFLNNGTLASFLFG-----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY----YNARISDFG 668 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~----~~~kl~DfG 668 (814)
++||.+. +|..+|+. ...++......|+.||+.|+.|||+ .-|+||||||.||||..+ |.+||+|||
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999977 56666642 2467888999999999999999995 599999999999999877 899999999
Q ss_pred Ccccccccccc-cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCc---c-hhhH--HHHH
Q 042262 669 LAKLLTLNQSK-AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGE---E-YAIL--TDWA 740 (814)
Q Consensus 669 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~---~-~~~l--~~~~ 740 (814)
+++.+...-.. .....++.|.+|+|||.+.+. .||+++|||+.|||+.||++-++.|...... . .... .+-+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99988654322 123456789999999999876 6999999999999999999999988654321 0 1111 0111
Q ss_pred HHHHh---cCCccccccCcc--------cccC--C----------hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 741 FDCYR---NGKLDDLVEGDT--------EAMN--D----------IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 741 ~~~~~---~~~~~~l~~~~~--------~~~~--~----------~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
.+.+. +.+.+.+..-+. +... + ...+....+|+..+|+.||.+|-|+++.++-. -.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~-yF 340 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP-YF 340 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-cc
Confidence 11111 111111111000 0000 0 00122367889999999999999999877632 22
Q ss_pred cCCCCCCCC
Q 042262 798 VEVDVPPNP 806 (814)
Q Consensus 798 ~~~~~pp~p 806 (814)
.+-+.||.|
T Consensus 341 ~~d~lpp~p 349 (438)
T KOG0666|consen 341 TEDPLPPLP 349 (438)
T ss_pred ccCCCCCCc
Confidence 334444444
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=289.35 Aligned_cols=246 Identities=25% Similarity=0.359 Sum_probs=203.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc--chhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|.|++|..|.+.. .+..||||.+++..-. ....+.+|+.+|..++|||||+++.+.+.....++||
T Consensus 58 y~i~~tig~g~f~~V~La~~~~---t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHIL---TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred eeeeeeeccceeEEEEeeEecC---CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4556789999999999999986 5778999999764322 2244889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||..+|.+.+++.............++.|+.++++||| +..|+|||||++||||+.+.++||+|||++..+....
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~-- 209 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL-- 209 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc--
Confidence 99999999999998888878999999999999999999 5699999999999999999999999999999876432
Q ss_pred cccccccCCCCccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
......|++.|.|||.+.+..+ .+++|+||+|++||-|++|..||+...-.+ +++..+. ...
T Consensus 210 -~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----------Lr~rvl~----gk~- 272 (596)
T KOG0586|consen 210 -MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----------LRPRVLR----GKY- 272 (596)
T ss_pred -cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----------ccchhee----eee-
Confidence 2456789999999999998876 468999999999999999999998543211 0000010 011
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..+.-...++.++++++|..+|.+|++++++.+-
T Consensus 273 -rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 -RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1122345678899999999999999999998763
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=287.33 Aligned_cols=238 Identities=26% Similarity=0.325 Sum_probs=196.5
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+...+|.|+|+.|-++.+.. .....+||++.+. ..+-.+|+.++... +|+||+++.+.+.++.+.++||
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~---t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSP---TDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred hhccccccCCCCccceeeeeccc---cccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 35566779999999999998875 5677899998654 34556777666665 7999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE-CCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL-DDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll-~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|.+.++-|.+.+....... ..+..|+.+|+.++.|||+ .+||||||||+|||+ ++.++++|+|||.++....+
T Consensus 396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999988887766555 7778899999999999995 699999999999999 69999999999999987655
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
....+-|..|.|||.+....+++++|+||||++||+||+|+.||.....+ ..+...+..+..
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~--------- 531 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKF--------- 531 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCcc---------
Confidence 12234578999999999999999999999999999999999999765433 111222222221
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....++...+|+.+|||.||.+||+|.|+..
T Consensus 532 ---s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 ---SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 2467789999999999999999999999876
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=288.94 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=192.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeec-cccceeeeeeeeccC----Cc
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG----QN 594 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~ 594 (814)
+.+.+.||+|+||.||++...... .+..+|+|++..... ...+.+.+|+.++.++ +|+||+++++++... ..
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCC-cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 345678999999999999986421 267899999865322 2245678899999998 599999999976432 45
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
.++++||+. ++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 678888885 6899998888889999999999999999999994 599999999999999999999999999998664
Q ss_pred ccccc--cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHH-------
Q 042262 675 LNQSK--AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY------- 744 (814)
Q Consensus 675 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~------- 744 (814)
..... .......|+..|+|||.+.+ ..++.++||||||++++++++|+.||........ + .......
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~--~-~~~~~~~~~~~~~~ 233 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ--L-NQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH--H-HHHHHHhCCCCHHH
Confidence 32211 11223468899999998865 4689999999999999999999999875432110 0 0000000
Q ss_pred ----hcCC-------ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 745 ----RNGK-------LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 745 ----~~~~-------~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.... ....-...... ........+.+++.+|++.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 00000000000 01123568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=304.47 Aligned_cols=246 Identities=28% Similarity=0.414 Sum_probs=188.7
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeee----------------
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGF---------------- 588 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~---------------- 588 (814)
+.||+||||.|||++.+- +++.+|||++.... ...-..+.+|++++.+|+|||||+++..
T Consensus 485 ~lLGkGGFG~VvkVRNKl---DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~ 561 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKL---DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS 561 (1351)
T ss_pred HHhcCCCCceEEEEeecc---cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence 469999999999999875 68899999997543 2334568899999999999999998733
Q ss_pred ------------------------------------------e---------c-----------cC--------------
Q 042262 589 ------------------------------------------C---------D-----------EG-------------- 592 (814)
Q Consensus 589 ------------------------------------------~---------~-----------~~-------------- 592 (814)
+ . ++
T Consensus 562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~ 641 (1351)
T KOG1035|consen 562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI 641 (1351)
T ss_pred chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence 0 0 00
Q ss_pred ---------------------------CceehhhhhccCCchhhhhcCCCCC-CHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 042262 593 ---------------------------QNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSAQI 644 (814)
Q Consensus 593 ---------------------------~~~~lV~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~~ia~gL~yLH~~~~~~i 644 (814)
...||-||||+...|.+++..+... .....++++.+|++||+|+|+ .+|
T Consensus 642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~---~gi 718 (1351)
T KOG1035|consen 642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD---QGI 718 (1351)
T ss_pred cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh---Cce
Confidence 1136778999888888888776554 456678999999999999995 589
Q ss_pred eecCCCCCcEEECCCCCeEEeecCCccccc----------------ccccccccccccCCCCccCcccccCCC---CCCc
Q 042262 645 IHCDIKPQNILLDDYYNARISDFGLAKLLT----------------LNQSKAIKTAIRGTKGYVAPEWFRNST---ITAK 705 (814)
Q Consensus 645 iH~Dikp~NIll~~~~~~kl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~k 705 (814)
|||||||.||+|+++..+||+|||+|.... ........+..+||.-|+|||.+.+.. |+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999998732 001111346678999999999997654 9999
Q ss_pred cchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCC
Q 042262 706 VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRP 785 (814)
Q Consensus 706 ~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 785 (814)
+|+||+||||+||+- ||...+.. ..+...++.|.++.- ++ ...+....-..++.+++++||.+||
T Consensus 799 iDmYSLGIVlFEM~y---PF~TsMER------a~iL~~LR~g~iP~~--~~----f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTSMER------ASILTNLRKGSIPEP--AD----FFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCchHHH------HHHHHhcccCCCCCC--cc----cccccchHHHHHHHHHhcCCCccCC
Confidence 999999999999986 56655432 123345566665543 11 1223344556899999999999999
Q ss_pred CHHHHHH
Q 042262 786 TMRKVSQ 792 (814)
Q Consensus 786 tm~eV~~ 792 (814)
|+.|++.
T Consensus 864 tA~eLL~ 870 (1351)
T KOG1035|consen 864 TATELLN 870 (1351)
T ss_pred CHHHHhh
Confidence 9999986
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=291.00 Aligned_cols=263 Identities=22% Similarity=0.258 Sum_probs=191.3
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccC--------
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-------- 592 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 592 (814)
++.+.+.||+|+||.||+|.... .+..|++|++........+.+.+|+++++.++||||+++++++...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~---~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSD---CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECC---CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 45566789999999999998864 5678999998765555567788999999999999999999876543
Q ss_pred ------CceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC-CCCCeEEe
Q 042262 593 ------QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARIS 665 (814)
Q Consensus 593 ------~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~ 665 (814)
...++|+||++ ++|.+++.. ..+++.....++.||++||.|||+ .+|+||||||+||+++ ++..+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence 34689999997 588887754 357899999999999999999995 5999999999999997 45678999
Q ss_pred ecCCcccccccccc-cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHH----
Q 042262 666 DFGLAKLLTLNQSK-AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW---- 739 (814)
Q Consensus 666 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~---- 739 (814)
|||+++.+...... .......++..|+|||.+.+ ..++.++||||||++++||++|+.||..............
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999865432211 11122357889999998754 5688899999999999999999999964432111000000
Q ss_pred ----HHHHHhcCCcccccc-Cccc-----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 740 ----AFDCYRNGKLDDLVE-GDTE-----AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 740 ----~~~~~~~~~~~~l~~-~~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....... ....... .... .........++.+++..||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 0000000 0000 0001234577889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.17 Aligned_cols=237 Identities=27% Similarity=0.293 Sum_probs=194.7
Q ss_pred ccccceeEEEEEEEeccCCcceEEEEEeecccccc---chhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
||+|+||.||++.... .++.+++|.+...... ....+..|+.+++.++|+||+++++.+..+...++||||+++
T Consensus 1 lg~G~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence 6999999999999864 4678999988654222 345788999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccccc
Q 042262 605 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA 684 (814)
Q Consensus 605 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 684 (814)
++|.+++.....+++.....++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++........ ....
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT 152 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence 9999999888789999999999999999999995 6999999999999999999999999999987654321 1234
Q ss_pred ccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChh
Q 042262 685 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIK 764 (814)
Q Consensus 685 ~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 764 (814)
..++..|+|||.+.+...+.++|+||||++++|+++|+.||...... .. ......+. ...+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~----~~~~~~~~----------~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EI----YEKILKDP----------LRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHhcCC----------CCCCCC
Confidence 45788999999999888999999999999999999999999644321 11 11111111 112223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHH
Q 042262 765 CTEKLVMVSIWCIQEDPSLRPTMRK 789 (814)
Q Consensus 765 ~~~~l~~l~~~Cl~~dP~~RPtm~e 789 (814)
.+..+.+++.+||+.||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 3678899999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=286.76 Aligned_cols=263 Identities=25% Similarity=0.296 Sum_probs=191.9
Q ss_pred HHHHHHHhh--hhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeec
Q 042262 515 KELEEATDN--FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCD 590 (814)
Q Consensus 515 ~el~~~~~~--~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 590 (814)
+++...+.. +.+.||+|+||.||+|.... .+..||+|++.... ....+.+.+|+.++++++|+||+++++++.
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcC---CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 344444443 34679999999999998764 46789999986532 223456788999999999999999999885
Q ss_pred cC------CceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEE
Q 042262 591 EG------QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 664 (814)
Q Consensus 591 ~~------~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl 664 (814)
.. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEE
Confidence 43 3467888876 78898877544 58999999999999999999995 59999999999999999999999
Q ss_pred eecCCcccccccccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHH--
Q 042262 665 SDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-- 741 (814)
Q Consensus 665 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-- 741 (814)
+|||+++..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||....... .+.....
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~ 234 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLV 234 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHh
Confidence 999998865322 223457889999999876 468899999999999999999999986432211 0000000
Q ss_pred --------HHHhcCCc-------cccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 742 --------DCYRNGKL-------DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 742 --------~~~~~~~~-------~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..+..... ........ .......+.++.+++.+|++.||.+||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000 00000000 00011235678899999999999999999998874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=282.66 Aligned_cols=259 Identities=23% Similarity=0.291 Sum_probs=191.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeecc-CCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV 598 (814)
+.+.+.||+|+||.||++.... .+..+|||++... .....+.+.+|+.++..++||||+++++++.. ....++|
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQL---TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred eEEEEeecccCCeEEEEEEECC---CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 4455789999999999998764 5678999988542 22234678889999999999999999998865 5678999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
+||+ +++|..++.. ..+++.....++.|+++||+|||+ .+|+|+||+|+||++++++.+||+|||++......
T Consensus 89 ~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 89 TELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred eehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 9998 5688887764 356788888999999999999994 69999999999999999999999999998754322
Q ss_pred ccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhh-HHHH-------HHHHHhcCCc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDW-------AFDCYRNGKL 749 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~-------~~~~~~~~~~ 749 (814)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||.......... +.+. ..+.+..+..
T Consensus 162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 123456889999999866 568999999999999999999999996443211100 0000 0000000110
Q ss_pred cccccC-ccccc-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 750 DDLVEG-DTEAM-----NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 750 ~~l~~~-~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.++... ..... .....+..+.+++.+||+.+|++|||+.|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001000 00000 011345789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=283.32 Aligned_cols=263 Identities=25% Similarity=0.305 Sum_probs=193.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCC------
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------ 593 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 593 (814)
+.+.+.||+|+||.||++.... .+..||||++.... ....+.+.+|+.++++++|+||+++++++....
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECC---CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 4455789999999999998764 46789999985422 222356788999999999999999999986543
Q ss_pred ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 594 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999998 7788888764 468899999999999999999994 69999999999999999999999999999865
Q ss_pred cccccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHH----------HH
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA----------FD 742 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~----------~~ 742 (814)
... .....++..|+|||.+.+ ..++.++||||||+++++|++|+.||....... .+.... ..
T Consensus 169 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 169 DSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHH
Confidence 432 223457889999999876 458899999999999999999999997442211 000000 00
Q ss_pred HHhcCCccccc-------cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHcCCcCC
Q 042262 743 CYRNGKLDDLV-------EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEGVVEV 800 (814)
Q Consensus 743 ~~~~~~~~~l~-------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~--~L~~~~~~ 800 (814)
.+......... .... .......+..+.+++.+|++.||.+|||+.++++ .++...+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred hhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 00000000000 0000 0011234567889999999999999999999994 44544333
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-31 Score=278.80 Aligned_cols=243 Identities=26% Similarity=0.408 Sum_probs=198.1
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
.+.||+|.||+||-|++.+ .++.||||++.+. ..+.+.++++|+.+|+.++||.||.+...|+..++.++|||-+
T Consensus 569 devLGSGQFG~VYgg~hRk---tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRK---TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecc---cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence 4689999999999999986 6789999999753 4456678999999999999999999999999999999999999
Q ss_pred cCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC---CCeEEeecCCccccccccc
Q 042262 603 NNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY---YNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 603 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DfGla~~~~~~~~ 678 (814)
.+.-|+-+|... .++++..-..++.||+.||.|||. .+|+|+||||+||||.+. -++||+|||.|+.+.....
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 776666666543 578888888999999999999994 699999999999999754 3599999999999875433
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
...++||+.|+|||+++++.|...-|+||.|||+|--++|..||..+.+-. +.+.+.. ++- .
T Consensus 723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn---------dQIQNAa---FMy---P 784 (888)
T KOG4236|consen 723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN---------DQIQNAA---FMY---P 784 (888)
T ss_pred ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh---------HHhhccc---ccc---C
Confidence 456789999999999999999999999999999999999999997654311 1111111 111 1
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVS 791 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~ 791 (814)
...-.+.+.+.++++...||..-++|-|...-+
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 112235667888999999999999998876544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=268.61 Aligned_cols=222 Identities=21% Similarity=0.167 Sum_probs=177.4
Q ss_pred cceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCCchhhh
Q 042262 531 GSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 610 (814)
Q Consensus 531 G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 610 (814)
|.+|.||++.... +++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++++|.++
T Consensus 4 g~~~~v~~~~~~~---~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTR---TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEcc---CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8899999999875 56789999986542 222333334445799999999999999999999999999999999
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCC
Q 042262 611 LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690 (814)
Q Consensus 611 l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 690 (814)
+.....+++.....++.|+++||+|||+ .+|+||||||+||++++++.++++|||.+..+... .....++..
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 9877779999999999999999999994 69999999999999999999999999987665432 122345678
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHH
Q 042262 691 YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLV 770 (814)
Q Consensus 691 y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~ 770 (814)
|+|||.+.+..++.++||||+|++++||++|+.|+....... ... .....+...+..+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~----~~~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTH----TTLNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccc----cccCCcccCCHHHH
Confidence 999999988889999999999999999999998865321100 000 00011223567889
Q ss_pred HHHHHccccCCCCCCCHHH
Q 042262 771 MVSIWCIQEDPSLRPTMRK 789 (814)
Q Consensus 771 ~l~~~Cl~~dP~~RPtm~e 789 (814)
+++.+|++.||++||++.+
T Consensus 207 ~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 207 SLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHccCCHHHhcCCCc
Confidence 9999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-31 Score=288.02 Aligned_cols=199 Identities=29% Similarity=0.454 Sum_probs=172.2
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeecccccc-chhhhhceeeEEeeccccceeeeeeeeccCC------cee
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------NRL 596 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~ 596 (814)
..+.||+|+||.||+|+.+. .|+.||||..+..... ..+...+|++++++++|+|||++++.-++.. ..+
T Consensus 17 ~~e~LG~Ga~g~V~rgrnke---tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKE---TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ehhhhcCCccceeeeecccc---cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 34679999999999999875 6889999999765433 3456788999999999999999999976654 568
Q ss_pred hhhhhccCCchhhhhcCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC--CCCC--eEEeecCC
Q 042262 597 LVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD--DYYN--ARISDFGL 669 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~--~~~~--~kl~DfGl 669 (814)
+|||||.+|+|...|.+. ..|++.+.+.++.++..||.|||++ +|+||||||.||++- +++. -||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999999865 4689999999999999999999964 999999999999983 3343 79999999
Q ss_pred cccccccccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCc
Q 042262 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGE 731 (814)
Q Consensus 670 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~ 731 (814)
|+.+..+. ..+..+||..|++||.+.. +.++..+|.|||||++||..||..||.+..+.
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99887554 2567889999999999984 88999999999999999999999999877654
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-31 Score=274.49 Aligned_cols=241 Identities=28% Similarity=0.347 Sum_probs=198.2
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
.+||+|+||.||-+.... .++.+|.|++.+. ..+++....+|-.+|.+++.+.||.+--.+++.+..+||+..|
T Consensus 191 RvlGkGGFGEV~acqvra---TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM 267 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRA---TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM 267 (591)
T ss_pred EEEecccccceeEEEEec---chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence 579999999999998875 5778898888542 2344556788889999999999999999999999999999999
Q ss_pred cCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 603 NNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 603 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
.+|+|.-+|... ..+++.....++.+|+.||++||. ..||.||+||+|||||+.|+++|+|+|+|..+...+.
T Consensus 268 NGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~-- 342 (591)
T KOG0986|consen 268 NGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP-- 342 (591)
T ss_pred cCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCc--
Confidence 999999999764 478999999999999999999995 5999999999999999999999999999998776554
Q ss_pred ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~ 760 (814)
.+..+||.||||||++.+..|+...|-||+||+||||+.|..||...... .+..+++..+.. ....
T Consensus 343 -~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK------------vk~eEvdrr~~~-~~~e 408 (591)
T KOG0986|consen 343 -IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK------------VKREEVDRRTLE-DPEE 408 (591)
T ss_pred -cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh------------hhHHHHHHHHhc-chhh
Confidence 33457999999999999999999999999999999999999999643211 111111111111 1123
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHH
Q 042262 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMR 788 (814)
Q Consensus 761 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~ 788 (814)
++...++++..|....|+.||.+|.--+
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCC
Confidence 4557788999999999999999997543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=284.43 Aligned_cols=254 Identities=25% Similarity=0.321 Sum_probs=191.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCc-----
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN----- 594 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 594 (814)
+.+.+.||+|++|.||+|.... .+..+|||++.... ....+.+.+|+.+++.++|+||+++++++...+.
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred eEEEEEeccCCceEEEEEEECC---CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 3455789999999999999875 46789999986432 2233567789999999999999999998866554
Q ss_pred -eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 595 -RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 595 -~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.+||+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999998 6689888865 468999999999999999999994 69999999999999999999999999999865
Q ss_pred cccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHH--------
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY-------- 744 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-------- 744 (814)
... .....++..|+|||.+.+. .++.++||||||++++|+++|+.||........ + ....+..
T Consensus 169 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--~-~~i~~~~~~~~~~~~ 240 (343)
T cd07851 169 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ--L-KRIMNLVGTPDEELL 240 (343)
T ss_pred ccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--H-HHHHHhcCCCCHHHH
Confidence 432 2234578899999998653 678999999999999999999999964432110 0 0000000
Q ss_pred ---hcCCccccccC-------cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 745 ---RNGKLDDLVEG-------DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 745 ---~~~~~~~l~~~-------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........+.. .... .....+..+.+++.+||+.+|.+|||+.||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000000 0000 01123678999999999999999999999977
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=302.88 Aligned_cols=144 Identities=27% Similarity=0.368 Sum_probs=127.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.++||+|+||.||+|.+.. .++.||||+++... ......+..|+.++..++|+||+++++++......+||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 4456789999999999999874 46789999986432 12235688899999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
|||+.+++|.+++.....+++...+.|+.||+.||+|||. .+|+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999877778999999999999999999995 599999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=267.88 Aligned_cols=262 Identities=26% Similarity=0.336 Sum_probs=203.8
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccc-----hhhhhceeeEEeeccccceeeeeee
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDG-----EKEFKNEVVVIGQTHHKNLVRLLGF 588 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~-----~~~~~~Ei~~l~~l~H~niv~l~g~ 588 (814)
-+...+|-+...||+|||+.|||+.+-. ..+.||||+-... ..+. .+...+|..+-+.+.||.||+++++
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~---EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy 535 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLT---EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY 535 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccc---hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence 3445556666789999999999999874 5678999986421 1111 2346788899999999999999999
Q ss_pred ec-cCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCCeEE
Q 042262 589 CD-EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARI 664 (814)
Q Consensus 589 ~~-~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl 664 (814)
+. +.+..+-|.||+++.+|+-+|+....+++++...|+.||+.||.||.+. +++|||-||||.||||.+ -|.+||
T Consensus 536 fslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 536 FSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 84 5567889999999999999999999999999999999999999999986 899999999999999964 578999
Q ss_pred eecCCcccccccccc-----cccccccCCCCccCcccccC----CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhh
Q 042262 665 SDFGLAKLLTLNQSK-----AIKTAIRGTKGYVAPEWFRN----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 735 (814)
Q Consensus 665 ~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~ 735 (814)
.|||+++.+..+... .......||.+|++||.+-- ..++.|.||||.|||+|..+-|+.||.......
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--- 691 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--- 691 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---
Confidence 999999998765433 23345679999999999843 357889999999999999999999997554321
Q ss_pred HHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 736 LTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 736 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+.+.+..+..... ......+.++.+...++++||+..-++|....++..
T Consensus 692 ------dILqeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 ------DILQENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ------HHHhhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 2222222211111 111223456678899999999999999977766553
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=254.18 Aligned_cols=264 Identities=23% Similarity=0.231 Sum_probs=199.0
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccC----Cceehhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG----QNRLLVYE 600 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~~~lV~e 600 (814)
++||-|-.|.|-.+..+. .++.+|+|++... ...++|+++--.. .|+|||.+++++++. +..++|||
T Consensus 68 qvLG~GinGkV~~C~~k~---T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKR---TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred hhhccccCCceEEEEecc---chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 579999999999998875 5678999998643 2334555543333 699999999998653 45678999
Q ss_pred hccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCCeEEeecCCcccccc
Q 042262 601 FLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARISDFGLAKLLTL 675 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DfGla~~~~~ 675 (814)
.|++|.|...+.+.. .+++.+.-.|++||+.|+.||| +.+|.||||||+|+|... +-.+||+|||+|+.-..
T Consensus 140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999999997654 5899999999999999999999 679999999999999964 55699999999987543
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.. ...+.+-|+-|.|||++....++..+|+||+||++|-|++|.+||....+.. +.--....++.|..+
T Consensus 217 ~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gqy~----- 285 (400)
T KOG0604|consen 217 PG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQYE----- 285 (400)
T ss_pred Cc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccCcc-----
Confidence 21 1344567899999999999999999999999999999999999998654421 111123333443321
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCCCCCCCCCcC
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFSGY 812 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~pp~p~~~~~~ 812 (814)
.....-...++...++++..|..+|.+|.|+.|++..===......|..|...+.+
T Consensus 286 -FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~ 341 (400)
T KOG0604|consen 286 -FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRM 341 (400)
T ss_pred -CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhh
Confidence 12222336678889999999999999999999998742111233344444444443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=260.71 Aligned_cols=239 Identities=29% Similarity=0.356 Sum_probs=195.3
Q ss_pred ceeEEEEEEEeccCCcceEEEEEeeccccccc-hhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCCchhhh
Q 042262 532 SFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 610 (814)
Q Consensus 532 ~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 610 (814)
+||.||+|.... .+..+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.++
T Consensus 1 ~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKK---TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECC---CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 589999999874 46789999997654443 67899999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCC
Q 042262 611 LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690 (814)
Q Consensus 611 l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 690 (814)
+.....+++..+..++.+++++|.|||+ .+++|+||+|+||++++++.++|+|||.+........ .....++..
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~ 151 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTTFVGTPE 151 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeeccccc---cccccCCcC
Confidence 9776668999999999999999999995 5999999999999999999999999999987764421 234457889
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHH
Q 042262 691 YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLV 770 (814)
Q Consensus 691 y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~ 770 (814)
|++||.+.+..++.++||||||+++++|++|..|+....... . ..+....+..... ......+.++.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~----~~~~~~~~~~~~~-------~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--E----LFKKIGKPKPPFP-------PPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H----HHHHHhccCCCCc-------cccccCCHHHH
Confidence 999999998889999999999999999999999986532111 1 1122222111100 00001567899
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 042262 771 MVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 771 ~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=267.22 Aligned_cols=271 Identities=22% Similarity=0.314 Sum_probs=208.8
Q ss_pred ccccCHHHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-c-cc----e
Q 042262 509 LRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-H-KN----L 582 (814)
Q Consensus 509 ~~~f~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H-~n----i 582 (814)
--.|...+....++.+.+.+|+|.||.|-+..+.. .+..||||+++.... ..+.-+-|+++++++. + |+ +
T Consensus 78 H~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 78 HYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---TKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred eEEEEeccccccceehhhhhcCCcccceEEEeecC---CCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 34566677778888888999999999999999875 367999999987643 3455677899999984 2 33 8
Q ss_pred eeeeeeeccCCceehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC--
Q 042262 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-- 658 (814)
Q Consensus 583 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-- 658 (814)
|.+.++++-.++.+||+|.+ +-|+.++|..+ ..++..++..|+.|+++++++|| +.+++|.||||+|||+.+
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSE 229 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccc
Confidence 88999999999999999987 66999999876 46788999999999999999999 569999999999999842
Q ss_pred ------------------CCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh
Q 042262 659 ------------------YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720 (814)
Q Consensus 659 ------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt 720 (814)
+..+||+|||.|..-+.. ...++.|..|.|||++.+-+++.++||||+||||.||.+
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 345899999999875443 356678999999999999999999999999999999999
Q ss_pred CCcCCcccCCcchhhHHHHHH--------------HHHhcCCcc-----------ccccCcc----cccCChhHHHHHHH
Q 042262 721 CRKSFDIEMGEEYAILTDWAF--------------DCYRNGKLD-----------DLVEGDT----EAMNDIKCTEKLVM 771 (814)
Q Consensus 721 G~~p~~~~~~~~~~~l~~~~~--------------~~~~~~~~~-----------~l~~~~~----~~~~~~~~~~~l~~ 771 (814)
|...|+.....+...+-+.+. ..+..|+++ .+.+... .......+..++.+
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 999998765433221111110 011111111 1111110 01123355678999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 042262 772 VSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 772 l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
|+..+|..||.+|+|+.|+++
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHccCccccccHHHHhc
Confidence 999999999999999999876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=252.82 Aligned_cols=258 Identities=26% Similarity=0.359 Sum_probs=200.0
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccC-----Cceehh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QNRLLV 598 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV 598 (814)
+.||.|+||+||.+++.. +++.|+.|++..... ...+.+.+|+++++.++|.|++..++...-. .+.|+|
T Consensus 59 RPIGYGAFGVVWsVTDPR---dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPR---SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CcccccceeEEEeccCCC---CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 579999999999998875 678999999976432 2357889999999999999999988876432 367899
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
.|.|. .+|..+|-+.+.++....+-++.||++||+||| +.+|.||||||.|.|++.+..+||+|||+++.-..++.
T Consensus 136 TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 99984 589999999999999999999999999999999 56999999999999999999999999999998877766
Q ss_pred ccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc------
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD------ 751 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------ 751 (814)
.. .+..+.|..|+|||++++. .|+.+.||||.||++.||+..+..|....+-....+ +.+.+....++.
T Consensus 212 ~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l---ItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 212 LN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM---IIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH---HHHHhCCCcHHHHHHHhh
Confidence 55 4555678999999999886 699999999999999999999999876654332221 222221111111
Q ss_pred -----ccc-----Cccc----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042262 752 -----LVE-----GDTE----AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794 (814)
Q Consensus 752 -----l~~-----~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L 794 (814)
++. +... ...+.....+...+...++..||++|.+..+.+..+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 000 1110 011112334566777888999999999988887754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=260.65 Aligned_cols=243 Identities=27% Similarity=0.334 Sum_probs=200.3
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--c-cchhhhhceeeEEeec-cccceeeeeeeeccCCc
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--Q-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 594 (814)
....+|..+||+|.||.|.++.-+. ..+.+|||++++.. + ++.+--+.|-++|... +-|.++++..++...+.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkg---tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ecccceEEEeccCccceeeeecccC---cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 3446888999999999999987653 56789999997632 1 1223346677777776 56889999999999999
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
.|.||||+.+|+|--+|++-.++.++....+|..||-||-+|| +.+||.||||..|||||.++++||+|||+.+.--
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999999999998888999999999999999999999 5699999999999999999999999999998543
Q ss_pred ccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.+.. ...+++||+.|+|||++...+|...+|-|||||+||||+.|++||+.+..++. .+.+.+.
T Consensus 502 ~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-------F~aI~eh------- 565 (683)
T KOG0696|consen 502 FDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQAIMEH------- 565 (683)
T ss_pred cCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHHc-------
Confidence 3222 24578899999999999999999999999999999999999999987654331 1222211
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCC
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT 786 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 786 (814)
...++...+.+...+....|...|.+|.-
T Consensus 566 ---nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 ---NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ---cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 22356677889999999999999999953
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=254.30 Aligned_cols=245 Identities=24% Similarity=0.252 Sum_probs=200.1
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccc---hhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.|.+.||+|.||+|-+++-+. .++.+|+|++++..--. ...-..|-++|+..+||.+..|--.+...++.+.||
T Consensus 171 dfLKvLGkGTFGKVIL~rEKa---t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKA---TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred hHHHHhcCCccceEEEEeecc---cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 566889999999999888764 67899999997642222 233456778888999999999988888999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||..+|.|.-+|.+...+++...+.+-..|..||.||| +.+||.||||.+|.|||.+|++||+|||+.+.--.. .
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~--g 322 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY--G 322 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc--c
Confidence 99999999999999999999988899999999999999 569999999999999999999999999999853221 1
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
....+++||+.|+|||++....|....|-|.+||++|||++|+.||.....+....+ +..++ .
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL-------Il~ed----------~ 385 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL-------ILMED----------L 385 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH-------HHhhh----------c
Confidence 225678999999999999999999999999999999999999999986544332211 11111 1
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 792 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~ 792 (814)
..+...+.+...|+...|..||.+|. .++||.+
T Consensus 386 kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 386 KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 23445667888899999999999996 3556554
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=230.13 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=188.4
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
.|+||+|.+|+|+||+... ..+.||+|+.+-. ++.-.....+|+-+++.++|+|||++++....+++..||+||+
T Consensus 7 mekigegtygtvfkarn~~---t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRE---THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred HHhhcCCcceeeEecccCC---ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 4689999999999998764 5789999998643 3333466789999999999999999999999999999999999
Q ss_pred cCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 603 NNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 603 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
.. .|..+..+ +..++.+....++.|+++||.++| +.++.|||+||+|.|++.+++.|++|||+++.+...-.-
T Consensus 84 dq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc-- 157 (292)
T KOG0662|consen 84 DQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-- 157 (292)
T ss_pred hH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe--
Confidence 54 66666543 467888999999999999999999 569999999999999999999999999999987644321
Q ss_pred cccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHH--HHhcCCcc---ccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD--CYRNGKLD---DLVEG 755 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--~~~~~~~~---~l~~~ 755 (814)
....+.|..|.+|+++-+. -|+...|+||-||++.||....+|..+..+...+ +....+. ...+...+ .+.|.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq-lkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH-HHHHHHHhCCCccccCCccccCCCC
Confidence 3345679999999999876 5899999999999999999855554333322211 1111111 11112222 22222
Q ss_pred cccccCC---------hhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 756 DTEAMND---------IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 756 ~~~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..-..++ +.....=.++....+.-+|..|-++++.++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111111 111222334555566669999999988765
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-29 Score=286.13 Aligned_cols=266 Identities=20% Similarity=0.252 Sum_probs=208.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.+.||+|+||.|..++... .++.+|.|++.+.. .....-|.+|-.+|..-+.+=|+.|.-.|.++.+.||
T Consensus 76 DfeilKvIGrGaFGEV~lVr~k~---t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 76 DFEILKVIGRGAFGEVALVRHKS---TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred hhHHHHHhcccccceeEEEEeec---cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 44566899999999999999975 56789999997732 2233568888888888888889999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||||+||+|-.++....+++.+..+.++..|.-||.-|| +.|+|||||||+|||||..|++||+|||.+-.+..+.
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 9999999999999988778999999999999999999999 6899999999999999999999999999988776443
Q ss_pred cccccccccCCCCccCccccc----C-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFR----N-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~----~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
. ......+||+.|++||+++ + +.|.+.+|-||+||++|||+.|..||..+.- .+.....+.....
T Consensus 230 ~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY~KIm~hk~~--- 299 (1317)
T KOG0612|consen 230 T-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETYGKIMNHKES--- 299 (1317)
T ss_pred c-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHHHHHhchhhh---
Confidence 3 2245678999999999995 3 5689999999999999999999999985532 1211111111111
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCCCCC---HHHHHHH--H-----cCCcCCCCCCCCC
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT---MRKVSQM--L-----EGVVEVDVPPNPS 807 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---m~eV~~~--L-----~~~~~~~~pp~p~ 807 (814)
+........+++..+||...+. +|+.|.. +.++... + +.+.+...|-.|.
T Consensus 300 ----l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPe 359 (1317)
T KOG0612|consen 300 ----LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPE 359 (1317)
T ss_pred ----cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence 1111223477888888888665 7888888 7777664 1 3444555554443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-29 Score=233.93 Aligned_cols=194 Identities=28% Similarity=0.403 Sum_probs=164.9
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhhhcc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN 603 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 603 (814)
+.||+|++|.|-+-++.. .+..+|||+++.. ..+..++...|+.+..+. .+|.+|.++|........++.||.|.
T Consensus 52 ~elGrGayG~vekmrh~~---sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQ---SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhcCCccchhhheeecc---CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 579999999999888875 6889999999753 344456778888877665 79999999999999999999999984
Q ss_pred CCchhhhh----cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 604 NGTLASFL----FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 604 ~gsL~~~l----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
.||+.+- ..+...++...-+|+..+.+||.|||+ ...+||||+||+|||++.+|++||+|||++..+..+-.
T Consensus 129 -tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA- 204 (282)
T KOG0984|consen 129 -TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA- 204 (282)
T ss_pred -hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH-
Confidence 4776653 456788999999999999999999998 57999999999999999999999999999988765433
Q ss_pred cccccccCCCCccCccccc----CCCCCCccchhhHHHHHHHHHhCCcCCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFR----NSTITAKVDVYSFGVLLLEIISCRKSFDIE 728 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~----~~~~t~k~DV~S~Gvvl~elltG~~p~~~~ 728 (814)
.+...|...|||||.+. ...|+.|+||||+|+.+.||.+++.|++.-
T Consensus 205 --kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 205 --KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred --HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 23345889999999984 347899999999999999999999999744
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=282.32 Aligned_cols=260 Identities=20% Similarity=0.192 Sum_probs=163.7
Q ss_pred hhhhccccccceeEEEEEEEecc-CCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeee------eccCCc
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTT-RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF------CDEGQN 594 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~-~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~~~~~ 594 (814)
+.+.++||+|+||.||+|.+..+ ...+..+|||++..... .+....| .+.+..+.++..++.. +.++..
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence 45567899999999999998752 11257899998764321 1111111 0111122222222211 345678
Q ss_pred eehhhhhccCCchhhhhcCCCC--------------------CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 042262 595 RLLVYEFLNNGTLASFLFGNLK--------------------PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 654 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NI 654 (814)
.+|||||+.+++|.+++..... .....+..|+.||++||+|||+ .+|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHE
Confidence 8999999999999998864321 1123456799999999999995 5999999999999
Q ss_pred EECC-CCCeEEeecCCcccccccccccccccccCCCCccCcccccCC----------------------CCCCccchhhH
Q 042262 655 LLDD-YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS----------------------TITAKVDVYSF 711 (814)
Q Consensus 655 ll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~k~DV~S~ 711 (814)
|+++ ++.+||+|||+++.+....... .....+++.|+|||.+... .++.++|||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9986 5789999999998664332221 3445689999999965322 23456799999
Q ss_pred HHHHHHHHhCCcCCcccCCcc-------hhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCC
Q 042262 712 GVLLLEIISCRKSFDIEMGEE-------YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLR 784 (814)
Q Consensus 712 Gvvl~elltG~~p~~~~~~~~-------~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 784 (814)
||+||||+++..+++.....- ...+..|.... ......++ ..... ..........+|+.+||+.||++|
T Consensus 366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~-~~~~~--~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV-EPRASPDL-RRGFE--VLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh-ccccchhh-hhhhh--hccccchHHHHHHHHHccCCcccC
Confidence 999999999776654211000 00011110000 00000000 00000 000112345689999999999999
Q ss_pred CCHHHHHHH
Q 042262 785 PTMRKVSQM 793 (814)
Q Consensus 785 Ptm~eV~~~ 793 (814)
||++|+++.
T Consensus 442 ~ta~e~L~H 450 (566)
T PLN03225 442 ISAKAALAH 450 (566)
T ss_pred CCHHHHhCC
Confidence 999999884
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=245.91 Aligned_cols=265 Identities=20% Similarity=0.303 Sum_probs=192.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecc--ccccchhhhhceeeEEeeccccceeeeeeeeccC-------
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------- 592 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------- 592 (814)
+.-..+||+|.||.||+|...+ .++.||+|+.-- ..+.-.....+|+++|..+.|+|++.++..|...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n---~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKN---TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcC---ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 3334579999999999998875 455688877632 1222234467899999999999999999999542
Q ss_pred -CceehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 593 -QNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 593 -~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
...+||+.+++. +|.-+|... .+++..++.+++.++..||.|+| ...|+|||+||.|+||+.++.+||+|||++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 237899999976 677777654 67899999999999999999999 569999999999999999999999999999
Q ss_pred ccccccccc--cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHH-----H
Q 042262 671 KLLTLNQSK--AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-----D 742 (814)
Q Consensus 671 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-----~ 742 (814)
+.+...+.. ...+..+.|..|++||.+.+. .++++.|||.-|||+.||.++.+-+..........+..... +
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 877544322 223445679999999999876 69999999999999999999998887553322222211111 1
Q ss_pred HHhcC---------CccccccCccc----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 743 CYRNG---------KLDDLVEGDTE----AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 743 ~~~~~---------~~~~l~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.|.+- +++.+...... ...+.....+.++|+..++..||.+|+++.+++..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11110 00101110000 00111123477889999999999999999988753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=272.94 Aligned_cols=257 Identities=22% Similarity=0.250 Sum_probs=174.5
Q ss_pred hhhhccccccceeEEEEEEEecc-------------CCcceEEEEEeeccccccchhhhh--------------ceeeEE
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTT-------------RTSTTAVAVKKLDRVFQDGEKEFK--------------NEVVVI 574 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~-------------~~~~~~vaVK~l~~~~~~~~~~~~--------------~Ei~~l 574 (814)
+.+.++||+|+||+||+|.+... +..++.||||++........++|. .|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 45567899999999999975321 123467999998654332223333 344455
Q ss_pred eeccccc-----eeeeeeeecc--------CCceehhhhhccCCchhhhhcCC------------------------CCC
Q 042262 575 GQTHHKN-----LVRLLGFCDE--------GQNRLLVYEFLNNGTLASFLFGN------------------------LKP 617 (814)
Q Consensus 575 ~~l~H~n-----iv~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~------------------------~~l 617 (814)
.+++|.+ +++++++|.. ....+|||||+++++|.++++.. ..+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 5565554 4677888753 35689999999999999988632 123
Q ss_pred CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccc
Q 042262 618 SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697 (814)
Q Consensus 618 ~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 697 (814)
++..+..|+.|++++|.|||+ .+|+||||||+|||++.++.+||+|||+++.+....... .....+++.|+|||.+
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEEL 382 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhh
Confidence 577888999999999999995 589999999999999999999999999997654332111 1122347899999988
Q ss_pred cCCCC----------------------CCccchhhHHHHHHHHHhCCc-CCcccCC--cc----hhhHHHHHHHHHhcCC
Q 042262 698 RNSTI----------------------TAKVDVYSFGVLLLEIISCRK-SFDIEMG--EE----YAILTDWAFDCYRNGK 748 (814)
Q Consensus 698 ~~~~~----------------------t~k~DV~S~Gvvl~elltG~~-p~~~~~~--~~----~~~l~~~~~~~~~~~~ 748 (814)
..... ..+.||||+||+++||++|.. |+..... .+ ...+.. +..+....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~--~r~~~~~~ 460 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR--WRMYKGQK 460 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH--HHhhcccC
Confidence 54321 235799999999999999875 6542110 00 000101 11111111
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDP---SLRPTMRKVSQ 792 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPtm~eV~~ 792 (814)
. .........+...+++.++|..+| .+|+|++|+++
T Consensus 461 ~--------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 Y--------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred C--------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1 111122346788899999998766 68999999986
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-29 Score=262.58 Aligned_cols=243 Identities=22% Similarity=0.275 Sum_probs=199.8
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecc---ccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
..||-|+||.|=++..... ....|+|.+++ .....++.+..|-++|...+.|.||+|+-.+.+.+..||.||-|
T Consensus 426 aTLGvGgFGRVELV~~~~~---~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC 502 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQ---KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC 502 (732)
T ss_pred hhcccCccceEEEEEeccc---chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence 3699999999999888753 22466666654 34455566788989999999999999999999999999999999
Q ss_pred cCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccc
Q 042262 603 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682 (814)
Q Consensus 603 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (814)
-+|.|...|.....++......++..+++|++||| +.+||.|||||+|.+|+.+|-+||.|||+|+.+..+.. .
T Consensus 503 lGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---T 576 (732)
T KOG0614|consen 503 LGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---T 576 (732)
T ss_pred cCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc---e
Confidence 99999999999999999999999999999999999 57999999999999999999999999999998876543 4
Q ss_pred ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
-+++||+.|.|||++.++..+..+|.||+|++++||++|++||....+-.. +..+..|- + ....+
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-------Yn~ILkGi-d-------~i~~P 641 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-------YNLILKGI-D-------KIEFP 641 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-------HHHHHhhh-h-------hhhcc
Confidence 568899999999999999999999999999999999999999986543111 11111110 0 11123
Q ss_pred hhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 792 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RPt-----m~eV~~ 792 (814)
........++++.....+|.+|.- +.+|.+
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 455677788888888899999986 455544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=267.15 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=203.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeec-----cCCc
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCD-----EGQN 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~-----~~~~ 594 (814)
+..|.++||.|.+|.||+++... .++..|||++... .+..++++.|.++++.. +|||++.++|++. .++.
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~---~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVK---TGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeee---cCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 34567899999999999999875 5677888887654 44567888899999887 7999999999984 3568
Q ss_pred eehhhhhccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 595 RLLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
.+||||||.+||.-++++. ...+.|..+.-|++.+++||.|||. ..++|||||-.||||++++.+||.|||++..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 9999999999999999875 4678999999999999999999994 5999999999999999999999999999987
Q ss_pred ccccccccccccccCCCCccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 747 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 747 (814)
+...-.+ ..+..||+-|||||++. ...|+..+|+||+|++-.||--|.+|+.....-. .+
T Consensus 173 ldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---------aL---- 237 (953)
T KOG0587|consen 173 LDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---------AL---- 237 (953)
T ss_pred eeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------hh----
Confidence 6543322 34567999999999994 3357789999999999999999999986332211 00
Q ss_pred CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 748 KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 748 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+.--..++.....+....+++.+++..||..|-++||++.++++.
T Consensus 238 -F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 238 -FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111123444455577889999999999999999999999988763
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-28 Score=268.95 Aligned_cols=239 Identities=31% Similarity=0.410 Sum_probs=182.1
Q ss_pred cccccccee-EEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhhhcc
Q 042262 526 EEVGRGSFG-IVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN 603 (814)
Q Consensus 526 ~~LG~G~fG-~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 603 (814)
+.+|.|..| .||+|... ++.||||++-.. ...-..+|+..++.- +|||||+.++.-.+....||..|.|.
T Consensus 515 eilG~Gs~Gt~Vf~G~ye-----~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE-----GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred HHcccCCCCcEEEEEeeC-----CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 568898876 57999984 779999998543 233457788888877 69999999999999999999999984
Q ss_pred CCchhhhhcCC-C---CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-----CCCeEEeecCCccccc
Q 042262 604 NGTLASFLFGN-L---KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-----YYNARISDFGLAKLLT 674 (814)
Q Consensus 604 ~gsL~~~l~~~-~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DfGla~~~~ 674 (814)
.+|.+++... . .......+.+..|+++||+||| +.+||||||||+||||+. ..+++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5999998763 1 1111345678899999999999 679999999999999975 2579999999999987
Q ss_pred cccccc-ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhC-CcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 675 LNQSKA-IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 675 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
.+++.- ......||.||+|||.+....-+.++||||+|||+|+.++| ..||......+ . .+..|.. .+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~--------NIl~~~~-~L 732 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-A--------NILTGNY-TL 732 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-h--------hhhcCcc-ce
Confidence 765432 13445699999999999998888899999999999999996 89986332111 0 1111111 01
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+. .....++ +..+|+.+|+.++|..||++.+|+.
T Consensus 733 ~~----L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 733 VH----LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ee----eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 0011122 8889999999999999999999874
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-28 Score=217.99 Aligned_cols=103 Identities=39% Similarity=0.596 Sum_probs=74.2
Q ss_pred CCeEEEEecCCCCCCCCC--CCcEEEEeecccEEEeCCCCCeEeee-ccCCCc--eeEEEEccCcCEEEEecCCcccccc
Q 042262 80 EKTVVWYTDNKDQNPAVP--RGSQVKLTADRGLVLNDPQGKQVWSS-KIDIGT--VAIGVMNDTGNFVLASSSSSKLWDS 154 (814)
Q Consensus 80 ~~t~vW~an~~~~~~~~~--~~~~l~~~~~g~l~l~~~~~~~~wst-~~~~~~--~~~~~l~~~GNlvl~~~~~~~~WQS 154 (814)
++||||+|||+. |..+ ...+|.|+.||+|+|++..|+++|++ ++.+.+ ...|+|+|+|||||++..+++||||
T Consensus 1 ~~tvvW~an~~~--p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~S 78 (114)
T PF01453_consen 1 PRTVVWVANRNS--PLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQS 78 (114)
T ss_dssp ---------TTE--EEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEES
T ss_pred Cccccccccccc--ccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEee
Confidence 479999999993 3323 45899999999999999999999999 566544 6899999999999999999999999
Q ss_pred cccccCccCCCCcccC----C--ceeeecCCCCCCC
Q 042262 155 FTNPSDTLLPGQMMET----E--QGLFSRKSDTNFS 184 (814)
Q Consensus 155 FD~PtDTlLpg~~l~~----~--~~L~S~~s~~dps 184 (814)
|||||||+||+|+|+. + ..|+||++.+|||
T Consensus 79 f~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 79 FDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp TTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred cCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999999876 2 3599999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=244.34 Aligned_cols=140 Identities=26% Similarity=0.402 Sum_probs=115.1
Q ss_pred cccCHHHHHH-HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-----c---c
Q 042262 510 RCFSYKELEE-ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-----H---K 580 (814)
Q Consensus 510 ~~f~~~el~~-~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-----H---~ 580 (814)
......+... ++|.+.++||-|.|++||++.+.. ..+.||+|+.+.. +...+.-+.||++|++++ | .
T Consensus 67 HpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq---~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~ 142 (590)
T KOG1290|consen 67 HPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQ---NKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKK 142 (590)
T ss_pred ceeeccccccCceEEEEEeccccccceeEEEeecc---CCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence 3445566666 888999999999999999999875 5678999998653 344556788999998873 3 3
Q ss_pred ceeeeeeeec----cCCceehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 042262 581 NLVRLLGFCD----EGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 654 (814)
Q Consensus 581 niv~l~g~~~----~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NI 654 (814)
.||+|+++|. ++.+.+||+|++ +.+|..+|... +.++....++|++||+.||.|||.+| +|||.||||+||
T Consensus 143 ~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENv 219 (590)
T KOG1290|consen 143 CVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENV 219 (590)
T ss_pred eeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCccee
Confidence 5999999994 467999999998 55666666543 66899999999999999999999964 999999999999
Q ss_pred EE
Q 042262 655 LL 656 (814)
Q Consensus 655 ll 656 (814)
|+
T Consensus 220 Ll 221 (590)
T KOG1290|consen 220 LL 221 (590)
T ss_pred ee
Confidence 98
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-27 Score=233.63 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=195.8
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEee-ccccceeeeeeeeccCCceehhh
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+..+||+|.+.+|-++.+.+ ..+.+|+|++++..- +...=.+.|-.+... -+||.+|.|..++..+...++|.
T Consensus 254 ll~vigrgsyakvl~~~~~~---t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKK---TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred eeeeecCcchhhhhheehcc---cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 45689999999999999986 467889998865322 122223444444444 37999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++|+|--++++..+++++....+...|.-||.|||+ .+||.||||..|+|+|.++++||.|+|+.+.--.+.
T Consensus 331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~g-- 405 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-- 405 (593)
T ss_pred EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCC--
Confidence 999999999999999999999999999999999999995 699999999999999999999999999998632221
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccC-CcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEM-GEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
....+++||+.|+|||++++..|....|-|++||+++||+.|+.||+.-. .....+..++..+.+.+..+.
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-------- 477 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-------- 477 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--------
Confidence 22567899999999999999999999999999999999999999998643 233344455556555443321
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCC
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPT 786 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 786 (814)
.+...+.....+++.-|..||.+|.-
T Consensus 478 --iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 --IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 12234455667888889999999853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-26 Score=229.43 Aligned_cols=210 Identities=35% Similarity=0.545 Sum_probs=182.7
Q ss_pred ccccceeEEEEEEEeccCCcceEEEEEeecccccc-chhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCCc
Q 042262 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT 606 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 606 (814)
||+|.+|.||++.... .+..+++|+....... ..+.+.+|+..++.++|++|+++++++......++++|++++++
T Consensus 1 l~~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecC---CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 6899999999999864 3678999998754322 34678999999999999999999999999999999999999999
Q ss_pred hhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCCeEEeecCCccccccccccccccc
Q 042262 607 LASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLNQSKAIKTA 684 (814)
Q Consensus 607 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 684 (814)
|.+++... ..+++..+..++.+++++|++||+ .+++|+||+|.||+++. +..++|+|||.+........ ....
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 99998765 578999999999999999999995 59999999999999999 89999999999987654321 1223
Q ss_pred ccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCCh
Q 042262 685 IRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDI 763 (814)
Q Consensus 685 ~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~ 763 (814)
..+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4477899999999887 888999999999999998
Q ss_pred hHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 764 KCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 764 ~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 567789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=232.08 Aligned_cols=271 Identities=25% Similarity=0.303 Sum_probs=195.4
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeec------cCCceehh
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD------EGQNRLLV 598 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~------~~~~~~lV 598 (814)
.+|.|.- .|--+.+.- .++.||+|++... .....++..+|..++..++|+||++++.++. +..+.++|
T Consensus 24 p~~~g~~-~v~~a~D~v---~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v 99 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQV---LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLV 99 (369)
T ss_pred ccCCCCc-eEEecchhh---ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHH
Confidence 4566665 444444432 4678999988542 2334567788999999999999999999983 34567999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+| ..+|...+. ..++-+....|+.|++.|++||| +.+|+||||||+||++..+...||.|||+++.-..+
T Consensus 100 ~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-- 171 (369)
T KOG0665|consen 100 MELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-- 171 (369)
T ss_pred HHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc--
Confidence 9999 457777776 45677788899999999999999 679999999999999999999999999999875544
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcc----------------hhhHHHHHHH
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE----------------YAILTDWAFD 742 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~----------------~~~l~~~~~~ 742 (814)
-..+.++.|.-|.|||++.+-.+.+.+||||.||++.||++|+..|.....-+ ...+...+..
T Consensus 172 -~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred -cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 22566778999999999998889999999999999999999999886432100 0011111111
Q ss_pred HHhcC------Cccccc-cCcc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hc---CCcCCCCCCCCCC
Q 042262 743 CYRNG------KLDDLV-EGDT--EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM--LE---GVVEVDVPPNPSP 808 (814)
Q Consensus 743 ~~~~~------~~~~l~-~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~--L~---~~~~~~~pp~p~~ 808 (814)
..+.. ...+++ |... ..+.+......+.+++.+||-.+|++|-+++++++. ++ .-.+++.|++| +
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe-~ 329 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPE-I 329 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCc-h
Confidence 11110 011111 1111 111223345677889999999999999999999883 55 55567777666 4
Q ss_pred CCc
Q 042262 809 FSG 811 (814)
Q Consensus 809 ~~~ 811 (814)
+..
T Consensus 330 ~d~ 332 (369)
T KOG0665|consen 330 YDK 332 (369)
T ss_pred hhh
Confidence 433
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=219.94 Aligned_cols=256 Identities=20% Similarity=0.333 Sum_probs=192.8
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-ccceeeeeeeeccC--Cceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEG--QNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~l 597 (814)
.+++.+++|+|.++.|+.|.... +.+.++||+++.. ..+.+.+|+.+|..+. ||||++|++...+. ....|
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~---~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINIT---NNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccC---CCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45666789999999999998764 4567999999865 3567899999999997 99999999998664 56789
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCCeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~ 676 (814)
|+||+.+.+...+- ++++...+...+.++++||.|+| +.+|+|||+||.|+++|. ...++|+|+|+|.+.++.
T Consensus 113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99999997766543 45677788899999999999999 789999999999999995 456999999999999877
Q ss_pred ccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHH--------HHh--
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD--------CYR-- 745 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------~~~-- 745 (814)
+.-. ..+.+.-|--||.+-.- .++..-|+|||||+|.+|+..+.||....+...+ +...+.- -+.
T Consensus 187 ~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 187 KEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred ceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhChHHHHHHHHHH
Confidence 6533 22345667889998654 5888999999999999999999999654433222 2222210 000
Q ss_pred ----cCCccccccCcc--------cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 746 ----NGKLDDLVEGDT--------EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 746 ----~~~~~~l~~~~~--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...++.... ......-...+.++++...|..|..+|||++|.+.
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111111111100 11112233478889999999999999999999865
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=245.67 Aligned_cols=200 Identities=25% Similarity=0.358 Sum_probs=170.7
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
+.||-|+||.|.++.... ....+|.|.|++.+- ......++|-.||..-..+=||+|+--|.+.+..|+||+|+
T Consensus 635 k~iGvGAFGeV~Lv~KvD---T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYI 711 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVD---TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 711 (1034)
T ss_pred eeecccccceeEEEeecc---hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEecc
Confidence 469999999999988764 467899999976432 23345788999999999999999999999999999999999
Q ss_pred cCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc------
Q 042262 603 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN------ 676 (814)
Q Consensus 603 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~------ 676 (814)
++|++-.+|.....+.+...+.++..+..|+++.| ..++|||||||+|||||.+|++||.||||..-+...
T Consensus 712 PGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 712 PGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred CCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99999999999889999999999999999999999 789999999999999999999999999998544210
Q ss_pred ---c----------------cc---------------cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCC
Q 042262 677 ---Q----------------SK---------------AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCR 722 (814)
Q Consensus 677 ---~----------------~~---------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~ 722 (814)
+ +. ......+||..|+|||++....++..+|-||.||||+||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 0 00 0011246999999999999999999999999999999999999
Q ss_pred cCCcccCCc
Q 042262 723 KSFDIEMGE 731 (814)
Q Consensus 723 ~p~~~~~~~ 731 (814)
.||-.+...
T Consensus 869 ~pf~~~tp~ 877 (1034)
T KOG0608|consen 869 PPFLADTPG 877 (1034)
T ss_pred CCccCCCCC
Confidence 999766543
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=200.84 Aligned_cols=114 Identities=32% Similarity=0.504 Sum_probs=98.9
Q ss_pred ceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEeecccEEEe
Q 042262 34 ATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLN 113 (814)
Q Consensus 34 ~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~~g~l~l~ 113 (814)
+.|.+++ +|+|++|.|++|||++.... .++++|||.+++ +++||.||++. +....+.|.|+.||+|+|+
T Consensus 2 ~~l~~~~---~l~s~~~~f~~G~~~~~~q~----~dgnlv~~~~~~-~~~vW~snt~~---~~~~~~~l~l~~dGnLvl~ 70 (116)
T cd00028 2 NPLSSGQ---TLVSSGSLFELGFFKLIMQS----RDYNLILYKGSS-RTVVWVANRDN---PSGSSCTLTLQSDGNLVIY 70 (116)
T ss_pred cCcCCCC---EEEeCCCcEEEecccCCCCC----CeEEEEEEeCCC-CeEEEECCCCC---CCCCCEEEEEecCCCeEEE
Confidence 3566666 49999999999999986321 479999999887 89999999983 3566789999999999999
Q ss_pred CCCCCeEeeeccCC-CceeEEEEccCcCEEEEecCCcccccccccc
Q 042262 114 DPQGKQVWSSKIDI-GTVAIGVMNDTGNFVLASSSSSKLWDSFTNP 158 (814)
Q Consensus 114 ~~~~~~~wst~~~~-~~~~~~~l~~~GNlvl~~~~~~~~WQSFD~P 158 (814)
|.+|.+||+|++.+ ....+++|+|+|||||++.++++||||||||
T Consensus 71 ~~~g~~vW~S~~~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 71 DGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred cCCCcEEEEecccCCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 99999999999876 5567899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-26 Score=244.54 Aligned_cols=192 Identities=22% Similarity=0.333 Sum_probs=165.4
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeecccc--------ccchhhhhceeeEEeecc---ccceeeeeeeeccCC
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--------QDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQ 593 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--------~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~ 593 (814)
.+.+|+|+||.|+.++++. ....|+||.+.+.. ....--+-.||.+|..++ |+||++++++|++++
T Consensus 566 lq~lG~GAyGkV~lai~K~---n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKE---NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred eeeccccccceEEEeeecc---cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 3579999999999999985 46789999886421 011123667999999997 999999999999999
Q ss_pred ceehhhhhc-cCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 594 NRLLVYEFL-NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 594 ~~~lV~e~~-~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
..+|++|-. ++-+|.++|.....+++.+..-|++||+.|++||| +.+|||||||-+||+++.+|-+||+|||.+..
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999965 46789999998999999999999999999999999 56999999999999999999999999999987
Q ss_pred ccccccccccccccCCCCccCcccccCCCCC-CccchhhHHHHHHHHHhCCcCCc
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNSTIT-AKVDVYSFGVLLLEIISCRKSFD 726 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DV~S~Gvvl~elltG~~p~~ 726 (814)
...+. ...++||.+|.|||.+.+.+|- ..-|||++|++||.++-...||.
T Consensus 720 ~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 720 TKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 65443 4567899999999999998865 45899999999999998888774
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-25 Score=224.86 Aligned_cols=198 Identities=30% Similarity=0.470 Sum_probs=171.7
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc-chhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
.+.+.||+|++|.||++.... .+..+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKG---TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcC---CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 345789999999999999874 3578999999765444 567889999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 602 LNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
+++++|.+++..... +++.....++.+++++|.+||+ .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 999999999987666 8999999999999999999995 49999999999999999999999999999887654211
Q ss_pred ccccccCCCCccCcccc-cCCCCCCccchhhHHHHHHHHHhCCcCCcc
Q 042262 681 IKTAIRGTKGYVAPEWF-RNSTITAKVDVYSFGVLLLEIISCRKSFDI 727 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~-~~~~~t~k~DV~S~Gvvl~elltG~~p~~~ 727 (814)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12334577889999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-25 Score=239.50 Aligned_cols=251 Identities=24% Similarity=0.286 Sum_probs=203.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+++...+|.|.+|.|||+++.. .++..|||.++-......+-+++|+-+++.-+|+||+.++|-+......++.|||
T Consensus 17 yellqrvgsgTygdvyKaRd~~---s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKR---SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred hhheeeecCCcccchhhhcccc---cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 3445689999999999999875 5778899998877667777889999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+.+|+|.+.-+....+++.++....+..++||+||| +.+=+|||||-.|||+++.+.+|++|||.+-.+...-.+
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K-- 168 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK-- 168 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhhh--
Confidence 999999999999999999999999999999999999 568899999999999999999999999998766533222
Q ss_pred cccccCCCCccCcccc---cCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 682 KTAIRGTKGYVAPEWF---RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~---~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
...+.||+.|||||+. +.+.|..++|||+.|+.-.|+--..+|...-.+-. . .-++. ....++. .
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~-----l~LmT----kS~~qpp-~ 236 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--A-----LFLMT----KSGFQPP-T 236 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--H-----HHHhh----ccCCCCC-c
Confidence 3446799999999987 46689999999999999999987777653222111 0 00100 1111111 1
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........+.+.++++.|+-.+|.+||++..+++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2224466788999999999999999999976554
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-25 Score=234.36 Aligned_cols=272 Identities=22% Similarity=0.228 Sum_probs=203.9
Q ss_pred ccccCHHHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc------ccce
Q 042262 509 LRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH------HKNL 582 (814)
Q Consensus 509 ~~~f~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~------H~ni 582 (814)
...+.+.|+....|.+....|+|-|++|-+|.+.. .+..||||++... +...+.=..|+++|++|+ .-++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~---r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA---RGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccC---CCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHH
Confidence 34567788999999998999999999999999876 4558999999764 223345567888999985 4579
Q ss_pred eeeeeeeccCCceehhhhhccCCchhhhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC
Q 042262 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY 659 (814)
Q Consensus 583 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~ 659 (814)
++|+..|.+.++.|||+|-+ .-+|.+.|+. +..|.......++.|+.-||.+|. ..+|+|.||||.|||+++.
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccC
Confidence 99999999999999999987 4588888864 345788899999999999999999 4699999999999999976
Q ss_pred C-CeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHH
Q 042262 660 Y-NARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 738 (814)
Q Consensus 660 ~-~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~ 738 (814)
. .+||||||.|.....++. +.+-.+.=|.|||++.+-+|+...|+||.||.||||.||+..|..........+.-
T Consensus 573 k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred cceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 4 589999999987765442 22234556999999999999999999999999999999999986543221111110
Q ss_pred H-----HHHHHhcCCccc---------------------------cccCc------c-----cccCChhHHHHHHHHHHH
Q 042262 739 W-----AFDCYRNGKLDD---------------------------LVEGD------T-----EAMNDIKCTEKLVMVSIW 775 (814)
Q Consensus 739 ~-----~~~~~~~~~~~~---------------------------l~~~~------~-----~~~~~~~~~~~l~~l~~~ 775 (814)
- ...+++.|.+.+ .+.+. + -..........+.+|+..
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 0 011111111110 01110 0 011123455678889999
Q ss_pred ccccCCCCCCCHHHHHH
Q 042262 776 CIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 776 Cl~~dP~~RPtm~eV~~ 792 (814)
|+..||++|.|..+.++
T Consensus 729 ml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALK 745 (752)
T ss_pred HhccChhhcCCHHHHhc
Confidence 99999999999988765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=211.47 Aligned_cols=251 Identities=19% Similarity=0.302 Sum_probs=187.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeee-eccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGF-CDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~-~~~~~~~~lV 598 (814)
.+++.+.||+|.||.+-++.++. ..+.+++|-.... ....++|.+|..---.| .|.||+.-++. +...+..+.+
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~---s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQ---SKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccC---CceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 46777899999999999999875 5678999988654 33467888888765555 69999998875 5666778899
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC--CCCCeEEeecCCccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD--DYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~--~~~~~kl~DfGla~~~~~~ 676 (814)
+||++.|+|.+-+... .+.+..-.+++.|++.||.||| +.++||||||.+||||- +..++||+|||+.+.....
T Consensus 101 qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999987653 3567778899999999999999 67999999999999993 4558999999998764421
Q ss_pred ccccccccccCCCCccCcccccCC-----CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNS-----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
.....-+..|.+||..... ...+.+|||.||++++.+++|+.|++.....+.. -|-+..|..+....
T Consensus 177 -----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~---Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 177 -----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP---YWEWEQWLKRKNPA 248 (378)
T ss_pred -----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch---HHHHHHHhcccCcc
Confidence 1222346689999987432 3567899999999999999999999855433222 23344444444332
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+.+. -...++.+.++.++-+.+++++|=-..++.++
T Consensus 249 ~P~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 249 LPKK------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred Cchh------hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 2111 11345778888888999999999655555554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=264.30 Aligned_cols=196 Identities=19% Similarity=0.216 Sum_probs=140.0
Q ss_pred eeccc-cceeeeeeee-------ccCCceehhhhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 042262 575 GQTHH-KNLVRLLGFC-------DEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 645 (814)
Q Consensus 575 ~~l~H-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 645 (814)
+.++| .||++++++| .+....++++|++ +++|.++|.. ...+++.+++.|+.||++||+||| +.+|+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 35667 6899999988 2233566778877 6699999965 356899999999999999999999 46999
Q ss_pred ecCCCCCcEEECC-------------------CCCeEEeecCCccccccccc--------------ccccccccCCCCcc
Q 042262 646 HCDIKPQNILLDD-------------------YYNARISDFGLAKLLTLNQS--------------KAIKTAIRGTKGYV 692 (814)
Q Consensus 646 H~Dikp~NIll~~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~ 692 (814)
||||||+||||+. ++.+||+|||+++....... ........||..|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566677776654211000 00011235788999
Q ss_pred CcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHH
Q 042262 693 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMV 772 (814)
Q Consensus 693 aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l 772 (814)
|||++.+..++.++|||||||+||||++|..|+..... .+ ..+....+. +. ..........+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~-----~~~~~~~~~----~~-----~~~~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TM-----SSLRHRVLP----PQ-----ILLNWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HH-----HHHHHhhcC----hh-----hhhcCHHHHHH
Confidence 99999999999999999999999999999887642110 01 111111100 00 01122345678
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 042262 773 SIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 773 ~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+.+||+.+|.+||+|.||++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 88999999999999999986
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=191.00 Aligned_cols=112 Identities=33% Similarity=0.512 Sum_probs=96.1
Q ss_pred ceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEeecccEEEe
Q 042262 34 ATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLN 113 (814)
Q Consensus 34 ~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~~g~l~l~ 113 (814)
+.|..++ .|+|++|.|++|||.+... .++++|||+..+ +++||.||++ .++..++.|.|+.||+|+|+
T Consensus 2 ~~l~~~~---~l~s~~~~f~~G~~~~~~q-----~dgnlV~~~~~~-~~~vW~snt~---~~~~~~~~l~l~~dGnLvl~ 69 (114)
T smart00108 2 NTLSSGQ---TLVSGNSLFELGFFTLIMQ-----NDYNLILYKSSS-RTVVWVANRD---NPVSDSCTLTLQSDGNLVLY 69 (114)
T ss_pred cccCCCC---EEecCCCcEeeeccccCCC-----CCEEEEEEECCC-CcEEEECCCC---CCCCCCEEEEEeCCCCEEEE
Confidence 3455555 4999999999999988532 479999999887 8999999998 34444588999999999999
Q ss_pred CCCCCeEeeeccC-CCceeEEEEccCcCEEEEecCCccccccccc
Q 042262 114 DPQGKQVWSSKID-IGTVAIGVMNDTGNFVLASSSSSKLWDSFTN 157 (814)
Q Consensus 114 ~~~~~~~wst~~~-~~~~~~~~l~~~GNlvl~~~~~~~~WQSFD~ 157 (814)
|.+|.+||+|++. +.+..+++|+|+|||||++..+.+|||||||
T Consensus 70 ~~~g~~vW~S~t~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 70 DGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred eCCCCEEEEecccCCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 9999999999987 4556789999999999999999999999997
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=203.84 Aligned_cols=165 Identities=24% Similarity=0.189 Sum_probs=124.7
Q ss_pred CchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccc
Q 042262 605 GTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT 683 (814)
Q Consensus 605 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 683 (814)
|+|.+++.. ...+++..++.|+.||++||+|||+. + ||+|||+++++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 688888876 45699999999999999999999964 2 999999999999999 99998764321
Q ss_pred cccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCCh
Q 042262 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDI 763 (814)
Q Consensus 684 ~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~ 763 (814)
..||..|+|||++.+..++.++|||||||++|||++|+.||....... ..+ .... .+...... .......
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~----~~~~-~~~~~~~~---~~~~~~~ 133 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AIL----EILL-NGMPADDP---RDRSNLE 133 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHH----HHHH-HHhccCCc---cccccHH
Confidence 258899999999999999999999999999999999999986443211 111 1111 11000000 0001122
Q ss_pred hHHH--HHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 764 KCTE--KLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 764 ~~~~--~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
.... ++.+++.+||+.+|.+||++.|+++.+..
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 2333 69999999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-24 Score=220.51 Aligned_cols=262 Identities=24% Similarity=0.318 Sum_probs=192.3
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
...++||+|.|++||++++.........||+|.+... .....+.+|++.|..+ -+.||+++.+++..++...+|+||
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 3456899999999999998864335678999998654 3356789999999998 599999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCCeEEeecCCcccccccc---
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLNQ--- 677 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~--- 677 (814)
+++....++... ++...+..++..+++||+|+| ..+||||||||+|+|.+. .+.-.|.|||+|......+
T Consensus 117 ~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 117 FEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred cCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 999888887744 557888999999999999999 569999999999999984 5678999999997211000
Q ss_pred ---------------------------------------cccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHH
Q 042262 678 ---------------------------------------SKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLE 717 (814)
Q Consensus 678 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~e 717 (814)
.........||+||.|||++... .-++++||||-|||++-
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 00001124599999999999655 57889999999999999
Q ss_pred HHhCCcCCcccCCcchhhHHHHHH---------HHHhcCC--ccc----------------c----ccC--c--ccc-cC
Q 042262 718 IISCRKSFDIEMGEEYAILTDWAF---------DCYRNGK--LDD----------------L----VEG--D--TEA-MN 761 (814)
Q Consensus 718 lltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~--~~~----------------l----~~~--~--~~~-~~ 761 (814)
+++++.||.....+-.... +.+. -....|. +-+ + +.+ . ... ..
T Consensus 271 lls~~~PFf~a~dd~~al~-ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~ 349 (418)
T KOG1167|consen 271 LLSRRYPFFKAKDDADALA-EIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG 349 (418)
T ss_pred hhccccccccCccccchHH-HHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence 9999999965443221111 1110 0011122 000 0 000 0 000 01
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
....+..+.+++.+|+..||.+|-|++|.++.
T Consensus 350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 350 SDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 11234588899999999999999999998763
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-23 Score=200.62 Aligned_cols=249 Identities=20% Similarity=0.323 Sum_probs=191.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeec--cccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~--~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
-++..+|.+...|..|+|+++. .-+++|++. .......++|.+|.-.|+.+.||||+.++|.|....+..++.
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg-----ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG-----NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhccCCCcccccccccC-----cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 3556678888899999999973 346666663 344445678999999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
.||+.|+|+..|++.. ..+..+..+++.+||+|++|||.- .+-|.---|....+++|++.+++|+- +-.++...
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfq-- 342 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ-- 342 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeee--
Confidence 9999999999998764 357788999999999999999974 33444456889999999999988842 11221111
Q ss_pred cccccccccCCCCccCcccccCCCCC---CccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTIT---AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t---~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.....-.+.||+||.++..+-+ ..+|+|||.++||||.|...||..-..-+.. ..+.-
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkial 403 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIAL 403 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhh
Confidence 1112246789999999887654 4799999999999999999999743321110 00112
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
+.+....++..+..+.+++.-|+..||.+||.+..|+-+||.+.
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 23334456678889999999999999999999999999998764
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=175.43 Aligned_cols=110 Identities=28% Similarity=0.593 Sum_probs=89.6
Q ss_pred eeccccCCCCCCCCcceeeecccccEEEEeccceeeeeeccccccCCccEEEEEEeeCceEEEEEecCCCCCCceEEecC
Q 042262 215 YTSGTYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYFYPKNGNGNWSAVWSQ 294 (814)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~lr~y~~~~~~~~~W~~~~~~ 294 (814)
||+|+|++..+.+.+ .+.....+.|.++.+..+.++++.. .+.+.++|++||.+|++++|.|. +++++|...|++
T Consensus 1 wrsG~WnG~~f~g~p--~~~~~~~~~~~fv~~~~e~~~t~~~--~~~s~~~r~~ld~~G~l~~~~w~-~~~~~W~~~~~~ 75 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIP--EMSSNSLYNYSFVSNNEEVYYTYSL--SNSSVLSRLVLDSDGQLQRYIWN-ESTQSWSVFWSA 75 (110)
T ss_pred CCccccCCeEECCcc--cccccceeEEEEEECCCeEEEEEec--CCCceEEEEEEeeeeEEEEEEEe-cCCCcEEEEEEe
Confidence 899999988765444 3333344667777888887777653 35677999999999999999994 567899999999
Q ss_pred CCCcCCCccCCCCcCCCCCCcccccCCCCCCccccCCCCcccC
Q 042262 295 PENICDNISGEFGSGACGFNSICTLDGDRRPMCECPKGYSLLD 337 (814)
Q Consensus 295 p~~~Cd~y~~~~~~g~CG~~giC~~~~~~~~~C~Cl~GF~~~~ 337 (814)
|.++||+| +.||+||+|+. +..|.|.||+||+|++
T Consensus 76 p~d~Cd~y------~~CG~~g~C~~--~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 76 PKDQCDVY------GFCGPNGICNS--NNSPKCSCLPGFEPKN 110 (110)
T ss_pred cccCCCCc------cccCCccEeCC--CCCCceECCCCcCCCc
Confidence 99999995 99999999964 6788999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-21 Score=209.47 Aligned_cols=173 Identities=21% Similarity=0.142 Sum_probs=129.4
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-----ccchhhhhceeeEEeeccccceee-eeeeeccCCc
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-----QDGEKEFKNEVVVIGQTHHKNLVR-LLGFCDEGQN 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~~~~ 594 (814)
.+.+.+.||+|+||+||+|.+... .+..+|||++.... ....+.|.+|++++.+++|+|++. ++++ ++
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGD--PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCC--CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 456678899999999999987642 35568999875321 122456899999999999999985 4432 45
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCcEEECCCCCeEEeecCCcccc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDI-KPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Di-kp~NIll~~~~~~kl~DfGla~~~ 673 (814)
.+|||||+++++|... .... ...++.+++++|+|||+ .+|+|||| ||+|||++.++.+||+|||+++.+
T Consensus 93 ~~LVmE~~~G~~L~~~-~~~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RPHG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred cEEEEEccCCCCHHHh-Cccc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 7999999999999732 1111 24678999999999994 69999999 999999999999999999999977
Q ss_pred cccccccc------cccccCCCCccCcccccCC------CCCCccchh
Q 042262 674 TLNQSKAI------KTAIRGTKGYVAPEWFRNS------TITAKVDVY 709 (814)
Q Consensus 674 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~------~~t~k~DV~ 709 (814)
........ .+...++..|+|||.+.-. ..+...|.|
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 54321111 1345688899999998532 223346666
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-21 Score=222.75 Aligned_cols=253 Identities=21% Similarity=0.259 Sum_probs=193.5
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeec----c-c-cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD----R-V-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~----~-~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
...+|.|++|.|+........ ...+.|... . . ..+....+..|+.+-..++|+|++..+..+.+.....-+
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~---~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDL---KSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred cceeeecccCceEEEEecCCC---ccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 457999999977766655322 222222211 1 1 111123377899999999999999999988887777777
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++ +|..++.+...+....+..+++|+++|++||| +.+|.|||+|++|+++..++.+||+|||.+..+.....
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 999999 99999988878899999999999999999999 57999999999999999999999999999988766554
Q ss_pred c--cccccccCCCCccCcccccCCCCCC-ccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 679 K--AIKTAIRGTKGYVAPEWFRNSTITA-KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 679 ~--~~~~~~~gt~~y~aPE~~~~~~~t~-k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
. .....++|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||.....++... .+....+... . .
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~-~--~ 547 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRN-I--F 547 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccc-c--c
Confidence 4 4456788999999999999999987 5899999999999999999998766543321 0000000000 0 0
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..........+.+...++.++|+.+|.+|-||++|++
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0011113356778889999999999999999999987
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-20 Score=198.74 Aligned_cols=261 Identities=21% Similarity=0.226 Sum_probs=193.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccc----cceeeeeeee-ccCCce
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH----KNLVRLLGFC-DEGQNR 595 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~ 595 (814)
.+.+.++||+|+||.||++...... ...+|+|............+..|+.++..+.+ +++.++++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 4566789999999999999987532 45788888765433333367888888888863 5788888888 577788
Q ss_pred ehhhhhccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-----CCeEEeecC
Q 042262 596 LLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-----YNARISDFG 668 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~-----~~~kl~DfG 668 (814)
+|||+.+ +.+|.++... ...++....++|+.|++.+|.+|| +.+++||||||.|+++... ..+.|.|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999976 7899998743 367899999999999999999999 5699999999999999854 469999999
Q ss_pred Ccc--cccccccc------cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCc-chhhHHHH
Q 042262 669 LAK--LLTLNQSK------AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDW 739 (814)
Q Consensus 669 la~--~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~-~~~~l~~~ 739 (814)
+++ ........ ......+||..|.++....+...+.+.|+||++.++.|++.|..|+...... ....+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 33222211 1123456999999999999999999999999999999999999998544321 11111111
Q ss_pred HHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 740 AFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 740 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
. . ...... .....+.++.++...+-..+..++|....+...|++...-
T Consensus 253 ~----~----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 253 P----R----KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred h----h----hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0 0 001100 1223445666666666678999999999999988665433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=193.38 Aligned_cols=258 Identities=28% Similarity=0.362 Sum_probs=195.7
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc---chhhhhceeeEEeecccc-ceeeeeeeeccCCceehh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHK-NLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV 598 (814)
.+.+.||.|.||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++.+++......+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 76 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV 76 (384)
T ss_pred eeEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence 34567999999999999976 57888888654333 366789999999999988 799999999777778999
Q ss_pred hhhccCCchhhhhcCCC---CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-CeEEeecCCccccc
Q 042262 599 YEFLNNGTLASFLFGNL---KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLT 674 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~ 674 (814)
++++.+++|.+++.... .+.......++.|++.++.|+|. .+++||||||+||+++... .++++|||+++.+.
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999997776654 68899999999999999999995 5899999999999999988 79999999998665
Q ss_pred cccccc----ccccccCCCCccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC
Q 042262 675 LNQSKA----IKTAIRGTKGYVAPEWFRN---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 747 (814)
Q Consensus 675 ~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 747 (814)
...... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..|+...... .........+...
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~ 230 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILEL 230 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhc
Confidence 443321 2355679999999999987 57889999999999999999999996654321 0001111222111
Q ss_pred CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 748 KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 748 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
... .................+.+++..|+..+|..|.++.+....
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111 000000000002334678889999999999999999887663
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.1e-21 Score=217.69 Aligned_cols=252 Identities=23% Similarity=0.272 Sum_probs=183.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeE--EeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVV--IGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
..++.+.||+++|=+|.++++. .| .|+||++-+.. .-..+.|.++++- ...++|||.+.+.-.-...+..||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~----eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR----EG-LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC----Cc-eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHH
Confidence 3456788999999999999986 34 48899885443 2233444443333 444689999999888888888899
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc--c
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT--L 675 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~--~ 675 (814)
|-+|+.+ +|+|.|....-+...+.+.|+.|++.||..+| ..+|+|||||.+||||+.-.-+.|+||..-+... .
T Consensus 99 vRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 99 VRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9999966 89999988888888899999999999999999 5699999999999999999999999998876532 2
Q ss_pred ccccc---ccccccCCCCccCcccccC----------CC-CCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHH
Q 042262 676 NQSKA---IKTAIRGTKGYVAPEWFRN----------ST-ITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 740 (814)
Q Consensus 676 ~~~~~---~~~~~~gt~~y~aPE~~~~----------~~-~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 740 (814)
+.... ...+.+.-.+|+|||.+-. .. .+++.||||.||+++||++ |+++|... .|
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL---- 244 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QL---- 244 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HH----
Confidence 22111 1112223458999998732 12 6789999999999999999 67777522 11
Q ss_pred HHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 741 FDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 741 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
-.++.|. ......-++... ...+..++..|+|.||.+|.++++.++.-.++
T Consensus 245 -~aYr~~~-~~~~e~~Le~Ie----d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 245 -LAYRSGN-ADDPEQLLEKIE----DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -HhHhccC-ccCHHHHHHhCc----CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1223332 111111111111 13678899999999999999999999985443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.2e-19 Score=196.29 Aligned_cols=219 Identities=26% Similarity=0.461 Sum_probs=165.7
Q ss_pred EeeccccceeeeeeeeccCCceehhhhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 042262 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQ 652 (814)
Q Consensus 574 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~ 652 (814)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ..++++.-+..++++|++||+|||. ++-..|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 3568999999999999999999999999999999999976 5788999999999999999999996 333499999999
Q ss_pred cEEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCC-------CCCCccchhhHHHHHHHHHhCCcCC
Q 042262 653 NILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS-------TITAKVDVYSFGVLLLEIISCRKSF 725 (814)
Q Consensus 653 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~k~DV~S~Gvvl~elltG~~p~ 725 (814)
|.++|..+.+||+|||+..+..............-..-|.|||.+.+. ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999999877431111111222234579999999763 2477899999999999999999999
Q ss_pred cccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 726 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 726 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
+........ .+.+.. ++.+ -....-+...... +..+++..++..||..+|++||++++|-..++.+...
T Consensus 159 ~~~~~~~~~--~eii~~-~~~~-~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDP--DEIILR-VKKG-GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCCh--HHHHHH-HHhc-CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 875432221 122222 2221 1111112221111 4455899999999999999999999999998766543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.5e-18 Score=172.84 Aligned_cols=199 Identities=22% Similarity=0.312 Sum_probs=166.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.++||+|.||+.+.|+.-- .++.||||.-... ...-++..|.+..+.| ..++|...+=|..++.+-.||+|
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~---nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLY---NNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ceeccccccCcceeeecccccc---cCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3456789999999999998654 5789999986443 2345788888888887 46999999999999999999999
Q ss_pred hccCCchhhhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-----CCCeEEeecCCccccc
Q 042262 601 FLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-----YYNARISDFGLAKLLT 674 (814)
Q Consensus 601 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DfGla~~~~ 674 (814)
.+ +-||+++.. ...+++.+....||.|++.-++|+|+ ..+|-|||||+|+||.. ...+.|+|||+|+...
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 88 779998774 56889999999999999999999995 59999999999999963 3458999999999876
Q ss_pred ccccccc-----cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccC
Q 042262 675 LNQSKAI-----KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEM 729 (814)
Q Consensus 675 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~ 729 (814)
....+.. ....-||.+||+--...+..-+.+.|.=|+|.++++.|-|..||..-.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 5443321 223459999999999999999999999999999999999999998643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-18 Score=168.76 Aligned_cols=257 Identities=19% Similarity=0.223 Sum_probs=189.0
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccc-cceeeeeeeeccCCceeh
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~l 597 (814)
...+.+.++||.|.||.+|.|.... .+..||||.-+... ...++..|.++.+.++| ..|..+..|..+...-.|
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~---~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISIT---SGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeecc---CCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 3456777899999999999999875 67899999976543 23466777778778865 678888888999999999
Q ss_pred hhhhccCCchhhhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC---CCeEEeecCCcccc
Q 042262 598 VYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY---YNARISDFGLAKLL 673 (814)
Q Consensus 598 V~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DfGla~~~ 673 (814)
||+.+ +-+|++++. .+..++.+..+-++-|++.-++|+|. .++|||||||+|+|..-+ ..+.++|||+++..
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99987 779988774 46778999999999999999999995 599999999999999744 45889999999876
Q ss_pred ccccccc-----ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC
Q 042262 674 TLNQSKA-----IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748 (814)
Q Consensus 674 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 748 (814)
....... ......||.+|.+--...+...+.+.|+=|+|.+|..+.-|..||+.-....... -++.+.+.+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q----KyEkI~EkK 240 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ----KYEKISEKK 240 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH----HHHHHHHhh
Confidence 5332221 1233458999999888888888899999999999999999999998654322211 122222222
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+...+. .--...+.++...+.-|=+.-=++-|...-+-++
T Consensus 241 ~s~~ie-----~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrql 280 (341)
T KOG1163|consen 241 MSTPIE-----VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQL 280 (341)
T ss_pred cCCCHH-----HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence 211111 0112345666667777766666666765544443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-18 Score=173.90 Aligned_cols=141 Identities=16% Similarity=0.146 Sum_probs=107.7
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeecccccc--c-------hhhh-----------------hceeeEEeecc
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--G-------EKEF-----------------KNEVVVIGQTH 578 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--~-------~~~~-----------------~~Ei~~l~~l~ 578 (814)
.+.||+|+||.||+|... +++.||||+++..... . ...| ..|++.+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05147 2 NGCISTGKEANVYHATTA----NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV 77 (190)
T ss_pred CCccccccceEEEEEECC----CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 357999999999999885 4789999999653211 1 1122 23888888888
Q ss_pred ccceeeeeeeeccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 042262 579 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 658 (814)
Q Consensus 579 H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~ 658 (814)
|+++.....+.. ...+|||||+++++|...+.....++......++.|++.+|.|||+ ..+|+||||||+|||++
T Consensus 78 ~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~- 152 (190)
T cd05147 78 TAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH- 152 (190)
T ss_pred HCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-
Confidence 777644333322 2348999999998877654445678899999999999999999942 45999999999999998
Q ss_pred CCCeEEeecCCccccc
Q 042262 659 YYNARISDFGLAKLLT 674 (814)
Q Consensus 659 ~~~~kl~DfGla~~~~ 674 (814)
++.++|+|||++....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.7e-19 Score=176.95 Aligned_cols=174 Identities=14% Similarity=0.089 Sum_probs=131.2
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhh---------hhceeeEEeeccccceeeee
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE---------FKNEVVVIGQTHHKNLVRLL 586 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~---------~~~Ei~~l~~l~H~niv~l~ 586 (814)
++....+...+.||.|+||.||.... ++..+|||.+++.....++. +++|+..+.+++|++|..+.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 34445566678899999999998544 24469999997544333332 67899999999999999999
Q ss_pred eeeccC--------CceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 042262 587 GFCDEG--------QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 658 (814)
Q Consensus 587 g~~~~~--------~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~ 658 (814)
.++... ...+|||||+++.+|.++.. ++. ....+++.+|..||+ .+++||||||+||+++.
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSK 170 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeC
Confidence 886532 35789999999999988732 222 345699999999995 59999999999999999
Q ss_pred CCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh
Q 042262 659 YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720 (814)
Q Consensus 659 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt 720 (814)
++ ++|+|||..+....+.... .++....+..++|||+||+.+..+..
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHHH
Confidence 88 9999999887653222111 13344456679999999999887643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.6e-18 Score=168.44 Aligned_cols=142 Identities=16% Similarity=0.081 Sum_probs=109.1
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeeccccccc--------------------------hhhhhceeeEEeecc
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG--------------------------EKEFKNEVVVIGQTH 578 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~--------------------------~~~~~~Ei~~l~~l~ 578 (814)
...||+|++|.||+|.+. +++.||||+++...... ...+..|...+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05145 2 NGCISTGKEANVYHARTG----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY 77 (190)
T ss_pred CceeecCCCcEEEEEEcC----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 357999999999999875 47899999987542110 011346777888888
Q ss_pred ccceeeeeeeeccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 042262 579 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 658 (814)
Q Consensus 579 H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~ 658 (814)
|+++.....+... ..+|||||++++++.........++......++.|++.++.+||+ ..+|+||||||+||+++
T Consensus 78 ~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 78 EAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred hCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 8887544443332 348999999988655443344567788899999999999999996 15999999999999999
Q ss_pred CCCeEEeecCCcccccc
Q 042262 659 YYNARISDFGLAKLLTL 675 (814)
Q Consensus 659 ~~~~kl~DfGla~~~~~ 675 (814)
++.++|+|||+++.+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-17 Score=182.96 Aligned_cols=236 Identities=22% Similarity=0.213 Sum_probs=185.1
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEeeccccccc--hhhhhceeeEEeecc-ccceeeeeeeeccCCceehhhhhcc
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLN 603 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~--~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 603 (814)
.+|+|.||.|+++.-....+.+...|.|.+++..... ......|..++...+ ||.++++.-.+....+.+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3789999999977655545567778888876532221 113445556666675 9999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccc
Q 042262 604 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT 683 (814)
Q Consensus 604 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 683 (814)
+|.|...+.....+...........++-+++++| ..+|+|||+|++||+++.+|.+|+.|||+.+..-....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----- 152 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence 9999999988888888888888889999999999 56999999999999999999999999999987654322
Q ss_pred cccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCCh
Q 042262 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDI 763 (814)
Q Consensus 684 ~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~ 763 (814)
.+||.-|||||++. .....+|-||||++.+||++|-.||..+ .....++ .+...+.
T Consensus 153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----------~~~~Il~-----------~~~~~p~ 208 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----------TMKRILK-----------AELEMPR 208 (612)
T ss_pred -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----------HHHHHhh-----------hccCCch
Confidence 27899999999998 5688999999999999999999999741 1111111 1223455
Q ss_pred hHHHHHHHHHHHccccCCCCCCCH--HHHHHHH
Q 042262 764 KCTEKLVMVSIWCIQEDPSLRPTM--RKVSQML 794 (814)
Q Consensus 764 ~~~~~l~~l~~~Cl~~dP~~RPtm--~eV~~~L 794 (814)
+.......++..+...+|.+|.-. ..+.+++
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 677778888888888899998755 3454544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-17 Score=177.12 Aligned_cols=172 Identities=26% Similarity=0.362 Sum_probs=131.7
Q ss_pred ceehhhhhccCCchhhhhcCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 594 NRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
..++.|+++...+|.++|.+. ...++...+.++.|++.|+.| .+.+|+|+||.||....+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999754 346788899999999999999 38999999999999999999999999998
Q ss_pred ccccccc----cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHh
Q 042262 671 KLLTLNQ----SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 745 (814)
Q Consensus 671 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 745 (814)
....... .....+...||..||+||.+.+..|+.|+||||+|++|+||+. -...++. .-...-++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhh
Confidence 7765444 2223456779999999999999999999999999999999998 3333221 11223344
Q ss_pred cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHH
Q 042262 746 NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790 (814)
Q Consensus 746 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV 790 (814)
.|.++.... .+. .+-..++.+++.+.|.+||++.++
T Consensus 474 ~g~ip~~~~--------~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGIIPPEFL--------QDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCCCChHHh--------hcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 454442111 111 223467888999999999955544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.4e-16 Score=185.24 Aligned_cols=199 Identities=22% Similarity=0.193 Sum_probs=156.4
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccccceeeeeeeeccC
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 592 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 592 (814)
++....+.+.+.||+|+||+||+|... ++..||+|+-+.... .-..+++..++ ..--+-|+.+.....-.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~----~~~~~alK~e~P~~~WEfYI~~q~~~RLk---~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHS----NGKLVALKVEKPPNPWEFYICLQVMERLK---PQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecC----CCcEEEEEeecCCCceeeeehHHHHHhhc---hhhhcchHHHHHHHccC
Confidence 344455566788999999999999987 478999999765321 11223333333 11123455555555567
Q ss_pred CceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC-------CCCCeEEe
Q 042262 593 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-------DYYNARIS 665 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~-------~~~~~kl~ 665 (814)
+..+||+||.+.|+|.+++...+.++|.....|+.|+++.+++|| ..+|||+||||+|+||. +...++|+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEE
Confidence 788999999999999999998899999999999999999999999 46999999999999994 34559999
Q ss_pred ecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcC
Q 042262 666 DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS 724 (814)
Q Consensus 666 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p 724 (814)
|||.+..+..-.........++|-++-.+|...|.+++..+|.|.+..+++-||.|+..
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99998765432222235667789999999999999999999999999999999998753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.9e-17 Score=167.26 Aligned_cols=227 Identities=22% Similarity=0.265 Sum_probs=141.3
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeecc----------ccceeeeeeeec-
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTH----------HKNLVRLLGFCD- 590 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~----------H~niv~l~g~~~- 590 (814)
.+.||.|+++.||.+++.. .++.+|||...... ....+++++|.-.+..+. |-.++-.++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~---t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVE---TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEETTEEEEEEEETT---TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred ccccccCCceEEEEEEEcc---CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3579999999999999975 57889999874322 222345555554443322 222333222221
Q ss_pred --------cC---C-----ceehhhhhccCCchhhhhc---CCC----CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 042262 591 --------EG---Q-----NRLLVYEFLNNGTLASFLF---GNL----KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHC 647 (814)
Q Consensus 591 --------~~---~-----~~~lV~e~~~~gsL~~~l~---~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~ 647 (814)
.. . ..+++|+-+ .++|.+++. ... .+....++.+..|+++.+++||. .+++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 11 1 224566655 557776643 221 23345567788999999999995 599999
Q ss_pred CCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccC--------CCCCCccchhhHHHHHHHHH
Q 042262 648 DIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN--------STITAKVDVYSFGVLLLEII 719 (814)
Q Consensus 648 Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~k~DV~S~Gvvl~ell 719 (814)
||+|+|++++.+|.+.|+||+.....+.... . ...+..|.+||.... -.++.+.|.|++|+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999987765443211 1 234578999997633 25788999999999999999
Q ss_pred hCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCC
Q 042262 720 SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLR 784 (814)
Q Consensus 720 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 784 (814)
+++.||+......... ... .... +.++.+..|+..+|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~-------------------~~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE-------------------WDF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG-------------------GGG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc-------------------ccc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999998653321110 011 1233 788999999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.4e-16 Score=160.15 Aligned_cols=133 Identities=20% Similarity=0.230 Sum_probs=103.0
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-----cccceeeeeeeeccCC---cee-
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-----HHKNLVRLLGFCDEGQ---NRL- 596 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~~~- 596 (814)
+.||+|+||.||+ ++. ... .+||++........+++.+|+.++..+ .||||++++|+++++. ..+
T Consensus 8 ~~LG~G~~~~Vy~--hp~---~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPE---DAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred ceecCCCceEEEE--CCC---CcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 5799999999995 332 233 468887654444567899999999999 5799999999998864 333
Q ss_pred hhhhh--ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCCeeecCCCCCcEEECC----CCCeEEeecCC
Q 042262 597 LVYEF--LNNGTLASFLFGNLKPSWNLRTNIAFQIARGL-LYLHEDCSAQIIHCDIKPQNILLDD----YYNARISDFGL 669 (814)
Q Consensus 597 lV~e~--~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiH~Dikp~NIll~~----~~~~kl~DfGl 669 (814)
+|+|| +.+++|.+++... .+++. ..++.+++.++ +|||+ .+|+||||||+|||++. +..++|+||+-
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5589999999664 35544 35678888888 99995 59999999999999973 34799999443
Q ss_pred c
Q 042262 670 A 670 (814)
Q Consensus 670 a 670 (814)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-16 Score=156.96 Aligned_cols=185 Identities=16% Similarity=0.058 Sum_probs=133.9
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeeccccccc----hhhhhceeeEEeecc-ccceeeeeeeeccCCceehhh
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG----EKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~----~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 599 (814)
...|++|+||+||.+.- .+..++.+.+.....-. ...+.+|+++|++++ |+++.+++++ +..+++|
T Consensus 7 ~~~l~~~~f~~v~~~~~-----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred ceeecCCCcceEEEeec-----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 35799999999995543 35566666665432211 125789999999995 5889999886 4569999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDI-KPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Di-kp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+.+.+|...+.. ....++.|++++|.++|+ .+|+|||| ||+|||++.++.++|+|||++........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99999998754321 124578899999999995 59999999 79999999999999999999986543321
Q ss_pred c-------cc----cccccCCCCccCcccccCC-CCC-CccchhhHHHHHHHHHhCCcCCccc
Q 042262 679 K-------AI----KTAIRGTKGYVAPEWFRNS-TIT-AKVDVYSFGVLLLEIISCRKSFDIE 728 (814)
Q Consensus 679 ~-------~~----~~~~~gt~~y~aPE~~~~~-~~t-~k~DV~S~Gvvl~elltG~~p~~~~ 728 (814)
. .. .-....+..|++|+...-- ..+ ...+-++-|.-+|.++|++.++-.+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 00 0112256777777754322 222 4678889999999999999887543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-15 Score=156.99 Aligned_cols=142 Identities=17% Similarity=0.171 Sum_probs=108.0
Q ss_pred hhhhccccccceeEEEEEE-EeccCCcceEEEEEeecccccc------------------------chhhhhceeeEEee
Q 042262 522 DNFEEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQD------------------------GEKEFKNEVVVIGQ 576 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~-~~~~~~~~~~vaVK~l~~~~~~------------------------~~~~~~~Ei~~l~~ 576 (814)
+.+.+.||+|++|.||+|. ... .++.||||+++..... ....+..|+..+.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDG---SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCC---CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4566789999999999998 322 5788999998643210 01225678888888
Q ss_pred ccccc--eeeeeeeeccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eeecCCCCCc
Q 042262 577 THHKN--LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ-IIHCDIKPQN 653 (814)
Q Consensus 577 l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-iiH~Dikp~N 653 (814)
+.+.. +.+++++ ...+|||||+.+.+|.........+.......++.||+.+|++||+ .+ |+|+||||+|
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 87532 3444443 2358999999999987766444455666678899999999999995 47 9999999999
Q ss_pred EEECCCCCeEEeecCCccccc
Q 042262 654 ILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 654 Ill~~~~~~kl~DfGla~~~~ 674 (814)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.8e-15 Score=154.16 Aligned_cols=134 Identities=20% Similarity=0.258 Sum_probs=111.3
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccccc--------chhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
+.||+|++|.||+|... +..++||+....... ....+.+|++++..++|++|.....++......++
T Consensus 2 ~~l~~G~~~~vy~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL-----GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFII 76 (211)
T ss_pred cccccCceEEEEEEeeC-----CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEE
Confidence 46899999999999873 456888876432211 12357789999999999999888888777788899
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
||||+++++|.+++..... .+..++.+++.+|.+||+ .+++|+|++|+|||++ ++.++|+|||.++.
T Consensus 77 v~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999998865332 788999999999999994 5999999999999999 78899999998875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.1e-15 Score=150.92 Aligned_cols=130 Identities=20% Similarity=0.294 Sum_probs=104.8
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEeecccccc--------chhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.||+|+||.||+|... +..+++|+....... ...++.+|++++..++|+++.....++......++|
T Consensus 1 ~ig~G~~~~vy~~~~~-----~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-----GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeecC-----CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEE
Confidence 3899999999999853 467888885432111 124577899999999988766666666666778999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
|||+++++|.+++..... .++.+++++|.+|| ..+++|+|++|+||+++ ++.+++.|||+++.
T Consensus 76 ~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999988754321 78999999999999 46999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.7e-15 Score=171.42 Aligned_cols=133 Identities=17% Similarity=0.267 Sum_probs=107.5
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEee-ccccc-------cchhhhhceeeEEeeccccceeeeeeeeccCCce
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DRVFQ-------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l-~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 595 (814)
..+.||+|+||+||+|.+.. ..+++|+. ..... ...+++.+|++++..++|++++....++......
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~-----~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLG-----RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccceeccCCcEEEEEEeecC-----ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 35789999999999998753 12333322 11111 1124688999999999999999988888777788
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
++||||+++++|.+++. .+..++.+++++|.|||+ .+++||||||+|||+ +++.++|+|||+++..
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999999874 467899999999999995 599999999999999 6789999999999764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-14 Score=148.13 Aligned_cols=196 Identities=22% Similarity=0.267 Sum_probs=132.3
Q ss_pred ccccceeeeeeeecc---------------------------CCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHH
Q 042262 577 THHKNLVRLLGFCDE---------------------------GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 629 (814)
Q Consensus 577 l~H~niv~l~g~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i 629 (814)
-+|||||+++++|.+ +...||||.-+ ..+|..++.... .+...+.-|+.|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-~s~r~~~~~laQl 350 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-RSYRTGRVILAQL 350 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-CchHHHHHHHHHH
Confidence 369999998887633 23457777655 347777776554 4556667788999
Q ss_pred HHHHHHhhhcCCCCeeecCCCCCcEEEC--CCC--CeEEeecCCccccccc----ccccccccccCCCCccCcccccCCC
Q 042262 630 ARGLLYLHEDCSAQIIHCDIKPQNILLD--DYY--NARISDFGLAKLLTLN----QSKAIKTAIRGTKGYVAPEWFRNST 701 (814)
Q Consensus 630 a~gL~yLH~~~~~~iiH~Dikp~NIll~--~~~--~~kl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~ 701 (814)
++|+.|||. .+|.|||+|.+||||. +|. ...|+|||.+-.-... ..........|...-||||+...-+
T Consensus 351 LEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 999999995 5999999999999983 443 3688999976321110 0000012234778899999985432
Q ss_pred -----C-CCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHH
Q 042262 702 -----I-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIW 775 (814)
Q Consensus 702 -----~-t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~ 775 (814)
+ -.|+|.|+.|.+-||+++...||..... -.... ..+++..++.+ +..++..+.+++..
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~-----r~Yqe~qLPal---------p~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDT-----RTYQESQLPAL---------PSRVPPVARQLVFD 492 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccch-heech-----hhhhhhhCCCC---------cccCChHHHHHHHH
Confidence 1 2489999999999999999999975211 00000 11222222222 33567788999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 042262 776 CIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 776 Cl~~dP~~RPtm~eV~~ 792 (814)
.|++||++||+..=...
T Consensus 493 lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAAN 509 (598)
T ss_pred HhcCCccccCCccHHHh
Confidence 99999999998754333
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.4e-15 Score=147.98 Aligned_cols=137 Identities=17% Similarity=0.169 Sum_probs=104.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc----------------------chhhhhceeeEEeeccc
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD----------------------GEKEFKNEVVVIGQTHH 579 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~----------------------~~~~~~~Ei~~l~~l~H 579 (814)
+.+.+.||+|+||.||++... +++.+|||+++..... ....+..|+.++..+.|
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred hhcCCccccCcceEEEEEEcC----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 556688999999999999875 4778999986532100 01125667777777877
Q ss_pred cc--eeeeeeeeccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC
Q 042262 580 KN--LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 657 (814)
Q Consensus 580 ~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~ 657 (814)
++ +...++. ...++||||+++++|...... .....++.++++++.++|+ .+|+|+||||+||+++
T Consensus 93 ~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 93 EGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVD 159 (198)
T ss_pred cCCCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEc
Confidence 74 4444432 345899999999998776431 3456788999999999995 6999999999999999
Q ss_pred CCCCeEEeecCCcccccc
Q 042262 658 DYYNARISDFGLAKLLTL 675 (814)
Q Consensus 658 ~~~~~kl~DfGla~~~~~ 675 (814)
+++.++|+|||++.....
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=9.8e-15 Score=168.80 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=191.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeecc-ccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|.|+.|-....... ....+|+|.+.... ....+....|..+-..+. |+|++++++...+....+++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~--~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRD--PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccchhhhhhhcCC--CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34445699999999987766432 34567777775442 233445666888888886 99999999999999999999
Q ss_pred hhhccCCchhhhh-cCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-CeEEeecCCcccccc
Q 042262 599 YEFLNNGTLASFL-FGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLTL 675 (814)
Q Consensus 599 ~e~~~~gsL~~~l-~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~ 675 (814)
.||..++++.+.+ .... ..+......++.|+..++.|+|. ..++.|+||||+|.+++..+ ..|++|||+|..+..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999998 5544 56677778899999999999994 35899999999999999999 999999999988766
Q ss_pred -cccccccccccC-CCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 676 -NQSKAIKTAIRG-TKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 676 -~~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
+..........| +..|+|||...+. ...+..|+||.|+++.-+++|..|++......... ..|. +..
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~-----~~~---- 247 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWK-----SNK---- 247 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeec-----ccc----
Confidence 333333444567 9999999999885 45678999999999999999999997654432111 0110 000
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
................++...++..+|..|.+.+++..
T Consensus 248 --~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 --GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00001112234456777888889899999999988754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.3e-14 Score=162.88 Aligned_cols=203 Identities=22% Similarity=0.296 Sum_probs=137.5
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 605 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 605 (814)
+.|..|++|.||...+.. ..+.+|.|+-+... -+++ ++.....|. .| |
T Consensus 89 klisngAygavylvrh~~---trqrfa~kiNkq~l-----ilRn---ilt~a~npf---------------vv------g 136 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKE---TRQRFAMKINKQNL-----ILRN---ILTFAGNPF---------------VV------G 136 (1205)
T ss_pred EeeccCCCCceeeeeccc---cccchhhcccccch-----hhhc---cccccCCcc---------------ee------c
Confidence 568899999999998864 34567774422211 0010 111112222 22 3
Q ss_pred chhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc--------
Q 042262 606 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ-------- 677 (814)
Q Consensus 606 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~-------- 677 (814)
+-...++....++.. ++.+++||| +.+|+|||+||+|.+|..-+++|+.|||+.+..-...
T Consensus 137 Dc~tllk~~g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 137 DCATLLKNIGPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred hhhhhcccCCCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence 334444443444332 277999999 6799999999999999999999999999987542211
Q ss_pred ----cc-cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 678 ----SK-AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 678 ----~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
.+ -....++||+.|+|||++....|...+|-|++|+|+||.+-|..||..+-.++.. ...+.+.+ ..
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf--g~visd~i---~w--- 277 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF--GQVISDDI---EW--- 277 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH--hhhhhhhc---cc---
Confidence 11 1123457999999999999999999999999999999999999999877554321 11111110 01
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCCCC
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRP 785 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 785 (814)
.+.+...+.++.+++...|+.+|.+|-
T Consensus 278 ------pE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 278 ------PEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ------cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 111334567888999999999999995
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.4e-13 Score=131.48 Aligned_cols=134 Identities=22% Similarity=0.179 Sum_probs=113.9
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccc--cceeeeeeeeccCCceehhhhhcc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLN 603 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~ 603 (814)
+.||+|.++.||++... +..+++|....... ...+.+|+.++..++| .++.+++++....+..++++||++
T Consensus 4 ~~i~~g~~~~v~~~~~~-----~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 4 KLLKGGLTNRVYLLGTK-----DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred eecccccccceEEEEec-----CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 56899999999999975 25789998765432 4578899999999977 589999999988889999999999
Q ss_pred CCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 604 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 604 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
++.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.+...
T Consensus 77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 8887655 56677889999999999999754467999999999999999899999999988753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=9.9e-14 Score=138.38 Aligned_cols=139 Identities=19% Similarity=0.186 Sum_probs=92.4
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeeccccccc--hhhh----------------------hceeeEEeecccc
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG--EKEF----------------------KNEVVVIGQTHHK 580 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~--~~~~----------------------~~Ei~~l~~l~H~ 580 (814)
.+.||+|+||+||+|.+. ++..||||++....... ...+ ..|...+.++.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECC----CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 467999999999999875 46789999886432111 1111 1222222222222
Q ss_pred --ceeeeeeeeccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 042262 581 --NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 658 (814)
Q Consensus 581 --niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~ 658 (814)
.+.+.+++ ...+|||||++++.+........... .....++.+++.++.++|. ..+|+|+||||+||+++
T Consensus 78 ~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 78 GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 12333332 24589999999955432211111111 5678899999999999995 26999999999999999
Q ss_pred CCCeEEeecCCcccccc
Q 042262 659 YYNARISDFGLAKLLTL 675 (814)
Q Consensus 659 ~~~~kl~DfGla~~~~~ 675 (814)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.8e-13 Score=136.72 Aligned_cols=135 Identities=19% Similarity=0.128 Sum_probs=102.7
Q ss_pred cccc-ccceeEEEEEEEeccCCcceEEEEEeecccc-------------ccchhhhhceeeEEeeccccce--eeeeeee
Q 042262 526 EEVG-RGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-------------QDGEKEFKNEVVVIGQTHHKNL--VRLLGFC 589 (814)
Q Consensus 526 ~~LG-~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-------------~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~ 589 (814)
..|| .|+.|+||++... +..++||+..... ......+.+|++++.+++|++| ++++++.
T Consensus 37 ~~lg~~~g~gtv~~v~~~-----~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~ 111 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-----GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR 111 (239)
T ss_pred ceeecCCCCccEEEEEeC-----CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence 4687 8899999998874 4568888774310 1123457889999999998875 7777775
Q ss_pred ccCC----ceehhhhhccC-CchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEE
Q 042262 590 DEGQ----NRLLVYEFLNN-GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 664 (814)
Q Consensus 590 ~~~~----~~~lV~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl 664 (814)
.... ..+||+|++++ .+|.+++... .++.. .+.+|+++|.+||+ .+|+|+||||.|||++.++.++|
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence 4432 23599999997 6898887553 34433 36789999999995 59999999999999999889999
Q ss_pred eecCCcccc
Q 042262 665 SDFGLAKLL 673 (814)
Q Consensus 665 ~DfGla~~~ 673 (814)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988753
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.22 E-value=8e-12 Score=100.84 Aligned_cols=56 Identities=25% Similarity=0.440 Sum_probs=49.1
Q ss_pred eeeEEccCCCCCCCccccc-CCCChhhHHHHhccCCCcccceeC----CccceeeeccCCC
Q 042262 365 FDFHELKDTDWPSSDYEHF-SPYDEVQCKNTCLSDCFCAVAIFG----IESCWLVKLPLNN 420 (814)
Q Consensus 365 ~~f~~l~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~----~~~C~~~~~~l~~ 420 (814)
++|++|++|++|++..... .++++++|++.||+||||+||+|. +++|++|.+.|.|
T Consensus 5 d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 5 DGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 4799999999999866543 679999999999999999999996 3789999988765
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.3e-11 Score=104.08 Aligned_cols=72 Identities=25% Similarity=0.433 Sum_probs=61.1
Q ss_pred ceeeEEccCCCCCCCcccccCCCChhhHHHHhccCCCcccceeC--CccceeeeccCCCCCCCCccccceeEecc
Q 042262 364 LFDFHELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCAVAIFG--IESCWLVKLPLNNGRADSSVNRKAFIKYK 436 (814)
Q Consensus 364 ~~~f~~l~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~~l~~~~~~~~~~~~~ylkv~ 436 (814)
.++|++++++++|+..+.. .++++++|++.|++||+|+||+|. +++|++|..++.+.+........+|+|++
T Consensus 11 ~~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 11 TDGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CCEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 3579999999999886655 788999999999999999999995 58999999999988765545578898873
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.20 E-value=1e-11 Score=139.55 Aligned_cols=141 Identities=20% Similarity=0.204 Sum_probs=97.9
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccch----------------------------------------h
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE----------------------------------------K 565 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~----------------------------------------~ 565 (814)
+.||.|++|.||+|++. +++.||||+.+....... -
T Consensus 123 ~plasaSigQVh~A~l~----~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~El 198 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV----DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRREL 198 (437)
T ss_pred cceeeeehhheEEEEec----CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHH
Confidence 36999999999999987 578899999865321110 0
Q ss_pred hhhceeeEEeecc----ccceeeeeeee-ccCCceehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHH-HHHHhhh
Q 042262 566 EFKNEVVVIGQTH----HKNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIAR-GLLYLHE 638 (814)
Q Consensus 566 ~~~~Ei~~l~~l~----H~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~-gL~yLH~ 638 (814)
+|..|...+.+++ |.+-+.+-..+ ...+..+|||||+++++|.++.... ... .+..++..+++ .+..+|.
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh
Confidence 2334444444432 22223333333 2345679999999999998876432 111 34567777766 4677884
Q ss_pred cCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 639 ~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
.+++|+|+||.||++++++.+++.|||++..+...
T Consensus 276 ---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 276 ---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred ---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 59999999999999999999999999999887643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.7e-11 Score=123.30 Aligned_cols=196 Identities=21% Similarity=0.255 Sum_probs=134.3
Q ss_pred eccccceeeeeeeeccC-----CceehhhhhccCCchhhhhcCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 042262 576 QTHHKNLVRLLGFCDEG-----QNRLLVYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIH 646 (814)
Q Consensus 576 ~l~H~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 646 (814)
.+-|.|||++..|..+. .+..++.|||+.|+|..+|++. ..+..+.-.+++-||+.||.|||. |.+.|+|
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppiih 201 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPIIH 201 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcccc
Confidence 45699999999987553 3467889999999999999753 456777778899999999999997 4999999
Q ss_pred cCCCCCcEEECCCCCeEEeecCCcccccccccc---cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCc
Q 042262 647 CDIKPQNILLDDYYNARISDFGLAKLLTLNQSK---AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRK 723 (814)
Q Consensus 647 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~ 723 (814)
+++.-+-|++..++-+||.- +.....+..... .......+-.+|.|||+=.....+..+|||+||+.-+|+.-+..
T Consensus 202 gnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 202 GNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred CCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 99999999999998888742 222222211110 11122336689999999888888899999999999999877654
Q ss_pred CCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 724 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 724 p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
-...... ......-.. .....+.. ..-..++..|++..|..||+|++++.
T Consensus 281 q~tnseS--~~~~ee~ia------~~i~~len-----------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 281 QSTNSES--KVEVEENIA------NVIIGLEN-----------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred ccCCCcc--eeehhhhhh------hheeeccC-----------ccccCcCcccccCCCCCCcchhhhhc
Confidence 3211110 000000000 00000111 11124567799999999999998765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.5e-11 Score=131.01 Aligned_cols=257 Identities=24% Similarity=0.265 Sum_probs=183.6
Q ss_pred HHHHHHHHhhhhccccc--cceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeec-cccceeeeeee
Q 042262 514 YKELEEATDNFEEEVGR--GSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT-HHKNLVRLLGF 588 (814)
Q Consensus 514 ~~el~~~~~~~~~~LG~--G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~ 588 (814)
..+.+..+..+.+.+|. |.+|.||.+.... ..+...+|+|+-+.... ...+.=.+|......+ .|+|.++....
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCc-ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 34556666777888999 9999999998733 23677899998554333 3333345566555566 49999998888
Q ss_pred eccCCceehhhhhccCCchhhhhcCCCC-CCHHHHHHHHHHHHH----HHHHhhhcCCCCeeecCCCCCcEEECCC-CCe
Q 042262 589 CDEGQNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIAR----GLLYLHEDCSAQIIHCDIKPQNILLDDY-YNA 662 (814)
Q Consensus 589 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~ 662 (814)
.++.+..++-.|++. .+|..+.+.... ++....+.+..+... ||.++| +..++|-|+||.||++..+ ...
T Consensus 187 ~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 187 WEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheeccccccee
Confidence 899999999899875 677777665443 667777788888888 999999 6799999999999999999 889
Q ss_pred EEeecCCcccccccccccc---cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHH
Q 042262 663 RISDFGLAKLLTLNQSKAI---KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 739 (814)
Q Consensus 663 kl~DfGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 739 (814)
++.|||+...+........ .....|...|++||.+.+ .++.+.|||++|.+++|..++........-. .|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W 335 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------SW 335 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc
Confidence 9999999988765442111 112257788999998865 5788999999999999999987665422111 11
Q ss_pred HHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 740 AFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 740 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..++.+-+ ..++-..-..++..++..+++.+|..|++.+++..
T Consensus 336 --~~~r~~~i--------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 --SQLRQGYI--------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --cccccccC--------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111111 11111122334445888999999999999877665
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.1e-10 Score=132.76 Aligned_cols=142 Identities=15% Similarity=0.144 Sum_probs=88.3
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccccc----------------------------------chhhhhcee
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD----------------------------------GEKEFKNEV 571 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~----------------------------------~~~~~~~Ei 571 (814)
+.||+|++|.||+|++.. +++.||||+++..... -.+.+.+|+
T Consensus 125 ~PlasaSiaQVh~A~l~~---~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~El 201 (537)
T PRK04750 125 KPLASASIAQVHFARLKD---NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDEL 201 (537)
T ss_pred hhhcCCCccEEEEEEECC---CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhh
Confidence 369999999999999973 3788999999753211 011223333
Q ss_pred eE------Eeecc----ccceeeeeeeecc-CCceehhhhhccCCchhhhh--cCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 042262 572 VV------IGQTH----HKNLVRLLGFCDE-GQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHE 638 (814)
Q Consensus 572 ~~------l~~l~----H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l--~~~~~l~~~~~~~i~~~ia~gL~yLH~ 638 (814)
.. +.+++ +.+.+.+-.++.+ ....+|||||+.++.+.++- .... .+ +..++...++. |+++
T Consensus 202 D~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d---~~~la~~~v~~--~~~Q 275 (537)
T PRK04750 202 DLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TD---MKLLAERGVEV--FFTQ 275 (537)
T ss_pred CHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CC---HHHHHHHHHHH--HHHH
Confidence 33 33321 2333333333322 34578999999999998742 2211 11 12222222221 2222
Q ss_pred cCCCCeeecCCCCCcEEECCCC----CeEEeecCCccccccc
Q 042262 639 DCSAQIIHCDIKPQNILLDDYY----NARISDFGLAKLLTLN 676 (814)
Q Consensus 639 ~~~~~iiH~Dikp~NIll~~~~----~~kl~DfGla~~~~~~ 676 (814)
-...+++|+|+||.||+++.++ .+++.|||+...+...
T Consensus 276 if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 2235999999999999999888 9999999999887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.4e-10 Score=111.91 Aligned_cols=130 Identities=19% Similarity=0.131 Sum_probs=95.0
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecccccee-eeeeeeccCCceehhhhhccC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~ 604 (814)
+.|+.|.++.||++... +..+++|....... ....+..|..++..+.+.+++ +++.+.. ...++||||+++
T Consensus 4 ~~l~~G~~~~vy~~~~~-----~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-----NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eecCCcccCceEEEEEC-----CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 46788999999998864 56799998754321 234567888888888665544 4454433 345899999999
Q ss_pred CchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 605 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC--SAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 605 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
.++.... .....++.+++++|+.||... ...++|+|++|.||+++ ++.+++.||+.+..
T Consensus 76 ~~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Ccccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 8876530 112346789999999999642 22369999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.1e-09 Score=121.28 Aligned_cols=243 Identities=20% Similarity=0.218 Sum_probs=171.5
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhh--hceeeEEeec-cccceeeeeeeeccCCceehhhh
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEF--KNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~--~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 600 (814)
....||.|.|+.|++..... .++..+++|.+.+.......++ ..|+-+...+ .|.++++.+.........++--|
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~--~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRP--EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred eeEEccCCccccceeeeecC--CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 34579999999999887442 2567788888865433322221 2233333333 58888888777777788889999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-YNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGla~~~~~~~~~ 679 (814)
|+.++++...+.-...++...++++..|++.++.++| ++.++|+|+||+||++..+ +..++.|||.+..+.....
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~- 422 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG- 422 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccceecc-
Confidence 9999999888755567788889999999999999999 6899999999999999886 8899999999875332211
Q ss_pred cccccccCCCCc-cCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGY-VAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y-~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.....+..| .+++......+-.+.|+||||.-+.|.+++........ + +..++.|....
T Consensus 423 ---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~--~~~i~~~~~p~------- 482 (524)
T KOG0601|consen 423 ---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------Q--SLTIRSGDTPN------- 482 (524)
T ss_pred ---cccccccccccchhhccccccccccccccccccccccccCcccCcccc--------c--ceeeecccccC-------
Confidence 111123334 35666667788999999999999999999876543111 0 01112222111
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
.......+..++..++.+++..||.+.+...+.+
T Consensus 483 ---~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 483 ---LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ---CCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1123367777888899999999999988776543
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.2e-09 Score=89.46 Aligned_cols=64 Identities=13% Similarity=0.172 Sum_probs=54.8
Q ss_pred eeEEccCCCCCCCcccccCCCChhhHHHHhcc---CCCcccceeC--CccceeeeccC-CCCCCCCccccceeEe
Q 042262 366 DFHELKDTDWPSSDYEHFSPYDEVQCKNTCLS---DCFCAVAIFG--IESCWLVKLPL-NNGRADSSVNRKAFIK 434 (814)
Q Consensus 366 ~f~~l~~~~~~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~--~~~C~~~~~~l-~~~~~~~~~~~~~ylk 434 (814)
.|+++.++++|++.. +++++|++.|++ ||||+||+|. +.+|++|..++ .+.+...+.+..+|+|
T Consensus 10 ~fl~~~~~klpd~~~-----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 10 TTLIKIALKIKTTKA-----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred eEEEeecccCCcccc-----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 499999999997755 688999999999 9999999994 46899999999 8888776667778876
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.3e-09 Score=104.16 Aligned_cols=141 Identities=15% Similarity=0.204 Sum_probs=96.0
Q ss_pred ccccccceeEEEEEEEecc---CCcceEEEEEeecccccc--c--------------------hhhhh----ceeeEEee
Q 042262 526 EEVGRGSFGIVYKGVIQTT---RTSTTAVAVKKLDRVFQD--G--------------------EKEFK----NEVVVIGQ 576 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~---~~~~~~vaVK~l~~~~~~--~--------------------~~~~~----~Ei~~l~~ 576 (814)
..||.|.-+.||.|..... ...+..+|||+.+..... . .+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4689999999999975421 012468999988532110 0 01122 56666666
Q ss_pred ccc--cceeeeeeeeccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeecCCCCCc
Q 042262 577 THH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL-HEDCSAQIIHCDIKPQN 653 (814)
Q Consensus 577 l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH~Dikp~N 653 (814)
+.. -++.+++++ ...+|||||+.+..+.........++......+..+++.+|..| | ..+|+|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHH
Confidence 642 355556654 46689999998754433222222345556677889999999999 6 4599999999999
Q ss_pred EEECCCCCeEEeecCCccccc
Q 042262 654 ILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 654 Ill~~~~~~kl~DfGla~~~~ 674 (814)
||+++ +.+.|+|||.+....
T Consensus 156 IL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEEC-CcEEEEECCCceeCC
Confidence 99974 679999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.5e-09 Score=106.97 Aligned_cols=142 Identities=18% Similarity=0.219 Sum_probs=109.9
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccc--cceeeeeeeeccCC---ceehhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHH--KNLVRLLGFCDEGQ---NRLLVY 599 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~---~~~lV~ 599 (814)
+.|+.|..+.||++... ++..+++|....... ....++..|.++++.+++ .++.+++.+..+.. ..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~----~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec----CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 45899999999999874 246789998754322 134578889999988865 44677788776643 568999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC--------------------------------------- 640 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------- 640 (814)
||+++.+|.+.+.. ..++...+..++.++++.|++||+..
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999988886542 35677788889999999999998521
Q ss_pred --------------CCCeeecCCCCCcEEECC--CCCeEEeecCCccc
Q 042262 641 --------------SAQIIHCDIKPQNILLDD--YYNARISDFGLAKL 672 (814)
Q Consensus 641 --------------~~~iiH~Dikp~NIll~~--~~~~kl~DfGla~~ 672 (814)
...++|+|+++.||+++. +..+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999988764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.2e-09 Score=122.44 Aligned_cols=245 Identities=19% Similarity=0.207 Sum_probs=158.7
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCCc
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT 606 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 606 (814)
.+-+|.++.+..+.-...+........+..........+....+-.++-..+||-+++..--+.-.....||++|..+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 45566777766554332211111112222222212223334444444444455666655444445667889999999999
Q ss_pred hhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc-----------
Q 042262 607 LASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL----------- 675 (814)
Q Consensus 607 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~----------- 675 (814)
|...|+.....+..........+...++||| +..+.|+|++|.|++...++..+++|||.......
T Consensus 891 ~~Skl~~~~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~ 967 (1205)
T KOG0606|consen 891 LPSKLHNSGCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPS 967 (1205)
T ss_pred chhhhhcCCCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCcCCccccc
Confidence 9999988766665555556666788999999 44689999999999999999999999984332110
Q ss_pred ----------cccc--------cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHH
Q 042262 676 ----------NQSK--------AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 737 (814)
Q Consensus 676 ----------~~~~--------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 737 (814)
.... .......+|..|.+||.+.+......+|.|++|++++|.++|..||.....+..
T Consensus 968 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~---- 1043 (1205)
T KOG0606|consen 968 SSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI---- 1043 (1205)
T ss_pred ccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh----
Confidence 0000 001234589999999999999999999999999999999999999986544321
Q ss_pred HHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHH
Q 042262 738 DWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMR 788 (814)
Q Consensus 738 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~ 788 (814)
.+.+..+.+.- ...+.+.+.+..+++..-+..+|.+|-.|.
T Consensus 1044 ---f~ni~~~~~~~-------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1044 ---FENILNRDIPW-------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ---hhccccCCCCC-------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 12222222111 112334556777788888889999997776
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.6e-09 Score=116.76 Aligned_cols=164 Identities=18% Similarity=0.210 Sum_probs=119.9
Q ss_pred cceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHH
Q 042262 547 STTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA 626 (814)
Q Consensus 547 ~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~ 626 (814)
++.+|.|...+...........+-++.++.++||||++++...++.+..|||.|-+. .|...+... ......-.+
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~v~~Gl 110 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEEVCLGL 110 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHHHHHHH
Confidence 456777777765544344556777888999999999999999999999999999763 233333222 244556678
Q ss_pred HHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCcc
Q 042262 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKV 706 (814)
Q Consensus 627 ~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~ 706 (814)
.||+.||.+||+. .+++|++|..+.|+|++.|+.||++|.++......... .....--..|..|+.+.... -..
T Consensus 111 ~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~s~ 184 (690)
T KOG1243|consen 111 FQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--WSI 184 (690)
T ss_pred HHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--cch
Confidence 9999999999984 68999999999999999999999999887543321110 11111223566776554322 346
Q ss_pred chhhHHHHHHHHHhC
Q 042262 707 DVYSFGVLLLEIISC 721 (814)
Q Consensus 707 DV~S~Gvvl~elltG 721 (814)
|.|-||++++|++.|
T Consensus 185 D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhHHHHHHHHhCc
Confidence 999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.1e-08 Score=97.71 Aligned_cols=130 Identities=21% Similarity=0.323 Sum_probs=98.9
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEee-ccccccc-------hhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DRVFQDG-------EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l-~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.+++|+-+.+|.+.+. +..+++|.- ++..... .....+|..++.+++--.|...+-+..+.....|+
T Consensus 3 ~i~~GAEa~i~~~~~~-----g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~ 77 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-----GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIV 77 (204)
T ss_pred hhhCCcceeEEeeecc-----CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEE
Confidence 5788999999998663 223444433 2221111 13467788888888766666666677788888999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
|||+++..|.+.+... +..++..+-+-+.-|| ..+|+|+||.++||++.... +.++||||+..
T Consensus 78 me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA-------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999999888665 3667888888899999 46999999999999998875 99999999975
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.2e-07 Score=103.04 Aligned_cols=167 Identities=20% Similarity=0.274 Sum_probs=126.5
Q ss_pred eeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeecc----CCceehhhhhccC-Cch
Q 042262 533 FGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNRLLVYEFLNN-GTL 607 (814)
Q Consensus 533 fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~-gsL 607 (814)
-.+.||+.... +|..+++|+++............-++.++++.|.|+|++..++.. ....+|||+|.++ ++|
T Consensus 289 ~~Ttyk~~s~~---DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNV---DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeecc---CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 35789998875 677899999843322222223344667788999999999998863 4567899999885 677
Q ss_pred hhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 608 ASFLFGN---------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 608 ~~~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
.+.-+.. .+.++...+.++.|+..||.++| +.|+..+-|.+++||++.+.+++|+..|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceee
Confidence 7765421 34577889999999999999999 45888899999999999999999999998877
Q ss_pred ccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcC
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS 724 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p 724 (814)
+..+.... +.+ -.+-|.=.||.+++.|.||...
T Consensus 443 l~~d~~~~----------------le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 443 LQEDPTEP----------------LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ecCCCCcc----------------hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 76544111 111 2357889999999999999764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.8e-08 Score=94.23 Aligned_cols=140 Identities=21% Similarity=0.299 Sum_probs=101.8
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEe-ecccccc-------chhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKK-LDRVFQD-------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~-l~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
+.|-+|+-+.|+++... ++..+||. ..+.... ..++.++|.+.+.+.+--.|.-..-++.+...-.|
T Consensus 13 ~likQGAEArv~~~~~~-----Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-----GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred eeeeccceeeEeeeccC-----CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE
Confidence 56789999999999885 44444543 2222111 23567888888888876666666667777777889
Q ss_pred hhhhccC-CchhhhhcCCC-CCCH-HHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC---CeEEeecCCcc
Q 042262 598 VYEFLNN-GTLASFLFGNL-KPSW-NLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---NARISDFGLAK 671 (814)
Q Consensus 598 V~e~~~~-gsL~~~l~~~~-~l~~-~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DfGla~ 671 (814)
+|||+++ .++.+++.... .... +....++..|-+.|.-|| ..+|||+||..+||+|..++ .+.++|||++.
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 9999976 47788876532 2222 233688999999999999 46999999999999997554 35899999986
Q ss_pred cc
Q 042262 672 LL 673 (814)
Q Consensus 672 ~~ 673 (814)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 53
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.8e-08 Score=113.19 Aligned_cols=153 Identities=20% Similarity=0.284 Sum_probs=107.9
Q ss_pred HHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc-------cccccccccCCCCccCccccc
Q 042262 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ-------SKAIKTAIRGTKGYVAPEWFR 698 (814)
Q Consensus 626 ~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~ 698 (814)
+.+++.||.|+|. +.++||+.|.|++|.++..+.+||+.|+.+....... .........-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3456699999997 6899999999999999999999999999875433211 011111123456899999999
Q ss_pred CCCCCCccchhhHHHHHHHHH-hCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHcc
Q 042262 699 NSTITAKVDVYSFGVLLLEII-SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCI 777 (814)
Q Consensus 699 ~~~~t~k~DV~S~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl 777 (814)
+...+.++|+||+|++++-+. .|+.-+..........+ ....+.........+.+.++.+=+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-------------~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-------------SRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-------------hhcccccccccccccCcHHHHHHHHHHh
Confidence 988899999999999999999 45555544332221111 1111111111223467788889899999
Q ss_pred ccCCCCCCCHHHHHHH
Q 042262 778 QEDPSLRPTMRKVSQM 793 (814)
Q Consensus 778 ~~dP~~RPtm~eV~~~ 793 (814)
..++.-||++.++...
T Consensus 250 ~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSI 265 (700)
T ss_pred cCCcccCcchhhhhcc
Confidence 9999999988877553
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.6e-07 Score=83.92 Aligned_cols=77 Identities=26% Similarity=0.438 Sum_probs=59.9
Q ss_pred EEEeecccEEEeCCC-CCeEeeeccCCC--ceeEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCceeeecC
Q 042262 102 VKLTADRGLVLNDPQ-GKQVWSSKIDIG--TVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRK 178 (814)
Q Consensus 102 l~~~~~g~l~l~~~~-~~~~wst~~~~~--~~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L~S~~ 178 (814)
+.++.||+||+++.. +.+||++++... ....+.|.++|||||++.++..+|+|= |-
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~-----t~---------------- 82 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSN-----TT---------------- 82 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEec-----cc----------------
Confidence 455689999999865 589999998643 225789999999999999888999871 10
Q ss_pred CCCCCCCCceEEEEecCCceeeeec
Q 042262 179 SDTNFSRGRFQFRLLEDGDLVLNVA 203 (814)
Q Consensus 179 s~~dps~G~~~~~~~~~g~~~~~~~ 203 (814)
...|.+.+.|+++|+++++..
T Consensus 83 ----~~~~~~~~~L~ddGnlvl~~~ 103 (114)
T smart00108 83 ----GANGNYVLVLLDDGNLVIYDS 103 (114)
T ss_pred ----CCCCceEEEEeCCCCEEEECC
Confidence 135678999999999988743
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.7e-07 Score=84.07 Aligned_cols=85 Identities=27% Similarity=0.441 Sum_probs=64.3
Q ss_pred EEee-cccEEEeCCC-CCeEeeeccCC--CceeEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCceeeecC
Q 042262 103 KLTA-DRGLVLNDPQ-GKQVWSSKIDI--GTVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRK 178 (814)
Q Consensus 103 ~~~~-~g~l~l~~~~-~~~~wst~~~~--~~~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L~S~~ 178 (814)
.++. ||+||+++.. +.+||++++.. .....+.|.++|||||++.++.++|||=-.
T Consensus 25 ~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~--------------------- 83 (116)
T cd00028 25 IMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTT--------------------- 83 (116)
T ss_pred CCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEeccc---------------------
Confidence 4455 8999999765 58999999864 244678999999999999988999986321
Q ss_pred CCCCCCCCceEEEEecCCceeeeeccCCcccccccceecc
Q 042262 179 SDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSG 218 (814)
Q Consensus 179 s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~ 218 (814)
.+.+.+.+.|+++|+++++-.+. ...|.+.
T Consensus 84 ----~~~~~~~~~L~ddGnlvl~~~~~------~~~W~Sf 113 (116)
T cd00028 84 ----RVNGNYVLVLLDDGNLVLYDSDG------NFLWQSF 113 (116)
T ss_pred ----CCCCceEEEEeCCCCEEEECCCC------CEEEcCC
Confidence 13567899999999999875432 3457654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.4e-07 Score=89.58 Aligned_cols=127 Identities=21% Similarity=0.194 Sum_probs=79.5
Q ss_pred EEEEEEEeccCCcceEEEEEeeccccccc--------------------------hhhhhceeeEEeecccc--ceeeee
Q 042262 535 IVYKGVIQTTRTSTTAVAVKKLDRVFQDG--------------------------EKEFKNEVVVIGQTHHK--NLVRLL 586 (814)
Q Consensus 535 ~Vykg~~~~~~~~~~~vaVK~l~~~~~~~--------------------------~~~~~~Ei~~l~~l~H~--niv~l~ 586 (814)
.||.|... ++..+|||..+.....- ....++|.+.|.++... ++.+++
T Consensus 1 ~Vy~~~~~----~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~ 76 (188)
T PF01163_consen 1 DVYHAIDP----DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPY 76 (188)
T ss_dssp EEEEEEEC----TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EE
T ss_pred CEEEEECC----CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEE
Confidence 37888875 56789999875321100 01245677778777654 456666
Q ss_pred eeeccCCceehhhhhcc--CCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEE
Q 042262 587 GFCDEGQNRLLVYEFLN--NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 664 (814)
Q Consensus 587 g~~~~~~~~~lV~e~~~--~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl 664 (814)
.+. ..+|||||++ +..+..+.... ++......++.++++.+..+++ ..+|+|+||.+.|||++++ .+.|
T Consensus 77 ~~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 77 DYN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp EEE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTSEEEETT-CEEE
T ss_pred EEe----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhhEEeecc-eEEE
Confidence 553 4589999998 65555443222 1134456778888886666432 5699999999999999988 9999
Q ss_pred eecCCccccc
Q 042262 665 SDFGLAKLLT 674 (814)
Q Consensus 665 ~DfGla~~~~ 674 (814)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.2e-07 Score=95.20 Aligned_cols=129 Identities=16% Similarity=0.096 Sum_probs=92.5
Q ss_pred EEEEEEeccCCcceEEEEEeeccccc-----------cchhhhhceeeEEeeccccce--eeeeeeecc-----CCceeh
Q 042262 536 VYKGVIQTTRTSTTAVAVKKLDRVFQ-----------DGEKEFKNEVVVIGQTHHKNL--VRLLGFCDE-----GQNRLL 597 (814)
Q Consensus 536 Vykg~~~~~~~~~~~vaVK~l~~~~~-----------~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~-----~~~~~l 597 (814)
|.++.+ .++.+.||+...... .....+.+|...+.++...+| ..++++.+. ....+|
T Consensus 38 vvr~~~-----~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 38 TLRFEL-----AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred EEEEEE-----CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 556655 356788897643211 011136788888888754443 444556543 235789
Q ss_pred hhhhccCC-chhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-------CCCeEEeec
Q 042262 598 VYEFLNNG-TLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-------YYNARISDF 667 (814)
Q Consensus 598 V~e~~~~g-sL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-------~~~~kl~Df 667 (814)
|+|++++- +|.+++.. ....+...+..++.++++.++-||+ .+|+|+|++++|||++. +..+.|+||
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 99999985 89888753 3345667788999999999999995 59999999999999975 467999999
Q ss_pred CCccc
Q 042262 668 GLAKL 672 (814)
Q Consensus 668 Gla~~ 672 (814)
+.++.
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1e-06 Score=99.89 Aligned_cols=145 Identities=21% Similarity=0.268 Sum_probs=93.7
Q ss_pred hhh-ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchh------------------------------------
Q 042262 523 NFE-EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK------------------------------------ 565 (814)
Q Consensus 523 ~~~-~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~------------------------------------ 565 (814)
+|+ +.|+.++-|.||+|+++ +|+.||||+.+....+..+
T Consensus 127 eF~~~PiAsASIaQVH~A~L~----sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l 202 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLK----SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL 202 (517)
T ss_pred HcCCCchhhhhHhhheeEEec----CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence 455 46999999999999998 4889999998754321110
Q ss_pred ----hhhceeeEEeecc-----ccceeeeeeeec-cCCceehhhhhccCCchhhhhc-CCCCCCHHHHHHHHHHHHHHHH
Q 042262 566 ----EFKNEVVVIGQTH-----HKNLVRLLGFCD-EGQNRLLVYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLL 634 (814)
Q Consensus 566 ----~~~~Ei~~l~~l~-----H~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~ 634 (814)
++..|...+.+++ .++ +++=.++. -.+..+|+|||+.|-.+.+... .....+ +..|+..++++.
T Consensus 203 ~~ElDy~~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f- 277 (517)
T COG0661 203 REELDYRREAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAF- 277 (517)
T ss_pred HHHhCHHHHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHH-
Confidence 1233333333331 222 22223333 3567899999999999988842 223344 333333333331
Q ss_pred HhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 635 yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
+.+-...+++|.|.+|.||+++.++.+.+.|||+...+....
T Consensus 278 -~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~ 319 (517)
T COG0661 278 -LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKF 319 (517)
T ss_pred -HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCHHH
Confidence 111112399999999999999999999999999998876543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.8e-06 Score=87.30 Aligned_cols=106 Identities=21% Similarity=0.213 Sum_probs=83.7
Q ss_pred hhhhceeeEEeeccc--cceeeeeeeeccCC----ceehhhhhccC-CchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 042262 565 KEFKNEVVVIGQTHH--KNLVRLLGFCDEGQ----NRLLVYEFLNN-GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637 (814)
Q Consensus 565 ~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~----~~~lV~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH 637 (814)
....+|...+.++.. -...+++++.+... ..+||+|++++ .+|.+++.....++...+..++.++++.++-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 356777777777643 34556666665432 45899999987 489999877555777788999999999999999
Q ss_pred hcCCCCeeecCCCCCcEEECCCC---CeEEeecCCcccc
Q 042262 638 EDCSAQIIHCDIKPQNILLDDYY---NARISDFGLAKLL 673 (814)
Q Consensus 638 ~~~~~~iiH~Dikp~NIll~~~~---~~kl~DfGla~~~ 673 (814)
+ .+|+|+|++++|||++.+. .+.++||+-++..
T Consensus 136 ~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 D---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred H---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 5 5999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.8e-06 Score=69.19 Aligned_cols=67 Identities=22% Similarity=0.388 Sum_probs=50.7
Q ss_pred eeEEccCCCCCCCcccccCCCChhhHHHHhcc-CCCcccceeC--Cccceeee-ccCCCCCCCCcccccee
Q 042262 366 DFHELKDTDWPSSDYEHFSPYDEVQCKNTCLS-DCFCAVAIFG--IESCWLVK-LPLNNGRADSSVNRKAF 432 (814)
Q Consensus 366 ~f~~l~~~~~~~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~--~~~C~~~~-~~l~~~~~~~~~~~~~y 432 (814)
.|++++++.+++.........++++|++.|++ +|+|.++.|. ++.|++|. .++.+.+.........|
T Consensus 5 ~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~~~~~~~~~~y 75 (78)
T smart00473 5 CFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDARLFPSGGVDLY 75 (78)
T ss_pred eeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccceecccCCceeE
Confidence 59999999998654433467899999999999 9999999996 68999999 66666553333333333
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.04 E-value=4e-05 Score=69.27 Aligned_cols=100 Identities=28% Similarity=0.452 Sum_probs=67.2
Q ss_pred ceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEeecccEEEeCCCCCeEeee
Q 042262 44 PWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSS 123 (814)
Q Consensus 44 ~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~~g~l~l~~~~~~~~wst 123 (814)
++.+.+|.+.|-|...| -|-|.- ...+++|..+... ......+.+.|..||||||+|..+.++|+|
T Consensus 13 p~~~~s~~~~L~l~~dG---------nLvl~~---~~~~~iWss~~t~--~~~~~~~~~~L~~~GNlvl~d~~~~~lW~S 78 (114)
T PF01453_consen 13 PLTSSSGNYTLILQSDG---------NLVLYD---SNGSVIWSSNNTS--GRGNSGCYLVLQDDGNLVLYDSSGNVLWQS 78 (114)
T ss_dssp EEEECETTEEEEEETTS---------EEEEEE---TTTEEEEE--S-T--TSS-SSEEEEEETTSEEEEEETTSEEEEES
T ss_pred ccccccccccceECCCC---------eEEEEc---CCCCEEEEecccC--CccccCeEEEEeCCCCEEEEeecceEEEee
Confidence 35555588999998765 466643 2357799883321 111157889999999999999999999999
Q ss_pred ccCCCceeEEEEcc--CcCEEEEecCCccccccccccc
Q 042262 124 KIDIGTVAIGVMND--TGNFVLASSSSSKLWDSFTNPS 159 (814)
Q Consensus 124 ~~~~~~~~~~~l~~--~GNlvl~~~~~~~~WQSFD~Pt 159 (814)
. ...+.+.+..++ .||++ +.....+.|.|=+.|+
T Consensus 79 f-~~ptdt~L~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 79 F-DYPTDTLLPGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp T-TSSS-EEEEEET--TSEEE-EESTSSEEEESS----
T ss_pred c-CCCccEEEeccCcccCCCc-cccceEEeECCCCCCC
Confidence 4 334556677777 88988 7666778898876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=6.3e-06 Score=83.71 Aligned_cols=136 Identities=16% Similarity=0.162 Sum_probs=90.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc----------------------chhhhhceeeEEeeccc
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD----------------------GEKEFKNEVVVIGQTHH 579 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~----------------------~~~~~~~Ei~~l~~l~H 579 (814)
+.+.++||.|.-+.||.|..+ .+..+|||.=+..... .....++|.+.|.++.-
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred HhhccccccCccceEEEEECC----CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 456688999999999999987 4678999865321100 01124556666666643
Q ss_pred c--ceeeeeeeeccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC
Q 042262 580 K--NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 657 (814)
Q Consensus 580 ~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~ 657 (814)
. .+.+.+++ +...+||||+++-.|...-- +.+....|+..|++-+..+- ..+|||+|+.+=||+++
T Consensus 169 ~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~ 236 (304)
T COG0478 169 EGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVT 236 (304)
T ss_pred cCCCCCCcccc----ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEe
Confidence 3 45555544 45589999999977766532 22223334444444433333 25899999999999999
Q ss_pred CCCCeEEeecCCcccc
Q 042262 658 DYYNARISDFGLAKLL 673 (814)
Q Consensus 658 ~~~~~kl~DfGla~~~ 673 (814)
+++.+.++||-.+...
T Consensus 237 ~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 237 EDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCCEEEEeCcccccC
Confidence 9999999999766543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.1e-05 Score=80.30 Aligned_cols=136 Identities=17% Similarity=0.122 Sum_probs=100.8
Q ss_pred ccccceeEEEEEEEeccCCcceEEEEEeecccc------ccchhhhhceeeEEeecccc--ceeeeeeeeccC-----Cc
Q 042262 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF------QDGEKEFKNEVVVIGQTHHK--NLVRLLGFCDEG-----QN 594 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~------~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~~-----~~ 594 (814)
-|+||.+-|++..+. +..+-+|+-.... .-+...|.+|...|.++... .+.+++ ++... -.
T Consensus 26 ~~rgG~SgV~r~~~~-----g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r 99 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR 99 (216)
T ss_pred cCCCCcceEEEEEeC-----CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence 367999999998774 3468888876321 22456799999999998543 344444 43221 23
Q ss_pred eehhhhhccC-CchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC--eEEeecCC
Q 042262 595 RLLVYEFLNN-GTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN--ARISDFGL 669 (814)
Q Consensus 595 ~~lV~e~~~~-gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DfGl 669 (814)
.+||.|-+.+ .+|.+++... .+.+...+..++.++++.|+-||+ .++.|+|+.+.||+++.++. ++++||.-
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 5788886653 6888887553 356778889999999999999995 69999999999999986666 99999976
Q ss_pred ccc
Q 042262 670 AKL 672 (814)
Q Consensus 670 a~~ 672 (814)
.+.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.94 E-value=6.9e-05 Score=79.93 Aligned_cols=173 Identities=15% Similarity=0.180 Sum_probs=115.0
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCCccCc
Q 042262 615 LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694 (814)
Q Consensus 615 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 694 (814)
...+|...++.++.+|.+.+-||+ .+.+-+|++++|+|++++..+.|.|-..-..-..+ ......+|...|.+|
T Consensus 112 P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng---~~~~cpVg~~eftPP 185 (637)
T COG4248 112 PHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANG---TLHLCPVGVSEFTPP 185 (637)
T ss_pred CccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeeccCC---ceEecccCccccCCH
Confidence 346899999999999999999996 48889999999999999999999885443322111 112335688899999
Q ss_pred cccc-----CCCCCCccchhhHHHHHHHHHhC-CcCCcccCC--cchhhHHHHHHHHHhcCCccccccCcc-----ccc-
Q 042262 695 EWFR-----NSTITAKVDVYSFGVLLLEIISC-RKSFDIEMG--EEYAILTDWAFDCYRNGKLDDLVEGDT-----EAM- 760 (814)
Q Consensus 695 E~~~-----~~~~t~k~DV~S~Gvvl~elltG-~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~l~~~~~-----~~~- 760 (814)
|.-. +..-+...|-|.+||++++|+.| +.||..... .....+. ..+..|.+..--+... ...
T Consensus 186 ElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E----~~Ia~g~f~ya~~~~~g~~p~P~~~ 261 (637)
T COG4248 186 ELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE----TDIAHGRFAYASDQRRGLKPPPRSI 261 (637)
T ss_pred HHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----hhhhcceeeechhccCCCCCCCCCC
Confidence 9764 34567789999999999999987 899875321 1111110 0111122211111110 111
Q ss_pred CChhHHHHHHHHHHHccccC--CCCCCCHHHHHHHHcCC
Q 042262 761 NDIKCTEKLVMVSIWCIQED--PSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 761 ~~~~~~~~l~~l~~~Cl~~d--P~~RPtm~eV~~~L~~~ 797 (814)
.-.-.+..+..+..+|.... +.-|||++..+..|..+
T Consensus 262 P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 262 PLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred ChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 11233467777888888644 56899999998887543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.9e-05 Score=74.80 Aligned_cols=101 Identities=25% Similarity=0.394 Sum_probs=81.0
Q ss_pred ceeeEEeeccc-cceeeeeeeeccCCceehhhhhccCCchhhh---hcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 042262 569 NEVVVIGQTHH-KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF---LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQI 644 (814)
Q Consensus 569 ~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 644 (814)
.|.-++..+++ +++.+++|+|-+ ++|.||...+++... +..-...+|..|.+||.++++.+.+|++.....+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 35556666765 599999999944 778999987766532 1122346899999999999999999998655678
Q ss_pred eecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 645 IHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 645 iH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
.-.|++++|+-+++++++|+.|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 88999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=3.3e-05 Score=87.38 Aligned_cols=145 Identities=20% Similarity=0.254 Sum_probs=92.2
Q ss_pred hhh-ccccccceeEEEEEEEeccCCcceEEEEEeeccccccc-------------------------------------h
Q 042262 523 NFE-EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG-------------------------------------E 564 (814)
Q Consensus 523 ~~~-~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~-------------------------------------~ 564 (814)
.|+ +.||.-..|.||+|+++ +++.||||+.+...++. +
T Consensus 163 ~f~~~piaaASlaQVhrA~L~----~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E 238 (538)
T KOG1235|consen 163 EFDEEPIAAASLAQVHRARLK----NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE 238 (538)
T ss_pred hcCcchhhhcchhheEEEEec----CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence 454 46999999999999998 47889999987543321 0
Q ss_pred hhhhceeeEEeec----cccce---eeeeeeecc-CCceehhhhhccCCchhhhhc-CCCCCCHHHHHHHHHHHHHHHHH
Q 042262 565 KEFKNEVVVIGQT----HHKNL---VRLLGFCDE-GQNRLLVYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLY 635 (814)
Q Consensus 565 ~~~~~Ei~~l~~l----~H~ni---v~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~y 635 (814)
-+|..|.+-..++ .|-++ |.+=.++.+ ...++|+||||+|..+.+.-. ....++.. .|+..+.++ |
T Consensus 239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~---~i~~~l~~~--~ 313 (538)
T KOG1235|consen 239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPH---DILNKLVEA--Y 313 (538)
T ss_pred cchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHH---HHHHHHHHH--H
Confidence 1233444433333 34441 112223322 357899999999988887643 12233333 333333333 2
Q ss_pred hhhcCCCCeeecCCCCCcEEECC----CCCeEEeecCCccccccc
Q 042262 636 LHEDCSAQIIHCDIKPQNILLDD----YYNARISDFGLAKLLTLN 676 (814)
Q Consensus 636 LH~~~~~~iiH~Dikp~NIll~~----~~~~kl~DfGla~~~~~~ 676 (814)
+++-...|++|+|-+|.||++.. +.++.+-|||+...+...
T Consensus 314 ~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 314 LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 22222348999999999999983 678999999998876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.65 E-value=7.6e-05 Score=75.24 Aligned_cols=138 Identities=19% Similarity=0.194 Sum_probs=87.1
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEeeccccccch---------hhhh---------------ceeeEEeecc--cc
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE---------KEFK---------------NEVVVIGQTH--HK 580 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~---------~~~~---------------~Ei~~l~~l~--H~ 580 (814)
.|..|.-+.||+|.-. ++..+|||+.+....... ..|+ .|..-|.++. +-
T Consensus 55 ~istGKEA~Vy~a~~~----~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 55 CISTGKEANVYLAETG----DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eecCCcceEEEeeccC----CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 4778999999998863 577899999875432221 1121 2222222221 22
Q ss_pred ceeeeeeeeccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC
Q 042262 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY 660 (814)
Q Consensus 581 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~ 660 (814)
.+.+.+++. +-.|||||+....+..=.-....+.......+..++++.+.-|-. ..++||+||..=|||+. ++
T Consensus 131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CC
Confidence 233333332 347999998764222111111222333566777788888887774 36999999999999999 88
Q ss_pred CeEEeecCCcccccc
Q 042262 661 NARISDFGLAKLLTL 675 (814)
Q Consensus 661 ~~kl~DfGla~~~~~ 675 (814)
.+.|+|++.+.....
T Consensus 204 ~p~iID~~QaV~~~h 218 (268)
T COG1718 204 EPYIIDVSQAVTIDH 218 (268)
T ss_pred eEEEEECccccccCC
Confidence 999999999876553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00018 Score=73.70 Aligned_cols=137 Identities=15% Similarity=0.203 Sum_probs=82.5
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccc--eeeeeeeeccCCceehhhhhcc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFCDEGQNRLLVYEFLN 603 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~ 603 (814)
+.||+|.-+.||+.. +...++|...... ......+|.++++.+..-. +.+.++++...+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~~-------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEec-------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 468999999999831 2246677765422 3345788888888886444 4667778777777788999998
Q ss_pred CCc-hhhhh---------------------cCC--CCCCHHHHH-HHHH----------HHHH-HHHHhhh-cCCCCeee
Q 042262 604 NGT-LASFL---------------------FGN--LKPSWNLRT-NIAF----------QIAR-GLLYLHE-DCSAQIIH 646 (814)
Q Consensus 604 ~gs-L~~~l---------------------~~~--~~l~~~~~~-~i~~----------~ia~-gL~yLH~-~~~~~iiH 646 (814)
|.. +...+ +.- .......+. ++.. .+.+ ...+|.. .....++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 21111 110 000111100 0000 0111 1112211 11345789
Q ss_pred cCCCCCcEEECCCCCeEEeecCCccc
Q 042262 647 CDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 647 ~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
+|+.|.||++++++ +.|.||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999988 99999987754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00012 Score=73.13 Aligned_cols=130 Identities=16% Similarity=0.114 Sum_probs=79.2
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhh---------ceeeEEeeccc---cceeeeeeee----
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK---------NEVVVIGQTHH---KNLVRLLGFC---- 589 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~---------~Ei~~l~~l~H---~niv~l~g~~---- 589 (814)
+.+-......|.+... ++...++|..+......++.|+ +++..+.+++. ..+..++.+.
T Consensus 37 kv~k~~~r~~ValIei-----~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~ 111 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEI-----DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKI 111 (229)
T ss_pred EeecCCCccEEEEEEE-----CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeee
Confidence 4455555556665554 3567888877654333333222 22222222221 1222222222
Q ss_pred -ccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecC
Q 042262 590 -DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 668 (814)
Q Consensus 590 -~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfG 668 (814)
.-....+|||||++|..|.+... ++. .++..+.++|.-||+ .++.|+|++|+|+++++++ +++.||+
T Consensus 112 ~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 112 FRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred ccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-EEEEECc
Confidence 22234578999999988876532 221 355667788999995 5999999999999999654 9999998
Q ss_pred Cccc
Q 042262 669 LAKL 672 (814)
Q Consensus 669 la~~ 672 (814)
..+.
T Consensus 180 ~k~~ 183 (229)
T PF06176_consen 180 GKRM 183 (229)
T ss_pred cccc
Confidence 7654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.45 E-value=2.2e-05 Score=87.81 Aligned_cols=181 Identities=17% Similarity=0.149 Sum_probs=128.7
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccc-eeeeeeeeccCCceehhhhhccC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN-LVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
..++++++++++|.+... .+...++.+... ....-++++|.+.+||| .+..++-+..+....+++++...
T Consensus 248 h~fvK~altknpKkRpta----eklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTA----EKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred HHHHHHHhcCCCccCCCh----hhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 346788999999877542 223335544322 34555777888999999 66667777777788899999987
Q ss_pred C--chhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccccc
Q 042262 605 G--TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682 (814)
Q Consensus 605 g--sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (814)
+ +..........+...+...+...-+++++|||. ..=+|+| ||+..+ ...|..||+....+.... ..
T Consensus 319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~ 387 (829)
T KOG0576|consen 319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP 387 (829)
T ss_pred CccccccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence 7 222222222334455556677778899999994 3347888 777666 688999999988776543 13
Q ss_pred ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCc
Q 042262 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 726 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~ 726 (814)
....++..++|||......+..+-|+|+.|+--.++--|-.|-.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 45668999999999999999999999999986666666666543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00026 Score=73.62 Aligned_cols=137 Identities=13% Similarity=0.052 Sum_probs=81.3
Q ss_pred ccccce-eEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-ccceeeeeeeeccCCceehhhhhccCC
Q 042262 528 VGRGSF-GIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNG 605 (814)
Q Consensus 528 LG~G~f-G~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~g 605 (814)
|-.|.. ..||+.... +..+.||+..... ..++.+|++++..+. +--+.+++++...++..++|||++++.
T Consensus 6 ~~~g~~~~~v~~~~~~-----~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK-----NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC-----CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 334444 788988643 2467778765432 345677888877773 344567777777666789999999998
Q ss_pred chhhhh-------------------cCCC----CCC--HHHHHHH-HH-------------------HHHHHHHHhhh--
Q 042262 606 TLASFL-------------------FGNL----KPS--WNLRTNI-AF-------------------QIARGLLYLHE-- 638 (814)
Q Consensus 606 sL~~~l-------------------~~~~----~l~--~~~~~~i-~~-------------------~ia~gL~yLH~-- 638 (814)
+|.... +.-. ... ...+..- .. .+.+.+..|-.
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 776432 1100 000 0000000 00 01111111211
Q ss_pred --cCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 639 --DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 639 --~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
.....++|+|+.|.|||++++....|+||+.+..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 0135689999999999999987788999987753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00018 Score=73.93 Aligned_cols=140 Identities=21% Similarity=0.196 Sum_probs=81.3
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccc--eeeeeeeecc---CCceehhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFCDE---GQNRLLVYE 600 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~---~~~~~lV~e 600 (814)
+.|+.|..+.||+.... + ..+++|..... .....+..|..++..+.... +.+++.++.. ....+++|+
T Consensus 3 ~~l~~G~~n~~~~v~~~----~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTD----D-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEESSSSEEEEEEET----T-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred ccCCCCCeeeEEEEEEC----C-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 46888999999999875 2 47899987554 34567778888888875433 4566664422 234688999
Q ss_pred hccCCchhh----------------hh---cCC----CCCCHHH---------HHHH------------HHHHHH-HHHH
Q 042262 601 FLNNGTLAS----------------FL---FGN----LKPSWNL---------RTNI------------AFQIAR-GLLY 635 (814)
Q Consensus 601 ~~~~gsL~~----------------~l---~~~----~~l~~~~---------~~~i------------~~~ia~-gL~y 635 (814)
++++..+.. .+ +.. ..+.+.. .... ...+.+ .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 999888777 11 111 0111100 0000 111222 3333
Q ss_pred hhh----cCCCCeeecCCCCCcEEEC-CCCCeEEeecCCccc
Q 042262 636 LHE----DCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKL 672 (814)
Q Consensus 636 LH~----~~~~~iiH~Dikp~NIll~-~~~~~kl~DfGla~~ 672 (814)
+++ .....++|+|+.|+|||++ +++.+.|.||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 332 1356799999999999999 566667999987754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00026 Score=58.43 Aligned_cols=50 Identities=20% Similarity=0.440 Sum_probs=39.6
Q ss_pred eEEccCCCCCCCcccccCCCChhhHHHHhccCCCcccceeC--Cccceeeec
Q 042262 367 FHELKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCAVAIFG--IESCWLVKL 416 (814)
Q Consensus 367 f~~l~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~ 416 (814)
|..+++++++..++......+.++|+..|+.||+|.|+.|. .+.|+++..
T Consensus 6 ~~~~~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 6 FRQGSNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred ccccCCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 44446777777766555567899999999999999999984 578998865
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00085 Score=82.24 Aligned_cols=81 Identities=12% Similarity=0.237 Sum_probs=55.7
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeecc-ccce--eeeeeeeccC---Cceehh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTH-HKNL--VRLLGFCDEG---QNRLLV 598 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 598 (814)
+.++.|....+|+....... ....+++|+..... ......+.+|.++++.+. |.++ .+++.+|.+. +..++|
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~-~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGG-SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEeCCCCcCceEEEEECCCC-cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45788999999998764321 11356667654321 123356889999999985 6665 7888888764 467899
Q ss_pred hhhccCCch
Q 042262 599 YEFLNNGTL 607 (814)
Q Consensus 599 ~e~~~~gsL 607 (814)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0009 Score=80.22 Aligned_cols=196 Identities=20% Similarity=0.153 Sum_probs=136.0
Q ss_pred hhceeeEEeeccccceeeeeeeeccCCcee----hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 042262 567 FKNEVVVIGQTHHKNLVRLLGFCDEGQNRL----LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642 (814)
Q Consensus 567 ~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 642 (814)
...|++.+..+.|+|++.++.|..+....- +.-|+++.-++...+..-...+....+.+..++.+||+|+|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 455677778889999999999986654332 3457888889988888888888999999999999999999964
Q ss_pred CeeecCCCCC---cEEECCCCCeEEe--ecCCcccccccccccccccccCCCCccCcccccCCCCCC--ccchhhHHHHH
Q 042262 643 QIIHCDIKPQ---NILLDDYYNARIS--DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITA--KVDVYSFGVLL 715 (814)
Q Consensus 643 ~iiH~Dikp~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--k~DV~S~Gvvl 715 (814)
...|.-+..+ +...+.++...++ ||+..+.+....... ...-...+.|||.......+. ..|+|.+|..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 3333333333 4444556667776 898887765433221 122345677888877665544 47999999999
Q ss_pred HHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042262 716 LEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQML 794 (814)
Q Consensus 716 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L 794 (814)
..+..|..+-..... +..+++. .....+.+....|+..++++|++..+++...
T Consensus 383 ~~~~~~~~i~~~~~~------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAV------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCcccccccc------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 999988765432110 0001110 1111566778889999999999999998864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0029 Score=67.80 Aligned_cols=75 Identities=8% Similarity=0.032 Sum_probs=52.4
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccc---cceeeeeeeecc---CCceehhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH---KNLVRLLGFCDE---GQNRLLVY 599 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~---~~~~~lV~ 599 (814)
+.||.|..+.||+.... ++ .+.+|..+.. .....+..|.+.++.+.- ..+.+++++|.. .+..+|||
T Consensus 20 ~~i~~G~~~~vy~~~~~----~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 20 ECISEQPYAALWALYDS----QG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred eecCCccceeEEEEEcC----CC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 46999999999998653 22 3555664321 123478888888887742 357788887754 36689999
Q ss_pred hhccCCch
Q 042262 600 EFLNNGTL 607 (814)
Q Consensus 600 e~~~~gsL 607 (814)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0016 Score=67.29 Aligned_cols=32 Identities=28% Similarity=0.453 Sum_probs=26.5
Q ss_pred CCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 641 ~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
...++|+|+.+.||+++++...-|.||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 34589999999999998776567999997754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0031 Score=60.42 Aligned_cols=128 Identities=18% Similarity=0.322 Sum_probs=86.6
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceee-eeeeeccCCceehhhhhc
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR-LLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~~~~~~lV~e~~ 602 (814)
..+.|++|.+|.||+|.+. +..+|+|+-+.. .....++.|.+++..++-.++.. ++.|..+ ++.|||.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-----~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i 94 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-----GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI 94 (201)
T ss_pred hhhhhhcccccEEEEeecc-----CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence 3467999999999999985 557899987653 34567888888888887655533 4444333 4569999
Q ss_pred cCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC-CCcEEECCCCCeEEeecCCccc
Q 042262 603 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIK-PQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 603 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik-p~NIll~~~~~~kl~DfGla~~ 672 (814)
.+-.|.+.-... + .+-...+++. +|.-+ ..+|-|+.|. |..++|..+..+-|+||.-|..
T Consensus 95 ~G~~L~~~~~~~---~----rk~l~~vlE~-a~~LD--~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG---D----RKHLLRVLEK-AYKLD--RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc---c----HHHHHHHHHH-HHHHH--HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887877654322 1 1222334444 44333 4688888885 5555666666999999998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.0041 Score=62.02 Aligned_cols=131 Identities=18% Similarity=0.202 Sum_probs=83.8
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc----------------ccchhhhhceeeEEeec------ccccee
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF----------------QDGEKEFKNEVVVIGQT------HHKNLV 583 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~----------------~~~~~~~~~Ei~~l~~l------~H~niv 583 (814)
..||+|+.-.||.-- ......||+..... ....++..+|+.-...+ .+..|.
T Consensus 7 ~~i~~G~~R~cy~HP------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred cccccCCCceEEECC------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence 468999999999533 23346677775543 11234455555444443 488899
Q ss_pred eeeeeeccCCceehhhhhccC------CchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC
Q 042262 584 RLLGFCDEGQNRLLVYEFLNN------GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 657 (814)
Q Consensus 584 ~l~g~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~ 657 (814)
+++|+.+++...-+|+|.+.+ -+|.+++.... ++. ...+.+.+ -..||- ..+|+.+|++|+||++.
T Consensus 81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~~~~L~~---f~~~l~---~~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-ELRQALDE---FKRYLL---DHHIVIRDLNPHNIVVQ 152 (199)
T ss_pred cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-HHHHHHHH---HHHHHH---HcCCeecCCCcccEEEE
Confidence 999999999999999998753 35666664443 443 33333333 334454 34799999999999996
Q ss_pred CC--C--CeEEee-cCCc
Q 042262 658 DY--Y--NARISD-FGLA 670 (814)
Q Consensus 658 ~~--~--~~kl~D-fGla 670 (814)
.. + .+.|+| ||-.
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 32 2 466776 4433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.0039 Score=61.70 Aligned_cols=125 Identities=26% Similarity=0.344 Sum_probs=84.5
Q ss_pred HHhhhhccccccce-eEEEEEEEeccCCcceEEEEEeeccccc---------------------cchhhhhceeeEEeec
Q 042262 520 ATDNFEEEVGRGSF-GIVYKGVIQTTRTSTTAVAVKKLDRVFQ---------------------DGEKEFKNEVVVIGQT 577 (814)
Q Consensus 520 ~~~~~~~~LG~G~f-G~Vykg~~~~~~~~~~~vaVK~l~~~~~---------------------~~~~~~~~Ei~~l~~l 577 (814)
+..+|.+.||.|.. |.|||+.+. +..+|+|..+.... ....-|..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-----g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRL 111 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-----GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRL 111 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-----CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHH
Confidence 55677789999999 999999984 67899999322100 0112467777877777
Q ss_pred c---ccce--eeeeeeeccC-Cc-----------------eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 042262 578 H---HKNL--VRLLGFCDEG-QN-----------------RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 634 (814)
Q Consensus 578 ~---H~ni--v~l~g~~~~~-~~-----------------~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~ 634 (814)
+ +.++ |+.+||..-. ++ +.||.||++... ....+-+.+|.+-|.
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~~~~~~~dl~ 178 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRDIPQMLRDLK 178 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhHHHHHHHHHH
Confidence 4 4456 8888887221 11 123444443322 223344567778888
Q ss_pred HhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 635 yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
.+| ..+|+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 899 569999999999986 6689999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.0038 Score=66.98 Aligned_cols=139 Identities=16% Similarity=0.151 Sum_probs=81.6
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccc--eeeeeeee------ccCCceeh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFC------DEGQNRLL 597 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~------~~~~~~~l 597 (814)
+.|..|.-..+|+.... +..+++|+... ....++..|++++..+++.+ +.+++... ..++..++
T Consensus 20 ~~i~~G~~n~~y~v~~~-----~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 20 EGISAGIENTNYFVTTD-----SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred ecccCccccceEEEEeC-----CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 34667777889987653 23578887654 23345666777777775433 44444321 22345678
Q ss_pred hhhhccCCchhhh----h----------cC---C--------CCCCHHHHH----------HHHHHHHHHHHHhhh----
Q 042262 598 VYEFLNNGTLASF----L----------FG---N--------LKPSWNLRT----------NIAFQIARGLLYLHE---- 638 (814)
Q Consensus 598 V~e~~~~gsL~~~----l----------~~---~--------~~l~~~~~~----------~i~~~ia~gL~yLH~---- 638 (814)
|+++++|..+... . +. . ....|.... .....+.+.+.++..
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9999988765430 0 10 0 001222111 011123344444443
Q ss_pred cCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 639 ~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
.....++|+|+.|.||+++++..+.|.||+.+..
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 1235799999999999999987788999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.0084 Score=61.87 Aligned_cols=32 Identities=19% Similarity=0.337 Sum_probs=27.5
Q ss_pred CCCeeecCCCCCcEEECC-CCCeEEeecCCccc
Q 042262 641 SAQIIHCDIKPQNILLDD-YYNARISDFGLAKL 672 (814)
Q Consensus 641 ~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~ 672 (814)
...++|+|+.+.|||+++ +..+.|.||..+..
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 357999999999999998 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.0092 Score=62.52 Aligned_cols=135 Identities=13% Similarity=0.099 Sum_probs=74.4
Q ss_pred ccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccce-eeeeeeeccCCceehhhhhccCCc
Q 042262 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLNNGT 606 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gs 606 (814)
+..|-...+|+... .+..+++|..........-+..+|.++++.+....+ .+++..+. ..+||||+++..
T Consensus 4 ~~~G~tn~~y~~~~-----~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-----PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEEe-----CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 45566778898763 345677887543322211235677777777754333 33444432 368999999876
Q ss_pred hhhh-----------------hcCC----CCCCHHHH-HHHHHH---------HHHHHHHhhhc-----CCCCeeecCCC
Q 042262 607 LASF-----------------LFGN----LKPSWNLR-TNIAFQ---------IARGLLYLHED-----CSAQIIHCDIK 650 (814)
Q Consensus 607 L~~~-----------------l~~~----~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~iiH~Dik 650 (814)
+... |+.. ..++...+ .....+ +.+.+..+... ....++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 6431 1111 11121111 111111 11112222111 13468999999
Q ss_pred CCcEEECCCCCeEEeecCCccc
Q 042262 651 PQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 651 p~NIll~~~~~~kl~DfGla~~ 672 (814)
|.||++++++ +.|.||..+..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 9999999876 78999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.02 Score=63.49 Aligned_cols=75 Identities=15% Similarity=0.158 Sum_probs=49.1
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc-------ccchhhhhceeeEEeecc---ccceeeeeeeeccCCce
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-------QDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-------~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~ 595 (814)
+.||.|.+..||++.... ..+.++||.-.... ......+..|.+.|..+. -..+.+++.+.. +..
T Consensus 32 ~elggGn~N~VyrV~~~~---g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~ 106 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTE---GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELA 106 (401)
T ss_pred eEcCCCceEEEEEEEeCC---CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCC
Confidence 468999999999999852 12479999854211 112344566666666652 245677777643 557
Q ss_pred ehhhhhccCC
Q 042262 596 LLVYEFLNNG 605 (814)
Q Consensus 596 ~lV~e~~~~g 605 (814)
++||||+++.
T Consensus 107 ~lVME~L~~~ 116 (401)
T PRK09550 107 VTVMEDLSDH 116 (401)
T ss_pred EEEEecCCCc
Confidence 8999998763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.027 Score=60.58 Aligned_cols=140 Identities=23% Similarity=0.284 Sum_probs=78.1
Q ss_pred ccccceeEEEEEEEecc---CCcceEEEEEeeccccccchhhhhceeeEEeeccccce-eeeeeeeccCCceehhhhhcc
Q 042262 528 VGRGSFGIVYKGVIQTT---RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLN 603 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~---~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~ 603 (814)
|..|---.+|+...... +..+..+++|+..... ....+...|.+++..+....+ .++++++.. .+|+||++
T Consensus 6 l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~ 80 (302)
T cd05156 6 ISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP 80 (302)
T ss_pred ecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence 44455557888765421 1124578888865432 223455677777777643333 345555532 35899998
Q ss_pred CCchhhh-----------------hcCC--C-------CCC--HHHHHH--------------------------HHHHH
Q 042262 604 NGTLASF-----------------LFGN--L-------KPS--WNLRTN--------------------------IAFQI 629 (814)
Q Consensus 604 ~gsL~~~-----------------l~~~--~-------~l~--~~~~~~--------------------------i~~~i 629 (814)
|..+... ++.. . ..+ +..... +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 8766431 0110 0 000 111000 11222
Q ss_pred HHHHHHhhh------cCCCCeeecCCCCCcEEECCC----CCeEEeecCCccc
Q 042262 630 ARGLLYLHE------DCSAQIIHCDIKPQNILLDDY----YNARISDFGLAKL 672 (814)
Q Consensus 630 a~gL~yLH~------~~~~~iiH~Dikp~NIll~~~----~~~kl~DfGla~~ 672 (814)
.+-+..|.. .....++|+|+.+.|||++++ +.++++||..+..
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 233334432 235678999999999999985 8899999988754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.36 E-value=0.058 Score=57.11 Aligned_cols=31 Identities=29% Similarity=0.547 Sum_probs=25.8
Q ss_pred CCeeecCCCCCcEEECCCCC-eEEeecCCccc
Q 042262 642 AQIIHCDIKPQNILLDDYYN-ARISDFGLAKL 672 (814)
Q Consensus 642 ~~iiH~Dikp~NIll~~~~~-~kl~DfGla~~ 672 (814)
..++|+|+++.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998765
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.00 E-value=0.095 Score=57.43 Aligned_cols=140 Identities=20% Similarity=0.195 Sum_probs=76.0
Q ss_pred ccccceeEEEEEEEeccC-CcceEEEEEeeccccccchhhhhceeeEEeecccccee-eeeeeeccCCceehhhhhccCC
Q 042262 528 VGRGSFGIVYKGVIQTTR-TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFLNNG 605 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~~-~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~g 605 (814)
|-.|---.+|+....... ..+..+++|+....... .-+-.+|..++..+...++. ++++++..+ .|+||+++.
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 333555678887654321 12357888877554322 22236677777777544443 455555433 478888776
Q ss_pred chhhh-----------------hcCCC----C-CC-HHHHHHHHH-----------------HHHHHHHHhhh-----cC
Q 042262 606 TLASF-----------------LFGNL----K-PS-WNLRTNIAF-----------------QIARGLLYLHE-----DC 640 (814)
Q Consensus 606 sL~~~-----------------l~~~~----~-l~-~~~~~~i~~-----------------~ia~gL~yLH~-----~~ 640 (814)
+|... +|... . .. +.....+.. .+...+..|.. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 65421 11111 0 11 222212211 11112222211 12
Q ss_pred CCCeeecCCCCCcEEECC-CCCeEEeecCCccc
Q 042262 641 SAQIIHCDIKPQNILLDD-YYNARISDFGLAKL 672 (814)
Q Consensus 641 ~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~ 672 (814)
...++|+|+++.|||+++ +..+.|+||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 457899999999999986 46899999988764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=93.99 E-value=0.022 Score=70.38 Aligned_cols=156 Identities=12% Similarity=-0.041 Sum_probs=107.0
Q ss_pred hceeeEEeeccccceeeeeeee--ccCCceehhhhhccCCchhhhhcCC----CCCCHHHHHHHHHHHHHHHHHhhhc--
Q 042262 568 KNEVVVIGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHED-- 639 (814)
Q Consensus 568 ~~Ei~~l~~l~H~niv~l~g~~--~~~~~~~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~-- 639 (814)
..|...++...|+++.....-. .+..+-+.+++|+..|.+.+.|-.+ ..++..-......+......-.|..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 3444455556788877655444 2345678999999999999988543 1222222222222223333443432
Q ss_pred CCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHH
Q 042262 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 719 (814)
Q Consensus 640 ~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ell 719 (814)
...-.+|+++|+-|.+|+.+.++|+.++|+.+...+.... .....+++-|++|+....-.++.++|+|..|.-++++.
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2345789999999999999999999999999954433221 23345677788898887778898999999999999998
Q ss_pred hCCcCC
Q 042262 720 SCRKSF 725 (814)
Q Consensus 720 tG~~p~ 725 (814)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887776
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.039 Score=57.94 Aligned_cols=132 Identities=13% Similarity=0.093 Sum_probs=80.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--ccc--------------------chhhhhceeeEEeeccc
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQD--------------------GEKEFKNEVVVIGQTHH 579 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~--------------------~~~~~~~Ei~~l~~l~H 579 (814)
+.+.+.||-|.-+.||.+... .+...++|.-+.. +.. ..-....|...|+.+..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~----~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE----EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE 169 (465)
T ss_pred hhhccccccccccceEEEecC----CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence 456688999999999999886 4566666643210 000 00112344444544432
Q ss_pred --cceeeeeeeeccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC
Q 042262 580 --KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 657 (814)
Q Consensus 580 --~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~ 657 (814)
--+.+.+++ +..++|||++.+-.|...-+-. +..... ..+..-|.-|. ..++||+|..-=||+++
T Consensus 170 ~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~---d~~~ly---~~lm~~Iv~la---~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 170 RGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE---DPPTLY---DDLMGLIVRLA---NHGLIHGDFNEFNIMVK 236 (465)
T ss_pred cCCCCCCcccc----cceeeHHHhhcccceeeeeecC---ChHHHH---HHHHHHHHHHH---HcCceecccchheeEEe
Confidence 113333333 4568999999888876654222 222222 22223333344 34999999999999999
Q ss_pred CCCCeEEeecCCc
Q 042262 658 DYYNARISDFGLA 670 (814)
Q Consensus 658 ~~~~~kl~DfGla 670 (814)
++..++++||-..
T Consensus 237 dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 DDDKIVVIDFPQM 249 (465)
T ss_pred cCCCEEEeechHh
Confidence 9999999999644
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.09 E-value=0.056 Score=58.47 Aligned_cols=60 Identities=20% Similarity=0.248 Sum_probs=42.2
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 657 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~ 657 (814)
.+|+-+|+.+-++..++..... ++..+.+++.-.+.+|.-+-. -.+.+|.|++|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~~-pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKSQ-PEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcccC-hHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence 3566678888888888765443 345666677666666655443 34899999999999995
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.02 E-value=0.09 Score=55.80 Aligned_cols=72 Identities=19% Similarity=0.297 Sum_probs=45.3
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc---ccceeeeeeeeccCCceehhhhhc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
+.++.|....+|+... ++..+-||.-. ......|..|.+-|+.|. -..+.+++++....+..+||+||+
T Consensus 23 ~~v~GG~i~~a~~~~~-----~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 23 EPVSGGDINEAYRLDT-----DGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp EEE--SSSSEEEEEET-----TS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred EecCCCChhheEEEEC-----CCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3578888889988762 46678888865 233456788888887773 455778888887777889999998
Q ss_pred cCC
Q 042262 603 NNG 605 (814)
Q Consensus 603 ~~g 605 (814)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=92.22 E-value=0.27 Score=53.52 Aligned_cols=140 Identities=19% Similarity=0.269 Sum_probs=74.5
Q ss_pred ccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecccccee-eeeeeeccCCceehhhhhccCCc
Q 042262 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFLNNGT 606 (814)
Q Consensus 528 LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~gs 606 (814)
|..|---.+|+............+++|+...... ..-+-.+|..+++.+...++. ++++++..+ +|.+|+++..
T Consensus 22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~~ 96 (330)
T PLN02421 22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINART 96 (330)
T ss_pred eCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCCC
Confidence 3335555678876543211233688887654322 122335677777777655553 455555322 4788887665
Q ss_pred hhhh-----------------hcCCC-----CC-CHHHHHHHHHH----------------------HHHHHHHhhh---
Q 042262 607 LASF-----------------LFGNL-----KP-SWNLRTNIAFQ----------------------IARGLLYLHE--- 638 (814)
Q Consensus 607 L~~~-----------------l~~~~-----~l-~~~~~~~i~~~----------------------ia~gL~yLH~--- 638 (814)
|..- +|... .. -|....++..+ +.+-+..+..
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 5321 11111 01 12222222111 1111222211
Q ss_pred --cCCCCeeecCCCCCcEEECC-CCCeEEeecCCccc
Q 042262 639 --DCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKL 672 (814)
Q Consensus 639 --~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~ 672 (814)
....-+.|+|+.+.|||+++ ++.++++||..+..
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11234799999999999975 57899999988764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=92.17 E-value=0.42 Score=52.98 Aligned_cols=72 Identities=17% Similarity=0.230 Sum_probs=45.1
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccc-------cchhhhhceeeEEeecc---ccceeeeeeeeccCCce
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-------DGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-------~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~ 595 (814)
+.||-|..-.||+.... +..++||+-..... ....+-..|.+.|+.+. ...+.+++.++.+ ..
T Consensus 38 ~eiggGn~N~VyrV~~~-----~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~ 110 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-----SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MA 110 (418)
T ss_pred EEcCCCceeeEEEEEcC-----CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CC
Confidence 46899999999997753 23588888752111 12222233344444432 2478888888874 45
Q ss_pred ehhhhhccC
Q 042262 596 LLVYEFLNN 604 (814)
Q Consensus 596 ~lV~e~~~~ 604 (814)
+++||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 778999866
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.30 E-value=0.37 Score=51.65 Aligned_cols=34 Identities=26% Similarity=0.427 Sum_probs=30.2
Q ss_pred CCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 642 ~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
..++|+|+++.||+++.+...-|.||+++..-.+
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 4699999999999999998899999999976544
|
|
| >smart00223 APPLE APPLE domain | Back alignment and domain information |
|---|
Probab=91.19 E-value=0.23 Score=41.50 Aligned_cols=47 Identities=23% Similarity=0.386 Sum_probs=38.9
Q ss_pred ccCCCCCCCcccccCCCChhhHHHHhccCCCcccceeC--Cc---cceeeec
Q 042262 370 LKDTDWPSSDYEHFSPYDEVQCKNTCLSDCFCAVAIFG--IE---SCWLVKL 416 (814)
Q Consensus 370 l~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~--~~---~C~~~~~ 416 (814)
.++++|++.++......+.++|++.|..+=.|.++.|. +. .|+++..
T Consensus 6 ~~~~df~G~Dl~~~~~~~~~~Cq~~Ct~~~~C~~FTf~~~~~~~~~C~LK~s 57 (79)
T smart00223 6 YKNVDFRGSDINTVYVPSAQVCQKRCTSHPRCLFFTFSTNEPPEEKCLLKDS 57 (79)
T ss_pred ccCccccCceeeeeecCCHHHHHHhhcCCCCccEEEeeCCCCCCCEeEeCcC
Confidence 36788888888888888999999999999999999994 33 6777643
|
Four-fold repeat in plasma kallikrein and coagulation factor XI. Factor XI apple 3 mediates binding to platelets. Factor XI apple 1 binds high-molecular-mass kininogen. Apple 4 in factor XI mediates dimer formation and binds to factor XIIa. Mutations in apple 4 cause factor XI deficiency, an inherited bleeding disorder. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=89.74 E-value=1.4 Score=48.00 Aligned_cols=32 Identities=16% Similarity=0.316 Sum_probs=26.0
Q ss_pred CCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 641 ~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
...++|||+.+.||+++++ .+++.|+..+..-
T Consensus 191 ~~~llHGDl~~gNi~~~~~-~~~~iD~e~~~~G 222 (370)
T TIGR01767 191 AETLLHGDLHSGSIFVSEH-ETKVIDPEFAFYG 222 (370)
T ss_pred cceeeeccCCcccEEEcCC-CCEEEcCcccccC
Confidence 4578999999999999776 4789998766543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.36 E-value=0.12 Score=57.68 Aligned_cols=161 Identities=23% Similarity=0.298 Sum_probs=85.4
Q ss_pred hhhceeeEEeeccccceeeeeeeeccCCc-eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 042262 566 EFKNEVVVIGQTHHKNLVRLLGFCDEGQN-RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQI 644 (814)
Q Consensus 566 ~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 644 (814)
++.-....++.+.|+|+...+.+...... ..+|+|++ +-||++.+..+. +-. .... -| ++
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~------~s~~------~~-----~~ 88 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKD------ESLL------AH-----GV 88 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cch------hhhc------cc-----cc
Confidence 34444556677889999999998866544 55678887 668888775443 111 1111 12 22
Q ss_pred eecCCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcC
Q 042262 645 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS 724 (814)
Q Consensus 645 iH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p 724 (814)
.|- || .+++| -+ .+ .| | .+..+|+||||+|.++.|+.-|...
T Consensus 89 ~~~-----~~-------~~~td-~~------------~t------~~--~-----~~~~pKsdVwsl~~i~~el~L~~~l 130 (725)
T KOG1093|consen 89 LHL-----NI-------IYITD-HF------------LT------KY--P-----SPIGPKSDVWSLGFIILELYLGISL 130 (725)
T ss_pred cee-----hh-------hhccc-cc------------cc------cC--C-----CCCCcchhhhhHHHHHHHHHHhhHH
Confidence 221 11 22223 00 00 00 1 1112499999999999999998876
Q ss_pred CcccCCcchhhHHHHHHHHHh-cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHH
Q 042262 725 FDIEMGEEYAILTDWAFDCYR-NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRK 789 (814)
Q Consensus 725 ~~~~~~~~~~~l~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~e 789 (814)
+..-...+... ....... .+....+.. +.....++....+++...|+-..|..||...+
T Consensus 131 ~~~~~~s~~l~---~i~k~~~~d~~~~~~a~---e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 131 EAELTESEYLE---ILLKYYTDDQELLSTAM---EHLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred HHHHHHHHHHH---HHHHhccCchhHHHHHH---HHHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 54221111110 0000000 011111110 01223466678888899999999998886544
|
|
| >PF14295 PAN_4: PAN domain; PDB: 2YIL_E 2YIP_C 2YIO_A | Back alignment and domain information |
|---|
Probab=88.69 E-value=0.26 Score=37.03 Aligned_cols=35 Identities=23% Similarity=0.537 Sum_probs=17.0
Q ss_pred CCCCCcccc--cCCCChhhHHHHhccCCCcccceeCC
Q 042262 374 DWPSSDYEH--FSPYDEVQCKNTCLSDCFCAVAIFGI 408 (814)
Q Consensus 374 ~~~~~~~~~--~~~~s~~~C~~~Cl~nCsC~a~~~~~ 408 (814)
+++..++.. ....+.++|.+.|..+=.|.++.|..
T Consensus 2 d~~G~dl~~~~~~~~s~~~C~~~C~~~~~C~~~~~~~ 38 (51)
T PF14295_consen 2 DYPGGDLRSFPVTASSPEECQAACAADPGCQAFTFNP 38 (51)
T ss_dssp ----------------HHHHHHHHHTSTT--EEEEET
T ss_pred cccccccccccccCCCHHHHHHHccCCCCCCEEEEEC
Confidence 344444433 35678899999999999999988843
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 814 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-54 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-53 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-42 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-42 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-41 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-39 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-23 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-21 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-20 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-20 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-20 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-20 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-19 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-19 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-18 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-18 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-18 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-18 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-18 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-17 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-17 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-17 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-17 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-17 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-17 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-16 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 8e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 9e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 374 bits (963), Expect = e-124
Identities = 121/303 (39%), Positives = 177/303 (58%), Gaps = 14/303 (4%)
Query: 508 NLRCFSYKELEEATDNFEEE--VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR-VFQDGE 564
L+ FS +EL+ A+DNF + +GRG FG VYKG + T VAVK+L Q GE
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERTQGGE 71
Query: 565 KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS----WN 620
+F+ EV +I H+NL+RL GFC RLLVY ++ NG++AS L + W
Sbjct: 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 621 LRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680
R IA ARGL YLH+ C +IIH D+K NILLD+ + A + DFGLAKL+ +
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 190
Query: 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDI--EMGEEYAILTD 738
+ TA+RGT G++APE+ + K DV+ +GV+LLE+I+ +++FD+ ++ +L D
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 739 WAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798
W + KL+ LV+ D + + E+L+ V++ C Q P RP M +V +MLEG
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310
Query: 799 EVD 801
+
Sbjct: 311 LAE 313
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 346 bits (889), Expect = e-113
Identities = 103/309 (33%), Positives = 159/309 (51%), Gaps = 13/309 (4%)
Query: 499 NPGDATIETNLRCFSYKELEEATDNFEEE--VGRGSFGIVYKGVIQTTRTSTTAVAVKKL 556
+ +LEEAT+NF+ + +G G FG VYKGV++ VA+K+
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----DGAKVALKRR 71
Query: 557 DRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK 616
G +EF+ E+ + H +LV L+GFCDE +L+Y+++ NG L L+G+
Sbjct: 72 TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 617 P----SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672
P SW R I ARGL YLH IIH D+K NILLD+ + +I+DFG++K
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732
T + T ++GT GY+ PE+F +T K DVYSFGV+L E++ R + + E
Sbjct: 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 733 YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792
L +WA + + NG+L+ +V+ + + K ++ C+ RP+M V
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 793 MLEGVVEVD 801
LE + +
Sbjct: 309 KLEYALRLQ 317
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 343 bits (883), Expect = e-112
Identities = 110/310 (35%), Positives = 164/310 (52%), Gaps = 30/310 (9%)
Query: 506 ETNLRCFSYKELEEATDNFEEE--------VGRGSFGIVYKGVIQTTRTSTTAVAVKKLD 557
+T FS+ EL+ T+NF+E +G G FG+VYKG + + T VAVKKL
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLA 63
Query: 558 RVFQD----GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG 613
+ +++F E+ V+ + H+NLV LLGF +G + LVY ++ NG+L L
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 614 --NLKP-SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670
P SW++R IA A G+ +LHE+ IH DIK NILLD+ + A+ISDFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 730
+ + + I GT Y+APE R IT K D+YSFGV+LLEII+ + D
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 731 EEYAILTDWAFDCYRN-GKLDDLVEGDTEAMN-DIKCTEKLVMVSIWCIQEDPSLRPTMR 788
+ L D + ++D + D + + D E + V+ C+ E + RP ++
Sbjct: 240 PQL--LLDIKEEIEDEEKTIEDYI--DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 789 KVSQMLEGVV 798
KV Q+L+ +
Sbjct: 296 KVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 5e-73
Identities = 77/309 (24%), Positives = 125/309 (40%), Gaps = 33/309 (10%)
Query: 512 FSYKELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG-EKEFK 568
+ L + + E RG FG V+K + VAVK QD + +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-----VAVKIFPI--QDKQSWQNE 66
Query: 569 NEVVVIGQTHHKNLVRLLGFCDEGQN----RLLVYEFLNNGTLASFLFGNLKPSWNLRTN 624
EV + H+N+++ +G G + L+ F G+L+ FL N SWN +
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCH 125
Query: 625 IAFQIARGLLYLHEDCSAQ-------IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677
IA +ARGL YLHED I H DIK +N+LL + A I+DFGLA +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 678 SKAIKTAIRGTKGYVAPEWFRNS-----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732
S GT+ Y+APE + ++D+Y+ G++L E+ S + D + E
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 733 YAILTDWAFDCYRNGKLDDLV---EGDTEAMNDIKCTEKLVMVS---IWCIQEDPSLRPT 786
+ + ++V + + + + M+ C D R +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 787 MRKVSQMLE 795
V + +
Sbjct: 306 AGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-62
Identities = 74/302 (24%), Positives = 135/302 (44%), Gaps = 34/302 (11%)
Query: 514 YKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DRVFQDGEKEFKNEV 571
+ +L +E++G GSFG V++ + VAVK L + EF EV
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRAEWHGS-----DVAVKILMEQDFHAERVNEFLREV 85
Query: 572 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQ 628
++ + H N+V +G + N +V E+L+ G+L L + + R ++A+
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 629 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGT 688
+A+G+ YLH + I+H ++K N+L+D Y ++ DFGL++L + + GT
Sbjct: 146 VAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGT 202
Query: 689 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748
++APE R+ K DVYSFGV+L E+ + ++ + + K
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG-NLN-----PAQVVAAVGFKCK 256
Query: 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP-PNPS 807
++ ++ + C +P RP+ + +L +++ VP PN S
Sbjct: 257 RLEIPRN---------LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307
Query: 808 PF 809
Sbjct: 308 DL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 2e-60
Identities = 81/302 (26%), Positives = 138/302 (45%), Gaps = 42/302 (13%)
Query: 514 YKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 573
YKE+E EE VGRG+FG+V K + VA+K+++ + K F E+
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKA-----KWRAKDVAIKQIES--ESERKAFIVELRQ 54
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIA 630
+ + +H N+V+L G C LV E+ G+L + L G + + Q +
Sbjct: 55 LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
+G+ YLH +IH D+KP N+LL +I DFG A + + T +G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSA 167
Query: 690 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 749
++APE F S + K DV+S+G++L E+I+ RK FD G + I + + +
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MWAVHNGTRP 223
Query: 750 DDLVEGDTEAMNDI--KCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPS 807
+ + + + C +DPS RP+M ++ +++ ++ P
Sbjct: 224 ------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR-YFPGADE 270
Query: 808 PF 809
P
Sbjct: 271 PL 272
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-59
Identities = 82/347 (23%), Positives = 127/347 (36%), Gaps = 71/347 (20%)
Query: 512 FSYKELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN 569
+ E DN + E +GRG +G VYKG + VAVK + F N
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER-----PVAVKVFS---FANRQNFIN 54
Query: 570 EVVV--IGQTHHKNLVRLLGFCDEG-----QNRLLVYEFLNNGTLASFLFGNLKPSWNLR 622
E + + H N+ R + + LLV E+ NG+L +L + W
Sbjct: 55 EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSS 113
Query: 623 TNIAFQIARGLLYLHEDCSA------QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676
+A + RGL YLH + I H D+ +N+L+ + ISDFGL+ LT N
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 677 QSKAIK------TAIRGTKGYVAPEWFRNS-------TITAKVDVYSFGVLLLEIIS-CR 722
+ + GT Y+APE + + +VD+Y+ G++ EI C
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 723 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD--TEAMNDIKCTEKL----------- 769
F E EY + AF V E M + EK
Sbjct: 234 DLFPGESVPEYQM----AF--------QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN 281
Query: 770 -----VMVSI--WCIQEDPSLRPTMRKVSQMLEGVV-EVDVPPNPSP 808
+ C +D R T + + + ++ + + SP
Sbjct: 282 SLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-59
Identities = 80/294 (27%), Positives = 116/294 (39%), Gaps = 42/294 (14%)
Query: 514 YKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL----DRVFQDGEKEFKN 569
+ EL EE +G G FG VY+ VAVK D + +
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAFWIGD-----EVAVKAARHDPDEDISQTIENVRQ 55
Query: 570 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 629
E + H N++ L G C + N LV EF G L L G + ++ N A QI
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQI 114
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR--------ISDFGLAKLLTLNQSKAI 681
ARG+ YLH++ IIH D+K NIL+ I+DFGLA+ +
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTT 170
Query: 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 741
K + G ++APE R S + DV+S+GVLL E+++ F + + A+ A
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR-GI-DGLAVAYGVAM 228
Query: 742 DCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ C E + C DP RP+ + L
Sbjct: 229 NKLALPIPST-------------CPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 9e-59
Identities = 74/311 (23%), Positives = 128/311 (41%), Gaps = 38/311 (12%)
Query: 515 KELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI 574
+ + E +G+G FG K T R + + +K+L R ++ ++ F EV V+
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKV---THRETGEVMVMKELIRFDEETQRTFLKEVKVM 61
Query: 575 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGL 633
H N+++ +G + + + E++ GTL + W+ R + A IA G+
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS------------KAI 681
YLH S IIH D+ N L+ + N ++DFGLA+L+ ++ +
Sbjct: 122 AYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWA 740
+ + G ++APE + KVDV+SFG++L EII + D L
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238
Query: 741 FDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV--- 797
F + C +++ C DP RP+ K+ LE +
Sbjct: 239 F--LDRYCPPN-------------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
Query: 798 VEVDVPPNPSP 808
+ +P P
Sbjct: 284 LAGHLPLGPQL 294
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 9e-57
Identities = 72/278 (25%), Positives = 121/278 (43%), Gaps = 27/278 (9%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQTHHKN 581
+ +G GSFG VYKG VAVK L + FKNEV V+ +T H N
Sbjct: 28 VGQRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDC 640
++ +G+ +V ++ +L L K +IA Q ARG+ YLH
Sbjct: 82 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS 700
+ IIH D+K NI L + +I DFGLA + + G+ ++APE R
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 701 TI---TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757
+ + DVY+FG++L E+++ + + + I+ R DL + +
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQII--EMVG--RGSLSPDLSKVRS 252
Query: 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
C +++ + C+++ RP+ ++ +E
Sbjct: 253 N------CPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 4e-56
Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 514 YKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DRVFQDGEKEFKNEV 571
+++LE E +G+G FG VY G VA++ + +R +D K FK EV
Sbjct: 32 FEQLE-----IGELIGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREV 80
Query: 572 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIA 630
+ QT H+N+V +G C + ++ TL S + + N IA +I
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK---TAIRG 687
+G+ YLH + I+H D+K +N+ D+ I+DFGL + + Q+ + G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 688 TKGYVAPEWFRNSTI---------TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 738
++APE R + + DV++ G + E+ + F E I
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAII--- 252
Query: 739 WAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ K + ++ I +++ + ++C + RPT K+ MLE
Sbjct: 253 --WQMGTGMKPN---------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 5e-56
Identities = 73/297 (24%), Positives = 128/297 (43%), Gaps = 44/297 (14%)
Query: 514 YKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-------KE 566
E+E +E+++G+G FG+V+KG + ++ VA+K L +GE +E
Sbjct: 18 DNEIE-----YEKQIGKGGFGLVHKGRLVKDKSV---VAIKSLILGDSEGETEMIEKFQE 69
Query: 567 FKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNI 625
F+ EV ++ +H N+V+L G +V EF+ G L L P W+++ +
Sbjct: 70 FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRL 127
Query: 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-----YNARISDFGLAKLLTLNQSKA 680
IA G+ Y+ + + I+H D++ NI L A+++DFGL++ +
Sbjct: 128 MLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---- 182
Query: 681 IKTAIRGTKGYVAPEWF--RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 738
+ + G ++APE + T K D YSF ++L I++ FD + +
Sbjct: 183 -VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241
Query: 739 WAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ R +D C +L V C DP RP + + L
Sbjct: 242 IREEGLRPTIPED-------------CPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 3e-54
Identities = 59/291 (20%), Positives = 108/291 (37%), Gaps = 42/291 (14%)
Query: 514 YKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DRVFQDGEKEFKNEV 571
+K+L F ++ G ++KG Q + VK L ++F E
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRWQGN-----DIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 572 VVIGQTHHKNLVRLLGFCDE--GQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAF 627
+ H N++ +LG C + L+ ++ G+L + L N + A
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 628 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRG 687
+ARG+ +LH I + +++++D+ ARIS +
Sbjct: 119 DMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMY 170
Query: 688 TKGYVAPEWFRNS---TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 744
+VAPE + T D++SF VLL E+++ F ++ I A +
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-DL-SNMEIGMKVALEGL 228
Query: 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
R + G + + + C+ EDP+ RP + +LE
Sbjct: 229 R----PTIPPG---------ISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 1e-49
Identities = 73/310 (23%), Positives = 119/310 (38%), Gaps = 61/310 (19%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV--IGQTHHKN 581
E VG+G +G V++G Q VAVK +D EK + E + H+N
Sbjct: 12 LLECVGKGRYGEVWRGSWQGE-----NVAVKIFSS--RD-EKSWFRETELYNTVMLRHEN 63
Query: 582 LVRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637
++ + ++ L+ + G+L +L I IA GL +LH
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLH 122
Query: 638 EDCSAQ-----IIHCDIKPQNILLDDYYNARISDFGLAKLL--TLNQSKAIKTAIRGTKG 690
+ I H D+K +NIL+ I+D GLA + + NQ GTK
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 691 YVAPEWFRNSTITA------KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 744
Y+APE + +VD+++FG++L E+ S I E+Y F
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV--EDYKP----PF--- 233
Query: 745 RNGKLDDLVEGD--TEAMNDIKCTEKL---------------VMVSI--WCIQEDPSLRP 785
D+V D E M + C ++ + + C ++PS R
Sbjct: 234 -----YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
Query: 786 TMRKVSQMLE 795
T ++ + L
Sbjct: 289 TALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-48
Identities = 71/310 (22%), Positives = 116/310 (37%), Gaps = 61/310 (19%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNE--VVVIGQTHHKN 581
+E +G+G FG V++G + VAVK E+ + E + H+N
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEE-----VAVKIFS---SREERSWFREAEIYQTVMLRHEN 97
Query: 582 LVRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637
++ + ++ LV ++ +G+L +L + +A A GL +LH
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLH 156
Query: 638 EDCSAQ-----IIHCDIKPQNILLDDYYNARISDFGLAKLL--TLNQSKAIKTAIRGTKG 690
+ I H D+K +NIL+ I+D GLA + GTK
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 691 YVAPEWFRNSTITA------KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 744
Y+APE +S + D+Y+ G++ EI I E+Y + Y
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH--EDYQL-------PY 267
Query: 745 RNGKLDDLVEGD--TEAMNDIKCTEKL---------------VMVSI--WCIQEDPSLRP 785
DLV D E M + C +KL VM I C + + R
Sbjct: 268 -----YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322
Query: 786 TMRKVSQMLE 795
T ++ + L
Sbjct: 323 TALRIKKTLS 332
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 9e-48
Identities = 70/308 (22%), Positives = 117/308 (37%), Gaps = 57/308 (18%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV--IGQTHHKN 581
+++G+G +G V+ G + + VAVK + E + E + H+N
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEK-----VAVKVFFT--TE-EASWFRETEIYQTVLMRHEN 92
Query: 582 LVRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637
++ + +G L+ ++ NG+L +L + +A+ GL +LH
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 638 EDCSAQ-----IIHCDIKPQNILLDDYYNARISDFGLAKLL--TLNQSKAIKTAIRGTKG 690
+ + I H D+K +NIL+ I+D GLA N+ GTK
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 691 YVAPE------WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 744
Y+ PE + D+YSFG++L E+ S I EEY + Y
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI--VEEYQL-------PY 262
Query: 745 RNGKLDDLVEGDTEAMNDIKCTEKL---------------VMVSI--WCIQEDPSLRPTM 787
+ D E M +I C +KL M + C +P+ R T
Sbjct: 263 HDLVPSDP---SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
Query: 788 RKVSQMLE 795
+V + L
Sbjct: 320 LRVKKTLA 327
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 77/296 (26%), Positives = 133/296 (44%), Gaps = 29/296 (9%)
Query: 515 KELEEATDNFEEEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDRVFQDGEKEFKNEVVV 573
EE + ++G+G+FG V +T VAVK+L D +++F+ E+ +
Sbjct: 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 574 IGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQI 629
+ H +V+ G Q+ LV E+L +G L FL + + + + QI
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQI 136
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA----- 684
+G+ YL S + +H D+ +NIL++ + +I+DFGLAKLL L++ +
Sbjct: 137 CKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 685 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 743
I APE ++ + + DV+SFGV+L E+ + C KS E+ + D
Sbjct: 194 IFWY----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC--SPSAEFLRMMGCERDV 247
Query: 744 YRNGKLDDLVEGDT--EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
+L +L+E A C ++ +M W P RP+ + L+
Sbjct: 248 PALSRLLELLEEGQRLPAPPA--CPAEVHELMKLCW--APSPQDRPSFSALGPQLD 299
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-41
Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 37/285 (12%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNL 582
E++GRG+FG V+ G + R T VAVK + + D + +F E ++ Q H N+
Sbjct: 118 LGEQIGRGNFGEVFSGRL---RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCS 641
VRL+G C + Q +V E + G +FL + + A G+ YL S
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---S 231
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA----IRGTKGYVAPEWF 697
IH D+ +N L+ + +ISDFG+++ A ++ T APE
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEAL 287
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD 756
+++ DV+SFG+LL E S G Y L+ N + + VE
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSL--------GASPYPNLS--------NQQTREFVEKG 331
Query: 757 TEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
C + + +M W +P RP+ + Q L+ + +
Sbjct: 332 GRLPCPELCPDAVFRLMEQCW--AYEPGQRPSFSTIYQELQSIRK 374
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 70/294 (23%), Positives = 133/294 (45%), Gaps = 26/294 (8%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVI 574
+ EE F +++G+G+FG V + +T VAVKKL ++ ++F+ E+ ++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 575 GQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIA 630
H N+V+ G C +N L+ E+L G+L +L + K + QI
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQIC 124
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA-----I 685
+G+ YL + + IH D+ +NIL+++ +I DFGL K+L ++ I
Sbjct: 125 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 745
APE S + DV+SFGV+L E+ + + E ++ +
Sbjct: 182 FWY----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 746 NGKLDDLVEGDT--EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
L +L++ + + C +++ +M W + + RP+ R ++ ++
Sbjct: 238 VFHLIELLKNNGRLPRPDG--CPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 70/294 (23%), Positives = 133/294 (45%), Gaps = 26/294 (8%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVI 574
+ EE F +++G+G+FG V + +T VAVKKL ++ ++F+ E+ ++
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 575 GQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIA 630
H N+V+ G C +N L+ E+L G+L +L + K + QI
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQIC 155
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA-----I 685
+G+ YL + + IH D+ +NIL+++ +I DFGL K+L ++ I
Sbjct: 156 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 212
Query: 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 745
APE S + DV+SFGV+L E+ + + E ++ +
Sbjct: 213 FWY----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 746 NGKLDDLVEGDT--EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
L +L++ + + C +++ +M W + + RP+ R ++ ++
Sbjct: 269 VFHLIELLKNNGRLPRPDG--CPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 318
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 37/281 (13%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKN 581
F+ E+GRGSF VYKG+ T T VA + ++ + + FK E ++ H N
Sbjct: 30 FDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86
Query: 582 LVRLLGFC---DEGQNRLLVY-EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637
+VR +G+ +++ E + +GTL ++L + + QI +GL +LH
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 638 EDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
+ IIH D+K NI + + +I D GLA L + +KA+ GT ++APE
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEM 201
Query: 697 FRNSTITAKVDVYSFGVLLLEIISCRKSF-DIE-MGEEYAILTDWAFDCYRNGKLDDLVE 754
+ VDVY+FG+ +LE+ + + + + + Y +T + D +
Sbjct: 202 YEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV----KPASFDKVA- 255
Query: 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
E I+ CI+++ R + + +L
Sbjct: 256 -IPEVKEIIE----------GCIRQNKDERYS---IKDLLN 282
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 42/306 (13%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTT-RTSTTAVAVKKL-DRVFQDGEKEFKNEVVV 573
E+ ++G G FG V + VAVK L + + K E+ +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 574 IGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQI 629
+ +H+N+V+ G C D G L+ EFL +G+L +L N K NL+ A QI
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQI 135
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA----- 684
+G+ YL S Q +H D+ +N+L++ + +I DFGL K + ++
Sbjct: 136 CKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192
Query: 685 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-------CRKSFDIEMGEEYAILT 737
+ APE S DV+SFGV L E+++ F +G + +T
Sbjct: 193 VFWY----APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248
Query: 738 DWAFDCYRNGKLDDLVEGDT--EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQM 793
+L + ++ + C +++ +M W + PS R + + + +
Sbjct: 249 --------VTRLVNTLKEGKRLPCPPN--CPDEVYQLMRKCW--EFQPSNRTSFQNLIEG 296
Query: 794 LEGVVE 799
E +++
Sbjct: 297 FEALLK 302
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-39
Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 35/279 (12%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
+ ++G G +G VY+GV + + VAVK L + +EF E V+ + H NLV
Sbjct: 224 MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 641
+LLG C ++ EF+ G L +L + + +A QI+ + YL
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---K 336
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIKTAIRGTKGYVAPEWFR 698
IH ++ +N L+ + + +++DFGL++L+T + K I+ T APE
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLA 392
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD-- 756
+ + K DV++FGVLL EI + S Y + ++ +L+E D
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMS-------PYPGID--------LSQVYELLEKDYR 437
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
E C EK+ + C Q +PS RP+ ++ Q E
Sbjct: 438 MERPEG--CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 76/293 (25%), Positives = 117/293 (39%), Gaps = 41/293 (13%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL---DRVFQDGEKEFKNEVVVIGQTHHK 580
E++G GSFG+V +G T +VAVK L + +F EV + H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 638
NL+RL G +V E G+L L + + + L T A Q+A G+ YL
Sbjct: 82 NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE- 138
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ-----SKAIKTAIRGTKGYVA 693
S + IH D+ +N+LL +I DFGL + L N + K A
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----A 192
Query: 694 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDL 752
PE + T + D + FGV L E+ + G+E + L ++
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTY--------GQEPWIGLN--------GSQILHK 236
Query: 753 VEGDTEAMND-IKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 802
++ + E + C + + VMV W P RPT + L D+
Sbjct: 237 IDKEGERLPRPEDCPQDIYNVMVQCW--AHKPEDRPTFVALRDFLLEAQPTDM 287
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-39
Identities = 68/285 (23%), Positives = 122/285 (42%), Gaps = 42/285 (14%)
Query: 524 FEEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKN 581
+ +G G+FG VYKG+ I VA+K+L + KE +E V+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 639
+ RLLG C L+ + + G L ++ + K + + N QIA+G+ YL +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED- 135
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----QSKAIKTAIRGTKGYVAPE 695
+++H D+ +N+L+ + +I+DFGLAKLL ++ K I+ A E
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189
Query: 696 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE 754
+ T + DV+S+GV + E+++ G + Y + ++ ++E
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT--------FGSKPYDGIP--------ASEISSILE 233
Query: 755 GDT--EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
CT + +M W D RP R++
Sbjct: 234 KGERLPQPPI--CTIDVYMIMRKCW--MIDADSRPKFRELIIEFS 274
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-39
Identities = 71/309 (22%), Positives = 116/309 (37%), Gaps = 34/309 (11%)
Query: 516 ELEEATDNFEEEVGRGSFGIVYKGVIQ-TTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVV 573
+ ++G G FG V T + VAVK L +K E+ +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 574 IGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 631
+ +H+++++ G C + LV E++ G+L +L + A QI
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICE 145
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA-----IR 686
G+ YLH + IH D+ +N+LLD+ +I DFGLAK + +
Sbjct: 146 GMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 687 GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 745
APE + DV+SFGV L E+++ C S I
Sbjct: 203 WY----APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA-----QG 253
Query: 746 NGKLDDLVEGDT-----EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798
+ L E + C ++ +M + W + + S RPT + +L+ V
Sbjct: 254 QMTVLRLTELLERGERLPRPDK--CPAEVYHLMKNCW--ETEASFRPTFENLIPILKTVH 309
Query: 799 EVDVPPNPS 807
E PS
Sbjct: 310 EKYQGQAPS 318
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 60/281 (21%), Positives = 112/281 (39%), Gaps = 30/281 (10%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQ 576
NF +++GRG F VY+ VA+KK+ K E+ ++ Q
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGV---PVALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARG 632
+H N+++ E +V E + G L+ + K + Q+
Sbjct: 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
L ++H +++H DIKP N+ + ++ D GL + + + A + + GT Y+
Sbjct: 149 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-HSLV-GTPYYM 203
Query: 693 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752
+PE + K D++S G LL E+ + + F + Y++ +
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-------------KI 250
Query: 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793
+ D + +E+L + CI DP RP + V +
Sbjct: 251 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 71/299 (23%), Positives = 128/299 (42%), Gaps = 41/299 (13%)
Query: 515 KELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 573
+F E +GRG FG VY G + AVK L+R+ GE +F E ++
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 574 IGQTHHKNLVRLLGFCDEGQN-RLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIA 630
+ H N++ LLG C + L+V ++ +G L +F+ + ++ Q+A
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVA 138
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL------TLNQSKAIKTA 684
+G+ YL S + +H D+ +N +LD+ + +++DFGLA+ + +++ K
Sbjct: 139 KGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195
Query: 685 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFD 742
++ A E + T K DV+SFGVLL E+++ G Y + +
Sbjct: 196 VKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTFDITV 243
Query: 743 CYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
G+ E C + L VM+ W +RP+ ++ + +
Sbjct: 244 YLLQGRRLLQPEY---------CPDPLYEVMLKCW--HPKAEMRPSFSELVSRISAIFS 291
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 74/292 (25%), Positives = 136/292 (46%), Gaps = 37/292 (12%)
Query: 515 KELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 573
+E+E + + E+ +G G G V G ++ VA+K L + + ++ +F +E +
Sbjct: 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIAR 631
+GQ H N++RL G G+ ++V E++ NG+L +FL + + + + +
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGA 162
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
G+ YL +H D+ +N+L+D ++SDFGL+++L + A T G K
Sbjct: 163 GMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT--TGGKIP 217
Query: 692 V---APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNG 747
+ APE T ++ DV+SFGV++ E+++ GE Y +T N
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAY--------GERPYWNMT--------NR 261
Query: 748 KLDDLVEGDT--EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ VE A C L +M+ W +D + RP ++ +L+
Sbjct: 262 DVISSVEEGYRLPAPMG--CPHALHQLMLDCW--HKDRAQRPRFSQIVSVLD 309
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-38
Identities = 69/300 (23%), Positives = 127/300 (42%), Gaps = 41/300 (13%)
Query: 514 YKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVV 572
+F E +GRG FG VY G + AVK L+R+ GE +F E +
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 573 VIGQTHHKNLVRLLGFCDEGQN-RLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQI 629
++ H N++ LLG C + L+V ++ +G L +F+ + ++ Q+
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQV 201
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA----- 684
A+G+ +L S + +H D+ +N +LD+ + +++DFGLA+ + + ++
Sbjct: 202 AKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258
Query: 685 -IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AF 741
++ A E + T K DV+SFGVLL E+++ G Y + +
Sbjct: 259 PVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTFDIT 306
Query: 742 DCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
G+ E C + L VM+ W +RP+ ++ + +
Sbjct: 307 VYLLQGRRLLQPEY---------CPDPLYEVMLKCW--HPKAEMRPSFSELVSRISAIFS 355
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-37
Identities = 74/282 (26%), Positives = 119/282 (42%), Gaps = 47/282 (16%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKN 581
+ +G+G FG V G + + VAVK + ++ + F E V+ Q H N
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNK-----VAVKCI----KNDATAQAFLAEASVMTQLRHSN 247
Query: 582 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 638
LV+LLG E + L +V E++ G+L +L + + + + YL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 306
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR 698
+H D+ +N+L+ + A++SDFGL K + Q K ++ T APE R
Sbjct: 307 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVKWT----APEALR 359
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD- 756
+ K DV+SFG+LL EI S G Y + + VE
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSF--------GRVPYPRIP--------LKDVVPRVEKGY 403
Query: 757 -TEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
+A + C + VM + W D + RPT ++ + LE
Sbjct: 404 KMDAPDG--CPPAVYDVMKNCW--HLDAATRPTFLQLREQLE 441
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 75/298 (25%), Positives = 131/298 (43%), Gaps = 42/298 (14%)
Query: 515 KELEEATDNFEEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVV 572
+ +E + +G G FG V+KGV I + V +K ++ + + ++
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML 67
Query: 573 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIA 630
IG H ++VRLLG C G + LV ++L G+L + + + + + N QIA
Sbjct: 68 AIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIA 125
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----QSKAIKTAIR 686
+G+ YL E ++H ++ +N+LL +++DFG+A LL + KT I+
Sbjct: 126 KGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 687 GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYR 745
A E T + DV+S+GV + E+++ G E YA L
Sbjct: 183 WM----ALESIHFGKYTHQSDVWSYGVTVWELMTF--------GAEPYAGLR-------- 222
Query: 746 NGKLDDLVEGDT--EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
++ DL+E CT + VMV W D ++RPT ++++ +
Sbjct: 223 LAEVPDLLEKGERLAQPQI--CTIDVYMVMVKCW--MIDENIRPTFKELANEFTRMAR 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 62/303 (20%), Positives = 119/303 (39%), Gaps = 57/303 (18%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDRVFQDGEKE-FKNEVVVIGQT 577
+FE + +GRG FG+V++ A+K++ ++ +E EV + +
Sbjct: 5 TDFEPIQCLGRGGFGVVFEA----KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 60
Query: 578 HHKNLVRLLG-FCDEG--------QNRLLVY---EFLNNGTLASFLF---GNLKPSWNLR 622
H +VR + ++ ++ +Y + L ++ + ++
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 623 TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA-- 680
+I QIA + +LH S ++H D+KP NI ++ DFGL + ++ +
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 681 --------IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732
T GTK Y++PE ++ + KVD++S G++L E++ F +M
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-- 232
Query: 733 YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792
R L D+ + K + VMV + P RP
Sbjct: 233 ------------RVRTLTDVRNLKFPPLFTQKYPCEYVMVQ-DMLSPSPMERPE---AIN 276
Query: 793 MLE 795
++E
Sbjct: 277 IIE 279
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-37
Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 37/279 (13%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
E ++G+G FG V+ G T T VA+K L E F E V+ + H+ LV
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLV 242
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 641
+L E + +V E+++ G+L FL G L ++A QIA G+ Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 298
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIKTAIRGTKGYVAPEWFR 698
+H D++ NIL+ + +++DFGLA+L+ N+ + K I+ T APE
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAAL 354
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD-- 756
T K DV+SFG+LL E+ + + Y + N ++ D VE
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMV--------NREVLDQVERGYR 399
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ C E L + C +++P RPT + LE
Sbjct: 400 MPCPPE--CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 47/282 (16%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKN 581
+ +G+G FG V G + + VAVK + ++ + F E V+ Q H N
Sbjct: 25 LLQTIGKGEFGDVMLGDYRGNK-----VAVKCI----KNDATAQAFLAEASVMTQLRHSN 75
Query: 582 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 638
LV+LLG E + L +V E++ G+L +L + + + + YL
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 134
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR 698
+H D+ +N+L+ + A++SDFGL K + Q K ++ T APE R
Sbjct: 135 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVKWT----APEALR 187
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDT 757
+ K DV+SFG+LL EI S G Y + + VE
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYS--------FGRVPYPRIP--------LKDVVPRVEKGY 231
Query: 758 --EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
+A + C + VM + W D ++RP+ ++ + LE
Sbjct: 232 KMDAPDG--CPPAVYEVMKNCW--HLDAAMRPSFLQLREQLE 269
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 67/311 (21%), Positives = 120/311 (38%), Gaps = 66/311 (21%)
Query: 524 FEEEVGRGSFGIVYKGVIQTT----RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 579
F E +G+G+F ++KGV + + T V +K LD+ ++ + F ++ + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYL 636
K+LV G C G +LV EF+ G+L ++L N + W L +A Q+A + +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAAMHFL 129
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNAR--------ISDFGLAKLLTLNQSKAIKTAIRGT 688
+IH ++ +NILL + + +SD G++ + + I
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL--QERIPWV 184
Query: 689 KGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRN 746
PE N D +SFG L EI S G++ + L
Sbjct: 185 ----PPECIENPKNLNLATDKWSFGTTLWEICS--------GGDKPLSALD--------- 223
Query: 747 GKLDDLVEGDTEAMNDIKCTEKL----------VMVSIWCIQEDPSLRPTMRKVSQMLEG 796
+ + +L ++ + +P RP+ R + + L
Sbjct: 224 ---------SQRKLQFYEDRHQLPAPKAAELANLINNCM--DYEPDHRPSFRAIIRDLNS 272
Query: 797 VVEVDVPPNPS 807
+ D+ P S
Sbjct: 273 LFTPDLVPRGS 283
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
+E+G G FG+V G + VAVK + E EF E + + H LV
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQ----YDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLV 66
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 641
+ G C + +V E+++NG L ++L + + + + G+ +L S
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLE---S 122
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIKTAIRGTKGYVAPEWFR 698
Q IH D+ +N L+D ++SDFG+ + + +Q S K ++ + APE F
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFH 178
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDT 757
++K DV++FG+L+ E+ S +G+ Y + T N ++ V
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS--------LGKMPYDLYT--------NSEVVLKVSQGH 222
Query: 758 --EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801
+ ++ + +M S W E P RPT +++ +E + E D
Sbjct: 223 RLYRPHL--ASDTIYQIMYSCW--HELPEKRPTFQQLLSSIEPLREKD 266
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-37
Identities = 78/279 (27%), Positives = 126/279 (45%), Gaps = 37/279 (13%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
E ++G+G FG V+ G T T VA+K L + + F E V+ + H+ LV
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGT----TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 641
+L E + +V E+++ G+L FL G L ++A QIA G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 381
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIKTAIRGTKGYVAPEWFR 698
+H D++ NIL+ + +++DFGLA+L+ N+ + K I+ T APE
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAAL 437
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD-- 756
T K DV+SFG+LL E+ + + Y + N ++ D VE
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMV--------NREVLDQVERGYR 482
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ C E L + C +++P RPT + LE
Sbjct: 483 MPCPPE--CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-37
Identities = 67/291 (23%), Positives = 114/291 (39%), Gaps = 56/291 (19%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNL 582
+G G FG VY+GV + VAVK D +++F +E V++ H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 640
V+L+G +E + ++ E G L +L N K S + T + QI + + YL
Sbjct: 76 VKLIGIIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE--- 130
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIKTAIRGTKGYVAPEWF 697
S +H DI +NIL+ ++ DFGL++ + + + I+ +PE
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESI 186
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD 756
T DV+ F V + EI+S G++ + L +
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS--------FGKQPFFWLE------------------N 220
Query: 757 TEAMNDI----------KCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ + + C L +M W DPS RP ++ L
Sbjct: 221 KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCW--DYDPSDRPRFTELVCSLS 269
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-37
Identities = 74/300 (24%), Positives = 136/300 (45%), Gaps = 53/300 (17%)
Query: 515 KELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 573
KEL+ + ++ VG G FG V G ++ +VA+K L + + ++ +F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIAR 631
+GQ H N++RL G + + ++V E++ NG+L SFL + + + + IA
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIAS 158
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
G+ YL +H D+ +NIL++ ++SDFGL ++L + A T RG K
Sbjct: 159 GMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT--RGGKIP 213
Query: 692 V---APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNG 747
+ +PE T+ DV+S+G++L E++S GE Y ++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPYWEMS---------- 255
Query: 748 KLDDLVEGDTEAMNDI----------KCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ + + + C L +M+ W Q+D + RP ++ +L+
Sbjct: 256 --------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCW--QKDRNNRPKFEQIVSILD 305
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 68/290 (23%), Positives = 130/290 (44%), Gaps = 41/290 (14%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNL 582
+ +G+G FG+VY G + A+K L R+ + + F E +++ +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 583 VRLLGFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 639
+ L+G + + ++ +G L F+ + + ++ + Q+ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA-- 141
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL------TLNQSKAIKTAIRGTKGYVA 693
+ +H D+ +N +LD+ + +++DFGLA+ + ++ Q + + ++ T A
Sbjct: 142 -EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----A 196
Query: 694 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCYRNGKLDD 751
E + T K DV+SFGVLL E+++ G Y + + G+
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT--------RGAPPYRHIDPFDLTHFLAQGRRLP 248
Query: 752 LVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
E C + L VM W + DP++RPT R + +E +V
Sbjct: 249 QPEY---------CPDSLYQVMQQCW--EADPAVRPTFRVLVGEVEQIVS 287
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 76/281 (27%), Positives = 121/281 (43%), Gaps = 37/281 (13%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNL 582
++E+G G+FG V KG Q + VAVK K + + E E V+ Q + +
Sbjct: 22 DKELGSGNFGTVKKGYYQM-KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
VR++G C E ++ +LV E G L +L N + Q++ G+ YL E +
Sbjct: 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-E--ES 136
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV---APEWFRN 699
+H D+ +N+LL + A+ISDFGL+K L +++ A K V APE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGKWPVKWYAPECINY 194
Query: 700 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDT- 757
++K DV+SFGVL+ E S G++ Y + ++ ++E
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSY--------GQKPYRGMK--------GSEVTAMLEKGER 238
Query: 758 -EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
C ++ +M W D RP V L
Sbjct: 239 MGCPAG--CPREMYDLMNLCW--TYDVENRPGFAAVELRLR 275
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 69/269 (25%), Positives = 114/269 (42%), Gaps = 36/269 (13%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 587
+G+G++GIVY G + + +A+K++ + E+ + HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQV---RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 588 FCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQI 644
E + E + G+L++ L +G LK + QI GL YLH++ QI
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 645 IHCDIKPQNILLDDYY-NARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI- 702
+H DIK N+L++ Y +ISDFG +K L GT Y+APE
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPRG 201
Query: 703 -TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD---LVEGDTE 758
D++S G ++E+ + + F E+GE A + ++ G + E +
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPF-YELGEPQAAM-------FKVGMFKVHPEIPESMSA 253
Query: 759 AMND-IKCTEKLVMVSIWCIQEDPSLRPT 786
I C + DP R
Sbjct: 254 EAKAFILK----------CFEPDPDKRAC 272
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 72/286 (25%), Positives = 125/286 (43%), Gaps = 43/286 (15%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
F +E+G G FG+V+ G VA+K + R E++F E V+ + H LV
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNK----DKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 641
+L G C E LV EF+ +G L+ +L + + T + + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYL---EE 122
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIKTAIRGTKGYVAPEWFR 698
A +IH D+ +N L+ + ++SDFG+ + + +Q S K ++ +PE F
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFS 178
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDT 757
S ++K DV+SFGVL+ E+ S G+ Y + N ++ + +
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS--------EGKIPYENRS--------NSEVVEDISTGF 222
Query: 758 --EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
+ + +M W +E P RP ++ + L + E
Sbjct: 223 RLYKPRL--ASTHVYQIMNHCW--RERPEDRPAFSRLLRQLAEIAE 264
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 69/285 (24%), Positives = 123/285 (43%), Gaps = 42/285 (14%)
Query: 524 FEEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKN 581
+ +G G+FG VYKG+ I VA+K+L + KE +E V+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 639
+ RLLG C L+ + + G L ++ + K + + N QIA+G+ YL +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED- 135
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----QSKAIKTAIRGTKGYVAPE 695
+++H D+ +N+L+ + +I+DFGLAKLL ++ K I+ A E
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189
Query: 696 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE 754
+ T + DV+S+GV + E+++ G + Y + ++ ++E
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT--------FGSKPYDGIP--------ASEISSILE 233
Query: 755 GDT--EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
CT + +MV W D RP R++
Sbjct: 234 KGERLPQPPI--CTIDVYMIMVKCW--MIDADSRPKFRELIIEFS 274
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-36
Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 43/282 (15%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
E+++G G FG V+ T VAVK + + + F E V+ H LV
Sbjct: 192 LEKKLGAGQFGEVWMATYNKH----TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 641
+L + + ++ EF+ G+L FL + L + + QIA G+ ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 302
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIKTAIRGTKGYVAPEWFR 698
IH D++ NIL+ +I+DFGLA+++ N+ + K I+ T APE
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAIN 358
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD- 756
+ T K DV+SFG+LL+EI++ G Y ++ N ++ +E
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTY--------GRIPYPGMS--------NPEVIRALERGY 402
Query: 757 -TEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ C E+L +M+ W + P RPT + +L+
Sbjct: 403 RMPRPEN--CPEELYNIMMRCW--KNRPEERPTFEYIQSVLD 440
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 69/283 (24%), Positives = 116/283 (40%), Gaps = 40/283 (14%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNL 582
+G G FG V++G+ + AVA+K D + +F E + + Q H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 640
V+L+G E ++ E G L SFL K S +L + A+Q++ L YL
Sbjct: 79 VKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE--- 133
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIKTAIRGTKGYVAPEWF 697
S + +H DI +N+L+ ++ DFGL++ + + + K I+ APE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 189
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD 756
T+ DV+ FGV + EI+ G + + + N + +E
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILM--------HGVKPFQGVK--------NNDVIGRIENG 233
Query: 757 T--EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ C L +M W DPS RP ++ L
Sbjct: 234 ERLPMPPN--CPPTLYSLMTKCW--AYDPSRRPRFTELKAQLS 272
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 70/288 (24%), Positives = 128/288 (44%), Gaps = 43/288 (14%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
F +E+G G FG+V G + VA+K + + E EF E V+ H+ LV
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQ----YDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 641
+L G C + + ++ E++ NG L ++L + + + + + + YL S
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---S 138
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIKTAIRGTKGYVAPEWFR 698
Q +H D+ +N L++D ++SDFGL++ + ++ S K +R + PE
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLM 194
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDT 757
S ++K D+++FGVL+ EI S G+ Y T N + + +
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSL--------GKMPYERFT--------NSETAEHIAQGL 238
Query: 758 --EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801
+ +EK+ +M S W E RPT + + + V++ +
Sbjct: 239 RLYRPHL--ASEKVYTIMYSCW--HEKADERPTFKILLSNILDVMDEE 282
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
+ ++G G +G VY+GV + + VAVK L + +EF E V+ + H NLV
Sbjct: 17 MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 641
+LLG C ++ EF+ G L +L + + +A QI+ + YL
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---K 129
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIKTAIRGTKGYVAPEWFR 698
IH D+ +N L+ + + +++DFGL++L+T + K I+ T APE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLA 185
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDT 757
+ + K DV++FGVLL EI + G Y + ++ +L+E D
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT--------YGMSPYPGID--------LSQVYELLEKDY 229
Query: 758 --EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
E C EK+ +M + W Q +PS RP+ ++ Q E
Sbjct: 230 RMERPEG--CPEKVYELMRACW--QWNPSDRPSFAEIHQAFE 267
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 67/312 (21%), Positives = 122/312 (39%), Gaps = 48/312 (15%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKN 581
+G+G FG V + ++ S VAVK K D + +EF E + + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 582 LVRLLGFCDEGQNR------LLVYEFLNNGTLASFLFGNLKPSWNLR------TNIAFQI 629
+ +L+G + + +++ F+ +G L +FL + I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----QSKAIKTAI 685
A G+ YL S IH D+ +N +L + ++DFGL++ + Q A K +
Sbjct: 147 ACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDC 743
+ A E ++ T DV++FGV + EI++ G+ YA + + ++
Sbjct: 204 KWL----ALESLADNLYTVHSDVWAFGVTMWEIMT--------RGQTPYAGIENAEIYNY 251
Query: 744 YRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801
G C E++ +M W DP RP+ + LE ++
Sbjct: 252 LIGGNRLKQPPE---------CMEEVYDLMYQCW--SADPKQRPSFTCLRMELENILGHL 300
Query: 802 VPPNPSPFSGYM 813
+ S Y+
Sbjct: 301 SVLSTSQDPLYI 312
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 36/286 (12%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQT 577
+++E +G GS+G K ++ + K+LD + +EV ++ +
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKI---LVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 578 HHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIAR 631
H N+VR D L +V E+ G LAS + K L + Q+
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 632 GLLYLHE--DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
L H D ++H D+KP N+ LD N ++ DFGLA++L + S A KT + GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFV-GTP 180
Query: 690 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 749
Y++PE + K D++S G LL E+ + F L R GK
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKEL----AGKIREGKF 233
Query: 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ ++ +N+I ++ + RP+ V ++LE
Sbjct: 234 RRIPYRYSDELNEI--------IT-RMLNLKDYHRPS---VEEILE 267
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 70/293 (23%), Positives = 134/293 (45%), Gaps = 38/293 (12%)
Query: 515 KELEEATDNFEEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVV 572
E+ + ++ +G G FG VYKG+ ++ VA+K L + + ++ +F E
Sbjct: 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 98
Query: 573 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIA 630
++GQ H N++RL G + + +++ E++ NG L FL +++ + IA
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIA 157
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690
G+ YL + +H D+ +NIL++ ++SDFGL+++L + T G K
Sbjct: 158 AGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT--SGGKI 212
Query: 691 YV---APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRN 746
+ APE T+ DV+SFG+++ E+++ GE Y L+ N
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT--------YGERPYWELS--------N 256
Query: 747 GKLDDLVEGDT--EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
++ + D C + +M+ W Q++ + RP + +L+
Sbjct: 257 HEVMKAINDGFRLPTPMD--CPSAIYQLMMQCW--QQERARRPKFADIVSILD 305
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 77/297 (25%), Positives = 128/297 (43%), Gaps = 47/297 (15%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKN 581
+ +G G FG V +G ++ ++ VAVK KLD Q +EF +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 582 LVRLLGFCDEGQNR-----LLVYEFLNNGTLASFL----FGNLKPSWNLRT--NIAFQIA 630
++RLLG C E ++ +++ F+ G L ++L L+T IA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----QSKAIKTAIR 686
G+ YL + +H D+ +N +L D ++DFGL+K + Q + K ++
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 687 GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCY 744
A E + T+K DV++FGV + EI + G Y + + +D
Sbjct: 215 WI----AIESLADRVYTSKSDVWAFGVTMWEIAT--------RGMTPYPGVQNHEMYDYL 262
Query: 745 RNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
+G E C ++L +M S W + DP RPT + LE ++E
Sbjct: 263 LHGHRLKQPED---------CLDELYEIMYSCW--RTDPLDRPTFSVLRLQLEKLLE 308
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 49/302 (16%)
Query: 524 FEEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHK 580
E+G+GSFG+VY+GV + T VA+K ++ E+ EF NE V+ + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT----------NIAFQIA 630
++VRLLG +GQ L++ E + G L S+L N +A +IA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN-----QSKAIKTAI 685
G+ YL+ + + +H D+ +N ++ + + +I DFG+ + + K +
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG-LLPV 204
Query: 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDC 743
R +PE ++ T DV+SFGV+L EI + + E+ Y L++
Sbjct: 205 RWM----SPESLKDGVFTTYSDVWSFGVVLWEIAT--------LAEQPYQGLSNEQVLRF 252
Query: 744 YRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801
G L D + C + L +M W Q +P +RP+ ++ ++ +E
Sbjct: 253 VMEGGLLDKPDN---------CPDMLFELMRMCW--QYNPKMRPSFLEIISSIKEEMEPG 301
Query: 802 VP 803
Sbjct: 302 FR 303
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 63/290 (21%), Positives = 117/290 (40%), Gaps = 56/290 (19%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 579
+F+ E +G G FG V+K R +K++ ++ + EV + + H
Sbjct: 11 MDFKEIELIGSGGFGQVFKA---KHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDH 63
Query: 580 KNLVRLLG-FCDEGQNRL---------------LVYEFLNNGTLASFL---FGNLKPSWN 620
N+V G + + + EF + GTL ++ G
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 621 LRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680
+ QI +G+ Y+H S ++I+ D+KP NI L D +I DFGL L +
Sbjct: 124 AL-ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---NDG 176
Query: 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 740
+T +GT Y++PE + +VD+Y+ G++L E++ + E + + L
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF-ETSKFFTDL---- 231
Query: 741 FDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
R+G + D+ D + ++ + + P RP ++
Sbjct: 232 ----RDGIISDIF--DKKEKTLLQ----------KLLSKKPEDRPNTSEI 265
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 69/302 (22%), Positives = 128/302 (42%), Gaps = 52/302 (17%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 581
+ E+G G+FG V+ VAVK L K+F+ E ++ H++
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----------------I 625
+V+ G C +G ++V+E++ +G L FL + + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA- 684
A QIA G++YL S +H D+ +N L+ +I DFG+++ + +
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 685 ---IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW- 739
IR PE T + DV+SFGV+L EI + G++ + L++
Sbjct: 196 MLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTY--------GKQPWFQLSNTE 243
Query: 740 AFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGV 797
+C G++ + C +++ VM+ W Q +P R ++++ ++L +
Sbjct: 244 VIECITQGRVLERPRV---------CPKEVYDVMLGCW--QREPQQRLNIKEIYKILHAL 292
Query: 798 VE 799
+
Sbjct: 293 GK 294
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 82/282 (29%), Positives = 127/282 (45%), Gaps = 43/282 (15%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
E +G G FG V+ G T VAVK L + F E ++ Q H+ LV
Sbjct: 17 LVERLGAGQFGEVWMGYYNGH----TKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 641
RL + + ++ E++ NG+L FL + ++A QIA G+ ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIKTAIRGTKGYVAPEWFR 698
IH D++ NIL+ D + +I+DFGLA+L+ N+ + K I+ T APE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAIN 183
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDT 757
T T K DV+SFG+LL EI++ G Y +T N ++ +E
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT--------HGRIPYPGMT--------NPEVIQNLERGY 227
Query: 758 --EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
++ C E+L +M W +E P RPT + +LE
Sbjct: 228 RMVRPDN--CPEELYQLMRLCW--KERPEDRPTFDYLRSVLE 265
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 75/282 (26%), Positives = 123/282 (43%), Gaps = 39/282 (13%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLV 583
+ E+G G+FG V +GV R VA+K L + +E E ++ Q + +V
Sbjct: 15 DIELGCGNFGSVRQGVY-RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDCS 641
RL+G C + + +LV E G L FL G + P N+ + Q++ G+ YL
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYL---EE 128
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV---APEWFR 698
+H D+ +N+LL + + A+ISDFGL+K L + S TA K + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECIN 186
Query: 699 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDT 757
+++ DV+S+GV + E +S G++ Y + ++ +E
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALS--------YGQKPYKKMK--------GPEVMAFIEQGK 230
Query: 758 --EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
E + C +L +M W RP V Q +
Sbjct: 231 RMECPPE--CPPELYALMSDCW--IYKWEDRPDFLTVEQRMR 268
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 70/307 (22%), Positives = 124/307 (40%), Gaps = 58/307 (18%)
Query: 524 FEEEVGRGSFGIVYKG----VIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-T 577
+ +G G FG V + + VAVK L + + + +E+ ++
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------------- 624
HKN++ LLG C + ++ E+ + G L +L P +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 625 ---IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----- 676
+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YA 734
+ + ++ APE + T + DV+SFGVL+ EI + +G
Sbjct: 262 TTNG-RLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPG 308
Query: 735 ILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQ 792
I + F + G D CT +L +M W PS RPT +++ +
Sbjct: 309 IPVEELFKLLKEGHRMDKPAN---------CTNELYMMMRDCW--HAVPSQRPTFKQLVE 357
Query: 793 MLEGVVE 799
L+ ++
Sbjct: 358 DLDRILT 364
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-35
Identities = 69/281 (24%), Positives = 111/281 (39%), Gaps = 39/281 (13%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKN 581
++ +G G+ G + + R VAVK++ EV ++ + H N
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDNR----DVAVKRILPEC---FSFADREVQLLRESDEHPN 79
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT-NIAFQIARGLLYLHEDC 640
++R + Q + + E L TL ++ L + Q GL +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH--- 135
Query: 641 SAQIIHCDIKPQNILL-----DDYYNARISDFGLAKLLTLNQ-SKAIKTAIRGTKGYVAP 694
S I+H D+KP NIL+ A ISDFGL K L + + S + ++ + GT+G++AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 695 EWFRNSTI---TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNGKL 749
E T VD++S G + +IS + +L + DC L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC-----L 250
Query: 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
D A I+ I DP RP+ + V
Sbjct: 251 HPEKHEDVIARELIE----------KMIAMDPQKRPSAKHV 281
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 75/299 (25%), Positives = 120/299 (40%), Gaps = 51/299 (17%)
Query: 521 TDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 578
+FE +G+G+FG V K A+KK+ ++ +EV+++ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRY---YAIKKIRHT-EEKLSTILSEVMLLASLN 60
Query: 579 HKNLVRLLGFCDEGQNRL-------------LVYEFLNNGTLASFL-FGNLKPSWNLRTN 624
H+ +VR E +N + + E+ NGTL + NL +
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 625 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA 684
+ QI L Y+H S IIH D+KP NI +D+ N +I DFGLAK + + +
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 685 IR------------GTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGE 731
GT YVA E + K+D+YS G++ E+I S +E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-YPFSTGMERVN 236
Query: 732 EYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
L R+ ++ + D M K K++ I DP+ RP R +
Sbjct: 237 ILKKL--------RSVSIEFPPDFDDNKMKVEK---KIIR---LLIDHDPNKRPGARTL 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 80/320 (25%), Positives = 123/320 (38%), Gaps = 49/320 (15%)
Query: 498 NNPGDATIETNLRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKK 555
+NP KE+ +G G+FG VY+G + S VAVK
Sbjct: 8 HNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT 67
Query: 556 LDRVFQDGEK-EFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN 614
L V + ++ +F E ++I + +H+N+VR +G + R ++ E + G L SFL
Sbjct: 68 LPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET 127
Query: 615 LKPSWNLRT-------NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR---I 664
+ ++A IA G YL IH DI +N LL R I
Sbjct: 128 RPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 184
Query: 665 SDFGLAKLLTLN-----QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 719
DFG+A+ + A ++ PE F T+K D +SFGVLL EI
Sbjct: 185 GDFGMARDIYRASYYRKGGCA-MLPVKWM----PPEAFMEGIFTSKTDTWSFGVLLWEIF 239
Query: 720 SCRKSFDIEMGEE-YAILTDW-AFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIW 775
S +G Y ++ + +G D + C + +M W
Sbjct: 240 S--------LGYMPYPSKSNQEVLEFVTSGGRMDPPKN---------CPGPVYRIMTQCW 282
Query: 776 CIQEDPSLRPTMRKVSQMLE 795
Q P RP + + +E
Sbjct: 283 --QHQPEDRPNFAIILERIE 300
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 6e-35
Identities = 69/283 (24%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNL 582
+G G FG V++G+ + AVA+K D + +F E + + Q H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 640
V+L+G E ++ E G L SFL K S +L + A+Q++ L YL
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE--- 508
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN---QSKAIKTAIRGTKGYVAPEWF 697
S + +H DI +N+L+ ++ DFGL++ + + ++ K I+ APE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 564
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD 756
T+ DV+ FGV + EI+ G + + + N + +E
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMH--------GVKPFQGVK--------NNDVIGRIENG 608
Query: 757 T--EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ C L +M W DPS RP ++ L
Sbjct: 609 ERLPMPPN--CPPTLYSLMTKCW--AYDPSRRPRFTELKAQLS 647
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 72/313 (23%), Positives = 126/313 (40%), Gaps = 58/313 (18%)
Query: 524 FEEEVGRGSFGIVYKG----VIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-T 577
+ +G G+FG V + + VAVK L + + + +E+ ++
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------------- 624
HKN++ LLG C + ++ E+ + G L +L P +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 625 ---IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681
+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---- 211
Query: 682 KTAIRGTKGYV-----APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YA 734
+ T G + APE + T + DV+SFGVL+ EI + +G
Sbjct: 212 -YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPG 262
Query: 735 ILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQ 792
I + F + G D CT +L +M W PS RPT +++ +
Sbjct: 263 IPVEELFKLLKEGHRMDKPAN---------CTNELYMMMRDCW--HAVPSQRPTFKQLVE 311
Query: 793 MLEGVVEVDVPPN 805
L+ ++ +
Sbjct: 312 DLDRILTLTTNEE 324
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 70/298 (23%), Positives = 124/298 (41%), Gaps = 53/298 (17%)
Query: 524 FEEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 581
+ E+G G+FG V+ VAVK L + ++F+ E ++ H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN---------------IA 626
+VR G C EG+ L+V+E++ +G L FL + + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN-----QSKAI 681
Q+A G++YL +H D+ +N L+ +I DFG+++ + +
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT- 220
Query: 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW- 739
IR PE T + DV+SFGV+L EI + G++ + L++
Sbjct: 221 MLPIRWM----PPESILYRKFTTESDVWSFGVVLWEIFT--------YGKQPWYQLSNTE 268
Query: 740 AFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
A DC G+ + C ++ +M W Q +P R +++ V L+
Sbjct: 269 AIDCITQGRELERPRA---------CPPEVYAIMRGCW--QREPQQRHSIKDVHARLQ 315
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 61/283 (21%), Positives = 111/283 (39%), Gaps = 39/283 (13%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQ 576
+ + +++G GSFG +K+++ KE + EV V+
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQ---YVIKEINISRMS-SKEREESRREVAVLAN 79
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL----FGNLKPSWNLRTNIAFQIARG 632
H N+V+ +E + +V ++ G L + + L QI
Sbjct: 80 MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD--WFVQICLA 137
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
L ++H +I+H DIK QNI L ++ DFG+A++L A + I GT Y+
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-RACI-GTPYYL 192
Query: 693 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752
+PE N K D+++ G +L E+ + + +F+ L +G +
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNL----VLKIISGSFPPV 245
Query: 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ + LV + +P RP+ V+ +LE
Sbjct: 246 SLHYSYDLRS------LVS---QLFKRNPRDRPS---VNSILE 276
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 79/335 (23%), Positives = 133/335 (39%), Gaps = 60/335 (17%)
Query: 499 NPGDATIETNLRCFSYK----ELEEATDNFEEEVGRGSFGIVYKGVIQ--TTRTSTTAVA 552
+P + ++ + Y E + +GRG+FG V + + VA
Sbjct: 2 DPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVA 61
Query: 553 VKKLDRVFQDGEK-EFKNEVVVIGQ-THHKNLVRLLGFC-DEGQNRLLVYEFLNNGTLAS 609
VK L E +E+ ++ HH N+V LLG C G +++ EF G L++
Sbjct: 62 VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 610 FLFGNLKPSWNLRTN----------------IAFQIARGLLYLHEDCSAQIIHCDIKPQN 653
+L + +FQ+A+G+ +L S + IH D+ +N
Sbjct: 122 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN 178
Query: 654 ILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV-----APEWFRNSTITAKVDV 708
ILL + +I DFGLA+ + + +R + APE + T + DV
Sbjct: 179 ILLSEKNVVKICDFGLARDIYKDP-----DYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 709 YSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCT 766
+SFGVLL EI S S +++ EE + R D T
Sbjct: 234 WSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGTRMRAPDY-------------TT 277
Query: 767 EKL--VMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
++ M+ W +PS RPT ++ + L +++
Sbjct: 278 PEMYQTMLDCW--HGEPSQRPTFSELVEHLGNLLQ 310
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 81/331 (24%), Positives = 135/331 (40%), Gaps = 58/331 (17%)
Query: 496 IRNNPGDATIETNLRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKK 555
++ + + N Y L+ F++ +G G+FG V K I+ A+K+
Sbjct: 1 MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKR 59
Query: 556 LDRVFQDGEK-EFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG 613
+ + +F E+ V+ + HH N++ LLG C+ L E+ +G L FL
Sbjct: 60 MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 119
Query: 614 NLKPSWNLRTN----------------IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 657
+ + A +ARG+ YL Q IH D+ +NIL+
Sbjct: 120 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVG 176
Query: 658 DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV-----APEWFRNSTITAKVDVYSFG 712
+ Y A+I+DFGL S+ + ++ T G + A E S T DV+S+G
Sbjct: 177 ENYVAKIADFGL--------SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 228
Query: 713 VLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKL- 769
VLL EI+S + + E Y L YR K + C +++
Sbjct: 229 VLLWEIVSLGGTPYCGMTCAELYEKLPQG----YRLEKPLN-------------CDDEVY 271
Query: 770 -VMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
+M W +E P RP+ ++ L ++E
Sbjct: 272 DLMRQCW--REKPYERPSFAQILVSLNRMLE 300
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 76/300 (25%), Positives = 125/300 (41%), Gaps = 55/300 (18%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHK 580
F EE+G FG VYKG + T AVA+K L D+ +EF++E ++ + H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN---------------- 624
N+V LLG + Q +++ + ++G L FL S T+
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 625 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN-----QSK 679
+ QIA G+ YL S ++H D+ +N+L+ D N +ISD GL + +
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTD 738
+ IR APE + D++S+GV+L E+ S G + Y ++
Sbjct: 190 S-LLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS--------YGLQPYCGYSN 236
Query: 739 W-AFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ RN ++ + C + +M+ W E PS RP + + L
Sbjct: 237 QDVVEMIRNRQVLPCPDD---------CPAWVYALMIECW--NEFPSRRPRFKDIHSRLR 285
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-34
Identities = 80/301 (26%), Positives = 117/301 (38%), Gaps = 58/301 (19%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKN 581
E+ +G GS G V R VAVK++ F D E+ ++ ++ H N
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGR----PVAVKRMLIDFCD---IALMEIKLLTESDDHPN 70
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT-------NIAFQIARGLL 634
++R + + E L N L + NL+ ++ QIA G+
Sbjct: 71 VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 635 YLHEDCSAQIIHCDIKPQNILLD-------------DYYNARISDFGLAKLLTLNQS--- 678
+LH S +IIH D+KPQNIL+ + ISDFGL K L QS
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 679 KAIKTAIRGTKGYVAPEWFRNSTI-------TAKVDVYSFGVLLLEIISCRKS-FDIEMG 730
+ GT G+ APE S T +D++S G + I+S K F +
Sbjct: 187 TNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 731 EEYAILT-DWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRK 789
E I+ ++ D + L+ EA + I I DP RPT K
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIA---EATDLIS----------QMIDHDPLKRPTAMK 292
Query: 790 V 790
V
Sbjct: 293 V 293
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 80/320 (25%), Positives = 122/320 (38%), Gaps = 49/320 (15%)
Query: 498 NNPGDATIETNLRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKK 555
NP KE+ +G G+FG VY+G + S VAVK
Sbjct: 49 YNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT 108
Query: 556 LDRVFQDGEK-EFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN 614
L V + ++ +F E ++I + +H+N+VR +G + R ++ E + G L SFL
Sbjct: 109 LPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET 168
Query: 615 LKPSWNLRT-------NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR---I 664
+ ++A IA G YL IH DI +N LL R I
Sbjct: 169 RPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 225
Query: 665 SDFGLAKLLTLN-----QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 719
DFG+A+ + A ++ PE F T+K D +SFGVLL EI
Sbjct: 226 GDFGMARDIYRAGYYRKGGCA-MLPVKWM----PPEAFMEGIFTSKTDTWSFGVLLWEIF 280
Query: 720 SCRKSFDIEMGEE-YAILTDW-AFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIW 775
S +G Y ++ + +G D + C + +M W
Sbjct: 281 S--------LGYMPYPSKSNQEVLEFVTSGGRMDPPKN---------CPGPVYRIMTQCW 323
Query: 776 CIQEDPSLRPTMRKVSQMLE 795
Q P RP + + +E
Sbjct: 324 --QHQPEDRPNFAIILERIE 341
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 72/308 (23%), Positives = 128/308 (41%), Gaps = 59/308 (19%)
Query: 524 FEEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-THH 579
F + +G G+FG V + + VAVK L E+ +E+ V+ +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN--------------- 624
N+V LLG C G L++ E+ G L +FL +T+
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 625 ---IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----- 676
++Q+A+G+ +L S IH D+ +NILL +I DFGLA+ + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEE-Y 733
+ A + ++ APE N T + DV+S+G+ L E+ S S + + + Y
Sbjct: 204 KGNA-RLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 734 AILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVS 791
++ + +R + ++ +M + W DP RPT +++
Sbjct: 259 KMIKEG----FRMLSPEH-------------APAEMYDIMKTCW--DADPLKRPTFKQIV 299
Query: 792 QMLEGVVE 799
Q++E +
Sbjct: 300 QLIEKQIS 307
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-34
Identities = 74/317 (23%), Positives = 131/317 (41%), Gaps = 58/317 (18%)
Query: 524 FEEEVGRGSFGIVYKG----VIQTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-T 577
+ +G G+FG V + + T VAVK L + + + +E+ ++
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------------FGNLKPSWNLR--- 622
HKN++ LLG C + ++ E+ + G L +L + P L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 623 -TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----- 676
+ A+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YA 734
+ + ++ APE + T + DV+SFGVLL EI + +G
Sbjct: 250 TTNG-RLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGSPYPG 296
Query: 735 ILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQ 792
+ + F + G D CT +L +M W PS RPT +++ +
Sbjct: 297 VPVEELFKLLKEGHRMDKPSN---------CTNELYMMMRDCW--HAVPSQRPTFKQLVE 345
Query: 793 MLEGVVEVDVPPNPSPF 809
L+ +V + +
Sbjct: 346 DLDRIVALTSNQEMGYY 362
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 62/296 (20%), Positives = 110/296 (37%), Gaps = 62/296 (20%)
Query: 521 TDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQ 576
T F E++G G FG V+K V R A+K+ + E+ EV
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCV---KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 577 -THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIAR 631
H ++VR E + L+ E+ N G+LA + N + + ++ Q+ R
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLD-------------------DYYNARISDFGLAKL 672
GL Y+H S ++H DIKP NI + + +I D G
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 673 LTLNQSKAIKTAIRGTKGYVAPE-WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 731
++ Q + G ++A E N T K D+++ + ++ G+
Sbjct: 184 ISSPQVE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR--NGD 235
Query: 732 EYAILTDWAFDCYRNGKLDDLVEGDTEAMND-IKCTEKLVMVSIWCIQEDPSLRPT 786
++ + R G+L + + ++ + +K I DP RP+
Sbjct: 236 QWHEI--------RQGRLPRIPQVLSQEFTELLK----------VMIHPDPERRPS 273
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 73/306 (23%), Positives = 127/306 (41%), Gaps = 55/306 (17%)
Query: 524 FEEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-THH 579
F + +G G+FG V + + VAVK L EK +E+ ++ H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL----------FGNLKPSWNLRTN----I 625
+N+V LLG C G L++ E+ G L +FL + T
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI 685
+ Q+A+G+ +L S IH D+ +N+LL + + A+I DFGLA+ + + I
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-----NYI 221
Query: 686 RGTKGYV-----APEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEE-YAILT 737
+ APE + T + DV+S+G+LL EI S + I + + Y ++
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281
Query: 738 DWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
D Y+ + + + +M + W +P+ RPT +++ L+
Sbjct: 282 DG----YQMAQPAF-------------APKNIYSIMQACW--ALEPTHRPTFQQICSFLQ 322
Query: 796 GVVEVD 801
+ D
Sbjct: 323 EQAQED 328
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 74/312 (23%), Positives = 134/312 (42%), Gaps = 63/312 (20%)
Query: 524 FEEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHK 580
+ +G G FG V K R T VAVK L E + +E V+ Q +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR------------------ 622
++++L G C + LL+ E+ G+L FL + K
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 623 ------TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676
+ A+QI++G+ YL +++H D+ +NIL+ + +ISDFGL++ +
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 677 QSKAIKTAIRGTKGYV-----APEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEM 729
+ ++ ++G + A E + T + DV+SFGVLL EI++ + I
Sbjct: 204 D-----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 730 GEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTM 787
+ +L +R + D+ C+E++ +M+ W +++P RP
Sbjct: 259 ERLFNLLKTG----HRMERPDN-------------CSEEMYRLMLQCW--KQEPDKRPVF 299
Query: 788 RKVSQMLEGVVE 799
+S+ LE ++
Sbjct: 300 ADISKDLEKMMV 311
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 54/286 (18%), Positives = 116/286 (40%), Gaps = 50/286 (17%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNL- 582
+++G G V++ + + + A+K ++ D + ++NE+ + + +
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 583 -VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 639
+RL + Q +V E N L S+L ++ P R + + + +H
Sbjct: 90 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERKSYWKNMLEAVHTIH-- 144
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE---- 695
I+H D+KP N L+ D ++ DFG+A + + + +K + GT Y+ PE
Sbjct: 145 -QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 696 -------WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748
S I+ K DV+S G +L + + F ++ + + L +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKL-------HAIID 254
Query: 749 LDDLVEG----DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+ +E + + + +K C++ DP R ++ ++
Sbjct: 255 PNHEIEFPDIPEKDLQDVLK----------CCLKRDPKQRISIPEL 290
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-33
Identities = 74/294 (25%), Positives = 124/294 (42%), Gaps = 39/294 (13%)
Query: 513 SYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DRVFQDGEKEFKNEV 571
+ + E+G G+FG V +GV R VA+K L + +E E
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVY-RMRKKQIDVAIKVLKQGTEKADTEEMMREA 387
Query: 572 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQI 629
++ Q + +VRL+G C + + +LV E G L FL G + P N+ + Q+
Sbjct: 388 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQV 445
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
+ G+ YL +H ++ +N+LL + + A+ISDFGL+K L + S TA K
Sbjct: 446 SMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGK 500
Query: 690 GYV---APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYR 745
+ APE +++ DV+S+GV + E +S G++ Y +
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY--------GQKPYKKMK-------- 544
Query: 746 NGKLDDLVEGDT--EAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 795
++ +E E + C +L +M W RP V Q +
Sbjct: 545 GPEVMAFIEQGKRMECPPE--CPPELYALMSDCW--IYKWEDRPDFLTVEQRMR 594
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 56/286 (19%), Positives = 118/286 (41%), Gaps = 50/286 (17%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIG--QTHHKN 581
+++G G V++ + + + A+K ++ D + ++NE+ + Q H
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 639
++RL + Q +V E N L S+L ++ P R + + + +H+
Sbjct: 71 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERKSYWKNMLEAVHTIHQ- 126
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE---- 695
I+H D+KP N L+ D ++ DFG+A + + + +K + GT Y+ PE
Sbjct: 127 --HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 696 -------WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748
S I+ K DV+S G +L + + F ++ + + L +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKL-------HAIID 235
Query: 749 LDDLVEG----DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+ +E + + + +K C++ DP R ++ ++
Sbjct: 236 PNHEIEFPDIPEKDLQDVLK----------CCLKRDPKQRISIPEL 271
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 64/273 (23%), Positives = 101/273 (36%), Gaps = 39/273 (14%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQ- 576
+F+ +G GS+G V+K ++ AVK+ F+ EV +
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVR---SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLL 634
H VRL +EG L E +L +G P + L
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW-GYLRDTLLALA 171
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694
+LH S ++H D+KP NI L ++ DFGL L + G Y+AP
Sbjct: 172 HLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAP 225
Query: 695 EWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL-DDLV 753
E + S DV+S G+ +LE+ + GE + L R G L +
Sbjct: 226 ELLQGS-YGTAADVFSLGLTILEVACNMELPH--GGEGWQQL--------RQGYLPPEFT 274
Query: 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT 786
G + + +++ ++ DP LR T
Sbjct: 275 AGLSSELRS------VLV---MMLEPDPKLRAT 298
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 60/198 (30%), Positives = 84/198 (42%), Gaps = 19/198 (9%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
VGRGSFG V++ + T AVKK+ + E E+V +V L
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQ---CAVKKVR--LEVFRVE---ELVACAGLSSPRIVPL 115
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 643
G EG + E L G+L + G L Q GL YLH + +
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED--RALYYLGQALEGLEYLH---TRR 170
Query: 644 IIHCDIKPQNILLDDY-YNARISDFGLAKLLT---LNQSKAIKTAIRGTKGYVAPEWFRN 699
I+H D+K N+LL A + DFG A L L +S I GT+ ++APE
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 700 STITAKVDVYSFGVLLLE 717
AKVD++S ++L
Sbjct: 231 KPCDAKVDIWSSCCMMLH 248
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 53/286 (18%), Positives = 119/286 (41%), Gaps = 50/286 (17%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNL- 582
+++G G V++ + + + A+K ++ D + ++NE+ + + +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 583 -VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 639
+RL + Q +V E N L S+L ++ P R + + + +H+
Sbjct: 118 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERKSYWKNMLEAVHTIHQ- 173
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
I+H D+KP N L+ D ++ DFG+A + + + +K + G Y+ PE ++
Sbjct: 174 --HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 700 ST-----------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748
+ I+ K DV+S G +L + + F ++ + + L +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKL-------HAIID 282
Query: 749 LDDLVEG----DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+ +E + + + +KC C++ DP R ++ ++
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKC----------CLKRDPKQRISIPEL 318
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 64/313 (20%)
Query: 524 FEEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-THH 579
F + +G G+FG V + + VAVK L E+ +E+ ++ Q H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN--------------- 624
+N+V LLG C L++E+ G L ++L +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 625 --------IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676
A+Q+A+G+ +L +H D+ +N+L+ +I DFGLA+ + +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 677 QSKAIKTAIRGTKGYV-----APEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEM 729
+ + APE T K DV+S+G+LL EI S + I +
Sbjct: 226 S-----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280
Query: 730 GEE-YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPT 786
Y ++ + ++ + TE++ +M S W D RP+
Sbjct: 281 DANFYKLIQNG----FKMDQPFY-------------ATEEIYIIMQSCW--AFDSRKRPS 321
Query: 787 MRKVSQMLEGVVE 799
++ L +
Sbjct: 322 FPNLTSFLGCQLA 334
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 69/312 (22%), Positives = 125/312 (40%), Gaps = 63/312 (20%)
Query: 524 FEEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHK 580
+ ++G G+FG V++ T VAVK L + +F+ E ++ + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN---------------- 624
N+V+LLG C G+ L++E++ G L FL + ++
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 625 --------IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676
IA Q+A G+ YL + +H D+ +N L+ + +I+DFGL++ +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 677 -----QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 731
IR PE + T + DV+++GV+L EI S G
Sbjct: 228 DYYKADGND-AIPIRWM----PPESIFYNRYTTESDVWAYGVVLWEIFS--------YGL 274
Query: 732 E-YAILTDW-AFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTM 787
+ Y + R+G + E C +L +M W + P+ RP+
Sbjct: 275 QPYYGMAHEEVIYYVRDGNILACPEN---------CPLELYNLMRLCW--SKLPADRPSF 323
Query: 788 RKVSQMLEGVVE 799
+ ++L+ + E
Sbjct: 324 CSIHRILQRMCE 335
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 38/241 (15%), Positives = 73/241 (30%), Gaps = 23/241 (9%)
Query: 515 KELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTA--VAVKKLDRVFQDGEKEFKNE 570
E + + +G G+F VY+ + +K
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 571 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSW-----NLRTNI 625
+ + + ++ +LV E + GTL + + L +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA-----------RISDFGLAKLLT 674
A ++ + +H +IIH DIKP N +L + + + D G + +
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 675 LNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 734
L I TA T G+ E N ++D + + ++ G E
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294
Query: 735 I 735
Sbjct: 295 P 295
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 61/293 (20%), Positives = 104/293 (35%), Gaps = 44/293 (15%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
F +++G G F V A+K++ Q +E + E + +H N++
Sbjct: 33 FIQKLGEGGFSYVDLV---EGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 584 RLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRT----NIAFQIARGLLY 635
RL+ +C + L+ F GTL + + L + I RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI-------RGT 688
+H + H D+KP NILL D + D G ++ + + R T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 689 KGYVAPEWF---RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 745
Y APE F + I + DV+S G +L ++ + +D
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM-FGEG---------------PYD-MV 249
Query: 746 NGKLDDL---VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
K D + V+ + + L + + DP RP + + LE
Sbjct: 250 FQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 8e-32
Identities = 63/318 (19%), Positives = 111/318 (34%), Gaps = 57/318 (17%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLV 583
+ G F VY+ + A+K+L ++ + EV + + + H N+V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGRE---YALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 584 RLLGFC-------DEGQNRLLVYEFLNNGTLASFLF-----GNLKPSWNLRTNIAFQIAR 631
+ D GQ L+ L G L FL G L L+ I +Q R
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK--IFYQTCR 147
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR----- 686
+ ++H IIH D+K +N+LL + ++ DFG A ++ + R
Sbjct: 148 AVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 687 -----GTKGYVAPE---WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT- 737
T Y PE + N I K D+++ G +L + + F E G + I+
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--EDGAKLRIVNG 264
Query: 738 --DWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ L+ +Q +P R ++ +V L+
Sbjct: 265 KYSIPPHDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVVHQLQ 304
Query: 796 GVVEVDVPPNPSPFSGYM 813
+ SP + +
Sbjct: 305 EIAAARNVNPKSPITELL 322
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 525 EEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHK 580
+++G G VY VA+K + ++ E K F+ EV Q H+
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIK----VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 640
N+V ++ +E LV E++ TL+ ++ + S + N QI G+ + H+
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD-- 129
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLL---TLNQSKAIKTAIRGTKGYVAPEWF 697
+I+H DIKPQNIL+D +I DFG+AK L +L Q+ + GT Y +PE
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT----NHVLGTVQYFSPEQA 184
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFD 726
+ D+YS G++L E++ F+
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 29/217 (13%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKN 581
+ +G+G+ V++G + T A+K + + + E V+ + +HKN
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDL---FAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 582 LVRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLY 635
+V+L +E R L+ EF G+L + L ++ L + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNH 127
Query: 636 LHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
L I+H +IKP NI+ D +++DFG A+ L + + GT+ Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLY-GTEEY 181
Query: 692 VAPEWFRNSTI--------TAKVDVYSFGVLLLEIIS 720
+ P+ + + + A VD++S GV +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
++G GS GIV + + VAVK +D Q + NEVV++ H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQ---VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEM 107
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAF---QIARGLLYLHEDCS 641
G+ ++ EFL G L + L IA + + L YLH +
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ-----IATVCEAVLQALAYLH---A 159
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+IH DIK +ILL ++SDFG ++ + K K+ + GT ++APE S
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLV-GTPYWMAPEVISRSL 217
Query: 702 ITAKVDVYSFGVLLLEII 719
+VD++S G++++E++
Sbjct: 218 YATEVDIWSLGIMVIEMV 235
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
E++G+G+ G VY + T VA+++++ Q ++ NE++V+ + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAF---QIARGLLYLHEDCS 641
L G +V E+L G+L + + IA + + L +LH S
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-----IAAVCRECLQALEFLH---S 134
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
Q+IH DIK NILL + +++DFG +T QSK T + GT ++APE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMV-GTPYWMAPEVVTRKA 192
Query: 702 ITAKVDVYSFGVLLLEII 719
KVD++S G++ +E+I
Sbjct: 193 YGPKVDIWSLGIMAIEMI 210
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 525 EEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHK 580
E +G G V+ ++ R VAVK L F+ E +H
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRD----VAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 581 NLVRLL--GFCDEGQNRLLVY---EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 635
+V + G E L Y E+++ TL + + + + L +
Sbjct: 73 AIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT-AIRGTKGYVAP 694
H+ IIH D+KP NI++ ++ DFG+A+ + + + +T A+ GT Y++P
Sbjct: 132 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 695 EWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 726
E R ++ A+ DVYS G +L E+++ F
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-30
Identities = 48/212 (22%), Positives = 91/212 (42%), Gaps = 29/212 (13%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKN 581
+ +G+G+ V++G + T A+K + + + E V+ + +HKN
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDL---FAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 582 LVRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLY 635
+V+L +E R L+ EF G+L + L ++ L + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNH 127
Query: 636 LHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
L I+H +IKP NI+ D +++DFG A+ L + + GT+ Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLY-GTEEY 181
Query: 692 VAPEWFRNSTI--------TAKVDVYSFGVLL 715
+ P+ + + + A VD++S GV
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDG-EKEFKNEVVVIGQ 576
++FE +G+G FG VY + S +A+K L + + + G E + + EV +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLA---REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARG 632
H N++RL G+ + L+ E+ GT+ + L+ ++A
Sbjct: 66 LRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANA 121
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
L Y H S ++IH DIKP+N+LL +I+DFG + S GT Y+
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLC-GTLDYL 174
Query: 693 APEWFRNSTITAKVDVYSFGVLLLEII 719
PE KVD++S GVL E +
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 2e-29
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNL 582
+E +G G FG V + + Q T VA+K+ + +E + E+ ++ + +H N+
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQ---VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 583 VRLLGFCDEGQN------RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARG 632
V D Q LL E+ G L +L + L+ I+
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSA 133
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLD---DYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
L YLHE +IIH D+KP+NI+L +I D G AK L Q + + GT
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFV-GTL 187
Query: 690 GYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
Y+APE T VD +SFG L E I+
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 20/225 (8%)
Query: 502 DATIETNLRCFSYKELEEATDNFE---EEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KL 556
+ ++ ++ +E + + +E+GRG F +V + ++++ A K K
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQC---ISKSTGQEYAAKFLKK 64
Query: 557 DRVFQDGEKEFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNL 615
R QD E +E+ V+ ++ L + +L+ E+ G + S L
Sbjct: 65 RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124
Query: 616 KPSWNLR--TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLA 670
+ + QI G+ YLH I+H D+KPQNILL + +I DFG++
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181
Query: 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 715
+ + + ++ + GT Y+APE IT D+++ G++
Sbjct: 182 RK--IGHACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDG-EKEFKNEVVVIGQ 576
D+F+ +G+G FG VY + + +A+K L + + ++G E + + E+ +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAR---EKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARG 632
H N++R+ + + + L+ EF G L + L+ + ++A
Sbjct: 71 LRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADA 126
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
L Y H ++IH DIKP+N+L+ +I+DFG + S +T GT Y+
Sbjct: 127 LHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRTMC-GTLDYL 179
Query: 693 APEWFRNSTITAKVDVYSFGVLLLE 717
PE T KVD++ GVL E
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYE 204
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 22/211 (10%)
Query: 525 EEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKL------DRVFQDGEKEFKNEVVVIGQT 577
VGRG G VY+ R VA+K + D VF+ + E G+
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERI----VALKLMSETLSSDPVFR---TRMQREARTAGRL 91
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLY 635
++V + F + + +N LA+ L G L P + I QI L
Sbjct: 92 QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA--IVRQIGSALDA 149
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE 695
H A H D+KP+NIL+ A + DFG+A T + + + GT Y+APE
Sbjct: 150 AHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPE 205
Query: 696 WFRNSTITAKVDVYSFGVLLLEIISCRKSFD 726
F S T + D+Y+ +L E ++ +
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 60/237 (25%), Positives = 101/237 (42%), Gaps = 26/237 (10%)
Query: 492 KKKWIRNNPGDATIETNLRCFSYKELEEATDNFE------EEVGRGSFGIVYKGVIQTTR 545
K + N D E + + + +E + EE+G G+FG+V++ V + T
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76
Query: 546 TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 605
K ++ + + KNE+ ++ Q HH L+ L ++ +L+ EFL+ G
Sbjct: 77 RV---FVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133
Query: 606 TLASFLFGNLKPSWNLRT-----NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY 660
LF + + N Q GL ++H I+H DIKP+NI+ +
Sbjct: 134 E----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKK 186
Query: 661 NAR--ISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 715
+ I DFGLA LN + +K T + APE + D+++ GVL
Sbjct: 187 ASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVK-----KLDRVFQDGEKE-FKNEVVVIGQ 576
+ EE+G G F IV K +++ A K + + +E + EV ++ Q
Sbjct: 15 DIGEELGSGQFAIVKKC---REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARG 632
H N++ L + + +L+ E ++ G L F L +L T+ QI G
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDG 127
Query: 633 LLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLNQSKAIKTAIRGT 688
+ YLH + +I H D+KP+NI+L + ++ DFGLA + K GT
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GT 181
Query: 689 KGYVAPEWFRNSTITAKVDVYSFGVLL 715
+VAPE + + D++S GV+
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 44/201 (21%), Positives = 88/201 (43%), Gaps = 23/201 (11%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 582
E++GRG FGIV++ +S K + D + K E+ ++ H+N+
Sbjct: 8 MIAEDLGRGEFGIVHRC---VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNI 63
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTL------ASFLFGNLKPSWNLRTNIAFQIARGLLYL 636
+ L + + ++++EF++ + ++F + + Q+ L +L
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-----QVCEALQFL 118
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNA--RISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694
H S I H DI+P+NI+ ++ +I +FG A+ L + Y AP
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLF-TAPEYYAP 172
Query: 695 EWFRNSTITAKVDVYSFGVLL 715
E ++ ++ D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 18/199 (9%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVR 584
E++G+GSFG V+KG+ T+ VA+K +D +D ++ + E+ V+ Q + +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKV---VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 585 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAF---QIARGLLYLHEDC 640
G + ++ E+L G+ L G L + IA +I +GL YLH
Sbjct: 85 YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREILKGLDYLH--- 136
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS 700
S + IH DIK N+LL ++ +++DFG+A LT Q K T + GT ++APE + S
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFV-GTPFWMAPEVIKQS 194
Query: 701 TITAKVDVYSFGVLLLEII 719
+K D++S G+ +E+
Sbjct: 195 AYDSKADIWSLGITAIELA 213
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-28
Identities = 56/298 (18%), Positives = 100/298 (33%), Gaps = 52/298 (17%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL----DRVFQDGEKEFKNEVVVIGQTHHK 580
+ + G G +Y + + V +K L D Q E + + H
Sbjct: 85 KGCIAHGGLGWIYLAL--DRNVNGRPVVLKGLVHSGDAEAQ---AMAMAERQFLAEVVHP 139
Query: 581 NLVRLLGFCDEGQNRL-----LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 635
++V++ F + +V E++ +L L + + +I L Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSY 197
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE 695
LH +++ D+KP+NI+L + ++ D G + + GT G+ APE
Sbjct: 198 LHS---IGLVYNDLKPENIMLTE-EQLKLIDLGAVSRIN--SF----GYLYGTPGFQAPE 247
Query: 696 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755
R T D+Y+ G L + + + G L + L+
Sbjct: 248 IVRTGP-TVATDIYTVGRTLAALTLDLPTRN---GRYVDGLPEDDPVLKTYDSYGRLLR- 302
Query: 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRP-TMRKVSQMLEGVV-EVDVPPNPSPFSG 811
+ + DP R T ++S L GV+ EV P G
Sbjct: 303 --------RAIDP-----------DPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPG 341
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 521 TDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 578
+ F+ E++G GS+G VYK + + T VA+K++ + +E E+ ++ Q
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQI---VAIKQVP--VESDLQEIIKEISIMQQCD 82
Query: 579 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAF---QIARGLL 634
++V+ G + + +V E+ G+++ + K L IA +GL
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLE 139
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694
YLH + IH DIK NILL+ +A+++DFG+A LT +K T I GT ++AP
Sbjct: 140 YLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-NTVI-GTPFWMAP 194
Query: 695 EWFRNSTITAKVDVYSFGVLLLEII 719
E + D++S G+ +E+
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMA 219
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 46/208 (22%), Positives = 81/208 (38%), Gaps = 36/208 (17%)
Query: 600 EFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 656
+ L ++ + +I QIA + +LH S ++H D+KP NI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFF 197
Query: 657 DDYYNARISDFGLAKLLTLNQSKA----------IKTAIRGTKGYVAPEWFRNSTITAKV 706
++ DFGL + ++ + T GTK Y++PE + + KV
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 707 DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCT 766
D++S G++L E++ SF +M E I+TD RN K L + +
Sbjct: 258 DIFSLGLILFELLY---SFSTQM-ERVRIITD-----VRNLKFPLLFTQKYPQEHMM--- 305
Query: 767 EKLVMVSI-WCIQEDPSLRPTMRKVSQM 793
+ + P+ RP + +
Sbjct: 306 -------VQDMLSPSPTERPEATDIIEN 326
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 521 TDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 578
+ +E E+G G+FG VYK + T A K ++ ++ +++ E+ ++
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGAL---AAAKVIETKSEEELEDYIVEIEILATCD 74
Query: 579 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAF---QIARGLL 634
H +V+LLG ++ EF G + + + + L I Q+ L
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALN 131
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694
+LH S +IIH D+K N+L+ + R++DFG++ K + I GT ++AP
Sbjct: 132 FLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFI-GTPYWMAP 186
Query: 695 E-----WFRNSTITAKVDVYSFGVLLLEII 719
E +++ K D++S G+ L+E+
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMA 216
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 30/220 (13%)
Query: 512 FSYKELEEATDNFE--------EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG 563
F ++ + E +G G FG V+K + +A K +
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC---EETATGLKLAAKIIKTRGMKD 129
Query: 564 EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL------ASFLFGNLKP 617
++E KNE+ V+ Q H NL++L + + +LV E+++ G L S+ L
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 618 SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI--SDFGLAKLLTL 675
QI G+ ++H I+H D+KP+NIL + +I DFGLA+
Sbjct: 190 I-----LFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARR--Y 239
Query: 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 715
+ +K GT ++APE ++ D++S GV+
Sbjct: 240 KPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVK-----KLDRVFQDGEKE-FKNEVVVIGQ 576
+ EE+G G F IV K +++ A K + + +E + EV ++ Q
Sbjct: 15 DIGEELGSGQFAIVKKC---REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARG 632
H N++ L + + +L+ E ++ G L F L +L T+ QI G
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDG 127
Query: 633 LLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLNQSKAIKTAIRGT 688
+ YLH + +I H D+KP+NI+L + ++ DFGLA + K GT
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GT 181
Query: 689 KGYVAPEWFRNSTITAKVDVYSFGVLL 715
+VAPE + + D++S GV+
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVK-----KLDRVFQDGEKE-FKNEVVVIGQ 576
EE+G G F IV K + T A K +L + +E + EV ++ +
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGK---EYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 636
H N++ L + + +L+ E ++ G L FL + + T QI G+ YL
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 637 HEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
H S +I H D+KP+NI+L ++ DFG+A + K GT +V
Sbjct: 125 H---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIF-GTPEFV 178
Query: 693 APEWFRNSTITAKVDVYSFGVLL 715
APE + + D++S GV+
Sbjct: 179 APEIVNYEPLGLEADMWSIGVIT 201
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 61/194 (31%), Positives = 97/194 (50%), Gaps = 18/194 (9%)
Query: 529 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDG-EKEFKNEVVVIGQTHHKNLVRL 585
G+GSF VY+ + + VA+K +D+ +++ G + +NEV + Q H +++ L
Sbjct: 20 GKGSFAGVYRA---ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCS 641
+ ++ LV E +NG + +L +KP N A QI G+LYLH S
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQIITGMLYLH---S 130
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
I+H D+ N+LL N +I+DFGLA L + K T + GT Y++PE S
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-HYT-LCGTPNYISPEIATRSA 188
Query: 702 ITAKVDVYSFGVLL 715
+ DV+S G +
Sbjct: 189 HGLESDVWSLGCMF 202
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-28
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 40/223 (17%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR-----------------VFQD 562
+++ + +G F + A+KK ++ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILC-----EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKS 85
Query: 563 GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWN 620
+FKNE+ +I ++ + G ++YE++ N ++ F F L ++
Sbjct: 86 KYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 621 LRT------NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674
I + Y+H I H D+KP NIL+D ++SDFG ++ +
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM- 202
Query: 675 LNQSKAIKTAIRGTKGYVAPEWFRNSTIT--AKVDVYSFGVLL 715
K IK + RGT ++ PE+F N + AKVD++S G+ L
Sbjct: 203 --VDKKIKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 62/371 (16%), Positives = 139/371 (37%), Gaps = 72/371 (19%)
Query: 492 KKKWIRNNPGDATIETNLRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAV 551
++ + T + + + E+ E+G G+ G+V+K + S +
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEK-----ISELGAGNGGVVFKVSH---KPSGLVM 61
Query: 552 AVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVRLLG-FCDEGQNRLLVY---EFLNNGT 606
A K + + + E+ V+ + + +V G F +G+ + E ++ G+
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE----ISICMEHMDGGS 117
Query: 607 LASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 665
L L P L ++ + +GL YL E +I+H D+KP NIL++ ++
Sbjct: 118 LDQVLKKAGRIPEQILGK-VSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLC 174
Query: 666 DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 725
DFG++ L S A + + GT+ Y++PE + + + + D++S G+ L+E+ R +
Sbjct: 175 DFGVSGQLI--DSMA-NSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR--Y 228
Query: 726 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIW---------- 775
I + + + + + + ++I+
Sbjct: 229 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP 288
Query: 776 -------------------CIQEDPSLRPTMRK----------------VSQMLEGVVEV 800
C+ ++P+ R +++ + L + +
Sbjct: 289 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGL 348
Query: 801 DVPPNPSPFSG 811
+ P P+ +G
Sbjct: 349 NQPSTPTHAAG 359
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-27
Identities = 48/200 (24%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 582
+ EE+G G+FG+V++ + T + A K + + ++ + E+ + H L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNN---FAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT-----NIAFQIARGLLYLH 637
V L ++ +++YEF++ G L F + N + Q+ +GL ++H
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARI--SDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE 695
+H D+KP+NI+ + + DFGL L + +++K GT + APE
Sbjct: 273 ---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTT-GTAEFAAPE 326
Query: 696 WFRNSTITAKVDVYSFGVLL 715
+ D++S GVL
Sbjct: 327 VAEGKPVGYYTDMWSVGVLS 346
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 36/242 (14%), Positives = 75/242 (30%), Gaps = 59/242 (24%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDRVFQDGEKEFKNEVVVIGQ------ 576
+G+ + Q T S V +R + K+ K EV+ +
Sbjct: 79 TVLGQEDPYAYLEATDQETGES---FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 577 -------------------THHKNLVRLLGFCDEGQ--NRLLVYEFLNN------GTLAS 609
K ++R+ + +R +Y + + L S
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 610 FLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 669
+ + R + Q+ R L LH ++H ++P +I+LD ++ F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWF-----------RNSTITAKVDVYSFGVLLLEI 718
+ ++G+ PE R + +T D ++ G+++ I
Sbjct: 253 LVRDGA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 719 IS 720
Sbjct: 307 WC 308
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR---------VFQDGEKEFKNEVVVI 574
+E +GRG +V + + + AVK +D Q+ + EV ++
Sbjct: 21 PKEILGRGVSSVVRRC---IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 575 GQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 633
+ + H N+++L + LV++ + G L +L + S I + +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
LH I+H D+KP+NILLDD N +++DFG + L+ + ++ GT Y+A
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVC-GTPSYLA 191
Query: 694 PEWFRNSTITA------KVDVYSFGVLL 715
PE S +VD++S GV++
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 32/307 (10%), Positives = 63/307 (20%), Gaps = 62/307 (20%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHK 580
E + G +V+ A+K + + + +
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLED---FALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 581 NLV------RLLGFCDEGQ--------------------NRLLVYEFLNNGTLASFL--- 611
+ RLL D N LL+ + L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL 181
Query: 612 ----FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDF 667
+ Q+ R L S ++H P N+ + + D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 668 GLAKLLTLNQSKAIKTAIRGTKGYVAPEWF--RNSTITAKVDVYSFGVLLLEIISCRKSF 725
+ A Y E+ +T T ++ + G+ + + F
Sbjct: 239 SALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293
Query: 726 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT--EAMNDIKCTEKLVMVSIWCIQEDPSL 783
+ + L I + D
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR----------FLNFDRRR 343
Query: 784 RPTMRKV 790
R +
Sbjct: 344 RLLPLEA 350
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 41/210 (19%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 582
F E +G G+F V+ R + A+K + + + +NE+ V+ + H+N+
Sbjct: 12 IFMEVLGSGAFSEVFLV---KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAFQ 628
V L + + LV + ++ G L AS + Q
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI--------------QQ 114
Query: 629 IARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKTAI 685
+ + YLH I+H D+KP+N+L ++ I+DFGL+K+ Q+ + TA
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTAC 168
Query: 686 RGTKGYVAPEWFRNSTITAKVDVYSFGVLL 715
GT GYVAPE + VD +S GV+
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 48/204 (23%), Positives = 81/204 (39%), Gaps = 20/204 (9%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVK-----KLDRVFQDGEKEFKNEVVVIGQTH 578
E +G+G F +V + + + T AVK K ++ K E +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQ---FAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 579 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLL 634
H ++V LL +V+EF++ L + + ++ QI L
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 635 YLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
Y H IIH D+KP +LL ++ ++ FG+A L + + GT +
Sbjct: 145 YCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRV-GTPHF 199
Query: 692 VAPEWFRNSTITAKVDVYSFGVLL 715
+APE + VDV+ GV+L
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 35/225 (15%)
Query: 516 ELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 573
L + FE E VG G++G VYKG T A+K +D V D E+E K E+ +
Sbjct: 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQL---AAIKVMD-VTGDEEEEIKQEINM 73
Query: 574 IGQT-HHKNLVRLLG-----FCDEGQNRL-LVYEFLNNGTLA----SFLFGNLKPSWNLR 622
+ + HH+N+ G ++L LV EF G++ + LK W
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--- 130
Query: 623 TNIAF---QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679
IA+ +I RGL +LH ++IH DIK QN+LL + ++ DFG++ L +
Sbjct: 131 --IAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 680 AIKTAIRGTKGYVAPE-----WFRNSTITAKVDVYSFGVLLLEII 719
T I GT ++APE ++T K D++S G+ +E+
Sbjct: 186 R-NTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVK-----KLDRVFQDGEKE-FKNEVVVIGQ 576
+ EE+G G F +V K +++ A K + + +E + EV ++ +
Sbjct: 14 DTGEELGSGQFAVVKKC---REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 636
H N++ L + + +L+ E + G L FL + T QI G+ YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 637 HEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
H S QI H D+KP+NI+L +I DFGLA + + K GT +V
Sbjct: 131 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF-GTPEFV 184
Query: 693 APEWFRNSTITAKVDVYSFGVLL 715
APE + + D++S GV+
Sbjct: 185 APEIVNYEPLGLEADMWSIGVIT 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 42/212 (19%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHK 580
+ +EE+G+G+F +V + V +TT A K ++ ++ ++ + E + + H
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIA 626
N+VRL E LV++ + G L AS
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-------------- 111
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA---RISDFGLAKLLTLNQSKAIKT 683
QI + Y H S I+H ++KP+N+LL +++DFGLA + N S+A
Sbjct: 112 QQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHG 166
Query: 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 715
GT GY++PE + + VD+++ GV+L
Sbjct: 167 FA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 48/196 (24%), Positives = 81/196 (41%), Gaps = 13/196 (6%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 582
E +GRGS+G V + + A KK+ + F + FK E+ ++ H N+
Sbjct: 12 TLENTIGRGSWGEVKIA---VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
+RL ++ + LV E G L + + I + + Y H
Sbjct: 69 IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KL 125
Query: 643 QIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
+ H D+KP+N L ++ DFGLA K ++T + GT YV+P+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPYYVSPQVLEG 182
Query: 700 STITAKVDVYSFGVLL 715
+ D +S GV++
Sbjct: 183 L-YGPECDEWSAGVMM 197
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 51/226 (22%)
Query: 515 KELEEATDNFE------EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK 568
++L + F E++G GS+ + + + + T AVK +D+ +D
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATN---MEFAVKIIDKSKRDP----T 63
Query: 569 NEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFG 613
E+ ++ + H N++ L D+G+ +V E + G L AS +
Sbjct: 64 EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL- 122
Query: 614 NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGL 669
F I + + YLH + ++H D+KP NIL + + RI DFG
Sbjct: 123 -------------FTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166
Query: 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 715
AK L + T T +VAPE A D++S GVLL
Sbjct: 167 AKQLRAENGL-LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKN 581
F+ ++G G+FG V+ R+S +K ++ Q ++ + E+ V+ H N
Sbjct: 25 IFKRKLGSGAFGDVHLV---EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYLH 637
++++ ++ N +V E G L + L + Q+ L Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 638 EDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694
S ++H D+KP+NIL + +I DFGLA+L + A GT Y+AP
Sbjct: 142 ---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAA-GTALYMAP 195
Query: 695 EWFRNSTITAKVDVYSFGVLL 715
E F+ +T K D++S GV++
Sbjct: 196 EVFKRD-VTFKCDIWSAGVVM 215
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 49/221 (22%), Positives = 91/221 (41%), Gaps = 52/221 (23%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--------VFQDGEKEFKNEVVVIG 575
++ +GRG +V + V + T AVK ++ ++ + + E ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGH---EFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 576 Q-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWN 620
Q H +++ L+ + LV++ + G L +
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM-------- 206
Query: 621 LRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680
+ + +LH + I+H D+KP+NILLDD R+SDFG + L +
Sbjct: 207 ------RSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEK 255
Query: 681 IKTAIRGTKGYVAPEWFRNSTITA------KVDVYSFGVLL 715
++ GT GY+APE + S +VD+++ GV+L
Sbjct: 256 LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 15/197 (7%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKN 581
+++G G++G V + + A+K + V + EV V+ H N
Sbjct: 41 RVKKLGSGAYGEVLLC---RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN 97
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 641
+++L F ++ +N LV E G L + +K + I Q+ G+ YLH
Sbjct: 98 IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---K 154
Query: 642 AQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR 698
I+H D+KP+N+LL + +I DFGL+ + K +K + GT Y+APE R
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERL-GTAYYIAPEVLR 211
Query: 699 NSTITAKVDVYSFGVLL 715
K DV+S GV+L
Sbjct: 212 KK-YDEKCDVWSIGVIL 227
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHH 579
+ +G+GSFG V + + AVK + + + ++ EV ++ Q H
Sbjct: 29 KGQRVLGKGSFGEVILC---KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 639
N+++L F ++ LV E G L + + S I Q+ G+ Y+H
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH-- 143
Query: 640 CSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
+I+H D+KP+N+LL N RI DFGL+ SK +K I GT Y+APE
Sbjct: 144 -KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKI-GTAYYIAPEV 199
Query: 697 FRNSTITAKVDVYSFGVLL 715
+ K DV+S GV+L
Sbjct: 200 LHGT-YDEKCDVWSTGVIL 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--------VFQDGEKEFKNEVVVI 574
+ +G G+ G V R + VA++ + + D + E+ ++
Sbjct: 138 IMSKTLGSGACGEVKLAF---ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 575 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 634
+ +H ++++ F D ++ +V E + G L + GN + +Q+ +
Sbjct: 195 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 635 YLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
YLH IIH D+KP+N+LL ++ +I+DFG +K+L ++ ++T GT Y
Sbjct: 254 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLC-GTPTY 307
Query: 692 VAPEWFRNSTI---TAKVDVYSFGVLL 715
+APE + VD +S GV+L
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-26
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 40/217 (18%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLV 583
+ +G GSFG+VY+ + + VA+KK V QD K FKN E+ ++ + H N+V
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGEL---VAIKK---VLQD--KRFKNRELQIMRKLDHCNIV 110
Query: 584 RLLG-FCDEGQNRL-----LVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGL 633
RL F G+ + LV +++ T+ + L +Q+ R L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 634 LYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
Y+H S I H DIKPQN+LLD D ++ DFG AK L + Y+
Sbjct: 170 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---------NVSYI 217
Query: 693 APEWFR------NSTI-TAKVDVYSFGVLLLEIISCR 722
++R +T T+ +DV+S G +L E++ +
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 45/190 (23%), Positives = 82/190 (43%), Gaps = 11/190 (5%)
Query: 529 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVRL 585
G+G F ++ T+ A K + + + + ++E E+ + H+++V
Sbjct: 24 GKGGFAKCFEISDADTKEV---FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 645
GF ++ +V E +L + QI G YLH ++I
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 137
Query: 646 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAK 705
H D+K N+ L++ +I DFGLA + + + K + GT Y+APE + +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 706 VDVYSFGVLL 715
VDV+S G ++
Sbjct: 196 VDVWSIGCIM 205
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 43/212 (20%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHK 580
N +G+GSFG V K R + AVK ++ EV ++ + H
Sbjct: 25 NIVCMLGKGSFGEVLKC---KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIA 626
N+++L ++ + +V E G L A+ +
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII-------------- 127
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKT 683
Q+ G+ Y+H I+H D+KP+NILL + + +I DFGL+ Q+ +K
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKD 182
Query: 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 715
I GT Y+APE R + K DV+S GV+L
Sbjct: 183 RI-GTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 42/209 (20%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
E E+GRG+ IVY+ + + A+K L + +K + E+ V+ + H N++
Sbjct: 57 VESELGRGATSIVYRC---KQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNII 111
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAFQI 629
+L + LV E + G L A+ QI
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK--------------QI 157
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKTAIR 686
+ YLH I+H D+KP+N+L +I+DFGL+K++ +KT
Sbjct: 158 LEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVC- 211
Query: 687 GTKGYVAPEWFRNSTITAKVDVYSFGVLL 715
GT GY APE R +VD++S G++
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 45/190 (23%), Positives = 82/190 (43%), Gaps = 11/190 (5%)
Query: 529 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVRL 585
G+G F ++ T+ A K + + + + ++E E+ + H+++V
Sbjct: 50 GKGGFAKCFEISDADTKEV---FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 645
GF ++ +V E +L + QI G YLH ++I
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 163
Query: 646 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAK 705
H D+K N+ L++ +I DFGLA + + + K + GT Y+APE + +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 706 VDVYSFGVLL 715
VDV+S G ++
Sbjct: 222 VDVWSIGCIM 231
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 42/211 (19%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKN 581
+EE+G+G+F +V + V +TT A K ++ ++ ++ + E + + H N
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAF 627
+VRL E LV++ + G L AS
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI--------------Q 135
Query: 628 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA---RISDFGLAKLLTLNQSKAIKTA 684
QI + Y H S I+H ++KP+N+LL +++DFGLA + N S+A
Sbjct: 136 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGF 190
Query: 685 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 715
GT GY++PE + + VD+++ GV+L
Sbjct: 191 A-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLV 583
+ +G GSFG+V++ + + VA+KK V QD K FKN E+ ++ H N+V
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDE----VAIKK---VLQD--KRFKNRELQIMRIVKHPNVV 95
Query: 584 RLLGF-----CDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGL 633
L F + + L LV E++ T+ K + +Q+ R L
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 634 LYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
Y+H S I H DIKPQN+LLD ++ DFG AK+L + Y+
Sbjct: 155 AYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---------NVSYI 202
Query: 693 ------APEW-FRNSTITAKVDVYSFGVLLLEIISCR 722
APE F + T +D++S G ++ E++ +
Sbjct: 203 CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 61/248 (24%), Positives = 103/248 (41%), Gaps = 45/248 (18%)
Query: 500 PGDATIETNLRCFSYKELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD 557
PG + + N + + + D F+ G+G+FG V G ++T S VA+KK
Sbjct: 2 PG-SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMS---VAIKK-- 55
Query: 558 RVFQDGEKEFKN----EVVVIGQTHHKNLVRLL------GFCDEGQNRL-LVYEFLNNGT 606
V QD F+N + + HH N+V+L G D L +V E++ + T
Sbjct: 56 -VIQD--PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-T 111
Query: 607 LASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA 662
L + FQ+ R + LH S + H DIKP N+L+++
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170
Query: 663 -RISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR------NSTI-TAKVDVYSFGVL 714
++ DFG AK L+ ++ Y+ ++R + T VD++S G +
Sbjct: 171 LKLCDFGSAKKLSPSEPNV---------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCI 221
Query: 715 LLEIISCR 722
E++
Sbjct: 222 FAEMMLGE 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 43/212 (20%)
Query: 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHK 580
D ++ +G GSF I K V + + A AVK + + E + E+ + H
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQ---AFAVKIISK---RMEANTQKEITALKLCEGHP 66
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIA 626
N+V+L + + LV E LN G L AS I
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--------------YIM 112
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKT 683
++ + ++H ++H D+KP+N+L +D +I DFG A+L + + +KT
Sbjct: 113 RKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKT 168
Query: 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 715
T Y APE + D++S GV+L
Sbjct: 169 PC-FTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 43/212 (20%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHK 580
N +G+GSFG V K R + AVK ++ EV ++ + H
Sbjct: 25 NIVCMLGKGSFGEVLKC---KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIA 626
N+++L ++ + +V E G L A+ I
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--------------RII 127
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKT 683
Q+ G+ Y+H I+H D+KP+NILL + + +I DFGL+ Q+ +K
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKD 182
Query: 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 715
I GT Y+APE R + K DV+S GV+L
Sbjct: 183 RI-GTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 60/257 (23%), Positives = 91/257 (35%), Gaps = 59/257 (22%)
Query: 512 FSYKELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVK-----KLDRVFQDGE 564
F L E + +G+GS+G+V + TR A+K K+ ++
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRA---IRAIKIMNKNKIRQINPKDV 72
Query: 565 KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----------------- 607
+ K EV ++ + HH N+ RL ++ Q LV E + G L
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 608 -------------ASFLFGNLKPSWNLRTNIAF----------QIARGLLYLHEDCSAQI 644
+ + QI L YLH + I
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGI 189
Query: 645 IHCDIKPQNILL--DDYYNARISDFGLAKLLTLNQSKAIK--TAIRGTKGYVAPEWFRNS 700
H DIKP+N L + + ++ DFGL+K + T GT +VAPE +
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249
Query: 701 T--ITAKVDVYSFGVLL 715
K D +S GVLL
Sbjct: 250 NESYGPKCDAWSAGVLL 266
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 52/221 (23%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--------VFQDGEKEFKNEVVVI 574
+ +G G+ G V R + VA+K + + D + E+ ++
Sbjct: 13 IMSKTLGSGACGEVKLA---FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 575 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWN 620
+ +H ++++ F D ++ +V E + G L F
Sbjct: 70 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-------- 120
Query: 621 LRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQ 677
+Q+ + YLH IIH D+KP+N+LL ++ +I+DFG +K+L +
Sbjct: 121 ------YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--E 169
Query: 678 SKAIKTAIRGTKGYVAPEWFRNSTI---TAKVDVYSFGVLL 715
+ ++T GT Y+APE + VD +S GV+L
Sbjct: 170 TSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR-------------VFQDGEKEFKNE 570
++G G++G V + + A+K + + + +E NE
Sbjct: 40 KVRKLGSGAYGEVLLC---KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 571 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 630
+ ++ H N+++L ++ + LV EF G L + K NI QI
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKTAIRG 687
G+ YLH I+H DIKP+NILL + N +I DFGL+ ++ ++ + G
Sbjct: 157 SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKLRDRL-G 210
Query: 688 TKGYVAPEWFRNSTITAKVDVYSFGVLL 715
T Y+APE + K DV+S GV++
Sbjct: 211 TAYYIAPEVLKKK-YNEKCDVWSCGVIM 237
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 29/218 (13%)
Query: 517 LEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-KEFKNEV-V 572
+E D+ E E+GRG++G+V K + +AVK++ E K ++ +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQ---IMAVKRIRATVNSQEQKRLLMDLDI 58
Query: 573 VIGQTHHKNLVRLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPSWNLRTN---- 624
+ V G EG V+ E ++ +L F + + +
Sbjct: 59 SMRTVDCPFTVTFYGALFREGD----VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGK 113
Query: 625 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA 684
IA I + L +LH +IH D+KP N+L++ ++ DFG++ L A
Sbjct: 114 IAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDID 169
Query: 685 IRGTKGYVAPE----WFRNSTITAKVDVYSFGVLLLEI 718
G K Y+APE + K D++S G+ ++E+
Sbjct: 170 A-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-25
Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 41/211 (19%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDGEKEFKNEVVVIGQTHHKN 581
EE+G+G+F +V + + A ++ + ++ + E + H N
Sbjct: 15 LFEELGKGAFSVVRRC---VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAF 627
+VRL E + L+++ + G L AS
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI--------------Q 117
Query: 628 QIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKTA 684
QI +L+ H ++H ++KP+N+LL +++DFGLA + Q +A
Sbjct: 118 QILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGF 173
Query: 685 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 715
GT GY++PE R VD+++ GV+L
Sbjct: 174 A-GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 31/234 (13%), Positives = 67/234 (28%), Gaps = 48/234 (20%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDRVFQDGEKEFKNEVVVIGQT----- 577
+G+ + Q T S V +R + K+ K EV+ +
Sbjct: 84 TVLGQEDPYAYLEATDQETGES---FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140
Query: 578 -----------------HHKNLVRLLGFCDEGQNRLLVYEFL-------NNGTLASFLFG 613
+++ + ++ ++ F N T L
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200
Query: 614 NLK----PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 669
+ + R + Q+ R L LH ++H ++P +I+LD ++ F
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEI 718
+ + A + +T D ++ G+ + I
Sbjct: 258 LVRDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTH 578
D++E E +G G+ +V + VA+K+++ Q E E+ + Q H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEK---VAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 579 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN-----IAF---QIA 630
H N+V LV + L+ G++ + + + IA ++
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI----KTAIR 686
GL YLH IH D+K NILL + + +I+DFG++ L KT +
Sbjct: 132 EGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV- 187
Query: 687 GTKGYVAPEWF-RNSTITAKVDVYSFGVLLLEII 719
GT ++APE + K D++SFG+ +E+
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 32/222 (14%)
Query: 515 KELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-KEFKNEV 571
+ + ++ + E+GRG++G V K V + + +AVK++ + E K+ ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQ---IMAVKRIRSTVDEKEQKQLLMDL 71
Query: 572 -VVIGQTHHKNLVRLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPSWNLRTN-- 624
VV+ + +V+ G EG + E ++ + F + +
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGD----CWICMELMS-TSFDKFY-KYVYSVLDDVIPEE 125
Query: 625 ----IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680
I + L +L E+ +IIH DIKP NILLD N ++ DFG++ L S A
Sbjct: 126 ILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIA 181
Query: 681 IKTAIRGTKGYVAPE----WFRNSTITAKVDVYSFGVLLLEI 718
KT G + Y+APE + DV+S G+ L E+
Sbjct: 182 -KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 68/317 (21%), Positives = 113/317 (35%), Gaps = 76/317 (23%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR------VFQDGEKEFKNEVV----VI 574
+G+G FG V+ G T R VA+K + R EV V
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQ---VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 575 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIA 630
H ++RLL + + + +LV E LF + L + F Q+
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQD---LFDYITEKGPLGEGPSRCFFGQVV 149
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
+ + H S ++H DIK +NIL+D A++ DFG LL + GT+
Sbjct: 150 AAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFD-GTR 202
Query: 690 GYVAPEWFRNSTIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA-FDCYRNG 747
Y PEW V+S G+LL Y ++ F+ +
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILL-----------------YDMVCGDIPFERDQ-- 243
Query: 748 KLDDLVEGD--------TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ---MLEG 796
+++E + + I+ C+ PS RP++ ++ M
Sbjct: 244 ---EILEAELHFPAHVSPDCCALIR----------RCLAPKPSSRPSLEEILLDPWMQTP 290
Query: 797 VVEVDVPP---NPSPFS 810
+V + P P+P +
Sbjct: 291 AEDVPLNPSKGGPAPLA 307
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 50/219 (22%), Positives = 86/219 (39%), Gaps = 48/219 (21%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLV 583
E+ +G G+ V ++ AVK +++ EV ++ Q H+N++
Sbjct: 18 EDVLGEGAHARVQTC---INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAFQI 629
L+ F +E LV+E + G++ AS + +
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--------------VVVQDV 120
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKTAIR 686
A L +LH + I H D+KP+NIL + +I DF L + LN + +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 687 -----GTKGYVAPEWFRNSTITAK-----VDVYSFGVLL 715
G+ Y+APE + A D++S GV+L
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 37/220 (16%), Positives = 73/220 (33%), Gaps = 33/220 (15%)
Query: 521 TDNFE--EEVGRG--SFGIVYKGVIQTTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVI 574
+E +G+G V + T V V++ L+ + + E+ V
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEY---VTVRRINLEACSNEMVTFLQGELHVS 80
Query: 575 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL----FGNLKPSWNLRTNIAF--- 627
+H N+V +V F+ G+ + + IA+
Sbjct: 81 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQ 135
Query: 628 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRG 687
+ + L Y+H +H +K +IL+ +S + + + +
Sbjct: 136 GVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ-RVVHDF 191
Query: 688 TKGYV------APEWFRNSTI--TAKVDVYSFGVLLLEII 719
K V +PE + + AK D+YS G+ E+
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 56/212 (26%), Positives = 84/212 (39%), Gaps = 30/212 (14%)
Query: 521 TDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIG 575
F E+G GSFG VY VA+KK+ + ++ EV +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEV---VAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 576 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNG--TLASFLFGNLKPSWNLRTNIAF---QIA 630
+ H N ++ G LV E+ L L+ IA
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGAL 164
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690
+GL YLH S +IH D+K NILL + ++ DFG A ++ A + + GT
Sbjct: 165 QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PA-NSFV-GTPY 215
Query: 691 YVAPE---WFRNSTITAKVDVYSFGVLLLEII 719
++APE KVDV+S G+ +E+
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 66/321 (20%), Positives = 117/321 (36%), Gaps = 85/321 (26%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR------VFQDGEKEFKNEVVVIGQT 577
+G G FG VY G+ + VA+K +++ EVV++ +
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 578 HHK--NLVRLLGFCDEGQNRLLVYEFLNN-GTLASFLF--GNLKPSWNLRTNIAFQIARG 632
++RLL + + + +L+ E L F+ G L+ L + +Q+
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE--ELARSFFWQVLEA 161
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
+ + H + ++H DIK +NIL+D + ++ DFG LL + GT+ Y
Sbjct: 162 VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD-GTRVY 214
Query: 692 VAPEWFRNSTITA-KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL- 749
PEW R V+S G+LL Y ++ G +
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILL-----------------YDMVC---------GDIP 248
Query: 750 ----DDLVEGD--------TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV------- 790
++++ G +E + I+ WC+ PS RPT ++
Sbjct: 249 FEHDEEIIRGQVFFRQRVSSECQHLIR----------WCLALRPSDRPTFEEIQNHPWMQ 298
Query: 791 ----SQMLEGVVEVDVPPNPS 807
Q + + P PS
Sbjct: 299 DVLLPQETAEIHLHSLSPGPS 319
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 65/194 (33%), Positives = 98/194 (50%), Gaps = 18/194 (9%)
Query: 529 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLG 587
G G++G V V + T + VAVK +D D + K E+ + +H+N+V+ G
Sbjct: 16 GEGAYGEVQLAVNRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 588 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHEDCSAQ 643
EG + L E+ + G L F ++P + A F Q+ G++YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 644 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLN-QSKAIKTAIRGTKGYVAPEWFRNSTI 702
I H DIKP+N+LLD+ N +ISDFGLA + N + + + GT YVAPE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184
Query: 703 T-AKVDVYSFGVLL 715
VDV+S G++L
Sbjct: 185 HAEPVDVWSCGIVL 198
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 529 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDR----VFQDGEKEFKNEVVVIGQTHHKNLVR 584
G GS+G V + + T AVK L + +GE K E+ ++ + HKN+++
Sbjct: 14 GEGSYGKVKEVLDSETLCR---RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 585 LLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHE 638
L+ +E + ++ +V E+ G + ++ P A F Q+ GL YLH
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSV-PEKRFPVCQAHGYFCQLIDGLEYLH- 126
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL-TLNQSKAIKTAIRGTKGYVAPEWF 697
S I+H DIKP N+LL +IS G+A+ L +T+ +G+ + PE
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPEIA 183
Query: 698 RNSTI--TAKVDVYSFGVLL 715
KVD++S GV L
Sbjct: 184 NGLDTFSGFKVDIWSAGVTL 203
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 25/217 (11%)
Query: 515 KELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-KEFKNEV 571
+ + ++ E E+G G+ G V+K + T +AVK++ R E K ++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGH---VIAVKQMRRSGNKEENKRILMDL 74
Query: 572 -VVIGQTHHKNLVRLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPSWNLRTNIA 626
VV+ +V+ G F V+ E + + +
Sbjct: 75 DVVLKSHDCPYIVQCFGTFITNTD----VFIAMELMGTCAEKLKKRMQGPIPERILGKMT 130
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR 686
I + L YL E +IH D+KP NILLD+ ++ DFG++ L KA K
Sbjct: 131 VAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKA-KDRSA 185
Query: 687 GTKGYVAPE-----WFRNSTITAKVDVYSFGVLLLEI 718
G Y+APE + DV+S G+ L+E+
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 65/194 (33%), Positives = 98/194 (50%), Gaps = 18/194 (9%)
Query: 529 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLG 587
G G++G V V + T + VAVK +D D + K E+ + +H+N+V+ G
Sbjct: 16 GEGAYGEVQLAVNRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 588 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHEDCSAQ 643
EG + L E+ + G L F ++P + A F Q+ G++YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 644 IIHCDIKPQNILLDDYYNARISDFGLAKLLTL-NQSKAIKTAIRGTKGYVAPEWFRNSTI 702
I H DIKP+N+LLD+ N +ISDFGLA + N+ + + GT YVAPE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184
Query: 703 T-AKVDVYSFGVLL 715
VDV+S G++L
Sbjct: 185 HAEPVDVWSCGIVL 198
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 12/195 (6%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDGEKEFKNEVVVIGQTHHKN 581
+ +G+G+F V T VA+K +D+ + ++ EV ++ +H N
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGRE---VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 641
+V+L + + L+ E+ + G + +L + + + QI + Y H+
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR- 134
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
I+H D+K +N+LLD N +I+DFG + T+ + G Y APE F+
Sbjct: 135 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFC-GAPPYAAPELFQGKK 189
Query: 702 IT-AKVDVYSFGVLL 715
+VDV+S GV+L
Sbjct: 190 YDGPEVDVWSLGVIL 204
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-22
Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 25/201 (12%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLV 583
++ +G G G V + + T A+K L + + EV Q + ++V
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQ---KCALKLLYDS-----PKARQEVDHHWQASGGPHIV 85
Query: 584 RLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLH 637
+L + + L++ E + G L S + ++ R I I + +LH
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 638 EDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694
S I H D+KP+N+L + +++DFG AK T N ++T T YVAP
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YTPYYVAP 198
Query: 695 EWFRNSTITAKVDVYSFGVLL 715
E D++S GV++
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 50/216 (23%), Positives = 81/216 (37%), Gaps = 52/216 (24%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNL 582
+ +G G G V + + + A+K L + + EV + + + ++
Sbjct: 66 TSQVLGLGINGKVLQI---FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHI 117
Query: 583 VRLLGFCDEGQNR----LLVYEFLNNGTL----------------ASFLFGNLKPSWNLR 622
VR++ + L+V E L+ G L AS
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS------------- 164
Query: 623 TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSK 679
I I + YLH S I H D+KP+N+L +++DFG AK T + S
Sbjct: 165 -EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 219
Query: 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 715
+ T T YVAPE D++S GV++
Sbjct: 220 -LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-21
Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQTHHKNLV 583
+GRG FG V+ +T + A KKL R+ + + E ++ + H + +V
Sbjct: 193 LGRGGFGEVF----ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIV 248
Query: 584 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHE 638
L + E + L LV +N G + ++ + + + A F QI GL +LH
Sbjct: 249 SLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH- 306
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR 698
II+ D+KP+N+LLDD N RISD GLA L Q+K GT G++APE
Sbjct: 307 --QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGTPGFMAPELLL 362
Query: 699 NSTITAKVDVYSFGVLLLEII 719
VD ++ GV L E+I
Sbjct: 363 GEEYDFSVDYFALGVTLYEMI 383
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--VFQDGEKEFKN------EVVVIGQ 576
+G G+FG V+ V + V VK + + V +D E E+ ++ +
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKE---VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF------GNLKPSWNLRTNIAFQIA 630
H N++++L + LV E +G LF L L + I Q+
Sbjct: 86 VEHANIIKVLDIFENQGFFQLVMEKHGSG---LDLFAFIDRHPRLDE--PLASYIFRQLV 140
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690
+ YL IIH DIK +NI++ + + ++ DFG A L + K T GT
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--RGKLFYTFC-GTIE 194
Query: 691 YVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFD 726
Y APE + +++++S GV L ++ F
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-21
Identities = 55/245 (22%), Positives = 95/245 (38%), Gaps = 58/245 (23%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLV 583
+ +G GSFGIV + + A+KK V QD +KN E+ ++ H N++
Sbjct: 12 GKTLGTGSFGIVCEVFDIESGKR---FALKK---VLQD--PRYKNRELDIMKVLDHVNII 63
Query: 584 RLL--------------------GFCDEGQNRLLVYEFLNNGTLASFLFGNL-------- 615
+L+ N + + + + N+
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 616 -----KPSWNLRTNI--------AFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYN 661
K +I +Q+ R + ++H S I H DIKPQN+L++
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNT 180
Query: 662 ARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIIS 720
++ DFG AK L ++ A ++ Y APE +T T +D++S G + E+I
Sbjct: 181 LKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 721 CRKSF 725
+ F
Sbjct: 238 GKPLF 242
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-21
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRL 585
+G G+ GIV + VA+KKL R FQ+ K E+V++ +HKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 586 L------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 639
L +E Q+ +V E ++ L + L + + +Q+ G+ +LH
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHE-RMSY-LLYQMLCGIKHLH-- 144
Query: 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699
SA IIH D+KP NI++ +I DFGLA+ + + T T+ Y APE
Sbjct: 145 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILG 200
Query: 700 STITAKVDVYSFGVLLLEIISCRKSF 725
VD++S G ++ E+I F
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAV-AVKKLD--RVFQDGEKEF-KNEVVVIG 575
++F+ + +G GSF V +T+ A+K L+ + ++ + + E V+
Sbjct: 30 EDFKFGKILGEGSFSTVV----LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 576 QTHHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QI 629
+ H V+L F D+ +L + NG L ++ + F +I
Sbjct: 86 RLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAEI 139
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
L YLH IIH D+KP+NILL++ + +I+DFG AK+L+ +A + GT
Sbjct: 140 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 690 GYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
YV+PE + D+++ G ++ ++++
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 1e-20
Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQTHHKNLV 583
+G+G FG V +T + A KKL R+ + + NE ++ + + + +V
Sbjct: 192 LGKGGFGEVC----ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 247
Query: 584 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDC 640
L + E ++ L LV +N G L ++ + + + A +I GL LH +
Sbjct: 248 SL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE- 305
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS 700
+I++ D+KP+NILLDD+ + RISD GLA + Q+ IK + GT GY+APE +N
Sbjct: 306 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNE 360
Query: 701 TITAKVDVYSFGVLLLEII 719
T D ++ G LL E+I
Sbjct: 361 RYTFSPDWWALGCLLYEMI 379
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 36/290 (12%), Positives = 72/290 (24%), Gaps = 56/290 (19%)
Query: 525 EEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHK 580
G ++ + R VA+ +D + +E + + + +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQ----VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 640
+ R+L L+V E++ G+L + P +R +A H
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAHR-- 147
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS 700
A + P + +S G L +
Sbjct: 148 -AGVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA----- 179
Query: 701 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDLVEGDTE 758
+ D+ G L ++ R D A +D +
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237
Query: 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSP 808
A + +Q D +R ++ M + D P
Sbjct: 238 A---------VAA---RSVQGDGGIRSASTLLNLMQQATAVADRTEVLGP 275
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 35/215 (16%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 583
VG G++G V + + + VA+KKL R FQ K E++++ H+N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEK---VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI 86
Query: 584 RLL------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637
LL + LV F+ L + ++ + +Q+ +GL Y+H
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEE-KIQ-YLVYQMLKGLKYIH 143
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
SA ++H D+KP N+ +++ +I DFGLA+ + GYV W+
Sbjct: 144 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----------GYVVTRWY 189
Query: 698 R-------NSTITAKVDVYSFGVLLLEIISCRKSF 725
R VD++S G ++ E+++ + F
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 52/214 (24%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 519 EATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ 576
D+++ ++GRG + V++ + T V VK L V +K+ K E+ ++
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEK---VVVKILKPVK---KKKIKREIKILEN 86
Query: 577 -THHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 633
N++ L D LV+E +NN L+ L ++R + ++I + L
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDY-DIRFYM-YEILKAL 143
Query: 634 LYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
Y H S I+H D+KP N+++D ++ R+ D+GLA+ Q ++ A ++ +
Sbjct: 144 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA---SRYFK 197
Query: 693 APEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSF 725
PE + + +D++S G +L +I ++ F
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 22/163 (13%)
Query: 522 DNFE--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVV 573
+ +E ++G GS+G+V+K T + VA+KK + + E+ +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQI----VAIKK---FLESEDDPVIKKIALREIRM 55
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIAR 631
+ Q H NLV LL + LV+E+ ++ T+ L + P ++ +I +Q +
Sbjct: 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTLQ 113
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674
+ + H IH D+KP+NIL+ + ++ DFG A+LLT
Sbjct: 114 AVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 48/225 (21%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR--------------------------V 559
+E+G+GS+G+V + T A+K L +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTY---YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 560 FQDGEKEFKNEVVVIGQTHHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKP 617
+ ++ E+ ++ + H N+V+L+ D ++ L +V+E +N G + LKP
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--MEVPTLKP 133
Query: 618 SWNLRTNIA---F-QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673
L + A F + +G+ YLH +IIH DIKP N+L+ + + +I+DFG++
Sbjct: 134 ---LSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTIT---AKVDVYSFGVLL 715
+ + T GT ++APE + +DV++ GV L
Sbjct: 188 KGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 54/191 (28%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 529 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 585
G G+FG V G Q T VAVK L+R D + K E+ + H ++++L
Sbjct: 20 GVGTFGKVKIGEHQLTGHK---VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 645
+ +V E+++ G L ++ + + + QI + Y H ++
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVV 133
Query: 646 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTIT-A 704
H D+KP+N+LLD + NA+I+DFGL+ +++ + ++T+ G+ Y APE
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVISGRLYAGP 190
Query: 705 KVDVYSFGVLL 715
+VD++S GV+L
Sbjct: 191 EVDIWSCGVIL 201
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 54/244 (22%), Positives = 101/244 (41%), Gaps = 77/244 (31%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE------------KEFKNEVVV 573
+++G+G++GIV+K + + T VAVKK+ FQ+ E
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEV---VAVKKIFDAFQNSTDAQRTFREIMILTELSG---- 67
Query: 574 IGQTHHKNLVRLLG-FCDEGQNRL-LVYEF----LNNGTLASFLFGNLKPSWNLRTN--- 624
H+N+V LL + + LV+++ L+ +R N
Sbjct: 68 -----HENIVNLLNVLRADNDRDVYLVFDYMETDLHA---------------VIRANILE 107
Query: 625 ------IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678
+ +Q+ + + YLH S ++H D+KP NILL+ + +++DFGL++ +
Sbjct: 108 PVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 679 KAIKTAIRGTK-------------GYVAPEWFR-------NSTITAKVDVYSFGVLLLEI 718
+ + YVA W+R ++ T +D++S G +L EI
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
Query: 719 ISCR 722
+ +
Sbjct: 225 LCGK 228
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 522 DNFE--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEKE-FKN----EVVV 573
+ +E VG GS+G+V K T R VA+KK + + + K E+ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRI----VAIKK---FLESDDDKMVKKIAMREIKL 77
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARG 632
+ Q H+NLV LL C + + LV+EF+++ T+ L + + FQI G
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674
+ + H S IIH DIKP+NIL+ ++ DFG A+ L
Sbjct: 137 IGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 53/225 (23%), Positives = 82/225 (36%), Gaps = 43/225 (19%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE--FKN---------EVVVI 574
+ GS+G V GV VA+K++ DG + E+ ++
Sbjct: 28 RFISSGSYGAVCAGVDSEGIP----VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 575 GQTHHKNLVRLL-----GFCDEGQNRLLVYEFLNNGT-LASFLFGNLKPSWNLRTN-IAF 627
HH N++ L LV E + T LA + +
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 628 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRG 687
I GL LH A ++H D+ P NILL D + I DF LA+ T + +
Sbjct: 142 HILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN--------- 189
Query: 688 TKGYVAPEWFR-------NSTITAKVDVYSFGVLLLEIISCRKSF 725
YV W+R T VD++S G ++ E+ + + F
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 45/229 (19%), Positives = 92/229 (40%), Gaps = 51/229 (22%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 583
+G G++G+V + T VA+KK+ F E+ ++ H+N++
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEI---VAIKKI-EPFDKPLFALRTLREIKILKHFKHENII 72
Query: 584 RLL-----GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPSWNLRTNI 625
+ + ++ E L++ + F++
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY------------- 119
Query: 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAI 685
Q R + LH + +IH D+KP N+L++ + ++ DFGLA+++ + + +
Sbjct: 120 --QTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 686 RGTK--GYVAPEWFR------NSTI-TAKVDVYSFGVLLLEIISCRKSF 725
+ + +VA W+R S + +DV+S G +L E+ R F
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 4e-19
Identities = 53/243 (21%), Positives = 104/243 (42%), Gaps = 46/243 (18%)
Query: 519 EATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVV 573
+ D +E +G GS+G V + + + VA+KK+ RVF+D + K E+ +
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRV---VAIKKILRVFED-LIDCKRILREIAI 105
Query: 574 IGQTHHKNLVRLLGFC----DEGQNRL-LVYEFLNNGT-LASFLFGNLKPSWNLRTNIAF 627
+ + +H ++V++L E + L +V E + + + + +
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLY 163
Query: 628 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRG 687
+ G+ Y+H SA I+H D+KP N L++ + ++ DFGLA+ + ++ + I
Sbjct: 164 NLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 688 TK-------------------GYVAPEWFR------NSTI-TAKVDVYSFGVLLLEIISC 721
+ G+V W+R T +DV+S G + E+++
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280
Query: 722 RKS 724
K
Sbjct: 281 IKE 283
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 4e-19
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 583
+ +G G+ GIV + VA+KKL R FQ+ K E+V++ +HKN++
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 584 RLL------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637
LL +E Q+ LV E ++ L + L + + +Q+ G+ +LH
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDH--ERMSYLLYQMLCGIKHLH 181
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
SA IIH D+KP NI++ +I DFGLA+ + + T T+ Y APE
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVI 235
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSF 725
VD++S G ++ E++ + F
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 60/228 (26%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 583
+ VG G++G V V T VA+KKL R FQ K E+ ++ H+N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAK---VAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 87
Query: 584 RLL------GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPSWNLRTN 624
LL D+ + LV F L + ++
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY------------ 135
Query: 625 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA 684
Q+ +GL Y+H +A IIH D+KP N+ +++ +I DFGLA+ +
Sbjct: 136 ---QMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT------ 183
Query: 685 IRGTKGYVAPEWFR-------NSTITAKVDVYSFGVLLLEIISCRKSF 725
GYV W+R T VD++S G ++ E+I+ + F
Sbjct: 184 -----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 21/205 (10%)
Query: 529 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 588
G G+FG+ + T+ VAVK ++R E + E++ H N+VR
Sbjct: 29 GSGNFGVARLMRDKLTKEL---VAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEV 84
Query: 589 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHEDCSAQI 644
+ ++ E+ + G L + + + A F Q+ G+ Y H S QI
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGR----FSEDEARFFFQQLLSGVSYCH---SMQI 137
Query: 645 IHCDIKPQNILLDD--YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI 702
H D+K +N LLD +I DFG +K L+ K+ + GT Y+APE
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTV-GTPAYIAPEVLLRQEY 194
Query: 703 T-AKVDVYSFGVLLLEIISCRKSFD 726
DV+S GV L ++ F+
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 47/160 (29%), Positives = 84/160 (52%), Gaps = 23/160 (14%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVVI 574
+ ++ E+VG G++G+VYK R VA+K++ R+ D E E E+ ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRI----VALKRI-RL--DAEDEGIPSTAIREISLL 73
Query: 575 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIAR 631
+ HH N+V L+ + LV+EF+ L L L+ S ++ +Q+ R
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDS-QIKI-YLYQLLR 130
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671
G+ + H +I+H D+KPQN+L++ +++DFGLA+
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 1e-18
Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 23/160 (14%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVVI 574
+ + E++G G++G+VYK T A+KK + + E E E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET----FALKK---IRLEKEDEGIPSTTIREISIL 54
Query: 575 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIAR 631
+ H N+V+L + +LV+E L+ L L G L+ ++ Q+
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESV-TAKS-FLLQLLN 111
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671
G+ Y H +++H D+KPQN+L++ +I+DFGLA+
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 1e-18
Identities = 52/218 (23%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 522 DNFE--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVV 573
+E E++G G++G V+K +T VA+K++ R+ D + E E+ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEI----VALKRV-RL--DDDDEGVPSSALREICL 54
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARG 632
+ + HKN+VRL + LV+EF + L + + + FQ+ +G
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRG----- 687
L + H S ++H D+KPQN+L++ ++++FGLA +A +R
Sbjct: 114 LGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLA--------RAFGIPVRCYSAEV 162
Query: 688 -TKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRK 723
T Y P+ + + + +D++S G + E+ + +
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 50/238 (21%), Positives = 95/238 (39%), Gaps = 57/238 (23%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 583
+GRGS+G VY + T + VA+KK++R+F+D K E+ ++ + ++
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKN---VAIKKVNRMFEDLIDCKRILREITILNRLKSDYII 88
Query: 584 RLLG-FCDEGQNRL----LVYEFLNNGT-LASFLFGNLKPSWNLRTNIA----------F 627
RL + + +V E + L +T I +
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLF----------KTPIFLTEEHIKTILY 136
Query: 628 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRG 687
+ G ++H + IIH D+KP N LL+ + ++ DFGLA+ + + I +
Sbjct: 137 NLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 688 TK--------------GYVAPEWFR------NSTI-TAKVDVYSFGVLLLEIISCRKS 724
+ +V W+R T +D++S G + E+++ +S
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 61/228 (26%), Positives = 92/228 (40%), Gaps = 60/228 (26%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 583
VG G++G V T VAVKKL R FQ K E+ ++ H+N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 91
Query: 584 RLL------GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPSWNLRTN 624
LL +E + LV L + + ++
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY------------ 139
Query: 625 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTA 684
QI RGL Y+H SA IIH D+KP N+ +++ +I DFGLA+ +
Sbjct: 140 ---QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT------ 187
Query: 685 IRGTKGYVAPEWFR------NSTI-TAKVDVYSFGVLLLEIISCRKSF 725
GYVA W+R N VD++S G ++ E+++ R F
Sbjct: 188 -----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 56/195 (28%), Positives = 98/195 (50%), Gaps = 21/195 (10%)
Query: 529 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 585
G G+FG V G + T VAVK L+R D + + E+ + H ++++L
Sbjct: 25 GVGTFGKVKVGKHELTGHK---VAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHEDCS 641
+ +V E+++ G L ++ N + L + F QI G+ Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGR----LDEKESRRLFQQILSGVDYCH---R 134
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
++H D+KP+N+LLD + NA+I+DFGL+ +++ + ++T+ G+ Y APE
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVISGRL 191
Query: 702 -ITAKVDVYSFGVLL 715
+VD++S GV+L
Sbjct: 192 YAGPEVDIWSSGVIL 206
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 50/160 (31%), Positives = 86/160 (53%), Gaps = 21/160 (13%)
Query: 522 DNFE--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVV 573
+NF+ E++G G++G+VYK T VA+KK+ R+ D E E E+ +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEV----VALKKI-RL--DTETEGVPSTAIREISL 55
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIAR 631
+ + +H N+V+LL LV+EFL+ L F+ + L + FQ+ +
Sbjct: 56 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671
GL + H S +++H D+KPQN+L++ +++DFGLA+
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 3e-18
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 522 DNFEEE--VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKEF----KNEVV 572
++F +GRG FG VY + T + A+K L R+ + + +
Sbjct: 189 NDFSVHRIIGRGGFGEVY----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 573 VIGQTHHKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 631
++ +V + + ++L + + +N G L L + S A +I
Sbjct: 245 LVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 303
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
GL ++H + +++ D+KP NILLD++ + RISD GLA + + A GT GY
Sbjct: 304 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGY 356
Query: 692 VAPE-WFRNSTITAKVDVYSFGVLLLEII 719
+APE + + D +S G +L +++
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 28/165 (16%)
Query: 522 DNFE--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVV 573
D + ++G G++G VYK + T T VA+K++ R+ + E+E EV +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNET----VAIKRI-RL--EHEEEGVPGTAIREVSL 86
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIAR 631
+ + H+N++ L L++E+ N L ++ ++ +++ +Q+
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMR-VIKS-FLYQLIN 143
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR-----ISDFGLAK 671
G+ + H S + +H D+KPQN+LL + I DFGLA+
Sbjct: 144 GVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 529 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 585
G GSFG V T+ VA+K + R D + E+ + H ++++L
Sbjct: 18 GEGSFGKVKLATHYKTQQK---VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHEDCS 641
+ ++V E+ G L ++ + + + F QI + Y H
Sbjct: 75 YDVITTPTDIVMVIEYAG-GELFDYIVEKKR----MTEDEGRRFFQQIICAIEYCH---R 126
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+I+H D+KP+N+LLDD N +I+DFGL+ ++T +KT+ G+ Y APE
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVINGKL 183
Query: 702 IT-AKVDVYSFGVLLLEIISCRKSFD 726
+VDV+S G++L ++ R FD
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-------------KE 566
+E E+G G++G V+K + + VA+K++ RV E +
Sbjct: 11 QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRH 67
Query: 567 FKNEVVVIGQTHHKNLVRLL----GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSW 619
+ H N+VRL + + +L LV+E ++ L ++L
Sbjct: 68 LE-------TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 620 NLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679
++ FQ+ RGL +LH ++H D+KPQNIL+ +++DFGLA++ + +
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA- 175
Query: 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
T++ T Y APE S+ VD++S G + E+
Sbjct: 176 --LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 520 ATDNFE--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV--- 573
AT +E E+G G++G VYK + VA+K + RV + +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHF----VALKSV-RV--PNGGGGGGGLPISTV 59
Query: 574 --------IGQTHHKNLVRLL----GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWN 620
+ H N+VRL+ + + ++ LV+E ++ L ++L P
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 621 LRT--NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678
T ++ Q RGL +LH + I+H D+KP+NIL+ +++DFGLA++ + +
Sbjct: 119 AETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 175
Query: 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 720
T + T Y APE ST VD++S G + E+
Sbjct: 176 ---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 37/222 (16%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTT-AVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRL 585
+G+GSFG V ++Q T A+ + + E E+ ++ H LV L
Sbjct: 23 IGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 586 LG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGL 633
F DE + +V + L G L ++L+ N+ F ++ L
Sbjct: 81 WYSFQDEE--DMFMVVDLLLGGDL----R------YHLQQNVHFKEETVKLFICELVMAL 128
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
YL + +IIH D+KP NILLD++ + I+DF +A +L T + GTK Y+A
Sbjct: 129 DYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMA 182
Query: 694 PEWFRNSTI---TAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732
PE F + + VD +S GV E++ R+ + I
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 53/230 (23%), Positives = 99/230 (43%), Gaps = 51/230 (22%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 583
+ +G G G+V+ V VA+KK+ V D + K E+ +I + H N+V
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKR---VAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 584 RLL--------------GFCDEGQNRLLVYEFLNNGT-LASFLFGNLKPSWNLRTN---- 624
++ G E + +V E++ T LA+ L L
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQG-----PLLEEHARL 124
Query: 625 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-YNARISDFGLAKLLTLNQSKAIK- 682
+Q+ RGL Y+H SA ++H D+KP N+ ++ +I DFGLA+++ + S
Sbjct: 125 FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 683 TAIRGTKGYVAPEWFR-------NSTITAKVDVYSFGVLLLEIISCRKSF 725
+ + +W+R + T +D+++ G + E+++ + F
Sbjct: 182 S------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 25/163 (15%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN--------EV 571
+E + +G G F VYK + T+ VA+KK+ ++ E K+ E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKA--RDKNTNQI-VAIKKI-KL--GHRSEAKDGINRTALREI 63
Query: 572 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQ 628
++ + H N++ LL N LV++F+ L + L PS +++
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPS-HIKA-YMLM 120
Query: 629 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671
+GL YLH I+H D+KP N+LLD+ +++DFGLAK
Sbjct: 121 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 22/163 (13%)
Query: 520 ATDNFE--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEKEFKN----EVV 572
++ F+ E++G G++ VYKG+ T VA+K++ ++ D E+ + E+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVY----VALKEV-KL--DSEEGTPSTAIREIS 55
Query: 573 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN---GTLASFLFGNLKPSWNLRT--NIAF 627
++ + H+N+VRL LV+EF++N + S GN L +
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 628 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670
Q+ +GL + H +I+H D+KPQN+L++ ++ DFGLA
Sbjct: 116 QLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 7e-17
Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 27/170 (15%)
Query: 522 DNFE---EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQT 577
D FE +VGRG++G VYK + + A+K+++ G E+ ++ +
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKD-YALKQIEG---TGISMSACREIALLREL 75
Query: 578 HHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN---------IA 626
H N++ L F ++ L++++ + L + + N + +
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR----ISDFGLAKL 672
+QI G+ YLH + ++H D+KP NIL+ R I+D G A+L
Sbjct: 135 YQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKN----EVVVIG 575
+ + +++G G++ VYKG + T VA+K++ ++G EV ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDN---LVALKEIRLEHEEG---APCTAIREVSLLK 55
Query: 576 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARG 632
H N+V L ++ LV+E+L+ L +L + N++ FQ+ RG
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMH-NVKL-FLFQLLRG 112
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671
L Y H +++H D+KPQN+L+++ +++DFGLA+
Sbjct: 113 LAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-17
Identities = 53/225 (23%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 522 DNFE--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVFQDGEKE-FKN----EVVV 573
+E ++G+G+FG V+K +T + VA+KK+ + + EKE F E+ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQK----VALKKV-LM--ENEKEGFPITALREIKI 69
Query: 574 IGQTHHKNLVRLLGFCDEGQNRL--------LVYEFLNN---GTLAS----FLFGNLKPS 618
+ H+N+V L+ C + LV++F + G L++ F +K
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-- 127
Query: 619 WNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678
+ + GL Y+H +I+H D+K N+L+ +++DFGLA+ +L ++
Sbjct: 128 -----RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 679 KAIK--TAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIIS 720
T T Y PE +D++ G ++ E+ +
Sbjct: 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 1e-16
Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 35/185 (18%)
Query: 624 NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT 683
+FQ+A+G+ +L S + IH D+ +NILL + +I DFGLA+ + +
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---- 249
Query: 684 AIRGTKGYV-----APEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAIL 736
+R + APE + T + DV+SFGVLL EI S S +++ EE
Sbjct: 250 -VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---F 305
Query: 737 TDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKL--VMVSIWCIQEDPSLRPTMRKVSQML 794
+ R D T ++ M+ W +PS RPT ++ + L
Sbjct: 306 CRRLKEGTRMRAPDY-------------TTPEMYQTMLDCW--HGEPSQRPTFSELVEHL 350
Query: 795 EGVVE 799
+++
Sbjct: 351 GNLLQ 355
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 35/153 (22%), Positives = 60/153 (39%), Gaps = 12/153 (7%)
Query: 524 FEEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQ-THH 579
+ +GRG+FG V + + VAVK L E + +E+ ++ HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 580 KNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 638
N+V LLG C G +++ EF G L+++L + R +G +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFRQG 138
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671
I D+K + + ++ S F K
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQTHHKNLVRL 585
+G+GSFG V+ + + A+K L + K E ++ + +H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 586 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGLL 634
+ + + +L L+ +FL G L F L + F ++A L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDL----F------TRLSKEVMFTEEDVKFYLAELALALD 140
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694
+LH S II+ D+KP+NILLD+ + +++DFGL+K ++ KA + GT Y+AP
Sbjct: 141 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA--YSFCGTVEYMAP 195
Query: 695 EWFRNSTITAKVDVYSFGVLLLE 717
E T D +SFGVL+ E
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFE 218
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 56/228 (24%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 583
+G G++G+V + VA+KK+ F+ + E+ ++ + H+N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVR---VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENII 88
Query: 584 RLL-----GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPSWNLRTNI 625
+ ++ ++ +V + L+N + FL+
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY------------- 135
Query: 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK-TA 684
QI RGL Y+H SA ++H D+KP N+LL+ + +I DFGLA++ + T
Sbjct: 136 --QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT- 189
Query: 685 IRGTKGYVAPEWFR-------NSTITAKVDVYSFGVLLLEIISCRKSF 725
YVA W+R + T +D++S G +L E++S R F
Sbjct: 190 -----EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 33/223 (14%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDRVFQDGEKEFK-----NEVVVIGQT 577
++G G F V+ T VA+K + E E K N+ +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNT---HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 578 H--HKNLVRLLG-FCDEGQNRL---LVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQI 629
++++LL F +G N + +V+E L L + + L I+ Q+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDD------YYNARISDFGLAKLLTLNQSKAIKT 683
GL Y+H C IIH DIKP+N+L++ +I+D G A + + +I+
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ- 197
Query: 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 726
T+ Y +PE + D++S L+ E+I+ F+
Sbjct: 198 ----TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 24/204 (11%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKE-FKNEVVVIGQTHHKNLV 583
+GRG+F V T V A+K + + + GE F+ E V+ + +
Sbjct: 69 IGRGAFSEVA----VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 584 RLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDC 640
+L F + +N L LV E+ G L + L FG P+ R +A +I + +H
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVH--- 179
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS 700
+H DIKP NILLD + R++DFG L + + A+ GT Y++PE +
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAV 238
Query: 701 TITAKVDVY-------SFGVLLLE 717
Y + GV E
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYE 262
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 30/213 (14%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKE-FKNEVVVIG 575
++FE + +GRG+FG V + V A+K L + + E F+ E V+
Sbjct: 74 EDFEILKVIGRGAFGEVA----VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV 129
Query: 576 QTHHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QI 629
K + L F D+ N L LV ++ G L + L K L +A F ++
Sbjct: 130 NGDSKWITTLHYAFQDD--NNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEM 184
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
+ +H +H DIKP NIL+D + R++DFG L + + A+ GT
Sbjct: 185 VIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTP 240
Query: 690 GYVAPEWFRNSTITAK-----VDVYSFGVLLLE 717
Y++PE + D +S GV + E
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 6e-16
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 34/214 (15%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQTHHKNLV 583
+G+G+FG K VI +T A+K L + + E E V+ + H L
Sbjct: 156 LGKGTFG---K-VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 584 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARG 632
L + + +RL V E+ N G L F ++L F +I
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGEL----F------FHLSRERVFSEDRARFYGAEIVSA 260
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
L YLH + + +++ D+K +N++LD + +I+DFGL K + +KT GT Y+
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKT-FCGTPEYL 316
Query: 693 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 726
APE ++ VD + GV++ E++ R F
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-16
Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 21/200 (10%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKE-FKNEVVVIGQTHHKNLV 583
+GRG+FG V ST V A+K L + + + F E ++ + +V
Sbjct: 77 IGRGAFGEVQ----LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 584 RLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 641
+L F D+ L +V E++ G L + + P R A ++ L +H S
Sbjct: 133 QLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLALDAIH---S 186
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
IH D+KP N+LLD + +++DFG + TA+ GT Y++PE ++
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245
Query: 702 ITAK----VDVYSFGVLLLE 717
D +S GV L E
Sbjct: 246 GDGYYGRECDWWSVGVFLYE 265
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 43/206 (20%), Positives = 76/206 (36%), Gaps = 53/206 (25%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNL 582
+ +G G G V + + + A+K L + + EV + + + ++
Sbjct: 22 TSQVLGLGINGKVLQI---FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHI 73
Query: 583 VRLLGFCDEGQNR----LLVYEFLNNGTLASFLF------GNLKPSWNLRTNIAFQIARG 632
VR++ + L+V E L+ G LF G+ + + I I
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 633 LLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
+ YLH S I H D+KP+N+L +++DFG AK T +
Sbjct: 130 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------GE 173
Query: 690 GYVAPEWFRNSTITAKVDVYSFGVLL 715
Y D++S GV++
Sbjct: 174 KY-----------DKSCDMWSLGVIM 188
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKE-FKNEVVVIG 575
D F+ + +G GSFG V + A+K L +V + + E NE ++
Sbjct: 41 DQFDRIKTLGTGSFGRVM----LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 576 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIAR 631
+ LV+L + N +V E++ G + F +L+ A F QI
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY 691
YLH S +I+ D+KP+N+L+D +++DFG AK + K + GT
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEA 204
Query: 692 VAPEWFRNSTITAKVDVYSFGVLLLE 717
+APE + VD ++ GVL+ E
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYE 230
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 35/214 (16%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQTHHKNLV 583
+G+G+FG K VI +T A+K L + + E E V+ T H L
Sbjct: 13 LGKGTFG---K-VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 584 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARG 632
L + + +RL V E+ N G L F ++L F +I
Sbjct: 69 ALK-YAFQTHDRLCFVMEYANGGEL----F------FHLSRERVFTEERARFYGAEIVSA 117
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
L YLH S +++ DIK +N++LD + +I+DFGL K + + KT GT Y+
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KT-FCGTPEYL 172
Query: 693 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 726
APE ++ VD + GV++ E++ R F
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 7e-15
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 40/213 (18%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKE-FKNEVVVIG 575
+F+ +G GSFG V+ A+K L + V + + E +E +++
Sbjct: 6 QDFQILRTLGTGSFGRVH----LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 576 QTHHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QI 629
H ++R+ G F D ++ ++ +++ G L F L+ S +A F ++
Sbjct: 62 IVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEV 115
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL-----TLNQSKAIKTA 684
L YLH S II+ D+KP+NILLD + +I+DFG AK + TL
Sbjct: 116 CLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL--------- 163
Query: 685 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLE 717
GT Y+APE +D +SFG+L+ E
Sbjct: 164 -CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 195
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 21/200 (10%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DRVFQDGEKEF---KNEVVVIGQTHHKNL 582
+G+G +G V++ T + A+K L + ++ K+ K E ++ + H +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFI 83
Query: 583 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 637
V L+ + + +L L+ E+L+ G L F L+ + A F +I+ L +LH
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
II+ D+KP+NI+L+ + +++DFGL K + + T GT Y+APE
Sbjct: 139 ---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HT-FCGTIEYMAPEIL 193
Query: 698 RNSTITAKVDVYSFGVLLLE 717
S VD +S G L+ +
Sbjct: 194 MRSGHNRAVDWWSLGALMYD 213
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 68/223 (30%), Positives = 104/223 (46%), Gaps = 26/223 (11%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQ-THHKNL 582
+G+GSFG K V+ T + AVK L D + QD + E E ++ +H L
Sbjct: 31 LGKGSFG---K-VMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 583 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 637
+L C + +RL V EF+N G L +++ S A F +I L++LH
Sbjct: 87 TQLF-CCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
II+ D+K N+LLD + +++DFG+ K N GT Y+APE
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFCGTPDYIAPEIL 196
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 738
+ VD ++ GVLL E++ F+ E ++ AIL D
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQ-THHKNL 582
+G+GSFG K V+ + AVK L + + E++ +E V+ + H L
Sbjct: 46 IGKGSFG---K-VLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 583 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 637
V L F + ++L V +++N G L F +L+ A F +IA L YLH
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
S I++ D+KP+NILLD + ++DFGL K + S + GT Y+APE
Sbjct: 157 ---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--STFCGTPEYLAPEVL 211
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFD 726
VD + G +L E++ F
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 69/223 (30%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQ-THHKNL 582
+G+GSFG K V+ + R T + AVK L D V QD + E E V+ L
Sbjct: 28 LGKGSFG---K-VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 583 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 637
+L C + +RL V E++N G L +++ + A F +IA GL +L
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
II+ D+K N++LD + +I+DFG+ K + KT GT Y+APE
Sbjct: 139 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT-KT-FCGTPDYIAPEII 193
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 738
VD ++FGVLL E+++ + F+ E +E +I+
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DRVFQDGEKEF--KNEVVVIGQT-HHKNL 582
+G G++G V+ + + A+K L + Q + + E V+ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 583 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 637
V L + + + +L L+ +++N G L F +L + +I L +LH
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL----FTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
II+ DIK +NILLD + ++DFGL+K ++++ GT Y+AP+
Sbjct: 177 ---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIV 232
Query: 698 RNSTI--TAKVDVYSFGVLLLEIISCRKSFDIE 728
R VD +S GVL+ E+++ F ++
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 70/223 (31%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQ-THHKNL 582
+G+GSFG K V+ + R T + AVK L D V QD + E E V+ L
Sbjct: 349 LGKGSFG---K-VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 583 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 637
+L C + +RL V E++N G L +++ + A F +IA GL +L
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
S II+ D+K N++LD + +I+DFG+ K + KT GT Y+APE
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT-KT-FCGTPDYIAPEII 514
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 738
VD ++FGVLL E+++ + F+ E +E +I+
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQ-THHKNL 582
+GRGS+ K V+ T + A+K + + V D + ++ + E V Q ++H L
Sbjct: 17 IGRGSYA---K-VLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 583 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 637
V L C + ++RL V E++N G L +++ L A F +I+ L YLH
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
II+ D+K N+LLD + +++D+G+ K + GT Y+APE
Sbjct: 128 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEIL 182
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732
R VD ++ GVL+ E+++ R FDI +
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 67/231 (29%), Positives = 99/231 (42%), Gaps = 42/231 (18%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKEF----KNEVVVIGQTHHK 580
+G+GSFG K V T A+K L D V D + E K V+ H
Sbjct: 25 LGKGSFG---K-VFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR--VLSLAWEHP 78
Query: 581 NLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QI 629
L + + + L V E+LN G L +++++ F +I
Sbjct: 79 FLTHMF-CTFQTKENLFFVMEYLNGGDL----M------YHIQSCHKFDLSRATFYAAEI 127
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
GL +LH I++ D+K NILLD + +I+DFG+ K L +K GT
Sbjct: 128 ILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTP 182
Query: 690 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 738
Y+APE VD +SFGVLL E++ + F + EE ++I D
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 50/211 (23%), Positives = 82/211 (38%), Gaps = 39/211 (18%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDRVFQDGEKEFK--NEVVVIGQTHHK 580
+ +G+GSFG V K VA+K R + +E + + + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQH---VALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 581 NLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 629
N++ +L E N +YE + F S L A I
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMN---LYELIKKNKFQGF-------SLPLVRKFAHSI 209
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA--RISDFGLAKLLTLNQSKAIKTAIRG 687
+ L LH +IIHCD+KP+NILL + ++ DFG + I+
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ----- 261
Query: 688 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEI 718
++ Y APE + +D++S G +L E+
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 24/215 (11%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQ-THHKNL 582
+GRGS+ K V+ T + A++ + + V D + ++ + E V Q ++H L
Sbjct: 60 IGRGSYA---K-VLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 583 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 637
V L C + ++RL V E++N G L +++ L A F +I+ L YLH
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
E II+ D+K N+LLD + +++D+G+ K + GT Y+APE
Sbjct: 171 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEIL 225
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732
R VD ++ GVL+ E+++ R FDI +
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 50/201 (24%), Positives = 81/201 (40%), Gaps = 19/201 (9%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDRVFQDGEKEFK--NEVVVIGQTHHK 580
+G+GSFG V K + + VA+K + E + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEW---VAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 638
+V L + LV+E L+ L L +L A Q+ LL+L
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 639 DCSAQIIHCDIKPQNILLDDYYNA--RISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
IIHCD+KP+NILL + + +I DFG + + I I+ ++ Y +PE
Sbjct: 176 P-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQYIQ-SRFYRSPEV 229
Query: 697 FRNSTITAKVDVYSFGVLLLE 717
+D++S G +L+E
Sbjct: 230 LLGMPYDLAIDMWSLGCILVE 250
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 2e-11
Identities = 35/240 (14%), Positives = 65/240 (27%), Gaps = 69/240 (28%)
Query: 520 ATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL--------DRVFQDGEKEFKN 569
T+ + E++G G FG V++ T VA+K + + Q +E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQT-----IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 570 EVVV---------IGQTHHKNLVRLLGFC------------------------------D 590
E+++ + + L
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 591 EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIK 650
+ +V EF G + L S +I Q+ L + H D+
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKL-SSLATAKSILHQLTASLAVAEASL--RFEHRDLH 189
Query: 651 PQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGY-VAPEWFRNSTITAKVDVY 709
N+LL ++ K T+ + G V+ + S + V
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTI-----------PSCGLQVSIIDYTLSRLERDGIVV 238
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 48/211 (22%), Positives = 79/211 (37%), Gaps = 65/211 (30%)
Query: 579 HKNLVRLLG-FCDEGQN---RLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIAR 631
+ +V+LL F G N +V+E L + L ++ P ++ I Q+ +
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK-IIQQVLQ 157
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILL--DDYY----------------------------- 660
GL YLH C +IIH DIKP+NILL ++ Y
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 661 ------------------NARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI 702
+I+D G A + + ++ I+ T+ Y + E S
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSGY 270
Query: 703 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 733
D++S + E+ + F+ GEEY
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEY 301
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 45/228 (19%), Positives = 83/228 (36%), Gaps = 57/228 (25%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDRVFQDGEKEFK--NEVVVIGQTHHK 580
+G G+FG V + + R + VA+K + + + E ++ + +
Sbjct: 25 GNLGEGTFGKVVE-CLDHARGKSQ-VALKIIRNVGKYREAARLEINVLKKIKEKDKENKF 82
Query: 581 NLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 629
V + + + E G+N +EFL + ++A+Q+
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGKN---TFEFLKENNFQPY-------PLPHVRHMAYQL 132
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK------- 682
L +LHE Q+ H D+KP+NIL + + + + ++ +I+
Sbjct: 133 CHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 683 -------TAIRGTKGYVAPE------WFRNSTITAKVDVYSFGVLLLE 717
T I T+ Y PE W DV+S G +L E
Sbjct: 190 TFDHEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFE 231
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 1e-10
Identities = 78/542 (14%), Positives = 155/542 (28%), Gaps = 182/542 (33%)
Query: 348 DFELSCNGGGQ---GYNKELFDFHE--LKDTD-----------WPSSDYEHF--SPYDEV 389
DFE G+ Y L F + + + D + +H S
Sbjct: 8 DFET-----GEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVS 62
Query: 390 QCKNTCLSDCFC-----AVAIFGIESC------WLVKLPLNNGRADSSVNRKAFIKYK-- 436
L V F +E +L+ P+ + S+ + +I+ +
Sbjct: 63 GTLR--LFWTLLSKQEEMVQKF-VEEVLRINYKFLMS-PIKTEQRQPSMMTRMYIEQRDR 118
Query: 437 --KDDDPDPP-SVPRPPDPEDKKKRKMMNA--TGSVLL------GSSVFVNFAMVC---A 482
D+ +V R P K ++ ++ +VL+ G + VC
Sbjct: 119 LYNDNQVFAKYNVSRL-QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA--LDVCLSYK 175
Query: 483 FVLGFFF-IYKKKWI----RNNPGD---------ATIETNL--RCFSYKELEEATDNFEE 526
F I+ W+ N+P I+ N R ++ + +
Sbjct: 176 VQCKMDFKIF---WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 527 EVGR-----------------------GSFGIVYKGVIQTTR----------TSTTAVAV 553
E+ R +F + K ++ TTR +TT +++
Sbjct: 233 ELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK-ILLTTRFKQVTDFLSAATTTHISL 291
Query: 554 KKLDRVFQDGE-------------KEFKNEVVVIGQTHHKNLVRLLG-FCDEGQNRLLVY 599
E ++ EV+ T + + ++ +G +
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVL----TTNPRRLSIIAESIRDGLATWDNW 347
Query: 600 EFLNNGTLASFL---FGNLKPSWNLRTN-----IAFQ----IARGLL------------- 634
+ +N L + + L+P+ R + F I LL
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPA-EYRKMFDRLSV-FPPSAHIPTILLSLIWFDVIKSDVM 405
Query: 635 -YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
+++ ++ K I + Y L + L A+ +I Y
Sbjct: 406 VVVNKLHKYSLVEKQPKESTISIPSIY--------LELKVKLENEYALHRSIVDH--YNI 455
Query: 694 PEWFRNSTITA-KVDVYSFGVL---LLEIISCRKSFDIEMGEEYAILTDWAFDCYR--NG 747
P+ F + + +D Y + + L +IE E + D +R
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHL---------KNIEHPERMTLFRMVFLD-FRFLEQ 505
Query: 748 KL 749
K+
Sbjct: 506 KI 507
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 2e-04
Identities = 46/357 (12%), Positives = 104/357 (29%), Gaps = 90/357 (25%)
Query: 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD-RVFQDGEKE-FKNEVV--VIGQTHHKNL 582
E G + YK ++ + V D + QD K E + +I +
Sbjct: 10 ETGEHQYQ--YKDILSVFEDAF----VDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSG 63
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
L + + +V +F+ ++ F L + R + +
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLRINYKF--LMSPIKTEQRQPSMMTRMYIEQRDR--- 118
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAK--LLTLNQSKAIKTAIRGTKGY----VAPEW 696
++ D + Y +R+ + + LL L +K + I G G VA +
Sbjct: 119 --LYNDNQV----FAKYNVSRLQPYLKLRQALLELRPAKNV--LIDGVLGSGKTWVALDV 170
Query: 697 FRNSTITAKVD--VY--SFG-----VLLLEII-----------------SCRKSFDIE-- 728
+ + K+D ++ + +LE++ S I
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 729 --------MGEEYA----ILTD-W------AFD--C-----YRNGKLDDLVEGDTE---A 759
+ Y +L + AF+ C R ++ D + T +
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290
Query: 760 MNDIKCT----EKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFSGY 812
++ T E ++ + L + + ++ + + + +
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW 347
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 20/156 (12%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNL 582
+++G G+FG + G T VA+K + E++ + +
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEY---VAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---I 67
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 640
++ F G+ +V E L G LF +++L+T IA Q+ + Y+H
Sbjct: 68 PQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH--- 122
Query: 641 SAQIIHCDIKPQNILLDDYYNAR-----ISDFGLAK 671
S +I+ D+KP+N L+ N I DF LAK
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 62.0 bits (149), Expect = 1e-10
Identities = 42/272 (15%), Positives = 71/272 (26%), Gaps = 40/272 (14%)
Query: 24 AQNNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTV 83
+P TL+AG +SP+ F + N L I N
Sbjct: 11 GVGTSVLPAYQTLSAG---QYLLSPNQRFKLLLQ-----GDGN----LVIQDNGATVWVA 58
Query: 84 VWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGT------VAIGVMND 137
P + + + G L+D ++VW + T V+ D
Sbjct: 59 NEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQD 118
Query: 138 TGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDGD 197
GN VL S + + ++ L G + DG+
Sbjct: 119 DGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGA---GASKLVFQGDGN 175
Query: 198 LVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDLTTGRV 257
LV A + +GT R +F G + + + +
Sbjct: 176 LVAY------GPNGAATWNAGT-----QGKGAVRAVFQGDGNLVVYGAGNAVL-WHSH-- 221
Query: 258 VPAADFYHRATLNFDGVFAQYFYPKNGNGNWS 289
L +G A + W+
Sbjct: 222 -TGGHASAVLRLQANGSIAIL----DEKPVWA 248
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.3 bits (98), Expect = 4e-04
Identities = 10/80 (12%), Positives = 20/80 (25%), Gaps = 7/80 (8%)
Query: 81 KTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGTVAIGVMNDTGN 140
W + + + D LV+ +W S A+ + G+
Sbjct: 183 GAATWNAGTQGKG-----AVRAVFQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGS 237
Query: 141 FVLASSSSSKLWDSFTNPSD 160
+ +W F
Sbjct: 238 IAILDEKP--VWARFGFQPT 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 33/173 (19%), Positives = 63/173 (36%), Gaps = 31/173 (17%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDRVFQDGEKEFK--NEVVVIGQTHHK 580
+ +G G+FG V + + VAVK +DR + E + +
Sbjct: 20 DTLGEGAFGKVVEC--IDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTF 77
Query: 581 NLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 629
V++L + + E G + Y+F+ F + +A+QI
Sbjct: 78 RCVQMLEWFEHHGHICIVFELLGLS---TYDFIKENGFLPF-------RLDHIRKMAYQI 127
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682
+ + +LH ++ H D+KP+NIL + + + + IK
Sbjct: 128 CKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 34/157 (21%), Positives = 63/157 (40%), Gaps = 20/157 (12%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKN 581
+G GSFG++++G VA+K E++ ++ G T
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQ---QVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG--- 67
Query: 582 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 639
+ + F EG + +LV + L G L ++++T A Q+ + +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH-- 123
Query: 640 CSAQIIHCDIKPQNILLDDYYNAR-----ISDFGLAK 671
+++ DIKP N L+ + + DFG+ K
Sbjct: 124 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 32/168 (19%), Positives = 67/168 (39%), Gaps = 26/168 (15%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTA-----VAVK------KLDRVFQDGEKEFKNEVVV 573
+ R + GI+Y+ +T T + ++K +L ++ K V
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 574 IGQTHHKNLV----RLLGF-CDEGQNRLLVYEFLNNGT-LASFLFGNLKPSWNLRT--NI 625
+ + + +GF + + R LV L G L S L + K + R+ +
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQV 164
Query: 626 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI--SDFGLAK 671
A ++ L +LH + +H ++ +NI +D +++ + +G A
Sbjct: 165 ACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 47/237 (19%), Positives = 79/237 (33%), Gaps = 71/237 (29%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDRVFQDGEKEFK-----NEVVVIGQT 577
++G G+FG V + AVK + + + + E
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKY---YAVKVVRNIKKYTRSAKIEADILKKIQN----DDI 93
Query: 578 HHKNLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA 626
++ N+V+ G E G + +YE + F
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPLGPS---LYEIITRNNYNGF-------HIEDIKLYC 143
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDD--YYNARISDFGLAKLLTLNQSKAIKTA 684
+I + L YL + + H D+KP+NILLDD + + I+ + + + T
Sbjct: 144 IEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 685 IR----G--------------TKGYVAPE------WFRNSTITAKVDVYSFGVLLLE 717
I+ G T+ Y APE W D++SFG +L E
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAE 251
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 40/153 (26%), Positives = 60/153 (39%), Gaps = 16/153 (10%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLV 583
++G GSFG +Y G VA+K + + E + +
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGE---EVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIP 68
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 641
+ EG ++V E L G LF ++L+T +A Q+ + Y+H S
Sbjct: 69 TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 123
Query: 642 AQIIHCDIKPQNILLDDYYNA---RISDFGLAK 671
IH D+KP N L+ I DFGLAK
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 42/153 (27%), Positives = 63/153 (41%), Gaps = 16/153 (10%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV- 583
++G GSFG +Y G T VA+K + + + E + +
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNE---EVAIKLENV--KTKHPQLLYESKIYRILQGGTGIP 66
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 641
+ F EG +LV + L G LF +L+T +A Q+ + ++H S
Sbjct: 67 NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---S 121
Query: 642 AQIIHCDIKPQNILLDDYYNAR---ISDFGLAK 671
+H DIKP N L+ A I DFGLAK
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 33/167 (19%), Positives = 56/167 (33%), Gaps = 27/167 (16%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFK-----NEVVVIGQTHH 579
+++G G FG++Y VK + E K + I +
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 580 KNLVRLLGF----------CDEGQNRLLVYEFLNNGT-LASFLFGNLKPSWNLRT--NIA 626
+ + LG R +V E L G L N T +
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFK--KSTVLQLG 157
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI--SDFGLAK 671
++ L Y+H + +H DIK N+LL ++ +D+GL+
Sbjct: 158 IRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 29/165 (17%), Positives = 67/165 (40%), Gaps = 26/165 (15%)
Query: 528 VGRGSFGIVYKGVIQTTRTSTTA--VAVKKL----------DRVFQD-GEKEFKNEVVVI 574
+G+G FG +Y + ++ + + VK + +Q + E + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 575 GQTHHKNLVRLLGFCDEGQN----RLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQ 628
+ + + + G +N R ++ + G+ ++ ++ +T ++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 629 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI--SDFGLAK 671
I L Y+H + +H DIK N+LL+ ++ D+GLA
Sbjct: 161 ILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-06
Identities = 28/135 (20%), Positives = 45/135 (33%), Gaps = 30/135 (22%)
Query: 159 SDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSG 218
SD L G ++T L G + F + D +LVL N A + SG
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNN-------RAVWASG 44
Query: 219 TYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDLTTGRVVPAADFYHRATLNFDGVFAQY 278
T SG + G + I + + T R + + L D Y
Sbjct: 45 TN----GKASGCVLKMQNDGNLVIYSGSRAIWASNTNR----QNGNYYLILQRDRNVVIY 96
Query: 279 FYPKNGNGNWSAVWS 293
+ + +A+W+
Sbjct: 97 ------DNSNNAIWA 105
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-05
Identities = 19/78 (24%), Positives = 35/78 (44%), Gaps = 7/78 (8%)
Query: 81 KTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTG 139
T VW ++ +G + L +D V+ D +G+ +W+S G + V+ + G
Sbjct: 37 STSVWASN---TGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDG 93
Query: 140 NFVLASSSSSKLWDSFTN 157
N V+ S +W + T
Sbjct: 94 NVVI---YGSDIWSTGTY 108
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-05
Identities = 14/79 (17%), Positives = 30/79 (37%), Gaps = 8/79 (10%)
Query: 82 TVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGTVAIG-VMNDTGN 140
VW ++ G ++ L + LV+ D + +W +K + V+ N
Sbjct: 39 KPVWASNTGGLGS----GCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRN 94
Query: 141 FVLASSSSSKLWDSFTNPS 159
V+ +W + + P+
Sbjct: 95 VVI---YGPVVWATGSGPA 110
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 39.4 bits (92), Expect = 5e-04
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 27/98 (27%)
Query: 104 LTADRGLVLNDPQGKQVWSSKID-IGTVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTL 162
+ D VL D GK VW+S +G+ +++ GN V+ S+ +W
Sbjct: 26 MQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIW---------- 74
Query: 163 LPGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDGDLVL 200
++ TN + L +D ++V+
Sbjct: 75 ---------------QTKTNGKEDHYVLVLQQDRNVVI 97
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 1e-04
Identities = 34/219 (15%), Positives = 65/219 (29%), Gaps = 32/219 (14%)
Query: 84 VWYTDNK---DQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGTVA-IGVMNDTG 139
V + + N A G + L +D LV+ Q WSS + V+
Sbjct: 39 VLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDR 98
Query: 140 NFVLASSSSSKLWDSFTN-----PSDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLLE 194
+ S + + + + + + ++ +
Sbjct: 99 TVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMET 158
Query: 195 DGDLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDLTT 254
D +LVL + D +++ T +G R + +G M +L + T+
Sbjct: 159 DCNLVLFDRD-------DRVWSTNTAG----KGTGCRAVLQPNGRMDVLTNQNIAV-WTS 206
Query: 255 GRVVPAADFYHRATLNFDGVFAQYFYPKNGNGNWSAVWS 293
G A + L D A Y A+W+
Sbjct: 207 GNSRSAGRY--VFVLQPDRNLAIY---------GGALWT 234
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 6e-04
Identities = 33/220 (15%), Positives = 66/220 (30%), Gaps = 28/220 (12%)
Query: 104 LTADRGLVLNDPQGKQVWSSKIDIGTVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLL 163
+ +D LVL D +VW+S T V+ G V+ ++ ++ W S T S
Sbjct: 32 MQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIG-- 88
Query: 164 PGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDST 223
++ + + G + + ++ + + + +
Sbjct: 89 NYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQ---GNDNHPQTLHATQ 145
Query: 224 NSSNSGYRVMFNESGYMYILRRNSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYFYPKN 283
+ S YR+ + + R+ + + T RA L +G
Sbjct: 146 SLQLSPYRLSMETDCNLVLFDRDDRVWSTNT----AGKGTGCRAVLQPNGRMDVL----- 196
Query: 284 GNGNWSAVWSQPENICDNISGEFGSGACGFNSICTLDGDR 323
AVW+ G+ + L DR
Sbjct: 197 -TNQNIAVWT------------SGNSRSAGRYVFVLQPDR 223
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 3e-04
Identities = 16/118 (13%), Positives = 36/118 (30%), Gaps = 27/118 (22%)
Query: 84 VWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKID-IGTVAIGVMNDTGNFV 142
+ + + + + D LVL D +W++ +G V+ G V
Sbjct: 16 ILHATESLEILFGTHVYRFIMQTDCNLVLYD-NNNPIWATNTGGLGNGCRAVLQPDGVLV 74
Query: 143 LASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDGDLVL 200
+ ++ + +W +S G + L D ++V+
Sbjct: 75 VITNENVTVW-------------------------QSPVAGKAGHYVLVLQPDRNVVI 107
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 39.1 bits (91), Expect = 7e-04
Identities = 27/151 (17%), Positives = 43/151 (28%), Gaps = 42/151 (27%)
Query: 159 SDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSG 218
+ LL GQ + + L + G + + +LV + S
Sbjct: 2 DNVLLSGQTLHADHSLQA---------GAYTLTIQNKCNLVKYQNG-------RQIWASN 45
Query: 219 TYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDLTTGRVVPAADFY-----HRATLNFDG 273
T SG R+ G + I N V + + + L DG
Sbjct: 46 TD----RRGSGCRLTLLSDGNLVIYDHN--------NNDVWGSACWGDNGKYALVLQKDG 93
Query: 274 VFAQYFYPKNGNGNWSAVWSQPENICDNISG 304
F Y +WS N C ++G
Sbjct: 94 RFVIY---------GPVLWSLGPNGCRRVNG 115
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 814 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.8 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.8 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.79 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.79 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.76 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.75 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.71 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.65 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.63 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.62 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.62 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.6 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.58 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.55 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.53 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.44 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.4 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.28 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.25 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.23 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.22 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.17 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.05 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.04 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.97 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.93 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.76 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.7 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.97 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.92 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.79 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.68 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.64 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.58 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.27 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.9 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.71 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.58 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.44 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.33 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.49 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.39 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.37 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.23 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.71 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 94.58 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 94.47 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.85 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 88.97 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 84.45 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 80.52 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=449.42 Aligned_cols=269 Identities=26% Similarity=0.380 Sum_probs=219.7
Q ss_pred CHHHHHHHHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeee
Q 042262 513 SYKELEEATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFC 589 (814)
Q Consensus 513 ~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 589 (814)
.++|+...+..|.++||+|+||+||+|.+.. ....++.||||+++.... ...++|.+|+.++++++|||||+++|+|
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 3344555566788999999999999999853 223567899999975433 3356899999999999999999999999
Q ss_pred ccCCceehhhhhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 042262 590 DEGQNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 653 (814)
Q Consensus 590 ~~~~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~N 653 (814)
.+++..+|||||+++|+|.++|... ..++|..+++|+.|||+||+|||+ .+||||||||+|
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~N 175 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRN 175 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccc
Confidence 9999999999999999999999542 358999999999999999999995 599999999999
Q ss_pred EEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcc
Q 042262 654 ILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 732 (814)
Q Consensus 654 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~ 732 (814)
|||++++.+||+|||+++.+.............||.+|||||++.++.++.++|||||||+||||+| |+.||......+
T Consensus 176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999998765544443455679999999999999999999999999999999999 899997543211
Q ss_pred hhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 733 YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 733 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
+...+..+... ..+..++.++.+|+.+||+.||++||||.||++.|+....+
T Consensus 256 -------~~~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl 307 (308)
T 4gt4_A 256 -------VVEMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307 (308)
T ss_dssp -------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred -------HHHHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence 22333333322 12346778899999999999999999999999999876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-52 Score=448.85 Aligned_cols=259 Identities=25% Similarity=0.452 Sum_probs=208.4
Q ss_pred hhhccccccceeEEEEEEEec--cCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.++||+|+||+||+|.+.. ...++..||||+++.......++|.+|++++++++|||||+++|+|.+++..+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 456789999999999999863 233578999999987666667889999999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEe
Q 042262 601 FLNNGTLASFLFGN---------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 665 (814)
Q Consensus 601 ~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 665 (814)
|+++|+|.++++.. ..++|.++++|+.|||+||+|||+ .+||||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEc
Confidence 99999999998653 358999999999999999999995 599999999999999999999999
Q ss_pred ecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHH
Q 042262 666 DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY 744 (814)
Q Consensus 666 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 744 (814)
|||+++.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +...+
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~~~i 273 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AIDCI 273 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------HHHHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------HHHHH
Confidence 9999998765544433455679999999999999999999999999999999999 899997543211 12223
Q ss_pred hcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 745 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
..+... ..+..+++++.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 274 ~~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 333211 12345678899999999999999999999999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=447.25 Aligned_cols=260 Identities=23% Similarity=0.460 Sum_probs=215.7
Q ss_pred HhhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.+.+.++||+|+||+||+|.+.. .+.++..||||+++.......++|.+|++++++++|||||+++|+|.+++..+||
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 34567899999999999999863 2235778999999876666678899999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEe
Q 042262 599 YEFLNNGTLASFLFGN-------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 665 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 665 (814)
|||+++|+|.++|+.. ..++|.++++|+.|||+||+|||+ .+||||||||+||||++++.+||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEEC
Confidence 9999999999999643 468999999999999999999995 599999999999999999999999
Q ss_pred ecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHH
Q 042262 666 DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY 744 (814)
Q Consensus 666 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 744 (814)
|||+++...............||..|||||.+.+..++.|+|||||||+||||+| |+.||...... .+...+
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-------~~~~~i 243 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EVIECI 243 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHH
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHH
Confidence 9999997765444333344568999999999999999999999999999999999 89999754321 122233
Q ss_pred hcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 745 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
..+... ..+..+++++.+|+.+||+.||++||||+||++.|+++.+
T Consensus 244 ~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 244 TQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 333321 1234567899999999999999999999999999987653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=429.82 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=201.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
..+.++||+|+||+||+|.+. ..||||+++... .+..++|.+|+.++++++|||||+++|+|.+ +..+|||
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWH------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESS------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred eEEeeEEeeCCCcEEEEEEEC------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 456788999999999999864 248999986432 3345679999999999999999999999865 5689999
Q ss_pred hhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++|+|.++|+.. ..+++.++..|+.|||+||+|||+ .+||||||||+||||++++.+||+|||+++.......
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999999754 579999999999999999999995 5999999999999999999999999999997754433
Q ss_pred ccccccccCCCCccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 679 KAIKTAIRGTKGYVAPEWFRN---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
........||+.|||||++.+ +.++.|+|||||||+||||+||+.||....... .....+..+... +
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~~----p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYAS----P 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCCC----C
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCC----C
Confidence 333455679999999999964 468999999999999999999999997543221 112222222111 1
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
.. ...+.++++++.+|+.+||+.||++||||.||++.|+.+
T Consensus 258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 112346778999999999999999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=417.80 Aligned_cols=258 Identities=23% Similarity=0.225 Sum_probs=208.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.++||+|+||+||+|.+.. .++.||||+++.. ....+|+.+++.++|||||++++++.+++..+|||||
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~---~g~~vAiK~i~~~-----~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETT-----TCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred eEeCcEeccCCCeEEEEEEECC---CCCEEEEEEECHH-----HhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 3445789999999999999875 5789999998642 2345799999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-CeEEeecCCccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~~~~ 680 (814)
+++|+|.++|.....+++..+..|+.||+.||+||| +.+||||||||+||||+.++ .+||+|||+++.+..+....
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999999988888999999999999999999999 56999999999999999987 69999999999876543211
Q ss_pred ---ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 681 ---IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 681 ---~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.....+||+.|||||++.+..++.++|||||||+||||++|+.||........ + ..+..+.. .
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~-----~~i~~~~~-------~ 274 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--C-----LKIASEPP-------P 274 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--H-----HHHHHSCC-------G
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--H-----HHHHcCCC-------C
Confidence 12345799999999999999999999999999999999999999975443221 1 11111111 0
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC----CcCCCCCC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG----VVEVDVPP 804 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~----~~~~~~pp 804 (814)
....+..++.++.+++.+||+.||.+|||+.|+++.|.. +..+.+|.
T Consensus 275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw 325 (336)
T 4g3f_A 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325 (336)
T ss_dssp GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence 112244677899999999999999999999999887643 34455554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=417.90 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=209.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.++||+|+||+||+|.... +++.||||+++.......+.+.+|+.+++.++|||||++++++.+++..+|||||
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEeecCcCeEEEEEEECC---CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4556789999999999999875 5789999999766566667899999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++|+|.+++.. ..+++..+..|+.||+.||+|||+ .+||||||||+||||++++.+||+|||+++.+......
T Consensus 153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-- 226 (346)
T 4fih_A 153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-- 226 (346)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--
Confidence 999999999865 468999999999999999999995 59999999999999999999999999999977543322
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
....+||+.|||||++.+..++.++|||||||+||||++|+.||......+ ....+..+... ....
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~~-------~~~~ 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLPP-------RLKN 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSSCC-------CCSC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCCC-------CCCc
Confidence 345789999999999999999999999999999999999999997543211 11222222111 1112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....++++.+|+.+||+.||++|||+.|+++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2356788999999999999999999999876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=430.14 Aligned_cols=266 Identities=26% Similarity=0.367 Sum_probs=216.6
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEeccC--CcceEEEEEeeccccc-cchhhhhceeeEEeeccc-cceeeeeeeecc
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHH-KNLVRLLGFCDE 591 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~ 591 (814)
|+....+.+.++||+|+||+||+|.+.... ...+.||||+++.... ...++|.+|++++.+++| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 344455677789999999999999987532 2456899999976433 335679999999999965 999999999976
Q ss_pred C-CceehhhhhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 042262 592 G-QNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 654 (814)
Q Consensus 592 ~-~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NI 654 (814)
. +..+||||||++|+|.++|+.. ..+++..++.|+.|||+||+|||+ .+||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccce
Confidence 4 5689999999999999999642 347899999999999999999995 5999999999999
Q ss_pred EECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcch
Q 042262 655 LLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY 733 (814)
Q Consensus 655 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~ 733 (814)
||++++.+||+|||+++.+..+..........||..|||||++.+..++.++|||||||+||||+| |+.||.......
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~- 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999998765544443455679999999999999999999999999999999998 899997543221
Q ss_pred hhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 734 AILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 734 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.....+.++... ..+..++.++.+++..||+.||++||||.||++.|+.+++
T Consensus 296 -----~~~~~i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 296 -----EFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp -----HHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 122333333221 1233567889999999999999999999999999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=408.90 Aligned_cols=247 Identities=27% Similarity=0.417 Sum_probs=200.2
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeecc----CCcee
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNRL 596 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~ 596 (814)
.+.++||+|+||+||+|.+.. .+..||||++... .....+.|.+|++++++++|||||++++++.+ ++..+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 456789999999999999864 5678999999643 22334679999999999999999999999865 34579
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCCeEEeecCCcccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTL 675 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~~ 675 (814)
|||||+++|+|.+++.....+++..+..|+.||++||+|||++ ..+||||||||+||||+. ++.+||+|||+|+....
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999999999888899999999999999999999964 234999999999999984 78999999999986443
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.. ....+||+.|||||++.+ .++.++|||||||+||||+||+.||...... ......+..+....
T Consensus 185 ~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~~~---- 249 (290)
T 3fpq_A 185 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPA---- 249 (290)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCG----
T ss_pred Cc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCCCC----
Confidence 21 345679999999999875 6999999999999999999999999643221 11222333332211
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 250 ----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112234567899999999999999999999976
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=414.36 Aligned_cols=266 Identities=21% Similarity=0.272 Sum_probs=201.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCC----ceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----NRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~l 597 (814)
+.+.++||+|+||+||+|.+. ++.||||+++... .....++.|+..+.+++|||||+++|+|.+.+ ..+|
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~~-----g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKWR-----GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEET-----TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEEC-----CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 456688999999999999873 6789999997542 22233456777788899999999999997654 5789
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-----SAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
||||+++|+|.++|+.. .++|..+.+|+.|+++||+|||+++ .++||||||||+||||++++.+||+|||+++.
T Consensus 79 V~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999999754 5899999999999999999999652 45999999999999999999999999999987
Q ss_pred ccccccc--cccccccCCCCccCcccccCC------CCCCccchhhHHHHHHHHHhCCcCCcccCCcc---------hhh
Q 042262 673 LTLNQSK--AIKTAIRGTKGYVAPEWFRNS------TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE---------YAI 735 (814)
Q Consensus 673 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~---------~~~ 735 (814)
....... .......||+.|||||++.+. .++.|+|||||||+||||+||+.|+....... ...
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6543322 112345799999999999764 46789999999999999999998875432211 001
Q ss_pred HHHHHHHHHhcCCccccccCccc-ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 736 LTDWAFDCYRNGKLDDLVEGDTE-AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 736 l~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
. .........+. ..+..+ .....+.++.+.+|+.+||+.||++||||.||+++|+.+.+
T Consensus 238 ~-~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 238 V-EEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp H-HHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-HHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1 11122221111 111211 11234677889999999999999999999999999987653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=417.48 Aligned_cols=248 Identities=21% Similarity=0.321 Sum_probs=201.3
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.|.+.++||+|+||+||+|.... .++.||||+++.. .....+.+.+|+.++++++|||||++++++.+++..+||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTE---DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CEEEEEEC------CEEEEEETT---TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 35667899999999999999864 5789999999643 223346799999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 599 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||+++|+|.++|... ..+++.+.+.|+.||+.||+|||+ .+||||||||+||||++++.+||+|||+++.+...
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999999643 456889999999999999999995 59999999999999999999999999999987543
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.. ..+..+||+.|||||++.+..++.++|||||||+||||++|+.||...... +. ...+..+....
T Consensus 179 ~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~-~~~i~~~~~~~----- 244 (350)
T 4b9d_A 179 VE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NL-VLKIISGSFPP----- 244 (350)
T ss_dssp HH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HH-HHHHHHTCCCC-----
T ss_pred cc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HH-HHHHHcCCCCC-----
Confidence 22 134567999999999999999999999999999999999999999754321 11 12222232221
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 245 ----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 ----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12356788999999999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=410.64 Aligned_cols=247 Identities=22% Similarity=0.284 Sum_probs=210.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||+||+|.... +++.||||++++. .....+.+.+|++++++++|||||++++++.+++..+||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cEEEEEEecccCeEEEEEEECC---CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 5677899999999999999875 5789999999653 233456789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+||||++++.+||+|||+++.+.....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999999888889999999999999999999995 5999999999999999999999999999998765544
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.......+||+.|||||++.+..++.++||||+||+||||++|+.||......+ ....+..+...
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~~-------- 252 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-------IFAKIIKLEYD-------- 252 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC--------
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC--------
Confidence 444556789999999999999999999999999999999999999997543211 12222222211
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVS 791 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~ 791 (814)
.+...+.++.+|+.+||+.||++|||++|+.
T Consensus 253 --~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 --FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1234567899999999999999999999863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=404.06 Aligned_cols=250 Identities=24% Similarity=0.273 Sum_probs=201.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.+++.+.||+|+||+||+|....++..++.||||+++... .....++.+|++++++++|||||++++++.+++..+||
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 3667789999999999999986655567899999996532 23345688999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+++.....+++.+...++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 9999999999999988889999999999999999999995 5999999999999999999999999999987543322
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. .....||+.|||||.+.+..++.++||||+||+||||++|+.||......+ ....+..+..
T Consensus 182 ~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~--------- 243 (304)
T 3ubd_A 182 K--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-------TMTMILKAKL--------- 243 (304)
T ss_dssp C--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC---------
T ss_pred c--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-------HHHHHHcCCC---------
Confidence 2 345679999999999999999999999999999999999999997543211 1122222221
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTM-----RKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm-----~eV~~ 792 (814)
..+...+.++.+|+.+||+.||++|||+ +|+++
T Consensus 244 -~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 -GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1133466789999999999999999984 56664
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=418.50 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=209.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.++||+|+||+||+|.... .++.||||++........+.+.+|+.+|+.++|||||++++++.+++..+|||||
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeeEeccCcCcEEEEEEECC---CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4556789999999999999875 5789999999766556667799999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
|++|+|.+++.. ..+++.++..|+.||+.||+|||+ .+||||||||+||||+.++.+||+|||+++.+......
T Consensus 230 ~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-- 303 (423)
T 4fie_A 230 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-- 303 (423)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC--
T ss_pred CCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc--
Confidence 999999999865 468999999999999999999995 59999999999999999999999999999977544322
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+ +...+..+.... ...
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~~~-------~~~ 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLPPR-------LKN 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCCC-------CSC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCCCC-------Ccc
Confidence 345689999999999999999999999999999999999999997543211 112222221111 112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....+.++.+|+.+||+.||++|||+.|+++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2346688999999999999999999999877
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=394.18 Aligned_cols=245 Identities=25% Similarity=0.355 Sum_probs=193.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.+.||+|+||+||+|.... +++.||||+++... ....+.+.+|++++++++|||||++++++.+++..+|
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTT---TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46677899999999999998764 57899999996432 2334578999999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+ +|+|.+++.....+++.+...++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 99999 68999999888889999999999999999999995 599999999999999999999999999998765432
Q ss_pred cccccccccCCCCccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
. .....||+.|+|||.+.+..+ +.++||||+||+||||++|+.||...... .....+..+...
T Consensus 167 ~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-------~~~~~i~~~~~~------ 230 (275)
T 3hyh_A 167 F---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-------VLFKNISNGVYT------ 230 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC------
T ss_pred c---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCC------
Confidence 2 345679999999999998876 57999999999999999999999754221 112222333211
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+...++++.+++.+||+.||++|||++|+++
T Consensus 231 ----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 ----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 12345678899999999999999999999987
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=385.74 Aligned_cols=247 Identities=22% Similarity=0.351 Sum_probs=186.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCC-------
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------- 593 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------- 593 (814)
+++.+.||+|+||+||+|.... +++.||||+++.... ...+.+.+|+.++++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKV---DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETT---TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred CEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 5667899999999999999864 567899999965432 23467899999999999999999999986544
Q ss_pred -----ceehhhhhccCCchhhhhcCCCC---CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEe
Q 042262 594 -----NRLLVYEFLNNGTLASFLFGNLK---PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 665 (814)
Q Consensus 594 -----~~~lV~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 665 (814)
..+|||||+++|+|.+++..... .++...+.|+.||++||+|||+ .+|+||||||+||||+.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 36899999999999999976543 4566788999999999999995 599999999999999999999999
Q ss_pred ecCCccccccccccc----------ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhh
Q 042262 666 DFGLAKLLTLNQSKA----------IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 735 (814)
Q Consensus 666 DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~ 735 (814)
|||+++.+..+.... ..+..+||+.|||||.+.+..++.++|||||||+||||++ ||..... .
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----~ 233 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----R 233 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----H
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----H
Confidence 999999876443211 1234579999999999999999999999999999999996 6642211 0
Q ss_pred HHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 736 LTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 736 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
. . ..........+.. .......+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~-~-~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 V-R-TLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H-H-HHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-H-HHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0 1112222222211 1233456678999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=376.20 Aligned_cols=273 Identities=35% Similarity=0.624 Sum_probs=236.2
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
.+.+.||+|+||.||+|.+. ++..||||++........+++.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 42 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 117 (321)
T 2qkw_B 42 DHKFLIGHGVFGKVYKGVLR----DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117 (321)
T ss_dssp SCCCCSCBCSSSEEEEEECT----TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred CccceeecCCCeeEEEEEEC----CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence 34568999999999999964 46789999987765566678999999999999999999999999999999999999
Q ss_pred cCCchhhhhcCCC----CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 603 NNGTLASFLFGNL----KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 603 ~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
++++|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194 (321)
T ss_dssp TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999997643 58999999999999999999995 5999999999999999999999999999987554333
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
........||..|+|||.+.+..++.++||||||++++||++|+.||......+......|.......+.+...+++...
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA 274 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence 32234456899999999999889999999999999999999999999876665555666676667777777777777776
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCC
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 802 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~ 802 (814)
.......+..+.+++.+||+.||++|||+.||++.|+.++.+..
T Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 66778899999999999999999999999999999988766543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=386.74 Aligned_cols=261 Identities=20% Similarity=0.311 Sum_probs=200.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeecc------CC
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------GQ 593 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~ 593 (814)
+.+.+.||+|+||+||+|.+.. .++.||||+++... ....+.+.+|+++|+.++|||||++++++.. .+
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRL---TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred eEEEEEEecccCeEEEEEEECC---CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 5667899999999999999875 57899999996532 2234568899999999999999999998753 46
Q ss_pred ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 594 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
+.+|||||+. |+|.+++.....+++..+..|+.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++.+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 7899999995 7899999988899999999999999999999995 59999999999999999999999999999876
Q ss_pred ccccc--ccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 674 TLNQS--KAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 674 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
..... .......+||+.|+|||++.+. .++.++||||+||+++||++|+.||......+.. ..+..........
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l---~~I~~~~g~p~~~ 285 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL---QLIMMVLGTPSPA 285 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH---HHHHHHHCCCCGG
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhcCCCChH
Confidence 54321 2223457899999999998875 5699999999999999999999999754322111 1111111100000
Q ss_pred c-----------cccCc-cccc-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 751 D-----------LVEGD-TEAM-----NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 751 ~-----------l~~~~-~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
. .+... .... .....+.++.+|+.+||+.||.+|||+.|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 00000 0000 01134578899999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=375.38 Aligned_cols=286 Identities=42% Similarity=0.727 Sum_probs=240.6
Q ss_pred CccccCHHHHHHHHhhh--hccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceee
Q 042262 508 NLRCFSYKELEEATDNF--EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVR 584 (814)
Q Consensus 508 ~~~~f~~~el~~~~~~~--~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~ 584 (814)
..+.|++.++.....++ .+.||+|+||.||+|.+. ++..||||++.... ......+.+|+++++.++||||++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence 45678888888877665 468999999999999754 46789999997543 233457899999999999999999
Q ss_pred eeeeeccCCceehhhhhccCCchhhhhcCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC
Q 042262 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY 660 (814)
Q Consensus 585 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~ 660 (814)
+++++.+.+..++||||+++|+|.+++... ..+++..+..|+.|+++||+|||+.+..+|+||||||+|||+++++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 999999999999999999999999999764 3489999999999999999999976556999999999999999999
Q ss_pred CeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccC--CcchhhHHH
Q 042262 661 NARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEM--GEEYAILTD 738 (814)
Q Consensus 661 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~--~~~~~~l~~ 738 (814)
.+||+|||+++......... .....||..|+|||.+.+..++.++||||||++++||++|+.||+... .........
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp CEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred CEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 99999999998765443322 344569999999999998899999999999999999999999996432 223344556
Q ss_pred HHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 739 WAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 739 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
|.........+..+.+...........+..+.+++.+||+.||.+|||+.||+++|++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 666666677777777777777778889999999999999999999999999999998743
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=376.68 Aligned_cols=261 Identities=20% Similarity=0.262 Sum_probs=197.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.++||+|+||+||+|+.......++.||||++... ....++.+|++++..+ +||||+++++++.+.++.+||||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 56678899999999999998654446789999998653 2345688899999988 69999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-YNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++|+|.+++. .+++.+...++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+|+........
T Consensus 101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 999999999984 58999999999999999999995 599999999999999876 79999999999865432211
Q ss_pred --------------------------cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcc
Q 042262 680 --------------------------AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732 (814)
Q Consensus 680 --------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~ 732 (814)
...+..+||+.|+|||++.+. .++.++||||+||+++||++|+.||.....+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~ 254 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 112345799999999999876 58999999999999999999999996544321
Q ss_pred hhhHHHHHHHHH----------------------------------hcC--Cccccc----cCcccccCChhHHHHHHHH
Q 042262 733 YAILTDWAFDCY----------------------------------RNG--KLDDLV----EGDTEAMNDIKCTEKLVMV 772 (814)
Q Consensus 733 ~~~l~~~~~~~~----------------------------------~~~--~~~~l~----~~~~~~~~~~~~~~~l~~l 772 (814)
.. +... .... +.. ...... ............++++.+|
T Consensus 255 ~~-l~~I-~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 255 TA-LAQI-MTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HH-HHHH-HHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HH-HHHH-HHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 11 1110 0000 000 000000 0000001112345788999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 042262 773 SIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 773 ~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+.+||+.||.+|||++|+++
T Consensus 333 l~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHCcCChhHCcCHHHHhc
Confidence 99999999999999999886
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=357.06 Aligned_cols=230 Identities=20% Similarity=0.293 Sum_probs=182.5
Q ss_pred hhcCCCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCC----C
Q 042262 24 AQNNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPR----G 99 (814)
Q Consensus 24 ~~~~~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~----~ 99 (814)
+++.|+|++|++|+++++ |||++|+|+||||.++ ++|| |+ +.+ |||+|||+. |.... +
T Consensus 11 ~~~~~~l~~g~~l~~~~~---l~S~~g~F~lgf~~~~-------~~~l---y~--~~~-vvW~Anr~~--p~~~~~~~~~ 72 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQY---LLSPNQRFKLLLQGDG-------NLVI---QD--NGA-TVWVANEQQ--PFSSTIPLRN 72 (276)
T ss_dssp CTTSSEECTTEEBCTTCE---EECTTSSEEEEECTTS-------CEEE---EE--TTE-EEEECSTTS--TTEEEEECCC
T ss_pred cccCCEecCCCEecCCCE---EEcCCCcEEEEEECCC-------CeEE---EC--CCC-eEEECCCCC--CcCCcccccc
Confidence 356799999999999874 9999999999999432 3677 77 777 999999993 33332 7
Q ss_pred cEEEEeecccEEE--eCCCCCeEeeeccCC------CceeEEEEccCcCEEEEecCCcccccccccccCccCCCCc----
Q 042262 100 SQVKLTADRGLVL--NDPQGKQVWSSKIDI------GTVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQM---- 167 (814)
Q Consensus 100 ~~l~~~~~g~l~l--~~~~~~~~wst~~~~------~~~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~---- 167 (814)
++|+|+.||+|+| .|++|++||||+++. .+.++|+|+|+|||||++ +.+|||| |||||||||||
T Consensus 73 ~~l~l~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~ 148 (276)
T 3m7h_A 73 KKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLL 148 (276)
T ss_dssp TTCCSEEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEE
T ss_pred eEEEEeCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccc
Confidence 8899999999999 788899999999865 345789999999999998 7899999 99999999999
Q ss_pred ccCCceeeecCCCCCCCCCceEEEEecCCceeeeeccCCcccccccceeccccCCCCCCCCcceeeecccccEEEEeccc
Q 042262 168 METEQGLFSRKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYMYILRRNS 247 (814)
Q Consensus 168 l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (814)
|..+++| ++.+||++|.|+++++++|+++++. .. ...||++++|+.. . ..+.++.+|.+.++..+.
T Consensus 149 l~~g~~L---~S~~dps~G~fsl~l~~dGnlvLy~-~~-----~~~yW~Sgt~~~~----~-~~l~l~~dGnLvl~d~~~ 214 (276)
T 3m7h_A 149 LAPGSEL---VQGVVYGAGASKLVFQGDGNLVAYG-PN-----GAATWNAGTQGKG----A-VRAVFQGDGNLVVYGAGN 214 (276)
T ss_dssp ECSSEEE---CTTCEEEETTEEEEECTTSCEEEEC-TT-----SSEEEECCCTTTT----C-CEEEECTTSCEEEECTTS
T ss_pred cccCccc---ccCCCCCCceEEEeecCCceEEEEe-CC-----CeEEEECCCCCCc----c-EEEEEcCCCeEEEEeCCC
Confidence 6778888 5688999999999999999877642 22 2679999998642 2 467778888887776654
Q ss_pred eeeeeeccccccCCccEEEEEEeeCceEEEEEecCCCCCCceEEecCCCC
Q 042262 248 QRFDLTTGRVVPAADFYHRATLNFDGVFAQYFYPKNGNGNWSAVWSQPEN 297 (814)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~r~~L~~dG~lr~y~~~~~~~~~W~~~~~~p~~ 297 (814)
..+..+... . ...+|++|+.||+|++|.| ...|..++.+|+.
T Consensus 215 ~~vWsS~t~--~--~~~~rl~Ld~dGnLvly~~----~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 215 AVLWHSHTG--G--HASAVLRLQANGSIAILDE----KPVWARFGFQPTY 256 (276)
T ss_dssp CEEEECSCT--T--CTTCEEEECTTSCEEEEEE----EEEEESSSCCTTS
T ss_pred cEEEEecCC--C--CCCEEEEEcCCccEEEEcC----CCeEEccCccCCc
Confidence 444333221 1 1247999999999999988 2458777777754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=390.04 Aligned_cols=247 Identities=23% Similarity=0.249 Sum_probs=200.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhh---ceeeEEeeccccceeeeeeeeccCCce
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFK---NEVVVIGQTHHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~---~Ei~~l~~l~H~niv~l~g~~~~~~~~ 595 (814)
+.+.+.||+|+||+||+|.... .++.+|||++++.. ......+. .++.+++.++|||||++++++.+.+..
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~---tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred eEEEEEEecccCeEEEEEEECC---CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 4566889999999999999875 57899999996421 12222233 345667778999999999999999999
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
||||||+++|+|.++|.....+++.....++.||+.||+||| +.+||||||||+||||++++.+||+|||+++.+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999999988888999999999999999999999 56999999999999999999999999999987654
Q ss_pred cccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.. ....+||+.|||||++.+ ..++.++||||+||+||||++|+.||..........+ .........
T Consensus 345 ~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i----~~~i~~~~~----- 411 (689)
T 3v5w_A 345 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAV----- 411 (689)
T ss_dssp CC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH----HHHHHHCCC-----
T ss_pred CC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhhcCCCC-----
Confidence 33 334679999999999975 5799999999999999999999999975443221111 111111111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 792 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~eV~~ 792 (814)
..+...+.++.+|+.+||+.||.+|++ +.||.+
T Consensus 412 -----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 -----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 123356788999999999999999998 677765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=394.25 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=208.6
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.|.+.+.||+|+||+||+|.... .++.||+|++........+.+.+|+.+|+.++|||||++++++.+.+..+||||
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~---tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 35677899999999999999875 577899999976555556778999999999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC--CCeEEeecCCcccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY--YNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~--~~~kl~DfGla~~~~~~~ 677 (814)
|+++|+|.++|.. ...+++.+...++.||++||+|||+ .+|+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999999998864 4578999999999999999999995 599999999999999854 899999999999876443
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
. ....+||+.|||||++.+..++.++||||+||+||||++|+.||......+ ....+..+... .
T Consensus 312 ~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-------~~~~i~~~~~~------~ 375 (573)
T 3uto_A 312 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWN------M 375 (573)
T ss_dssp E---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCCC------C
T ss_pred c---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHhCCCC------C
Confidence 2 345679999999999999999999999999999999999999997543221 11222222211 1
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........++++.+|+.+||+.||.+|||+.|+++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112345678999999999999999999999987
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=360.65 Aligned_cols=261 Identities=28% Similarity=0.446 Sum_probs=200.6
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.+.+.+.||+|+||+||+|.. .+..||||++.... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEW-----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred HceeeeEeecCCCeEEEEEEE-----CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 445668899999999999976 36789999986543 22345789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCC---CCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 599 YEFLNNGTLASFLFGNLK---PSWNLRTNIAFQIARGLLYLHEDCSAQ--IIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
|||+++++|.+++..... +++..++.++.||++||+|||+ .+ |+||||||+||+++.++.+||+|||+++..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999987543 8999999999999999999995 47 999999999999999999999999999865
Q ss_pred cccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
...... .....||..|+|||.+.+..++.++||||||+++|||++|+.||........ .........
T Consensus 190 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~------~~~~~~~~~----- 256 (309)
T 3p86_A 190 ASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV------VAAVGFKCK----- 256 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHHSCC-----
T ss_pred cccccc--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcCC-----
Confidence 433211 2345689999999999999999999999999999999999999975432211 111111111
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCCCCC
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNP 806 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~pp~p 806 (814)
....+...+.++.+++.+||+.||.+|||+.||++.|+.+++-..||.+
T Consensus 257 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 257 ----RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred ----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 1112335667899999999999999999999999999998876666544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=366.03 Aligned_cols=266 Identities=23% Similarity=0.418 Sum_probs=215.0
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
...+.+.+.||+|+||.||+|.+...+..+..||||+++.. .....+++.+|+.++++++||||+++++++.+++..+|
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 34556678899999999999999866656778999999754 33345679999999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
||||+++++|.+++... ..+++..+..|+.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999654 578999999999999999999995 59999999999999999999999999999877544
Q ss_pred cccc-ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 677 QSKA-IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 677 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.... ......+|..|+|||.+.+..++.++||||||++++||++ |+.||....... ....+..+.
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~------ 271 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEGY------ 271 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTC------
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCC------
Confidence 3221 1222346778999999998999999999999999999999 999996443221 112222221
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCC
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 803 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~p 803 (814)
....+..++..+.+++..||+.||.+|||+.||+++|+.++..+..
T Consensus 272 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 272 ---RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ---CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 1112345678899999999999999999999999999987665444
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.88 Aligned_cols=280 Identities=39% Similarity=0.645 Sum_probs=224.8
Q ss_pred cCccccCHHHHHHHHhhhhc--------cccccceeEEEEEEEeccCCcceEEEEEeecccc----ccchhhhhceeeEE
Q 042262 507 TNLRCFSYKELEEATDNFEE--------EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVI 574 (814)
Q Consensus 507 ~~~~~f~~~el~~~~~~~~~--------~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~----~~~~~~~~~Ei~~l 574 (814)
.....|++.++.+++.+|.+ .||+|+||.||+|.. .+..+|||++.... ....+.+.+|+.++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l 84 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHH
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----CCceEEEEEEecccCcchHHHHHHHHHHHHHH
Confidence 34678999999999998874 599999999999986 35689999986532 22346789999999
Q ss_pred eeccccceeeeeeeeccCCceehhhhhccCCchhhhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 042262 575 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKP 651 (814)
Q Consensus 575 ~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp 651 (814)
+.++||||+++++++.+.+..++||||+++++|.+++.. ...+++..+..|+.||++||+|||+ .+|+||||||
T Consensus 85 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp 161 (307)
T 2nru_A 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKS 161 (307)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCG
T ss_pred HhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCH
Confidence 999999999999999999999999999999999999864 3468999999999999999999995 5999999999
Q ss_pred CcEEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCc
Q 042262 652 QNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 731 (814)
Q Consensus 652 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~ 731 (814)
+||++++++.+||+|||+++...............||..|+|||.+.+ .++.++||||||++++||++|+.||......
T Consensus 162 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred HHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 999999999999999999987654333322344568999999998875 5899999999999999999999999765432
Q ss_pred chhhHHHHHHHHHh-cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 732 EYAILTDWAFDCYR-NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 732 ~~~~l~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.. +..+...... ...+...++... ...+...++.+.+++..||+.||.+|||+.||++.|+++.
T Consensus 241 ~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 241 QL--LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SB--TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HH--HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 21 1111111111 112233333322 2235677889999999999999999999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=358.72 Aligned_cols=259 Identities=26% Similarity=0.438 Sum_probs=210.8
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||+||+|.+.. .+..+|+|++........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~---~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRE---TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HeeccceecCCCCEEEEEEEECC---CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 34556789999999999999864 567899999876656667789999999999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++++|.+++.. ...+++..+..|+.||++||+|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999976 5678999999999999999999995 59999999999999999999999999999876543221
Q ss_pred c------------ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC
Q 042262 680 A------------IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 747 (814)
Q Consensus 680 ~------------~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 747 (814)
. ......||..|+|||.+.+..++.++||||||++++||++|..|+...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~----------- 233 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG----------- 233 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-----------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-----------
Confidence 1 01145689999999999999999999999999999999999999865433211000
Q ss_pred CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 748 KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 748 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
...........+..++..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 234 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 234 ---LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp ---BCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---hhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000000111233456778999999999999999999999999987643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=365.65 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=212.5
Q ss_pred HhhhhccccccceeEEEEEEEec----cCCcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeeeccCCc
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQT----TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~----~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 594 (814)
.+.+.+.||+|+||.||+|.+.. ....+..||||+++... ....+++.+|+.+++++ +||||+++++++.+.+.
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 45567889999999999999753 12356789999997542 23346789999999999 89999999999999999
Q ss_pred eehhhhhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 042262 595 RLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 658 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~ 658 (814)
.++||||+++|+|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECC
Confidence 99999999999999998653 247899999999999999999995 59999999999999999
Q ss_pred CCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHH
Q 042262 659 YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILT 737 (814)
Q Consensus 659 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~ 737 (814)
++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~----- 313 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----- 313 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 99999999999987654433222334457889999999999999999999999999999999 999997543222
Q ss_pred HHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 738 DWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 738 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
....+..+.. ...+..++.++.+++..||+.||.+|||+.|+++.|+.++.
T Consensus 314 --~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 314 --LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp --HHHHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122222221 11234567889999999999999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=358.30 Aligned_cols=269 Identities=28% Similarity=0.362 Sum_probs=206.8
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCc----ee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN----RL 596 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----~~ 596 (814)
.+.+.+.||+|+||+||+|.+. ++.||||++.... .....+..|+.++.+++||||+++++++.+... .+
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL-----NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET-----TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hchhhheecccCceEEEEEEEC-----CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 3456688999999999999874 5789999996542 234456678999999999999999999977543 69
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC-------CCCeeecCCCCCcEEECCCCCeEEeecCC
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-------SAQIIHCDIKPQNILLDDYYNARISDFGL 669 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------~~~iiH~Dikp~NIll~~~~~~kl~DfGl 669 (814)
+||||+++|+|.+++... .+++..+..|+.||++||+|||+.+ +.+|+||||||+|||+++++.+||+|||+
T Consensus 99 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 999999999999999664 4899999999999999999999421 12999999999999999999999999999
Q ss_pred cccccccccccccccccCCCCccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHH------
Q 042262 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRN-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD------ 738 (814)
Q Consensus 670 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~------ 738 (814)
++...............||..|+|||.+.+ ..++.++||||||+++|||++|+.||..........+..
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 987765444333344679999999999986 356678999999999999999999997654322111110
Q ss_pred ---HHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 739 ---WAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 739 ---~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
................ ........++++.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLR---DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCC---GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccCCCCcc---ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111111111111111 111233567889999999999999999999999999987643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=350.21 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=206.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.+.||+|+||+||+|.... .++.||||++........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTT---TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEECC---CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4556789999999999998754 5778999999766555667789999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172 (297)
T ss_dssp CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--
T ss_pred CCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc--
Confidence 9999999998754 58999999999999999999995 59999999999999999999999999999876544332
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||..|+|||.+.+..++.++||||||+++|||++|+.||........ .......+.. ....
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~~--------~~~~ 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP--------ELQN 238 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC--------CCSC
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC--------CCCC
Confidence 3445699999999999999999999999999999999999999975432111 1111111111 1112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 3356678999999999999999999999987
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=349.87 Aligned_cols=261 Identities=25% Similarity=0.348 Sum_probs=214.3
Q ss_pred cccCHHHHHHHHhh------------hhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec
Q 042262 510 RCFSYKELEEATDN------------FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 577 (814)
Q Consensus 510 ~~f~~~el~~~~~~------------~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l 577 (814)
..|+++++..++.. ..+.||+|+||.||+|.+.. .++.||||++........+.+.+|+.+++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMDLRKQQRRELLFNEVVIMRDY 99 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCSHHHHHHHHHHHTTC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECC---CCcEEEEEEEeccchhHHHHHHHHHHHHHhC
Confidence 56888888887754 23579999999999999864 5778999999766555667799999999999
Q ss_pred cccceeeeeeeeccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC
Q 042262 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 657 (814)
Q Consensus 578 ~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~ 657 (814)
+||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+||+++
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT 175 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEC
Confidence 999999999999999999999999999999998865 468999999999999999999995 5999999999999999
Q ss_pred CCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHH
Q 042262 658 DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 737 (814)
Q Consensus 658 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 737 (814)
.++.+||+|||+++........ .....||..|+|||.+.+..++.++||||||++++||++|+.||.......
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~----- 248 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----- 248 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----
T ss_pred CCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 9999999999999876543222 234569999999999999999999999999999999999999997543211
Q ss_pred HHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 738 DWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 738 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
....+.......+ ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 249 --~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 --AMKRLRDSPPPKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --HHHHHHHSSCCCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHHhcCCCCCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112222211111 1123456789999999999999999999999873
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=368.95 Aligned_cols=260 Identities=25% Similarity=0.452 Sum_probs=200.0
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
..+.+.+.||+|+||.||+|.+......+..||||+++... ....++|.+|+.++++++||||+++++++.+.+..+||
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 34556688999999999999987544467789999997542 33456799999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||+++++|.+++... ..+++..+..|+.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999999999765 468999999999999999999995 599999999999999999999999999998775443
Q ss_pred cccc-cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 678 SKAI-KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 678 ~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..+
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~i~~~-------- 266 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAVDEG-------- 266 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHHHHTT--------
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC--------
Confidence 2211 112235678999999999999999999999999999998 999996443211 11122222
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.....+..++..+.+++..||+.||.+||+|.||+++|+.++
T Consensus 267 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 267 -YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp -EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 111223356788999999999999999999999999997664
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=360.28 Aligned_cols=268 Identities=25% Similarity=0.416 Sum_probs=208.0
Q ss_pred HHHhhhhccccccceeEEEEEEEec-cCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeecc--CCce
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNR 595 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 595 (814)
...+.+.+.||+|+||+||+|.+.. ....+..||||++........+++.+|+.++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 3456677899999999999998642 233678999999987655556789999999999999999999999854 3568
Q ss_pred ehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 596 LLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999999765 458999999999999999999995 599999999999999999999999999998765
Q ss_pred ccccc-cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCc---------chhhHHHHHHHHH
Q 042262 675 LNQSK-AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE---------EYAILTDWAFDCY 744 (814)
Q Consensus 675 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~~~~~~ 744 (814)
..... .......++..|+|||.+.+..++.++||||||++++||++|..|+.....+ ............+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 43321 1122344677899999999999999999999999999999999998643210 0000001111111
Q ss_pred hcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 745 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
..+ .....+..+++++.+++..||+.||++|||+.||++.|+.+.
T Consensus 246 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 246 KNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111 112224466789999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=364.13 Aligned_cols=263 Identities=27% Similarity=0.386 Sum_probs=211.6
Q ss_pred HHHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccccc-cchhhhhceeeEEeec-cccceeeeeeeeccCCc
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 594 (814)
...+.+.+.||+|+||.||+|.+.. ....++.||||+++.... ...+.+.+|++++.++ +||||+++++++.+.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 3455667899999999999999764 334678999999976432 3346799999999999 79999999999987654
Q ss_pred -eehhhhhccCCchhhhhcCCCC---------------------------------------------------------
Q 042262 595 -RLLVYEFLNNGTLASFLFGNLK--------------------------------------------------------- 616 (814)
Q Consensus 595 -~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 616 (814)
.++||||+++|+|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 8999999999999999975432
Q ss_pred ---------CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccccC
Q 042262 617 ---------PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRG 687 (814)
Q Consensus 617 ---------l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 687 (814)
+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.............|
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 8899999999999999999995 5999999999999999999999999999987654433333445568
Q ss_pred CCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHH
Q 042262 688 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCT 766 (814)
Q Consensus 688 t~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 766 (814)
|..|+|||.+.+..++.++||||||++++||++ |+.||........ ....+..+... ..+...+
T Consensus 258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~ 322 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRM---------RAPDYTT 322 (359)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCC---------CCCTTCC
T ss_pred CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCCC---------CCCCCCC
Confidence 899999999999999999999999999999998 9999975433221 12222222211 1123456
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 767 EKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 767 ~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.++.+++..||+.||.+||||.||++.|+.+++
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 789999999999999999999999999987653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=366.45 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=208.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.+.||+|+||.||+|.+.. .+..||||.++... ....++|.+|++++++++||||+++++++.+.+..+|||
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRA---DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT---TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HeEEeeEeccCCCCeEEEEEEec---CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 45567889999999999999864 46789999987542 233467999999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++|+|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999999764 468999999999999999999995 5999999999999999999999999999986543322
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..+..
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~-------- 333 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGR-------- 333 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCC--------
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC--------
Confidence 211122235678999999998899999999999999999998 999986543211 1222222211
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
...+..++..+.+++..||+.||++|||+.||++.|+.+.
T Consensus 334 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 334 -LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1123346678999999999999999999999999998653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=346.98 Aligned_cols=264 Identities=25% Similarity=0.354 Sum_probs=210.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.+.||+|+||.||+|.... .+..+|+|++.... ....+.+.+|+.++.+++||||+++++++.+++..++
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTI---LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT---TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECC---CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 45667889999999999998764 56789999985432 2234678999999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+++++|.+++.....+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999999888889999999999999999999995 599999999999999999999999999998765432
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
... .....||..|+|||.+.+..++.++||||||+++|||++|+.||....... ........ .... .
T Consensus 166 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~-~~~~-----~ 232 (294)
T 4eqm_A 166 LTQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQD-SVPN-----V 232 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSS-CCCC-----H
T ss_pred ccc-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhc-cCCC-----c
Confidence 221 334568999999999999999999999999999999999999997543211 11111111 1111 1
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCC-CHHHHHHHHcCCcCCCCC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRP-TMRKVSQMLEGVVEVDVP 803 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-tm~eV~~~L~~~~~~~~p 803 (814)
........+..+.+++.+||+.||.+|| +++++.+.|+.++.....
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 1122335678899999999999999998 999999999987655443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.96 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=205.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||.||+|.+.. .++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHIL---TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4556889999999999999864 56789999996532 233456889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 169 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK- 169 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence 999999999999888889999999999999999999995 5999999999999999999999999999987654322
Q ss_pred cccccccCCCCccCcccccCCCCC-CccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t-~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.....||..|+|||.+.+..++ .++||||||++++||++|+.||....... ....+..+..
T Consensus 170 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~--------- 231 (328)
T 3fe3_A 170 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-------LRERVLRGKY--------- 231 (328)
T ss_dssp --GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC---------
T ss_pred --cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC---------
Confidence 3456799999999999988775 79999999999999999999997543211 1122222221
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..+...+.++.+++.+||+.||.+|||+.|+++.
T Consensus 232 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 -RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122456788999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=345.36 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=210.1
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
..+.+.+.||+|+||.||+|.+. .+..||||+++... ...+++.+|+.++.+++||||+++++++.+.+..++||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWK----GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hheeeeeeeccCCCceEEEEEec----CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 44566789999999999999876 45679999997543 34567899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++++|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999999764 458999999999999999999995 5999999999999999999999999999987654432
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.. .....+|..|+|||.+.+..++.++||||||++++||++ |+.||....... .......+..
T Consensus 160 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~-------- 223 (268)
T 3sxs_A 160 VS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGHR-------- 223 (268)
T ss_dssp EE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCC--------
T ss_pred hc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-------HHHHHHcCCC--------
Confidence 22 233446778999999999899999999999999999999 999997543221 1111122211
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~ 801 (814)
...+...++.+.+++..||+.||.+|||+.|+++.|+.+.+.+
T Consensus 224 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 224 -LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp -CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred -CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1112234578999999999999999999999999999886643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=358.63 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=202.9
Q ss_pred HhhhhccccccceeEEEEEEEeccCC-cceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRT-STTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~-~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.+.+.+.||+|+||+||+|.+..++. ....||+|.+... .....+++.+|+.++++++||||++++++|.++. .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v 94 (327)
T 3poz_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEE
T ss_pred HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEE
Confidence 45566889999999999999864321 2235789988643 2344578999999999999999999999998754 7889
Q ss_pred hhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
+||+.+|+|.+++.. ...+++..++.|+.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 999999999999876 4578999999999999999999995 599999999999999999999999999998876544
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.........+|..|+|||.+.+..++.++||||||++++||++ |+.||........ ...+..+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~~~~~~-------- 236 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGE-------- 236 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTC--------
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-------HHHHHcCC--------
Confidence 4333344557889999999999999999999999999999999 9999975433221 11122221
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
....+..++..+.+++.+||+.||.+||||.||++.|+.+.
T Consensus 237 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11123356678999999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=364.53 Aligned_cols=266 Identities=28% Similarity=0.397 Sum_probs=216.2
Q ss_pred HHHhhhhccccccceeEEEEEEEeccC----CcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeeeccC
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTR----TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG 592 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~----~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 592 (814)
...+.+.+.||+|+||.||+|.+.... ..+..||||+++... ....+++.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 345667789999999999999986421 345689999997542 23346789999999999 999999999999999
Q ss_pred CceehhhhhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 042262 593 QNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 656 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll 656 (814)
+..++||||+++|+|.+++... ..+++..++.|+.||++||+|||+ .+|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 9999999999999999998653 348999999999999999999995 599999999999999
Q ss_pred CCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhh
Q 042262 657 DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI 735 (814)
Q Consensus 657 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 735 (814)
++++.+||+|||+++...............+|..|+|||.+.+..++.++||||||++++||++ |+.||......+
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--- 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999987754433332344557889999999999999999999999999999999 999986443211
Q ss_pred HHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCC
Q 042262 736 LTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 803 (814)
Q Consensus 736 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~p 803 (814)
....+..+... ..+..++.++.+++.+||+.||++|||++||++.|+.++.....
T Consensus 302 ----~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 302 ----LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp ----HHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred ----HHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 22223332211 12235567899999999999999999999999999887655433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=374.98 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=213.2
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
..+.+.++||+|+||.||+|.+.. .+..||||+++... ...++|.+|+.++++++||||++++++|.+....+|||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGG---GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcC---CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 345667899999999999999874 46789999997543 34578999999999999999999999999999999999
Q ss_pred hhccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++|+|.+++.. ...+++..++.|+.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++....+.
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999975 3568999999999999999999995 599999999999999999999999999998765433
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
... .....++..|+|||.+.+..++.++||||||++||||++ |+.||....... + ...+..+
T Consensus 373 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~--------- 435 (495)
T 1opk_A 373 YTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V----YELLEKD--------- 435 (495)
T ss_dssp EEC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H----HHHHHTT---------
T ss_pred eee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcC---------
Confidence 221 233446788999999999999999999999999999999 999987543221 1 1122221
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
.....+..+++.+.+|+.+||+.||.+|||+.||++.|+.+.+.
T Consensus 436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 11223445678899999999999999999999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=350.90 Aligned_cols=252 Identities=27% Similarity=0.386 Sum_probs=204.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.+.||+|+||+||+|.... .++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..+||||
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceeeeEEecCCCEEEEEEEECC---CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 4566889999999999999864 56789999986432 2334678999999999999999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
|+++++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999999999988889999999999999999999995 599999999999999999999999999998765444333
Q ss_pred ccccccCCCCccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
......||..|+|||.+.+..+ +.++||||||++++||++|+.||........ .. ..+..... ..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~-----~~~~~~~~--------~~ 228 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY-----SDWKEKKT--------YL 228 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HH-----HHHHTTCT--------TS
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HH-----HHHhcccc--------cC
Confidence 3445679999999999988765 7799999999999999999999975443211 11 11111110 01
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
......+..+.+++.+||+.||.+|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1123456788899999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=371.22 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=209.6
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
..+.+.+.||+|+||.||+|.+. .+..||||+++... ...++|.+|+.++++++||||+++++++. .+..+|||
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET----TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HHeEEEEEcccCCceEEEEEEEC----CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34566789999999999999986 35679999997643 34678999999999999999999999986 56789999
Q ss_pred hhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++|+|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999999764 368899999999999999999995 599999999999999999999999999998765432
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
... .....++..|+|||.+....++.++||||||++||||++ |+.||......+ ....+..+.
T Consensus 339 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~-------- 402 (454)
T 1qcf_A 339 YTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGY-------- 402 (454)
T ss_dssp HHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHHTC--------
T ss_pred eec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC--------
Confidence 211 223446788999999998899999999999999999999 999996433211 112222221
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
....+..+++++.+++.+||+.||++|||+.+|+++|+++...
T Consensus 403 -~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 403 -RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1112345678899999999999999999999999999988654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.96 Aligned_cols=254 Identities=27% Similarity=0.445 Sum_probs=208.8
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||+|... .+..||||++.... ...+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEET----TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hceeeheecCCCccEEEEEEec----CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 3556688999999999999986 35679999997543 345679999999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++++|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999999654 568999999999999999999995 59999999999999999999999999999876543322
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. .....++..|+|||.+.+..++.++||||||++++||++ |+.||....... ....+..+. .
T Consensus 163 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-------~~~~~~~~~---------~ 225 (269)
T 4hcu_A 163 S-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGF---------R 225 (269)
T ss_dssp S-TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTC---------C
T ss_pred c-ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhcCc---------c
Confidence 2 233456778999999998999999999999999999999 999997543221 112222221 1
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
...+...+..+.+++..||+.||.+|||+.|+++.|+++.+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11223456789999999999999999999999999987643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=355.40 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=212.3
Q ss_pred HhhhhccccccceeEEEEEEEeccC--CcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.+.||+|+||.||+|...... ..+..||||+++... ....+++.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 127 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence 3455678999999999999987422 345889999997543 2335678999999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCC------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 042262 598 VYEFLNNGTLASFLFGN------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 653 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~N 653 (814)
||||+++++|.+++... ..+++..++.|+.||++||+|||+ .+|+||||||+|
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~N 204 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 204 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcce
Confidence 99999999999998653 468999999999999999999995 599999999999
Q ss_pred EEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcc
Q 042262 654 ILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 732 (814)
Q Consensus 654 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~ 732 (814)
|++++++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 284 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH
Confidence 9999999999999999987654332222334567889999999998899999999999999999999 999996443211
Q ss_pred hhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 733 YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 733 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
....+..+.... .+..++..+.+++.+||+.||.+|||+.||++.|+++.+-
T Consensus 285 -------~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 285 -------VIYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp -------HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred -------HHHHHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 122233333221 2235667899999999999999999999999999987653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=361.52 Aligned_cols=260 Identities=28% Similarity=0.398 Sum_probs=208.6
Q ss_pred HHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
..+.+.+.||+|+||.||+|.+.. ....+..||||+++.. ......++.+|+.++++++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 445667899999999999999753 2235678999999653 3334567889999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC---CeEEee
Q 042262 597 LVYEFLNNGTLASFLFGN-------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---NARISD 666 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~D 666 (814)
+||||+++|+|.+++... ..+++..++.|+.||++||+|||+ .+|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999999643 358999999999999999999995 5999999999999999554 599999
Q ss_pred cCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHh
Q 042262 667 FGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 745 (814)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 745 (814)
||+++.+.............+|..|+|||.+.+..++.++||||||++++||++ |+.||....... ....+.
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~~~~i~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFVT 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHH
Confidence 999986644332222334567899999999999999999999999999999998 999997543211 112222
Q ss_pred cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 746 NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 746 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.+.. ...+..++..+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 301 ~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 SGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 2221 1123355678999999999999999999999999996543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.40 Aligned_cols=259 Identities=28% Similarity=0.438 Sum_probs=212.0
Q ss_pred HhhhhccccccceeEEEEEEEecc--CCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.+.||+|+||.||+|..... ...+..||||+++... ....+++.+|+++++.++||||+++++++.+.+..++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 103 (314)
T 2ivs_A 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL 103 (314)
T ss_dssp GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence 455668899999999999998532 2356889999997532 2334678999999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCCC------------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 042262 598 VYEFLNNGTLASFLFGNL------------------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 653 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~N 653 (814)
||||+++++|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+|
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~N 180 (314)
T 2ivs_A 104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARN 180 (314)
T ss_dssp EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchhe
Confidence 999999999999997543 27899999999999999999995 599999999999
Q ss_pred EEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcc
Q 042262 654 ILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 732 (814)
Q Consensus 654 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~ 732 (814)
|++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||.......
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987654433322334457788999999999899999999999999999999 999997543322
Q ss_pred hhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 733 YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 733 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
....+..+.. ...+...++.+.+++.+||+.||.+|||+.||++.|++++
T Consensus 261 -------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 261 -------LFNLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp -------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1122222221 1123356788999999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.46 Aligned_cols=254 Identities=24% Similarity=0.403 Sum_probs=206.4
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||++.+. .+..||||+++... ...+++.+|++++.+++|+||+++++++.+.+..++|||
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GEEEEEECC---CEEEEEEEET----TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHhHhhcCCCCCceEEEEEEc----CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 4556688999999999999876 45679999997542 345679999999999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 9999999999976 4678999999999999999999995 59999999999999999999999999999876543222
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. .....+|..|+|||.+.+..++.++||||||++++||++ |+.||....... ....+..+. .
T Consensus 177 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~---------~ 239 (283)
T 3gen_A 177 S-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGL---------R 239 (283)
T ss_dssp S-TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTC---------C
T ss_pred c-ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-------HHHHHhccc---------C
Confidence 1 233446778999999998899999999999999999998 999997543221 111122221 1
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
...+...++.+.+++.+||+.||.+|||++|+++.|+++.+
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 11223446789999999999999999999999999987653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=350.89 Aligned_cols=250 Identities=25% Similarity=0.323 Sum_probs=206.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc------chhhhhceeeEEeeccccceeeeeeeeccCCc
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 594 (814)
.+.+.+.||+|+||.||++.... .+..+|||.++..... ..+.+.+|+.++..++||||+++++++.+.+.
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceEEeeEEeeCcCEEEEEEEECC---CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 35667899999999999999864 5678999999754322 23578999999999999999999999999999
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC----CeEEeecCCc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY----NARISDFGLA 670 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DfGla 670 (814)
.+|||||+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||+++++ .+||+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 99999999999999999888889999999999999999999995 5999999999999998877 7999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
+....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+..+...
T Consensus 167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~ 236 (361)
T 2yab_A 167 HEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITAVSYD 236 (361)
T ss_dssp EECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCCC
T ss_pred eEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhcCCC
Confidence 87654322 234569999999999999999999999999999999999999997543221 11222222111
Q ss_pred ccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 751 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.........++.+.+++..||+.||.+|||+.|+++
T Consensus 237 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 ------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011111244678899999999999999999999885
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.00 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=206.9
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc------chhhhhceeeEEeeccccceeeeeeeeccC
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 592 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 592 (814)
...+.+.+.||+|+||.||++.... .+..+|||.+...... ..+++.+|+.++++++||||+++++++.+.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccceEeceEEeeCCCeEEEEEEECC---CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3456778899999999999999864 5678999998653221 245689999999999999999999999999
Q ss_pred CceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC----CeEEeecC
Q 042262 593 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY----NARISDFG 668 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DfG 668 (814)
...++||||+++++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||+++++ .+||+|||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999999888889999999999999999999995 5999999999999999887 79999999
Q ss_pred CcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC
Q 042262 669 LAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748 (814)
Q Consensus 669 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 748 (814)
+++....... .....||..|+|||.+.+..++.++||||||++++||++|+.||......+ ....+....
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~ 233 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVN 233 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHTC
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHHhcC
Confidence 9987654322 234569999999999999999999999999999999999999997543211 111111111
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.. .........+..+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 YE------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CC------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 10 011111234678899999999999999999999987
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=347.77 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=198.2
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
..+.+.+.||+|+||.||+|.+...+..+..||||+++... ....+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 45667789999999999999987655456789999987543 233467899999999999999999999984 4678999
Q ss_pred hhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||+++++|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999999999754 468999999999999999999995 599999999999999999999999999998765432
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
... .....++..|+|||.+.+..++.++||||||++++||++ |+.||......+. ...+..+...
T Consensus 171 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-------~~~i~~~~~~------ 236 (281)
T 1mp8_A 171 YYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIENGERL------ 236 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCCC------
T ss_pred ccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-------HHHHHcCCCC------
Confidence 221 223346788999999998899999999999999999997 9999975433221 1112222111
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
..+..++..+.+++..||+.||.+|||+.||++.|+.++
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 237 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 123356788999999999999999999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.02 Aligned_cols=261 Identities=22% Similarity=0.380 Sum_probs=194.7
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCce--
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR-- 595 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-- 595 (814)
..+.+.+.||+|+||.||+|.+...+.....||||+++.. .....+++.+|+.++++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 4566678999999999999998754433348999999654 334457799999999999999999999999877655
Q ss_pred ----ehhhhhccCCchhhhhcCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEe
Q 042262 596 ----LLVYEFLNNGTLASFLFGN------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 665 (814)
Q Consensus 596 ----~lV~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 665 (814)
++||||+++++|.+++... ..+++..+..|+.||++||+|||+ .+|+||||||+|||+++++.+||+
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEEC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEe
Confidence 9999999999999998543 258999999999999999999995 599999999999999999999999
Q ss_pred ecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHH
Q 042262 666 DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY 744 (814)
Q Consensus 666 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 744 (814)
|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||......+. ...+
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~ 252 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-------YNYL 252 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHH
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-------HHHH
Confidence 9999987655443332334457788999999999999999999999999999999 9999975433221 1111
Q ss_pred hcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 745 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
..+.. ...+...++++.+++.+||+.||.+|||+.|+++.|++++.
T Consensus 253 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 253 IGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111 11233566889999999999999999999999999987654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=349.72 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=204.7
Q ss_pred hhhhccccccceeEEEEEEEeccCC-cceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRT-STTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~-~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||+||+|.+...+. ....|++|.+.... ....+++.+|+.+++.++||||+++++++. ++..++|+
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 4556789999999999999865332 22358888875432 334467888999999999999999999986 46789999
Q ss_pred hhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+.+|+|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 94 QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp ECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999999765 578999999999999999999995 5999999999999999999999999999998765544
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..+..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~-------- 235 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKGER-------- 235 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHHHHHTTCB--------
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCC--------
Confidence 433455668889999999999999999999999999999999 999997543322 1122222211
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
...+..++.++.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 236 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 -LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1112234557889999999999999999999999997654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.28 Aligned_cols=262 Identities=18% Similarity=0.206 Sum_probs=210.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.+.||+|+||.||+|.... .+..||||++... ...+++.+|+.++..+ +|+|++++++++.++...++||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 35566889999999999999754 5789999998643 2345788899999999 7999999999999999999999
Q ss_pred hhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC-----eEEeecCCcccc
Q 042262 600 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN-----ARISDFGLAKLL 673 (814)
Q Consensus 600 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~DfGla~~~ 673 (814)
||+ +++|.+++... ..+++..+..|+.||++||+||| +.+|+||||||+||+++.++. +||+|||+++..
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999 99999999764 46899999999999999999999 469999999999999987776 999999999877
Q ss_pred ccccccc-----ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC
Q 042262 674 TLNQSKA-----IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748 (814)
Q Consensus 674 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 748 (814)
....... ......||..|+|||.+.+..++.++||||||++++||++|+.||.......................
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 5443211 12345699999999999999999999999999999999999999986543222211111111111111
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
... ....+++++.+++..||+.||.+|||+++|++.|+++.+-
T Consensus 242 ~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 242 LRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 111 1124568899999999999999999999999999887643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.62 Aligned_cols=247 Identities=23% Similarity=0.268 Sum_probs=205.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||++.... .++.+|||+++.. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 4556789999999999999864 5678999999653 233456688999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|..++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 9999999999999888889999999999999999999995 5999999999999999999999999999986433222
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. .....||..|+|||.+.+..++.++||||||+++|||++|+.||....... ....+..+..
T Consensus 161 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~--------- 222 (337)
T 1o6l_A 161 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI--------- 222 (337)
T ss_dssp C--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC---------
T ss_pred c--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC---------
Confidence 1 344679999999999999999999999999999999999999997543211 1112212211
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQM 793 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~~ 793 (814)
..+...+.++.+++.+||+.||.+|| +++||++.
T Consensus 223 -~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11234567899999999999999999 89998763
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=347.86 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=213.1
Q ss_pred HHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccccc-cchhhhhceeeEEeec-cccceeeeeeeeccCCce
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 595 (814)
..+.+.+.||+|+||.||+|.+.. ....+..||||+++.... ...+.+.+|+.++.++ +||||+++++++.+++..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 345677899999999999999753 234678999999975432 2346789999999999 999999999999999999
Q ss_pred ehhhhhccCCchhhhhcCCC------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC
Q 042262 596 LLVYEFLNNGTLASFLFGNL------------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 657 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~ 657 (814)
++||||+++|+|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEc
Confidence 99999999999999986543 48999999999999999999995 5999999999999999
Q ss_pred CCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhH
Q 042262 658 DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL 736 (814)
Q Consensus 658 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 736 (814)
+++.+||+|||+++...............+|..|+|||.+.+..++.++||||||++++||++ |+.||........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--- 256 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH---
Confidence 999999999999987765543332334557889999999999999999999999999999999 9999975433211
Q ss_pred HHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 737 TDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 737 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.......+. ....+...+..+.+++.+||+.||.+|||+.||++.|++++
T Consensus 257 ---~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 257 ---FYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ---HHHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHhccCC---------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111222211 11122345688999999999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=351.10 Aligned_cols=264 Identities=24% Similarity=0.368 Sum_probs=211.7
Q ss_pred HHHhhhhccccccceeEEEEEEEecc--CCcceEEEEEeeccc-cccchhhhhceeeEEeec-cccceeeeeeeeccCCc
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 594 (814)
...+.+.+.||+|+||.||+|.+... ...+..||||++... .....+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 34556678999999999999998532 235678999999753 233456789999999999 89999999999999999
Q ss_pred eehhhhhccCCchhhhhcCCC-----------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 042262 595 RLLVYEFLNNGTLASFLFGNL-----------------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKP 651 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp 651 (814)
.+|||||+++|+|.+++.... .+++..++.++.||++||+|||+ .+|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCh
Confidence 999999999999999997542 37899999999999999999995 5999999999
Q ss_pred CcEEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCC
Q 042262 652 QNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMG 730 (814)
Q Consensus 652 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~ 730 (814)
+||+++.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||++++||++ |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987755443333344557889999999999999999999999999999998 9999975433
Q ss_pred cchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 731 EEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 731 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
... ....+..+. ....+...++++.+++.+||+.||.+|||+.||++.|+.+...
T Consensus 281 ~~~------~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 281 DAN------FYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp SHH------HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHH------HHHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 211 112222221 1112334568899999999999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=367.59 Aligned_cols=257 Identities=29% Similarity=0.458 Sum_probs=205.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.++||+|+||.||+|.+. ....||||+++... ...++|.+|+.++++++||||+++++++.+ +..+||||
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEET----TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HceeeeeecCCCCeEEEEEEEC----CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 4556788999999999999986 34679999997643 345689999999999999999999999976 67899999
Q ss_pred hccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 601 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 601 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|+++|+|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999999999753 568999999999999999999995 5999999999999999999999999999987654322
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+.
T Consensus 336 ~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~--------- 398 (452)
T 1fmk_A 336 TA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGY--------- 398 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC---------
T ss_pred ec-ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC---------
Confidence 21 233446789999999998899999999999999999999 999996433211 112222221
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 803 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~p 803 (814)
....+..+++.+.+++.+||+.||++|||+.+|++.|+++.....|
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 1112345678899999999999999999999999999998765443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=345.64 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=205.9
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCC----cceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCc
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRT----STTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~----~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 594 (814)
...+.+.+.||+|+||.||+|.....+. ....||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3456677899999999999999875331 135799999977666667789999999999999999999999999999
Q ss_pred eehhhhhccCCchhhhhcCCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC--------eEEe
Q 042262 595 RLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN--------ARIS 665 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~--------~kl~ 665 (814)
.++||||+++++|.+++..... +++..+..++.||++||+|||+ .+|+||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999999999976644 8999999999999999999995 58999999999999998887 9999
Q ss_pred ecCCcccccccccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHH
Q 042262 666 DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 744 (814)
Q Consensus 666 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 744 (814)
|||++...... ....+|..|+|||.+.+ ..++.++||||||++++||++|..|+........ .....
T Consensus 164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~------~~~~~ 231 (289)
T 4fvq_A 164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR------KLQFY 231 (289)
T ss_dssp CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHH
T ss_pred cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH------HHHHh
Confidence 99999765432 23447889999999987 6799999999999999999996655443322111 01111
Q ss_pred hcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCC
Q 042262 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 802 (814)
Q Consensus 745 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~ 802 (814)
.... ..+...+.++.+++..||+.||.+|||+.|+++.|+.+..-..
T Consensus 232 ~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 232 EDRH-----------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HTTC-----------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred hccC-----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 1100 0111234568899999999999999999999999999876433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=364.94 Aligned_cols=252 Identities=20% Similarity=0.243 Sum_probs=202.3
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.++||+|+||+||+|.+.. .++.+|||+++... ......+.+|+.++..++||||+++++++.+.+..+|||
T Consensus 77 ~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 77 EILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp EEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEEeCCCEEEEEEEEcC---CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 445789999999999999874 56889999996522 223345889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++....+..
T Consensus 154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999999999987 5779999999999999999999995 5999999999999999999999999999987654433
Q ss_pred ccccccccCCCCccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
.. .....||..|+|||++. ...++.++|||||||++|||++|+.||......+. ....+..... +
T Consensus 231 ~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~--~- 300 (437)
T 4aw2_A 231 VQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKER--F- 300 (437)
T ss_dssp EE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTHHHH--C-
T ss_pred cc-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH------HHhhhhcccc--c-
Confidence 22 33467999999999997 56789999999999999999999999975432211 1111110000 0
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSL--RPTMRKVSQM 793 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPtm~eV~~~ 793 (814)
... ......++++.+++.+||+.+|++ ||+++|+++.
T Consensus 301 --~~p-~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 301 --QFP-TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --CCC-SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --cCC-cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 000 011235678999999999888888 9999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.94 Aligned_cols=260 Identities=25% Similarity=0.425 Sum_probs=208.0
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCce-ehhhhh
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR-LLVYEF 601 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV~e~ 601 (814)
..+.||+|+||+||+|.+.........+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|+||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 34789999999999999876655667899999975433 3346789999999999999999999999876665 999999
Q ss_pred ccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc-
Q 042262 602 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK- 679 (814)
Q Consensus 602 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~- 679 (814)
+.+++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 105 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 105 MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred ccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 999999999976 4568999999999999999999995 59999999999999999999999999999866443211
Q ss_pred -cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 -AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 -~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.......++..|+|||.+.+..++.++||||||++++||++|..|+....... .+ ......+. .
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~----~~~~~~~~---------~ 246 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DL----THFLAQGR---------R 246 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GH----HHHHHTTC---------C
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HH----HHHhhcCC---------C
Confidence 11233457889999999999999999999999999999999666654332221 11 11111211 1
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCC
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~ 801 (814)
...+...++.+.+++.+||+.||.+|||++|+++.|+++++..
T Consensus 247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 1123345678999999999999999999999999998765443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.20 Aligned_cols=252 Identities=31% Similarity=0.440 Sum_probs=193.9
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc----cchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ----DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
.+.+.+.||+|+||.||+|.+. +..+|||+++.... ...+.+.+|+++++.++||||+++++++.+++..+
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI-----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-----TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred heeeeeeeccCCCeEEEEEEEc-----CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 3456688999999999999973 67899999865322 22467889999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC--------CCCeEEeecC
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD--------YYNARISDFG 668 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~--------~~~~kl~DfG 668 (814)
+||||+++++|.+++. ...+++..+..++.|+++||+|||+....+|+||||||+||+++. ++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999999985 457899999999999999999999753334999999999999986 6789999999
Q ss_pred CcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC
Q 042262 669 LAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748 (814)
Q Consensus 669 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 748 (814)
+++....... ....||..|+|||.+.+..++.++||||||++++||++|+.||....... ........ .
T Consensus 162 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~-~ 230 (271)
T 3dtc_A 162 LAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGVAMN-K 230 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHTS-C
T ss_pred cccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhhhcC-C
Confidence 9986653322 23468999999999999899999999999999999999999997543211 11111111 1
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
.....+..+++.+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 231 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 --------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11112335668899999999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=362.53 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=204.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCC-ceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-NRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~ 599 (814)
.+.+.+.||+|+||.||+|.+. +..||||+++... ..++|.+|+.++++++||||+++++++.+.. ..+|||
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~~-----~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-----TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred HeEEEeeecCcCCeeEEEEEec-----CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 3455678999999999999874 5689999997543 4578999999999999999999999987655 789999
Q ss_pred hhccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++|+|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 9999999999997643 37899999999999999999995 599999999999999999999999999998643221
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
....++..|+|||.+.+..++.++||||||++||||++ |+.||......+ + ...+..+.
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~----~~~i~~~~-------- 403 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPRVEKGY-------- 403 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---H----HHHHHTTC--------
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCC--------
Confidence 22357889999999999999999999999999999999 999997543322 1 11222221
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
....+..++..+.+++..||+.||.+|||+.||++.|+.+..
T Consensus 404 -~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 404 -KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 112234567899999999999999999999999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=355.31 Aligned_cols=253 Identities=22% Similarity=0.285 Sum_probs=207.0
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
...+.+.+.||+|+||+||++.... .+..+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~---~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETT---TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECC---CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 4456777899999999999999864 57889999986432 233456899999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC---CCCCeEEeecCCcccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD---DYYNARISDFGLAKLL 673 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DfGla~~~ 673 (814)
+||||+++|+|.+.+.....+++..+..++.||++||+|||+ .+|+||||||+|||++ +++.+||+|||+++..
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999999999888889999999999999999999995 5999999999999998 5678999999999876
Q ss_pred cccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
...... .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||......+ ....+..+....
T Consensus 164 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~-- 232 (444)
T 3soa_A 164 EGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGAYDF-- 232 (444)
T ss_dssp CTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCC--
T ss_pred cCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhCCCCC--
Confidence 543322 234579999999999999999999999999999999999999996543211 122233332211
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........+.++.+++..||+.||.+|||+.|+++
T Consensus 233 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 ----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111245678999999999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=334.92 Aligned_cols=251 Identities=27% Similarity=0.479 Sum_probs=201.4
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccc-------hhhhhceeeEEeeccccceeeeeeeeccCC
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG-------EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 593 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 593 (814)
.+.+.+.||+|+||.||+|.+.. .++.||||++....... .+++.+|+.++++++||||+++++++.+..
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 20 EIEYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp TEEEEEECCCCSSSCEEEEEETT---TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred cceehhccccCCceeEEEEEEcC---CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 45566889999999999999864 56789999986432221 157889999999999999999999997655
Q ss_pred ceehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEECCCCC-----eEEe
Q 042262 594 NRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQ--IIHCDIKPQNILLDDYYN-----ARIS 665 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~Dikp~NIll~~~~~-----~kl~ 665 (814)
++||||+++++|.+++... ..+++..++.++.|+++||+|||+ .+ |+||||||+||+++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 6999999999998887654 578999999999999999999995 46 999999999999988776 9999
Q ss_pred ecCCcccccccccccccccccCCCCccCcccc--cCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHH
Q 042262 666 DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF--RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 743 (814)
Q Consensus 666 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 743 (814)
|||+++..... .....||..|+|||.+ ....++.++||||||++++||++|+.||.......... ....
T Consensus 172 Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~ 242 (287)
T 4f0f_A 172 DFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF----INMI 242 (287)
T ss_dssp CCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH----HHHH
T ss_pred CCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH----HHHH
Confidence 99999854332 3345689999999999 45567899999999999999999999997544332111 1111
Q ss_pred HhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 744 YRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 744 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
...+. ....+..++.++.+++..||+.||.+|||+.||++.|+++
T Consensus 243 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REEGL---------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHSCC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hccCC---------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111 1122335678899999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=342.32 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=198.4
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEee--ccccceeeeeeeecc----CCc
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ--THHKNLVRLLGFCDE----GQN 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~----~~~ 594 (814)
.+.+.+.||+|+||+||+|.. .++.||||++... ....+..|.+++.. ++||||+++++++.+ ...
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW-----QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE-----CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 456678999999999999987 3678999998653 23445555555555 799999999998644 345
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEECCCCCeEEeecCC
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-----SAQIIHCDIKPQNILLDDYYNARISDFGL 669 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~Dikp~NIll~~~~~~kl~DfGl 669 (814)
.++||||+++|+|.+++.. ..+++..++.|+.||++||+|||... +.+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 8899999999999999954 46899999999999999999999321 45999999999999999999999999999
Q ss_pred ccccccccccc--ccccccCCCCccCcccccCC------CCCCccchhhHHHHHHHHHhC----------CcCCcccCCc
Q 042262 670 AKLLTLNQSKA--IKTAIRGTKGYVAPEWFRNS------TITAKVDVYSFGVLLLEIISC----------RKSFDIEMGE 731 (814)
Q Consensus 670 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~k~DV~S~Gvvl~elltG----------~~p~~~~~~~ 731 (814)
++......... ......||..|+|||.+.+. .++.++||||||+++|||++| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 98765433221 12234689999999999876 456799999999999999999 7777544322
Q ss_pred chhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 732 EYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 732 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
... ...........+..... .........+..+.+++.+||+.||.+|||+.||++.|+++
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPS-FEDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCC-HHHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccc-hhhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 111 11111111111111111 11112345788999999999999999999999999999754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.56 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=202.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccC--Ccee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRL 596 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 596 (814)
.+.+.+.||+|+||.||+|.+. +..+|||+++... ....+++.+|+.++++++||||+++++++.+. ...+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQ-----GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEET-----TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred HhHHHHHhcCCCcceEEEEEEC-----CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 3456688999999999999974 6779999987532 23346799999999999999999999999877 7889
Q ss_pred hhhhhccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 597 LVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
+||||+++|+|.+++.... .+++..++.++.||++||+|||+. ...|+||||||+||++++++.++|+|||+.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999999998764 489999999999999999999953 1229999999999999999999999988876432
Q ss_pred ccccccccccccCCCCccCcccccCCCCCC---ccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRNSTITA---KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
.....||..|+|||.+.+...+. ++||||||++++||++|+.||....... ........+..
T Consensus 165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~-- 229 (271)
T 3kmu_A 165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEGLR-- 229 (271)
T ss_dssp -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSCCC--
T ss_pred -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcCCC--
Confidence 22345789999999998765554 7999999999999999999997443211 11122222211
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
...+...+..+.+++..||+.||.+|||+.|+++.|+.+.+
T Consensus 230 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 -------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11233566789999999999999999999999999987653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.41 Aligned_cols=250 Identities=30% Similarity=0.492 Sum_probs=197.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||+|... +..||||++... ...+.+.+|++++++++||||+++++++.+ ..++|||
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR-----AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-----TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred HeeeeeEeecCCCceEEEEEEC-----CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 3456688999999999999874 567999998643 345678999999999999999999999874 4799999
Q ss_pred hccCCchhhhhcCCC---CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC-eEEeecCCccccccc
Q 042262 601 FLNNGTLASFLFGNL---KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN-ARISDFGLAKLLTLN 676 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~-~kl~DfGla~~~~~~ 676 (814)
|+++++|.+++.... .+++..++.++.|+++||+|||+....+|+||||||+||++++++. +||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999998654 4688999999999999999999643368999999999999998886 799999999765432
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.....||..|+|||.+.+..++.++||||||++++||++|+.||......... ..+ ....+....
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~-~~~~~~~~~----- 224 (307)
T 2eva_A 160 -----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMW-AVHNGTRPP----- 224 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----HHH-HHHTTCCCC-----
T ss_pred -----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----HHH-HHhcCCCCC-----
Confidence 22345899999999999999999999999999999999999999754332211 111 111222111
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.....+..+.+++.+||+.||.+|||+.||+++|+.+.
T Consensus 225 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 225 ----LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp ----CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred ----cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 12345678999999999999999999999999997654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=349.92 Aligned_cols=248 Identities=24% Similarity=0.321 Sum_probs=200.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeec-cccceeeeeeeeccCCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 597 (814)
+.+.+.||+|+||+||+|.... .++.+|||+++... ....+.+..|..++.++ +||||+++++++.+.+..+|
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~---~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4566889999999999999874 57889999997542 22334578888888876 89999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+++|+|..++.....+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++......
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 99999999999999888889999999999999999999995 599999999999999999999999999998633222
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcc--hhhHHHHHHHHHhcCCccccccC
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||......+ .........+.+..+..
T Consensus 208 ~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 208 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp C--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred C--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 1 1345679999999999999999999999999999999999999996543211 11111222233322221
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTM 787 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 787 (814)
..+...+.++.+++..||+.||.+||++
T Consensus 280 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ----RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1233456789999999999999999995
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=338.21 Aligned_cols=264 Identities=20% Similarity=0.256 Sum_probs=208.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCC--ceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ--NRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV 598 (814)
+.+.+.||+|+||+||+|.... .++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..+||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred EEEEEEecCCCCeEEEEEEECC---CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 5566889999999999999874 46789999997543 233567889999999999999999999987655 77999
Q ss_pred hhhccCCchhhhhcCCC---CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----CCCCCeEEeecCCcc
Q 042262 599 YEFLNNGTLASFLFGNL---KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAK 671 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DfGla~ 671 (814)
|||+++++|.+++.... .+++..++.|+.||++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999997653 38999999999999999999995 599999999999999 788889999999998
Q ss_pred cccccccccccccccCCCCccCccccc--------CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHH
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFR--------NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 743 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 743 (814)
....... .....||..|+|||.+. +..++.++||||||+++|||++|+.||......... .......
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~ 239 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI 239 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHH
Confidence 7654432 23456899999999986 578899999999999999999999999754432211 1112222
Q ss_pred Hhc---CCccccc-----------cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 744 YRN---GKLDDLV-----------EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 744 ~~~---~~~~~l~-----------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
... ..+..+. ...............+.+++.+||+.||++|||++|+++...+
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 211 1111100 0011122346778899999999999999999999999998765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.95 Aligned_cols=257 Identities=18% Similarity=0.185 Sum_probs=205.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.+.||+|+||.||+|.... .++.||||++... ...+++.+|+.+++++ +|+||+++++++.+++..+||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETT---TTEEEEEEEEETT--CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEeeccCCceEEEEEECC---CCcEEEEEEeccc--cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4556789999999999999754 5789999998653 2345789999999999 99999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC-----eEEeecCCccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN-----ARISDFGLAKLLT 674 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~DfGla~~~~ 674 (814)
|+ +++|.+++.. ...+++..++.|+.||++||+|||+ .+|+||||||+|||++.++. +||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 9999999876 4679999999999999999999995 59999999999999998887 9999999998765
Q ss_pred cccccc-----ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCc
Q 042262 675 LNQSKA-----IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 749 (814)
Q Consensus 675 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 749 (814)
...... ......||..|+|||.+.+..++.++||||||++++||++|+.||........................
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 433211 123467999999999999999999999999999999999999999865433221111111110000000
Q ss_pred cccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 750 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
. ......+ ++.+++..||+.||.+||++.+|++.|+++
T Consensus 242 ~---------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 242 E---------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp H---------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred H---------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0 0011234 899999999999999999999999998654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=343.16 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=212.7
Q ss_pred HHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 517 LEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 517 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
+....+.+.+.||+|+||.||+|.+.. .+..+|||++... ....+++.+|+.++++++||||+++++++.+.+..+
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGG---GTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecC---CCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 344556677899999999999999874 4678999998753 334567899999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 597 LVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999975 34589999999999999999999964 99999999999999999999999999998765
Q ss_pred ccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
...... .....++..|+|||.+.+..++.++||||||++++||++ |+.||........ ...+..+
T Consensus 163 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-------~~~~~~~------ 228 (288)
T 3kfa_A 163 GDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKD------ 228 (288)
T ss_dssp SSSSEE-ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHHHHTT------
T ss_pred CCcccc-ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcc------
Confidence 443222 333457889999999998999999999999999999999 9999875432221 1111111
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.....+..+++.+.+++..||+.||.+|||+.||++.|+.+.
T Consensus 229 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 229 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 111223456688999999999999999999999999997653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.50 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=184.3
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-ccceeeeeeeeccCCceehhhhhccC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
+.||+|+||.||+|.+.. .++.||||++... ....+.+|+.++..+. ||||+++++++.+....+|||||+++
T Consensus 17 ~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKK---SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CCSEEETTEEEEEEEETT---TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CccccCCCeEEEEEEECC---CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 579999999999999864 5678999998643 3456788999999997 99999999999999999999999999
Q ss_pred CchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC---CeEEeecCCcccccccccccc
Q 042262 605 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---NARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 605 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DfGla~~~~~~~~~~~ 681 (814)
++|.+++.....+++..+..|+.||++||+|||+ .+|+||||||+|||++.++ .+||+|||+++........
T Consensus 91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-- 165 (325)
T 3kn6_A 91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-- 165 (325)
T ss_dssp CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--
Confidence 9999999988889999999999999999999995 5999999999999997665 8999999999876543222
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||..|+|||.+.+..++.++||||||++++||++|+.||..................+..+.... ....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF------EGEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC------CSHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC------Cccc
Confidence 2345689999999999999999999999999999999999999975433211111112223333332211 1111
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
....++++.+++.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 12456789999999999999999999999853
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.79 Aligned_cols=244 Identities=25% Similarity=0.359 Sum_probs=202.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||+|.+.. .++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYK---TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4566889999999999999864 56789999986432 22345789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+ +|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 9999 789999988878899999999999999999999964 999999999999999999999999999987654332
Q ss_pred ccccccccCCCCccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.....||..|+|||.+.+..+ +.++||||||++++||++|+.||........ ...+...
T Consensus 164 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~~- 223 (336)
T 3h4j_B 164 ---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNSC- 223 (336)
T ss_dssp ---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCSS-
T ss_pred ---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHcC-
Confidence 234569999999999988876 7899999999999999999999975432110 0011100
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11123345678999999999999999999999987
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=346.93 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=207.4
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
...+.+.+.||+|+||.||+|.... .+..+|||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 4567778899999999999999864 56789999996432 223457889999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC---CeEEeecCCcccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---NARISDFGLAKLL 673 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DfGla~~~ 673 (814)
+||||+++|+|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++ .+||+|||+++..
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 999999999999999888889999999999999999999995 5999999999999998654 5999999999876
Q ss_pred cccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
..... .....||..|+|||.+.+..++.++||||||+++|||++|+.||....... ....+..+....
T Consensus 182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~~-- 249 (362)
T 2bdw_A 182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYDY-- 249 (362)
T ss_dssp TTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC--
T ss_pred cCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCCC--
Confidence 53322 234569999999999999999999999999999999999999997543211 122222332211
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
........+.++.+++.+||+.||.+|||+.|+++.
T Consensus 250 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011112456789999999999999999999998763
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.83 Aligned_cols=249 Identities=20% Similarity=0.295 Sum_probs=204.9
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||++.... .+..+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEeeeEEecCCCeEEEEEEECC---CCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 34567889999999999999864 5788999998643 2344568899999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC--CCCeEEeecCCcccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD--YYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~~ 677 (814)
|+++++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||++. ++.+||+|||+++.+....
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999999765 478999999999999999999995 59999999999999987 7899999999998775433
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
. .....||+.|+|||.+.+..++.++||||||++++||++|+.||....... ....+..+... .
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~------~ 222 (321)
T 1tki_A 159 N---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT------F 222 (321)
T ss_dssp E---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC------C
T ss_pred c---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-------HHHHHHcCCCC------C
Confidence 2 234568999999999999889999999999999999999999997543221 11112222111 0
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........+.++.+++.+||+.||.+|||+.|+++
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00011245678999999999999999999999998
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.66 Aligned_cols=257 Identities=26% Similarity=0.479 Sum_probs=197.0
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeecc-CCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~e 600 (814)
.+.+.||+|+||+||+|.+.........+|||.++... ....+++.+|+.++++++||||+++++++.+ ++..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 45578999999999999987554456689999986533 2345679999999999999999999998754 567899999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++|+|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.+......
T Consensus 172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999765 458899999999999999999995 59999999999999999999999999999876433221
Q ss_pred c--ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 680 A--IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 680 ~--~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
. ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+. . ..+..+..
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~----~~~~~~~~------- 314 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---T----VYLLQGRR------- 314 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---H----HHHHTTCC-------
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---H----HHHHcCCC-------
Confidence 1 1233457788999999999999999999999999999999 6677754432221 1 11122211
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
...+..++..+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 315 --~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 315 --LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1123346678999999999999999999999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.70 Aligned_cols=269 Identities=16% Similarity=0.172 Sum_probs=203.3
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc-----------chhhhhceeeEEeeccccceeeeeee
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD-----------GEKEFKNEVVVIGQTHHKNLVRLLGF 588 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~l~g~ 588 (814)
..+.+.+.||+|+||.||+|........+..+|||+....... ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 3456678999999999999999765556788999998653221 12335677788888999999999999
Q ss_pred ecc----CCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC--Ce
Q 042262 589 CDE----GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY--NA 662 (814)
Q Consensus 589 ~~~----~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~--~~ 662 (814)
+.+ ....+|||||+ +++|.+++.....+++..++.|+.||++||+|||+ .+|+||||||+|||++.++ .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCcE
Confidence 977 67899999999 99999999887789999999999999999999995 5999999999999999887 99
Q ss_pred EEeecCCcccccccccc-----cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHH
Q 042262 663 RISDFGLAKLLTLNQSK-----AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 737 (814)
Q Consensus 663 kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 737 (814)
||+|||+++.+...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~-- 270 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV-- 270 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH--
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH--
Confidence 99999999877543221 11234569999999999999999999999999999999999999996543222111
Q ss_pred HHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 738 DWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 738 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.......... +...+. ........++++.+++..||+.||.+|||+.||++.|+.+.
T Consensus 271 ~~~~~~~~~~-~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAKTNLLDE-LPQSVL---KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHT-TTHHHH---HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHhhccc-ccHHHH---hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1111111111 111100 00011245678999999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.93 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=199.4
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCC----
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ---- 593 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 593 (814)
..+.+.+.||+|+||.||+|.+......+..||||+++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 34556678999999999999988765567799999986532 223467899999999999999999999997755
Q ss_pred -ceehhhhhccCCchhhhhc------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEee
Q 042262 594 -NRLLVYEFLNNGTLASFLF------GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISD 666 (814)
Q Consensus 594 -~~~lV~e~~~~gsL~~~l~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 666 (814)
..++||||+++++|.+++. ....+++..++.++.||++||.||| +.+|+||||||+||++++++.+||+|
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEee
Confidence 3499999999999999983 3456899999999999999999999 46999999999999999999999999
Q ss_pred cCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHh
Q 042262 667 FGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 745 (814)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 745 (814)
||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....... . .....
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~ 263 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---M----YDYLL 263 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H----HHHHH
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H----HHHHH
Confidence 999987654432222334557889999999999999999999999999999999 888886543322 1 11112
Q ss_pred cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 746 NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 746 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.+.. ...+..++..+.+++..||+.||.+|||+.|+++.|+.+.
T Consensus 264 ~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 264 HGHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp TTCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2211 1123356678999999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=337.49 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=195.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--------------------------cchhhhhceeeEEe
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--------------------------DGEKEFKNEVVVIG 575 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--------------------------~~~~~~~~Ei~~l~ 575 (814)
+.+.+.||+|+||.||+|.... .++.||||++..... ...+++.+|+++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNEN---DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETT---TTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred eEEEeEEeecCCEEEEEEEECC---CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4566889999999999999864 578999999864321 12356889999999
Q ss_pred eccccceeeeeeeecc--CCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 042262 576 QTHHKNLVRLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 653 (814)
Q Consensus 576 ~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~N 653 (814)
+++||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.||++||+|||+ .+|+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHH
Confidence 9999999999999976 567899999999999998764 3568999999999999999999995 599999999999
Q ss_pred EEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCC---CCCccchhhHHHHHHHHHhCCcCCcccCC
Q 042262 654 ILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST---ITAKVDVYSFGVLLLEIISCRKSFDIEMG 730 (814)
Q Consensus 654 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~k~DV~S~Gvvl~elltG~~p~~~~~~ 730 (814)
||++.++.+||+|||+++........ .....||..|+|||.+.+.. .+.++||||||++++||++|+.||.....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999876543221 23456999999999998765 47889999999999999999999964321
Q ss_pred cchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 731 EEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 731 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
. . ....+..+... .......++.+.+++.+||+.||++|||+.|+++
T Consensus 246 ~------~-~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 M------C-LHSKIKSQALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H------H-HHHHHHHCCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H------H-HHHHHhcccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 1 11122222111 1112245678999999999999999999999865
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.29 Aligned_cols=270 Identities=21% Similarity=0.296 Sum_probs=203.6
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc---chhhhhceeeEEeeccccceeeeeeeeccCCce--
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR-- 595 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-- 595 (814)
.+.+.+.||+|+||.||++.+.. .++.||||+++..... ....+.+|+.++.+++||||+++++++......
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLR---DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cEEEEEEEccCCCEEEEEEEECC---CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 45667899999999999999864 5789999999754222 235688999999999999999999998766544
Q ss_pred --ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 596 --LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 596 --~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
++||||+++++|.+++.....+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++.+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 9999999999999999887889999999999999999999995 59999999999999999999999999999876
Q ss_pred cccccc-cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 674 TLNQSK-AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 674 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||...... .............
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~-- 238 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP-- 238 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC--
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCC--
Confidence 543222 1123456899999999999999999999999999999999999999754321 1122222222111
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHH-HHHHHcCCcCCCCCCCCCCC
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRK-VSQMLEGVVEVDVPPNPSPF 809 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~e-V~~~L~~~~~~~~pp~p~~~ 809 (814)
........+.++.+++.+||+.||.+||++.+ +.+.|..+.....|+.|...
T Consensus 239 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~~ 291 (311)
T 3ork_A 239 -----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVL 291 (311)
T ss_dssp -----HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCCC
T ss_pred -----cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCccc
Confidence 11112245678999999999999999996555 44556555554445444443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=349.69 Aligned_cols=264 Identities=26% Similarity=0.410 Sum_probs=212.2
Q ss_pred HHHhhhhccccccceeEEEEEEEecc----CCcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeeeccC
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTT----RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG 592 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~----~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 592 (814)
...+.+.+.||+|+||.||+|.+... ...+..||||+++... ....+++.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 34566778999999999999998531 1356789999997542 23346789999999999 899999999999999
Q ss_pred CceehhhhhccCCchhhhhcCCC----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 042262 593 QNRLLVYEFLNNGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 656 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll 656 (814)
+..++||||+++++|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 99999999999999999997543 37899999999999999999995 599999999999999
Q ss_pred CCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhh
Q 042262 657 DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI 735 (814)
Q Consensus 657 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 735 (814)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||......+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence 9999999999999987654433222334457788999999998899999999999999999999 999986443211
Q ss_pred HHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCC
Q 042262 736 LTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801 (814)
Q Consensus 736 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~ 801 (814)
....+..+... ..+..++..+.+++.+||+.||.+|||+.||++.|+.++...
T Consensus 268 ----~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 268 ----LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp ----HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----HHHHHhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11222222211 123356678999999999999999999999999998876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=347.00 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=205.4
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.+.||+|+||.||++.... .+..+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34566889999999999999864 5678999998643 22334678899999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+.+|+|..++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 99999999999999988889999999999999999999995 599999999999999999999999999998765432
Q ss_pred cccccccccCCCCccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRN---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
. .....||..|+|||++.+ ..++.++|||||||++|||++|+.||..........+ ...+....
T Consensus 170 ~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~----~~~~~~~~------ 236 (384)
T 4fr4_A 170 Q---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI----VHTFETTV------ 236 (384)
T ss_dssp C---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH----HHHHHHCC------
T ss_pred c---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH----HHHHhhcc------
Confidence 2 345679999999999964 4589999999999999999999999975543322211 11111111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT-MRKVSQ 792 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-m~eV~~ 792 (814)
...+...+..+.+++.+||+.||.+||+ +.+|.+
T Consensus 237 ----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1123355688999999999999999998 777765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=343.34 Aligned_cols=248 Identities=26% Similarity=0.332 Sum_probs=190.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.+.||+|+||.||+|.... .++.||||+++... ..+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKG---TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEeeCCCEEEEEEEECC---CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4566889999999999999864 46789999997542 346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCCeEEeecCCccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DfGla~~~~~~~~ 678 (814)
+++++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 9999999999888889999999999999999999995 59999999999999975 88999999999987643221
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.....||..|+|||.+.+..++.++||||||+++|||++|+.||....... .....+..+.... .
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~~~------~ 271 (349)
T 2w4o_A 207 ---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEYYF------I 271 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCCCC------C
T ss_pred ---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCCcc------C
Confidence 234568999999999999999999999999999999999999997543321 1112222222110 0
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.......+.++.+++.+||+.||++|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112345678999999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.93 Aligned_cols=253 Identities=32% Similarity=0.490 Sum_probs=206.8
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
..+.+.+.||+|+||.||+|... .+..||||++.... ...+.+.+|+++++.++||||+++++++.+ +..++||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HhhhheeeecCCCCeEEEEEEEc----CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 34566789999999999999975 45679999987542 345679999999999999999999999864 5689999
Q ss_pred hhccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++++|.+++.... .+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999997643 68999999999999999999995 599999999999999999999999999998765433
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
... .....++..|+|||.+.+..++.++||||||++++||++ |+.||......+ ....+..+.
T Consensus 164 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~-------- 227 (279)
T 1qpc_A 164 YTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERGY-------- 227 (279)
T ss_dssp EEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC--------
T ss_pred ccc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-------HHHHHhccc--------
Confidence 221 233456789999999998899999999999999999999 899986433211 112222221
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
....+...++.+.+++..||+.||++|||+.++++.|+++.
T Consensus 228 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 228 -RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 11123355688999999999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=356.32 Aligned_cols=247 Identities=23% Similarity=0.265 Sum_probs=196.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||+|.... .+..||||+++.. .......+.+|+.+++.++||||+++++++.+.+..+||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred cEEeEEEeeCcCEEEEEEEEcC---CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 4566889999999999999864 5778999999753 233346688999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+++.....+++..+..++.||++||+|||+. .+|+||||||+||||+.++.+||+|||+++.......
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 99999999999998888899999999999999999999951 5899999999999999999999999999986433222
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. .....||..|+|||++.+..++.++||||||++++||++|+.||....... ....+..+..
T Consensus 305 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~--------- 366 (446)
T 4ejn_A 305 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI--------- 366 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC---------
T ss_pred c--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHHhCCC---------
Confidence 1 344679999999999999999999999999999999999999997543221 1111111111
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~ 792 (814)
..+...+.++.+++.+||+.||.+|| +++|+++
T Consensus 367 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11234567899999999999999999 9999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=338.52 Aligned_cols=258 Identities=23% Similarity=0.299 Sum_probs=197.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||+||+|.+. .++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDS----QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEET----TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhhccCCCCeEEEEEEEC----CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 455678999999999999975 467899999865322 22467889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++ +|.+.+... ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 99985 777766554 568999999999999999999995 5999999999999999999999999999987653322
Q ss_pred ccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc------
Q 042262 679 KAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD------ 751 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------ 751 (814)
. .....||..|+|||.+.+ ..++.++||||||++++||++|+.||......+.. ..............
T Consensus 175 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 175 S--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp -----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGGGTT
T ss_pred c--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhhhhc
Confidence 1 234568999999999976 56899999999999999999999999765443211 11111111111000
Q ss_pred ----------cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 752 ----------LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 752 ----------l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..............+.++.+++.+||+.||.+|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000112234578899999999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.70 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=206.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.+.||+|+||.||+|.+......+..||||.+... .....+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEE
Confidence 345668899999999999998865556678999998754 23345678999999999999999999999875 4568999
Q ss_pred hhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++++|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 92 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 92 ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 999999999999764 458999999999999999999995 5999999999999999999999999999987654332
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.. .....++..|+|||.+.+..++.++||||||++++||++ |+.||........ ...+..+...
T Consensus 169 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~-------~~~~~~~~~~------- 233 (281)
T 3cc6_A 169 YK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-------IGVLEKGDRL------- 233 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH-------HHHHHHTCCC-------
T ss_pred cc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH-------HHHHhcCCCC-------
Confidence 21 233457889999999998899999999999999999998 9999975433221 1111222111
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
..+..+++.+.+++.+||+.||.+|||+.|+++.|+.+.+
T Consensus 234 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 234 --PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 1123456789999999999999999999999999987643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=348.82 Aligned_cols=251 Identities=25% Similarity=0.326 Sum_probs=206.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||+|.... .+..+|+|++..........+.+|+.++..++||||+++++++.+....+||||
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCEEEEEEEECC---CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 35667889999999999999864 567899999876544455678999999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC--CCCeEEeecCCcccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD--YYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~~ 677 (814)
|+++++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999998765 478999999999999999999995 59999999999999974 5779999999998765432
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
. .....||..|+|||.+.+..++.++||||||++++||++|+.||....... . ...+...... .
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~-~~~i~~~~~~------~ 269 (387)
T 1kob_A 206 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------T-LQNVKRCDWE------F 269 (387)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------H-HHHHHHCCCC------C
T ss_pred c---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH------H-HHHHHhCCCC------C
Confidence 2 234468999999999999999999999999999999999999997543211 1 1111121111 1
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
........+.++.+++.+||+.||.+|||+.|+++.
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111123456789999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=370.80 Aligned_cols=259 Identities=29% Similarity=0.455 Sum_probs=211.3
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
...+.+.++||+|+||.||+|.+. ....||||+++... ...++|.+|++++++++|+||+++++++.+ +..+||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET----TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhhhhhheecccCCCeEEEEEEEC----CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 344567789999999999999986 34679999997643 345689999999999999999999999976 678999
Q ss_pred hhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 599 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||+++|+|.+++... ..+++..++.|+.||++||+|||+ .+|+||||||+||||++++.+||+|||+++.....
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999999753 568999999999999999999995 59999999999999999999999999999876533
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.... .....++..|+|||.+.+..++.++||||||++||||++ |+.||......+ ....+..+.
T Consensus 417 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~------- 481 (535)
T 2h8h_A 417 EYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGY------- 481 (535)
T ss_dssp HHHT-TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTTC-------
T ss_pred ceec-ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC-------
Confidence 2111 223446788999999998899999999999999999999 999986443211 122222221
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCC
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 803 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~p 803 (814)
....+..+++.+.+|+.+||+.||++|||+.+|+++|+.+..-..|
T Consensus 482 --~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 482 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 1112335678899999999999999999999999999998764443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=337.81 Aligned_cols=243 Identities=25% Similarity=0.340 Sum_probs=204.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||++.... .++.+|+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 4566889999999999999864 57799999996532 23345678899999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+++.....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 999999999999988888999999999999999999999 569999999999999999999999999999875432
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.....||..|+|||.+.+..++.++||||||++++||++|+.||....... ....+..+..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~--------- 220 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAEL--------- 220 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHCCC---------
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC---------
Confidence 234569999999999999999999999999999999999999997543211 1111222211
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~ 792 (814)
..+...+.++.+++.+||+.||.+|| +++||++
T Consensus 221 -~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11234567899999999999999999 8888885
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.27 Aligned_cols=250 Identities=23% Similarity=0.252 Sum_probs=196.6
Q ss_pred HHHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeec-cccceeeeeeeec
Q 042262 514 YKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT-HHKNLVRLLGFCD 590 (814)
Q Consensus 514 ~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 590 (814)
..++....+.+.++||+|+||+||+|.+.. +++.||||++..... ....++..|+..+.++ +|+||+++++++.
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKE---DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETT---TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECC---CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 445666778888899999999999999874 577899999864322 2223445555555554 8999999999999
Q ss_pred cCCceehhhhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCC
Q 042262 591 EGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 669 (814)
Q Consensus 591 ~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl 669 (814)
+++..+|||||+ +++|.+++.. ...+++..++.|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred eCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEcccee
Confidence 999999999999 6788888765 4569999999999999999999995 5899999999999999999999999999
Q ss_pred cccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCc
Q 042262 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 749 (814)
Q Consensus 670 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 749 (814)
++....... .....||.+|+|||++.+ .++.++||||||++++||++|..++.... .+..+..+..
T Consensus 204 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~ 269 (311)
T 3p1a_A 204 LVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYL 269 (311)
T ss_dssp CEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCC
T ss_pred eeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCC
Confidence 987653322 334568999999999876 78999999999999999999977664221 1122222222
Q ss_pred cccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 750 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.. ......++++.+++.+||+.||++|||+.|+++
T Consensus 270 ~~--------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 PP--------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CH--------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cc--------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 112245688999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=350.99 Aligned_cols=268 Identities=24% Similarity=0.350 Sum_probs=212.4
Q ss_pred HHhhhhccccccceeEEEEEEEec-cCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeec--cCCcee
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD--EGQNRL 596 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~ 596 (814)
..+.+.+.||+|+||.||++.+.. ....+..||||++........+.+.+|+.++++++|+||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 345667899999999999998643 23367899999998765555677999999999999999999999886 455688
Q ss_pred hhhhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 597 LVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
+||||+++++|.+++.. ...+++..++.|+.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 99999999999999976 3568999999999999999999995 5999999999999999999999999999987654
Q ss_pred ccccc-ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcc--------hhhHHHHHHHHHhc
Q 042262 676 NQSKA-IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--------YAILTDWAFDCYRN 746 (814)
Q Consensus 676 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~--------~~~l~~~~~~~~~~ 746 (814)
..... ......+|..|+|||.+.+..++.++||||||++++||++|+.||....... .............
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 258 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE- 258 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH-
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh-
Confidence 33221 1233457888999999999899999999999999999999999986432110 0000011111111
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.......+..+++.+.+++.+||+.||.+|||+.||++.|+.+..
T Consensus 259 --------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 259 --------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp --------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred --------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 112222344667899999999999999999999999999987654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=349.43 Aligned_cols=279 Identities=25% Similarity=0.352 Sum_probs=210.4
Q ss_pred hhhccccccceeEEEEEEEec-cCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccC--Cceehh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLV 598 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 598 (814)
.+.+.||+|+||+||++.... ....++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 566889999999999997643 33467899999997543 23346789999999999999999999999774 567899
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++++|.+++... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 9999999999999765 48999999999999999999995 5999999999999999999999999999987754332
Q ss_pred c-cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 K-AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
. .......+|..|+|||.+.+..++.++||||||++++||++|+.||........ ....+.........+.+.+....
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHHHTTC
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHHhccc
Confidence 1 112334578889999999998999999999999999999999999864321100 00000000000001111122222
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCCCCC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNP 806 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~pp~p 806 (814)
....+..++.++.+++.+||+.||.+|||+.||++.|+.+.+.-.++.|
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 2223446678999999999999999999999999999887655444443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=338.85 Aligned_cols=270 Identities=25% Similarity=0.378 Sum_probs=210.1
Q ss_pred HHHHHhhhhccccccceeEEEEEEEec-cCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccC--
Q 042262 517 LEEATDNFEEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-- 592 (814)
Q Consensus 517 l~~~~~~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-- 592 (814)
+....+.+.+.||+|+||.||+|.+.. ....+..||||++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 334456677899999999999998642 23467899999997532 33446789999999999999999999999776
Q ss_pred CceehhhhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 593 QNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
...++||||+++++|.+++.. ...+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence 668999999999999999954 4568999999999999999999995 599999999999999999999999999998
Q ss_pred cccccccc-cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCc--------chhhHHHHHHH
Q 042262 672 LLTLNQSK-AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE--------EYAILTDWAFD 742 (814)
Q Consensus 672 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~--------~~~~l~~~~~~ 742 (814)
........ .......+|..|+|||.+.+..++.++||||||++++||++|+.|+...... ...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 77544321 1123455788899999999999999999999999999999999986432110 00000011111
Q ss_pred HHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 743 CYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 743 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.+..+. ....+..+++.+.+++.+||+.||.+|||+.||++.|+.++
T Consensus 255 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111 12223456788999999999999999999999999998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=374.14 Aligned_cols=251 Identities=29% Similarity=0.419 Sum_probs=203.7
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhcc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 603 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 603 (814)
++||+|+||.||+|.+.... .+..||||+++.... ...+++.+|++++.+++||||+++++++.+ +..+|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSS-CEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCC-cceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 47999999999999876432 567899999976432 235689999999999999999999999964 56889999999
Q ss_pred CCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc-ccc
Q 042262 604 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK-AIK 682 (814)
Q Consensus 604 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~ 682 (814)
+|+|.+++.....+++..++.|+.||++||+|||+ .+|+||||||+||||++++.+||+|||+++.+..+... ...
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999999888889999999999999999999995 59999999999999999999999999999877544321 112
Q ss_pred ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
....+|..|+|||.+.+..++.++||||||++|+||++ |+.||......+ +...+..+... ..
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~---------~~ 593 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERM---------GC 593 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC---------CC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC---------CC
Confidence 33446788999999999999999999999999999998 999997543221 22233333211 12
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
+..++.++.+++..||+.||++|||+.+|+++|+++
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 345678999999999999999999999999999764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.55 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=200.8
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeec-cccceeeeeeeeccCCcee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 596 (814)
.+.+.+.||+|+||+||+|.... .++.+|||+++.. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcC---CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 45667889999999999999874 5678999999753 223345678889999887 7999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||||+++|+|..++.....+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.....
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 999999999999999888889999999999999999999995 59999999999999999999999999999864332
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
... .....||..|+|||++.+..++.++||||||+++|||++|+.||......+ ....+..+..
T Consensus 178 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~------- 241 (353)
T 3txo_A 178 GVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV------- 241 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-------
T ss_pred Ccc--ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence 221 345679999999999999899999999999999999999999997543221 1122222221
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTM------RKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm------~eV~~ 792 (814)
..+...+..+.+++..||+.||.+||++ +|+++
T Consensus 242 ---~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ---VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1123456788999999999999999998 66665
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=338.79 Aligned_cols=259 Identities=25% Similarity=0.468 Sum_probs=201.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeec-cCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCD-EGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~ 599 (814)
+.+.+.||+|+||+||+|.+.........+|||.+..... ...+++.+|+.++++++||||+++++++. .++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 4556789999999999999875544556799999875332 33467899999999999999999999864 456789999
Q ss_pred hhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 99999999999976 4568999999999999999999995 5999999999999999999999999999987654332
Q ss_pred c--cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhC-CcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 679 K--AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 679 ~--~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
. .......+|..|+|||.+.+..++.++||||||++++||++| ..||........ ......+..
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~------ 250 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------TVYLLQGRR------ 250 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-------HHHHHTTCC------
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhcCCC------
Confidence 1 112334577899999999999999999999999999999995 455543322211 111111111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
...+...+..+.+++..||+.||.+|||+.|+++.|+.+..
T Consensus 251 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 251 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11123456789999999999999999999999999987654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=349.87 Aligned_cols=269 Identities=15% Similarity=0.174 Sum_probs=203.5
Q ss_pred HhhhhccccccceeEEEEEEEeccC--CcceEEEEEeeccccccc-----------hhhhhceeeEEeeccccceeeeee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVFQDG-----------EKEFKNEVVVIGQTHHKNLVRLLG 587 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vaVK~l~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~l~g 587 (814)
.+.+.+.||+|+||.||+|.+..++ ..++.||||++....... ...+..|+..+..++|+||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 4566788999999999999987532 124789999986532111 112334445567778999999999
Q ss_pred eeccC----CceehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC--CCC
Q 042262 588 FCDEG----QNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD--DYY 660 (814)
Q Consensus 588 ~~~~~----~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~--~~~ 660 (814)
++.+. ...+|||||+ +++|.+++... ..+++..++.|+.||++||+|||+ .+|+||||||+|||++ .++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSCTT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCCCC
Confidence 98764 4589999999 99999999765 679999999999999999999995 5999999999999999 889
Q ss_pred CeEEeecCCccccccccccc-----ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhh
Q 042262 661 NARISDFGLAKLLTLNQSKA-----IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 735 (814)
Q Consensus 661 ~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~ 735 (814)
.+||+|||+++.+....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~- 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY- 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH-
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH-
Confidence 99999999998775433221 113345999999999999999999999999999999999999999854332211
Q ss_pred HHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 736 LTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 736 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
......... ..+..+++..+ ....++.++.+++..||+.||.+||++.+|+++|+++++
T Consensus 271 -~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 271 -VRDSKIRYR-ENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp -HHHHHHHHH-HCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHhh-hhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 111111111 11222222211 112456789999999999999999999999999977654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=347.30 Aligned_cols=246 Identities=24% Similarity=0.295 Sum_probs=197.8
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
.+.||+|+||.||+|.... .+..||||+++.......+++.+|+.++++++||||+++++++.+.+..+|||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETA---TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETT---TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcC---CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 3579999999999999864 5678999999765545567899999999999999999999999999999999999999
Q ss_pred CchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE--CCCCCeEEeecCCcccccccccccc
Q 042262 605 GTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL--DDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 605 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll--~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--- 244 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--- 244 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence 9999988654 568999999999999999999995 599999999999999 6678999999999987654332
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||..|+|||.+.+..++.++||||||++++||++|+.||......+ ..... ...... .....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i-~~~~~~------~~~~~ 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNI-LACRWD------LEDEE 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH-HHTCCC------SCSGG
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HhccCC------CChhh
Confidence 233469999999999999999999999999999999999999997543221 11111 111110 11111
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....++++.+++.+||+.||.+|||+.|+++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1245678999999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.64 Aligned_cols=254 Identities=27% Similarity=0.432 Sum_probs=208.1
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||+|... .+..+|+|++.... ...+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred heeeeeEecCCCceeEEEEEec----CCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 3456688999999999999986 35679999997643 234678999999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++++|.+++... ..+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999999764 568999999999999999999995 59999999999999999999999999999876433221
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. .....++..|+|||.+.+..++.++||||||++++||++ |+.||....... ....+..+..
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~i~~~~~--------- 223 (267)
T 3t9t_A 161 S-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFR--------- 223 (267)
T ss_dssp S-TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC---------
T ss_pred c-cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-------HHHHHhcCCc---------
Confidence 1 233456788999999998899999999999999999999 899987543211 1122222211
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
...+...+..+.+++.+||+.||.+|||+.|+++.|+++.+
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11123456789999999999999999999999999987643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.10 Aligned_cols=259 Identities=24% Similarity=0.448 Sum_probs=201.8
Q ss_pred HhhhhccccccceeEEEEEEEeccC-CcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTR-TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~-~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.+.+.+.||+|+||.||+|.+.... ..+..||||+++... .....++.+|+.++++++||||+++++++.+.+..+||
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 124 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 124 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence 3445678999999999999987532 235679999997542 23345789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||+++++|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 125 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 125 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 9999999999999754 678999999999999999999995 599999999999999999999999999998765432
Q ss_pred ccc-ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 678 SKA-IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 678 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
... ......+|..|+|||.+.+..++.++||||||++++||++ |+.||......+ ....+..+..
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~~------ 268 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFR------ 268 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC------
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHCCCc------
Confidence 221 1122345778999999999999999999999999999999 999996432211 1122222211
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
...+..++..+.+++.+||+.||.+||++.||++.|+.++
T Consensus 269 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 269 ---LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp ---CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1123356678999999999999999999999999987654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.88 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=200.8
Q ss_pred HhhhhccccccceeEEEEEEEeccCC-cceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRT-STTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~-~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.+.+.+.||+|+||.||+|.+...+. -...|++|.+... .....+++.+|+.++++++||||+++++++.++. .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v 94 (327)
T 3lzb_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence 35566889999999999999865332 2235788887543 3344577999999999999999999999998754 7889
Q ss_pred hhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
+||+.+|+|.+++.. ...+++..++.|+.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 999999999999876 4568999999999999999999995 599999999999999999999999999998775544
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.........+|..|+|||.+.+..++.++||||||++++||++ |+.||........ ...+..+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~~~~-------- 236 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGE-------- 236 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTC--------
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCC--------
Confidence 3332334456788999999999999999999999999999999 9999975443221 11122221
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
....+..++.++.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 237 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 -RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111233466789999999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=335.67 Aligned_cols=261 Identities=20% Similarity=0.265 Sum_probs=200.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||+||+|.... .++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..+|||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeeeEecCCCCeEEEEEEECC---CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 4556789999999999999864 567899999965322 22367889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+.++.+..+......+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 999875555555556789999999999999999999995 59999999999999999999999999999876533221
Q ss_pred cccccccCCCCccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC---Cccccc--
Q 042262 680 AIKTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLDDLV-- 753 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~l~-- 753 (814)
.....||..|+|||.+.+.. ++.++||||||++++||++|..|+........ .+ .......... ......
T Consensus 158 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~-~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp --CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HH-HHHHHHHCCCCTTTCTTGGGS
T ss_pred --ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HH-HHHHHHhCCCChhhhhhhccc
Confidence 33456899999999998765 89999999999999999999988654332211 11 1111111110 000000
Q ss_pred -c---------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 754 -E---------GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 754 -~---------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+ ...........+.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00001112346688999999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=330.36 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=207.1
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
..+.+.+.||+|+||.||+|.... .+..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKG---TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCC---CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 456677899999999999999864 46789999998766666778999999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---CCCCCeEEeecCCccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DfGla~~~~~~ 676 (814)
||+++++|.+++.....+++..+..|+.|+++||+|||+ .+|+||||||+||++ +.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999999999888889999999999999999999995 599999999999999 78899999999999876543
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.. .....||..|+|||.+.+. ++.++||||||++++||++|+.||......+ ....+..+....
T Consensus 163 ~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~----- 226 (277)
T 3f3z_A 163 KM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTFTF----- 226 (277)
T ss_dssp SC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC-----
T ss_pred cc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCCC-----
Confidence 32 2345689999999998764 8999999999999999999999997543211 112222222110
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........+..+.+++.+||+.||.+|||+.|+++
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 -PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00001135678999999999999999999999976
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=339.86 Aligned_cols=251 Identities=23% Similarity=0.267 Sum_probs=197.4
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc----ccchhhhhceeeEEeeccccceeeeeeeeccCCce
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 595 (814)
..+.+.+.||+|+||.||++........++.+|+|+++... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 34566789999999999999986544568899999997532 22345678899999999999999999999999999
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
+|||||+++++|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 9999999999999999887889999999999999999999995 5999999999999999999999999999986433
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
... ......||..|+|||.+.+..++.++||||||+++|||++|+.||....... . ...+..+..
T Consensus 174 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~-~~~i~~~~~------ 238 (327)
T 3a62_A 174 DGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------T-IDKILKCKL------ 238 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------H-HHHHHHTCC------
T ss_pred CCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------H-HHHHHhCCC------
Confidence 221 1234569999999999999999999999999999999999999997543211 1 111111111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 792 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~ 792 (814)
..+...+.++.+++.+||+.||.+|| ++.|+++
T Consensus 239 ----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11234567899999999999999999 7778776
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=340.88 Aligned_cols=242 Identities=23% Similarity=0.313 Sum_probs=203.3
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--------cchhhhhceeeEEeeccccceeeeeeeecc
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE 591 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 591 (814)
..+.+.+.||+|+||.||+|.... .+..||||+++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKE---KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETT---TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cceEEEeEEEecCCEEEEEEEECC---CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 455667889999999999999764 578899999865321 133568889999999999999999999999
Q ss_pred CCceehhhhhccCC-chhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 592 GQNRLLVYEFLNNG-TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 592 ~~~~~lV~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
.+..++||||+.+| +|.+++.....+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 99999999999777 999999988889999999999999999999995 59999999999999999999999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCc
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 749 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 749 (814)
+....... .....||..|+|||.+.+..+ +.++||||||++++||++|+.||.....
T Consensus 178 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------- 235 (335)
T 3dls_A 178 AYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------- 235 (335)
T ss_dssp EECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------------
T ss_pred eECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------------
Confidence 87654332 234568999999999988876 8899999999999999999999963211
Q ss_pred cccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 750 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
...... ..+...+.++.+++..||+.||.+|||+.|+++.
T Consensus 236 --~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 --TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 1122356789999999999999999999999984
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=341.20 Aligned_cols=261 Identities=27% Similarity=0.458 Sum_probs=210.9
Q ss_pred HHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
..+.+.+.||+|+||.||+|.+.. ....+..||||++..... ....++.+|+.+++.++||||+++++++.+++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 345667899999999999998763 122467899999975422 23456889999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEee
Q 042262 597 LVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISD 666 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 666 (814)
+||||+++++|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECc
Confidence 999999999999998642 356899999999999999999995 5999999999999999999999999
Q ss_pred cCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHh
Q 042262 667 FGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 745 (814)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 745 (814)
||+++...............+|..|+|||.+.+..++.++||||||++++||++ |+.||....... ....+.
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~ 254 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVM 254 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HHHHHH
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-------HHHHHH
Confidence 999987654433222333456889999999999899999999999999999999 888886432211 112222
Q ss_pred cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 746 NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 746 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.+... ..+...+..+.+++.+||+.||.+|||+.|+++.|+++.+
T Consensus 255 ~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 255 EGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 22221 1123566789999999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=336.36 Aligned_cols=264 Identities=27% Similarity=0.436 Sum_probs=198.0
Q ss_pred HHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccC
Q 042262 515 KELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 592 (814)
Q Consensus 515 ~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 592 (814)
.|+....+.+.+.||+|+||+||+|... ..+|||+++... ....+.+.+|+.++++++|+||+++++++ ..
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 3445556677789999999999999854 249999986432 23346789999999999999999999976 45
Q ss_pred CceehhhhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 593 QNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
...++||||+++++|.+++.. ...+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecc
Confidence 568999999999999999964 4568999999999999999999995 599999999999999999999999999998
Q ss_pred cccccccccccccccCCCCccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 748 (814)
...............||..|+|||.+. +..++.++||||||++++||++|+.||....... ........+.
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~ 242 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGS 242 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTS
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccc
Confidence 665433222234456899999999986 6678899999999999999999999997543321 1222222332
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
...... .....++..+.+++..||+.||.+|||+.||++.|+++.+
T Consensus 243 ~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 LSPDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCcchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 221111 1123566889999999999999999999999999988754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=341.63 Aligned_cols=248 Identities=25% Similarity=0.319 Sum_probs=200.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeec-cccceeeeeeeeccCCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 597 (814)
+.+.+.||+|+||.||+|.... .++.+|||+++.... ...+.+.+|+.++.++ +||||+++++++.+.+..+|
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 4566889999999999999864 578999999975422 2235578899999887 89999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+++|+|.+++.....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999999887889999999999999999999995 599999999999999999999999999998643222
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcc--hhhHHHHHHHHHhcCCccccccC
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
. ......||..|+|||.+.+..++.++||||||++++||++|+.||....... ...........+..+..
T Consensus 165 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 165 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred C--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 1 1345679999999999999999999999999999999999999996532211 00111222222222221
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTM 787 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 787 (814)
..+...+.++.+++.+||+.||.+||++
T Consensus 237 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ----RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1123456789999999999999999995
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=346.35 Aligned_cols=253 Identities=24% Similarity=0.297 Sum_probs=203.8
Q ss_pred HHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-----ccchhhhhceeeEEeeccccceeeeeeeeccC
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 592 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 592 (814)
....+.+.+.||+|+||+||+|.... .++.||||++.... ....+++.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccceEEeeEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 34567788999999999999999864 56789999985421 12356789999999999999999999999999
Q ss_pred CceehhhhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC---eEEe
Q 042262 593 QNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN---ARIS 665 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~ 665 (814)
+..+|||||+++++|.+.+.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++. +||+
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEe
Confidence 999999999999999887753 2358999999999999999999995 59999999999999986655 9999
Q ss_pred ecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHh
Q 042262 666 DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 745 (814)
Q Consensus 666 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 745 (814)
|||+++........ .....||..|+|||.+.+..++.++||||||+++|||++|+.||..... .....+.
T Consensus 176 Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~ 245 (351)
T 3c0i_A 176 GFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGII 245 (351)
T ss_dssp CCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHH
T ss_pred cCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHH
Confidence 99999876543221 2345699999999999999999999999999999999999999975321 1112222
Q ss_pred cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 746 NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 746 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+.... ........++++.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 246 KGKYKM------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HTCCCC------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCCC------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 222110 00001234678999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.52 Aligned_cols=262 Identities=27% Similarity=0.385 Sum_probs=210.6
Q ss_pred HHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccccc-cchhhhhceeeEEeec-cccceeeeeeeeccCC-c
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ-N 594 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~-~ 594 (814)
..+.+.+.||+|+||.||+|.+.. ....++.||||+++.... ...+.+.+|+.++.++ +||||+++++++.+.+ .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 345667899999999999999754 234678999999975432 2345789999999999 7999999999987754 5
Q ss_pred eehhhhhccCCchhhhhcCCCC----------------CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 042262 595 RLLVYEFLNNGTLASFLFGNLK----------------PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 658 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~ 658 (814)
.++||||+++++|.+++..... +++..++.++.||++||.|||+ .+|+||||||+||+++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECC
Confidence 8999999999999999976543 7899999999999999999995 59999999999999999
Q ss_pred CCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHH
Q 042262 659 YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILT 737 (814)
Q Consensus 659 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~ 737 (814)
++.+||+|||+++...............+|..|+|||.+.+..++.++||||||++++||++ |+.||........
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---- 259 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 259 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH----
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH----
Confidence 99999999999987654433332334557889999999999999999999999999999998 9999975433221
Q ss_pred HHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 738 DWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 738 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
....+..+... ..+...+..+.+++.+||+.||.+|||+.||++.|+.+++
T Consensus 260 --~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 260 --FCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp --HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHhccCccC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11222222211 1122456789999999999999999999999999987653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=337.36 Aligned_cols=256 Identities=29% Similarity=0.413 Sum_probs=206.1
Q ss_pred hhhhc-cccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEE-EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~-~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+ .||+|+||.||+|.+.... .+..||||+++.... ...+++.+|+.+++.++||||+++++++ +.+..++|
T Consensus 18 y~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 18 LTLEDKELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSS-SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhccCccccccCeeeEeeeecCCC-ceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 44455 8999999999999775432 578899999975432 2246799999999999999999999999 56778999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++++|.+++.....+++..++.++.||++||+|||+ .+|+|+||||+||+++.++.+||+|||+++.......
T Consensus 96 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 9999999999999888889999999999999999999995 5999999999999999999999999999987654432
Q ss_pred cc-ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 679 KA-IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 679 ~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.. ......++..|+|||.+.+..++.++||||||++++||++ |+.||....... ....+..+...
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~------ 239 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERM------ 239 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC------
T ss_pred cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC------
Confidence 21 1222346788999999998889999999999999999999 999997543221 12222222211
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
..+..++..+.+++..||+.||.+||++.||++.|+++.
T Consensus 240 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 240 ---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 123356788999999999999999999999999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=339.47 Aligned_cols=260 Identities=23% Similarity=0.268 Sum_probs=204.1
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeec----cCCcee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD----EGQNRL 596 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----~~~~~~ 596 (814)
.+.+.+.||+|+||.||++.... .++.||||++........+.+.+|+.+++.++||||+++++++. .....+
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLH---DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecC---CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 45667889999999999999864 56799999987655555678999999999999999999999986 345788
Q ss_pred hhhhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 597 LVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
+|+||+++++|.+++.. ...+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999998864 4678999999999999999999995 5999999999999999999999999999876
Q ss_pred cccccccc-------ccccccCCCCccCcccccCCC---CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHH
Q 042262 673 LTLNQSKA-------IKTAIRGTKGYVAPEWFRNST---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 742 (814)
Q Consensus 673 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 742 (814)
........ ......||..|+|||.+.+.. ++.++||||||++++||++|+.||......... + ..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~----~~ 258 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-V----AL 258 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-H----HH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-h----hH
Confidence 54321110 012345799999999997654 789999999999999999999999642111100 0 00
Q ss_pred HHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 743 CYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 743 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
.... ..........+..+.+++.+||+.||.+|||+.||++.|+.+...
T Consensus 259 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 259 AVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred Hhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 1111 111112234567899999999999999999999999999876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=330.04 Aligned_cols=253 Identities=27% Similarity=0.389 Sum_probs=207.1
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
..+.+.+.||+|+||.||+|.... .++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECC---CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 456677899999999999999864 46789999986432 23456789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
+||+++++|.+++.....+++..+..++.|+++||+|||+ .+|+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 9999999999999888889999999999999999999995 5999999999999999999999999999987654433
Q ss_pred ccccccccCCCCccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
........|+..|+|||.+.+..+ +.++||||||++++||++|+.||........ .. ..+.....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-----~~~~~~~~-------- 226 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY-----SDWKEKKT-------- 226 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HH-----HHHHTTCT--------
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HH-----HHhhhccc--------
Confidence 222345668999999999987765 7799999999999999999999976543221 11 11111110
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........+..+.+++..||+.||.+|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00112245678899999999999999999999876
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=344.33 Aligned_cols=257 Identities=21% Similarity=0.262 Sum_probs=206.9
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc----ccchhhhhceeeEEeec-cccceeeeeeeeccCCce
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 595 (814)
.+.+.+.||+|+||.||++........++.||||+++... ....+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 3566788999999999999986544568899999987532 23346788899999999 699999999999999999
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
+|||||+++++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 135 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred EEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 9999999999999999887889999999999999999999995 5999999999999999999999999999987654
Q ss_pred cccccccccccCCCCccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
..... .....||..|+|||.+.+. .++.++||||||++||||++|+.||........ .......... ..
T Consensus 212 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~-~~----- 282 (355)
T 1vzo_A 212 DETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILK-SE----- 282 (355)
T ss_dssp GGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHH-CC-----
T ss_pred CCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhc-cC-----
Confidence 33222 3345699999999999863 578999999999999999999999975433211 1111111111 11
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQML 794 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~~L 794 (814)
...+...+..+.+++.+||+.||.+|| ++.|+++..
T Consensus 283 -----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 -----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 112335567889999999999999999 999998753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=345.39 Aligned_cols=249 Identities=20% Similarity=0.294 Sum_probs=194.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccc--cceeeeeeeeccCCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~l 597 (814)
+.+.+.||+|+||.||++... .+..||||++.... ....+.+.+|+.++.+++| +||+++++++.+.+..+|
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECT----TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred EEEEEEEecCCCeEEEEEEeC----CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 456688999999999999874 46789999986432 2334678999999999976 999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||| +.+++|.+++.....+++..+..|+.||++||+|||+ .+|+||||||+|||++ ++.+||+|||+++.+....
T Consensus 87 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 999 5688999999988889999999999999999999995 5999999999999997 5789999999998876544
Q ss_pred cccccccccCCCCccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRN-----------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
.........||..|+|||.+.+ ..++.++||||||++++||++|+.||....... .......
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~~~-- 234 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAII-- 234 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHH--
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HHHHHHh--
Confidence 3333445679999999999864 678999999999999999999999996432211 1111111
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+.......+...+.++.+++..||+.||.+|||+.|+++.
T Consensus 235 -------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 -------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111112223345688999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=344.64 Aligned_cols=247 Identities=28% Similarity=0.364 Sum_probs=203.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeec-cccceeeeeeeeccCCcee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 596 (814)
.+.+.+.||+|+||.||+|.... .++.+|||+++... ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 34566889999999999999864 57899999997532 23345677888888876 8999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 999999999999999887889999999999999999999995 59999999999999999999999999999865332
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
... .....||..|+|||.+.+..++.++||||||++++||++|+.||......+ ....+..+..
T Consensus 172 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~------- 235 (345)
T 1xjd_A 172 DAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNP------- 235 (345)
T ss_dssp TCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-------
T ss_pred CCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCCC-------
Confidence 221 345679999999999999999999999999999999999999997543211 1122222211
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMR-KVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~-eV~~ 792 (814)
..+...+.++.+++.+||+.||.+||++. ||++
T Consensus 236 ---~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 236 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11234567899999999999999999998 6653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=346.65 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=194.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||+||++.... .++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKL---TKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETT---TCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 35667889999999999999874 56789999996532 334678899999999999999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC--eEEeecCCccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN--ARISDFGLAKLLTLNQS 678 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DfGla~~~~~~~~ 678 (814)
|+++|+|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++. +||+|||+++.......
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 99999999999887889999999999999999999995 59999999999999987765 99999999975432221
Q ss_pred ccccccccCCCCccCcccccCCCCCCc-cchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k-~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.....||..|+|||.+.+..++.+ +||||||+++|||++|+.||........ ......... .. ..
T Consensus 174 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~-~~--------~~ 239 (361)
T 3uc3_A 174 ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRIL-SV--------KY 239 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHH-TT--------CC
T ss_pred ---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHh-cC--------CC
Confidence 234569999999999988887666 8999999999999999999975433221 111111111 11 11
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
........+.++.+++.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111122456788999999999999999999999873
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.48 Aligned_cols=270 Identities=23% Similarity=0.307 Sum_probs=199.0
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhhhccC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
+.||+|+||.||+|.... .+..||||+++.........+.+|+.++.++ +||||+++++++.+++..++||||+++
T Consensus 19 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLI---TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG 95 (316)
T ss_dssp CCCCCCSSEEEEEEECSS---SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred ceecCCceEEEEEEEEcC---CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCC
Confidence 579999999999998764 5678999999766555567889999999884 799999999999999999999999999
Q ss_pred CchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC---eEEeecCCcccccccccc--
Q 042262 605 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN---ARISDFGLAKLLTLNQSK-- 679 (814)
Q Consensus 605 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DfGla~~~~~~~~~-- 679 (814)
++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+||+++.++. +||+|||+++........
T Consensus 96 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 96 GSILSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred CcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence 9999999888889999999999999999999995 59999999999999998776 999999999866432211
Q ss_pred ---cccccccCCCCccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchh--------hHHHHHHHH
Q 042262 680 ---AIKTAIRGTKGYVAPEWFRN-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--------ILTDWAFDC 743 (814)
Q Consensus 680 ---~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~--------~l~~~~~~~ 743 (814)
.......||..|+|||.+.+ ..++.++||||||++++||++|+.||......+.. .........
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
T 2ac3_A 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252 (316)
T ss_dssp ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence 11223458999999999975 56899999999999999999999999765332100 000111222
Q ss_pred HhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHcCCcCCCCCCCCC
Q 042262 744 YRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEGVVEVDVPPNPS 807 (814)
Q Consensus 744 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~--~L~~~~~~~~pp~p~ 807 (814)
+..+.... ........+..+.+++.+||+.||.+|||+.|+++ .+++.......|.|.
T Consensus 253 i~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~~ 312 (316)
T 2ac3_A 253 IQEGKYEF------PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPM 312 (316)
T ss_dssp HHHCCCCC------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC------------
T ss_pred HhccCccc------CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccCCCcc
Confidence 22222110 00001134678999999999999999999999998 345443333334333
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.15 Aligned_cols=260 Identities=24% Similarity=0.373 Sum_probs=190.4
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.+.||+|+||.||+|.... .+..||||+++... ....+.+.+|+.++++++||||+++++++.+++..+|||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKT---TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp -------------CEEEEEECSS---SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ceeEeeEECCCCCEEEEEEEECC---CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 45566889999999999998764 56789999986543 233467889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 600 EFLNNGTLASFLFGN------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 600 e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
||++ ++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 5898887542 358899999999999999999995 59999999999999999999999999999876
Q ss_pred cccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC---Cc
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KL 749 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~ 749 (814)
...... .....||..|+|||.+.+. .++.++||||||++++||++|+.||......+.. .......... ..
T Consensus 159 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 159 GIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLW 233 (317)
T ss_dssp TSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTC
T ss_pred CCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHh
Confidence 533221 2345689999999999764 6899999999999999999999999754432211 1111111100 00
Q ss_pred cccc-----cCc------------ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 750 DDLV-----EGD------------TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 750 ~~l~-----~~~------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.... .+. .........+.++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 000 001111235678999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=366.87 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=202.3
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCC
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 605 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 605 (814)
+||+|+||.||+|.+...+ .+..||||+++... ....++|.+|++++++++||||++++++|.+ +..+|||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSS-CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCC-CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 6999999999999987433 46789999997643 2345789999999999999999999999976 5689999999999
Q ss_pred chhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc-ccc
Q 042262 606 TLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA-IKT 683 (814)
Q Consensus 606 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~ 683 (814)
+|.+++... ..+++..+..|+.||++||+|||+ .+|+||||||+||||++++.+||+|||+++.+....... ...
T Consensus 421 ~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp BHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred cHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 999999754 568999999999999999999995 599999999999999999999999999998775433211 112
Q ss_pred cccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCC
Q 042262 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMND 762 (814)
Q Consensus 684 ~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 762 (814)
...++..|+|||++.+..++.++|||||||+||||++ |+.||......+ +...+..+.. ...+
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~---------~~~p 561 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKR---------MECP 561 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCC---------CCCC
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCC---------CCCC
Confidence 2335689999999999999999999999999999998 999997544322 1222333321 1223
Q ss_pred hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 763 IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 763 ~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
..++.++.+|+..||+.||++||++.+|++.|+.+
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 45778999999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=341.87 Aligned_cols=243 Identities=24% Similarity=0.254 Sum_probs=204.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||++.... .+..+|||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 4556789999999999999864 56789999986532 23345688899999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 9999999999999887789999999999999999999995 59999999999999999999999999999876432
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.....||..|+|||.+.+..++.++||||||++++||++|+.||....... ....+..+...
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~-------- 256 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVR-------- 256 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC--------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-------HHHHHHcCCCC--------
Confidence 234568999999999999999999999999999999999999997543211 12222223211
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~eV~~ 792 (814)
.+...+.++.+++.+||+.||.+||+ ++||++
T Consensus 257 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 12345678999999999999999998 888876
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.91 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=206.8
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc------chhhhhceeeEEeeccccceeeeeeeeccC
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 592 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 592 (814)
...+.+.+.||+|+||.||+|.... .+..+|||.+...... ..+++.+|+.+++.++||||+++++++.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccEEEeeEeeecCCEEEEEEEECC---CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4456778899999999999999864 5678999998654322 245689999999999999999999999999
Q ss_pred CceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC----CeEEeecC
Q 042262 593 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY----NARISDFG 668 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DfG 668 (814)
+..++||||+++++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+||++++++ .+||+|||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999999888889999999999999999999995 5999999999999999888 79999999
Q ss_pred CcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC
Q 042262 669 LAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748 (814)
Q Consensus 669 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 748 (814)
+++....... .....||..|+|||.+.+..++.++||||||++++||++|+.||......+ ....+..+.
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITSVS 234 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTC
T ss_pred cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcc
Confidence 9987654322 234568999999999999999999999999999999999999997543211 111111111
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.. .........++.+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 YD------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CC------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cc------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 10 000111234578899999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=349.30 Aligned_cols=249 Identities=20% Similarity=0.283 Sum_probs=195.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeecc--ccceeeeeeeeccCCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTH--HKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~l 597 (814)
+.+.+.||+|+||.||++... .+..||||++... .....+.+.+|+.++.+++ |+||+++++++...+..+|
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcC----CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 556688999999999999865 3678999998643 2234467899999999996 5999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||| +.+++|.+++.....+++..+..|+.||++||+||| +.+|+||||||+|||++ ++.+||+|||+++.+....
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999 678899999988888999999999999999999999 46999999999999995 5789999999999876544
Q ss_pred cccccccccCCCCccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRN-----------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
.........||..|+|||++.+ ..++.++|||||||+||||++|+.||....... ........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~~~~~- 282 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAIID- 282 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHHHHC-
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHHHHhC-
Confidence 3332345679999999999865 468899999999999999999999996433211 11111111
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.......+...+.++.+++.+||+.||.+|||+.||++.
T Consensus 283 --------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 283 --------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111122335688999999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.05 Aligned_cols=262 Identities=26% Similarity=0.406 Sum_probs=210.2
Q ss_pred HHHhhhhccccccceeEEEEEEEeccC--CcceEEEEEeeccccc-cchhhhhceeeEEeec-cccceeeeeeeeccCCc
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 594 (814)
...+.+.+.||+|+||.||+|.....+ .....||||.+..... ...+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 344566788999999999999986532 1335899999975432 3346789999999999 89999999999999999
Q ss_pred eehhhhhccCCchhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC
Q 042262 595 RLLVYEFLNNGTLASFLFG--------------NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY 660 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~ 660 (814)
.++||||+++|+|.+++.. ...+++..++.++.||++||+|||+ .+|+||||||+||++++++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 9999999999999999864 2357899999999999999999995 5999999999999999999
Q ss_pred CeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHH
Q 042262 661 NARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW 739 (814)
Q Consensus 661 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 739 (814)
.+||+|||+++...............+|..|+|||.+.+..++.++||||||++++||++ |..||........
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------ 275 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------ 275 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH------
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH------
Confidence 999999999987654433322334457889999999998899999999999999999999 9999875433221
Q ss_pred HHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 740 AFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 740 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.......+.. ...+...+..+.+++..||+.||.+|||+.||++.|+++.
T Consensus 276 ~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 276 FYKLVKDGYQ---------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1122222211 1112344678999999999999999999999999997643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=349.71 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=205.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||+|.+.. .++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..+||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHEL---TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETT---TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4566889999999999999864 56789999996532 22345788999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+++.....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 999999999999988888999999999999999999999 46999999999999999999999999999987654322
Q ss_pred ccccccccCCCCccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.....||..|+|||.+.+..+ +.++||||||++++||++|+.||....... ....+..+...
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~------- 234 (476)
T 2y94_A 172 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-------LFKKICDGIFY------- 234 (476)
T ss_dssp ---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-------HHHHHHTTCCC-------
T ss_pred ---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCcC-------
Confidence 334569999999999988765 689999999999999999999997543221 11222222211
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+...+.++.+++.+||+.||.+|||+.||++
T Consensus 235 ---~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 ---TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 12234578899999999999999999999997
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.25 Aligned_cols=262 Identities=21% Similarity=0.215 Sum_probs=201.1
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc---chhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.+.||+|+||.||+|.... .++.||||++...... ..+.+.+|+.++++++||||+++++++.+++..++
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTV---RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcC---CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 35566889999999999999864 5688999999754322 23678899999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|+||+++++|.+++.....+++..+..++.||++||+|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999999999887789999999999999999999995 599999999999999999999999999998765432
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
... .....|+..|+|||.+.+..++.++||||||++++||++|+.||...... .....+.... ..
T Consensus 189 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~-~~------ 253 (309)
T 2h34_A 189 LTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAI-PR------ 253 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCC-CC------
T ss_pred ccc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCC-CC------
Confidence 221 23456899999999999999999999999999999999999999743211 1111111111 10
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCC-CHHHHHHHHcCCcCCCCC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRP-TMRKVSQMLEGVVEVDVP 803 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-tm~eV~~~L~~~~~~~~p 803 (814)
........+.++.+++.+||+.||++|| +++++++.|+..+....+
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 1112335667899999999999999999 999999999886655443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.13 Aligned_cols=244 Identities=27% Similarity=0.297 Sum_probs=193.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeE-EeeccccceeeeeeeeccCCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVV-IGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
+.+.+.||+|+||.||+|.... .+..+|||+++... ....+.+..|..+ ++.++||||+++++++.+.+..+|
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETT---TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4566899999999999999864 56789999996542 2233456677776 577899999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 99999999999999888889999999999999999999995 599999999999999999999999999998643222
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
. ......||..|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+..+.+
T Consensus 194 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~-------- 256 (373)
T 2r5t_A 194 S--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNKPL-------- 256 (373)
T ss_dssp C--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-------HHHHHHHSCC--------
T ss_pred C--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhccc--------
Confidence 1 1345679999999999999999999999999999999999999997543211 1122222211
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV 790 (814)
..+...+..+.+++..||+.||.+||++.+.
T Consensus 257 --~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 257 --QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp --CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 1122456789999999999999999998543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.92 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=196.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||+||+|... .+..+|||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred chhhhhcccCCCEEEEEEEcC----CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 456688999999999999873 46789999986432 223467889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++ +|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 99975 888888654 678999999999999999999995 5999999999999999999999999999987643222
Q ss_pred ccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC---cccc--
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---LDDL-- 752 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~l-- 752 (814)
. .....||..|+|||.+.+. .++.++||||||++++||++|+.||......+ .+ ........... ....
T Consensus 156 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 K--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QL-MRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH-HHHHHHHCCCCTTTSTTGGG
T ss_pred c--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HH-HHHHHHHCCCChhhchhhhc
Confidence 1 2334689999999999764 58999999999999999999999997543221 11 11111111100 0000
Q ss_pred ---ccCcc-------cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 753 ---VEGDT-------EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 753 ---~~~~~-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.++.. ........++++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 00112245678899999999999999999999976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=335.86 Aligned_cols=272 Identities=22% Similarity=0.308 Sum_probs=200.6
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEE--eeccccceeeeeeeeccC-
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI--GQTHHKNLVRLLGFCDEG- 592 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l--~~l~H~niv~l~g~~~~~- 592 (814)
+.....+.+.+.||+|+||.||+|... +..||||++.... ...+..|.+++ ..++||||+++++++.+.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-----GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-----TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-----CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 344556778899999999999999874 6789999985432 22333333333 345999999999999776
Q ss_pred ---CceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEECCCCCeEE
Q 042262 593 ---QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-----SAQIIHCDIKPQNILLDDYYNARI 664 (814)
Q Consensus 593 ---~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~Dikp~NIll~~~~~~kl 664 (814)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 6789999999999999999654 6899999999999999999999531 229999999999999999999999
Q ss_pred eecCCcccccccccccc--cccccCCCCccCcccccCCCCCCc------cchhhHHHHHHHHHhC----------CcCCc
Q 042262 665 SDFGLAKLLTLNQSKAI--KTAIRGTKGYVAPEWFRNSTITAK------VDVYSFGVLLLEIISC----------RKSFD 726 (814)
Q Consensus 665 ~DfGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~k------~DV~S~Gvvl~elltG----------~~p~~ 726 (814)
+|||+++.+........ .....||..|+|||.+.+...+.+ +||||||+++|||++| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 99999987654332211 124568999999999988776665 9999999999999999 55554
Q ss_pred ccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCC
Q 042262 727 IEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801 (814)
Q Consensus 727 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~ 801 (814)
........ . ............... .........+++++.+++.+||+.||.+|||+.||++.|+.+.+-.
T Consensus 264 ~~~~~~~~-~-~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 264 DLVPSDPS-Y-EDMREIVCIKKLRPS---FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTSCSSCC-H-HHHHHHHTTSCCCCC---CCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhcCCCCc-h-hhhHHHHhhhccCcc---ccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 33221111 1 111111111111111 1111123377889999999999999999999999999998876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.33 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=203.5
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccCCceeh
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 597 (814)
...+.+.+.||+|+||.||++.... .++.+|||+++... ....+|++++.++ +||||+++++++.+++..++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 3456677899999999999999864 57899999986542 2456677778777 79999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC----CCeEEeecCCcccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY----YNARISDFGLAKLL 673 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~----~~~kl~DfGla~~~ 673 (814)
||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||+.++ +.+||+|||+++..
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999999888889999999999999999999995 599999999999998543 34999999999876
Q ss_pred cccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
...... .....||..|+|||.+.+..++.++||||||+++|||++|+.||.......... ....+..+....
T Consensus 171 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~~~~i~~~~~~~-- 242 (342)
T 2qr7_A 171 RAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE----ILARIGSGKFSL-- 242 (342)
T ss_dssp BCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH----HHHHHHHCCCCC--
T ss_pred cCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH----HHHHHccCCccc--
Confidence 543322 334568999999999998889999999999999999999999997543222111 222333333221
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........++++.+++.+||+.||.+|||+.|+++
T Consensus 243 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 ----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11112346688999999999999999999999886
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.94 Aligned_cols=263 Identities=25% Similarity=0.301 Sum_probs=199.0
Q ss_pred HHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-----cchhhhhceeeEEeecc---ccceeeeeee
Q 042262 517 LEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-----DGEKEFKNEVVVIGQTH---HKNLVRLLGF 588 (814)
Q Consensus 517 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-----~~~~~~~~Ei~~l~~l~---H~niv~l~g~ 588 (814)
+....+.+.+.||+|+||+||+|.+.. .++.||||++..... .....+.+|+.++++++ ||||++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTT---TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 444567778899999999999998754 567899999864321 12345677888777775 9999999999
Q ss_pred eccCC-----ceehhhhhccCCchhhhhcCCCC--CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC
Q 042262 589 CDEGQ-----NRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 661 (814)
Q Consensus 589 ~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~ 661 (814)
+.... ..++||||+. ++|.+++..... +++..+..|+.||++||+|||+ .+|+||||||+|||++.++.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSC
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCC
Confidence 97655 4789999997 599999876543 8999999999999999999995 58999999999999999999
Q ss_pred eEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHH
Q 042262 662 ARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 741 (814)
Q Consensus 662 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 741 (814)
+||+|||+++....... .....||..|+|||.+.+..++.++||||||++++||++|+.||........ + ....
T Consensus 159 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~-~~i~ 232 (308)
T 3g33_A 159 VKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--L-GKIF 232 (308)
T ss_dssp EEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH--H-HHHH
T ss_pred EEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHH
Confidence 99999999987653322 3445689999999999999999999999999999999999999975433221 1 1111
Q ss_pred HHHhcC---Ccccccc----------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 742 DCYRNG---KLDDLVE----------GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 742 ~~~~~~---~~~~l~~----------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
...... ....... +........+.++.+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 211111 0000000 00000011245678999999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=346.29 Aligned_cols=260 Identities=15% Similarity=0.186 Sum_probs=201.2
Q ss_pred Hhhhhcccccc--ceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 521 TDNFEEEVGRG--SFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 521 ~~~~~~~LG~G--~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
.+.+.+.||+| +||.||+|.... .++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcC---CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45667899999 999999999874 57799999996543 223466888999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 597 LVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
|||||+++++|.+++... ..+++..+..|+.||++||+|||+ .+|+||||||+|||++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999765 678999999999999999999995 599999999999999999999999999987543
Q ss_pred cccc-----ccccccccCCCCccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC
Q 042262 675 LNQS-----KAIKTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 747 (814)
Q Consensus 675 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 747 (814)
.... ........||..|+|||.+.+ ..++.++|||||||+++||++|+.||......... ... ..+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~-----~~~ 252 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEK-----LNG 252 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHH-----hcC
Confidence 2211 111223468899999999987 57999999999999999999999999754322110 000 000
Q ss_pred Ccccccc------------------------------------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 042262 748 KLDDLVE------------------------------------GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVS 791 (814)
Q Consensus 748 ~~~~l~~------------------------------------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~ 791 (814)
....+.+ ...........+..+.+|+.+||+.||.+|||+.|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 0000000 0000112234567899999999999999999999998
Q ss_pred HH
Q 042262 792 QM 793 (814)
Q Consensus 792 ~~ 793 (814)
+.
T Consensus 333 ~h 334 (389)
T 3gni_B 333 NH 334 (389)
T ss_dssp TS
T ss_pred cC
Confidence 64
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.50 Aligned_cols=247 Identities=25% Similarity=0.314 Sum_probs=203.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeec-cccceeeeeeeeccCCcee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 596 (814)
.+.+.+.||+|+||.||+|.... .++.+|||+++... ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT---EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35566889999999999999864 57899999997532 23345678888888887 8999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||||+++|+|.+++.....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 999999999999999887789999999999999999999995 59999999999999999999999999999864322
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
... .....||..|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+..+..
T Consensus 175 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~------- 238 (353)
T 2i0e_A 175 GVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNV------- 238 (353)
T ss_dssp TCC--BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-------
T ss_pred Ccc--cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCCC-------
Confidence 211 345679999999999999999999999999999999999999997543211 1122222221
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~eV~~ 792 (814)
..+...+.++.+++.+||+.||.+||+ ++||++
T Consensus 239 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 122356688999999999999999995 466665
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=350.67 Aligned_cols=251 Identities=19% Similarity=0.253 Sum_probs=202.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||+||+|.... .+..+|+|+++.. .....+.+.+|+.++..++||||+++++++.+.+..+||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cEEEEEEEcCCCEEEEEEEECC---CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3445789999999999999874 5678999998652 223345688999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp ECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 999999999999865 468999999999999999999995 5999999999999999999999999999987654332
Q ss_pred ccccccccCCCCccCcccccCCC----CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNST----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~----~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.. .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ ...+..+..
T Consensus 224 ~~-~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~----- 290 (410)
T 3v8s_A 224 VR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------YSKIMNHKN----- 290 (410)
T ss_dssp EE-CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTHHH-----
T ss_pred cc-ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-------HHHHHhccc-----
Confidence 11 33567999999999998765 78999999999999999999999975432211 111111100
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSL--RPTMRKVSQM 793 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPtm~eV~~~ 793 (814)
..........+.++.+++.+||+.+|.+ ||+++||++.
T Consensus 291 -~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 -SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0000111245688999999999999988 9999999984
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.20 Aligned_cols=245 Identities=27% Similarity=0.387 Sum_probs=201.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||+|.... .+..+|||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeeEEecCCCeEEEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4556789999999999999864 56789999985432 22346788999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++++|.+++.....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~- 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 163 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence 999999999999988788999999999999999999999 4699999999999999999999999999986544322
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||....... ....+.....
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~--------- 224 (279)
T 3fdn_A 164 ---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF--------- 224 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCC---------
T ss_pred ---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-------HHHHHHhCCC---------
Confidence 234568999999999999999999999999999999999999997543211 1111111111
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..+...++.+.+++.+||+.||.+|||++||++.
T Consensus 225 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1123456788999999999999999999999973
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=336.83 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=195.1
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCC------
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------ 593 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 593 (814)
.+.+.+.||+|+||.||+|.+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKV---DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETT---TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcC---CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 45667889999999999999864 56789999986432 334567999999999999999999999985543
Q ss_pred ---------------------------------------------------ceehhhhhccCCchhhhhcCCC---CCCH
Q 042262 594 ---------------------------------------------------NRLLVYEFLNNGTLASFLFGNL---KPSW 619 (814)
Q Consensus 594 ---------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~---~l~~ 619 (814)
..++||||+++++|.+++.... ...+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 2789999999999999997653 3466
Q ss_pred HHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc----------cccccccCCC
Q 042262 620 NLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK----------AIKTAIRGTK 689 (814)
Q Consensus 620 ~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~ 689 (814)
..++.|+.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++........ .......||.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 6789999999999999995 59999999999999999999999999999887654221 1123456999
Q ss_pred CccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHH
Q 042262 690 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKL 769 (814)
Q Consensus 690 ~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l 769 (814)
.|+|||.+.+..++.++||||||++++||++|..|+... .........+.... ........+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---------~~~~~~~~~~~~~~---------~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---------VRIITDVRNLKFPL---------LFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---------HHHHHHHHTTCCCH---------HHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---------HHHHHHhhccCCCc---------ccccCChhH
Confidence 999999999999999999999999999999987764211 01111122222111 122445677
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 042262 770 VMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 770 ~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+++.+||+.||.+|||+.|+++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 89999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=341.09 Aligned_cols=253 Identities=18% Similarity=0.185 Sum_probs=201.3
Q ss_pred HHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccccccchhhhhceeeEEeecc---ccceeeeeeeeccCCc
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQN 594 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~ 594 (814)
..+.+.+.||+|+||+||+|.+.. ....++.||||+++.. ...++..|+.++.+++ |+||+++++++...+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 345566789999999999996422 1235678999998754 3445666666666665 9999999999999999
Q ss_pred eehhhhhccCCchhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-----------
Q 042262 595 RLLVYEFLNNGTLASFLF-----GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD----------- 658 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~----------- 658 (814)
.+|||||+++|+|.+++. ....+++..++.|+.||++||+|||+ .+|+||||||+||||+.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccc
Confidence 999999999999999997 35679999999999999999999994 69999999999999998
Q ss_pred CCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHH
Q 042262 659 YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 738 (814)
Q Consensus 659 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~ 738 (814)
++.+||+|||+++.+.............||..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----- 293 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----- 293 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence 899999999999876533333334556799999999999999999999999999999999999999864432110
Q ss_pred HHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCC-CCHHHHHHHHcCCcC
Q 042262 739 WAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLR-PTMRKVSQMLEGVVE 799 (814)
Q Consensus 739 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ptm~eV~~~L~~~~~ 799 (814)
.+..... .....+.+.+++..|++.+|.+| |+++++.+.|++.++
T Consensus 294 -------------~~~~~~~---~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 294 -------------KPEGLFR---RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp -------------EECSCCT---TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred -------------eechhcc---ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 0111111 11235678889999999999999 688998888876544
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=343.26 Aligned_cols=264 Identities=17% Similarity=0.179 Sum_probs=204.5
Q ss_pred HhhhhccccccceeEEEEEEEeccCC-----cceEEEEEeeccccccchhhhhceeeEEeeccccceee-----------
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRT-----STTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR----------- 584 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~-----~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~----------- 584 (814)
.+.+.+.||+|+||.||+|....+.. .+..||||++... +.+.+|++++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 45567889999999999999875321 3678999998643 57889999999999999998
Q ss_pred ----eeeeecc-CCceehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC
Q 042262 585 ----LLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 657 (814)
Q Consensus 585 ----l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~ 657 (814)
+++++.. ++..+|||||+ +++|.+++... ..+++..++.|+.||++||+|||+ .+|+||||||+|||++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVD 193 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEEc
Confidence 5666655 67889999999 99999999875 779999999999999999999995 5999999999999999
Q ss_pred CCC--CeEEeecCCccccccccccc-----ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCC
Q 042262 658 DYY--NARISDFGLAKLLTLNQSKA-----IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 730 (814)
Q Consensus 658 ~~~--~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~ 730 (814)
.++ .+||+|||+++.+....... ......||..|+|||.+.+..++.++||||||++++||++|+.||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 89999999998765433211 12334689999999999999999999999999999999999999986542
Q ss_pred cchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 731 EEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 731 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.... +... ...+.. ....+..... .....+.++.+++.+||+.||.+|||+.||+++|+++.+
T Consensus 274 ~~~~-~~~~-~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 274 NTED-IMKQ-KQKFVD-KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp CHHH-HHHH-HHHHHH-SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CHHH-HHHH-HHhccC-Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 2211 1111 111111 1111111110 112346889999999999999999999999999987654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=332.62 Aligned_cols=252 Identities=28% Similarity=0.429 Sum_probs=204.4
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 604 (814)
+.||+|+||.||+|.+.... .+..||||+++... ....+++.+|++++.+++||||+++++++ +.+..++||||+++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~ 93 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGG 93 (287)
T ss_dssp EEEECCTTEEEEEEEEC----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred ccccccCceeEEEeEeccCC-CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence 38999999999999875332 46789999997642 23456789999999999999999999999 55678999999999
Q ss_pred CchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc-cc
Q 042262 605 GTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA-IK 682 (814)
Q Consensus 605 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~ 682 (814)
++|.+++... ..+++..+..++.||++||.|||+ .+|+||||||+||++++++.+||+|||+++......... ..
T Consensus 94 ~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 170 (287)
T 1u59_A 94 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170 (287)
T ss_dssp EEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred CCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecc
Confidence 9999998654 568999999999999999999995 599999999999999999999999999998775433221 12
Q ss_pred ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
....+|..|+|||.+.+..++.++||||||++++||++ |+.||......+ ....+..+... ..
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~~~~---------~~ 234 (287)
T 1u59_A 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM---------EC 234 (287)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCC---------CC
T ss_pred ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcCCcC---------CC
Confidence 23346889999999998899999999999999999998 999997543321 11222222211 12
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
+..++..+.+++..||+.||.+||++.||++.|+.+.
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 3356789999999999999999999999999997754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=339.25 Aligned_cols=257 Identities=29% Similarity=0.463 Sum_probs=204.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEeec-cccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 598 (814)
.+.+.+.||+|+||.||+|....++ ....++||+++.. .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETT-EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HccceeeeecCCCceEEEEEEccCC-cccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 4566789999999999999987532 1224699988653 233456789999999999 899999999999999999999
Q ss_pred hhhccCCchhhhhcCCC----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCe
Q 042262 599 YEFLNNGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA 662 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ 662 (814)
|||+++++|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997653 68999999999999999999995 599999999999999999999
Q ss_pred EEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHH
Q 042262 663 RISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF 741 (814)
Q Consensus 663 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 741 (814)
||+|||+++....... .....++..|+|||.+.+..++.++||||||++++||++ |+.||....... ..
T Consensus 182 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY 251 (327)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HH
T ss_pred EEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HH
Confidence 9999999975432211 233456889999999998889999999999999999998 999996543211 12
Q ss_pred HHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 742 DCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 742 ~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
..+..+. ....+...+..+.+++.+||+.||.+|||+.|+++.|+.+++-
T Consensus 252 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 252 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 2222221 1112335668899999999999999999999999999765543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.28 Aligned_cols=264 Identities=23% Similarity=0.291 Sum_probs=199.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||+||+|.... .++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceEeeEEeecCCeEEEEEEeCC---CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 4556789999999999999864 467899998865322 22456889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++++|.+++.....+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999999999999888889999999999999999999995 59999999999999999999999999999876533221
Q ss_pred cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHH--------HHHHhcCCc-
Q 042262 680 AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCYRNGKL- 749 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~~- 749 (814)
.....||..|+|||.+.+ ..++.++||||||++++||++|+.||......+........ ...+.....
T Consensus 159 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 159 --YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred --cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 234568999999999976 57899999999999999999999999765432211110000 001111100
Q ss_pred cccccCcccc-----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 750 DDLVEGDTEA-----MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 750 ~~l~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.....+.... ......+..+.+++.+||+.||.+|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 0012456789999999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=329.50 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=206.6
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.+.||+|+||.||+|.... .+..+|||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hceeeheecCCCCeEEEEEEEcC---CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 35566889999999999999864 56789999986432 2234678999999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+++++|.+++.....+++..+..++.||++||+||| +.+|+|+||||+||+++.++.+||+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999999988778999999999999999999999 4699999999999999999999999999987654322
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||....... ....+.....
T Consensus 169 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~-------- 229 (284)
T 2vgo_A 169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-------THRRIVNVDL-------- 229 (284)
T ss_dssp ----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC--------
T ss_pred ----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-------HHHHHhcccc--------
Confidence 234568999999999999999999999999999999999999997543211 1111111111
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHcCC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEGV 797 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~--~L~~~ 797 (814)
..+...+..+.+++.+||+.||.+|||+.|+++ .++..
T Consensus 230 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 230 --KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 112345678899999999999999999999987 44443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=337.72 Aligned_cols=268 Identities=25% Similarity=0.337 Sum_probs=193.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeee-----ccCCcee
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFC-----DEGQNRL 596 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-----~~~~~~~ 596 (814)
+.+.+.||+|+||.||+|.. .++.||||++..... .......|+..+..++|+||+++++.+ ......+
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~-~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSL-----DERPVAVKVFSFANR-QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEE-----TTEEEEEEEEEGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hheeeecccCCCeEEEEEEE-----CCeEEEEEEeeccch-hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 45567899999999999976 467899999864321 111223444445568999999999854 2334568
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC------SAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
|||||+++|+|.+++.... .++..+..|+.||++||+|||+.+ ..+|+||||||+|||++.++.+||+|||++
T Consensus 89 lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 9999999999999996543 488999999999999999999531 129999999999999999999999999999
Q ss_pred cccccccc------ccccccccCCCCccCcccccC-------CCCCCccchhhHHHHHHHHHhCCcCCcccCCcch-h--
Q 042262 671 KLLTLNQS------KAIKTAIRGTKGYVAPEWFRN-------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-A-- 734 (814)
Q Consensus 671 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~-~-- 734 (814)
+.+..... ........||..|+|||.+.+ ..++.++||||||+++|||++|..|+........ .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 87653321 111234569999999999987 4567899999999999999999887754332110 0
Q ss_pred ---------hHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 735 ---------ILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 735 ---------~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.................+. .........+..+.+++.+||+.||++|||++||++.|+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFP---EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCC---TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCC---cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 0001111111111111110 0111233577889999999999999999999999999987653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=343.91 Aligned_cols=266 Identities=24% Similarity=0.413 Sum_probs=209.6
Q ss_pred HhhhhccccccceeEEEEEEEec-cCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCC--ceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ--NRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~l 597 (814)
.+.+.+.||+|+||.||++.... ....+..||||++........+++.+|+.++++++||||+++++++...+ ..++
T Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 45667889999999999998642 23367899999998765556678999999999999999999999986654 7899
Q ss_pred hhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
||||+++++|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 122 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp EECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred EEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 99999999999999765 468999999999999999999995 59999999999999999999999999999877544
Q ss_pred cccc-ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCc---------chhhHHHHHHHHHhc
Q 042262 677 QSKA-IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE---------EYAILTDWAFDCYRN 746 (814)
Q Consensus 677 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~~~~~~~~ 746 (814)
.... ......++..|+|||.+.+..++.++||||||++++||++|+.|+...... ..........+.+..
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence 3211 122344677899999999888999999999999999999999987632100 000000111111111
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
+ .....+..++.++.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 279 ~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 279 N---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 111223456788999999999999999999999999998653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=329.37 Aligned_cols=262 Identities=18% Similarity=0.211 Sum_probs=205.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeee-ccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFC-DEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~e 600 (814)
+.+.+.||+|+||.||+|.... .++.||||++.... ..+++.+|+.++..++|++++..+.++ .+++..++|||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEEccCCCeEEEEEEEcC---CCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 4566789999999999999754 57899999986532 345789999999999998877766666 55677899999
Q ss_pred hccCCchhhhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---CCCCCeEEeecCCccccccc
Q 042262 601 FLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 601 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DfGla~~~~~~ 676 (814)
|+ +++|.+++. ....+++..+..++.||++||+|||+ .+|+||||||+||++ ++++.+||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 999999997 35678999999999999999999995 599999999999999 48889999999999876544
Q ss_pred cccc-----ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 677 QSKA-----IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 677 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
.... ......||..|+|||.+.+..++.++||||||++++||++|+.||.........................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE- 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-
Confidence 3211 1234568999999999999999999999999999999999999997643322111111111110000000
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCC
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~ 801 (814)
......++++.+++.+||+.||.+|||+.||++.|+.+....
T Consensus 241 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 241 --------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp --------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 011245678999999999999999999999999998765443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.68 Aligned_cols=262 Identities=18% Similarity=0.210 Sum_probs=203.7
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeee-ccCCceehh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFC-DEGQNRLLV 598 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV 598 (814)
..+.+.+.||+|+||.||+|.... .++.||||++... ....++.+|+.++..++|++++..+..+ .+++..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcC---CCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 456677899999999999999764 5778999986543 2345688899999999988877777766 566778999
Q ss_pred hhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---CCCCCeEEeecCCccccc
Q 042262 599 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLT 674 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DfGla~~~~ 674 (814)
|||+ +++|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||+ ++++.+||+|||+++...
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 9999999874 4678999999999999999999995 599999999999999 788999999999998765
Q ss_pred cccccc-----ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCc
Q 042262 675 LNQSKA-----IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 749 (814)
Q Consensus 675 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 749 (814)
...... ......||..|+|||.+.+..++.++||||||++++||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 443211 123456899999999999999999999999999999999999999764432221111111111000000
Q ss_pred cccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 750 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
. ......++++.+++..||+.||++|||+.||++.|+++.+
T Consensus 240 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 240 E---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp H---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred h---------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0 0112346789999999999999999999999999987653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.43 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=204.6
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.+.+.+.||+|+||.||+|.... .+..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhcCcCCeEEEEEEEcC---CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 34566889999999999999864 56789999986532 22346688999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC---eEEeecCCcccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN---ARISDFGLAKLLTL 675 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DfGla~~~~~ 675 (814)
|||+++++|.+.+.....+++..+..++.|+++||+|||+ .+|+||||||+||+++.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 9999999999999888889999999999999999999995 59999999999999986655 99999999987654
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
... .....||..|+|||.+.+..++.++||||||++++||++|+.||....... ....+..+....
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~---- 226 (284)
T 3kk8_A 161 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYDY---- 226 (284)
T ss_dssp SCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC----
T ss_pred Ccc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHHhccccC----
Confidence 322 234568999999999999999999999999999999999999996543221 112222222111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........+.++.+++..||+.||.+|||+.|+++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 --PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp --CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01112245678999999999999999999999988
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=327.68 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=196.5
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
..+.+.+.||+|+||.||++.... .+..+|+|++.... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEcc---CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 456778899999999999999864 56789999986543 33457789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---CCCCCeEEeecCCcc
Q 042262 599 YEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAK 671 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DfGla~ 671 (814)
|||+++++|.+.+.. ...+++..+..|+.||++||+|||+ .+|+||||||+||++ +.++.+||+|||+++
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999998854 3678999999999999999999995 599999999999999 456789999999998
Q ss_pred cccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
....... .....||..|+|||.+. ..++.++||||||++++||++|+.||........ ...........
T Consensus 176 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~ 244 (285)
T 3is5_A 176 LFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-------QQKATYKEPNY 244 (285)
T ss_dssp C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCCC
T ss_pred ecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-------HhhhccCCccc
Confidence 7654322 23456899999999986 4689999999999999999999999975432211 11111111100
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
. ......+.++.+++.+||+.||.+|||+.||++
T Consensus 245 ~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 A-------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C-------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c-------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011124578889999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=346.32 Aligned_cols=252 Identities=20% Similarity=0.220 Sum_probs=200.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||++.... .++.+|||++++.. ....+.+.+|..++..++||||+++++++.+.+..+||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~---~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 3445789999999999999864 57799999996532 22345688899999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999999999764 478999999999999999999995 599999999999999999999999999998765433
Q ss_pred cccccccccCCCCccCccccc-------CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFR-------NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~-------~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
... .....||..|+|||++. +..++.++|||||||++|||++|+.||......+. ..........
T Consensus 217 ~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~~- 288 (412)
T 2vd5_A 217 TVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------YGKIVHYKEH- 288 (412)
T ss_dssp CEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTHHHH-
T ss_pred ccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------HHHHHhcccC-
Confidence 211 23457999999999997 45789999999999999999999999975432211 1111110000
Q ss_pred ccccCcccccCChhHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 042262 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLR---PTMRKVSQM 793 (814)
Q Consensus 751 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ptm~eV~~~ 793 (814)
+..+ ......+.++.+++.+||+ +|.+| |+++||++.
T Consensus 289 -~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 289 -LSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -cCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0000 0122456889999999999 99998 589998774
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=330.43 Aligned_cols=257 Identities=25% Similarity=0.340 Sum_probs=207.8
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
...+.+.+.||+|+||.||++.... .++.+|||+++.......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRL---TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECC---CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 3456777899999999999999864 5678999999765444556789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---CCCCCeEEeecCCcccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DfGla~~~~~ 675 (814)
|||+++++|.+++.....+++..+..++.|+++||+|||+ .+|+|+||||+||++ ++++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999999999877789999999999999999999995 599999999999999 7889999999999976543
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.. .....||..|+|||.+.+..++.++||||||++++||++|+.||....... ....+..+...
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~----- 225 (304)
T 2jam_A 162 GI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LFEKIKEGYYE----- 225 (304)
T ss_dssp BT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHCCCC-----
T ss_pred Cc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCC-----
Confidence 21 233458999999999999999999999999999999999999996543211 11222222211
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHcCCc
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEGVV 798 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~--~L~~~~ 798 (814)
.........+..+.+++.+||+.||.+|||+.|+++ .+++..
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 226 -FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred -CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 011112345688999999999999999999999987 455443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.16 Aligned_cols=263 Identities=28% Similarity=0.395 Sum_probs=204.1
Q ss_pred HHHHHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCC
Q 042262 517 LEEATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 593 (814)
Q Consensus 517 l~~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 593 (814)
+....+.+.+.||+|+||.||+|.+.. ....+..||||++... ......++.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 334456677899999999999998643 2235678999999643 2334567899999999999999999999999999
Q ss_pred ceehhhhhccCCchhhhhcCC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCCeE
Q 042262 594 NRLLVYEFLNNGTLASFLFGN-------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNAR 663 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~k 663 (814)
..++||||+++++|.+++... ..+++..++.++.||++||.|||+ .+|+||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999754 348899999999999999999995 59999999999999984 45699
Q ss_pred EeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHH
Q 042262 664 ISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD 742 (814)
Q Consensus 664 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 742 (814)
|+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....... ...
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~ 256 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLE 256 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-------HHH
Confidence 999999986543332222334457889999999998899999999999999999998 999986543211 112
Q ss_pred HHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 743 CYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 743 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.+..+... ..+..++..+.+++..||+.||.+|||+.||++.|+.+.
T Consensus 257 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 257 FVTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 22222211 122345678999999999999999999999999997654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.23 Aligned_cols=261 Identities=21% Similarity=0.336 Sum_probs=198.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||+|.... ++..||||+++... .....++.+|+.++++++||||+++++++.+.+..++|
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETT---TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eEEEEeecCCCCceEEEEEEcC---CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 5566889999999999999864 56789999986422 23346788999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 599 YEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
|||+++++|.+++.. ...+++..++.++.||++||.|||+ .+|+|+||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999864 4568999999999999999999995 599999999999999999999999999998765
Q ss_pred ccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
..... .....|+..|+|||.+.+..++.++||||||++++||++|+.||........ . ....+..+.....
T Consensus 188 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~-~~~~~~~~~~~~~-- 258 (310)
T 2wqm_A 188 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----S-LCKKIEQCDYPPL-- 258 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH----H-HHHHHHTTCSCCC--
T ss_pred CCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH----H-HHHHhhcccCCCC--
Confidence 33221 2334689999999999999999999999999999999999999964432211 1 1122222222211
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCC
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 803 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~p 803 (814)
.....++++.+++.+||+.||.+|||+.||++.|+.+.+...+
T Consensus 259 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 259 ------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp ------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 1234567899999999999999999999999999887654433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=344.97 Aligned_cols=268 Identities=20% Similarity=0.254 Sum_probs=210.3
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCC--ceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ--NRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~l 597 (814)
.+.+.+.||+|+||+||+|.+.. .++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..+|
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred ceEEEEEEEcCCCeEEEEEEECC---CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 35567889999999999999864 46799999997543 233466789999999999999999999997655 6799
Q ss_pred hhhhccCCchhhhhcCCC---CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----CCCCCeEEeecCCc
Q 042262 598 VYEFLNNGTLASFLFGNL---KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLA 670 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DfGla 670 (814)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999997643 38999999999999999999995 599999999999999 77888999999999
Q ss_pred ccccccccccccccccCCCCccCcccccC--------CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHH
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRN--------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 742 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 742 (814)
+....... .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ......
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~ 238 (396)
T 4eut_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK 238 (396)
T ss_dssp EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHH
T ss_pred eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHH
Confidence 87654332 234568999999999865 56788999999999999999999999754432211 111222
Q ss_pred HHhcCCccccc---------------cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 743 CYRNGKLDDLV---------------EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 743 ~~~~~~~~~l~---------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
... +...... ...............+.+++..||+.||++||++.|+++.|+++++.
T Consensus 239 ~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 239 IIT-GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHH-SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred Hhc-CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 222 1111100 00111123457788999999999999999999999999998876654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.88 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=203.2
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc------chhhhhceeeEEeeccccceeeeeeeeccC
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 592 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 592 (814)
...+.+.+.||+|+||.||++.... .++.+|||.++..... ..+++.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 80 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC---CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence 3456778899999999999999864 4678999998653211 246789999999999999999999999999
Q ss_pred CceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC----CeEEeecC
Q 042262 593 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY----NARISDFG 668 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DfG 668 (814)
+..++||||+++++|.+++.....+++..+..++.||++||+|||+ .+|+|+||||+||++++++ .+||+|||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999999999887789999999999999999999995 5999999999999999877 89999999
Q ss_pred CcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC
Q 042262 669 LAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748 (814)
Q Consensus 669 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 748 (814)
++........ .....|+..|+|||.+.+..++.++||||||++++||++|+.||....... ....+....
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-------TLTNISAVN 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTC
T ss_pred cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-------HHHHhHhcc
Confidence 9987654322 233458999999999999999999999999999999999999997543211 111111111
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.. .........++.+.+++.+||+.||.+|||+.|+++
T Consensus 228 ~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 YD------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CC------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 10 011111244678899999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=341.90 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=186.5
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-ccceeeeeeee--------cc
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFC--------DE 591 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~--------~~ 591 (814)
.+.+.+.||+|+||.||+|.+.. .++.||||++........+.+.+|+.++.++. ||||+++++++ ..
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVG---SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred eEEEEEEEccCCceEEEEEEECC---CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 45667889999999999999864 56789999986655555677899999999996 99999999998 33
Q ss_pred CCceehhhhhccCCchhhhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEECCCCCeEEee
Q 042262 592 GQNRLLVYEFLNNGTLASFLFG---NLKPSWNLRTNIAFQIARGLLYLHEDCSAQ--IIHCDIKPQNILLDDYYNARISD 666 (814)
Q Consensus 592 ~~~~~lV~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~Dikp~NIll~~~~~~kl~D 666 (814)
....++|+||+. |+|.+++.. ...+++..++.|+.||++||+|||+ .+ |+||||||+|||++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEec
Confidence 445789999995 788888754 4568999999999999999999995 46 99999999999999999999999
Q ss_pred cCCccccccccccc----------ccccccCCCCccCcccc---cCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcch
Q 042262 667 FGLAKLLTLNQSKA----------IKTAIRGTKGYVAPEWF---RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 733 (814)
Q Consensus 667 fGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~ 733 (814)
||+++......... ......||..|+|||.+ .+..++.++||||||++++||++|+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 99998765432211 01134589999999998 56678999999999999999999999996432110
Q ss_pred hhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 734 AILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 734 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
..............+..+.+++..||+.||.+|||+.|+++.|+.+...
T Consensus 261 ------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 261 ------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0011111111223345678999999999999999999999999876544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=338.09 Aligned_cols=255 Identities=25% Similarity=0.288 Sum_probs=198.1
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc-----cccchhhhhceeeEEeeccccceeeeeeeeccCC
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-----FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 593 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 593 (814)
...+.+.+.||+|+||.||+|.... .+..+|+|++... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQ---TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhheeecceeeecCCeEEEEEEECC---CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 3456677899999999999998764 5678999998643 2344567899999999999999999999999999
Q ss_pred ceehhhhhccCCchhhhhcC----------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 042262 594 NRLLVYEFLNNGTLASFLFG----------------------------------------NLKPSWNLRTNIAFQIARGL 633 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~----------------------------------------~~~l~~~~~~~i~~~ia~gL 633 (814)
..+|||||+++|+|.+++.. ...+++..+..|+.||++||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999998852 11125667888999999999
Q ss_pred HHhhhcCCCCeeecCCCCCcEEECCCC--CeEEeecCCccccccccccc--ccccccCCCCccCcccccC--CCCCCccc
Q 042262 634 LYLHEDCSAQIIHCDIKPQNILLDDYY--NARISDFGLAKLLTLNQSKA--IKTAIRGTKGYVAPEWFRN--STITAKVD 707 (814)
Q Consensus 634 ~yLH~~~~~~iiH~Dikp~NIll~~~~--~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~t~k~D 707 (814)
+|||+ .+|+||||||+||+++.++ .+||+|||+++.+....... ......||..|+|||.+.+ ..++.++|
T Consensus 182 ~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 99995 5999999999999998776 89999999998764322211 1234568999999999975 67899999
Q ss_pred hhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCH
Q 042262 708 VYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTM 787 (814)
Q Consensus 708 V~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 787 (814)
|||||++++||++|+.||......+ ......... .. .........+..+.+++..||+.||.+|||+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~-~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKK-LC------FENPNYNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-CC------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcc-cc------cCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 9999999999999999997543221 111121111 10 0111122356789999999999999999999
Q ss_pred HHHHH
Q 042262 788 RKVSQ 792 (814)
Q Consensus 788 ~eV~~ 792 (814)
.|+++
T Consensus 326 ~~~l~ 330 (345)
T 3hko_A 326 MRALQ 330 (345)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.09 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=198.5
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+...+.||+|+||+||+|.... .++.||||++..... ...+++.+|++++++++||||+++++++.+++..+|
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEcc---CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 35566789999999999999764 578999999864322 223568899999999999999999999999999999
Q ss_pred hhhhccCCchhhhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
||||+. |+|.+++. ....+++..+..++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 999997 67777774 45678999999999999999999995 59999999999999999999999999999876432
Q ss_pred ccccccccccCCCCccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
....||..|+|||.+. +..++.++||||||++++||++|+.||...... ......... ....
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~-~~~~-- 272 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-ESPA-- 272 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCCC--
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhc-CCCC--
Confidence 2346899999999984 567899999999999999999999998644221 111122111 1111
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
......++.+.+++..||+.||++|||+.|+++.
T Consensus 273 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 ------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1123456788999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=326.43 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=181.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||+|.... .+..||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeeeecCCCceEEEEEEEcc---CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 4556789999999999999864 56789999986432 22246788999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||+++++|.+++... ..+++..+..++.|+++||+|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999765 678999999999999999999995 599999999999999999999999999998765332
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.. .....||..|+|||.+.+..++.++||||||++++||++|+.||......... ........
T Consensus 167 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~ 229 (278)
T 3cok_A 167 EK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLADY 229 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCC
T ss_pred Cc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhccc
Confidence 22 22356899999999999989999999999999999999999999754322100 00111111
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...+.++.+++.+||+.||++|||+.|+++
T Consensus 230 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 --EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 122345678999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=344.29 Aligned_cols=263 Identities=19% Similarity=0.313 Sum_probs=203.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.+.||+|+||.||++.+.. .+..+|+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceeeeeecCCCCeEEEEEEECC---CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 44556789999999999999864 56789999986542 233467899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++++|.+++.....+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++......
T Consensus 111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 186 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 186 (360)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc--
Confidence 9999999999998878899999999999999999999952 379999999999999999999999999997654321
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHH---------H----------
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW---------A---------- 740 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~---------~---------- 740 (814)
.....||..|+|||.+.+..++.++||||||++++||++|+.||.............. .
T Consensus 187 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 187 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp ------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred --ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 2345689999999999999999999999999999999999999975432211100000 0
Q ss_pred ----HHHHhcCCccc----cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 741 ----FDCYRNGKLDD----LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 741 ----~~~~~~~~~~~----l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..........+ +.............+.++.+++.+||+.||.+|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000000 00011111112235678999999999999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=327.56 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=198.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeecc----CCce
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNR 595 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~ 595 (814)
+.+.+.||+|+||.||+|.... .+..||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~---~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred EEeeeeccCCCCeEEEEeEecC---CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3455689999999999998864 56789999986532 3334678999999999999999999998854 4568
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC-CCCCeEEeecCCccccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLT 674 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DfGla~~~~ 674 (814)
++||||+++++|.+++.....+++..+..++.||++||+|||+. ..+|+|+||||+||+++ +++.+||+|||++....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999999998878899999999999999999999954 12399999999999998 78999999999997654
Q ss_pred ccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
... .....||..|+|||.+.+ .++.++||||||++++||++|+.||....... . .......+....
T Consensus 184 ~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~-~~~~~~~~~~~~--- 249 (290)
T 1t4h_A 184 ASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----Q-IYRRVTSGVKPA--- 249 (290)
T ss_dssp TTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----H-HHHHHTTTCCCG---
T ss_pred ccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----H-HHHHHhccCCcc---
Confidence 332 234568999999998874 58999999999999999999999996543221 1 112222221111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...+.++.+++..||+.||.+|||+.||++
T Consensus 250 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112233467999999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=337.08 Aligned_cols=260 Identities=20% Similarity=0.297 Sum_probs=193.1
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.+.+.+.||+|+||+||+|.... .++.||||+++.... ...+.+.+|+.++++++||||+++++++.+++..+||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTV---TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred hEEEEEEEEecCCeEEEEEEECC---CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 35566889999999999998764 578999999964322 2245688999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE-----CCCCCeEEeecCCcccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL-----DDYYNARISDFGLAKLL 673 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll-----~~~~~~kl~DfGla~~~ 673 (814)
|||++ ++|.+++.....+++..+..|+.||++||+|||+ .+|+||||||+|||+ ++++.+||+|||+++..
T Consensus 112 ~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99997 5999999888889999999999999999999995 599999999999999 45556999999999876
Q ss_pred cccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC---Cc
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KL 749 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~ 749 (814)
...... .....||..|+|||.+.+. .++.++||||||++++||++|+.||......+ .+.. ........ ..
T Consensus 188 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 188 GIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFK-IFEVLGLPDDTTW 262 (329)
T ss_dssp C-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCCCTTTS
T ss_pred CCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHH-HHHHhCCCchhhh
Confidence 533221 2344689999999999875 48999999999999999999999997543221 1111 11111100 00
Q ss_pred -------------cccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 750 -------------DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 750 -------------~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.......+........+.++.+++.+||+.||.+|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000001111111225578899999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=346.13 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=194.6
Q ss_pred HHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--------ccchhhhhceeeEEeeccccceeeeeeee
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--------QDGEKEFKNEVVVIGQTHHKNLVRLLGFC 589 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 589 (814)
....+.+.+.||+|+||+||+|.... .++.||||++.... ......+.+|+.++++++||||+++++++
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECC---CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34456777899999999999999875 56789999986431 12234588999999999999999999998
Q ss_pred ccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC---CCeEEee
Q 042262 590 DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY---YNARISD 666 (814)
Q Consensus 590 ~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~---~~~kl~D 666 (814)
.. +..++||||+++|+|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.+ ..+||+|
T Consensus 210 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 210 DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp ES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred ec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEee
Confidence 54 4579999999999999999988899999999999999999999995 599999999999999754 4599999
Q ss_pred cCCcccccccccccccccccCCCCccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHH
Q 042262 667 FGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 743 (814)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 743 (814)
||+++....... .....||..|+|||++.+ ..++.++||||||++++||++|+.||........ + ...
T Consensus 286 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~----~~~ 356 (419)
T 3i6u_A 286 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L----KDQ 356 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--H----HHH
T ss_pred cccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--H----HHH
Confidence 999987653321 344669999999999863 5688899999999999999999999975433211 1 112
Q ss_pred HhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 744 YRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 744 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+..+..... .......++.+.+++.+||+.||.+|||+.|+++
T Consensus 357 i~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYNFI------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCCCC------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCCC------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 222221110 0011235678999999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.61 Aligned_cols=247 Identities=27% Similarity=0.397 Sum_probs=196.1
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccC-Cceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-QNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~ 599 (814)
.+.+.+.||+|+||.||++... +..+|||+++.. ...+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-----TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hceEEeEEecCCCceEEEEEEc-----CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 4566688999999999999863 678999998753 2456789999999999999999999997554 5789999
Q ss_pred hhccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++++|.+++.... .+++..+..++.|+++||+|||+ .+|+|+||||+||+++.++.+||+|||+++......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 9999999999997653 37899999999999999999995 599999999999999999999999999998654321
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
....++..|+|||.+.+..++.++||||||++++||++ |+.||........ ...+..+.
T Consensus 172 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-------~~~~~~~~-------- 231 (278)
T 1byg_A 172 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGY-------- 231 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------HHHHTTTC--------
T ss_pred -----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcCC--------
Confidence 22347889999999998899999999999999999998 9999875432211 11122221
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
....+...+..+.+++..||+.||.+|||+.|+++.|+.+.
T Consensus 232 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 232 -KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 11123356788999999999999999999999999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=326.65 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=206.1
Q ss_pred HHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeecc---
Q 042262 515 KELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--- 591 (814)
Q Consensus 515 ~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--- 591 (814)
.......+.+.+.||+|+||.||+|.... +++.+|||++... ...+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETT---TCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcC---CCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 34455567778899999999999999864 5678999998643 2467889999999999999999998854
Q ss_pred -------------CCceehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 042262 592 -------------GQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 656 (814)
Q Consensus 592 -------------~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll 656 (814)
....++||||+++++|.+++... ..+++..++.++.||++||.|||+ .+|+|+||||+||++
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFL 155 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEE
Confidence 44579999999999999999643 678999999999999999999995 599999999999999
Q ss_pred CCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhH
Q 042262 657 DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 736 (814)
Q Consensus 657 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l 736 (814)
++++.+||+|||+++....... .....|+..|+|||.+.+..++.++||||||++++||++|..|+...
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------- 224 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------- 224 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------
T ss_pred cCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------
Confidence 9999999999999987654332 23446899999999999999999999999999999999999887421
Q ss_pred HHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 737 TDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 737 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
......+..+.+ +...+..+.+++.+||+.||.+|||+.|+++.|+.+..-
T Consensus 225 -~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 225 -SKFFTDLRDGII------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -HHHHHHHHTTCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -HHHHHHhhcccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 011122222221 123456788999999999999999999999999776543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=329.41 Aligned_cols=259 Identities=23% Similarity=0.330 Sum_probs=184.4
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.+.||+|+||.||+|.... .+..||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC-------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred hhhhhheeccccceEEEEEEECC---CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 34566889999999999998754 46789999986432 334567899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 600 EFLNNGTLASFLFG--------NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 600 e~~~~gsL~~~l~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
||+++++|.+++.. ...+++..+..++.||++||+|||+ .+|+|+||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999863 3568999999999999999999995 599999999999999999999999999998
Q ss_pred cccccccc---cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC
Q 042262 672 LLTLNQSK---AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 747 (814)
Q Consensus 672 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 747 (814)
........ .......||..|+|||.+.+ ..++.++||||||++++||++|+.||......... .... .+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~-~~ 242 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTL-QN 242 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHH-TS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHh-cc
Confidence 76433211 11234568999999999976 56899999999999999999999999754332211 1111 11
Q ss_pred CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 748 KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 748 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..................+.++.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111111111112345678999999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=337.30 Aligned_cols=264 Identities=26% Similarity=0.355 Sum_probs=200.4
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc--chhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.+.+.+.||+|+||.||+|.... .++.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETT---TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeEEeecCCEEEEEEEECC---CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 35556789999999999999864 4778999998543222 245678999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999999999998888889999999999999999999995 5999999999999999999999999999987654322
Q ss_pred ccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHH--------HHHHHHhc---
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD--------WAFDCYRN--- 746 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~--- 746 (814)
. .....||..|+|||.+.+. .++.++||||||++++||++|+.||......+...... .....+..
T Consensus 180 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 180 V--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred c--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 1 2345689999999999876 78999999999999999999999997654322111000 00000110
Q ss_pred ---CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 747 ---GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 747 ---~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+................++.+.+++.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111111111112345788999999999999999999999876
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=333.62 Aligned_cols=259 Identities=20% Similarity=0.307 Sum_probs=194.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.+.||+|+||+||+|.... .+..||||++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKL---TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred eEEEEEEcCCCCEEEEEEEECC---CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 4556789999999999999864 467899999865332 233467889999999999999999999999999999999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+. ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 997 5888877654 568999999999999999999995 59999999999999999999999999999865433221
Q ss_pred cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC---CccccccC
Q 042262 680 AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLDDLVEG 755 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~l~~~ 755 (814)
.....||..|+|||.+.+ ..++.++||||||++++||++|+.||......+.. .......... ........
T Consensus 157 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 157 --YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGC
T ss_pred --cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhhcc
Confidence 234468999999999876 56899999999999999999999999755432211 1112211111 01111000
Q ss_pred -------------cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 756 -------------DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 756 -------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..........+.++.+++.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000112245678899999999999999999999988
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.22 Aligned_cols=260 Identities=26% Similarity=0.370 Sum_probs=200.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.+.||+|+||+||+|.+.........||||+++... ....+++.+|++++++++||||+++++++.++. .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 4566788999999999999986544455679999986532 234567899999999999999999999998765 889
Q ss_pred hhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|+||+++++|.+++... ..+++..+..++.||++||.|||+ .+|+|+||||+||+++.++.+||+|||+++.....
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 99999999999998764 568999999999999999999995 59999999999999999999999999999877544
Q ss_pred cccc-ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 677 QSKA-IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 677 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.... ......+|..|+|||.+.+..++.++||||||++++||++ |+.||....... ........+.
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~------ 242 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGE------ 242 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCC------
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HHHHHHccCC------
Confidence 3221 1233457888999999998889999999999999999999 999997543211 1111111111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
....+..++..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 243 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 ---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ---CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 111233567889999999999999999999999999987653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=327.90 Aligned_cols=247 Identities=21% Similarity=0.321 Sum_probs=204.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||++.... .++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEeecCCEEEEEEEECC---CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4556789999999999999864 46789999986532 22345688999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++++|.+++.....+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.+||+|||+++.......
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 9999999999999887889999999999999999999995 5999999999999999999999999999987653322
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. .....||..|+|||.+.+..++.++||||||++++||++|+.||......+ ....+..+..
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~--------- 232 (294)
T 2rku_A 171 R--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNEY--------- 232 (294)
T ss_dssp C--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC---------
T ss_pred c--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhhccC---------
Confidence 1 234568999999999999999999999999999999999999997543211 1111122211
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1122455788999999999999999999999973
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=331.85 Aligned_cols=261 Identities=24% Similarity=0.332 Sum_probs=205.9
Q ss_pred ccCHHHHHHHHhhhh-ccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeec-cccceeeee
Q 042262 511 CFSYKELEEATDNFE-EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQT-HHKNLVRLL 586 (814)
Q Consensus 511 ~f~~~el~~~~~~~~-~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~ 586 (814)
.|...+.....+.+. +.||+|+||.||+|.... .++.||||+++... .....++.+|+.++..+ +||||++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 344445555556665 789999999999999864 56789999987533 22346788999999998 569999999
Q ss_pred eeeccCCceehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCC
Q 042262 587 GFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYN 661 (814)
Q Consensus 587 g~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~---~~~ 661 (814)
+++.+.+..++||||+++|+|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+||+++. ++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999999998654 678999999999999999999995 59999999999999998 789
Q ss_pred eEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHH
Q 042262 662 ARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 741 (814)
Q Consensus 662 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 741 (814)
+||+|||+++....... .....||..|+|||.+.+..++.++||||||++++||++|+.||......+. .
T Consensus 173 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~ 242 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-------Y 242 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------H
T ss_pred EEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-------H
Confidence 99999999987653322 2345689999999999999999999999999999999999999975432211 1
Q ss_pred HHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 742 DCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 742 ~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..+..... ..........+..+.+++.+||+.||.+|||++|+++.
T Consensus 243 ~~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 243 LNISQVNV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHTCC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHhccc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11111111 11111223466789999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.83 Aligned_cols=272 Identities=21% Similarity=0.300 Sum_probs=208.6
Q ss_pred CHHHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEee--ccccceeeeeeeec
Q 042262 513 SYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ--THHKNLVRLLGFCD 590 (814)
Q Consensus 513 ~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~ 590 (814)
...+.....+.+.+.||+|+||.||+|.. .++.||||++... ..+.+.+|.+++.. ++||||+++++++.
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE-----cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 34455566778889999999999999987 3678999998643 34566777777776 78999999999998
Q ss_pred cCC----ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEECCCCC
Q 042262 591 EGQ----NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-----SAQIIHCDIKPQNILLDDYYN 661 (814)
Q Consensus 591 ~~~----~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~Dikp~NIll~~~~~ 661 (814)
... ..++||||+++|+|.+++... .+++..++.++.|+++||+|||... +.+|+||||||+||+++.++.
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence 775 789999999999999999653 6899999999999999999999321 359999999999999999999
Q ss_pred eEEeecCCccccccccccc--ccccccCCCCccCcccccCC------CCCCccchhhHHHHHHHHHhC----------Cc
Q 042262 662 ARISDFGLAKLLTLNQSKA--IKTAIRGTKGYVAPEWFRNS------TITAKVDVYSFGVLLLEIISC----------RK 723 (814)
Q Consensus 662 ~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~k~DV~S~Gvvl~elltG----------~~ 723 (814)
+||+|||+++......... ......||..|+|||.+.+. .++.++||||||++++||++| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999999998765433211 12345689999999999876 334689999999999999999 66
Q ss_pred CCcccCCcchhhHHHHHHHHHhcCCccccccCccc-ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 724 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE-AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 724 p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
||........ .... ....+...... +... .....+.+..+.+++.+||+.||.+|||+.||++.|+.+.+
T Consensus 266 p~~~~~~~~~-~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 266 PYYDLVPSDP-SVEE-MRKVVCEQKLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TTTTTSCSSC-CHHH-HHHHHTTSCCC----CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccCcCcc-cHHH-HHHHHHHHHhC----CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 7754332111 1111 11222221111 1111 11234678899999999999999999999999999987653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=338.16 Aligned_cols=264 Identities=23% Similarity=0.273 Sum_probs=199.3
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-----ccceeeeeeeec
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-----HKNLVRLLGFCD 590 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-----H~niv~l~g~~~ 590 (814)
++....+.+.++||+|+||+||+|.... .++.||||+++.. ....+.+..|+.+++.++ ||||+++++++.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECC---CCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 3344556677899999999999999864 5678999998643 233455677888887775 999999999999
Q ss_pred cCCceehhhhhccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC----------
Q 042262 591 EGQNRLLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---------- 658 (814)
Q Consensus 591 ~~~~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~---------- 658 (814)
..+..+|||||+ +++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccch
Confidence 999999999999 999999997653 58999999999999999999995 59999999999999986
Q ss_pred ---------------CCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCc
Q 042262 659 ---------------YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRK 723 (814)
Q Consensus 659 ---------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~ 723 (814)
++.+||+|||+++..... .....||..|+|||.+.+..++.++||||||++++||++|+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 788999999999864432 234568999999999999999999999999999999999999
Q ss_pred CCcccCCcchhhHHH---------HHHHHHhcCCccccccCcccc-----c---------------CChhHHHHHHHHHH
Q 042262 724 SFDIEMGEEYAILTD---------WAFDCYRNGKLDDLVEGDTEA-----M---------------NDIKCTEKLVMVSI 774 (814)
Q Consensus 724 p~~~~~~~~~~~l~~---------~~~~~~~~~~~~~l~~~~~~~-----~---------------~~~~~~~~l~~l~~ 774 (814)
||......+...... +.................... . ......+.+.+++.
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 997543322111000 000000000000000000000 0 00111267889999
Q ss_pred HccccCCCCCCCHHHHHH
Q 042262 775 WCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 775 ~Cl~~dP~~RPtm~eV~~ 792 (814)
+||+.||.+|||+.|+++
T Consensus 338 ~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHCCSSGGGSCCHHHHTT
T ss_pred HHhcCChhhCCCHHHHhc
Confidence 999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=334.77 Aligned_cols=246 Identities=21% Similarity=0.326 Sum_probs=204.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||++.+.. .++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4456789999999999999864 46789999986532 22346788999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+.+++|.+++.....+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 9999999999999887889999999999999999999995 5999999999999999999999999999987653322
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. .....||..|+|||.+.+..++.++||||||++++||++|+.||......+ ....+..+..
T Consensus 197 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~--------- 258 (335)
T 2owb_A 197 R--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNEY--------- 258 (335)
T ss_dssp C--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCC---------
T ss_pred c--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHhcCCC---------
Confidence 1 234568999999999999999999999999999999999999997543211 1111111111
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 259 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112244578899999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=346.43 Aligned_cols=237 Identities=14% Similarity=0.139 Sum_probs=185.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhcee---eEEeeccccceeeee-------ee
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEV---VVIGQTHHKNLVRLL-------GF 588 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~ 588 (814)
+.+.+.||+|+||+||+|.+.. +++.||||++... .....+.+.+|+ .+++.++||||++++ ++
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-C---CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred EEEcceeecCCCEEEEEEEECC---CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 3445789999999999999754 4679999999642 233446788999 666777899999998 55
Q ss_pred eccCC-----------------ceehhhhhccCCchhhhhcCCCCCC-------HHHHHHHHHHHHHHHHHhhhcCCCCe
Q 042262 589 CDEGQ-----------------NRLLVYEFLNNGTLASFLFGNLKPS-------WNLRTNIAFQIARGLLYLHEDCSAQI 644 (814)
Q Consensus 589 ~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~l~-------~~~~~~i~~~ia~gL~yLH~~~~~~i 644 (814)
+.+.+ ..+|||||+ +|+|.+++.....++ +..++.|+.||++||+|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 54443 278999999 689999997643333 58888999999999999995 599
Q ss_pred eecCCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCC-----------CCCCccchhhHHH
Q 042262 645 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS-----------TITAKVDVYSFGV 713 (814)
Q Consensus 645 iH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~k~DV~S~Gv 713 (814)
+||||||+|||++.++.+||+|||+++..... .....| ..|+|||.+.+. .++.++||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999864321 334557 999999999887 8999999999999
Q ss_pred HHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 714 LLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 714 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
++|||++|+.||....... ....+.. .....++++.+++.+||+.||.+|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~---------------~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG---------------GSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------C---------------CSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCccccccc---------------chhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999996432211 0111111 01245678999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=340.19 Aligned_cols=245 Identities=23% Similarity=0.285 Sum_probs=189.2
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEee-ccccceeeeeeeecc----CCceehhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVRLLGFCDE----GQNRLLVYE 600 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~----~~~~~lV~e 600 (814)
+.||+|+||+||++.+.. .++.||||+++. ...+.+|+.++.+ .+||||+++++++.. ....+||||
T Consensus 68 ~~LG~G~~g~V~~~~~~~---~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKR---TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp EEEEEETTEEEEEEEETT---TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ceeeeccCeEEEEEEECC---CCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 579999999999999864 567899999863 2356677777644 589999999998865 567899999
Q ss_pred hccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCCeEEeecCCcccccc
Q 042262 601 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARISDFGLAKLLTL 675 (814)
Q Consensus 601 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DfGla~~~~~ 675 (814)
|+++|+|.+++... ..+++..+..|+.||++||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 99999999999764 358999999999999999999995 59999999999999997 78999999999987543
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
... .....||..|+|||++.+..++.++|||||||++|||++|+.||.......... .....+..+...
T Consensus 217 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~i~~~~~~----- 285 (400)
T 1nxk_A 217 HNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQYE----- 285 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC---SHHHHHHHTCCC-----
T ss_pred CCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH---HHHHHHHcCccc-----
Confidence 221 344568999999999999999999999999999999999999997654322100 011112222211
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.........+.++.+++..||+.||.+|||+.||++.
T Consensus 286 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 -FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111112456789999999999999999999999973
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=350.69 Aligned_cols=249 Identities=26% Similarity=0.306 Sum_probs=204.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||+|.... .++.||||++... .......+.+|+.++..++||||+++++++.+.+..+||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 4455789999999999999864 5779999999653 223345688999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 599 YEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.+...
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999987653 48999999999999999999995 59999999999999999999999999999876543
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||......... ......+....
T Consensus 340 ~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~~~-------- 405 (576)
T 2acx_A 340 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVP-------- 405 (576)
T ss_dssp CC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHHCC--------
T ss_pred cc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhccc--------
Confidence 22 23457999999999999999999999999999999999999999765332111 11112221111
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~ 792 (814)
...+...+.++.+++.+||+.||.+|| +++||++
T Consensus 406 --~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 --EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 112234568899999999999999999 7888876
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=345.99 Aligned_cols=269 Identities=20% Similarity=0.269 Sum_probs=187.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeecc-----CC
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-----GQ 593 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~ 593 (814)
.+.+.+.||+|+||+||+|.+.. .++.||||++.... ....+++.+|++++++++||||+++++++.. ..
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKL---EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp TEEECCC-------CEEEEEECC-----CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CeEEeeEeeecCCeEEEEEEECC---CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 35667889999999999999875 56789999986532 2234678899999999999999999999943 35
Q ss_pred ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 594 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
..+|||||+ +++|.+++.....+++..+..|+.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++..
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 789999987 57999999888889999999999999999999995 59999999999999999999999999999876
Q ss_pred cccccc-------------------------cccccccCCCCccCcccc-cCCCCCCccchhhHHHHHHHHHh-------
Q 042262 674 TLNQSK-------------------------AIKTAIRGTKGYVAPEWF-RNSTITAKVDVYSFGVLLLEIIS------- 720 (814)
Q Consensus 674 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~k~DV~S~Gvvl~ellt------- 720 (814)
...... ...+..+||..|+|||++ .+..++.++|||||||+|+||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 532211 113445789999999986 56679999999999999999999
Q ss_pred ----CCcCCcccCCc-----------------chhhHHHHHHHHHhcCCc------------------cccccCcccccC
Q 042262 721 ----CRKSFDIEMGE-----------------EYAILTDWAFDCYRNGKL------------------DDLVEGDTEAMN 761 (814)
Q Consensus 721 ----G~~p~~~~~~~-----------------~~~~l~~~~~~~~~~~~~------------------~~l~~~~~~~~~ 761 (814)
|+++|...... ........+...+..... .......+ ...
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 365 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL-AER 365 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG-GGG
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH-HHH
Confidence 45555332100 000000111111100000 00000000 011
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HcCC
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEGV 797 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~--L~~~ 797 (814)
....+.++.+|+.+||+.||.+|||++|+++. ++++
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 12346789999999999999999999999984 4443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=342.76 Aligned_cols=263 Identities=22% Similarity=0.374 Sum_probs=189.4
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeecc-ccceeeeeeeeccC--Cc
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEG--QN 594 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~ 594 (814)
..+.+.+.||+|+||.||+|.+.. .++.||||++... .....+.+.+|+.++..+. ||||+++++++... ..
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETT---TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECC---CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 345667899999999999999865 5678999998643 2233456788999999997 99999999999654 47
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
.+|||||+. ++|..++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 899999997 589888865 468999999999999999999995 599999999999999999999999999998653
Q ss_pred ccc-------------------cccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchh
Q 042262 675 LNQ-------------------SKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 734 (814)
Q Consensus 675 ~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~ 734 (814)
... .....+...||..|+|||.+.+ ..++.++|||||||+++||++|+.||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~- 239 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ- 239 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 211 1111344579999999999987 6789999999999999999999999975432211
Q ss_pred hHHHHHHHHHhcCCcccc-----------c----------cCcc------------cccCChhHHHHHHHHHHHccccCC
Q 042262 735 ILTDWAFDCYRNGKLDDL-----------V----------EGDT------------EAMNDIKCTEKLVMVSIWCIQEDP 781 (814)
Q Consensus 735 ~l~~~~~~~~~~~~~~~l-----------~----------~~~~------------~~~~~~~~~~~l~~l~~~Cl~~dP 781 (814)
+ ..+...+.......+ + .... ........++++.+|+.+||+.||
T Consensus 240 -~-~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 240 -L-ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp -H-HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred -H-HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 1 111111100000000 0 0000 000111345789999999999999
Q ss_pred CCCCCHHHHHHH
Q 042262 782 SLRPTMRKVSQM 793 (814)
Q Consensus 782 ~~RPtm~eV~~~ 793 (814)
.+|||+.|+++.
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=344.99 Aligned_cols=257 Identities=24% Similarity=0.287 Sum_probs=190.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccC------C
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------Q 593 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 593 (814)
+.+.+.||+|+||+||+|.+.. .++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred eEEEEEeecCCCeEEEEEEECC---CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4556789999999999999864 5788999999653 233356788999999999999999999999654 4
Q ss_pred ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 594 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
+.+|||||+.++ |.+.+.. .+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 569999999765 5555543 48899999999999999999995 59999999999999999999999999999876
Q ss_pred cccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc-------
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN------- 746 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------- 746 (814)
..... .+...||..|+|||.+.+..++.++|||||||+++||++|+.||......+. + ..+...+..
T Consensus 215 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~--~-~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 215 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--W-NKVIEQLGTPCPEFMK 288 (464)
T ss_dssp --CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHHHCSCCHHHHT
T ss_pred CCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHhcCCCCHHHHH
Confidence 54321 3456799999999999999999999999999999999999999975432111 1 001111000
Q ss_pred -----------CC-------ccccccCcc---cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 747 -----------GK-------LDDLVEGDT---EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 747 -----------~~-------~~~l~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.. +........ ........+.++.+|+.+||+.||.+|||++|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000000000 000011236789999999999999999999999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=345.52 Aligned_cols=259 Identities=18% Similarity=0.214 Sum_probs=204.1
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccc-cceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.++||+|+||.||+|.+.. .++.||||++.... ...++..|++++..++| ++|..+..++.+.+..+|||
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETT---TCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEECC---CCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 35567889999999999999764 56789999876432 34568899999999977 55666666677788889999
Q ss_pred hhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---CCCCCeEEeecCCcccccc
Q 042262 600 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 600 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DfGla~~~~~ 675 (814)
||+ +++|.+++.. ...+++..++.|+.||+.||+|||+ .+|+||||||+|||| ++++.+||+|||+++.+..
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999 9999999974 5679999999999999999999995 599999999999999 6889999999999987754
Q ss_pred ccccc-----ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 676 NQSKA-----IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 676 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
..... ......||..|+|||.+.+..++.++||||||++||||++|+.||.......................+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 43221 1225669999999999999999999999999999999999999997654322221111111111111111
Q ss_pred ccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 751 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
.+ ...++.++.+++..||+.+|++||++.+|+++|+++
T Consensus 239 ~l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 239 AL---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HH---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HH---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11 123467899999999999999999999999998765
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.68 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=200.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeee--ccCCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFC--DEGQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~--~~~~~~~l 597 (814)
+.+.+.||+|+||.||++.... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++ ..+...++
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred eeeehhccCCCCcEEEEEEECC---CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4556889999999999999864 56789999986432 23346789999999999999999999987 44678899
Q ss_pred hhhhccCCchhhhhcCC----CCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 598 VYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDC--SAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
||||+++++|.+++... ..+++..++.++.|+++||+|||+.. ..+|+|+||||+||++++++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999998643 34899999999999999999999751 1229999999999999999999999999998
Q ss_pred cccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
........ .....|+..|+|||.+.+..++.++||||||++++||++|+.||....... ....+..+....
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRR 235 (279)
T ss_dssp HC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC
T ss_pred eecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-------HHHHHhhccccc
Confidence 76543221 233468999999999999999999999999999999999999997543211 122233333221
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
.+..++.++.+++.+||+.||.+|||+.||++.+.
T Consensus 236 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 236 ---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 12345688999999999999999999999998663
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=347.30 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=201.2
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
...+.+.+.||+|+||+||+|.... .+..+|||++.... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKV---THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETT---TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECC---CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 4457778899999999999999864 56789999986532 333567899999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC---CCeEEeecCCcccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY---YNARISDFGLAKLL 673 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DfGla~~~ 673 (814)
+||||+++|+|.+.+.....+++..+..|+.||++||+|||+ .+|+||||||+|||++.. +.+||+|||+++..
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999999999888889999999999999999999995 599999999999999764 45999999999876
Q ss_pred cccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
..... .....||..|+|||.+. ..++.++||||+|+++|||++|+.||......+ ....+..+....
T Consensus 190 ~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~-- 256 (494)
T 3lij_A 190 ENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYTF-- 256 (494)
T ss_dssp BTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC--
T ss_pred CCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC--
Confidence 54322 33456999999999986 469999999999999999999999997543221 122222222211
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........+..+.+++.+||+.||.+|||+.|+++
T Consensus 257 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 ----DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp ----CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00111245678999999999999999999999885
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=325.29 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=198.6
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeec-cccceeeeeeeeccCCce
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 595 (814)
...+.+.+.||+|+||+||+|.... .+..||||++... ......++.+|+..+..+ +||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRL---DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcC---CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 3456677899999999999999864 4678999998753 223456788899998888 999999999999999999
Q ss_pred ehhhhhccCCchhhhhcCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-------------
Q 042262 596 LLVYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD------------- 658 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~------------- 658 (814)
++||||+++++|.+++... ..+++..++.|+.||++||+|||+ .+|+||||||+||+++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC--------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 9999999999999999754 568999999999999999999995 59999999999999984
Q ss_pred ------CCCeEEeecCCcccccccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCc
Q 042262 659 ------YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGE 731 (814)
Q Consensus 659 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~ 731 (814)
...+||+|||++....... ...||..|+|||.+.+. .++.++||||||++++||++|..++....
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-- 235 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-- 235 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--
T ss_pred ccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--
Confidence 4479999999998765432 23489999999999876 56789999999999999999998764221
Q ss_pred chhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 732 EYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 732 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....+..+.... .+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 236 --------~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 --------QWHEIRQGRLPR---------IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --------HHHHHHTTCCCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HHHHHHcCCCCC---------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 112223333221 12345678999999999999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.35 Aligned_cols=245 Identities=25% Similarity=0.355 Sum_probs=196.2
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhccCC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 605 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 605 (814)
..||+|+||.||+|.... .+..||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus 28 ~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLS---NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp CEEEECSSSEEEEEEETT---TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEEeecCcEEEEEEEECC---CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 379999999999999864 56789999997765555678999999999999999999999999999999999999999
Q ss_pred chhhhhcCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCCeEEeecCCcccccccccccc
Q 042262 606 TLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 606 sL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+|.+++... ..+++..+..++.||++||+|||+ .+|+|+||||+||+++. ++.+||+|||+++........
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~-- 179 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-- 179 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--
Confidence 999998754 346788899999999999999995 59999999999999987 899999999999876432211
Q ss_pred cccccCCCCccCcccccCCC--CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 682 KTAIRGTKGYVAPEWFRNST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~--~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....|+..|+|||.+.+.. ++.++||||||++++||++|+.||.......... ........ ..
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~---------~~ 245 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM-----FKVGMFKV---------HP 245 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH-----HHHHHHCC---------CC
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH-----Hhhccccc---------cc
Confidence 23456899999999997654 8899999999999999999999996433221110 00000010 11
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...+.++.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 123355678999999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=346.58 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=206.2
Q ss_pred HHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCce
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 595 (814)
....+.+.+.||+|+||+||+|.... .+..||||++.... ......+.+|+.++++++||||+++++++.+....
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETT---TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECC---CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 44567788999999999999999864 56789999986432 33456789999999999999999999999999999
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC---CCCCeEEeecCCccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD---DYYNARISDFGLAKL 672 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DfGla~~ 672 (814)
++||||+.+++|.+.+.....+++..+..|+.||++||.|||+ .+|+||||||+|||++ .++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999999999887889999999999999999999995 5999999999999995 556799999999987
Q ss_pred ccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
...... .....||+.|+|||.+.+ .++.++||||+|+++|||++|+.||......+ ....+..+....
T Consensus 174 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~- 241 (486)
T 3mwu_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAF- 241 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCS-
T ss_pred CCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC-
Confidence 654322 234569999999999976 58999999999999999999999997543211 112222222211
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
........+.++.+++.+||+.||.+|||+.|+++.
T Consensus 242 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 -----DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -----CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -----CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111123456789999999999999999999999873
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=348.13 Aligned_cols=252 Identities=27% Similarity=0.327 Sum_probs=208.0
Q ss_pred HHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCc
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 594 (814)
....+.+.+.||+|+||.||++.... .+..||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECC---CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 45567788899999999999999864 56789999986432 2345678999999999999999999999999999
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---CCCCCeEEeecCCcc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAK 671 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DfGla~ 671 (814)
.++|+||+.+++|.+++.....+++..+..|+.||++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999999999888889999999999999999999995 599999999999999 567899999999998
Q ss_pred cccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
....... .....||+.|+|||.+.+ .++.++||||+|+++|||++|+.||......+ ....+..+....
T Consensus 178 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~ 246 (484)
T 3nyv_A 178 HFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYTF 246 (484)
T ss_dssp HBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC
T ss_pred Ecccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCC
Confidence 7654332 234569999999999976 68999999999999999999999997543211 122222332211
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........++++.+++.+||+.||.+|||+.|+++
T Consensus 247 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 ------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 11112345688999999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.34 Aligned_cols=264 Identities=25% Similarity=0.309 Sum_probs=195.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCC------
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------ 593 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 593 (814)
+.+.+.||+|+||.||+|.+.. .++.||||++.... ....+++.+|+.+++.++||||+++++++....
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp EEEEEEC------CEEEEEETT---TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred EEEeEEeeecCCeEEEEEEECC---CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4556789999999999999864 57789999985432 223467889999999999999999999997653
Q ss_pred ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 594 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 459999999 8899998876 568999999999999999999995 59999999999999999999999999999875
Q ss_pred cccccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC-----
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG----- 747 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----- 747 (814)
... .+...+|..|+|||.+.+ ..++.++||||+||+++||++|+.||........ + ..+.......
T Consensus 179 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l-~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 179 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--L-KEIMKVTGTPPAEFV 250 (367)
T ss_dssp CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHHHCCCCHHHH
T ss_pred ccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHhcCCCCHHHH
Confidence 432 334568999999999987 6799999999999999999999999975432111 1 0011100000
Q ss_pred -------------CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHcCCcCCCC
Q 042262 748 -------------KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEGVVEVDV 802 (814)
Q Consensus 748 -------------~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~--~L~~~~~~~~ 802 (814)
.+......... ......+..+.+++.+||+.||.+|||+.|+++ .++++.+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence 00000001111 112245678999999999999999999999998 4665544433
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=340.93 Aligned_cols=199 Identities=25% Similarity=0.408 Sum_probs=166.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccC-----C
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----Q 593 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~ 593 (814)
.+.+.+.||+|+||.||+|.... .++.||||++.... ....+++.+|++++++++|+||+++++++... .
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CEEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 45667899999999999999864 57889999997532 22346789999999999999999999999766 5
Q ss_pred ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 594 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
..+|||||+. ++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 7899999986 6999999988889999999999999999999995 59999999999999999999999999999876
Q ss_pred cccccc--------------------cccccccCCCCccCcccc-cCCCCCCccchhhHHHHHHHHHhCCcCCc
Q 042262 674 TLNQSK--------------------AIKTAIRGTKGYVAPEWF-RNSTITAKVDVYSFGVLLLEIISCRKSFD 726 (814)
Q Consensus 674 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~t~k~DV~S~Gvvl~elltG~~p~~ 726 (814)
...... ...+...||..|+|||.+ ....++.++|||||||+++||++|..|+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 543221 113556799999999986 55679999999999999999998655553
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.76 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=195.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||+|.+.. .++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQL---TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEeeecCCCCeEEEEEEECC---CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 4566789999999999999864 46789999986532 23345788999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++++|.+++.....+++..+..++.||++||+|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 99999999999998877899999999999999999999964 999999999999999999999999999987654322
Q ss_pred ccccccccCCCCccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.....|+..|+|||.+.+..+ +.++||||||++++||++|+.||....... ....+..+...
T Consensus 167 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------- 229 (276)
T 2h6d_A 167 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-------LFKKIRGGVFY------- 229 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-------
T ss_pred ---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHHhhcCccc-------
Confidence 233458999999999988765 689999999999999999999996532211 11222222110
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.+...+..+.+++.+||+.||.+|||+.||++.
T Consensus 230 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 ---IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 122345788999999999999999999999983
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=358.40 Aligned_cols=247 Identities=25% Similarity=0.311 Sum_probs=205.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeec-cccceeeeeeeeccCCcee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 596 (814)
.+.+.+.||+|+||.||+|.... .++.||||+++.. .....+.+..|..++..+ +|+||+++++++.+.+..+
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESS---SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECC---CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 34566789999999999999874 5678999999753 233445678888888887 7999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||||+++|+|..++.....+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 999999999999999888889999999999999999999995 59999999999999999999999999999864332
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
... .....||..|+|||++.+..++.++||||||++||||++|+.||......+ ....+..+..
T Consensus 496 ~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~------- 559 (674)
T 3pfq_A 496 GVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNV------- 559 (674)
T ss_dssp TCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHSSCC-------
T ss_pred Ccc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCCC-------
Confidence 221 345679999999999999999999999999999999999999997543221 1222222221
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTM-----RKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm-----~eV~~ 792 (814)
..+...+.++.+|+..||+.||.+||++ +||++
T Consensus 560 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1233567889999999999999999997 66664
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=333.03 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=202.4
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc--------chhhhhceeeEEeec-cccceeeeeeeec
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--------GEKEFKNEVVVIGQT-HHKNLVRLLGFCD 590 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--------~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 590 (814)
..+.+.+.||+|+||.||+|.+.. ++..||||+++..... ..+.+.+|+.++.++ +||||+++++++.
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRA---TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhcccceEEecCCCEEEEEEEECC---CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 345556889999999999999864 4678999998653211 134678899999998 7999999999999
Q ss_pred cCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 591 EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 591 ~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
..+..+|||||+++++|.+++.....+++..+..++.||++||.|||+ .+|+|+||||+||++++++.+||+|||++
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 999999999999999999999887789999999999999999999995 59999999999999999999999999999
Q ss_pred ccccccccccccccccCCCCccCcccccC------CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHH
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRN------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 744 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 744 (814)
..+..... .....||..|+|||++.+ ..++.++||||||+++|||++|+.||....... ....+
T Consensus 248 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-------~~~~i 317 (365)
T 2y7j_A 248 CHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-------MLRMI 317 (365)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred cccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-------HHHHH
Confidence 87654332 234568999999999863 358899999999999999999999996532211 11112
Q ss_pred hcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 745 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+..... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 318 ~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 MEGQYQFS------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHTCCCCC------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhCCCCCC------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22221100 0001134567899999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.74 Aligned_cols=247 Identities=26% Similarity=0.378 Sum_probs=203.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.+.||+|+||.||+|.... .+..||||++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHhhhhcccCCeEEEEEEECC---CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 4556789999999999998764 56789999986543 3345678999999999999999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
|+++++|.+++.. ..+++..+..++.||++||.|||+ .+|+|+||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 175 (303)
T 3a7i_A 101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 175 (303)
T ss_dssp CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC-
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccccc-
Confidence 9999999999865 468999999999999999999995 59999999999999999999999999999876543321
Q ss_pred ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~ 760 (814)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||....... ....+..+... .
T Consensus 176 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~ 238 (303)
T 3a7i_A 176 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNNPP---------T 238 (303)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCC---------C
T ss_pred -cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-------HHHHhhcCCCC---------C
Confidence 234568999999999999999999999999999999999999996443211 11111112111 1
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 761 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.+...+..+.+++..||+.||.+|||+.||++.
T Consensus 239 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 122456789999999999999999999999873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.48 Aligned_cols=263 Identities=19% Similarity=0.240 Sum_probs=196.1
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeecc-------
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------- 591 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------- 591 (814)
.+.+.+.||+|+||.||+|.... .++.||||++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETT---TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ceeEEEEEecCCCcEEEEEEECC---CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 45667889999999999999864 567899999854322 234567899999999999999999999876
Q ss_pred -CCceehhhhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCC
Q 042262 592 -GQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 669 (814)
Q Consensus 592 -~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl 669 (814)
.+..+|||||+.+ +|.+.+.. ...+++..+..|+.||++||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4468999999986 66555544 4679999999999999999999995 5999999999999999999999999999
Q ss_pred cccccccccc--cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 670 AKLLTLNQSK--AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 670 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
++.+...... .......||..|+|||.+.+ ..++.++||||||++++||++|+.||......... .........
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~ 247 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCGS 247 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCC
Confidence 9876532221 11234568999999999876 46899999999999999999999999765432211 111111110
Q ss_pred C---CccccccCc--------ccccCC-------hhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 747 G---KLDDLVEGD--------TEAMND-------IKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 747 ~---~~~~l~~~~--------~~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
- ......... ...... ...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 000000000 000000 0114568899999999999999999999873
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=324.63 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=200.1
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
...+.+.+.||+|+||.||+|.... .+..||||++... ...+++.+|+.++..++||||+++++++.+.+..++|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETT---TCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECC---CCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 3445667889999999999999864 4678999998653 3456789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||+++++|.+++. ....+++..+..++.||++||.|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999986 45678999999999999999999995 599999999999999999999999999998765432
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.. .....|+..|+|||.+.+..++.++||||||++++||++|+.||....... ... ....+....
T Consensus 180 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~~------ 244 (314)
T 3com_A 180 AK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIF-MIPTNPPPT------ 244 (314)
T ss_dssp SC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH-HHHHSCCCC------
T ss_pred cc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHH-HHhcCCCcc------
Confidence 21 234568999999999999999999999999999999999999997433211 011 111111111
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
...+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 245 -~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 -FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1112345678999999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=327.18 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=199.5
Q ss_pred HHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--------ccchhhhhceeeEEeeccccceeeeeeee
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--------QDGEKEFKNEVVVIGQTHHKNLVRLLGFC 589 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 589 (814)
....+.+.+.||+|+||.||+|.... .+..||||++.... ......+.+|+.++++++||||+++++++
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcC---CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 34567778999999999999999864 56889999986432 12234688999999999999999999998
Q ss_pred ccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC---eEEee
Q 042262 590 DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN---ARISD 666 (814)
Q Consensus 590 ~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~D 666 (814)
..+. .++||||+++++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+||+++.++. +||+|
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 7654 89999999999999999888889999999999999999999995 59999999999999987654 99999
Q ss_pred cCCcccccccccccccccccCCCCccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHH
Q 042262 667 FGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 743 (814)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 743 (814)
||+++....... .....||..|+|||.+. +..++.++||||||++++||++|+.||........ + ...
T Consensus 161 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~----~~~ 231 (322)
T 2ycf_A 161 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L----KDQ 231 (322)
T ss_dssp CTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--H----HHH
T ss_pred Cccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--H----HHH
Confidence 999987653221 23456899999999974 56789999999999999999999999975433211 1 111
Q ss_pred HhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 744 YRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 744 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+..+..... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 ITSGKYNFI------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHTCCCCC------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhCccccC------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 122221100 0011235678999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=362.94 Aligned_cols=259 Identities=24% Similarity=0.371 Sum_probs=207.3
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
...+.+.+.||+|+||.||+|.+...+..+..||||+++.... ...+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence 3456677899999999999999976555677899999875432 234678999999999999999999999854 56899
Q ss_pred hhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
||||+++|+|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999999999754 468999999999999999999995 59999999999999999999999999999876543
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.... .....+|..|+|||.+.+..++.++||||||+++|||++ |..||......+ ....+..+...
T Consensus 545 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~----- 611 (656)
T 2j0j_A 545 TYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERL----- 611 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHHTCCC-----
T ss_pred ccee-ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHcCCCC-----
Confidence 2221 223446789999999998899999999999999999997 999987543211 11122222211
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
..+..++..+.+++.+||+.||.+|||+.||++.|+.++
T Consensus 612 ----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 612 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 123356688999999999999999999999999998764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=321.84 Aligned_cols=249 Identities=25% Similarity=0.333 Sum_probs=197.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc----ccchhhhhceeeEEeeccccceeeeeeee--ccCCc
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHHKNLVRLLGFC--DEGQN 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~--~~~~~ 594 (814)
.+.+.+.||+|+||.||++.... .+..+|||++.... ....+.+.+|+.++++++|+||+++++++ .+...
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSE---TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTT---TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred ceeEeeEEecCCCeEEEEEEECC---CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 35567889999999999998754 56789999996532 23456789999999999999999999998 45568
Q ss_pred eehhhhhccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 595 RLLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
.++||||+.++ |.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999877 6666543 4568999999999999999999995 5999999999999999999999999999987
Q ss_pred ccccccccccccccCCCCccCcccccCCC--CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
..............||..|+|||.+.+.. .+.++||||||++++||++|+.||....... ....+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-------LFENIGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-------HHHHHhcCCC-
Confidence 65433332234556899999999997654 4789999999999999999999997543211 1122222221
Q ss_pred ccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 751 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..+..++..+.+++.+||+.||.+|||+.|+++.
T Consensus 231 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ---------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1122456788999999999999999999999973
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.34 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=197.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||.||+|.... .+|+|+++.. .....+.+.+|+.++++++|+||+++++++.+.+..++|+
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred eEEeeEeccCCceEEEEEEEcC------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 4566889999999999998752 3899988643 2334467899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++++|.+++.... .+++..+..++.||++||+|||+ .+|+||||||+||+++ ++.+||+|||+++.......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 9999999999998754 68999999999999999999995 5999999999999998 67999999999876532211
Q ss_pred ---ccccccccCCCCccCcccccC---------CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 679 ---KAIKTAIRGTKGYVAPEWFRN---------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 679 ---~~~~~~~~gt~~y~aPE~~~~---------~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
........|+..|+|||.+.+ ..++.++||||||++++||++|+.||....... .......
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~ 257 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQMGT 257 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-------HHHHHHT
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHhcc
Confidence 111233458999999999874 457889999999999999999999997543221 1112222
Q ss_pred CCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCC
Q 042262 747 GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 801 (814)
Q Consensus 747 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~ 801 (814)
+..... .....+.++.+++..||+.||.+|||+.||+++|+.+.+..
T Consensus 258 ~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 258 GMKPNL--------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TCCCCC--------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCC--------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 221111 11234567889999999999999999999999999887654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=324.09 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=198.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-ccceeeeeeeecc--CCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDE--GQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~l 597 (814)
.+.+.+.||+|+||.||+|.... .++.||||+++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred ceEEEEEecccCCeEEEEEEECC---CCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 35566889999999999999864 5678999998643 3567899999999997 9999999999987 667899
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-CeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~ 676 (814)
||||+.+++|.+++. .+++..+..++.||++||+|||+ .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 111 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 999999999999884 47899999999999999999995 5999999999999999776 8999999999876543
Q ss_pred ccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHH--------HHHHhcC
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCYRNG 747 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~ 747 (814)
.. .....|+..|+|||.+.+ ..++.++||||||++++||++|+.||......... +.... .+.+...
T Consensus 185 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 185 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHT
T ss_pred Cc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHh
Confidence 32 234468999999999987 67899999999999999999999999644332111 11100 0111110
Q ss_pred Ccc--------------ccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 748 KLD--------------DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 748 ~~~--------------~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
... ...............+.++.+++.+||+.||.+|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 000000111122335788999999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=326.63 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=184.4
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc--chhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
.+.+.+.||+|+||+||+|.... .++.||||+++..... ..+.+.++...++.++||||+++++++.+++..++|
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVP---SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred hhhhHHhcCCCCCeEEEEEEecC---CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 45566889999999999999864 5789999999653221 223344555557778999999999999999999999
Q ss_pred hhhccCCchhhhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 599 YEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 599 ~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
|||++ ++|.+++. ....+++..+..|+.||++||+|||+. .+|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99997 58777664 356799999999999999999999952 389999999999999999999999999998765
Q ss_pred ccccccccccccCCCCccCcccc----cCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWF----RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
.... .....||..|+|||.+ .+..++.++||||||++++||++|+.||....... ...........
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~-- 231 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEEPS-- 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHSCC--
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhccCC--
Confidence 4332 2334689999999996 56678999999999999999999999997432211 11111222111
Q ss_pred ccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 751 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
........+.++.+++.+||+.||.+|||+.|+++
T Consensus 232 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11112345678999999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.80 Aligned_cols=251 Identities=11% Similarity=0.037 Sum_probs=180.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeec--cccceeeee-------eee
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQT--HHKNLVRLL-------GFC 589 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l--~H~niv~l~-------g~~ 589 (814)
+.+.+.||+|+||.||+|.+.. .++.||||++..... ...+.+.+|+.++..+ +||||++++ +++
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVE---RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred eeeeeeccCCCCEEEEEEEECC---CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4456789999999999999864 578999999976432 2345677785444444 699988755 333
Q ss_pred ccC-----------------CceehhhhhccCCchhhhhcCC-CCCCHHHH------HHHHHHHHHHHHHhhhcCCCCee
Q 042262 590 DEG-----------------QNRLLVYEFLNNGTLASFLFGN-LKPSWNLR------TNIAFQIARGLLYLHEDCSAQII 645 (814)
Q Consensus 590 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ii 645 (814)
... ...+|||||++ ++|.+++... ..+.+..+ ..|+.||++||+|||+ .+|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCc
Confidence 222 33799999999 8999999763 34456666 7888999999999995 5999
Q ss_pred ecCCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccC--CCCCCccchhhHHHHHHHHHhCCc
Q 042262 646 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRK 723 (814)
Q Consensus 646 H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~Gvvl~elltG~~ 723 (814)
||||||+|||++.++.+||+|||+++..... .....+|..|+|||.+.+ ..++.++||||||++||||++|+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876432 113446799999999987 679999999999999999999999
Q ss_pred CCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 724 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 724 p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
||.......... +.....................+..+.+++.+||+.||++|||+.|+++
T Consensus 292 Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 997653321110 0000001111111111222356789999999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=330.52 Aligned_cols=262 Identities=23% Similarity=0.295 Sum_probs=197.5
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc-----chhhhhceeeEEeeccccceeeeeeeeccCCc
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD-----GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 594 (814)
..+.+.+.||+|+||.||+|.... .+..||||++...... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred cccEEEeEEeecCCEEEEEEEECC---CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 345667899999999999999764 4678999998643211 13467899999999999999999999999999
Q ss_pred eehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 595 RLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
.++||||+++ +|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999986 788877654 468999999999999999999995 58999999999999999999999999999876
Q ss_pred cccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC---Cc
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KL 749 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~ 749 (814)
...... .....||..|+|||.+.+. .++.++||||||++++||++|..||....... .+ .......... ..
T Consensus 163 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~-~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 163 GSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QL-TRIFETLGTPTEEQW 237 (346)
T ss_dssp TSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH-HHHHHHHCCCCTTTS
T ss_pred cCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HH-HHHHHHcCCCChhhh
Confidence 533221 3345689999999999764 58999999999999999999999987543221 11 1111111110 00
Q ss_pred cccc---cC---cccc-----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 750 DDLV---EG---DTEA-----MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 750 ~~l~---~~---~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.... +. .... ......+.++.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1000 00 0000 0012445789999999999999999999999884
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=346.13 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=201.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc-------------cchhhhhceeeEEeeccccceeeeee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-------------DGEKEFKNEVVVIGQTHHKNLVRLLG 587 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-------------~~~~~~~~Ei~~l~~l~H~niv~l~g 587 (814)
.+.+.++||+|+||+||+|.... .+..+|||++..... ...+++.+|+.++++++||||+++++
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEKN---GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ceEEEeEecccCCeEEEEEEECC---CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35566889999999999999864 567899999865321 23457889999999999999999999
Q ss_pred eeccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC---CeEE
Q 042262 588 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---NARI 664 (814)
Q Consensus 588 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl 664 (814)
++.+....+|||||+++|+|.+++.....+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++ .+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEE
Confidence 999999999999999999999999888889999999999999999999995 5999999999999998775 6999
Q ss_pred eecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHH
Q 042262 665 SDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 744 (814)
Q Consensus 665 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 744 (814)
+|||+++....... .....||+.|+|||.+.+ .++.++||||+|+++|+|++|+.||......+ ....+
T Consensus 191 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i 259 (504)
T 3q5i_A 191 VDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------IIKKV 259 (504)
T ss_dssp CCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred EECCCCEEcCCCCc---cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHH
Confidence 99999987654322 234569999999999874 68999999999999999999999997543221 12222
Q ss_pred hcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 745 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+....- .......+.++.+++.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~~------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 EKGKYYFD------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHCCCCCC------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HcCCCCCC------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 23322110 0011235678999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=335.56 Aligned_cols=255 Identities=23% Similarity=0.297 Sum_probs=194.4
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeecc---------
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--------- 591 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------- 591 (814)
.+.+.+.||+|+||+||+|.+.. .++.||||++... .....+|+.+++.++||||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETT---TCCEEEEEEEECC----TTSCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred eEEEEEEEEeccCEEEEEEEECC---CCCEEEEEEEecC----cchHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 45667899999999999999864 5779999998543 3345679999999999999999999843
Q ss_pred -----------------------------CCceehhhhhccCCchhhhhc----CCCCCCHHHHHHHHHHHHHHHHHhhh
Q 042262 592 -----------------------------GQNRLLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHE 638 (814)
Q Consensus 592 -----------------------------~~~~~lV~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~ 638 (814)
....++||||++ ++|.+.+. ....+++..+..++.||++||+|||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH- 158 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH- 158 (383)
T ss_dssp -----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 334789999998 47666654 4577999999999999999999999
Q ss_pred cCCCCeeecCCCCCcEEEC-CCCCeEEeecCCcccccccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHH
Q 042262 639 DCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLL 716 (814)
Q Consensus 639 ~~~~~iiH~Dikp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~ 716 (814)
+.+|+||||||+|||++ +++.+||+|||+++.+..... .....+|..|+|||.+.+. .++.++||||+|++++
T Consensus 159 --~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 --SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp --TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred --HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 56999999999999998 688999999999987654332 2345689999999998875 4899999999999999
Q ss_pred HHHhCCcCCcccCCcchhhHHHHHHHHHhc---------------CCccccccCcccccCChhHHHHHHHHHHHccccCC
Q 042262 717 EIISCRKSFDIEMGEEYAILTDWAFDCYRN---------------GKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDP 781 (814)
Q Consensus 717 elltG~~p~~~~~~~~~~~l~~~~~~~~~~---------------~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP 781 (814)
||++|+.||......+. +.... ..... -..............+...+.++.+++.+||+.||
T Consensus 234 ell~g~~pf~~~~~~~~--~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQ--LVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHSSCSSCCSSHHHH--HHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHhCCCCCCCCChHHH--HHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 99999999975433221 11111 11100 01111111111222334467789999999999999
Q ss_pred CCCCCHHHHHH
Q 042262 782 SLRPTMRKVSQ 792 (814)
Q Consensus 782 ~~RPtm~eV~~ 792 (814)
.+|||+.|+++
T Consensus 311 ~~R~t~~e~l~ 321 (383)
T 3eb0_A 311 DLRINPYEAMA 321 (383)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.65 Aligned_cols=250 Identities=20% Similarity=0.319 Sum_probs=198.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||.||+|.... .+..+|+|++........+++.+|+.++..++||||+++++++.+.+..++|||
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETT---TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred ceeecceeccCCCeEEEEEEEcC---CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 35567889999999999999864 467899999976655566789999999999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++++|.+++.. ...+++..+..++.||++||.|||+ .+|+|+||||+||+++.++.+||+|||++.........
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999999998865 4678999999999999999999995 59999999999999999999999999987643221111
Q ss_pred cccccccCCCCccCcccc-----cCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 680 AIKTAIRGTKGYVAPEWF-----RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~-----~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.....||..|+|||.+ .+..++.++||||||++++||++|+.||....... ..... ..+....
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~~~~~--- 241 (302)
T 2j7t_A 174 --RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKI-AKSDPPT--- 241 (302)
T ss_dssp -------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHH-HHSCCCC---
T ss_pred --cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHH-hccCCcc---
Confidence 2334689999999998 46678999999999999999999999997543211 11111 1111111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
...+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 242 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 ----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1123355678999999999999999999999876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=344.07 Aligned_cols=244 Identities=27% Similarity=0.322 Sum_probs=199.3
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.||+|+||.||+|.... .++.+|||++.... ......+.+|+.++++++||||+++++++.+.+..+|||
T Consensus 188 ~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 188 LDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp EEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 344679999999999999864 57899999996532 233456889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 600 EFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 600 e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999998653 468999999999999999999995 5999999999999999999999999999987654
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... ....+..+..
T Consensus 342 ~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~-~~~~i~~~~~------ 410 (543)
T 3c4z_A 342 GQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKE-LKQRVLEQAV------ 410 (543)
T ss_dssp TCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHH-HHHHHHHCCC------
T ss_pred CCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHH-HHHHHhhccc------
Confidence 3322 2345799999999999999999999999999999999999999976432111 111 1111111111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTM 787 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 787 (814)
..+...+..+.+++.+||+.||.+||++
T Consensus 411 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 ----TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ----CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 1233567889999999999999999976
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=321.00 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=202.5
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---------ccchhhhhceeeEEeecc-ccceeeeeeeecc
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---------QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDE 591 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---------~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~ 591 (814)
+.+.+.||+|+||.||+|.... .++.||||+++... ....+.+.+|+.+++++. ||||+++++++.+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cceeeeecCCCceEEEEEEEcC---cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4556789999999999999864 57889999986432 112356789999999995 9999999999999
Q ss_pred CCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 592 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 592 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
.+..++||||+++++|.+++.....+++..+..++.||++||+|||+ .+|+|+||||+||+++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999999999887889999999999999999999995 599999999999999999999999999998
Q ss_pred cccccccccccccccCCCCccCccccc------CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHh
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFR------NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 745 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 745 (814)
....... .....|+..|+|||.+. ...++.++||||||++++||++|+.||....... ....+.
T Consensus 173 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~ 242 (298)
T 1phk_A 173 QLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIM 242 (298)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH
T ss_pred hcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------HHHHHh
Confidence 7654322 23456899999999985 4568899999999999999999999996543211 112222
Q ss_pred cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 746 NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 746 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+.... ........+..+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNYQF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCCCC------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCccc------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 222111 01112346688999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=336.18 Aligned_cols=269 Identities=22% Similarity=0.268 Sum_probs=202.8
Q ss_pred cCHHHHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc--------cccee
Q 042262 512 FSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH--------HKNLV 583 (814)
Q Consensus 512 f~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~--------H~niv 583 (814)
+...++....+.+.++||+|+||+||+|.... .++.||||+++.. ....+.+.+|+.+++.++ |+||+
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecC---CCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 33444445567778899999999999998764 5789999999743 234567889999999885 88899
Q ss_pred eeeeeec----cCCceehhhhhccCCchhhhhc-CC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC
Q 042262 584 RLLGFCD----EGQNRLLVYEFLNNGTLASFLF-GN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 657 (814)
Q Consensus 584 ~l~g~~~----~~~~~~lV~e~~~~gsL~~~l~-~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~ 657 (814)
++++++. ++...+|||||+ +++|.+.+. .. ..+++..++.|+.||++||+|||+. .+|+||||||+|||++
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~ 181 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLS 181 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEEC
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEe
Confidence 9999987 667899999999 455555544 33 5689999999999999999999952 2899999999999999
Q ss_pred CCC-------------------------------------------------CeEEeecCCcccccccccccccccccCC
Q 042262 658 DYY-------------------------------------------------NARISDFGLAKLLTLNQSKAIKTAIRGT 688 (814)
Q Consensus 658 ~~~-------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt 688 (814)
.++ .+||+|||+++..... .....||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt 256 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQT 256 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSC
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCC
Confidence 775 7999999999876533 2334689
Q ss_pred CCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHH---HHHHHHHh--------cCCcc-ccccCc
Q 042262 689 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT---DWAFDCYR--------NGKLD-DLVEGD 756 (814)
Q Consensus 689 ~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---~~~~~~~~--------~~~~~-~l~~~~ 756 (814)
..|+|||.+.+..++.++|||||||+||||++|+.||..........-. ........ .+... ......
T Consensus 257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence 9999999999999999999999999999999999999765443211111 11111110 00000 000000
Q ss_pred -------------------ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 757 -------------------TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 757 -------------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.....+...+..+.+|+.+||+.||.+|||+.||++
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001124567788999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=337.71 Aligned_cols=255 Identities=25% Similarity=0.305 Sum_probs=191.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccC------Cce
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------QNR 595 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~ 595 (814)
+.+.+.||+|+||.||+|.+.. .++.||||++... .+.+.+|++++++++|+||+++++++... ...
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECC---CCcEEEEEEeccc----chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 4556789999999999999864 4678999998542 23456799999999999999999998432 236
Q ss_pred ehhhhhccCCchhhhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CCeEEeecCCc
Q 042262 596 LLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-YNARISDFGLA 670 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGla 670 (814)
+|||||+++ +|.+.+. ....+++..+..++.||++||+||| +.+|+||||||+||||+.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 789999986 5555443 3567899999999999999999999 4699999999999999965 56899999999
Q ss_pred ccccccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHH-------
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD------- 742 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~------- 742 (814)
+.+..... .....||..|+|||++.+. .++.++|||||||+||||++|+.||......+ .+......
T Consensus 205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTRE 279 (420)
T ss_dssp EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHH
T ss_pred hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 87654322 2345689999999999765 79999999999999999999999997643221 11111110
Q ss_pred HHh--cCCccccccC-----cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 743 CYR--NGKLDDLVEG-----DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 743 ~~~--~~~~~~l~~~-----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+. .....+...+ ..........+.++.+|+.+||+.||.+|||+.|+++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000 0001111000 0111122345678999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.84 Aligned_cols=256 Identities=25% Similarity=0.300 Sum_probs=180.5
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccC------
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------ 592 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 592 (814)
.+.+.+.||+|+||.||+|.... .+..||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp TEEEEEECC----CCEEEEEETT---TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred ceEEeeEEeecCCeEEEEEEECC---CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 34556789999999999998764 57899999986532 22346788999999999999999999998654
Q ss_pred CceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 593 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
...++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 5679999998 7899998865 568999999999999999999995 5999999999999999999999999999987
Q ss_pred ccccccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC---
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK--- 748 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 748 (814)
.... .+...||..|+|||.+.+ ..++.++||||||++++||++|+.||........ + ..+........
T Consensus 182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l-~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--L-KLILRLVGTPGAEL 253 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCSCCHHH
T ss_pred cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHhCCCCHHH
Confidence 5432 234568999999999987 6789999999999999999999999975432111 1 11111110000
Q ss_pred --------cccccc-------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 749 --------LDDLVE-------GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 749 --------~~~l~~-------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
....+. .... ......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000 0000 0011345778999999999999999999999873
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=324.75 Aligned_cols=249 Identities=21% Similarity=0.299 Sum_probs=192.8
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeecc--ccceeeeeeeeccCCcee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTH--HKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~ 596 (814)
.+.+.+.||+|+||.||++... .+..+|||++... .....+.+.+|+.++.+++ |+||+++++++.+.+..+
T Consensus 29 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 29 IYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp EEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eEEEEEEecCCCCEEEEEEEcC----CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 3556688999999999999875 4678999998643 2233467899999999997 499999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
+||| +.+++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+||++++ +.+||+|||+++.....
T Consensus 105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 9999 6788999999888889999999999999999999995 59999999999999965 89999999999877554
Q ss_pred ccccccccccCCCCccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHh
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRN-----------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 745 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 745 (814)
..........||..|+|||.+.+ ..++.++||||||++++||++|+.||....... ........
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~~ 254 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAIID 254 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHHHHHHh
Confidence 33322344568999999999875 468889999999999999999999996443211 11111111
Q ss_pred cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 746 NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 746 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
. ......+...+.++.+++.+||+.||.+|||+.|+++
T Consensus 255 ~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 255 P---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp T---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c---------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1 1111122233578899999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=326.94 Aligned_cols=255 Identities=20% Similarity=0.347 Sum_probs=202.8
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccch-----------------hhhhceeeEEeecccccee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-----------------KEFKNEVVVIGQTHHKNLV 583 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~-----------------~~~~~Ei~~l~~l~H~niv 583 (814)
.+.+.+.||+|+||.||+|.. .+..||||++........ +.+.+|+.++.+++||||+
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ceEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 355668899999999999998 478999999965322211 6789999999999999999
Q ss_pred eeeeeeccCCceehhhhhccCCchhhh------hcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 042262 584 RLLGFCDEGQNRLLVYEFLNNGTLASF------LFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNIL 655 (814)
Q Consensus 584 ~l~g~~~~~~~~~lV~e~~~~gsL~~~------l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIl 655 (814)
++++++.+.+..++||||+++++|.++ +.. ...+++..+..++.||++||+|||+ ..+|+|+||||+||+
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEE
Confidence 999999999999999999999999999 665 5678999999999999999999995 259999999999999
Q ss_pred ECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCC-CCCC-ccchhhHHHHHHHHHhCCcCCcccCCcch
Q 042262 656 LDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS-TITA-KVDVYSFGVLLLEIISCRKSFDIEMGEEY 733 (814)
Q Consensus 656 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-k~DV~S~Gvvl~elltG~~p~~~~~~~~~ 733 (814)
++.++.+||+|||++....... .....|+..|+|||.+.+. .++. ++||||||++++||++|+.||.......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 259 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV- 259 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred EcCCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence 9999999999999998764431 3345689999999999887 6666 9999999999999999999997554311
Q ss_pred hhHHHHHHHHHhcCCccccccC---------cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 734 AILTDWAFDCYRNGKLDDLVEG---------DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 734 ~~l~~~~~~~~~~~~~~~l~~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.....+..+....-... ..........+.++.+++.+||+.||.+|||+.|+++
T Consensus 260 -----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 -----ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -----HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11222233322111000 0000011346688999999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=334.64 Aligned_cols=196 Identities=24% Similarity=0.332 Sum_probs=167.6
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec------cccceeeeeeeeccCCc
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT------HHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~ 594 (814)
.+.+.+.||+|+||+||+|.... .++.||||+++.. ....+++.+|+++++.+ +|+||+++++++...+.
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~---~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETT---TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cEEEEEEcccCccEEEEEEEECC---CCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 35667899999999999999864 5789999999753 22345677777777776 57799999999999999
Q ss_pred eehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC--eEEeecCCc
Q 042262 595 RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN--ARISDFGLA 670 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DfGla 670 (814)
.+|||||+. ++|.+++... ..+++..+..|+.||++||+|||+. +|+||||||+||||+.++. +||+|||++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999996 6888888654 3589999999999999999999964 9999999999999999887 999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccC
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEM 729 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~ 729 (814)
...... .....||..|+|||++.+..++.++|||||||+|+||++|+.||....
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 765432 234568999999999999999999999999999999999999997554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.57 Aligned_cols=254 Identities=26% Similarity=0.323 Sum_probs=205.1
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCC
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 593 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 593 (814)
......+.+.+.||+|+||.||+|.... .++.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcC---CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC
Confidence 4445677788899999999999999864 46789999986532 234567889999999999999999999999999
Q ss_pred ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC---CCeEEeecCCc
Q 042262 594 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY---YNARISDFGLA 670 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DfGla 670 (814)
..++|+||+++++|.+.+.....+++..+..++.||++||+|||+ .+|+|+||||+||+++.+ ..+||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999999998877789999999999999999999995 599999999999999754 46999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
........ .....++..|+|||.+.+ .++.++||||||++++||++|+.||....... ....+..+...
T Consensus 172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~ 240 (287)
T 2wei_A 172 TCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYA 240 (287)
T ss_dssp GTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC
T ss_pred eeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC
Confidence 87654322 123347889999999876 48999999999999999999999997543211 11222222211
Q ss_pred ccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 751 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.. .......+.++.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FD------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CC------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 10 0111245678999999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=324.59 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=192.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeecc------CCc
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE------GQN 594 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~------~~~ 594 (814)
+.+.+.||+|+||.||+|.+.. .+..||||++... ....+++.+|+.++.++ +||||+++++++.. .+.
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred EEEEEEeccCCCEEEEEEEECC---CCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 4556889999999999999864 4678999998653 23456789999999998 89999999999976 467
Q ss_pred eehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 595 RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+|+||||+||+++.++.+||+|||++..
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 89999999999999999754 568999999999999999999995 5999999999999999999999999999987
Q ss_pred ccccccccccccccCCCCccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 747 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 747 (814)
....... .....||..|+|||.+. +..++.++||||||++++||++|+.||....... ..... ..+
T Consensus 179 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~ 249 (326)
T 2x7f_A 179 LDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFLI-PRN 249 (326)
T ss_dssp --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHH-HHS
T ss_pred cCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHHHh-hcC
Confidence 6432211 23446899999999997 5678999999999999999999999996433211 11111 111
Q ss_pred CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 748 KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 748 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.... ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 250 ~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 PAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCC--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccc--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111 112345678999999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=331.61 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=194.1
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCc------
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN------ 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------ 594 (814)
.+.+.+.||+|+||+||+|.+.. ...+|+|++... .....+|+.+++.++||||+++++++.....
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~----~~~~aikk~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVE----SDEVAIKKVLQD----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT----TEEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECC----CCeEEEEEEecC----cchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 35567889999999999999863 334888887532 2234578999999999999999999854433
Q ss_pred eehhhhhccCCchhhhh---cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC-CCCCeEEeecCCc
Q 042262 595 RLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLA 670 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DfGla 670 (814)
.++||||++++.+.... .....+++..+..++.||++||+|||+ .+|+||||||+|||++ .++.+||+|||++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 78999999876554433 235678999999999999999999995 5999999999999999 7999999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHh----
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---- 745 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---- 745 (814)
+....... .....+|..|+|||.+.+. .++.++|||||||+++||++|+.||......+. +.... ....
T Consensus 190 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~-~~~g~p~~ 263 (394)
T 4e7w_A 190 KILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEII-KVLGTPSR 263 (394)
T ss_dssp EECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-HHHCCCCH
T ss_pred ccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCCH
Confidence 87654332 2345689999999999765 589999999999999999999999976543211 11111 1100
Q ss_pred -----------cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HcCC
Q 042262 746 -----------NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEGV 797 (814)
Q Consensus 746 -----------~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~--L~~~ 797 (814)
...+................+.++.+++.+||+.||.+|||+.|+++. ++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 011111111111111223456789999999999999999999999874 5544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=324.03 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=200.7
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccc------eeeeeeeeccCC
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN------LVRLLGFCDEGQ 593 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~ 593 (814)
..+.+.+.||+|+||.||+|..... .+..||||+++.. ....+.+.+|+.+++.++|+| ++++++++.+.+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKA--GGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred CceEEEEEEecCCCeEEEEEEecCC--CCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 3566778999999999999987432 4688999998753 233567888999999988765 999999999999
Q ss_pred ceehhhhhccCCchhhhhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-------------
Q 042262 594 NRLLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD------------- 658 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~------------- 658 (814)
..++||||+ +++|.+++.... .+++..+..++.||++||+|||+ .+|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 889999987654 68899999999999999999995 59999999999999987
Q ss_pred ------CCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcc
Q 042262 659 ------YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732 (814)
Q Consensus 659 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~ 732 (814)
++.+||+|||+++..... .....||..|+|||.+.+..++.++||||||++++||++|+.||......+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 668999999999865432 234568999999999999999999999999999999999999997543322
Q ss_pred hhhHHHHHHHHHh--------cCCccccc---------------------cC-cccccCChhHHHHHHHHHHHccccCCC
Q 042262 733 YAILTDWAFDCYR--------NGKLDDLV---------------------EG-DTEAMNDIKCTEKLVMVSIWCIQEDPS 782 (814)
Q Consensus 733 ~~~l~~~~~~~~~--------~~~~~~l~---------------------~~-~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 782 (814)
.... ...... ........ .+ ..........++.+.+++.+||+.||.
T Consensus 242 ~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 242 HLAM---MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHH---HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHH---HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 1111 111100 00000000 00 000112335678899999999999999
Q ss_pred CCCCHHHHHH
Q 042262 783 LRPTMRKVSQ 792 (814)
Q Consensus 783 ~RPtm~eV~~ 792 (814)
+|||+.||++
T Consensus 319 ~Rpt~~ell~ 328 (339)
T 1z57_A 319 KRITLREALK 328 (339)
T ss_dssp TSCCHHHHTT
T ss_pred cccCHHHHhc
Confidence 9999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=327.34 Aligned_cols=260 Identities=24% Similarity=0.277 Sum_probs=187.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCC------
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------ 593 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 593 (814)
+.+.+.||+|+||.||+|.... .+..||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred eeEeeeeEecCCEEEEEEEECC---CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4556789999999999998864 56789999986532 233456889999999999999999999997654
Q ss_pred ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 594 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
..++||||+.+ +|.+.+. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 67999999975 7777775 358899999999999999999995 59999999999999999999999999999876
Q ss_pred cccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHH----------------
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT---------------- 737 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------------- 737 (814)
..... .....||..|+|||.+.+..++.++||||||++++||++|+.||............
T Consensus 178 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 178 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 43221 23456899999999999999999999999999999999999999754321100000
Q ss_pred HHHHHHHhcC-C-----ccccccCc---ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 738 DWAFDCYRNG-K-----LDDLVEGD---TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 738 ~~~~~~~~~~-~-----~~~l~~~~---~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.......... . +..+.... .........+..+.+++.+||+.||.+|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000000 0 00000000 0000112346789999999999999999999999873
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.49 Aligned_cols=271 Identities=21% Similarity=0.291 Sum_probs=201.3
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-----------ccceeeeee
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-----------HKNLVRLLG 587 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g 587 (814)
...+.+.+.||+|+||+||+|.... .++.||||++... ....+.+.+|+.++++++ |+||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC---CCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 3456677899999999999999764 5789999998743 223456788888888876 899999999
Q ss_pred eeccCC----ceehhhhhccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC----
Q 042262 588 FCDEGQ----NRLLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD---- 657 (814)
Q Consensus 588 ~~~~~~----~~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~---- 657 (814)
++...+ ..++||||+ +++|.+++.. ...+++..+..|+.||+.||+|||+. .+|+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEET
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCC
Confidence 987654 789999999 8999999865 35589999999999999999999952 2899999999999994
Q ss_pred --CCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhh
Q 042262 658 --DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 735 (814)
Q Consensus 658 --~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~ 735 (814)
..+.+||+|||+++..... .....||..|+|||.+.+..++.++||||||++++||++|+.||..........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4457999999999876532 233468999999999999999999999999999999999999998654321111
Q ss_pred HHHHHHHHHh-cCCccc---------------------cccC---------cccccCChhHHHHHHHHHHHccccCCCCC
Q 042262 736 LTDWAFDCYR-NGKLDD---------------------LVEG---------DTEAMNDIKCTEKLVMVSIWCIQEDPSLR 784 (814)
Q Consensus 736 l~~~~~~~~~-~~~~~~---------------------l~~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 784 (814)
-......... .+.++. .... ......+...+.++.+++.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 1111111110 011100 0000 00112345778899999999999999999
Q ss_pred CCHHHHHH--HHcCCcCCC
Q 042262 785 PTMRKVSQ--MLEGVVEVD 801 (814)
Q Consensus 785 Ptm~eV~~--~L~~~~~~~ 801 (814)
||+.||++ .+.+....+
T Consensus 326 pt~~ell~hp~f~~~~~~~ 344 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDTLGME 344 (373)
T ss_dssp BCHHHHHTCGGGTTCTTCT
T ss_pred CCHHHHhhChhhhcccCcc
Confidence 99999998 455554433
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=334.23 Aligned_cols=262 Identities=21% Similarity=0.326 Sum_probs=180.5
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeee--ccCCceehhhhhc
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFC--DEGQNRLLVYEFL 602 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~--~~~~~~~lV~e~~ 602 (814)
.++||+|+||+||+|...... .+..||||++... .....+.+|+.++++++||||+++++++ ......+|||||+
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~ 102 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 102 (405)
T ss_dssp SCCCC-----EEEEEEESSSS-CCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECC
T ss_pred CcEeeecCCeEEEEEEEccCC-CCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCC
Confidence 357999999999999976432 4678999999653 2345788999999999999999999999 4577889999999
Q ss_pred cCCchhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----CCCCCeEEeecCC
Q 042262 603 NNGTLASFLFG---------NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGL 669 (814)
Q Consensus 603 ~~gsL~~~l~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DfGl 669 (814)
.+ +|.+++.. ...+++..++.|+.||+.||+|||+ .+|+||||||+|||| ++++.+||+|||+
T Consensus 103 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 103 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp SE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred CC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 74 77776642 1248999999999999999999995 599999999999999 7788999999999
Q ss_pred cccccccccc-cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcc------hhhHHHHHH
Q 042262 670 AKLLTLNQSK-AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILTDWAF 741 (814)
Q Consensus 670 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~------~~~l~~~~~ 741 (814)
++........ .......||..|+|||.+.+. .++.++|||||||+++||++|+.||.....+. .........
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~ 258 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence 9876543211 113346789999999999874 58999999999999999999999996543210 000111111
Q ss_pred HHHhcC---Ccccccc-------------Cccc--------ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 742 DCYRNG---KLDDLVE-------------GDTE--------AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 742 ~~~~~~---~~~~l~~-------------~~~~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
..+... ....+.. .... .......+..+.+|+.+||+.||.+|||++|+++.
T Consensus 259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111100 0000000 0000 00001124678899999999999999999999883
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.37 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=199.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccC-----Cc
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QN 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 594 (814)
.+.+.+.||+|+||.||+|.... .+..||||++.... ....+.+.+|++++.+++||||+++++++... ..
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cEEEEEEeecCCCeEEEEEEECC---CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 35667889999999999999764 57889999997532 22346788999999999999999999998654 46
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
.++|+||+. ++|.+++.. ..+++..+..|+.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 899999997 589888865 458999999999999999999995 599999999999999999999999999998765
Q ss_pred cccccc-ccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc-
Q 042262 675 LNQSKA-IKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD- 751 (814)
Q Consensus 675 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~- 751 (814)
...... ......||..|+|||.+.+ ..++.++||||||++++||++|+.||......+.. ............+.
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQEDL 256 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH---HHHHHHHCSCCHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH---HHHHHHhCCCCHHHH
Confidence 443221 1234579999999998755 45899999999999999999999999755432211 11111110000000
Q ss_pred --------------cccCcc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 752 --------------LVEGDT--EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 752 --------------l~~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
...... ........+.++.+++.+||+.||.+|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000112345788999999999999999999999873
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=319.47 Aligned_cols=260 Identities=24% Similarity=0.339 Sum_probs=198.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeec---cccceeeeeeeec-----
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT---HHKNLVRLLGFCD----- 590 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~----- 590 (814)
.+.+.+.||+|+||.||+|..... .+..||||+++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred ceeeeeeecccccEEEEEEEecCC--CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 345668899999999999998522 467899999865322 2234567788877776 8999999999986
Q ss_pred cCCceehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecC
Q 042262 591 EGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 668 (814)
Q Consensus 591 ~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfG 668 (814)
.....++||||+. |+|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCc
Confidence 5677899999998 6999998654 348999999999999999999995 599999999999999999999999999
Q ss_pred CcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC
Q 042262 669 LAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748 (814)
Q Consensus 669 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 748 (814)
+++....... .....||..|+|||.+.+..++.++||||||++++||++|+.||....... .+ ...........
T Consensus 166 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~-~~i~~~~~~~~ 239 (326)
T 1blx_A 166 LARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QL-GKILDVIGLPG 239 (326)
T ss_dssp SCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH-HHHHHHHCCCC
T ss_pred ccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HH-HHHHHHcCCCC
Confidence 9987653321 334568999999999999999999999999999999999999997543221 11 11111111100
Q ss_pred cccc----------cc---CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 749 LDDL----------VE---GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 749 ~~~l----------~~---~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.... .. ...........+..+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00 00001112346688999999999999999999999996
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=324.26 Aligned_cols=260 Identities=21% Similarity=0.273 Sum_probs=190.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeec-----------
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD----------- 590 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----------- 590 (814)
+.+.+.||+|+||.||+|.... .++.||||++........+++.+|+.++++++||||+++++++.
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp EEEEEECC-----CEEEEEETT---TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred eeEEEEeccCCCeEEEEEEECC---CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4556789999999999999864 57899999987655555678899999999999999999999873
Q ss_pred ---cCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC-CCCCeEEee
Q 042262 591 ---EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISD 666 (814)
Q Consensus 591 ---~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~D 666 (814)
+....++||||+. |+|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+||+++ +++.+||+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4467899999997 699998864 468899999999999999999995 5999999999999997 567999999
Q ss_pred cCCcccccccccc-cccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHH
Q 042262 667 FGLAKLLTLNQSK-AIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 744 (814)
Q Consensus 667 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 744 (814)
||+++........ .......+|..|+|||.+.+ ..++.++||||||++++||++|+.||......+. + .......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~-~~~~~~~ 241 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--M-QLILESI 241 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHHS
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHhc
Confidence 9999876533211 11233457899999998865 6789999999999999999999999975432111 0 0000000
Q ss_pred hc----------CCccccccCcc------cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 745 RN----------GKLDDLVEGDT------EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 745 ~~----------~~~~~l~~~~~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.. ..+...+.... ........+.++.+++.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00 00000000000 00011245688999999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=325.43 Aligned_cols=256 Identities=24% Similarity=0.302 Sum_probs=193.2
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCce---
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR--- 595 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~--- 595 (814)
.+.+.+.||+|+||.||+|.+.. .++.||||++.... ....+++.+|+.+++.++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cEEEEeEEecCCCeEEEEEEECC---CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 34556789999999999999864 57899999997532 22346788999999999999999999999877655
Q ss_pred ---ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 596 ---LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 596 ---~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
++||||+. ++|.+.+.. .+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 688887743 48999999999999999999995 5999999999999999999999999999986
Q ss_pred ccccccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC---
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK--- 748 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 748 (814)
.... .....||..|+|||.+.+ ..++.++||||||++++||++|+.||......+. +.. .........
T Consensus 194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-i~~~~~~~~~~~ 265 (371)
T 4exu_A 194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQ-ILKVTGVPGTEF 265 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCHHH
T ss_pred cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCcHHH
Confidence 5432 234568999999999987 6899999999999999999999999975432111 100 111000000
Q ss_pred ---c---------cccccCcc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 749 ---L---------DDLVEGDT--EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 749 ---~---------~~l~~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
+ ..+..... ........+..+.+++.+||+.||.+|||+.|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 00000000 000112346789999999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=323.31 Aligned_cols=198 Identities=27% Similarity=0.351 Sum_probs=166.9
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-cc-----ceeeeeeeeccCCc
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HK-----NLVRLLGFCDEGQN 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~~~~~~~ 594 (814)
.+.+.+.||+|+||+||+|.... .++.||||+++.. .....++..|+.+++.++ |+ +|+++++++...+.
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eEEEEEEEeecCCEEEEEEEEcC---CCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 45667889999999999999864 5688999999743 223456677888877774 44 59999999999999
Q ss_pred eehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC--CCCCeEEeecCCc
Q 042262 595 RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD--DYYNARISDFGLA 670 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~--~~~~~kl~DfGla 670 (814)
.+|||||+. ++|.+++... ..+++..+..++.||+.||+|||.+ ..+|+||||||+|||++ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999996 5999988754 4689999999999999999999953 46899999999999995 5778999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccC
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEM 729 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~ 729 (814)
+..... .....||..|+|||.+.+..++.++|||||||+++||++|+.||....
T Consensus 209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 876432 234568999999999999999999999999999999999999997543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=321.06 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=192.9
Q ss_pred HHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc------cchhhhhceeeEEeec----cccceeeeee
Q 042262 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ------DGEKEFKNEVVVIGQT----HHKNLVRLLG 587 (814)
Q Consensus 518 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~------~~~~~~~~Ei~~l~~l----~H~niv~l~g 587 (814)
....+.+.+.||+|+||.||+|.... .++.||||++..... .....+.+|+.++.++ +|+||+++++
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLT---DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTT---TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEcc---CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34556777899999999999998754 567899999965322 2334577888888888 8999999999
Q ss_pred eeccCCceehhhhh-ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC-CCCCeEEe
Q 042262 588 FCDEGQNRLLVYEF-LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARIS 665 (814)
Q Consensus 588 ~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~ 665 (814)
++.+.+..++|+|| +.+++|.+++.....+++..++.++.||++||+|||+. +|+||||||+||+++ +++.+||+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEE
Confidence 99999999999999 78999999998877899999999999999999999964 999999999999999 88999999
Q ss_pred ecCCcccccccccccccccccCCCCccCcccccCCCCC-CccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHH
Q 042262 666 DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 744 (814)
Q Consensus 666 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 744 (814)
|||+++...... .....|+..|+|||.+.+..+. .++||||||++++||++|+.||..... .
T Consensus 183 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~- 245 (312)
T 2iwi_A 183 DFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------I- 245 (312)
T ss_dssp CCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------H-
T ss_pred EcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------H-
Confidence 999998765432 2345689999999999876664 589999999999999999999963210 0
Q ss_pred hcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 745 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..... ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 LEAEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHTCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhhcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01110 112345678899999999999999999999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=328.34 Aligned_cols=258 Identities=24% Similarity=0.298 Sum_probs=188.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccc-----------hhhhhceeeEEeeccccceeeeeeeec
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG-----------EKEFKNEVVVIGQTHHKNLVRLLGFCD 590 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~l~g~~~ 590 (814)
+.+.+.||+|+||.||+|... .+..||||++....... .+.+.+|++++++++||||+++++++.
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 24 YTVQRFISSGSYGAVCAGVDS----EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp CEEEEEEEEETTEEEEEEECT----TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred eEEeEEeccCCCEEEEEEECC----CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 344578999999999999875 47789999986532221 267899999999999999999999983
Q ss_pred -----cCCceehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEE
Q 042262 591 -----EGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 664 (814)
Q Consensus 591 -----~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl 664 (814)
.....++||||+. |+|.+.+... ..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEE
Confidence 3346799999998 5777777654 578999999999999999999995 59999999999999999999999
Q ss_pred eecCCcccccccccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHH
Q 042262 665 SDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 743 (814)
Q Consensus 665 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 743 (814)
+|||+++....... .....||..|+|||.+.+ ..++.++||||||++++||++|+.||......+. + ......
T Consensus 176 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~-~~i~~~ 249 (362)
T 3pg1_A 176 CDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ--L-NKIVEV 249 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHH
T ss_pred EecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHH
Confidence 99999986543322 234568899999999977 6789999999999999999999999975432111 1 111111
Q ss_pred HhcCCccc-----------cc-------cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 744 YRNGKLDD-----------LV-------EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 744 ~~~~~~~~-----------l~-------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
........ .. ............+..+.+++.+||+.||.+|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 11110000 00 0000011122446789999999999999999999999873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.92 Aligned_cols=262 Identities=22% Similarity=0.253 Sum_probs=184.3
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCc------
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN------ 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------ 594 (814)
.+.+.+.||+|+||.||+|.... .+..||||++... ......+.+|+..+..++||||+++++++.....
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp TEEEC----------CEEEEETT---TCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred ceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 34556789999999999999864 5678999998543 2233456677777888899999999999865433
Q ss_pred -eehhhhhccCCchh---hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCCeEEeecCC
Q 042262 595 -RLLVYEFLNNGTLA---SFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGL 669 (814)
Q Consensus 595 -~~lV~e~~~~gsL~---~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGl 669 (814)
.++||||++++.+. ..+.....+++..+..++.|++.||.|||.+ +.+|+||||||+|||++. ++.+||+|||+
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 78999999875332 2334566789999999999999999999943 459999999999999996 89999999999
Q ss_pred cccccccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc--
Q 042262 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-- 746 (814)
Q Consensus 670 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-- 746 (814)
++....... .....||..|+|||.+.+. .++.++||||||++++||++|+.||........ +... ......
T Consensus 179 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~-~~~~~~~~ 252 (360)
T 3e3p_A 179 AKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEI-VRVLGCPS 252 (360)
T ss_dssp CBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH-HHHHCCCC
T ss_pred ceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHH-HHHcCCCC
Confidence 987654332 2345689999999998765 489999999999999999999999976433211 1111 111000
Q ss_pred ---------CC-ccccccC------cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 747 ---------GK-LDDLVEG------DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 747 ---------~~-~~~l~~~------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.. ....... ..........+.++.+++.+||+.||.+|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 0000000 00011122367899999999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=323.30 Aligned_cols=264 Identities=19% Similarity=0.273 Sum_probs=198.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccC-----Cce
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QNR 595 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 595 (814)
+.+.+.||+|+||.||+|.... .+..||||++.... .....++.+|+.++++++||||+++++++... ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred eEEeeEEcCCCCeEEEEEEECC---CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4556789999999999999864 57899999996432 22345678999999999999999999988654 678
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
++||||+. ++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 99999997 689888865 468999999999999999999995 5999999999999999999999999999987653
Q ss_pred ccccc--------ccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc
Q 042262 676 NQSKA--------IKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 746 (814)
Q Consensus 676 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 746 (814)
..... ......||..|+|||.+.+ ..++.++||||||++++||++|+.||......... .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~ 241 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL---LLIFGIIGT 241 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHhCC
Confidence 32111 0123468999999998764 67899999999999999999999999754322111 111111110
Q ss_pred CCccc------------cc-------cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHcCC
Q 042262 747 GKLDD------------LV-------EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEGV 797 (814)
Q Consensus 747 ~~~~~------------l~-------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~--~L~~~ 797 (814)
..... .. .... .......+.++.+++.+||+.||.+|||+.|+++ .++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CchhccccccccchhhHHhhcccCCCCcch-hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 00000 00 0000 0011245678899999999999999999999988 35544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=323.65 Aligned_cols=240 Identities=24% Similarity=0.429 Sum_probs=198.9
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc------chhhhhceeeEEeecc--ccceeeeeeeecc
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTH--HKNLVRLLGFCDE 591 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~------~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~ 591 (814)
..+.+.+.||+|+||.||+|.... +++.||||+++..... ..+.+.+|+.++++++ |+||+++++++.+
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETT---TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CceEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 345667899999999999998764 5789999999654322 2356778899999986 5999999999999
Q ss_pred CCceehhhhhccC-CchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC-CCCCeEEeecCC
Q 042262 592 GQNRLLVYEFLNN-GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGL 669 (814)
Q Consensus 592 ~~~~~lV~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DfGl 669 (814)
.+..++|+|++.+ ++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++ +++.+||+|||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999986 8999999887889999999999999999999995 5999999999999999 789999999999
Q ss_pred cccccccccccccccccCCCCccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC
Q 042262 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748 (814)
Q Consensus 670 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 748 (814)
++...... .....||..|+|||.+.+..+ +.++||||||++++||++|+.||..... .. .+.
T Consensus 197 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~-~~~ 259 (320)
T 3a99_A 197 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------II-RGQ 259 (320)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HH-HCC
T ss_pred cccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hh-ccc
Confidence 98765332 234568999999999987665 6789999999999999999999963210 00 111
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
. ..+...++++.+++.+||+.||.+|||+.||++
T Consensus 260 ~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 V----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp C----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 112245678999999999999999999999988
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=294.64 Aligned_cols=212 Identities=20% Similarity=0.234 Sum_probs=159.3
Q ss_pred hcCCCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEE
Q 042262 25 QNNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKL 104 (814)
Q Consensus 25 ~~~~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~ 104 (814)
++.++|++|++|++|+. | ++|.|+|||+.++ .+.+ |.. +|+||+|||+. + ..+.|+|
T Consensus 6 ~~~~~i~~g~~L~~g~~---l--~~g~f~l~f~~~g---------nl~l-y~~---~~~vW~an~~~---~--~~~~l~l 62 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQS---L--ELSSFRFTMQSDC---------NLVL-FDS---DVRVWASNTAG---A--TGCRAVL 62 (236)
T ss_dssp CSSSSSCSCSCCCTTCE---E--CSTTEEEEECTTS---------CEEE-EES---SSEEECCCCCS---C--SCCBCCB
T ss_pred eccceeCCCCEECCCCE---E--EcCCEEEEECCCC---------cEEE-EEC---CEEEEECCCCC---C--CCeEEEE
Confidence 45689999999999984 7 5999999998654 1334 432 79999999983 3 5688999
Q ss_pred eecccEEEeCCCCCeEeeeccCCC-ceeEEEEccCcCEEEEecCCcccccccccccCcc----------CCCCcccCC-c
Q 042262 105 TADRGLVLNDPQGKQVWSSKIDIG-TVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTL----------LPGQMMETE-Q 172 (814)
Q Consensus 105 ~~~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTl----------Lpg~~l~~~-~ 172 (814)
+.||||||+|++|++||+|++... +..+|+|+|+|||||++. ++||||||||||+ +|||+++.+ +
T Consensus 63 ~~dGnLvl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~ 139 (236)
T 1dlp_A 63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQ 139 (236)
T ss_dssp CSSSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCC
T ss_pred cCCCcEEEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccc
Confidence 999999999999999999998643 335899999999999954 8999999998665 666666553 4
Q ss_pred eeeecCCCCCCCCCceEEEEecCCceeeeeccCCcccccccceeccccCCCCCCCCcceeeecccccEEEEeccceeeee
Q 042262 173 GLFSRKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDL 252 (814)
Q Consensus 173 ~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (814)
+|+| .+||++|.|+++++++|+++++ +.. ..||++++|+.. ......++.+|.++++..+..++..
T Consensus 140 ~L~s---~~d~s~G~~~l~l~~dG~LvL~--~~~-----~~~W~s~~~~~~----~~~~~~L~~~Gnl~ly~~~~~~vw~ 205 (236)
T 1dlp_A 140 TLHA---TQSLQLSPYRLSMETDCNLVLF--DRD-----DRVWSTNTAGKG----TGCRAVLQPNGRMDVLTNQNIAVWT 205 (236)
T ss_dssp EECS---SCCCBCSSCEEEEETTTEEEEE--BTT-----BCCSCCCCCSSC----SSCEEEEETTTEEEEEETTTEEEEE
T ss_pred eEEc---CcEeecCcEEEEECCCCcEEEE--cCC-----EeEEeCCCcCCC----CceEEEECCCCcEEEEeCCCcEEEE
Confidence 6774 7899999999999999976654 332 478999998542 2233445667776666655554444
Q ss_pred eccccccCCccEEEEEEeeCceEEEEE
Q 042262 253 TTGRVVPAADFYHRATLNFDGVFAQYF 279 (814)
Q Consensus 253 ~~~~~~~~~~~~~r~~L~~dG~lr~y~ 279 (814)
++... .. ..+|++|++||++++|.
T Consensus 206 s~~~~--~~-~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 206 SGNSR--SA-GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp CCCCC--SS-SCCEEEECSSSCEEEEC
T ss_pred eCCCC--CC-CCEEEEEcCCCcEEEeC
Confidence 33221 11 35789999999999983
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.51 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=175.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceee-EEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVV-VIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||.||+|.... .++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHKP---SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEETT---TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhehheeccCCCEEEEEEEEcC---CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 3455789999999999999864 57899999996542 222344555555 677789999999999999999999999
Q ss_pred hhccCCchhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 600 EFLNNGTLASFLFG-----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 600 e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
||+++ +|.+++.. ...+++..+..++.|+++||.|||+. .+|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 77777652 56789999999999999999999952 389999999999999999999999999998765
Q ss_pred ccccccccccccCCCCccCcccc----cCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWF----RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
.... .....||..|+|||.+ .+..++.++||||||++++||++|+.||....... +.. .....+..
T Consensus 178 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~-~~~~~~~~- 247 (327)
T 3aln_A 178 DSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQL-TQVVKGDP- 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC-
T ss_pred cccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHH-HHHhcCCC-
Confidence 4322 2234689999999999 46678999999999999999999999996432110 000 00000111
Q ss_pred ccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 751 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+..........+..+.+++.+||+.||.+|||+.||++
T Consensus 248 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 ----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111122346788999999999999999999999876
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.71 Aligned_cols=251 Identities=27% Similarity=0.379 Sum_probs=191.3
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeecc--------
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-------- 591 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-------- 591 (814)
..+.+.+.||+|+||.||+|.... +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNAL---DSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcC---CCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 345667889999999999999764 5678999998653 3345678999999999999999999998754
Q ss_pred -----CCceehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEe
Q 042262 592 -----GQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 665 (814)
Q Consensus 592 -----~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 665 (814)
.+..++||||+++++|.+++... ..+++..++.++.||++||+|||+ .+|+|+||||+||+++.++.+||+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 45678999999999999999743 467888999999999999999995 599999999999999999999999
Q ss_pred ecCCccccccccc------------ccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcc
Q 042262 666 DFGLAKLLTLNQS------------KAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732 (814)
Q Consensus 666 DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~ 732 (814)
|||+++....... ........||..|+|||.+.+. .++.++||||||++++||++ |+.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-- 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-- 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence 9999987643210 1112345689999999999865 68999999999999999998 4432111
Q ss_pred hhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 733 YAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 733 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.. . ....+..... ..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~~---~-~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 RV---N-ILKKLRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH---H-HHHHHHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH---H-HHHhcccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 00 1 1122222111 1112233455678899999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=322.01 Aligned_cols=254 Identities=24% Similarity=0.302 Sum_probs=193.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCc-----
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN----- 594 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 594 (814)
+.+.+.||+|+||.||+|.+.. .+..||||++.... ....+++.+|+.+++.++||||+++++++.....
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred EEEeeeEecCCCeEEEEEEECC---CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 4556789999999999999864 57899999986532 2234678899999999999999999999987654
Q ss_pred -eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 595 -RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 595 -~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
.++||||+. ++|.+++.. .+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999997 688888753 48999999999999999999995 59999999999999999999999999999865
Q ss_pred cccccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC-----
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG----- 747 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----- 747 (814)
... .....+|..|+|||.+.+ ..++.++||||||++++||++|+.||......+ .+.. ........
T Consensus 177 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~-i~~~~~~~~~~~~ 248 (353)
T 3coi_A 177 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQ-ILKVTGVPGTEFV 248 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHH-HHHHHCBCCHHHH
T ss_pred CCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHHHH
Confidence 432 234568999999999987 678999999999999999999999997543211 1111 11100000
Q ss_pred -------------CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 748 -------------KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 748 -------------~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.+........ .......+.++.+++.+||+.||.+|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 01123557889999999999999999999999873
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=320.72 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=198.3
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccc------eeeeeeeeccC
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN------LVRLLGFCDEG 592 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~ 592 (814)
...+.+.+.||+|+||+||+|..... .+..||||+++.. ....+.+.+|+.++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHAR--GKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCC--CceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 34566778999999999999998643 2478999999753 234567888999999998777 99999999999
Q ss_pred CceehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE--------------
Q 042262 593 QNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL-------------- 656 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll-------------- 656 (814)
+..+|||||+ +++|.+.+... ..+++..+..|+.||++||+||| +.+|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccc
Confidence 9999999999 55666666543 46899999999999999999999 4699999999999999
Q ss_pred -----CCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCc
Q 042262 657 -----DDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 731 (814)
Q Consensus 657 -----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~ 731 (814)
+.++.+||+|||+++..... .....||..|+|||.+.+..++.++||||||++++||++|+.||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999864432 23456899999999999999999999999999999999999999754432
Q ss_pred chhhHHHHHHHHHhcCCccc----------c-ccC---------------------cccccCChhHHHHHHHHHHHcccc
Q 042262 732 EYAILTDWAFDCYRNGKLDD----------L-VEG---------------------DTEAMNDIKCTEKLVMVSIWCIQE 779 (814)
Q Consensus 732 ~~~~l~~~~~~~~~~~~~~~----------l-~~~---------------------~~~~~~~~~~~~~l~~l~~~Cl~~ 779 (814)
..... ..... +.... . ... ..........+..+.+++.+||+.
T Consensus 246 ~~~~~---~~~~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 246 EHLVM---MEKIL--GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp HHHHH---HHHHH--CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred HHHHH---HHHHc--CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 21111 11110 00000 0 000 000112335567899999999999
Q ss_pred CCCCCCCHHHHHH
Q 042262 780 DPSLRPTMRKVSQ 792 (814)
Q Consensus 780 dP~~RPtm~eV~~ 792 (814)
||.+|||+.|+++
T Consensus 321 dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 321 DPAQRITLAEALL 333 (355)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=319.03 Aligned_cols=250 Identities=21% Similarity=0.234 Sum_probs=170.7
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeecc----CCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~ 601 (814)
+.||+|+||+||+|.+.. .++.||||++.... ...+++ ...+..++||||+++++++.. +...++||||
T Consensus 35 ~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~e~---~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 107 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRR---TGQKCALKLLYDSP-KARQEV---DHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107 (336)
T ss_dssp EEEEEETTEEEEEEEETT---TCCEEEEEEEESSH-HHHHHH---HHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeeeeCCCeEEEEEEECC---CCCEEEEEEecCcH-HHHHHH---HHHHHhcCCCChHHHHHHHhhccCCCceEEEEEec
Confidence 469999999999999874 46789999986431 111222 223455789999999999866 4458999999
Q ss_pred ccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCCeEEeecCCccccccc
Q 042262 602 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARISDFGLAKLLTLN 676 (814)
Q Consensus 602 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DfGla~~~~~~ 676 (814)
+++|+|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+||+++. ++.+||+|||+++.....
T Consensus 108 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~ 184 (336)
T 3fhr_A 108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184 (336)
T ss_dssp CTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence 9999999999765 368999999999999999999995 59999999999999986 455999999999865432
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
. .....||..|+|||.+.+..++.++||||||++++||++|+.||.......... ........+. ..
T Consensus 185 ~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~------~~ 251 (336)
T 3fhr_A 185 A----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQ------YG 251 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------C
T ss_pred c----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhccc------cc
Confidence 2 233468999999999998899999999999999999999999996543321100 0000011110 01
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHcCCc
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEGVV 798 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~--~L~~~~ 798 (814)
.........+.++.+++.+||+.||.+|||+.|+++ .+.+..
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 111112356788999999999999999999999998 455533
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=328.61 Aligned_cols=245 Identities=27% Similarity=0.318 Sum_probs=183.1
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhhhcc
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN 603 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 603 (814)
.+.||+|+||+||.+... .++.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..+|||||+.
T Consensus 20 ~~~LG~G~~g~V~~~~~~----~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSF----QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEEEEECSTTCEEEEEES----SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred cCeEeeCCCeEEEEEEEE----CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 467999999999865433 5779999998643 234578899999876 89999999999999999999999995
Q ss_pred CCchhhhhcCCCCC-------CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-------------CCeE
Q 042262 604 NGTLASFLFGNLKP-------SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-------------YNAR 663 (814)
Q Consensus 604 ~gsL~~~l~~~~~l-------~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~-------------~~~k 663 (814)
|+|.+++...... .+..++.|+.||+.||+|||+ .+|+||||||+|||++.+ ..+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999999765332 233457899999999999995 599999999999999654 4899
Q ss_pred EeecCCccccccccccc--ccccccCCCCccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCcCCcccCCcch
Q 042262 664 ISDFGLAKLLTLNQSKA--IKTAIRGTKGYVAPEWFRN-------STITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY 733 (814)
Q Consensus 664 l~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~ 733 (814)
|+|||+++.+....... ......||..|+|||.+.+ ..++.++|||||||+++||++ |+.||........
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 99999999876543221 1234569999999999975 578999999999999999999 9999964432211
Q ss_pred hhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 734 AILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 734 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
... .+... .+..........+.++.+++.+||+.||.+|||+.||++
T Consensus 249 --------~i~-~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 --------NII-RGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --------HHH-HTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HHh-cCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111 11110 011112234567889999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.22 Aligned_cols=249 Identities=21% Similarity=0.311 Sum_probs=176.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc-c-hhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD-G-EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~-~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||.||+|.+.. .+..||||++...... . .+.+.++..+++.++||||+++++++.+++..++||
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRK---TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp EEEEEEC------CEEEEEETT---TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccceeeecCCeeEEEEEEec---CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 4556789999999999999864 4678999999653221 1 233445555677789999999999999999999999
Q ss_pred hhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+ ++.+..+... ...+++..+..++.||++||+|||+. .+|+|+||||+||+++.++.+||+|||++........
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 999 4455554433 46789999999999999999999951 3899999999999999999999999999987654322
Q ss_pred ccccccccCCCCccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
.....||..|+|||.+. ...++.++||||||++++||++|+.||....... ....... .+....+
T Consensus 181 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~-~~~~~~~- 250 (318)
T 2dyl_A 181 ---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVL-QEEPPLL- 250 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHH-HSCCCCC-
T ss_pred ---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHh-ccCCCCC-
Confidence 23446899999999994 5568899999999999999999999997533211 1111111 1111111
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
......+.++.+++.+||+.||.+|||+.||++
T Consensus 251 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 ------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 112245678999999999999999999999876
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=337.06 Aligned_cols=256 Identities=26% Similarity=0.297 Sum_probs=196.6
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeecc------C
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------G 592 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~ 592 (814)
..+.+.+.||+|+||.||+|.+.. .+..||||+++.. .....+.+.+|++++++++||||+++++++.. +
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~---tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQD---TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTT---TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 456777899999999999998764 5678999998653 23345678999999999999999999999866 6
Q ss_pred CceehhhhhccCCchhhhhcCCC---CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC---eEEee
Q 042262 593 QNRLLVYEFLNNGTLASFLFGNL---KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN---ARISD 666 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~D 666 (814)
+..++||||+++++|.+++.... .+++..++.|+.||+.||+|||+ .+|+||||||+||+++.++. +||+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 77899999999999999997643 58999999999999999999995 59999999999999997665 99999
Q ss_pred cCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHH---
Q 042262 667 FGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC--- 743 (814)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~--- 743 (814)
||+++....... .....||..|+|||.+.+..++.++||||||++++||++|+.||....... .|....
T Consensus 168 FG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~ 239 (676)
T 3qa8_A 168 LGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREK 239 (676)
T ss_dssp CCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC--
T ss_pred cccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcc
Confidence 999987654332 234568999999999999999999999999999999999999996532110 000000
Q ss_pred -----HhcCCccccc----cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHH
Q 042262 744 -----YRNGKLDDLV----EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRK 789 (814)
Q Consensus 744 -----~~~~~~~~l~----~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~e 789 (814)
.......... ............+..+.+++..||+.||.+|||+.|
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000000000 001112234467899999999999999999999977
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=321.54 Aligned_cols=246 Identities=25% Similarity=0.305 Sum_probs=182.3
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+...+.||+|+||+|+..... +++.||||++... ....+.+|+.+++++ +||||+++++++.+.+..+||||
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~----~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMF----DNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEES----SSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EecCCeeecCcCEEEEEEEEe----CCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 344578999999996543332 4678999998643 234567889999988 79999999999999999999999
Q ss_pred hccCCchhhhhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-----CCCeEEeecCCccccc
Q 042262 601 FLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-----YYNARISDFGLAKLLT 674 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DfGla~~~~ 674 (814)
|+. |+|.+++.... .+....+..++.||++||+|||+ .+|+||||||+|||++. ...+||+|||+++...
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 996 69999987653 45555678999999999999995 59999999999999953 3468899999998775
Q ss_pred ccccc-cccccccCCCCccCccccc---CCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCc
Q 042262 675 LNQSK-AIKTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKL 749 (814)
Q Consensus 675 ~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 749 (814)
..... .......||..|+|||.+. ...++.++|||||||+++||++ |+.||....... ..........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~~ 247 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACSL 247 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCCc
Confidence 43221 1234467999999999997 4567889999999999999999 999985432211 0111111111
Q ss_pred cccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 750 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
. . ..........+.+++.+||+.||.+|||+.||++
T Consensus 248 ~-~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 D-C------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp T-T------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-c------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1 0 1112345677889999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=338.90 Aligned_cols=240 Identities=21% Similarity=0.294 Sum_probs=191.2
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCc----
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN---- 594 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---- 594 (814)
..+.+.+.||+|+||.||+|.+... +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNV--NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGG--TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCC--CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3466678899999999999998642 36789999986432 2334578899999999999999999999987665
Q ss_pred -eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 595 -RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 595 -~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
.+|||||+++++|.+++.. .+++..++.|+.||++||.|||+ .+|+||||||+|||++++ .+||+|||+++..
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 6999999999999998765 78999999999999999999995 599999999999999986 9999999999876
Q ss_pred cccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
... ....||.+|+|||.+.+.. +.++||||||++|+||++|..|+....... +.
T Consensus 232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------~~ 285 (681)
T 2pzi_A 232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------LP 285 (681)
T ss_dssp TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------CC
T ss_pred ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------cc
Confidence 432 3456999999999997654 889999999999999999998875321110 00
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCC-CHHHHHHHHcCC
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRP-TMRKVSQMLEGV 797 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-tm~eV~~~L~~~ 797 (814)
........+..+.+++.+||+.||.+|| +++++.+.|.++
T Consensus 286 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 ----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0011123456889999999999999999 566676666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-33 Score=298.97 Aligned_cols=230 Identities=13% Similarity=0.060 Sum_probs=182.1
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc---chhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+.+.+.||+|+||.||+|.+.. .++.||||++...... ..+++.+|+.++.+++||||+++++++.+.+..+|
T Consensus 32 ~y~i~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 32 RYRLLIFHGGVPPLQFWQALDTA---LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TEEEEEEEEBSTTCEEEEEEETT---TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cEEEEEEEcccCCeEEEEEEecC---CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 35566889999999999999864 4789999999754322 23678999999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+++++|.+++... ....+..+|+.||++||+|||+ .+|+||||||+|||+++++.+||++++
T Consensus 109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 99999999999999653 4566788999999999999995 599999999999999999999997543
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
|++ .++.++||||||+++|||++|+.||........... .........
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~~ 222 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQP 222 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSCB
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccCC
Confidence 333 368899999999999999999999975433210000 000000000
Q ss_pred --cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 758 --EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 758 --~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
........+.++.+++.+||+.||.+| |+.|+++.|+.+...
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 011123566889999999999999999 999999999775543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=294.87 Aligned_cols=230 Identities=22% Similarity=0.300 Sum_probs=177.4
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEE-eeccccceeeeeeeecc----CCceehhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI-GQTHHKNLVRLLGFCDE----GQNRLLVYE 600 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~~lV~e 600 (814)
+.||+|+||.||++.... .++.||||+++. ...+.+|+.++ +..+||||+++++++.. ....+||||
T Consensus 24 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKR---TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp EEEEEETTEEEEEEEETT---TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cccccCCCeEEEEEEEcC---CCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 679999999999999864 567999999864 24566777777 55699999999999876 677899999
Q ss_pred hccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCCeEEeecCCcccccc
Q 042262 601 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARISDFGLAKLLTL 675 (814)
Q Consensus 601 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DfGla~~~~~ 675 (814)
|+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++...
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 99999999999764 368999999999999999999995 59999999999999998 7889999999986532
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
+..++.++||||||++++||++|+.||........ ...........
T Consensus 172 -----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~~~~ 217 (299)
T 3m2w_A 172 -----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRIRMG 217 (299)
T ss_dssp -----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTT
T ss_pred -----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHHhhc
Confidence 23467899999999999999999999964432110 00000111110
Q ss_pred cc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHcCCcCCC
Q 042262 756 DT--EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEGVVEVD 801 (814)
Q Consensus 756 ~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~--~L~~~~~~~ 801 (814)
.. ........+.++.+++.+||+.||.+|||+.|+++ .+.+....+
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 00 00011245788999999999999999999999998 344444333
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-33 Score=312.17 Aligned_cols=234 Identities=15% Similarity=0.104 Sum_probs=173.0
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccc-cceeeee-------------
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHH-KNLVRLL------------- 586 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H-~niv~l~------------- 586 (814)
..+.||+|+||+||+|.+.. .++.||||++..... ...+.+++|+.++..++| +|.....
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEETTEEEEEEEETT---TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred EecccccCCCEEEEEEEecC---CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 34689999999999999864 467999999873322 235678899999888876 3221111
Q ss_pred --------eeecc-----CCceehhhhhccCCchhhhhc------C-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 042262 587 --------GFCDE-----GQNRLLVYEFLNNGTLASFLF------G-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIH 646 (814)
Q Consensus 587 --------g~~~~-----~~~~~lV~e~~~~gsL~~~l~------~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 646 (814)
.++.. ....+++|++ .+++|.+++. . ...+++..++.|+.||++||+|||+ .+|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred cCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccc
Confidence 11111 1234555554 4688988873 1 2346788999999999999999995 59999
Q ss_pred cCCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccc----------cCCCCCCccchhhHHHHHH
Q 042262 647 CDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF----------RNSTITAKVDVYSFGVLLL 716 (814)
Q Consensus 647 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~k~DV~S~Gvvl~ 716 (814)
|||||+||||+.++.+||+|||+++..... .....| ..|+|||.+ .+..++.++|||||||++|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999999999999999875433 234457 999999999 5667889999999999999
Q ss_pred HHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 042262 717 EIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVS 791 (814)
Q Consensus 717 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~ 791 (814)
||++|+.||........ ....+.. ....++.+.+++..||+.||++|||+.|++
T Consensus 309 elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHSSCCCCTTGGGSC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHCCCCCCCcchhhh---------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999975432110 1111110 113457899999999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-33 Score=302.29 Aligned_cols=241 Identities=15% Similarity=0.125 Sum_probs=181.4
Q ss_pred HHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--------cchhhhhceeeEEeecc------------
Q 042262 519 EATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--------DGEKEFKNEVVVIGQTH------------ 578 (814)
Q Consensus 519 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--------~~~~~~~~Ei~~l~~l~------------ 578 (814)
...+.+.+.||+|+||+||+|.. .++.||||+++.... ...+.+.+|+.++++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccchheeeecccCceEEEEEEe-----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 45677889999999999999987 358999999975421 12266888888888886
Q ss_pred --------------ccceeeeeeeecc-------------CCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHH
Q 042262 579 --------------HKNLVRLLGFCDE-------------GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 631 (814)
Q Consensus 579 --------------H~niv~l~g~~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~ 631 (814)
||||+++++++.+ .+..+|||||+++|++.+.+.. ..+++..++.|+.||+.
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTA 172 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHH
Confidence 4555555555543 6789999999999977666644 56799999999999999
Q ss_pred HHHHhh-hcCCCCeeecCCCCCcEEECCCC--------------------CeEEeecCCcccccccccccccccccCCCC
Q 042262 632 GLLYLH-EDCSAQIIHCDIKPQNILLDDYY--------------------NARISDFGLAKLLTLNQSKAIKTAIRGTKG 690 (814)
Q Consensus 632 gL~yLH-~~~~~~iiH~Dikp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 690 (814)
||+||| +. +|+||||||+|||++.++ .+||+|||+++.... ....||..
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDV 242 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCC
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeec
Confidence 999999 64 899999999999999887 899999999987653 23468999
Q ss_pred ccCcccccCCCCCCccchhhHHHH-HHHHHhCCcCCcccCCcchhhHHHHHHHHHh-cCCccccccCcccccCChhHHHH
Q 042262 691 YVAPEWFRNSTITAKVDVYSFGVL-LLEIISCRKSFDIEMGEEYAILTDWAFDCYR-NGKLDDLVEGDTEAMNDIKCTEK 768 (814)
Q Consensus 691 y~aPE~~~~~~~t~k~DV~S~Gvv-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~ 768 (814)
|+|||.+.+.. +.++||||++++ .+++++|..||.... .+ ....+.+. ..... ...........+.+
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----~~-~~~~~~~~~~~~~~----~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-----WL-HYLTDKMLKQMTFK----TKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-----HH-HHHHHHHHHTCCCS----SCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-----hh-hHHHHhhhhhhccC----cccchhhhhhcCHH
Confidence 99999998776 899999998777 778889999884210 00 00111111 11111 11111123467889
Q ss_pred HHHHHHHccccCCCCCCCHHHHH
Q 042262 769 LVMVSIWCIQEDPSLRPTMRKVS 791 (814)
Q Consensus 769 l~~l~~~Cl~~dP~~RPtm~eV~ 791 (814)
+.+|+.+||+.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999976 899887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.5e-28 Score=279.88 Aligned_cols=186 Identities=19% Similarity=0.101 Sum_probs=130.6
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEeecccc----------ccchhhhhceeeEEeec-cccceeeeeeeeccCCce
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF----------QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~----------~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 595 (814)
.++.|++|.+.++.-.. .++.++||.+.... +...++|.+|+++|+++ +|+||+++++++++++..
T Consensus 241 ~~~~~~~~~h~~~rr~~---fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYF---FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp C-C--------CCEEEE---ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred ccccCCccccccccccc---ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 45566666655544332 35678999885421 12235699999999999 799999999999999999
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
||||||++|++|.++|.....++.. +|+.||+.||+|||+ .+||||||||+||||++++.+||+|||+++....
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999999988877754 589999999999995 5999999999999999999999999999987754
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcC
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS 724 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p 724 (814)
+... .....||++|+|||.+.+ .+..++|+||+|++++++.++..+
T Consensus 392 ~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 4322 345679999999999976 467789999999999888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-24 Score=249.83 Aligned_cols=183 Identities=19% Similarity=0.250 Sum_probs=144.8
Q ss_pred hccccccceeEEEEEEEeccCCcceEEEEEeeccccc--------cchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 525 ~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
.+.||+|+||.||+|.. .+..+++|+...... ...+++.+|++++++++||||+++..++...++.+
T Consensus 341 ~~~LG~G~fg~Vy~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp -------CCEEEEEEEC-----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred CCEEeeCCCEEEEEEEE-----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 46899999999999944 356788887643211 11345899999999999999997777776778889
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||||+++++|.+++.. +..|+.|+++||+|||+ .+|+||||||+|||+++ .+||+|||+++.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999999876 56899999999999995 59999999999999999 9999999999987654
Q ss_pred cccc-----ccccccCCCCccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCC
Q 042262 677 QSKA-----IKTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSF 725 (814)
Q Consensus 677 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~Gvvl~elltG~~p~ 725 (814)
.... ......||..|+|||++.. ..|+.++|+|+..+-.++-+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3221 1235679999999999987 56888999999999888888777665
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.8e-19 Score=159.29 Aligned_cols=103 Identities=21% Similarity=0.404 Sum_probs=87.6
Q ss_pred CCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEeec
Q 042262 28 GTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTAD 107 (814)
Q Consensus 28 ~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~~ 107 (814)
++|.+||.|.+|+. |+| |.|.|.|...| .|.++. ..++||+||++ .+....+.|+|+.|
T Consensus 2 n~L~~g~~L~~g~~---L~s--g~y~l~~q~Dg---------NLvly~----~~~~vW~ant~---~~~~~~~~L~l~~d 60 (105)
T 4h3o_A 2 NILDNNEGLYAGQS---LDV--EPYHFIMQDDC---------NLVLYD----HSTSTWASNTE---IGGKSGCSAVLQSD 60 (105)
T ss_dssp CEECTTEEECTTCE---EEE--TTEEEEECTTS---------CEEEEE----TTEEEEECCCC---CTTCCSCEEEECTT
T ss_pred CCcCCCCEEcCCCE---EEE--CCEEEEECCCC---------eEEEEE----CCEEEEEecCC---CCCCccEEEEEeCC
Confidence 67899999999985 887 88999998765 477764 35899999998 45566789999999
Q ss_pred ccEEEeCCCCCeEeeeccCCC-ceeEEEEccCcCEEEEecCCcccccc
Q 042262 108 RGLVLNDPQGKQVWSSKIDIG-TVAIGVMNDTGNFVLASSSSSKLWDS 154 (814)
Q Consensus 108 g~l~l~~~~~~~~wst~~~~~-~~~~~~l~~~GNlvl~~~~~~~~WQS 154 (814)
|||||+|++|++||+|+++.. ...+|+|+|+|||||++. .||||
T Consensus 61 GnLvL~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 61 GNFVVYDSSGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp SCEEEECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred ccEEEECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 999999999999999998654 346899999999999964 59998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.80 E-value=2.8e-19 Score=161.81 Aligned_cols=107 Identities=19% Similarity=0.263 Sum_probs=90.5
Q ss_pred hcCCCCCCCceeecCCCCCcee--cCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEE
Q 042262 25 QNNGTVPVGATLTAGTNSSPWV--SPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQV 102 (814)
Q Consensus 25 ~~~~~~~~~~~l~~~~~~~~lv--s~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l 102 (814)
++.++|.+|++|.+|+. |+ |++|.|+|+|+.+| + | +||++ +++||+||++. + +.++.|
T Consensus 6 ~~~~~l~~g~~L~~g~~---l~~~S~~g~~~L~~~~dg-------n--l-vly~~---~~~vW~sn~~~---~-~~~~~l 65 (119)
T 1b2p_A 6 SKQPDDNHPQILHATES---LEILFGTHVYRFIMQTDC-------N--L-VLYDN---NNPIWATNTGG---L-GNGCRA 65 (119)
T ss_dssp CSCSSSCCCCEEETTCE---EEEEETTEEEEEEECTTS-------C--E-EEEET---TEEEEECCCTT---S-CSSCEE
T ss_pred ecCcccCCCCEEcCCCE---EEEeCCCCCEEEEEecCC-------C--E-EEEEC---CEEEEeCCCcc---C-CCceEE
Confidence 35689999999999995 99 99999999999765 1 2 57875 79999999982 2 345789
Q ss_pred EEeecccEEEeCCCCCeEeeeccCCC-ceeEEEEccCcCEEEEecCCcccccc
Q 042262 103 KLTADRGLVLNDPQGKQVWSSKIDIG-TVAIGVMNDTGNFVLASSSSSKLWDS 154 (814)
Q Consensus 103 ~~~~~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~~~GNlvl~~~~~~~~WQS 154 (814)
+|..||||||+|.+|.+||+|++... +..+++|+|+|||||++ .++|||
T Consensus 66 ~l~~dGNLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 66 VLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp EECTTSCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred EEccCCEEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 99999999999999999999997643 35689999999999997 379998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.6e-19 Score=159.97 Aligned_cols=109 Identities=16% Similarity=0.331 Sum_probs=91.0
Q ss_pred CCCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEee
Q 042262 27 NGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTA 106 (814)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~ 106 (814)
+|+|.+||.|.+|+. |+ ++|.|+|+|+..| .| |+|+ ..++||.||++. + ..++.++|..
T Consensus 1 ~d~l~~g~~L~~g~~---l~-~~~~~~l~~~~dG---------nl-vl~~---~~~~vW~sn~~~---~-~~~~~l~l~~ 59 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHS---LE-VGPSYRLIMQGDC---------NF-VLYD---SGKPVWASNTGG---L-GSGCRLTLHN 59 (110)
T ss_dssp CCEEETTCEECTTCE---EE-ETTTEEEEECTTS---------CE-EEEE---TTEEEEECCCTT---S-CSSCEEEECT
T ss_pred CCEeCCCCEECCCCE---EE-ECCCEEEEEcCCC---------cE-EEEE---CCEEEEECCCCC---C-CCcEEEEEeC
Confidence 378999999999985 99 9999999998765 13 5676 379999999973 2 2457899999
Q ss_pred cccEEEeCCCCCeEeeeccCCCc-eeEEEEccCcCEEEEecCCccccccccccc
Q 042262 107 DRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSFTNPS 159 (814)
Q Consensus 107 ~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~~~GNlvl~~~~~~~~WQSFD~Pt 159 (814)
||||||+|.+|.++|+|.+.... ..+++|+|+|||||++. .+||||+||.
T Consensus 60 dGNLVl~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 60 NGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred CCCEEEECCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 99999999999999999987543 35799999999999975 7999999983
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-20 Score=199.60 Aligned_cols=142 Identities=13% Similarity=0.088 Sum_probs=113.2
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeeccccc------------------cchhhhhceeeEEeeccccceeee
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ------------------DGEKEFKNEVVVIGQTHHKNLVRL 585 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~niv~l 585 (814)
+.+.||+|+||.||+|.. . .+..||||.++.... .....+.+|+.++++++ | +++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~---~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-E---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-T---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred ecCEeccCCCceEEEEEe-C---CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 347899999999999998 2 578999999964221 12346889999999998 4 666
Q ss_pred eeeeccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEe
Q 042262 586 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 665 (814)
Q Consensus 586 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 665 (814)
.+++.. +..++||||+++++|.+ +.. .....++.||++||.|||+ .+|+||||||+|||++ ++.+||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEEC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEE
Confidence 665533 56799999999999998 422 2345799999999999995 5999999999999999 9999999
Q ss_pred ecCCcccccccccccccccccCCCCccCcccccC
Q 042262 666 DFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRN 699 (814)
Q Consensus 666 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 699 (814)
|||+++.. ..+.|||++..
T Consensus 235 DFG~a~~~---------------~~~~a~e~l~r 253 (282)
T 1zar_A 235 DFPQSVEV---------------GEEGWREILER 253 (282)
T ss_dssp CCTTCEET---------------TSTTHHHHHHH
T ss_pred ECCCCeEC---------------CCCCHHHHHHH
Confidence 99999742 34788998753
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-18 Score=155.77 Aligned_cols=109 Identities=21% Similarity=0.360 Sum_probs=89.7
Q ss_pred CCCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEee
Q 042262 27 NGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTA 106 (814)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~ 106 (814)
.|+|.+||+|.++++ |+ +|.|+|+|+.+| ++. +|+ ..++||+||++. + ..++.|+|+.
T Consensus 2 ~dtl~~gq~L~~g~~---L~--~g~~~L~~~~dg-------nlv---ly~---~~~~vW~sn~~~---~-~~~~~l~l~~ 59 (115)
T 2dpf_A 2 DNVLLSGQTLHADHS---LQ--AGAYTLTIQNKC-------NLV---KYQ---NGRQIWASNTDR---R-GSGCRLTLLS 59 (115)
T ss_dssp CCEEETTCEEETTEE---EE--ETTEEEEECTTS-------CEE---EEE---TTEEEEECSCTT---S-CSSCEEEECT
T ss_pred CCEeCCCCEECCCCE---EE--CCCEEEEEcCCC-------cEE---EEe---CCEEEEeCCCCC---C-CCceEEEECC
Confidence 479999999999885 88 899999998654 232 365 379999999983 2 2467899999
Q ss_pred cccEEEeCCCCCeEeeeccCCC-ceeEEEEccCcCEEEEecCCcccccccccccC
Q 042262 107 DRGLVLNDPQGKQVWSSKIDIG-TVAIGVMNDTGNFVLASSSSSKLWDSFTNPSD 160 (814)
Q Consensus 107 ~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtD 160 (814)
||||||+|.++.+||+|++... +..+++|+|+|||||++. .+||||.+++.
T Consensus 60 ~GnLvl~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 60 DGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred CCcEEEECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 9999999998999999998643 345799999999999964 89999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.2e-18 Score=154.74 Aligned_cols=109 Identities=20% Similarity=0.436 Sum_probs=90.2
Q ss_pred CCCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEee
Q 042262 27 NGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTA 106 (814)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~ 106 (814)
+|||.+||+|.+|++ | ++|.|+|+|+.+|. | ++|++ .++||+||+.. ...++.++|..
T Consensus 1 tdtl~~gq~L~~g~~---L--~~~~~~L~~~~dgn---------l-vl~~~---~~~vW~sn~~~----~~~~~~l~l~~ 58 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGS---L--AEGGYLFIIQNDCN---------L-VLYDN---NRAVWASGTNG----KASGCVLKMQN 58 (112)
T ss_dssp CCEEETTEEECTTCE---E--EETTEEEEECTTSC---------E-EEEET---TEEEEECCCTT----SCSSEEEEECT
T ss_pred CCCCCCCCEECCCCE---E--eCCCEEEEEcCCCc---------E-EEEEC---CEEEEeCCCcC----CCCCEEEEEeC
Confidence 478999999999984 7 58999999998761 2 35764 68999999872 13467899999
Q ss_pred cccEEEeCCCCCeEeeeccCCC-ceeEEEEccCcCEEEEecCCcccccccccc
Q 042262 107 DRGLVLNDPQGKQVWSSKIDIG-TVAIGVMNDTGNFVLASSSSSKLWDSFTNP 158 (814)
Q Consensus 107 ~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~~~GNlvl~~~~~~~~WQSFD~P 158 (814)
||||||+| ++.++|+|.+... +..+++|+++|||||++..+.++||||+|.
T Consensus 59 ~GNLvl~d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 59 DGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp TSCEEEEE-TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred CCCEEEEc-CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 99999999 8889999987643 345799999999999987788999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=4e-17 Score=145.63 Aligned_cols=103 Identities=20% Similarity=0.397 Sum_probs=84.6
Q ss_pred CCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEeec
Q 042262 28 GTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTAD 107 (814)
Q Consensus 28 ~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~~ 107 (814)
+||.+||.|.+|+. |+ +|.|+|+|+.+| + |.+ |.. .++||.+|+.. + +.++.|+|..|
T Consensus 2 ntL~~gq~L~~g~~---L~--~g~~~L~~q~dG-------n--Lvl-y~~---~~~vW~snt~~---~-~~~~~l~l~~d 59 (109)
T 3dzw_A 2 NILYSGETLSPGEF---LN--NGRYVFIMQEDC-------N--LVL-YDV---DKPIWATNTGG---L-DRRCHLSMQSD 59 (109)
T ss_dssp CEEETTEEECTTCE---EE--ETTEEEEECTTS-------C--EEE-EET---TEEEEECCCTT---S-SSSCEEEECTT
T ss_pred CCcCCCCEeCCCCE---EE--CCCEEEEEcCCC-------c--EEE-EeC---CEEEEECCccc---C-CCCEEEEEeCC
Confidence 68999999999885 76 799999998765 2 333 654 58999999873 2 34578999999
Q ss_pred ccEEEeCCCCCeEeeeccCCCc-eeEEEEccCcCEEEEecCCccccccc
Q 042262 108 RGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSF 155 (814)
Q Consensus 108 g~l~l~~~~~~~~wst~~~~~~-~~~~~l~~~GNlvl~~~~~~~~WQSF 155 (814)
|||||+|.++.++|+|++.... ..+|+|+|+|||||++. .+|||=
T Consensus 60 GNLvl~~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~ 105 (109)
T 3dzw_A 60 GNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWATG 105 (109)
T ss_dssp SCEEEECTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCCC
T ss_pred CCEEEECCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCC
Confidence 9999999999999999986544 36899999999999985 799983
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=4e-17 Score=170.26 Aligned_cols=137 Identities=17% Similarity=0.133 Sum_probs=102.9
Q ss_pred hhhccccccceeEEEEEEEeccCCcceE--EEEEeecccccc------------------------chhhhhceeeEEee
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTA--VAVKKLDRVFQD------------------------GEKEFKNEVVVIGQ 576 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~--vaVK~l~~~~~~------------------------~~~~~~~Ei~~l~~ 576 (814)
.+.+.||+|+||.||+|.... ++.. ||||+++..... ....+.+|+.++.+
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~---~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVF---DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEE---TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcC---CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 345789999999999999843 4667 999987532111 01257889999999
Q ss_pred ccccce--eeeeeeeccCCceehhhhhccC-C----chhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 042262 577 THHKNL--VRLLGFCDEGQNRLLVYEFLNN-G----TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDI 649 (814)
Q Consensus 577 l~H~ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Di 649 (814)
++|+++ ..++.+ +..+|||||+.+ | +|.++... .++.....++.|++++|.|||. ..+|+||||
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl 197 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQ--EAELVHADL 197 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence 988864 344432 467899999952 4 56655432 2345678899999999999993 249999999
Q ss_pred CCCcEEECCCCCeEEeecCCcccc
Q 042262 650 KPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 650 kp~NIll~~~~~~kl~DfGla~~~ 673 (814)
||+|||+++ .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999764
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.63 E-value=5.2e-16 Score=138.33 Aligned_cols=104 Identities=15% Similarity=0.242 Sum_probs=83.3
Q ss_pred hcCCCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEE
Q 042262 25 QNNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKL 104 (814)
Q Consensus 25 ~~~~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~ 104 (814)
.+.|+|.+||.|.+|+. |+| |.|.|-|...| .|.+ |.. ++||.+|+.. .+.++.|+|
T Consensus 4 ~~~dtL~~gq~L~~g~~---L~s--g~~~L~~q~dG---------nLvl-~~~----~~vW~snt~~----~~~~~~l~l 60 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGR---LTA--KNHQLVMQGDC---------NLVL-YGG----KYGWQSNTHG----NGEHCFLRL 60 (110)
T ss_dssp CBTTEEETTCEEETTEE---EEC--SSCEEEECTTS---------CEEE-ECS----SSCEECCCTT----SSSSCEEEE
T ss_pred cccCEECCCCEecCCCE---EEe--CCEEEEEcCCC---------eEEE-ECC----eEEEECCCcC----CCcCEEEEE
Confidence 36799999999999985 987 55999775443 2555 654 4899999873 234578999
Q ss_pred eecccEEEeCCCCCeEeeeccCCC-ceeEEEEccCcCEEEEecCCcccccc
Q 042262 105 TADRGLVLNDPQGKQVWSSKIDIG-TVAIGVMNDTGNFVLASSSSSKLWDS 154 (814)
Q Consensus 105 ~~~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~~~GNlvl~~~~~~~~WQS 154 (814)
..||||||+|.+|.++|+|++... +..+|+|+|+|||||++ ..||+|
T Consensus 61 ~~dGNLvl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 61 NHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp CTTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred eCCCcEEEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 999999999999999999998643 33689999999999997 479987
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=4.2e-16 Score=139.13 Aligned_cols=89 Identities=22% Similarity=0.356 Sum_probs=74.6
Q ss_pred CCCcEEEEeecccEEEeCCCCCeEeeeccCCCc-eeEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCceee
Q 042262 97 PRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLF 175 (814)
Q Consensus 97 ~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L~ 175 (814)
+...+|.|+.||||||++ .+++||++++...+ ..+++|+++|||||++.++.+|||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~-------------------- 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTK-------------------- 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECC--------------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecC--------------------
Confidence 345789999999999998 57899999986543 36899999999999998889999999
Q ss_pred ecCCCCCCCCCceEEEEecCCceeeeeccCCcccccccceecccc
Q 042262 176 SRKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTY 220 (814)
Q Consensus 176 S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~ 220 (814)
+++++|.|++.++++|+++++. . .||+++++
T Consensus 78 -----t~~~~g~~~l~l~~dGnlvl~~--~-------~~W~S~~~ 108 (110)
T 3a0c_A 78 -----TNGKEDHYVLVLQQDRNVVIYG--P-------VVWATGSG 108 (110)
T ss_dssp -----CCCSSSCCEEEECTTSCEEEEC--S-------EEEECSCC
T ss_pred -----CCCCCCCEEEEEeCCccEEEEC--C-------CEecCCCc
Confidence 3557899999999999977742 1 58998765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1e-15 Score=137.32 Aligned_cols=92 Identities=27% Similarity=0.386 Sum_probs=76.7
Q ss_pred CCcEEEEeecccEEEeCCCCCeEeeeccCCCc-eeEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCceeee
Q 042262 98 RGSQVKLTADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFS 176 (814)
Q Consensus 98 ~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L~S 176 (814)
...+|.|+.||+|+|++. +++||++++...+ ..+++|+++|||||++ ++.++||||+
T Consensus 19 ~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~-------------------- 76 (112)
T 1xd5_A 19 GGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT-------------------- 76 (112)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC--------------------
T ss_pred CCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc--------------------
Confidence 457899999999999987 7899999986533 4689999999999999 7789999994
Q ss_pred cCCCCCCCCCceEEEEecCCceeeeeccCCcccccccceeccccCC
Q 042262 177 RKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDS 222 (814)
Q Consensus 177 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~~~ 222 (814)
+|++|.|++.++++|+++++.. .. .+||++++|++
T Consensus 77 -----~~~~g~~~l~l~~dGnlvl~~~-~~-----~~~W~S~~~~g 111 (112)
T 1xd5_A 77 -----NRQNGNYYLILQRDRNVVIYDN-SN-----NAIWATHTNVG 111 (112)
T ss_dssp -----CCSCCCCEEEECTTSCEEEECT-TS-----CEEEECCCCCC
T ss_pred -----cCCCCCEEEEEeCCCcEEEECC-CC-----ceEEECCCccC
Confidence 4578999999999999877632 12 57899999965
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.60 E-value=3.7e-15 Score=133.61 Aligned_cols=106 Identities=11% Similarity=0.170 Sum_probs=85.9
Q ss_pred cCCCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEe
Q 042262 26 NNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLT 105 (814)
Q Consensus 26 ~~~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~ 105 (814)
+.++|.+||.|.+++. |. +|.|.|-|...| .|.++..+ ..++||.+|+.. + ..++.|.|.
T Consensus 5 ~~~tL~~gq~L~~g~~---L~--~g~~~L~~q~dG---------NLvL~~~~--~~~~vWssnt~~---~-~~~~~l~l~ 64 (113)
T 3mez_B 5 VRNVLFSSQVMYDNAQ---LA--TRDYSLVMRDDC---------NLVLTKGS--KTNIVWESGTSG---R-GQHCFMRLG 64 (113)
T ss_dssp CSSEEETTCEEETTCE---EE--ETTEEEEECTTS---------CEEEEETT--TTEEEEECCCTT---S-CSSCEEEEC
T ss_pred cCCEeCCCCEECCCCE---eE--cCCEEEEEcCCC---------EEEEEECC--CCEEEEECCccc---C-CcCEEEEEe
Confidence 4689999999999884 76 488999997655 37775321 368999999873 2 245789999
Q ss_pred ecccEEEeCCCCCeEeeeccCCC-ceeEEEEccCcCEEEEecCCcccccc
Q 042262 106 ADRGLVLNDPQGKQVWSSKIDIG-TVAIGVMNDTGNFVLASSSSSKLWDS 154 (814)
Q Consensus 106 ~~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~~~GNlvl~~~~~~~~WQS 154 (814)
.||||||+|.+++++|+|++... +..+|+|+|+|||||++ ..||+|
T Consensus 65 ~dGNLVl~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 65 HSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp TTSCEEEECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred CCCcEEEECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 99999999999999999998643 33689999999999997 579987
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.58 E-value=3.2e-15 Score=135.14 Aligned_cols=86 Identities=21% Similarity=0.337 Sum_probs=73.1
Q ss_pred CcEEEEeecccEEEeCCCCCeEeeeccCCCc-eeEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCceeeec
Q 042262 99 GSQVKLTADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSR 177 (814)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L~S~ 177 (814)
...|.|..||||+|++. +++||++++...+ ...++|+|+|||||++.++++|||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~---------------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP---------------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS----------------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC----------------------
Confidence 46789999999999987 7899999986543 36899999999999999899999999
Q ss_pred CCCCCCCCCceEEEEecCCceeeeeccCCcccccccceeccc
Q 042262 178 KSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGT 219 (814)
Q Consensus 178 ~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~ 219 (814)
+||++|.|+++++++|+++++. ..||++++
T Consensus 88 ---~~~~~g~~~l~l~~~Gnlvl~~---------~~~W~Sg~ 117 (119)
T 1b2p_A 88 ---VAGKAGHYVLVLQPDRNVVIYG---------DALWATQT 117 (119)
T ss_dssp ---CCCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred ---CCCCCCCEEEEEECCCcEEEEC---------ccEeCCCC
Confidence 4567899999999999977653 25899875
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=8.8e-15 Score=131.82 Aligned_cols=89 Identities=20% Similarity=0.380 Sum_probs=75.2
Q ss_pred CcEEEEeecccEEEeCCCCCeEeeeccCCCc-eeEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCceeeec
Q 042262 99 GSQVKLTADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSR 177 (814)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L~S~ 177 (814)
...|.|+.||||+|++ .+++||++++.... ...++|+++|||||++.++.++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~-------------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACW-------------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCC--------------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCC--------------------
Confidence 4679999999999998 57899999986543 3689999999999999888899999998
Q ss_pred CCCCCCCCCceEEEEecCCceeeeeccCCcccccccceeccccCC
Q 042262 178 KSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDS 222 (814)
Q Consensus 178 ~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~~~ 222 (814)
+++|.|++.++++|+++++ +. .||++++|..
T Consensus 80 -----~~~g~~~l~l~~dGnlvl~--~~-------~~W~S~~~~~ 110 (115)
T 2dpf_A 80 -----GDNGKYALVLQKDGRFVIY--GP-------VLWSLGPNGC 110 (115)
T ss_dssp -----CSSSCCEEEECTTSCEEEE--CS-------EEECSSTTCB
T ss_pred -----CCCCCEEEEEeCCCeEEEE--CC-------CEEECCCCCC
Confidence 3678999999999997775 21 5899999954
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.3e-14 Score=129.12 Aligned_cols=107 Identities=22% Similarity=0.386 Sum_probs=84.9
Q ss_pred cCCCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEe
Q 042262 26 NNGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLT 105 (814)
Q Consensus 26 ~~~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~ 105 (814)
+.|||.+||.|.+|+. | .+|.|.|.|...| -|-+ |.. +|.+|+.. . +.++.|+|+
T Consensus 2 ~~dtL~~gq~L~~g~~---L--~~g~~~L~~q~dG---------NLvl-~~~------~Wssnt~~---~-~~~~~l~l~ 56 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGH---L--KNGDFDLVMQDDC---------NLVL-YNG------NWQSNTAN---N-GRDCKLTLT 56 (109)
T ss_dssp CCSEEETTCEECTTCE---E--EETTEEEEECTTS---------CEEE-ETT------TEECCCTT---S-CSSCEEEEC
T ss_pred ccCCcCCCCCcCCCCE---e--ECCCEEEEEecCC---------eEEE-EeC------eEEcCCCC---C-CCcEEEEEc
Confidence 5689999999999884 7 5799999997655 1334 432 69998872 2 346889999
Q ss_pred ecccEEEeCCCCCeEeeeccCCCc-eeEEEEccCcCEEEEecCCcccccccccccCccCCC
Q 042262 106 ADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPG 165 (814)
Q Consensus 106 ~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg 165 (814)
.||||||+|.++.++|+|++.... ..+|+|+|+|||||++ ..+|+| .|.+||
T Consensus 57 ~dGnLvl~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 57 DYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp TTSCEEEECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred CCCeEEEEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 999999999999999999986433 4589999999999997 579997 555554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.44 E-value=2.2e-14 Score=155.69 Aligned_cols=139 Identities=11% Similarity=0.031 Sum_probs=95.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc-----chhhhh---------ceeeEEeeccccceeeeee
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD-----GEKEFK---------NEVVVIGQTHHKNLVRLLG 587 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~-----~~~~~~---------~Ei~~l~~l~H~niv~l~g 587 (814)
+.+.+.||+|++|.||+|... .++.||||+++..... ...++. .+.++.....|+|+.+++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~----~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE----KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT----TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEECC----CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 455678999999999999875 5788999987642110 001111 1111111224666666654
Q ss_pred eecc------CCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC
Q 042262 588 FCDE------GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 661 (814)
Q Consensus 588 ~~~~------~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~ 661 (814)
.... ....+|||||+++++|..+... +....++.||+.+|.|||+ .+||||||||.|||+++++.
T Consensus 173 ~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 173 EGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp TTCSCCCEEEEETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEEC
T ss_pred cCCCCCeeeeccCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCC
Confidence 3221 1234799999999988776432 2345688999999999995 48999999999999987763
Q ss_pred ----------eEEeecCCcccc
Q 042262 662 ----------ARISDFGLAKLL 673 (814)
Q Consensus 662 ----------~kl~DfGla~~~ 673 (814)
+.|+||+.+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 899999987654
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.40 E-value=5e-13 Score=119.19 Aligned_cols=102 Identities=12% Similarity=0.231 Sum_probs=79.9
Q ss_pred CCCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEee
Q 042262 27 NGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTA 106 (814)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~ 106 (814)
.++|.+||.|.+|+. | .+|.|.|.|...| -|.+ |.. .. ||.+|+.. + ...+.|.|..
T Consensus 2 ~~~l~~gq~L~~g~~---L--~~g~~~L~~q~dG---------nLvl-~~~---~~-vW~snt~~---~-~~~~~l~l~~ 58 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQ---L--SYESAAFVMQGDC---------NLVL-YNE---AG-GFQSNTHG---R-GVDCTLRLNN 58 (111)
T ss_dssp TTEEETTCEECTTCE---E--EETTEEEEECTTS---------CEEE-ECS---SC-CEECCCTT---S-CSSCEEEECT
T ss_pred cCEeCCCCEeCCCCE---E--ecCCEEEEEccCC---------eEEE-ECC---CC-EEECCccc---C-CcCEEEEEcC
Confidence 578999999999884 7 4799999997655 2444 543 23 99999873 2 3357899999
Q ss_pred cccEEEeCCCCC-eEeeeccCC---CceeEEEEccCcCEEEEecCCcccccc
Q 042262 107 DRGLVLNDPQGK-QVWSSKIDI---GTVAIGVMNDTGNFVLASSSSSKLWDS 154 (814)
Q Consensus 107 ~g~l~l~~~~~~-~~wst~~~~---~~~~~~~l~~~GNlvl~~~~~~~~WQS 154 (814)
||||||+|.++. ++|+|++.. ....+++|+++|||||++ ..+|+|
T Consensus 59 dGNLVl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 59 RGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp TSCEEEECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred CCcEEEEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 999999999876 599999632 234689999999999997 679987
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.28 E-value=1.1e-11 Score=110.46 Aligned_cols=88 Identities=20% Similarity=0.288 Sum_probs=69.9
Q ss_pred CCcEEEEeecccEEEeCCCCCeEeeeccCCCce-eEEEEccCcCEEEEecCCc-ccccccccccCccCCCCcccCCceee
Q 042262 98 RGSQVKLTADRGLVLNDPQGKQVWSSKIDIGTV-AIGVMNDTGNFVLASSSSS-KLWDSFTNPSDTLLPGQMMETEQGLF 175 (814)
Q Consensus 98 ~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~-~~~~l~~~GNlvl~~~~~~-~~WQSFD~PtDTlLpg~~l~~~~~L~ 175 (814)
....|.|+.||||||++.++ +|++++..... ..++|+++|||||++.+++ ++|||.-+
T Consensus 20 g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------------ 79 (111)
T 3mez_A 20 ESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------------ 79 (111)
T ss_dssp TTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS------------------
T ss_pred CCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc------------------
Confidence 35789999999999999876 99999875433 6899999999999998776 49998721
Q ss_pred ecCCCCCCCCCceEEEEecCCceeeeeccCCcccccccceeccc
Q 042262 176 SRKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGT 219 (814)
Q Consensus 176 S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~ 219 (814)
.....|.|.+.++.+|+++++. .++|.+++
T Consensus 80 -----~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s~t 109 (111)
T 3mez_A 80 -----VNTVRGNYAATLGPDQHVTIYG---------PAIWSTPA 109 (111)
T ss_dssp -----CCCCSSCCEEEECTTSCEEEEC---------SEEEECCC
T ss_pred -----cCCCCcCEEEEECCCCeEEEec---------cCEEccCC
Confidence 1113578999999999999873 35787764
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.6e-11 Score=109.92 Aligned_cols=89 Identities=18% Similarity=0.254 Sum_probs=70.7
Q ss_pred CCCcEEEEeecccEEEeCC-CCCeEeeeccCCCc-eeEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCcee
Q 042262 97 PRGSQVKLTADRGLVLNDP-QGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGL 174 (814)
Q Consensus 97 ~~~~~l~~~~~g~l~l~~~-~~~~~wst~~~~~~-~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L 174 (814)
+....|.|+.||||||++. .++++|++++.... ...++|+++|||||++.++.++|||=.+-
T Consensus 23 ~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~~---------------- 86 (113)
T 3mez_B 23 TRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVG---------------- 86 (113)
T ss_dssp ETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCCC----------------
T ss_pred cCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCcC----------------
Confidence 3467899999999999998 48899999986543 36899999999999998888999973310
Q ss_pred eecCCCCCCCCCceEEEEecCCceeeeeccCCcccccccceeccc
Q 042262 175 FSRKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGT 219 (814)
Q Consensus 175 ~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~ 219 (814)
..|.|.+.++.+|+++++- .+.|.+++
T Consensus 87 ---------~~~~~~~~L~~dGnlvly~---------~~~W~s~~ 113 (113)
T 3mez_B 87 ---------QEGDYVLILQINGQAVVYG---------PAVWSTAA 113 (113)
T ss_dssp ---------SSSCCEEEECTTSCEEEEC---------SEEEESCC
T ss_pred ---------CCCCEEEEEcCCceEEEec---------CCEecCCC
Confidence 1356899999999998873 34687754
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.6e-11 Score=127.75 Aligned_cols=114 Identities=17% Similarity=0.300 Sum_probs=85.5
Q ss_pred cCCCCCCCce----eecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcE
Q 042262 26 NNGTVPVGAT----LTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQ 101 (814)
Q Consensus 26 ~~~~~~~~~~----l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~ 101 (814)
.+||+.||+. |..|+. |+|+ ..++.|+|...-... +.++ + |.+ ..+++|.+++.+ .. ...
T Consensus 135 ptdtlLpg~~~~~~l~~g~~---L~S~-~dps~G~fsl~l~~d--Gnlv--L-y~~--~~~~yW~Sgt~~---~~--~~~ 198 (276)
T 3m7h_A 135 PAIPLVPGAIDSLLLAPGSE---LVQG-VVYGAGASKLVFQGD--GNLV--A-YGP--NGAATWNAGTQG---KG--AVR 198 (276)
T ss_dssp TTSCCCCSCTTCEEECSSEE---ECTT-CEEEETTEEEEECTT--SCEE--E-ECT--TSSEEEECCCTT---TT--CCE
T ss_pred cccccccccccccccccCcc---cccC-CCCCCceEEEeecCC--ceEE--E-EeC--CCeEEEECCCCC---Cc--cEE
Confidence 5689999998 777663 7654 566666665532211 2233 3 332 258999998873 22 268
Q ss_pred EEEeecccEEEeCCCCCeEeeeccCCCceeEEEEccCcCEEEEecCCccccccccc
Q 042262 102 VKLTADRGLVLNDPQGKQVWSSKIDIGTVAIGVMNDTGNFVLASSSSSKLWDSFTN 157 (814)
Q Consensus 102 l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~l~~~GNlvl~~~~~~~~WQSFD~ 157 (814)
|.++.+|+|+++|.++.++|++++......+++|+++|||||++. +.+||||||
T Consensus 199 l~l~~dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 199 AVFQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp EEECTTSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred EEEcCCCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 999999999999998899999998755557899999999999986 689999997
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=3.1e-11 Score=107.29 Aligned_cols=78 Identities=24% Similarity=0.344 Sum_probs=64.5
Q ss_pred CcEEEEeecccEEEeCCCCCeEeeeccCCCc-eeEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCceeeec
Q 042262 99 GSQVKLTADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSR 177 (814)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L~S~ 177 (814)
...|.|+.||||||++. +++||++++...+ ...++|+++|||||++.++.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~------------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG------------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC-------------------
Confidence 46799999999999987 6899999986543 36899999999999998888999986321
Q ss_pred CCCCCCCCCceEEEEecCCceeeee
Q 042262 178 KSDTNFSRGRFQFRLLEDGDLVLNV 202 (814)
Q Consensus 178 ~s~~dps~G~~~~~~~~~g~~~~~~ 202 (814)
..+.|.+.++.+|+++++-
T Consensus 80 ------~~~~~~~~L~ddGNlvly~ 98 (109)
T 3dzw_A 80 ------ENGNYVCVLQKDRNVVIYG 98 (109)
T ss_dssp ------SSSCEEEEECTTSCEEEEE
T ss_pred ------CCCCEEEEEeCCCEEEEEC
Confidence 2356899999999998873
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.17 E-value=7.1e-11 Score=105.00 Aligned_cols=78 Identities=22% Similarity=0.364 Sum_probs=63.5
Q ss_pred CCcEEEEeecccEEEeCCCCCeEeeeccCCCce-eEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCceeee
Q 042262 98 RGSQVKLTADRGLVLNDPQGKQVWSSKIDIGTV-AIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFS 176 (814)
Q Consensus 98 ~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~-~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L~S 176 (814)
....|.|+.||||||++. +++|++++...+. ..++|+++|||||++.++.++|||-.+-
T Consensus 24 g~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~------------------ 83 (110)
T 3r0e_B 24 KNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS------------------ 83 (110)
T ss_dssp SSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC------------------
T ss_pred CCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC------------------
Confidence 347899999999999986 5899999865433 5899999999999998889999985321
Q ss_pred cCCCCCCCCCceEEEEecCCceeeee
Q 042262 177 RKSDTNFSRGRFQFRLLEDGDLVLNV 202 (814)
Q Consensus 177 ~~s~~dps~G~~~~~~~~~g~~~~~~ 202 (814)
..|.|.+.++.+|+++++.
T Consensus 84 -------~~~~~~~~L~~dGNlvly~ 102 (110)
T 3r0e_B 84 -------KQGEYVLILQDDGFGVIYG 102 (110)
T ss_dssp -------SSSCCEEEECTTSCEEEEC
T ss_pred -------CCCCEEEEEcCCccEEEec
Confidence 2355899999999998873
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.05 E-value=5.4e-10 Score=114.20 Aligned_cols=87 Identities=25% Similarity=0.367 Sum_probs=69.6
Q ss_pred CcEEEEeecccEEEeCCCCCeEeeeccCCCceeEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCceeeecC
Q 042262 99 GSQVKLTADRGLVLNDPQGKQVWSSKIDIGTVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRK 178 (814)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L~S~~ 178 (814)
...|.|..||+|+|++. +++||++|+.......++|+++|||||+|.++++||+|+++.
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~-------------------- 85 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKG-------------------- 85 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCC--------------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCccc--------------------
Confidence 45678888999999986 789999998655556789999999999999999999998751
Q ss_pred CCCCCCCCceEEEEecCCceeeeeccCCcccccccceecccc
Q 042262 179 SDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTY 220 (814)
Q Consensus 179 s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~ 220 (814)
++|.|.+.++.+|+++++- ..+|.+..+
T Consensus 86 -----~~~~~~~~l~d~Gnlvl~~---------~~~W~S~~~ 113 (236)
T 1dlp_A 86 -----SIGNYVLVLQPDRTVTIYG---------PGLWDSGTS 113 (236)
T ss_dssp -----CSSCCEEEECSSSCEEEEC---------SEEEECSCC
T ss_pred -----cCCcEEEEEeCCCCEEEec---------CCEEECCCC
Confidence 3467889999999998861 146776544
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.04 E-value=5.2e-10 Score=99.17 Aligned_cols=85 Identities=20% Similarity=0.325 Sum_probs=67.9
Q ss_pred CCcEEEEeecccEEEeCCCCCeEeeeccCCCc-eeEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCceeee
Q 042262 98 RGSQVKLTADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFS 176 (814)
Q Consensus 98 ~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L~S 176 (814)
....|.|+.||||||+++ +|+|++...+ ...++|+++|||||++.++.++|+|- |
T Consensus 21 g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~-----t--------------- 76 (109)
T 3r0e_A 21 GDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSG-----A--------------- 76 (109)
T ss_dssp TTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECC-----C---------------
T ss_pred CCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCC-----C---------------
Confidence 357899999999999984 8999987543 36889999999999998888999652 1
Q ss_pred cCCCCCCCCCceEEEEecCCceeeeeccCCcccccccceecccc
Q 042262 177 RKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTY 220 (814)
Q Consensus 177 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~ 220 (814)
....+.|.+.++++|+++++. .+.|.+++|
T Consensus 77 -----~~~~~~~~~~L~~dGNlvly~---------~~~W~s~t~ 106 (109)
T 3r0e_A 77 -----QSVKGNYAAVVHPDGRLVVFG---------PSVFKIDPW 106 (109)
T ss_dssp -----CCSSSCCEEEEETTTEEEEEC---------SEEEEECTT
T ss_pred -----cCCCcCEEEEEcCCCeEEEEe---------cCEECCCCc
Confidence 012467899999999998873 356999887
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.97 E-value=1.3e-09 Score=95.93 Aligned_cols=77 Identities=30% Similarity=0.565 Sum_probs=62.8
Q ss_pred CcEEEEeecccEEEeCCCCCeEeeeccCCC--ceeEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCceeee
Q 042262 99 GSQVKLTADRGLVLNDPQGKQVWSSKIDIG--TVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFS 176 (814)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~--~~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L~S 176 (814)
.-+|.|..||||||++. +++||++++... ....+.|+++|||||+|.++++||+|-.
T Consensus 20 ~y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t-------------------- 78 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHS-------------------- 78 (105)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCC--------------------
T ss_pred CEEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecC--------------------
Confidence 35789999999999984 579999998643 3457999999999999999999998621
Q ss_pred cCCCCCCCCCceEEEEecCCceeee
Q 042262 177 RKSDTNFSRGRFQFRLLEDGDLVLN 201 (814)
Q Consensus 177 ~~s~~dps~G~~~~~~~~~g~~~~~ 201 (814)
....+.|.+.|+++|+++++
T Consensus 79 -----~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 -----TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp -----CCCSSCEEEEECTTSCEEEE
T ss_pred -----CCCCCCEEEEEeCCCeEEEE
Confidence 12356789999999999886
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=4.1e-10 Score=117.14 Aligned_cols=139 Identities=15% Similarity=0.051 Sum_probs=108.2
Q ss_pred hhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-ccceeeeeeeeccCCceehhhhhc
Q 042262 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 524 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
+...++.|+.+.||++... +..+++|+...........+.+|+++++.+. |..+.++++++.+.+..++||||+
T Consensus 18 ~~~~~~g~s~~~v~~~~~~-----~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVGE-----NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp EEECCSCCSSSEEEEEECS-----SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred eEeeccCCCCCeEEEEECC-----CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 4456777888999998642 4679999986533234457889999999884 677889999998888899999999
Q ss_pred cCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-------------------------------------------
Q 042262 603 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED------------------------------------------- 639 (814)
Q Consensus 603 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 639 (814)
++.+|.+.+. +......++.+++++|+.||..
T Consensus 93 ~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 93 DGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred CCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 9999987632 1223457889999999999971
Q ss_pred -------------CCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 640 -------------CSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 640 -------------~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
....++|+|++|.|||++++..+.|+||+.+..
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014589999999999998766667999987754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.76 E-value=2.2e-09 Score=111.12 Aligned_cols=129 Identities=16% Similarity=0.062 Sum_probs=96.1
Q ss_pred cccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccc--eeeeeeeeccCCceehhhhhccCCc
Q 042262 529 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFCDEGQNRLLVYEFLNNGT 606 (814)
Q Consensus 529 G~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gs 606 (814)
+.|..+.||++... ++..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||+++.+
T Consensus 29 ~gg~~~~v~~~~~~----~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~ 101 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQ----GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 101 (264)
T ss_dssp CTTSSCEEEEEECT----TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCCCceEEEEecC----CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence 35556999998643 3456899987543 2356788998888886544 5568888888888999999999988
Q ss_pred hhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------------------
Q 042262 607 LASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC---------------------------------------------- 640 (814)
Q Consensus 607 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------- 640 (814)
|. ... .+ ...++.++++.|+.||...
T Consensus 102 l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 102 LL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp TT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 84 211 11 2467888889999998631
Q ss_pred ---------CCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 641 ---------SAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 641 ---------~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
...++|+|++|.||+++++..++|.||+.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.70 E-value=1.3e-08 Score=111.01 Aligned_cols=142 Identities=16% Similarity=0.201 Sum_probs=105.9
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeec--ccc-ccchhhhhceeeEEeecc--ccceeeeeeeeccC---Cceeh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--RVF-QDGEKEFKNEVVVIGQTH--HKNLVRLLGFCDEG---QNRLL 597 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~--~~~-~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~l 597 (814)
+.|+.|.+..||+.... +..+++|+.. ... ......+.+|..+++.+. +..+.+++.++.+. +..++
T Consensus 44 ~~l~~G~sn~~y~v~~~-----~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-----GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EECCC-CCSCEEEEECS-----SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEcCCcccceEEEEEEC-----CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 46889999999998753 3467888775 321 123457888999998886 45688899998776 45899
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------------
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC------------------------------------- 640 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 640 (814)
||||+++..+.+... ..++...+..++.++++.|+.||...
T Consensus 119 vme~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999999988755322 23678888999999999999999721
Q ss_pred ------------------CCCeeecCCCCCcEEECCCCC--eEEeecCCccccc
Q 042262 641 ------------------SAQIIHCDIKPQNILLDDYYN--ARISDFGLAKLLT 674 (814)
Q Consensus 641 ------------------~~~iiH~Dikp~NIll~~~~~--~kl~DfGla~~~~ 674 (814)
...++|+|+++.|||++.++. +.|.||+.+..-.
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 257999999999999997754 6899999987543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.41 E-value=3.5e-08 Score=104.96 Aligned_cols=186 Identities=18% Similarity=0.136 Sum_probs=120.0
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccc--eeeeeeeeccCC---ceehhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKN--LVRLLGFCDEGQ---NRLLVY 599 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~n--iv~l~g~~~~~~---~~~lV~ 599 (814)
+.++.|....||+.. ..+++|+.... .....+.+|.++++.+ .+.. +.+++....... ..++||
T Consensus 26 ~~~~~G~~n~v~~v~--------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN--------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST--------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC--------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 347889999999752 24788875432 2345788888888877 3332 345555544333 347889
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc----------------------------------------
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED---------------------------------------- 639 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 639 (814)
|++++.+|..... ..++..++..++.++++.|+.||..
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999988875433 3467778888999999999999861
Q ss_pred ---------------CCCCeeecCCCCCcEEECC--CCCeEEeecCCcccccccccccccccc------------cCCCC
Q 042262 640 ---------------CSAQIIHCDIKPQNILLDD--YYNARISDFGLAKLLTLNQSKAIKTAI------------RGTKG 690 (814)
Q Consensus 640 ---------------~~~~iiH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~------------~gt~~ 690 (814)
....++|+|++|.||++++ ...+.|.||+.+........-...... ....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 0145899999999999998 456789999988754321110000000 00001
Q ss_pred ccC-cccccCCCCCCccchhhHHHHHHHHHhCCcCC
Q 042262 691 YVA-PEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 725 (814)
Q Consensus 691 y~a-PE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~ 725 (814)
... |+.... .....+.|+++.+++++.+|..++
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 222111 011258999999999999998876
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.79 E-value=2.2e-05 Score=85.10 Aligned_cols=147 Identities=10% Similarity=0.089 Sum_probs=91.2
Q ss_pred ccc-cccceeEEEEEEEeccC---CcceEEEEEeecccc---ccchhhhhceeeEEeeccc---cceeeeeeeeccC---
Q 042262 526 EEV-GRGSFGIVYKGVIQTTR---TSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHH---KNLVRLLGFCDEG--- 592 (814)
Q Consensus 526 ~~L-G~G~fG~Vykg~~~~~~---~~~~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~--- 592 (814)
+.| +.|....+|+....... ..+..+++|+..... ......+..|..+++.+.. ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 356 78888999988764100 014568888765432 1123567888888888843 3567788887665
Q ss_pred CceehhhhhccCCchhhhhcCC------CCCCHHHHHHHHHHHHHHHHHhh-----------------------------
Q 042262 593 QNRLLVYEFLNNGTLASFLFGN------LKPSWNLRTNIAFQIARGLLYLH----------------------------- 637 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH----------------------------- 637 (814)
+..++||||+++..+.+.+... ..++..++..++.++++.|+-||
T Consensus 106 g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWV 185 (357)
T ss_dssp SSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHHH
T ss_pred CCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHHH
Confidence 3568999999987776432100 01222333333333333333333
Q ss_pred -------------------------hc-------CCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 638 -------------------------ED-------CSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 638 -------------------------~~-------~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
+. ....++|+|+++.|||++++..+.|.||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 186 RSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 11 135789999999999999654578999988764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=3.4e-05 Score=81.78 Aligned_cols=136 Identities=18% Similarity=0.192 Sum_probs=93.8
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecccc---ceeeeeeeec-cCCceehhhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK---NLVRLLGFCD-EGQNRLLVYEF 601 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~e~ 601 (814)
+.++.|....||+. +..++||+-.. ......+..|.+++..+.+. .+.+++.++. ..+..++|||+
T Consensus 25 ~~l~~G~~n~v~~v--------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV--------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE--------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE--------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 34777888889986 13477777432 22345788999999988642 3566676663 45667899999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED------------------------------------------ 639 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 639 (814)
+++..|...... .++...+..++.++++.|+.||..
T Consensus 95 i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 999888764222 234555666666666666666642
Q ss_pred ---------------CCCCeeecCCCCCcEEECC---CCC-eEEeecCCcccc
Q 042262 640 ---------------CSAQIIHCDIKPQNILLDD---YYN-ARISDFGLAKLL 673 (814)
Q Consensus 640 ---------------~~~~iiH~Dikp~NIll~~---~~~-~kl~DfGla~~~ 673 (814)
....++|+|+++.||+++. ++. ..|.||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235699999999999987 455 489999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=3.3e-05 Score=80.04 Aligned_cols=135 Identities=17% Similarity=0.125 Sum_probs=93.4
Q ss_pred cccccee-EEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-ccceeeeeeeeccCCceehhhhhccCC
Q 042262 528 VGRGSFG-IVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNG 605 (814)
Q Consensus 528 LG~G~fG-~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~g 605 (814)
+..|..+ .||+..... .+..+.||+-... ...++.+|...|+.+. +--+.++++++.+++..++|||++++.
T Consensus 32 ~~~G~S~~~v~rl~~~~---~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKP---NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCT---TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecC---CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 3334443 688866542 3456888876432 3456778888877773 334678888998888999999999998
Q ss_pred chhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------------------------
Q 042262 606 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC--------------------------------------------- 640 (814)
Q Consensus 606 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------- 640 (814)
++.+..... ...+..+..++++.|+-||...
T Consensus 106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 877654221 2233456666777777777420
Q ss_pred ----------CCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 641 ----------SAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 641 ----------~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
...++|+|+++.|||++++..+-|.||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999887778999988764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0002 Score=78.77 Aligned_cols=75 Identities=16% Similarity=0.084 Sum_probs=46.6
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccc-------cchhhhhceeeEEeeccc--c-ceeeeeeeeccCCce
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ-------DGEKEFKNEVVVIGQTHH--K-NLVRLLGFCDEGQNR 595 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--~-niv~l~g~~~~~~~~ 595 (814)
+.||.|..+.||++.+.. .+..++||....... .....+..|.+++..+.. + .+.+++.+. ....
T Consensus 36 ~~lg~G~~n~vyrv~~~~---~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~ 110 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMA 110 (397)
T ss_dssp EECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTT
T ss_pred EECCCCceEEEEEEEECC---CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCcc
Confidence 468999999999997542 345789997643211 123345667777777632 3 344565543 3456
Q ss_pred ehhhhhccCC
Q 042262 596 LLVYEFLNNG 605 (814)
Q Consensus 596 ~lV~e~~~~g 605 (814)
++|||++++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.00089 Score=71.58 Aligned_cols=44 Identities=20% Similarity=0.122 Sum_probs=34.6
Q ss_pred HHHHHHHhhh----------cCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 629 IARGLLYLHE----------DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 629 ia~gL~yLH~----------~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
+.+++.+|+. .....++|+|+++.|||++.++.+.|.||+.+..
T Consensus 199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4446667763 1257899999999999998888999999997753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.00097 Score=70.47 Aligned_cols=134 Identities=18% Similarity=0.155 Sum_probs=87.8
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc---ccceeeeeeeeccCCceehhhhhc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
+.|+.|....+|+... ++..++||+.... ....+..|.+.|+.+. ...+.+++.++...+..++||||+
T Consensus 42 ~~l~gG~~n~~y~v~~-----~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-----EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEECCSSSSEEEEEES-----SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred EEeCCccceeeeEEEE-----CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 3588899999999764 2456788876532 2456888888888874 256888888888788899999999
Q ss_pred cCCchhh-----------hhcC--C-C-------------------CCCHHHHH---HHHH----------------HHH
Q 042262 603 NNGTLAS-----------FLFG--N-L-------------------KPSWNLRT---NIAF----------------QIA 630 (814)
Q Consensus 603 ~~gsL~~-----------~l~~--~-~-------------------~l~~~~~~---~i~~----------------~ia 630 (814)
++..+.. .|+. . . .-+|.... ++.. .++
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 9876531 1111 0 0 01344321 1111 111
Q ss_pred HH-HHHhhh-cCCCCeeecCCCCCcEEECCCCCeEEeecC
Q 042262 631 RG-LLYLHE-DCSAQIIHCDIKPQNILLDDYYNARISDFG 668 (814)
Q Consensus 631 ~g-L~yLH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DfG 668 (814)
+- ...|.. ...+.++|+|+.+.||+++.++ +.|.|+.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 123421 2257899999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0015 Score=72.39 Aligned_cols=80 Identities=9% Similarity=0.016 Sum_probs=48.6
Q ss_pred CCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCC---CCCCccchhhHHHHHHH
Q 042262 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS---TITAKVDVYSFGVLLLE 717 (814)
Q Consensus 641 ~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~k~DV~S~Gvvl~e 717 (814)
...++|+|++|.|||+++++ ++|.||+.+..-.+...-... ...-...|.+|+..... .-....++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 56899999999999998876 999999988764422111100 00001245566554311 11123455677777887
Q ss_pred HHhCC
Q 042262 718 IISCR 722 (814)
Q Consensus 718 lltG~ 722 (814)
.+.++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0097 Score=58.31 Aligned_cols=102 Identities=13% Similarity=0.007 Sum_probs=66.3
Q ss_pred CchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccccc
Q 042262 605 GTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT 683 (814)
Q Consensus 605 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 683 (814)
-+|.++|.. +.++++++.+.++.|.++.|.-+-.. ... ..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc------------
Confidence 378888864 57899999999999999998776211 011 1233457899999999998864 1110
Q ss_pred cccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcC
Q 042262 684 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS 724 (814)
Q Consensus 684 ~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p 724 (814)
.....+.|||... ...+.+.=|||+|++||.-+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123466888764 3557888999999999998764433
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0029 Score=65.98 Aligned_cols=74 Identities=18% Similarity=0.206 Sum_probs=51.3
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccc---cceeeeeeeeccCCceehhhhhc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH---KNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
+.+|.|..+.||+..+. +++.+.||+...........|..|.+.|+.+.- --+.+++++. ..++||||+
T Consensus 21 ~~~g~G~~~~vyrv~l~----DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELA----DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEETTEEEEEEEET----TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred EecCCCCCeEEEEEEEC----CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 46899999999999986 567899998765433334567888888887742 1244455543 347888988
Q ss_pred cCCch
Q 042262 603 NNGTL 607 (814)
Q Consensus 603 ~~gsL 607 (814)
..+..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 76543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.49 E-value=0.0063 Score=64.40 Aligned_cols=139 Identities=13% Similarity=0.097 Sum_probs=76.3
Q ss_pred cccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccc--eeeeeeee------ccCCceehh
Q 042262 527 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFC------DEGQNRLLV 598 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~------~~~~~~~lV 598 (814)
.|+.|....+|+.... ++ .+++|+.... ....++..|+.++..+.... +.+++... ...+..+++
T Consensus 29 ~i~~G~~n~~~~v~~~----~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTT----KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EECC---EEEEEEEES----SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred ccCCCcccceEEEEeC----Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 4666777889988764 22 4778887642 12345566777777664322 23333221 123456889
Q ss_pred hhhccCCchhhh--------------hcC---C---CC---C---CHHHHHH------------HHHHHHHHHHHhhhc-
Q 042262 599 YEFLNNGTLASF--------------LFG---N---LK---P---SWNLRTN------------IAFQIARGLLYLHED- 639 (814)
Q Consensus 599 ~e~~~~gsL~~~--------------l~~---~---~~---l---~~~~~~~------------i~~~ia~gL~yLH~~- 639 (814)
++|+++..+... ++. . .. . .|..... +...+.+.++.+++.
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 999987654210 110 0 00 0 1222110 111234455555432
Q ss_pred ---CCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 640 ---CSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 640 ---~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
....++|+|+++.|||++++..+.|.||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 235799999999999999876668999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.39 E-value=0.01 Score=65.70 Aligned_cols=76 Identities=14% Similarity=0.256 Sum_probs=47.6
Q ss_pred ccccccceeEEEEEEEeccC----CcceEEEEEeeccccccchhhhhceeeEEeeccccce-eeeeeeeccCCceehhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTR----TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~----~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e 600 (814)
+.|+.|.-..+|+....... ..+..+++|+.... .....+..|..++..+...++ .++++.+.++ +|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~g----~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSGG----RLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETTE----EEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCCC----EEEE
Confidence 35777878899998875311 12457888887431 111455678888887754444 5667766542 7889
Q ss_pred hccCCch
Q 042262 601 FLNNGTL 607 (814)
Q Consensus 601 ~~~~gsL 607 (814)
|+++..|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9876444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.37 E-value=0.0096 Score=62.42 Aligned_cols=128 Identities=16% Similarity=0.187 Sum_probs=72.1
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccce-eeeeeeeccCCceehhhhhc-c
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFL-N 603 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~-~ 603 (814)
+.|+.|....+|+. ..+++|+...... ...+..+|..+++.+....+ .++++++. +..++|+||+ +
T Consensus 24 ~~l~gG~tN~~~~~---------~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~ 91 (301)
T 3dxq_A 24 LERLGGLTNLVFRA---------GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAG 91 (301)
T ss_dssp EEEESCSSEEEEEE---------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTT
T ss_pred eEcCCcccccccee---------eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCC
Confidence 56778888999987 1377787654321 11233567777776643333 35555543 3457889999 5
Q ss_pred CCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------------------
Q 042262 604 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE--------------------------------------------- 638 (814)
Q Consensus 604 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~--------------------------------------------- 638 (814)
+.+|....... +..++.++++.|+-||.
T Consensus 92 g~~l~~~~~~~-------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 92 AQTMSPEKFKT-------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp CEECCHHHHHH-------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred CccCCHhhHhh-------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 55543200000 00112222222222221
Q ss_pred -----cCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 639 -----DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 639 -----~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
.....++|+|+.+.||+ .+++.+.|+||..+..-
T Consensus 165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 12345899999999999 56667899999887643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.23 E-value=0.012 Score=62.75 Aligned_cols=34 Identities=29% Similarity=0.277 Sum_probs=28.7
Q ss_pred CCCeeecCCCCCcEEECCC----CCeEEeecCCccccc
Q 042262 641 SAQIIHCDIKPQNILLDDY----YNARISDFGLAKLLT 674 (814)
Q Consensus 641 ~~~iiH~Dikp~NIll~~~----~~~kl~DfGla~~~~ 674 (814)
...++|+|+.+.|||++.+ ..+.|.||+.+..-.
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 4579999999999999875 679999999886543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.71 E-value=0.042 Score=61.18 Aligned_cols=74 Identities=14% Similarity=0.088 Sum_probs=44.2
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccce-eeeeeeeccCCceehhhhhccC
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLNN 604 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~ 604 (814)
+.|+.|--..+|+..... .+..+++|+...... ..-+...|..++..+...++ .++++++.. .+||||+++
T Consensus 114 ~~lsgG~tN~~y~v~~~~---~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS---KQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETT---TTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECC---CCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 457778888999987642 135678887643211 11112477778887764444 467777642 248999987
Q ss_pred Cch
Q 042262 605 GTL 607 (814)
Q Consensus 605 gsL 607 (814)
..|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 555
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=94.58 E-value=0.021 Score=61.80 Aligned_cols=141 Identities=18% Similarity=0.245 Sum_probs=79.7
Q ss_pred cccccceeEEEEEEEecc----CCcceEEEEEeeccccccchhhhhceeeEEeeccccc-eeeeeeeeccCCceehhhhh
Q 042262 527 EVGRGSFGIVYKGVIQTT----RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN-LVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 527 ~LG~G~fG~Vykg~~~~~----~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~ 601 (814)
.|..|--..+|+...... ..++..+++|+.... ......+.+|.++++.+.-.+ ..++++++.++ +||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence 455566677888876421 112457888886332 123445668888888774322 35667776653 88999
Q ss_pred ccCCchhhh-----------------hcCC-----CCCC--HHHHHHHHHHHH-------------------HHHHHhhh
Q 042262 602 LNNGTLASF-----------------LFGN-----LKPS--WNLRTNIAFQIA-------------------RGLLYLHE 638 (814)
Q Consensus 602 ~~~gsL~~~-----------------l~~~-----~~l~--~~~~~~i~~~ia-------------------~gL~yLH~ 638 (814)
+++..|..- |+.. .... +.+..++..++. +.+..|.+
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 987665421 1111 1122 333333433322 12233322
Q ss_pred -----cCCCCeeecCCCCCcEEECCC----CCeEEeecCCccc
Q 042262 639 -----DCSAQIIHCDIKPQNILLDDY----YNARISDFGLAKL 672 (814)
Q Consensus 639 -----~~~~~iiH~Dikp~NIll~~~----~~~kl~DfGla~~ 672 (814)
.....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 123578999999999999876 7899999988764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=94.47 E-value=0.029 Score=60.61 Aligned_cols=77 Identities=13% Similarity=0.109 Sum_probs=41.9
Q ss_pred ccccccceeEEEEEEEeccC-----CcceEEEEEeeccccccchhhhhceeeEEeeccccce-eeeeeeeccCCceehhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTR-----TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~-----~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 599 (814)
+.|+.|..-.+|+....... ..+..+++|+...... ...+...|.++++.+...++ .++++... -.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 34677777889998765210 0125688887654221 11234567777777754443 35665442 36789
Q ss_pred hhccCCch
Q 042262 600 EFLNNGTL 607 (814)
Q Consensus 600 e~~~~gsL 607 (814)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99887544
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=88.97 E-value=17 Score=36.67 Aligned_cols=75 Identities=13% Similarity=0.269 Sum_probs=45.9
Q ss_pred EEEEEEeccCCCeEEEEecCCCCCCC----CCCCcEEEEeecccEEEeCCCCCeEeeeccCC-CceeEEEEccCcCEEEE
Q 042262 70 LLSIFYNKIPEKTVVWYTDNKDQNPA----VPRGSQVKLTADRGLVLNDPQGKQVWSSKIDI-GTVAIGVMNDTGNFVLA 144 (814)
Q Consensus 70 ylgiw~~~~~~~t~vW~an~~~~~~~----~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~-~~~~~~~l~~~GNlvl~ 144 (814)
.+.||= ....+++|.........+ ...++.+-++.++.+..+|.+|+.+|...... .....++.+.+||+++.
T Consensus 16 ~v~~~d--~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~ 93 (276)
T 3no2_A 16 KIAIIN--KDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVA 93 (276)
T ss_dssp EEEEEE--TTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEE
T ss_pred EEEEEE--CCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEE
Confidence 466662 235678898766421011 12234455566666777888999999988642 23445677778888775
Q ss_pred ec
Q 042262 145 SS 146 (814)
Q Consensus 145 ~~ 146 (814)
+.
T Consensus 94 ~~ 95 (276)
T 3no2_A 94 WC 95 (276)
T ss_dssp EE
T ss_pred ec
Confidence 43
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=84.45 E-value=8.1 Score=39.13 Aligned_cols=66 Identities=12% Similarity=0.041 Sum_probs=36.9
Q ss_pred CCeEEEEecCCCCCC--C-CCCCcEEEEeecc-cEEEeCCC-CCeEeeeccCC-C-----ceeEEEEccCcCEEEEe
Q 042262 80 EKTVVWYTDNKDQNP--A-VPRGSQVKLTADR-GLVLNDPQ-GKQVWSSKIDI-G-----TVAIGVMNDTGNFVLAS 145 (814)
Q Consensus 80 ~~t~vW~an~~~~~~--~-~~~~~~l~~~~~g-~l~l~~~~-~~~~wst~~~~-~-----~~~~~~l~~~GNlvl~~ 145 (814)
...++|...+...+. + ....-.+....++ .++.+|.+ |+++|+..... . ....+.++.+||+++.+
T Consensus 154 ~G~~~w~~~~~~~~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~ 230 (276)
T 3no2_A 154 NGQLLNSVKLSGTPFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICN 230 (276)
T ss_dssp TSCEEEEEECSSCCCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEE
T ss_pred CCCEEEEEECCCCccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEe
Confidence 467888776542111 0 1122233333333 46667776 88888876421 1 13566777888888866
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=80.52 E-value=1.7 Score=45.49 Aligned_cols=30 Identities=23% Similarity=0.222 Sum_probs=25.8
Q ss_pred CCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 641 ~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
...++|+|+++.|||++ + .+.|.||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 45689999999999999 4 899999987754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 814 | ||||
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-68 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-09 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-09 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-04 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 3e-07 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 6e-07 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-06 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 6e-04 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 225 bits (574), Expect = 4e-68
Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 34/304 (11%)
Query: 512 FSYKELEEATDNFEEEV-----------GRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF 560
F++++ EA F +E+ G G FG V G ++ VA+K L +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 561 -QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-S 618
+ ++F +E ++GQ H N++ L G + +++ EF+ NG+L SFL N +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 619 WNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678
+ IA G+ YL + +H D+ +NIL++ ++SDFGL++ L + S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 679 KAIKTA---IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 735
T+ + + APE + T+ DV+S+G+++ E++S +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---------- 233
Query: 736 LTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+ N + + +E D + C L + + C Q+D + RP ++ L+
Sbjct: 234 -----YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 796 GVVE 799
++
Sbjct: 289 KMIR 292
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 2e-67
Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 23/276 (8%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
+ +G GSFG VYKG AV + + + FKNEV V+ +T H N++
Sbjct: 12 VGQRIGSGSFGTVYKG----KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
+G+ Q +V ++ +L L K +IA Q A+G+ YLH
Sbjct: 68 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS-- 124
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR---N 699
IIH D+K NI L + +I DFGLA + + + G+ ++APE R
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 700 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759
+ + + DVY+FG++L E+++ + + + + Y + L +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLSKVRSN---- 237
Query: 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
C + + + C+++ RP ++ +E
Sbjct: 238 -----CPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 9e-64
Identities = 78/274 (28%), Positives = 124/274 (45%), Gaps = 27/274 (9%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
E +G G FG V+ G VAVK L + F E ++ Q H+ LV
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTK----VAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCS 641
RL + ++ E++ NG+L FL +K + N ++A QIA G+ ++ E
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
IH D++ NIL+ D + +I+DFGLA+L+ N+ A + + + APE T
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGT 186
Query: 702 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761
T K DV+SFG+LL EI++ + + N ++ +E +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP---------------YPGMTNPEVIQNLERGYRMVR 231
Query: 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
C E+L + C +E P RPT + +LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-63
Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 28/288 (9%)
Query: 515 KELEEATDNF---EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-KEFKNE 570
K+L DN + E+G G+FG V +GV + + VA+K L + + + +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ-IDVAIKVLKQGTEKADTEEMMRE 59
Query: 571 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQI 629
++ Q + +VRL+G C + + +LV E G L FL G + + + Q+
Sbjct: 60 AQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS-KAIKTAIRGT 688
+ G+ YL E +H D+ +N+LL + + A+ISDFGL+K L + S ++A +
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 689 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS-FDIEMGEEYAILTDWAFDCYRNG 747
+ APE +++ DV+S+GV + E +S + + G E G
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQG 228
Query: 748 KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
K + C +L + C RP V Q +
Sbjct: 229 KRMECPPE---------CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 3e-63
Identities = 68/293 (23%), Positives = 127/293 (43%), Gaps = 23/293 (7%)
Query: 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQ 576
+F E +GRG FG VY G + AVK L+R+ GE +F E +++
Sbjct: 25 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 577 THHKNLVRLLGFCDEGQNR-LLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLL 634
H N++ LLG C + L+V ++ +G L +F+ P+ Q+A+G
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-- 142
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI--KTAIRGTKGYV 692
+ S + +H D+ +N +LD+ + +++DFGLA+ + + ++ KT + ++
Sbjct: 143 -MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 693 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752
A E + T K DV+SFGVLL E+++ ++ D + +L
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRRLLQ- 255
Query: 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPN 805
C + L V + C +RP+ ++ + + + +
Sbjct: 256 ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-61
Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 25/278 (8%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 582
F +E+G G FG+V+ G VA+K + E++F E V+ + H L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDK----VAIKTIREGAMS-EEDFIEEAEVMMKLSHPKL 62
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCS 641
V+L G C E LV+EF+ +G L+ +L + + + G+ YL E C
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+IH D+ +N L+ + ++SDFG+ + + +Q + + + +PE F S
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSR 178
Query: 702 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761
++K DV+SFGVL+ E+ S K ++ N ++ + +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIP---------------YENRSNSEVVEDISTGFRLYK 223
Query: 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
+ + + C +E P RP ++ + L + E
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 3e-61
Identities = 60/274 (21%), Positives = 111/274 (40%), Gaps = 25/274 (9%)
Query: 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 582
F +E+G G FG+V G + VA+K + E EF E V+ H+ L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYD----VAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKL 61
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCS 641
V+L G C + + ++ E++ NG L ++L + + + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 120
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+H D+ +N L++D ++SDFGL++ + + + + PE S
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 702 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761
++K D+++FGVL+ EI S K ++ + N + + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYR 222
Query: 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+EK+ + C E RPT + + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (524), Expect = 5e-61
Identities = 72/316 (22%), Positives = 125/316 (39%), Gaps = 47/316 (14%)
Query: 513 SYKELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTT--AVAVKKLDR-VFQDGEKEF 567
LE +N E ++G G+FG V++ VAVK L D + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 568 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---------- 617
+ E ++ + + N+V+LLG C G+ L++E++ G L FL
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 618 --------------SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR 663
S + IA Q+A G+ YL E +H D+ +N L+ + +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180
Query: 664 ISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRK 723
I+DFGL++ + ++ PE + T + DV+++GV+L EI S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 724 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSL 783
M E R+G + E C +L + C + P+
Sbjct: 241 QPYYGMAHE------EVIYYVRDGNILACPEN---------CPLELYNLMRLCWSKLPAD 285
Query: 784 RPTMRKVSQMLEGVVE 799
RP+ + ++L+ + E
Sbjct: 286 RPSFCSIHRILQRMCE 301
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 2e-60
Identities = 73/274 (26%), Positives = 119/274 (43%), Gaps = 23/274 (8%)
Query: 525 EEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNL 582
++E+G G+FG V KG Q + T VAVK L D E E V+ Q + +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKT-VAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
VR++G C E ++ +LV E G L +L N + Q++ G+ YL E +
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 643 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA-IKTAIRGTKGYVAPEWFRNST 701
+H D+ +N+LL + A+ISDFGL+K L +++ +T + + APE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 702 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761
++K DV+SFGVL+ E S + + + ++ ++E
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERMGC 231
Query: 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
C ++ + C D RP V L
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 4e-60
Identities = 55/304 (18%), Positives = 121/304 (39%), Gaps = 39/304 (12%)
Query: 517 LEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVV 573
+E D+FE E+G G+ G+V+K + + +A K + + + E+ V
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGL---VMARKLIHLEIKPAIRNQIIRELQV 57
Query: 574 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 633
+ + + +V G + E ++ G+L L + + ++ + +GL
Sbjct: 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
YL E I+H D+KP NIL++ ++ DFG++ L + + + GT+ Y++
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMS 171
Query: 694 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL---------TDWAFDCY 744
PE + + + + D++S G+ L+E+ R +E ++ +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 745 RNGKLDDLVEGDTEAMNDIKCTEKLVMVSIW------------------CIQEDPSLRPT 786
G+ D+ I ++ C+ ++P+ R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 787 MRKV 790
++++
Sbjct: 292 LKQL 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-59
Identities = 68/281 (24%), Positives = 115/281 (40%), Gaps = 35/281 (12%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 579
+ + +G+G FG V G + + VAVK + + F E V+ Q H
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNK-----VAVKCIKN--DATAQAFLAEASVMTQLRH 59
Query: 580 KNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARGLLYL 636
NLV+LLG E + L +V E++ G+L +L + + + + + YL
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
+H D+ +N+L+ + A++SDFGL K + Q + + APE
Sbjct: 120 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEA 171
Query: 697 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756
R + K DV+SFG+LL EI S + + + G D +G
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGYKMDAPDG- 224
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797
C + V C D ++RP+ ++ + LE +
Sbjct: 225 --------CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 4e-59
Identities = 69/321 (21%), Positives = 128/321 (39%), Gaps = 47/321 (14%)
Query: 505 IETNLRCFSY-KELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTA--VAVKKLDRV 559
+ R + Y + E +N E + +G G+FG V + + VAVK L
Sbjct: 19 FYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK 78
Query: 560 FQDGEKE-FKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP 617
E+E +E+ ++ Q H+N+V LLG C L++E+ G L ++L +
Sbjct: 79 ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 138
Query: 618 -----------------------SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 654
++ A+Q+A+G+ +L +H D+ +N+
Sbjct: 139 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNV 195
Query: 655 LLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVL 714
L+ +I DFGLA+ + + + ++ R ++APE T K DV+S+G+L
Sbjct: 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255
Query: 715 LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSI 774
L EI S + + + L++ + TE++ ++
Sbjct: 256 LWEIFSLGVNPYPGIPVDANFY--------------KLIQNGFKMDQPFYATEEIYIIMQ 301
Query: 775 WCIQEDPSLRPTMRKVSQMLE 795
C D RP+ ++ L
Sbjct: 302 SCWAFDSRKRPSFPNLTSFLG 322
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 4e-59
Identities = 57/298 (19%), Positives = 112/298 (37%), Gaps = 29/298 (9%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
+E +G+G FG V++G + VAVK ++ + E+ H+N++
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEE-----VAVKIFSSR-EERSWFREAEIYQTVMLRHENIL 60
Query: 584 RLLGFCDEGQNRL----LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 639
+ ++ LV ++ +G+L +L + +A A GL +LH +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHME 119
Query: 640 CSAQ-----IIHCDIKPQNILLDDYYNARISDFGLAKLL--TLNQSKAIKTAIRGTKGYV 692
I H D+K +NIL+ I+D GLA + GTK Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 693 APEWFRNS------TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY----AILTDWAFD 742
APE +S + D+Y+ G++ EI I + + +D + +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 743 CYRNGKLDDLVEGDT-EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
R + + + + + + C + + R T ++ + L + +
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 6e-59
Identities = 71/298 (23%), Positives = 122/298 (40%), Gaps = 39/298 (13%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTA--VAVKKLDR-VFQDGEKEFKNEVVVIGQ-THH 579
F + +G G+FG V + S A VAVK L + +E+ V+ +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP------------------SWNL 621
N+V LLG C G L++ E+ G L +FL
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 622 RTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681
+ ++Q+A+G+ +L S IH D+ +NILL +I DFGLA+ + + + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 741
K R ++APE N T + DV+S+G+ L E+ S S
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------PYP 249
Query: 742 DCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
+ K +++ ++ ++ + C DP RPT +++ Q++E +
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (509), Expect = 6e-59
Identities = 78/291 (26%), Positives = 131/291 (45%), Gaps = 27/291 (9%)
Query: 513 SYKELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNE 570
+Y + E + ++G G +G VY+GV + VAVK L + E EF E
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL---TVAVKTLKEDTMEVE-EFLKE 63
Query: 571 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQ 628
V+ + H NLV+LLG C ++ EF+ G L +L + S + +A Q
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 629 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGT 688
I+ + YL IH D+ +N L+ + + +++DFGL++L+T + A +
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFP 179
Query: 689 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748
+ APE + + K DV++FGVLL EI + S + +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQ 224
Query: 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
+ +L+E D C EK+ + C Q +PS RP+ ++ Q E + +
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 6e-58
Identities = 75/283 (26%), Positives = 123/283 (43%), Gaps = 27/283 (9%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
E ++G+G FG V+ G T TT VA+K L + F E V+ + H+ LV
Sbjct: 21 LEVKLGQGCFGEVWMG----TWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 75
Query: 584 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS--WNLRTNIAFQIARGLLYLHEDCS 641
+L + +V E+++ G+L FL G ++A QIA G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNST 701
+H D++ NIL+ + +++DFGLA+L+ N+ A + + + APE
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGR 190
Query: 702 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761
T K DV+SFG+LL E+ + + + N ++ D VE
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNREVLDQVERGYRMPC 235
Query: 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPP 804
+C E L + C +++P RPT + LE P
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-57
Identities = 64/282 (22%), Positives = 110/282 (39%), Gaps = 24/282 (8%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTH 578
+ E +G G FG V++G+ + AVA+K D +E F E + + Q
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 579 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLH 637
H ++V+L+G E ++ E G L SFL A+Q++ L YL
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
+H DI +N+L+ ++ DFGL++ + + + + + ++APE
Sbjct: 126 SKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESI 181
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757
T+ DV+ FGV + EI+ + NG+ +
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERLPMPPN-- 233
Query: 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
C L + C DPS RP ++ L ++E
Sbjct: 234 -------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 3e-57
Identities = 67/313 (21%), Positives = 134/313 (42%), Gaps = 34/313 (10%)
Query: 504 TIETNLRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDRVF-Q 561
T E + C + ++ +G G FG VYKG+++T+ VA+K L + +
Sbjct: 1 TTEIHPSCVT----------RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE 50
Query: 562 DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWN 620
+F E ++GQ H N++RL G + + +++ E++ NG L FL S
Sbjct: 51 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL 110
Query: 621 LRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680
+ IA G+ YL +H D+ +NIL++ ++SDFGL+++L +
Sbjct: 111 QLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167
Query: 681 IKT-AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 739
T + + APE T+ DV+SFG+++ E+++ +
Sbjct: 168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-------------- 213
Query: 740 AFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
+ N ++ + + C + + + C Q++ + RP + +L+ ++
Sbjct: 214 -YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
Query: 800 VDVPPNPSPFSGY 812
P + + +
Sbjct: 273 --APDSLKTLADF 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 3e-57
Identities = 64/279 (22%), Positives = 113/279 (40%), Gaps = 21/279 (7%)
Query: 520 ATD-NFEEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQ 576
T+ + +G G+FG VYKG+ I VA+K+L KE +E V+
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 636
+ ++ RLLG C +L+ L N QIA+G+ YL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
+++H D+ +N+L+ + +I+DFGLAKLL + + + ++A E
Sbjct: 128 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 697 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756
+ T + DV+S+GV + E+++ +D ++ ++E
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKP---------------YDGIPASEISSILEKG 229
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
CT + M+ + C D RP R++
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 4e-57
Identities = 65/281 (23%), Positives = 114/281 (40%), Gaps = 33/281 (11%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQT 577
+++E +G GS+G K ++ + K+LD + +EV ++ +
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGK---ILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 578 HHKNLVRLLGFCDEGQNRLL--VYEFLNNGTLASFLFGNLKP----SWNLRTNIAFQIAR 631
H N+VR + N L V E+ G LAS + K + Q+
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 632 GLLYLHE--DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
L H D ++H D+KP N+ LD N ++ DFGLA++L + S A A GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTP 178
Query: 690 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 749
Y++PE + K D++S G LL E+ + F +E R GK
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKF 231
Query: 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+ ++ +N+ ++ + RP++ ++
Sbjct: 232 RRIPYRYSDELNE------IIT---RMLNLKDYHRPSVEEI 263
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-57
Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 24/273 (8%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTH 578
++++ + +G G++G V V + T AVAVK +D + D + K E+ + +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEE---AVAVKIVDMKRAVDCPENIKKEICINKMLN 61
Query: 579 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 638
H+N+V+ G EG + L E+ + G L + ++ Q+ G++YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH- 120
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFR 698
I H DIKP+N+LLD+ N +ISDFGLA + N + + + GT YVAPE +
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 699 NSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757
VDV+S G++L +++ +D + + +DW + D+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWD-QPSDSCQEYSDWKEKKTYLNPWKKI---DS 234
Query: 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+ + + E+PS R T+ +
Sbjct: 235 APLALLH----------KILVENPSARITIPDI 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-56
Identities = 69/274 (25%), Positives = 117/274 (42%), Gaps = 30/274 (10%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKN 581
F+ E+GRGSF VYKG+ T T VA +L ++ + + FK E ++ H N
Sbjct: 13 FDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 582 LVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637
+VR + +LV E + +GTL ++L + + QI +GL +LH
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 638 EDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
IIH D+K NI + + +I D GLA L + + A+ GT ++APE
Sbjct: 130 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEM 184
Query: 697 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756
+ VDVY+FG+ +LE+ + + + G
Sbjct: 185 YEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--------------YRRVTSGV 229
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
A D ++ + CI+++ R +++ +
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 1e-56
Identities = 70/281 (24%), Positives = 111/281 (39%), Gaps = 25/281 (8%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ 576
+ E++G GSFG+V +G T +VAVK L + +F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLY 635
H+NL+RL G + +V E G+L L + + A Q+A G+ Y
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK-AIKTAIRGTKGYVAP 694
L IH D+ +N+LL +I DFGL + L N ++ + + AP
Sbjct: 127 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 695 EWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754
E + T + D + FGV L E+ + + I + IL + R + +D
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPED--- 239
Query: 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
C + + V + C P RPT + L
Sbjct: 240 ----------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-56
Identities = 75/311 (24%), Positives = 132/311 (42%), Gaps = 45/311 (14%)
Query: 507 TNLRCFSYKELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEK 565
T + +++ F++ +G G+FG V K I+ A+K++ +D +
Sbjct: 2 TIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHR 55
Query: 566 EFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP------- 617
+F E+ V+ + HH N++ LLG C+ L E+ +G L FL +
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 618 ---------SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 668
S + A +ARG+ YL Q IH D+ +NIL+ + Y A+I+DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 172
Query: 669 LAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIE 728
L++ + KT R ++A E S T DV+S+GVLL EI+S +
Sbjct: 173 LSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--- 226
Query: 729 MGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMR 788
+ +L + + + C +++ + C +E P RP+
Sbjct: 227 ------------YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 274
Query: 789 KVSQMLEGVVE 799
++ L ++E
Sbjct: 275 QILVSLNRMLE 285
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (491), Expect = 4e-56
Identities = 62/283 (21%), Positives = 102/283 (36%), Gaps = 35/283 (12%)
Query: 518 EEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVV 572
++ F E+G GSFG VY VA+KK+ + ++ EV
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSE---VVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 573 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARG 632
+ + H N ++ G LV E+ + +G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
L YLH S +IH D+K NILL + ++ DFG A ++ S GT ++
Sbjct: 128 LAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWM 178
Query: 693 APEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 749
APE KVDV+S G+ +E+ + F+ L
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL---------------FNMNAMSAL 223
Query: 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792
+ + ++ A+ +E C+Q+ P RPT + +
Sbjct: 224 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-55
Identities = 66/274 (24%), Positives = 113/274 (41%), Gaps = 32/274 (11%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ 576
++FE +G+G FG VY + ++ +A+K L + E + + EV +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKF---ILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 636
H N++RL G+ + L+ E+ GT+ L K ++A L Y
Sbjct: 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
H S ++IH DIKP+N+LL +I+DFG + ++ + GT Y+ PE
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEM 175
Query: 697 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756
KVD++S GVL E + + F+ +E + +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEFTFPDFVT 228
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
A + I ++ +PS RP +R+V
Sbjct: 229 EGARDLIS----------RLLKHNPSQRPMLREV 252
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 5e-54
Identities = 64/282 (22%), Positives = 121/282 (42%), Gaps = 29/282 (10%)
Query: 513 SYKELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNE 570
S + + + E++G+G+ G VY + T VA+++++ Q ++ NE
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQ---EVAIRQMNLQQQPKKELIINE 67
Query: 571 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 630
++V+ + + N+V L G +V E+L G+L + + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECL 126
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690
+ L +LH S Q+IH DIK NILL + +++DFG +T QSK + + GT
Sbjct: 127 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPY 181
Query: 691 YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNGK 748
++APE KVD++S G++ +E+I + + + Y I T+ + K
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241
Query: 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
L + + C+ D R + +++
Sbjct: 242 LSA------IFRDFLN----------RCLDMDVEKRGSAKEL 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 8e-54
Identities = 59/278 (21%), Positives = 109/278 (39%), Gaps = 30/278 (10%)
Query: 521 TDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 578
D +E E+G G+FG VYK + T A K +D ++ +++ E+ ++
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSV---LAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 579 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLH 637
H N+V+LL N ++ EF G + + + +P + + + Q L YLH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
+IIH D+K NIL + +++DFG++ T + + GT ++APE
Sbjct: 128 ---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVV 182
Query: 698 RNST-----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752
T K DV+S G+ L+E+ + L
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPPTL 235
Query: 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+ + + C++++ R T ++
Sbjct: 236 AQPS-------RWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 2e-52
Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 31/289 (10%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTT--AVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHK 580
E+G+GSFG+VY+GV + VA+K ++ EF NE V+ + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIA 630
++VRLLG +GQ L++ E + G L S+L PS + +A +IA
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKG 690
G+ YL + + +H D+ +N ++ + + +I DFG+ + +
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 691 YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750
+++PE ++ T DV+SFGV+L EI + + + E G L
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVMEGGLL 254
Query: 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
D + C + L + C Q +P +RP+ ++ ++ +E
Sbjct: 255 DKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 7e-52
Identities = 77/299 (25%), Positives = 125/299 (41%), Gaps = 40/299 (13%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTST----TAVAVKKLDR-VFQDGEKEFKNEVVVIGQ-T 577
+ +G G+FG V T VAVK L + + +E+ ++
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----------------SWNL 621
HKN++ LLG C + ++ E+ + G L +L P S
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 622 RTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681
+ A+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 741
T R ++APE + T + DV+SFGVLL EI + S + E F
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ELF 247
Query: 742 DCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800
+ G D CT +L M+ C PS RPT +++ + L+ +V +
Sbjct: 248 KLLKEGHRMDKPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-51
Identities = 73/297 (24%), Positives = 124/297 (41%), Gaps = 38/297 (12%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTA--VAVKKLDR-VFQDGEKEFKNEVVVIGQT-HH 579
+ +GRG+FG V + + T VAVK L + +E+ ++ HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 580 KNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKP----------------SWNLR 622
N+V LLG C G +++ EF G L+++L +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 623 TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK 682
+FQ+A+G+ +L S + IH D+ +NILL + +I DFGLA+ + + K
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 742
R ++APE + T + DV+SFGVLL EI S S + + +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCR 248
Query: 743 CYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799
+ G + T ++ + C +PS RPT ++ + L +++
Sbjct: 249 RLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-48
Identities = 55/279 (19%), Positives = 107/279 (38%), Gaps = 28/279 (10%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQ 576
++F+ + +G GSF V T A+K L++ + ++ E V+ +
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSRE---YAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 636
H V+L + + + NG L ++ +I L YL
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
H IIH D+KP+NILL++ + +I+DFG AK+L+ +A + GT YV+PE
Sbjct: 125 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 697 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756
+ D+++ G ++ ++++ F F + D +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEYDFPEKFF 234
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
+A + ++ + D + R ++
Sbjct: 235 PKARDLVE----------KLLVLDATKRLGCEEMEGYGP 263
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (438), Expect = 2e-48
Identities = 60/274 (21%), Positives = 112/274 (40%), Gaps = 27/274 (9%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 579
D+++ EE+G G+FG+V++ + T + A K + + ++ + E+ + H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNN---FAAKFVMTPHESDKETVRKEIQTMSVLRH 82
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHE 638
LV L ++ +++YEF++ G L + S + Q+ +GL ++HE
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARI--SDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
+H D+KP+NI+ + + DFGL L QS GT + APE
Sbjct: 143 ---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEV 196
Query: 697 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756
+ D++S GVL ++S F E +E ++ +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWNMDDSAF 249
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+ D K + + DP+ R T+ +
Sbjct: 250 SGISEDGK---DFIR---KLLLADPNTRMTIHQA 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 9e-47
Identities = 63/283 (22%), Positives = 119/283 (42%), Gaps = 28/283 (9%)
Query: 514 YKELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR-VFQDGEKEFKNE 570
+K+ E+ D ++ + +G G+F V + T+ VA+K + + + E +NE
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQK---LVAIKCIAKKALEGKEGSMENE 57
Query: 571 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 630
+ V+ + H N+V L + G + L+ + ++ G L + + + + FQ+
Sbjct: 58 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 117
Query: 631 RGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIKTAIRG 687
+ YLH+ I+H D+KP+N+L D+ ISDFGL+K+ + + G
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACG 171
Query: 688 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 747
T GYVAPE + VD +S GV+ ++ F E + F+
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKA 224
Query: 748 KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+ + ++ +++DP R T +
Sbjct: 225 EYEFDSP------YWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (423), Expect = 2e-46
Identities = 63/274 (22%), Positives = 112/274 (40%), Gaps = 27/274 (9%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 579
D ++ EE+G G+FG+V++ V + T K ++ + + KNE+ ++ Q HH
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRV---FVAKFINTPYPLDKYTVKNEISIMNQLHH 85
Query: 580 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHE 638
L+ L ++ +L+ EFL+ G L + S N Q GL ++H
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH- 144
Query: 639 DCSAQIIHCDIKPQNILLDDYYNARI--SDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
I+H DIKP+NI+ + + + DFGLA L ++ I T + APE
Sbjct: 145 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEI 199
Query: 697 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756
+ D+++ GVL ++S F E E + + +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWEFDEDAF 252
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+ + K + +Q++P R T+
Sbjct: 253 SSVSPEAK---DFIK---NLLQKEPRKRLTVHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-44
Identities = 53/278 (19%), Positives = 113/278 (40%), Gaps = 28/278 (10%)
Query: 518 EEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIG 575
+E + + E++GRG FGIV++ V +++ + K + D + K E+ ++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKT---YMAKFVKVKGTD-QVLVKKEISILN 56
Query: 576 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLL 634
H+N++ L + + ++++EF++ + + + + + Q+ L
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 635 YLHEDCSAQIIHCDIKPQNILLD--DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYV 692
+LH S I H DI+P+NI+ +I +FG A+ L + + Y
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYY 170
Query: 693 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752
APE ++ ++ D++S G L+ ++S F E ++ + N +
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYTFD 223
Query: 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
E E + V + ++ R T +
Sbjct: 224 EEAFKEISIEAM---DFVD---RLLVKERKSRMTASEA 255
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 160 bits (405), Expect = 9e-44
Identities = 60/279 (21%), Positives = 105/279 (37%), Gaps = 33/279 (11%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVI-- 574
++F +GRG FG VY T A+K LD+ + GE NE +++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKM---YAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 575 -GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 633
+V + + + +N G L L + S A +I GL
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 634 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
++H +++ D+KP NILLD++ + RISD GLA + + A GT GY+A
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMA 173
Query: 694 PEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752
PE + + D +S G +L +++ F ++ + ++
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAVELP 229
Query: 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVS 791
E + ++ +Q D + R
Sbjct: 230 DSFSPELRSLLE----------GLLQRDVNRRLGCLGRG 258
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (397), Expect = 1e-43
Identities = 59/287 (20%), Positives = 110/287 (38%), Gaps = 40/287 (13%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---------RVFQDGEKEFKNE 570
+N+E E +GRG +V + + + T AVK +D Q+ + E
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKE---YAVKIIDVTGGGSFSAEEVQELREATLKE 59
Query: 571 VVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 629
V ++ + H N+++L + LV++ + G L +L + S I +
Sbjct: 60 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
+ LH I+H D+KP+NILLDD N +++DFG + L + + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173
Query: 690 GYVAPEWFRNST------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 743
Y+APE S +VD++S GV++ +++ F + ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW---HRKQMLMLRMIMSG 230
Query: 744 YRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+ + + + + P R T +
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVS----------RFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-43
Identities = 71/273 (26%), Positives = 109/273 (39%), Gaps = 31/273 (11%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQ 576
++F + +G+GSFG V+ + T A+K L + + D + E V+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQ---FFAIKALKKDVVLMDDDVECTMVEKRVLSL 58
Query: 577 T-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 635
H L + +N V E+LN G L + K + T A +I GL +
Sbjct: 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118
Query: 636 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE 695
L S I++ D+K NILLD + +I+DFG+ K L +K GT Y+APE
Sbjct: 119 L---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPE 173
Query: 696 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755
VD +SFGVLL E++ + F + EE F R
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPFYPRWL 226
Query: 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMR 788
+ EA + + +P R +R
Sbjct: 227 EKEAKDLLV----------KLFVREPEKRLGVR 249
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (394), Expect = 3e-43
Identities = 59/288 (20%), Positives = 108/288 (37%), Gaps = 30/288 (10%)
Query: 521 TDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIG 575
+D +E E +G G V+ VAVK L F+ E
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRD---VAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 576 QTHHKNLVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 631
+H +V + G +V E+++ TL + + + +
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKT-AIRGTKG 690
L + IIH D+KP NI++ ++ DFG+A+ + + + +T A+ GT
Sbjct: 123 ALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 691 YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750
Y++PE R ++ A+ DVYS G +L E+++ F + A+ R +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP 233
Query: 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRP-TMRKVSQMLEGV 797
+ + L V + + ++P R T ++ L V
Sbjct: 234 PSARHE-------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (394), Expect = 5e-43
Identities = 52/281 (18%), Positives = 90/281 (32%), Gaps = 26/281 (9%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
++G GSFG +Y G VA+K + + E + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEE---VAIKLECV--KTKHPQLHIESKIYKMMQGGVGI 65
Query: 584 RLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
+ +C EG ++V E L F F + K S +A Q+ + Y+H S
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 122
Query: 643 QIIHCDIKPQNIL---LDDYYNARISDFGLAKLLTLNQSKAI-----KTAIRGTKGYVAP 694
IH D+KP N L I DFGLAK ++ + GT Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 695 EWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754
+ + D+ S G +L+ + + + + ++ L +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
G +C +P + Q+
Sbjct: 243 GYPSEFATYLN---------FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (384), Expect = 2e-41
Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ 576
+F+ +G GSFG V+ + A+K L + + +E +++
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRY---YAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 636
H ++R+ G + Q ++ +++ G L S L + + + A ++ L YL
Sbjct: 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
H II+ D+KP+NILLD + +I+DFG AK + + + GT Y+APE
Sbjct: 121 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEV 172
Query: 697 FRNSTITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILT-DWAFDCYRNGKLDDLV 753
+D +SFG+L+ E+++ F M IL + F + N + DL+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232
Query: 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVS 791
I D S R +
Sbjct: 233 SR--------------------LITRDLSQRLGNLQNG 250
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-40
Identities = 61/282 (21%), Positives = 116/282 (41%), Gaps = 36/282 (12%)
Query: 522 DNFE---EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-T 577
D+++ + +G G G V + + T+ A+K L + + EV + + +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEK---FALKMLQDC-----PKARREVELHWRAS 62
Query: 578 HHKNLVRLLGFCD----EGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIAR 631
++VR++ + + L+V E L+ G L S + G+ + + I I
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 632 GLLYLHEDCSAQIIHCDIKPQNILLDDYYN---ARISDFGLAKLLTLNQSKAIKTAIRGT 688
+ YLH S I H D+KP+N+L +++DFG AK T + S T T
Sbjct: 123 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYT 176
Query: 689 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748
YVAPE D++S GV++ ++ F ++ R G+
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKTRIRMGQ 233
Query: 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+ +E +E++ M+ ++ +P+ R T+ +
Sbjct: 234 YEFPNPEWSE------VSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (374), Expect = 2e-40
Identities = 53/285 (18%), Positives = 108/285 (37%), Gaps = 24/285 (8%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQT 577
+ + E++G G++G+VYK T A+KK+ +D E+ ++ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET----FALKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637
H N+V+L + +LV+E L+ + Q+ G+ Y H
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
+++H D+KPQN+L++ +I+DFGLA+ + K I
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLM 173
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYRNGKLDDL 752
+ + +D++S G + E+++ F + + IL + N
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 753 VEGDTEAMNDIKCTEKLVMVSI-------WCIQEDPSLRPTMRKV 790
+ + + L + ++ DP+ R T ++
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-40
Identities = 60/278 (21%), Positives = 102/278 (36%), Gaps = 44/278 (15%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL------DRVFQDGEKEFKNEVVVIGQ- 576
+G G FG VY G+ + VA+K + D EVV++ +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNL---PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 577 -THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLL 634
+ ++RLL + + + +L+ E L + +Q+ +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 635 YLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVA 693
+ H ++H DIK +NIL+D + ++ DFG LL T GT+ Y
Sbjct: 125 HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSP 177
Query: 694 PEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752
PEW R V+S G+LL +++ F+ +E I F + + L
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE---HDEEIIRGQVFFRQRVSSECQHL 234
Query: 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+ WC+ PS RPT ++
Sbjct: 235 IR--------------------WCLALRPSDRPTFEEI 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (372), Expect = 4e-40
Identities = 44/283 (15%), Positives = 90/283 (31%), Gaps = 28/283 (9%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNL 582
+G GSFG++++G VA+K R + + ++E +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQ---VAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 583 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 642
+ F EG + +LV + L K S A Q+ + +H
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EK 120
Query: 643 QIIHCDIKPQNILLDDYYN-----ARISDFGLAKLLTLNQSKAI-----KTAIRGTKGYV 692
+++ DIKP N L+ + + DFG+ K +K K + GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 693 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752
+ + + D+ + G + + + + + + ++ L +L
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795
G E+ + P + +
Sbjct: 241 CAG---------FPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 31/294 (10%)
Query: 520 ATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVV-- 573
A +E E+G G++G V+K + + VA+K++ + EV V
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62
Query: 574 -IGQTHHKNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIA 626
+ H N+VRL C D LV+E ++ ++
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 627 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIR 686
FQ+ RGL +LH S +++H D+KPQNIL+ +++DFGLA++ + + T++
Sbjct: 123 FQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVV 176
Query: 687 GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD----------IEMGEEYAIL 736
T Y APE S+ VD++S G + E+ + F I
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 737 TDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
DW D + E + + C+ +P+ R +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 61/285 (21%), Positives = 106/285 (37%), Gaps = 25/285 (8%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHK 580
+ +G G F VYK + T VA+KK+ + K+ E+ ++ + H
Sbjct: 4 DFLGEGQFATVYKARDKNTNQ---IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 581 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 640
N++ LL N LV++F+ +L + + +GL YLH+
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 641 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNS 700
I+H D+KP N+LLD+ +++DFGLAK + T T+ Y APE +
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 701 T-ITAKVDVYSFGVLLLEIISCRKSFD----------IEMGEEYAILTDWAFDCYRNGKL 749
VD+++ G +L E++ I W C +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 750 DDLVEGDTEAMNDIK-CTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793
+ + L+ + +P R T + +M
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 7e-39
Identities = 64/293 (21%), Positives = 116/293 (39%), Gaps = 41/293 (13%)
Query: 512 FSYKELEEATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE----- 564
F + ++ D ++ EE+G G F +V K ++T A K + +
Sbjct: 3 FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQ---YAAKFIKKRRTKSSRRGVS 56
Query: 565 -KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT 623
++ + EV ++ + H N++ L + + +L+ E + G L FL + T
Sbjct: 57 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 624 NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY----YNARISDFGLAKLLTLNQSK 679
QI G ++ S QI H D+KP+NI+L D +I DFGLA +
Sbjct: 117 EFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 172
Query: 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 739
I GT +VAPE + + D++S GV+ ++S F + +E
Sbjct: 173 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------- 223
Query: 740 AFDCYRNGKLDDLVEGDTEAMNDI--KCTEKLVMVSIWCIQEDPSLRPTMRKV 790
L ++ + E ++ + + +DP R T++
Sbjct: 224 --------TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 7e-39
Identities = 66/287 (22%), Positives = 120/287 (41%), Gaps = 26/287 (9%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQT 577
+NF+ E++G G++G+VYK + T VA+KK+ D + E+ ++ +
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYL 636
+H N+V+LL LV+EFL+ L L + FQ+ +GL +
Sbjct: 59 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
H ++H D+KPQN+L++ +++DFGLA+ + T T Y APE
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEI 173
Query: 697 FRNS-TITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAIL--------TDWAFDCYR 745
+ VD++S G + E+++ R F D E+ + + I W
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 746 NGKLDDLVEGDTEAMNDI--KCTEKLVMVSIWCIQEDPSLRPTMRKV 790
+ + + + E + + DP+ R + +
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-38
Identities = 65/316 (20%), Positives = 122/316 (38%), Gaps = 31/316 (9%)
Query: 519 EATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIG 575
+ + +G G++G+V + VA+KK+ Q + E+ ++
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKV---RVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 576 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIARG 632
+ H+N++ + + +L + + L+ LK S + +QI RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 633 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK-AIKTAIRGTKGY 691
L Y+H SA ++H D+KP N+LL+ + +I DFGLA++ + T T+ Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 692 VAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYR 745
APE NS T +D++S G +L E++S R F + + IL + +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 746 NGKLDDLVEGDTEAMNDIKCTEKLVMVSI---------WCIQEDPSLRPTMRKVSQ---M 793
+ K + + + +P R + + +
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298
Query: 794 LEGVVEVDVPPNPSPF 809
+ D P +PF
Sbjct: 299 EQYYDPSDEPIAEAPF 314
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-36
Identities = 53/299 (17%), Positives = 110/299 (36%), Gaps = 36/299 (12%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQT 577
+E ++G+G+FG V+K + T VA+KK+ + E+ ++
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQK---VALKKVLMENEKEGFPITALREIKILQLL 66
Query: 578 HHKNLVRLLGFCDEGQNR--------LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 629
H+N+V L+ C + LV++F + +K + + + +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIK--TAIRG 687
GL + +I+H D+K N+L+ +++DFGLA+ +L ++ T
Sbjct: 127 LNGL---YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 688 TKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIE--------MGEEYAILTD 738
T Y PE +D++ G ++ E+ + + + +T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 739 WAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIW-------CIQEDPSLRPTMRKV 790
+ N +L + +E +K K + + + DP+ R
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-36
Identities = 61/295 (20%), Positives = 113/295 (38%), Gaps = 34/295 (11%)
Query: 518 EEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 577
+E + + +G GSFG+VY+ + + VA+KK+ + ++ E+ ++ +
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGE---LVAIKKVLQ----DKRFKNRELQIMRKL 70
Query: 578 HHKNLVRLLGFCDEGQNR------LLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQ 628
H N+VRL F + LV +++ + +Q
Sbjct: 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 629 IARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTAIRG 687
+ R L Y+H S I H DIKPQN+LLD D ++ DFG AK L + + + I
Sbjct: 131 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICS 185
Query: 688 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIE------------MGEEYAI 735
F + T+ +DV+S G +L E++ + F + +G
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 736 LTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKV 790
Y K + + + + + + ++ P+ R T +
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 5e-36
Identities = 52/286 (18%), Positives = 110/286 (38%), Gaps = 24/286 (8%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQT 577
+E E++G G++G V+K + T VA+K++ D E+ ++ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKEL 58
Query: 578 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637
HKN+VRL + LV+EF + F N + + FQ+ +GL + H
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
++H D+KPQN+L++ ++++FGLA+ + + F
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLF 174
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSF----DIEMGEEYAILTDWAFDCYRNGKLDDLV 753
+ +D++S G + E+ + + D++ + + + L
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 754 EGDTEAMNDIKCTEKLVMVSI---------WCIQEDPSLRPTMRKV 790
+ M + V+ + ++ +P R + +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 9e-36
Identities = 58/273 (21%), Positives = 101/273 (36%), Gaps = 30/273 (10%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ 576
++F+ + +G+G+FG V + T A+K L + +D E V+
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRY---YAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 636
T H L L V E+ N G L L + +I L
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL--- 118
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
S +++ DIK +N++LD + +I+DFGL K + + GT Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176
Query: 697 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756
++ VD + GV++ E++ R F + E F+ ++
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEIRFPRTLS 229
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRK 789
EA + + +++DP R
Sbjct: 230 PEAKSLLA----------GLLKKDPKQRLGGGP 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (336), Expect = 1e-34
Identities = 63/275 (22%), Positives = 112/275 (40%), Gaps = 33/275 (12%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQ 576
D F+ + +G GSFG V + + A+K LD+ K+ NE ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGN---HYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 636
+ LV+L + N +V E++ G + S L + S A QI YL
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 637 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEW 696
H S +I+ D+KP+N+L+D +++DFG AK + K + GT +APE
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 697 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756
+ VD ++ GVL+ E+ + F + + ++ +GK+
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVRFPSHFS 262
Query: 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVS 791
++ + ++ +Q D + R K
Sbjct: 263 SDLKDLLR----------NLLQVDLTKRFGNLKNG 287
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 5e-34
Identities = 60/277 (21%), Positives = 110/277 (39%), Gaps = 26/277 (9%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIG 575
+NFE + +G G++G V+ + + A+K L + + + E V+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 576 Q-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 634
LV L L+ +++N G L + L + + + +I L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 635 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAP 694
+LH+ II+ DIK +NILLD + ++DFGL+K ++++ GT Y+AP
Sbjct: 144 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAP 199
Query: 695 EWFR--NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752
+ R +S VD +S GVL+ E+++ F ++ + +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEPPYP 256
Query: 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRK 789
E A + I+ + +DP R
Sbjct: 257 QEMSALAKDLIQ----------RLLMKDPKKRLGCGP 283
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-32
Identities = 76/329 (23%), Positives = 127/329 (38%), Gaps = 44/329 (13%)
Query: 512 FSYKELEEATDNFE------EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE- 564
F +E+ + + VG G++G V V T VA+KKL R FQ
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGA---KVAIKKLYRPFQSELF 60
Query: 565 -KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR------LLVYEFLNNGTLASFLFGNLKP 617
K E+ ++ H+N++ LL + LV F+ GT L + K
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKL 118
Query: 618 SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677
+ + +Q+ +GL Y+H +A IIH D+KP N+ +++ +I DFGLA+ Q
Sbjct: 119 GEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----Q 170
Query: 678 SKAIKTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIE-------- 728
+ + T T+ Y APE N T VD++S G ++ E+I+ + F
Sbjct: 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230
Query: 729 ----MGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMNDI--KCTEKLVMVSIWCIQEDPS 782
G A + L E + + I + V + + D
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290
Query: 783 LRPTMRKVSQM--LEGVVEVDVPPNPSPF 809
R T + E + + + P +
Sbjct: 291 QRVTAGEALAHPYFESLHDTEDEPQVQKY 319
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (305), Expect = 7e-31
Identities = 58/297 (19%), Positives = 113/297 (38%), Gaps = 43/297 (14%)
Query: 522 DNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-TH 578
D+++ ++GRG + V++ + T V VK L V +K+ K E+ ++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEK---VVVKILKPVK---KKKIKREIKILENLRG 88
Query: 579 HKNLVRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 636
N++ L + +R LV+E +NN + ++I + L Y
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYC 145
Query: 637 HEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPE 695
H I+H D+KP N+++D ++ R+ D+GLA+ Q ++ + PE
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199
Query: 696 -WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL-------TDWAFDCYRNG 747
+D++S G +L +I ++ F ++ T+ +D
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 748 KLD-DLVEGDTEAMNDIKCTEKLVMVSIW-------------CIQEDPSLRPTMRKV 790
++ D D + K E+ V ++ D R T R+
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-30
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 583
+ +G G+ GIV + VA+KKL R FQ+ K E+V++ +HKN++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 584 RLLGFC------DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 637
LL +E Q+ LV E ++ + + + +Q+ G+ +LH
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH 136
Query: 638 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWF 697
IIH D+KP NI++ +I DFGLA+ + + T T+ Y APE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 698 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 732
VD++S G ++ E++ + F +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-29
Identities = 71/329 (21%), Positives = 122/329 (37%), Gaps = 42/329 (12%)
Query: 512 FSYKELE----EATDNFE--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGE- 564
F +EL E + ++ VG G++G V T VAVKKL R FQ
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGL---RVAVKKLSRPFQSIIH 60
Query: 565 -KEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----NRLLVYEFLNNGTLASFLFGNLKPS 618
K E+ ++ H+N++ LL + N + + L L + + K +
Sbjct: 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLT 119
Query: 619 WNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678
+ + +QI RGL Y+H IIH D+KP N+ +++ +I DFGLA +
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA-----RHT 171
Query: 679 KAIKTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAIL 736
T T+ Y APE N VD++S G ++ E+++ R F ++ ++
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231
Query: 737 TDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIW-------------CIQEDPSL 783
E + + K+ +++ + D
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291
Query: 784 RPTMRKVSQM--LEGVVEVDVPPNPSPFS 810
R T + + D P P+
Sbjct: 292 RITAAQALAHAYFAQYHDPDDEPVADPYD 320
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (267), Expect = 1e-25
Identities = 44/233 (18%), Positives = 83/233 (35%), Gaps = 23/233 (9%)
Query: 524 FEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 583
++G G F V+ T VA+K + + + ++E+ ++ + + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTH---VAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNT 72
Query: 584 RLLGFCDEGQNRLLVY----------------EFLNNGTLASFLFGNLKPSWNLRTNIAF 627
+ +LL + N + + I+
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 628 QIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIKTAIR 686
Q+ GL Y+H C IIH DIKP+N+L++ + +A L T
Sbjct: 133 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 687 GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 739
T+ Y +PE + D++S L+ E+I+ F+ + G Y D
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.8 bits (209), Expect = 2e-19
Identities = 29/208 (13%), Positives = 61/208 (29%), Gaps = 30/208 (14%)
Query: 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVK----------KLDRVFQDGEKEFKNEV 571
D + +G G V+ + VK K+ G+ F
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE----CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA 57
Query: 572 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN--IAFQI 629
+ + + L +L G Y + N L + + + I
Sbjct: 58 IRSARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMI 112
Query: 630 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTK 689
+ + I+H D+ N+L+ + I DF + + + + R +
Sbjct: 113 LEEVAKFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSV--EVGEEGWREILERDVR 166
Query: 690 GYVAPEWFRNSTITAKVDVYSFGVLLLE 717
+F + + D+ S +L+
Sbjct: 167 --NIITYFSRTY-RTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 53.8 bits (129), Expect = 2e-09
Identities = 27/126 (21%), Positives = 46/126 (36%), Gaps = 25/126 (19%)
Query: 33 GATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQ 92
G L AG + + F L L Y+ T VW ++
Sbjct: 7 GEGLYAGQSLD-----VEPYHFIM------QEDCNLVL----YDH---STSVWASNT--- 45
Query: 93 NPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKL 151
+G + L +D V+ D +G+ +W+S G + V+ + GN V+ S +
Sbjct: 46 GILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---I 102
Query: 152 WDSFTN 157
W + T
Sbjct: 103 WSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 53.8 bits (129), Expect = 2e-09
Identities = 23/129 (17%), Positives = 41/129 (31%), Gaps = 27/129 (20%)
Query: 72 SIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGTVA 131
SI Y+ T + Q ++ + D LVL D + ++ GT
Sbjct: 11 SILYSTQGNDNHPQ-TLHATQ-SLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGC 68
Query: 132 IGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFR 191
V+ G + ++ + +W S + S GR+ F
Sbjct: 69 RAVLQPNGRMDVLTNQNIAVWTSGN-------------------------SRSAGRYVFV 103
Query: 192 LLEDGDLVL 200
L D +L +
Sbjct: 104 LQPDRNLAI 112
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 40.3 bits (94), Expect = 1e-04
Identities = 26/165 (15%), Positives = 46/165 (27%), Gaps = 54/165 (32%)
Query: 134 VMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLL 193
V+ + GN +L S+ + N TL Q + ++ +
Sbjct: 4 VVANNGNSILYSTQGND------NHPQTLHATQ---------------SLQLSPYRLSME 42
Query: 194 EDGDLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDLT 253
D +LVL + +T +G R + +G M +L
Sbjct: 43 TDCNLVLFDRDDRV-----------WSTNTAGKGTGCRAVLQPNGRMDVLTNQ------- 84
Query: 254 TGRVV-----PAADFYHRATLNFDGVFAQYFYPKNGNGNWSAVWS 293
V + + L D A Y A+W+
Sbjct: 85 -NIAVWTSGNSRSAGRYVFVLQPDRNLAIY---------GGALWT 119
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 47.6 bits (113), Expect = 3e-07
Identities = 27/151 (17%), Positives = 47/151 (31%), Gaps = 39/151 (25%)
Query: 72 SIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGTVA 131
+I + E + T + Q + + +D LVL D +VW+S T
Sbjct: 2 NILFGLSHEGSHPQ-TLHAAQ-SLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGC 58
Query: 132 IGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFR 191
V+ G V+ ++ ++ W S T S G +
Sbjct: 59 RAVLQSDGLLVILTAQNTIRW-------------------------SSGTKGSIGNYVLV 93
Query: 192 LLEDGDLVLNVANLPTDFAYD-AYYTSGTYD 221
L D + + Y + SGT +
Sbjct: 94 LQPDRTVTI----------YGPGLWDSGTSN 114
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 46.7 bits (110), Expect = 6e-07
Identities = 22/132 (16%), Positives = 44/132 (33%), Gaps = 22/132 (16%)
Query: 29 TVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTD 88
+ G L G + + G + F N+ N + Y+ VW +
Sbjct: 3 RLNSGHQLDTGGSLA-----EGGYLFIIQ-----NDCN-----LVLYDN---NRAVWASG 44
Query: 89 NKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGTVAIGVMNDTGNFVLASSSS 148
+ G +K+ D LV+ S+ ++ N V+ +S+
Sbjct: 45 TNGKA----SGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN 100
Query: 149 SKLWDSFTNPSD 160
+ +W + TN +
Sbjct: 101 NAIWATHTNVGN 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 45.2 bits (106), Expect = 2e-06
Identities = 23/142 (16%), Positives = 42/142 (29%), Gaps = 30/142 (21%)
Query: 159 SDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSG 218
SD L G ++T L G + F + D +LVL N + SG
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNNRAVWASGTNGKASG 51
Query: 219 TYDSTNSSNSGYRVMFNESGYMYILRRNSQRFDLTTGRVVPAADFYHRATLNFDGVFAQY 278
+ G + I + + + + L D Y
Sbjct: 52 CV-----------LKMQNDGNLVIYSGSRAIWA----SNTNRQNGNYYLILQRDRNVVIY 96
Query: 279 FYPKNGNGNWSAVWSQPENICD 300
+ + +A+W+ N+ +
Sbjct: 97 ------DNSNNAIWATHTNVGN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 37.7 bits (87), Expect = 6e-04
Identities = 24/132 (18%), Positives = 47/132 (35%), Gaps = 26/132 (19%)
Query: 27 NGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWY 86
+ + G TL+ G + G F F + + N L ++ P W
Sbjct: 1 DNILYSGETLSTGEFLN-----YGSFVFIM-----QEDCN----LVLYDVDKPI----WA 42
Query: 87 TDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGTVA-IGVMNDTGNFVLAS 145
T+ + R + + D LV+ +P K +W+S + ++ N V+
Sbjct: 43 TNTGGLS----RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYG 98
Query: 146 SSSSKLWDSFTN 157
+ W + T+
Sbjct: 99 TD---RWATGTH 107
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 814 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.8 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.79 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.77 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.77 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.68 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.59 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.49 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.23 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.06 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.05 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.01 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.98 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.67 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.03 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.83 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.87 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.12 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 90.9 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 88.2 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 85.32 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 84.66 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 84.59 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 84.25 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 81.56 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 80.2 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-49 Score=422.41 Aligned_cols=272 Identities=24% Similarity=0.440 Sum_probs=210.8
Q ss_pred ccccCHHHHHHHHhhhh-----------ccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEee
Q 042262 509 LRCFSYKELEEATDNFE-----------EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQ 576 (814)
Q Consensus 509 ~~~f~~~el~~~~~~~~-----------~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~ 576 (814)
...|+++++.+++.+|. +.||+|+||+||+|.+..++.....||||++... .....++|.+|+.++++
T Consensus 4 ~d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~ 83 (299)
T d1jpaa_ 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83 (299)
T ss_dssp CCGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTT
T ss_pred cCCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHh
Confidence 34567778887776663 4699999999999998765545568999998653 33345679999999999
Q ss_pred ccccceeeeeeeeccCCceehhhhhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 042262 577 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNIL 655 (814)
Q Consensus 577 l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIl 655 (814)
++|||||+++|+|.+++..+|||||+++|+|.+++... ..+++.+++.|+.|||+||+|||+ .+|+||||||+|||
T Consensus 84 l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNIL 160 (299)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEE
Confidence 99999999999999999999999999999999988764 568999999999999999999995 59999999999999
Q ss_pred ECCCCCeEEeecCCcccccccccccc---cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCc
Q 042262 656 LDDYYNARISDFGLAKLLTLNQSKAI---KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGE 731 (814)
Q Consensus 656 l~~~~~~kl~DfGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~ 731 (814)
|+.++.+||+|||+++.+........ .....||..|+|||.+.++.++.++|||||||+||||+| |+.||......
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998765433221 122457899999999999999999999999999999998 89998644321
Q ss_pred chhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 732 EYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 732 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
+ ....+..+. ....+.++++++.+|+.+||+.||++||||.||++.|+.+++
T Consensus 241 ~-------~~~~i~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 241 D-------VINAIEQDY---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp H-------HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred H-------HHHHHHcCC---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 112222221 112344677889999999999999999999999999987654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=407.36 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=198.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.++||+|+||+||+|.+. ++..||||+++.. ....++|.+|++++++++|||||+++|+|.+++..+|||||
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEET----TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cEEEEEEeeCCCeEEEEEEEC----CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 356688999999999999986 4567999999754 34457899999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 602 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 602 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
+++|+|.+++... ..+++..++.|+.|||+||+|||+ .+|+||||||+|||+++++.+||+|||+++.........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999998654 568999999999999999999995 599999999999999999999999999998775443322
Q ss_pred ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~ 760 (814)
.....||..|+|||.+.+..++.|+|||||||++|||+|+..|+....... . ....+..+.. ..
T Consensus 159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~----~~~~i~~~~~---------~~ 222 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--E----VVEDISTGFR---------LY 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--H----HHHHHHHTCC---------CC
T ss_pred -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--H----HHHHHHhcCC---------CC
Confidence 334568999999999999999999999999999999999654443222211 1 1122222211 11
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 761 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.+..+++++.+++..||+.||++||||+||++.|+++.
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 23345678999999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-48 Score=411.48 Aligned_cols=261 Identities=28% Similarity=0.434 Sum_probs=215.8
Q ss_pred HHHHHHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCce
Q 042262 516 ELEEATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 516 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 595 (814)
|+....+.+.++||+|+||+||+|.+.. .++.||||+++.. ....++|.+|+.++++++|||||+++++|.+++..
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGG---GTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECC---CCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 3444456677899999999999999874 5678999999754 33456799999999999999999999999999999
Q ss_pred ehhhhhccCCchhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 596 LLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
+|||||+++|+|.+++.. ...+++..++.|+.||++||+|||+ .+|+||||||+||||++++.+||+|||+++..
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999999999864 3678999999999999999999995 59999999999999999999999999999987
Q ss_pred cccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
..+.... .....|+..|+|||++.+..++.|+|||||||++|||++|..|+....... ...+.+..+.
T Consensus 166 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~------~~~~~i~~~~----- 233 (287)
T d1opja_ 166 TGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDY----- 233 (287)
T ss_dssp CSSSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHTTC-----
T ss_pred CCCCcee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH------HHHHHHhcCC-----
Confidence 6543332 334558899999999999999999999999999999999877765433211 1122222221
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
....+..+++++.+|+..||+.||++||||.||++.|+.+.+
T Consensus 234 ----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 234 ----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122234567889999999999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=402.68 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=206.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.+.+.||+|+||+||+|.+.. +++.||||+++... .+..+++.+|++++++++|||||++++++.+++..+||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 4566899999999999999864 56789999986532 2345678999999999999999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
|+++|+|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.+..+....
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999999988889999999999999999999995 599999999999999999999999999999876554444
Q ss_pred ccccccCCCCccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccc
Q 042262 681 IKTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEA 759 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 759 (814)
.....+||+.|+|||.+.+..+ +.++||||+||+||||++|+.||......... . ........ ..
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~-----~~~~~~~~--------~~ 226 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y-----SDWKEKKT--------YL 226 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-H-----HHHHTTCT--------TS
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-H-----HHHhcCCC--------CC
Confidence 4556789999999999988876 57899999999999999999999754432211 1 11111111 11
Q ss_pred cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 760 MNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 760 ~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
......++++.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112345678899999999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=405.45 Aligned_cols=253 Identities=32% Similarity=0.482 Sum_probs=207.3
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
..+.+.+.||+|+||+||+|.++ ++..||||+++.. ....++|.+|+.++++++|||||+++|++.+ +..+|||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC----CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 34566788999999999999986 4678999999754 3345689999999999999999999998865 5678999
Q ss_pred hhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 600 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 600 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||+++|+|.+++... ..+++..+++|+.||++||+|||+ .+|+||||||+||||++++.+||+|||+++.+....
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999999987654 468999999999999999999995 599999999999999999999999999999876543
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
... .....||..|+|||.+.++.++.++|||||||+||||+||..|+....... .....+..+.
T Consensus 164 ~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~------~~~~~i~~~~--------- 227 (272)
T d1qpca_ 164 YTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERGY--------- 227 (272)
T ss_dssp EEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTC---------
T ss_pred ccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcC---------
Confidence 322 345668999999999999999999999999999999999766654332211 1122222221
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
....+..+++++.+|+.+||+.||++||||.||+++|++.
T Consensus 228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 1112335678899999999999999999999999999763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=406.15 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=201.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||+||+|++. ..||||+++.. .....++|++|+.++++++|||||++++++.+ .+.+|||
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EEEEEEEeeCCCcEEEEEEEC------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 456688999999999999753 24999998643 33445789999999999999999999999865 5689999
Q ss_pred hhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+++|+|.+++... ..+++..+..|+.|||+||+|||+ .+||||||||+||||++++.+||+|||+++.......
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999754 569999999999999999999995 5999999999999999999999999999988765444
Q ss_pred ccccccccCCCCccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 679 KAIKTAIRGTKGYVAPEWFRN---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
........||+.|+|||.+.+ ..++.++|||||||+||||+||+.||....... ........+.....
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~p~--- 230 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPD--- 230 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCCCC---
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCc---
Confidence 333455679999999999964 358999999999999999999999997543221 11222222221111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
....+.++++++.+|+.+||+.||.+||||+||++.|+.+.
T Consensus 231 --~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 231 --LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp --GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11123456789999999999999999999999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=401.93 Aligned_cols=250 Identities=29% Similarity=0.418 Sum_probs=204.8
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhcc
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 603 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 603 (814)
++||+|+||+||+|.+...+ .++.||||+++... ....++|.+|++++++++|||||+++|+|.+ +..+|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS-SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCC-cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 46999999999999986533 56789999996532 2234679999999999999999999999965 46789999999
Q ss_pred CCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc-cc
Q 042262 604 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA-IK 682 (814)
Q Consensus 604 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~ 682 (814)
+|+|.+++.....+++..++.|+.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++.+....... ..
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999999988889999999999999999999995 599999999999999999999999999999775443322 13
Q ss_pred ccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 683 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 683 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
....||..|+|||.+.+..++.++|||||||++|||+| |+.||......+ +...+..+... ..
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~---------~~ 231 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERM---------GC 231 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC---------CC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCCCC---------CC
Confidence 34568999999999999999999999999999999998 899997432211 22333333221 22
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
+..+++++.+|+.+||+.||++||||.||+++|+.
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 34567889999999999999999999999998865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=395.26 Aligned_cols=244 Identities=27% Similarity=0.388 Sum_probs=207.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||+||+|.... +++.||||++... .....+++.+|+.++++++|||||++++++.+++..+||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecCCCcEEEEEEECC---CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 5667899999999999999864 5678999998642 233456789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+++.....+++..+..|+.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 9999999999999888889999999999999999999995 599999999999999999999999999998765432
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.....||+.|+|||.+.+..++.++|||||||+||||++|+.||......+ ....+..+..
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~--------- 221 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF--------- 221 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC---------
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC---------
Confidence 234579999999999999999999999999999999999999996543211 1222222221
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...++++.+++.+||+.||++|||++||++
T Consensus 222 -~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 122345688999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=394.12 Aligned_cols=250 Identities=25% Similarity=0.410 Sum_probs=210.8
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhhc
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 602 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 602 (814)
++.++||+|+||+||+|+++ ++..||||+++.. ....++|++|++++++++||||++++|+|.+.+..++||||+
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCEETTEEEEEEEET----TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred EEeEEEecCCCeEEEEEEEC----CCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 46789999999999999985 4678999999764 334578999999999999999999999999999999999999
Q ss_pred cCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 603 NNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 603 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
++|+|..++.. ...+++..+.+|+.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.+.......
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~- 157 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS- 157 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC-
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCcee-
Confidence 99999999765 4678999999999999999999995 599999999999999999999999999998776543332
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccccc
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAM 760 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~ 760 (814)
.....||..|+|||.+.+..++.|+||||||+++|||+| |+.||......+ ....+..+.. ..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~---------~~ 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLR---------LY 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCC---------CC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhCCC---------CC
Confidence 344568999999999999999999999999999999998 899987543221 1222333321 11
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 761 NDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 761 ~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
.+...++++.+++.+||+.||++|||++||++.|.++
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2335667899999999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=404.10 Aligned_cols=261 Identities=24% Similarity=0.444 Sum_probs=204.2
Q ss_pred hhhhccccccceeEEEEEEEeccC-CcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTR-TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~-~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.+.||+|+||+||+|.+.... .....||||+++... .....+|.+|++++++++|||||+++|++.+.+..++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 345678999999999999987532 233579999996533 333457999999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+.+++|.+++... ..+++.++..++.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 89 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 89 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 999999999987654 679999999999999999999995 5999999999999999999999999999998755433
Q ss_pred cc-ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KA-IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.. ......||..|+|||.+.+..++.++|||||||++|||++|..|+....... .+...+..+.
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~------~~~~~i~~~~--------- 230 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDGF--------- 230 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTC---------
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH------HHHHHHhccC---------
Confidence 22 1234568999999999999999999999999999999999776665433221 1122233332
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
....+..++.++.+|+.+||+.||++||||.||+++|+.+++.
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1223345678899999999999999999999999999887654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=408.44 Aligned_cols=258 Identities=25% Similarity=0.381 Sum_probs=210.0
Q ss_pred HHhhhhccccccceeEEEEEEEeccCC--cceEEEEEeeccc-cccchhhhhceeeEEeec-cccceeeeeeeeccCCce
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRT--STTAVAVKKLDRV-FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~--~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 595 (814)
..+.+.++||+|+||+||+|.+..... ....||||++... .......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 345677899999999999999875332 3457999998653 334456789999999998 899999999999999999
Q ss_pred ehhhhhccCCchhhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 042262 596 LLVYEFLNNGTLASFLFGN-----------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQ 652 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~ 652 (814)
+|||||+++|+|.++|... ..+++..++.|+.||++||+|||+ .+|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 9999999999999999654 247899999999999999999995 59999999999
Q ss_pred cEEECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCc
Q 042262 653 NILLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGE 731 (814)
Q Consensus 653 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~ 731 (814)
|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||+||||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999998765544433445668999999999999999999999999999999998 89999754332
Q ss_pred chhhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHc
Q 042262 732 EYAILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 795 (814)
Q Consensus 732 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~ 795 (814)
. . ....+..+. ....+..+++++.+|+.+||+.||++||||+||+++|.
T Consensus 274 ~--~----~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 A--N----FYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp H--H----HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H--H----HHHHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 1 122222221 11234456788999999999999999999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=396.92 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=208.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.++||+|+||+||+|.... +++.||||+++.......+.+.+|++++++++|||||++++++.+++..+|||||
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTT---TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 5566889999999999999764 5779999999766555567799999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccccc
Q 042262 602 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 681 (814)
Q Consensus 602 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 681 (814)
+++|+|.+++.. ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..+...
T Consensus 99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-- 172 (293)
T d1yhwa1 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172 (293)
T ss_dssp CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--
T ss_pred cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc--
Confidence 999999998765 468999999999999999999995 59999999999999999999999999999987543322
Q ss_pred cccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcccccC
Q 042262 682 KTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTEAMN 761 (814)
Q Consensus 682 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 761 (814)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ........+.. ....
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~--------~~~~ 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP--------ELQN 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC--------CCSS
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCCC--------CCCC
Confidence 345679999999999999999999999999999999999999996443211 11222222211 1112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 762 DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 762 ~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
+...++++.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3456788999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=398.67 Aligned_cols=260 Identities=28% Similarity=0.438 Sum_probs=205.8
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||+||+|.+. .+..||||+++.. ....++|.+|+.++++++|||||+++|+|.+ +..++|||
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~----~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEET----TTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HEEEeeEEeeCCCeEEEEEEEC----CCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 4677789999999999999986 3457999999754 3445789999999999999999999999955 56889999
Q ss_pred hccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 601 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 601 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|+++|+|..++... ..++|.+++.|+.||++||+|||+ .+|+||||||+||||++++.+||+|||+++.......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 99999999988753 568999999999999999999995 5899999999999999999999999999987754433
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.. .....||..|+|||++.++.++.++||||||++||||++|..|+....... + ....+..+. .
T Consensus 169 ~~-~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-----~-~~~~i~~~~---------~ 232 (285)
T d1fmka3 169 TA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----E-VLDQVERGY---------R 232 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H-HHHHHHTTC---------C
T ss_pred ee-eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-----H-HHHHHHhcC---------C
Confidence 22 344568999999999999999999999999999999999776665433221 1 112222221 1
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCCCCCCC
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPN 805 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~~~pp~ 805 (814)
...+..+++++.+++.+||+.||++||||++|+++|++......|+.
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~ 279 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCC
Confidence 12234567889999999999999999999999999998766554443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=397.76 Aligned_cols=252 Identities=28% Similarity=0.440 Sum_probs=206.3
Q ss_pred hhc-cccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 524 FEE-EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 524 ~~~-~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+ +||+|+||+||+|.+...+ .+..||||+++... ....++|.+|++++++++|||||+++|+|.+ +..+|||||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~ 89 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM 89 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred ECCcEEecccCeEEEEEEEecCC-CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEe
Confidence 345 4999999999999876432 45689999997543 3345779999999999999999999999965 568999999
Q ss_pred ccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc-
Q 042262 602 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK- 679 (814)
Q Consensus 602 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~- 679 (814)
+++|+|.+++.. ...+++..+..|+.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++.+......
T Consensus 90 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 90 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred CCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 999999998765 4679999999999999999999995 59999999999999999999999999999987654322
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.......||..|+|||.+.++.++.++|||||||++|||+| |+.||......+ +...+..+...
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~-------- 231 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM-------- 231 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCC--------
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC--------
Confidence 22234568999999999999999999999999999999998 899997543221 12333343322
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
..+..++.++.+|+.+||+.||++||||.+|++.|+.
T Consensus 232 -~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 232 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1234567889999999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=407.24 Aligned_cols=263 Identities=19% Similarity=0.314 Sum_probs=205.4
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.++||+|+||+||+|.... +++.||||+++... ....+++.+|+.++++++|||||++++++.++++.+|||
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETT---TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35566889999999999999864 57899999996532 333467899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+++|+|.+++.....+++..+..++.||++||.|||+. .+|+||||||+||||++++.+||+|||+|+......
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 9999999999998888899999999999999999999962 379999999999999999999999999998764332
Q ss_pred cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHH---------HHHhcC---
Q 042262 680 AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF---------DCYRNG--- 747 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~--- 747 (814)
.....||..|+|||++.+..++.++||||+||+++||++|+.||................ .....+
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 334679999999999999999999999999999999999999997644321111000000 000000
Q ss_pred -----------Cccc----cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 748 -----------KLDD----LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 748 -----------~~~~----l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
...+ ..............+.++.+++.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000 00000011111234578999999999999999999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=391.00 Aligned_cols=247 Identities=27% Similarity=0.417 Sum_probs=199.6
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeecc----CCcee
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNRL 596 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~ 596 (814)
.|.++||+|+||+||+|.+.. ++..||+|++... .....+.|.+|++++++++|||||++++++.+ ....+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~---~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 456789999999999999864 5678999998653 22334578999999999999999999999854 34578
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC-CCCCeEEeecCCcccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTL 675 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DfGla~~~~~ 675 (814)
|||||+++|+|.+++.....+++..+..++.||++||+|||++ ..+|+||||||+||||+ +++.+||+|||+++....
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999999998888899999999999999999999964 23499999999999996 578999999999986543
Q ss_pred cccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.. .....||+.|+|||.+.+ .++.++|||||||++|||++|+.||....... .....+..+....
T Consensus 168 ~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~------~~~~~i~~~~~~~---- 232 (270)
T d1t4ha_ 168 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPA---- 232 (270)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCG----
T ss_pred Cc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH------HHHHHHHcCCCCc----
Confidence 32 335679999999999875 59999999999999999999999996433211 1222333322211
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...++++.+|+.+||+.||++|||+.|+++
T Consensus 233 ----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 112234567899999999999999999999976
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=394.80 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=206.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+.+.+.||+|+||+||+|.+.. .+..||||+++.......+++.+|++++++++|||||++++++.+.+..+|||||
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKE---TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEeEEEeeCCCcEEEEEEECC---CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 4566889999999999999864 5678999999876666678899999999999999999999999999999999999
Q ss_pred ccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 602 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 602 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
+++|+|.+++.. ...+++..+..|+.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~- 166 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR- 166 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH-
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCccc-
Confidence 999999998765 4679999999999999999999995 59999999999999999999999999999865432211
Q ss_pred ccccccCCCCccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 681 IKTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||......+ .+ ..+..+...
T Consensus 167 -~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~-----~~i~~~~~~----- 233 (288)
T d2jfla1 167 -RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VL-----LKIAKSEPP----- 233 (288)
T ss_dssp -HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HH-----HHHHHSCCC-----
T ss_pred -ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HH-----HHHHcCCCC-----
Confidence 23467999999999984 5568999999999999999999999997543322 11 111122111
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
....+...++++.+++.+||+.||.+|||++|+++
T Consensus 234 --~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 --TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11223456788999999999999999999999876
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=397.58 Aligned_cols=247 Identities=22% Similarity=0.272 Sum_probs=204.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||+||+|.... +++.||||+++.. .....+.+.+|++++++++||||+++++++.+++..+||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 5677899999999999999864 4678999998643 233446789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999999888889999999999999999999995 5999999999999999999999999999998765444
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
........||+.|+|||++.+..++.++|||||||+||||++|+.||....... ....+..+..
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~--------- 227 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEY--------- 227 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCC---------
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-------HHHHHHcCCC---------
Confidence 333445679999999999999999999999999999999999999997543211 1222222221
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVS 791 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~ 791 (814)
..+...++++.+|+.+||+.||.+|||++|++
T Consensus 228 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 228 -DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp -CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred -CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 11234567899999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=391.77 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=193.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeecc--CCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 597 (814)
+++.+.||+|+||+||+|.... +++.||||+++... ....+.+.+|++++++++|||||++++++.+ .+..+|
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 4567899999999999999864 56789999986532 2334568999999999999999999999854 456899
Q ss_pred hhhhccCCchhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 598 VYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDC--SAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.. ..+|+||||||+||||++++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999998853 457899999999999999999999752 2359999999999999999999999999999
Q ss_pred cccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccc
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 751 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 751 (814)
.+..+... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+..+....
T Consensus 163 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~~~~ 233 (269)
T d2java1 163 ILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRR 233 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCC
T ss_pred ecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCCC
Confidence 87543322 345679999999999999999999999999999999999999997543211 223333343322
Q ss_pred cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 752 LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 752 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+..+++++.+|+.+||+.||.+|||+.|+++
T Consensus 234 ---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 12346678999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-46 Score=396.13 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=212.0
Q ss_pred hhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccccc-cchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+++.++||+|+||+||+|.... ...+++.||||+++.... +..++|.+|++++++++||||++++++|.+.+..++|
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 4556889999999999999864 223567899999975433 3356799999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCC------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 042262 599 YEFLNNGTLASFLFGN------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 654 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NI 654 (814)
|||+++|+|.+++... ..+++..++.|+.||++||+|||+ .+||||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccce
Confidence 9999999999998532 247899999999999999999995 5999999999999
Q ss_pred EECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCC-cCCcccCCcch
Q 042262 655 LLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEY 733 (814)
Q Consensus 655 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~-~p~~~~~~~~~ 733 (814)
||+.++.+||+|||+++.+.........+...|+..|+|||.+.+..++.|+|||||||++|||++|. +||......+
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e- 250 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE- 250 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH-
Confidence 99999999999999998776554444345567899999999999999999999999999999999996 4565332211
Q ss_pred hhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 734 AILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 734 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
....+..+.... .+..++.++.+|+.+||+.||.+||||.||+++|+.+.+
T Consensus 251 ------~~~~v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 251 ------VIYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp ------HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ------HHHHHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 123334443322 233556789999999999999999999999999998764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-45 Score=391.46 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=192.6
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
.+++.+.||+|+||+||+|.... .++.||||++.... ....+.+.+|++++++++|||||++++++.+++..+|||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKR---TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETT---TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 36677899999999999999864 56789999986532 334467889999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC---CCCCeEEeecCCccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD---DYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DfGla~~~~~~ 676 (814)
||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||+. +++.+||+|||+++.....
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 999999999999988899999999999999999999995 5999999999999995 5789999999999876543
Q ss_pred ccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
.. .....||+.|+|||.+.+..++.++|||||||+||||++|+.||....... ....+..+...
T Consensus 164 ~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~------ 227 (307)
T d1a06a_ 164 SV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEYE------ 227 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHTTCCC------
T ss_pred Ce---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCCC------
Confidence 22 334679999999999999999999999999999999999999997543211 11222222211
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.........++++.+++.+||+.||.+|||++|+++
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111123356788999999999999999999999988
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=393.16 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=200.5
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc-chhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
..+++.+.||+|+||+||+|.+...+.....||||+++..... ..+.|.+|+.++++++|||||+++|++.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 3456778999999999999998765556678999999754333 34679999999999999999999999964 678999
Q ss_pred hhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||+++|+|.+++.. ...+++..++.++.||++||.|||+ .+|+||||||+||++++++.+||+|||+++.+....
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999998754 4578999999999999999999995 599999999999999999999999999998765443
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 756 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 756 (814)
... .....||..|+|||.+.+..++.++|||||||++|||++ |+.||......+ +...+..+...
T Consensus 163 ~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~~i~~~~~~------ 228 (273)
T d1mp8a_ 163 YYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERL------ 228 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCC------
T ss_pred cee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC------
Confidence 322 344568999999999999999999999999999999998 888987544322 11222333221
Q ss_pred ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 757 TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 757 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
..+..+++++.+|+..||+.||++|||+.||++.|+.++
T Consensus 229 ---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 229 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 123456788999999999999999999999999997654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-45 Score=392.21 Aligned_cols=246 Identities=23% Similarity=0.281 Sum_probs=203.6
Q ss_pred HHhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
..+...++||+|+||+||+|.... ++..||||+++.... ...+++.+|+.++++++|||||++++++.+++..+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECC---CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 345667889999999999999864 578899999865332 23356899999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
|||||+.+|+|..++.....+++..+..|+.||+.||.|||+ .+|+||||||+||||++++.+||+|||+++.....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999999998888777889999999999999999999995 59999999999999999999999999999875432
Q ss_pred ccccccccccCCCCccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRN---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
....||+.|+|||++.+ +.++.++|||||||++|||++|+.||...... +...... .+....
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~-~~~~~~-- 233 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA-QNESPA-- 233 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSCCCC--
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-hCCCCC--
Confidence 33569999999999864 46899999999999999999999999643221 1111111 121111
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...++++.+++.+||+.||.+|||+.|+++
T Consensus 234 ------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 ------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 122345688999999999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=392.77 Aligned_cols=259 Identities=25% Similarity=0.460 Sum_probs=207.1
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeecc-CCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~e 600 (814)
+|.++||+|+||+||+|.+...+.....||||+++.. .....++|.+|++++++++||||++++|++.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4567899999999999999765444567999999753 33345789999999999999999999999865 457899999
Q ss_pred hccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 601 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 601 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|+++|+|.+++... ..+++..+++++.|+++||.|||+ .+|+||||||+||||++++.+||+|||+++.+......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999988755 467888999999999999999995 59999999999999999999999999999987544332
Q ss_pred c--ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 680 A--IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 680 ~--~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
. ......||..|+|||.+.+..++.++||||||+++|||++|+.|+........ + ...+..|...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~----~~~i~~g~~~------- 253 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--I----TVYLLQGRRL------- 253 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------C----HHHHHTTCCC-------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--H----HHHHHcCCCC-------
Confidence 1 23345689999999999999999999999999999999998888764432211 1 1122223211
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
..+..+++++.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 254 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 254 --LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1233456789999999999999999999999999987643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=384.91 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=196.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeecc-CCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~e 600 (814)
+.+.+.||+|+||.||+|.+. +..||||+++.. ...++|.+|++++++++||||++++|+|.+ .+..+||||
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET-----TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred eEEeEEEecCCCeEEEEEEEC-----CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 356788999999999999984 567999999653 345789999999999999999999999865 456899999
Q ss_pred hccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 601 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 601 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|+++|+|.+++... ..+++..+++|+.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 99999999999654 358999999999999999999995 59999999999999999999999999999875433
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.....++..|+|||++.+..++.++||||||+++|||+| |+.|+....... + ...+..+...
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~----~~~i~~~~~~------- 219 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPRVEKGYKM------- 219 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---H----HHHHTTTCCC-------
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCCCC-------
Confidence 223457899999999999999999999999999999998 677776443221 1 1222333221
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
..+...+.++.+|+.+||+.||.+||||.||+++|+.+.
T Consensus 220 --~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 220 --DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 223355678999999999999999999999999998653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-44 Score=392.32 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=208.5
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.+.+.||+|+||+||+|.... .+..||||++........+.+.+|+.++++++|||||++++++.+++..+||||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~---~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46677899999999999999864 578999999976655556789999999999999999999999999999999999
Q ss_pred hccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC--CCCeEEeecCCcccccccc
Q 042262 601 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD--YYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 601 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~~ 677 (814)
|+++|+|.+++.. ...+++..+..|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.+....
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999999854 4579999999999999999999995 59999999999999964 6789999999998775433
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..+... .
T Consensus 181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~------~ 244 (350)
T d1koaa2 181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWN------M 244 (350)
T ss_dssp C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC------S
T ss_pred c---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC------C
Confidence 2 345679999999999999999999999999999999999999997443211 11122222111 1
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
........++++.+++.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111123456789999999999999999999999884
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=391.21 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=203.0
Q ss_pred hhhhccccccceeEEEEEEEeccC-CcceEEEEEeeccc-cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTR-TSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~-~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.++||+|+||+||+|.+..++ .....||||+++.. ..+..++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 456689999999999999986532 22346999998653 344567899999999999999999999999875 567888
Q ss_pred hhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+.+|+|.+++.. ...+++..+++|+.|||+||+|||+ .+|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 99999999887765 4678999999999999999999995 5999999999999999999999999999998766554
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
........||..|+|||.+.++.++.++|||||||+||||+| |+.||......+ + ...+..+..
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~----~~~i~~~~~-------- 231 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGER-------- 231 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---H----HHHHHHTCC--------
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCCC--------
Confidence 443445568999999999999999999999999999999998 788886543222 1 122222221
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
...+..+++++.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 232 -~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 -LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 122345678899999999999999999999999987543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=391.50 Aligned_cols=262 Identities=27% Similarity=0.378 Sum_probs=201.6
Q ss_pred HHhhhhccccccceeEEEEEEEeccC--CcceEEEEEeecccc-ccchhhhhceeeEEeec-cccceeeeeeeeccC-Cc
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG-QN 594 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~ 594 (814)
..+.+.++||+|+||.||+|.+.... ..++.||||+++... ....+++..|...+.++ +|+||+.+++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 34667789999999999999987532 345789999997533 23345677888887776 789999999998664 56
Q ss_pred eehhhhhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 042262 595 RLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 658 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~ 658 (814)
.++||||+++|+|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence 88999999999999998642 247899999999999999999995 59999999999999999
Q ss_pred CCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCC-cCCcccCCcchhhHH
Q 042262 659 YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILT 737 (814)
Q Consensus 659 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~ 737 (814)
++.+||+|||+++...............||..|+|||.+.+..++.++|||||||++|||++|. .||.......
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~----- 244 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 244 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-----
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 9999999999998776554444345567999999999999999999999999999999999975 5665433221
Q ss_pred HHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 738 DWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 738 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.....+..+.... .+...++++.+++.+||+.||++||||.||+++|+.+++
T Consensus 245 -~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 245 -EFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp -HHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1222333332221 223456789999999999999999999999999987653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=383.98 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=200.2
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||+||+|.+.........||||+++.. ..+..++|.+|++++++++||||++++|+|.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 45678899999999999998765555678999998653 22334679999999999999999999999976 467899
Q ss_pred hhhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 599 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|||+++|+|.+.+.. ...+++..++.++.|||+||.|||+ .+|+||||||+||+|+.++.+||+|||+++.+....
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 999999999987765 3569999999999999999999995 599999999999999999999999999999876544
Q ss_pred ccc-ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHHHHHHHHHhcCCccccccC
Q 042262 678 SKA-IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 755 (814)
Q Consensus 678 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 755 (814)
... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+ ......+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~~~~------ 233 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGER------ 233 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCCC------
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHHHHhCCCC------
Confidence 322 2334567889999999999999999999999999999998 899996443221 12222233221
Q ss_pred cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcC
Q 042262 756 DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEG 796 (814)
Q Consensus 756 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~ 796 (814)
...+..++.++.+|+.+||+.||++||||.||+++|++
T Consensus 234 ---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 ---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11233566789999999999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-45 Score=387.90 Aligned_cols=255 Identities=29% Similarity=0.457 Sum_probs=204.5
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeeccc-cccchhhhhceeeEEeec-cccceeeeeeeeccCCceehhhh
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 600 (814)
.+.++||+|+||+||+|.+..++ ....||||+++.. .....++|.+|++++.++ +|||||+++|+|.+++..++|||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETT-EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred EEEEEEeeCCCcEEEEEEECCCC-eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 45688999999999999987532 2346889988643 334566899999999998 79999999999999999999999
Q ss_pred hccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEE
Q 042262 601 FLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 664 (814)
Q Consensus 601 ~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl 664 (814)
|+++|+|.++|+.. ..+++..+.+++.|||+||.|||+ .+|+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEE
Confidence 99999999998643 568999999999999999999995 59999999999999999999999
Q ss_pred eecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCc-CCcccCCcchhhHHHHHHHH
Q 042262 665 SDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRK-SFDIEMGEEYAILTDWAFDC 743 (814)
Q Consensus 665 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~~~ 743 (814)
+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||...... .....
T Consensus 169 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-------~~~~~ 238 (309)
T d1fvra_ 169 ADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYEK 238 (309)
T ss_dssp CCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHH
T ss_pred cccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH-------HHHHH
Confidence 99999986654322 234458999999999999999999999999999999999765 55432111 11222
Q ss_pred HhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcCC
Q 042262 744 YRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 800 (814)
Q Consensus 744 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~~ 800 (814)
+..+.. ...+..+++++.+|+.+||+.||++||||+||++.|+.+++-
T Consensus 239 i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 239 LPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 223221 122345678999999999999999999999999999876643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.6e-44 Score=390.11 Aligned_cols=249 Identities=25% Similarity=0.339 Sum_probs=207.9
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
+++.+.||+|+||+||+|.... .++.||||+++.......+.+++|+.++++++|||||++++++.+++..+|||||
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 5677899999999999999864 5789999999765444566788999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC--CCCCeEEeecCCccccccccc
Q 042262 602 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD--DYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 602 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~--~~~~~kl~DfGla~~~~~~~~ 678 (814)
+++|+|.+++... ..+++.+++.|+.||++||+|||+ .+|+||||||+||||+ .++.+||+|||+++.+..+..
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999999877654 469999999999999999999995 5999999999999998 678999999999998765432
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.....||..|+|||++.+..++.++||||+||+||||++|+.||....... ....+..+... ..
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~~------~~ 248 (352)
T d1koba_ 185 ---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWE------FD 248 (352)
T ss_dssp ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCCC------CC
T ss_pred ---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC------CC
Confidence 344568999999999999999999999999999999999999996443211 11222222211 11
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.......+.++.+|+.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122356788999999999999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=382.84 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=206.8
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc------cchhhhhceeeEEeeccccceeeeeeeeccCCc
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 594 (814)
.+.+.+.||+|+||+||+|.... +++.||||+++.... ...+.+.+|+.++++++|||||++++++.+.+.
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CEEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 46677899999999999999864 577899999864321 124568999999999999999999999999999
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC----CeEEeecCCc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY----NARISDFGLA 670 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DfGla 670 (814)
.+|||||+++|+|.+++.....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999999999999888889999999999999999999995 5999999999999998776 4999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
+....... .....||..|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+..+...
T Consensus 165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~ 234 (293)
T d1jksa_ 165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNYE 234 (293)
T ss_dssp EECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCCC
T ss_pred hhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcCCC
Confidence 87754332 334568999999999999999999999999999999999999997543221 11222222211
Q ss_pred ccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 751 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.........+.++.+++.+||+.||.+|||++|+++
T Consensus 235 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 ------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111112245678899999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=384.85 Aligned_cols=260 Identities=28% Similarity=0.393 Sum_probs=209.2
Q ss_pred HhhhhccccccceeEEEEEEEeccC----CcceEEEEEeeccccc-cchhhhhceeeEEeec-cccceeeeeeeeccCCc
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTR----TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN 594 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~----~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 594 (814)
.+.+.+.||+|+||.||+|...... .....||||+++.... ....++.+|...+.++ +|||||+++++|.+++.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 4566789999999999999976432 2346899999976433 3346788899988888 89999999999999999
Q ss_pred eehhhhhccCCchhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 042262 595 RLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 658 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~ 658 (814)
.++||||+++|+|.++|... ..+++..++.++.||+.||+|||+ .+||||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecC
Confidence 99999999999999999643 358999999999999999999995 59999999999999999
Q ss_pred CCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCcccCCcchhhHH
Q 042262 659 YYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILT 737 (814)
Q Consensus 659 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~ 737 (814)
++.+||+|||+++...............+|..|+|||.+.++.++.|+||||||+++|||++ |..||......
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~------ 244 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ 244 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH------
Confidence 99999999999998766554443455678999999999999999999999999999999998 67777533221
Q ss_pred HHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 738 DWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 738 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.+...+..+... ..+..++.++.+|+.+||+.||++||||.||+++|+.++.
T Consensus 245 -~~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 -ELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 123334443322 1233466789999999999999999999999999987654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-45 Score=389.02 Aligned_cols=263 Identities=26% Similarity=0.412 Sum_probs=214.2
Q ss_pred HHHHHhhhhccccccceeEEEEEEEec--cCCcceEEEEEeeccccc-cchhhhhceeeEEeec-cccceeeeeeeeccC
Q 042262 517 LEEATDNFEEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG 592 (814)
Q Consensus 517 l~~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 592 (814)
+....+.+.+.||+|+||.||+|++.. ....++.||||+++.... ....+|.+|+.++.++ +|||||+++|+|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 444466778899999999999999864 234678999999975432 3345789999999998 799999999999999
Q ss_pred CceehhhhhccCCchhhhhcCC------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 042262 593 QNRLLVYEFLNNGTLASFLFGN------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 654 (814)
Q Consensus 593 ~~~~lV~e~~~~gsL~~~l~~~------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NI 654 (814)
...+|||||+++|+|.++++.. ..+++..++.++.||++||+|||+ .+|+||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccc
Confidence 9999999999999999998643 257899999999999999999995 5999999999999
Q ss_pred EECCCCCeEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhC-CcCCcccCCcch
Q 042262 655 LLDDYYNARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISC-RKSFDIEMGEEY 733 (814)
Q Consensus 655 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG-~~p~~~~~~~~~ 733 (814)
+++.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+|+ .+|+......+.
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999987655444445567799999999999999999999999999999999995 455543322211
Q ss_pred hhHHHHHHHHHhcCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCC
Q 042262 734 AILTDWAFDCYRNGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGV 797 (814)
Q Consensus 734 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~ 797 (814)
....+..+. ....+...+.++.+|+.+||+.||.+||||.||+++|++.
T Consensus 257 ------~~~~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 ------FYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ------HHHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHHhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 122222222 1122334568899999999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=384.87 Aligned_cols=261 Identities=27% Similarity=0.462 Sum_probs=212.3
Q ss_pred HHhhhhccccccceeEEEEEEEecc--CCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCCcee
Q 042262 520 ATDNFEEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 520 ~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 596 (814)
....+.++||+|+||+||+|.+... ...++.||||+++... ......|.+|+.++++++||||++++|+|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 3445678899999999999998632 1245789999997543 233456899999999999999999999999999999
Q ss_pred hhhhhccCCchhhhhcCC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEee
Q 042262 597 LVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISD 666 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 666 (814)
+||||+++|+|.+++... ..+++..+.+|+.|+|+||.|||+ .+|+||||||+|||+++++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 999999999999988532 346899999999999999999995 5999999999999999999999999
Q ss_pred cCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCC-cCCcccCCcchhhHHHHHHHHHh
Q 042262 667 FGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDCYR 745 (814)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~ 745 (814)
||+++.+.............||..|+|||.+.+..++.++||||||+++|||+||+ .|+...... + ....+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~-~~~~i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q-VLRFVM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H-HHHHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHH
Confidence 99999876554444344556899999999999999999999999999999999986 555432211 1 122223
Q ss_pred cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCcC
Q 042262 746 NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 799 (814)
Q Consensus 746 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~~ 799 (814)
.+.... .+..++..+.+++.+||+.+|++||||.||+++|++.++
T Consensus 250 ~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 332211 233566889999999999999999999999999988655
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=381.31 Aligned_cols=246 Identities=23% Similarity=0.269 Sum_probs=207.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||.||+|.... ++..+|||++++. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred cEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 4566899999999999999864 5789999999653 233456788999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|.+++.....+++...+.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 9999999999999988899999999999999999999995 5999999999999999999999999999987654322
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
. ....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .......+..
T Consensus 161 ~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~~--------- 222 (337)
T d1o6la_ 161 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI--------- 222 (337)
T ss_dssp C--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC---------
T ss_pred c--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHHHHhcCCC---------
Confidence 2 345679999999999999999999999999999999999999997543221 1222222221
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~eV~~ 792 (814)
..+...+.++.+|+.+||+.||.+||+ ++|+++
T Consensus 223 -~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 123356678899999999999999995 777776
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-43 Score=377.84 Aligned_cols=243 Identities=25% Similarity=0.335 Sum_probs=206.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceehh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 598 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 598 (814)
+.+.+.||+|+||+||+|.... +++.||||+++.. .....+.+.+|+.++++++|||||++++++.+++..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 4567899999999999999864 5789999999643 233456789999999999999999999999999999999
Q ss_pred hhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 599 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 599 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
|||+++|+|..++.....+++.....++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 999999999999998888999999999999999999999 569999999999999999999999999999876532
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.....||+.|+|||.+.+..++.++||||+||+||||++|+.||......+ ....+..+..
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~--------- 218 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAEL--------- 218 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHCCC---------
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-------HHHHHHcCCC---------
Confidence 334679999999999999999999999999999999999999997543211 1122222221
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~ 792 (814)
..+...++++.+++.+||+.||.+|| |++|+++
T Consensus 219 -~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 12234567899999999999999996 8999876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=377.69 Aligned_cols=266 Identities=21% Similarity=0.267 Sum_probs=200.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCC----ceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----NRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~l 597 (814)
+.+.++||+|+||+||+|++ .+..||||+++... .....++.|+..+..++|||||+++++|.+.+ ..+|
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-----~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-----TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 34567899999999999987 36789999986532 22223455666777889999999999997643 5789
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-----SAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
||||+++|+|.++|+.. .++|..+++++.|+|+||+|||... ..+|+||||||+||||++++.+||+|||+++.
T Consensus 79 v~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999999764 6899999999999999999999632 36999999999999999999999999999997
Q ss_pred cccccccc--ccccccCCCCccCcccccCCC------CCCccchhhHHHHHHHHHhCCcCCcccCCcch--------hhH
Q 042262 673 LTLNQSKA--IKTAIRGTKGYVAPEWFRNST------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--------AIL 736 (814)
Q Consensus 673 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~--------~~l 736 (814)
........ ......||+.|+|||++.+.. ++.|+|||||||+||||+||..|+........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 75433221 133467999999999987643 67799999999999999999988754322110 001
Q ss_pred HHHHHHHHhcCCccccccCccc-ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 737 TDWAFDCYRNGKLDDLVEGDTE-AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 737 ~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
..........+.+ .+... .....+....+.+|+.+||+.||++||||.||++.|+++.
T Consensus 238 ~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 238 VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1112222222111 11111 1123456778999999999999999999999999997654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=374.46 Aligned_cols=260 Identities=22% Similarity=0.274 Sum_probs=200.6
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccccc-----chhhhhceeeEEeeccccceeeeeeeeccCCceehhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD-----GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 600 (814)
+.||+|+||+||+|.+.. .++.||||+++..... ..+.+.+|+.++++++|||||++++++.++++.+||||
T Consensus 4 ~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eEeccCcCeEEEEEEECC---CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 679999999999999864 5778999998643221 23568899999999999999999999999999999999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 680 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 680 (814)
|+.++++..++.....+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~- 156 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA- 156 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence 99999988888778889999999999999999999995 59999999999999999999999999999876544322
Q ss_pred ccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc-----
Q 042262 681 IKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE----- 754 (814)
Q Consensus 681 ~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~----- 754 (814)
.....||..|+|||.+.+. .++.++|||||||+++||++|+.||......+. + ..+.+...........+
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l-~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--L-TRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHHHCCCCTTTSSSTTSST
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH--H-HHHHHhcCCCChhhccchhccc
Confidence 2345699999999998654 679999999999999999999999975433221 1 11111111100000000
Q ss_pred -----Cccc----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHcC
Q 042262 755 -----GDTE----AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEG 796 (814)
Q Consensus 755 -----~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~--~L~~ 796 (814)
.... .......++++.+|+.+||+.||++|||++|+++ .+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 0000 0001234578999999999999999999999987 3543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.3e-43 Score=368.04 Aligned_cols=249 Identities=22% Similarity=0.303 Sum_probs=205.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc---------chhhhhceeeEEeecc-ccceeeeeeeecc
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD---------GEKEFKNEVVVIGQTH-HKNLVRLLGFCDE 591 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~---------~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~ 591 (814)
+++.+.||+|+||+||+|+... +++.+|||+++..... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CEEceEEecCcCeEEEEEEECC---CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4567899999999999998764 5789999998653211 1235889999999997 9999999999999
Q ss_pred CCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 592 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 592 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
+++.+|||||+++|+|.++|.....+++.+++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999999888889999999999999999999995 599999999999999999999999999999
Q ss_pred cccccccccccccccCCCCccCcccccC------CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHh
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFRN------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 745 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 745 (814)
.+..... .+...||..|+|||++.+ ..++.++||||+||+|+||++|+.||....... ....+.
T Consensus 159 ~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i~ 228 (277)
T d1phka_ 159 QLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIM 228 (277)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH
T ss_pred EccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHHH
Confidence 8764332 344679999999999853 357889999999999999999999997543211 122222
Q ss_pred cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 746 NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 746 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.+... .........++++.+++.+||+.||.+|||+.||++
T Consensus 229 ~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 23221 111123356789999999999999999999999865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.4e-43 Score=371.30 Aligned_cols=257 Identities=22% Similarity=0.296 Sum_probs=202.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc---cchhhhhceeeEEeeccccceeeeeeeeccCC----c
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----N 594 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~ 594 (814)
+.+.+.||+|+||+||+|.+.. .++.||||+++.... ...+.|.+|+.+++.++||||+++++++...+ .
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred eEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 5677899999999999999864 578999999975332 23456899999999999999999999986644 3
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
.+|||||+++++|.+++.....+++.+++.|+.||++||+|||+ .+|+||||||+|||++.++..+|+|||.++...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhc
Confidence 78999999999999999888889999999999999999999995 599999999999999999999999999987664
Q ss_pred ccccc-cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccc
Q 042262 675 LNQSK-AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 753 (814)
Q Consensus 675 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 753 (814)
..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...... +......+.+...
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP--- 233 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC---
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCC---
Confidence 33221 2234567999999999999999999999999999999999999999754321 1222333332221
Q ss_pred cCcccccCChhHHHHHHHHHHHccccCCCCCC-CHHHHHHHHcCC
Q 042262 754 EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRP-TMRKVSQMLEGV 797 (814)
Q Consensus 754 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-tm~eV~~~L~~~ 797 (814)
........++++.+++.+||+.||.+|| |++|+.+.|..+
T Consensus 234 ----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 ----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1112335678899999999999999999 899998887654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-43 Score=375.98 Aligned_cols=246 Identities=28% Similarity=0.363 Sum_probs=203.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEe-eccccceeeeeeeeccCCceeh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIG-QTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~l 597 (814)
+.+.+.||+|+||+||+|+... +++.||||+++.. .....+.+..|..++. .++|||||++++++.+++..+|
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~---t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECC---CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 4567899999999999999874 5789999999643 2233345666766665 5899999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
||||+++|+|.+++.....+++.++..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 99999999999999988889999999999999999999995 599999999999999999999999999998765433
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.. .+...||..|+|||++.+..++.++|||||||++|||++|+.||....... ....+..+..
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~-------- 220 (320)
T d1xjda_ 158 AK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNP-------- 220 (320)
T ss_dssp CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC--------
T ss_pred cc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC--------
Confidence 22 345679999999999999999999999999999999999999997543221 1222222221
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRPTMR-KVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~-eV~~ 792 (814)
..+...+.++.+|+.+||+.||.+|||+. |+++
T Consensus 221 --~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 12234567899999999999999999996 7754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-42 Score=378.54 Aligned_cols=247 Identities=23% Similarity=0.257 Sum_probs=199.6
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc---ccchhhhhc---eeeEEeeccccceeeeeeeeccCCce
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF---QDGEKEFKN---EVVVIGQTHHKNLVRLLGFCDEGQNR 595 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~---~~~~~~~~~---Ei~~l~~l~H~niv~l~g~~~~~~~~ 595 (814)
+.+.+.||+|+||.||+|.... +++.||||++.... ......+.+ |+.+++.++|||||++++++.+.+..
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred CeeeeEEecCCCeEEEEEEECC---CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 4566889999999999999864 57799999986421 122233333 46677788899999999999999999
Q ss_pred ehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccc
Q 042262 596 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 675 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 675 (814)
+|||||+++|+|.++|.....+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+..
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999999999888889999999999999999999995 5999999999999999999999999999987654
Q ss_pred cccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 676 NQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 676 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.. .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||..........+ .......
T Consensus 160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~~~------- 224 (364)
T d1omwa3 160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTM------- 224 (364)
T ss_dssp SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----HHHSSSC-------
T ss_pred Cc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcccC-------
Confidence 32 234579999999999975 5689999999999999999999999976543321111 1111111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 792 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~eV~~ 792 (814)
....+...++++.+++.+||+.||.+||| ++|+++
T Consensus 225 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 ---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11123346678999999999999999999 678765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-42 Score=376.80 Aligned_cols=244 Identities=24% Similarity=0.251 Sum_probs=205.9
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc---cccchhhhhceeeEEeeccccceeeeeeeeccCCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 597 (814)
.+++.++||+|+||.||+|.+.. +++.||||+++.. .....+.+.+|+.+++.++|||||++++++.+....++
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~---~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 35666899999999999999864 5778999998642 22334568899999999999999999999999999999
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 677 (814)
|+||+.+|+|..++.....+++..+..|+.||+.||.|||+ .+||||||||+||||+.++.+||+|||+++.+...
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 99999999999999888889999999999999999999995 59999999999999999999999999999876532
Q ss_pred cccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCcc
Q 042262 678 SKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDT 757 (814)
Q Consensus 678 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 757 (814)
.....||+.|+|||.+.+..++.++|||||||+||||++|+.||....... ....+..+..
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~-------- 255 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKV-------- 255 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC--------
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-------HHHHHhcCCC--------
Confidence 234569999999999999999999999999999999999999997542211 1222222221
Q ss_pred cccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042262 758 EAMNDIKCTEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 792 (814)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----tm~eV~~ 792 (814)
..+...+.++.+++.+||+.||.+|+ |++|+++
T Consensus 256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11234667899999999999999994 8999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=371.35 Aligned_cols=248 Identities=20% Similarity=0.286 Sum_probs=204.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeeccCCceehhhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 601 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 601 (814)
|.+.+.||+|+||+||+|.... +++.+|||.++... .....+.+|+++++.++|||||++++++.++++.+|||||
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~---~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred eEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 5667899999999999999875 56789999997542 3345688999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC--CCCeEEeecCCccccccccc
Q 042262 602 LNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD--YYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 602 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~~~ 678 (814)
+++|+|.+++.... .+++.++..|+.||++||+|||+ .+|+||||||+|||++. ...+||+|||+++.......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999998664 78999999999999999999995 59999999999999985 45799999999987654332
Q ss_pred ccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCccc
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDTE 758 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 758 (814)
.....+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+ ....+..+... ..
T Consensus 160 ---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-------~~~~i~~~~~~------~~ 223 (321)
T d1tkia_ 160 ---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT------FD 223 (321)
T ss_dssp ---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC------CC
T ss_pred ---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC------CC
Confidence 234568999999999999999999999999999999999999997543221 11222222111 00
Q ss_pred ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 759 AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 759 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.......+.++.+++.+||+.||.+|||+.|+++
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111235678899999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=371.64 Aligned_cols=248 Identities=23% Similarity=0.276 Sum_probs=195.5
Q ss_pred hhhh-ccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeec-cccceeeeeeeecc----CCce
Q 042262 522 DNFE-EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE----GQNR 595 (814)
Q Consensus 522 ~~~~-~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~ 595 (814)
+.+. +.||+|+||+||+|.+.. +++.||||+++. .+.+.+|++++.++ +|||||++++++.+ ....
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECC---CCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3443 469999999999999864 567899999864 34577888886654 89999999999865 4668
Q ss_pred ehhhhhccCCchhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCCeEEeecCCc
Q 042262 596 LLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARISDFGLA 670 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DfGla 670 (814)
+|||||+++|+|.++|... ..+++.++..|+.||++||+|||+ .+|+||||||+|||+++ .+.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence 9999999999999999763 468999999999999999999995 59999999999999985 557999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcc
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 750 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 750 (814)
+....... .....||+.|+|||++.+..++.++|||||||+||||++|+.||......... .........+.
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~-- 233 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQ-- 233 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS--
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcCC--
Confidence 87664432 34467999999999999999999999999999999999999999754332211 00011111111
Q ss_pred ccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 751 DLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 751 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
...........++++.+|+.+||+.||++|||+.|+++
T Consensus 234 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 01111112356788999999999999999999999988
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=363.10 Aligned_cols=239 Identities=24% Similarity=0.423 Sum_probs=197.0
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc------chhhhhceeeEEeecc--ccceeeeeeeeccC
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTH--HKNLVRLLGFCDEG 592 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~------~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~ 592 (814)
.+.+.+.||+|+||+||+|.... +++.||||+++..... ...++.+|+.++++++ |||||++++++.+.
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred eEEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 45677899999999999999864 5688999998643211 2245778999999886 89999999999999
Q ss_pred CceehhhhhccC-CchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCCeEEeecCCc
Q 042262 593 QNRLLVYEFLNN-GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLA 670 (814)
Q Consensus 593 ~~~~lV~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla 670 (814)
+..++||||+.+ +++.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 999999999976 6788888877889999999999999999999995 59999999999999985 578999999999
Q ss_pred ccccccccccccccccCCCCccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCc
Q 042262 671 KLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 749 (814)
Q Consensus 671 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 749 (814)
+...... .+...||..|+|||++.+..+ +.++||||+||++|||++|+.||.... + ...+..
T Consensus 159 ~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~-i~~~~~ 221 (273)
T d1xwsa_ 159 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------E-IIRGQV 221 (273)
T ss_dssp EECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------H-HHHCCC
T ss_pred eeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------H-Hhhccc
Confidence 8754332 345679999999999987765 567999999999999999999996321 0 111111
Q ss_pred cccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 750 DDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 750 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..+...++++.+++.+||+.||++|||++|+++
T Consensus 222 ----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 ----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 112245678999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-41 Score=358.16 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=200.0
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.++||+|+||+||+|.+. .++.||||+++.. .....+++.+|+.++++++||||+++++++.++++.++++
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ceeccEEecCCCcEEEEEEeC----CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 455678999999999999875 4678999999653 2333567999999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
||+.++.+..+......+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 999998888888888889999999999999999999995 59999999999999999999999999999876543222
Q ss_pred cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC------cccc
Q 042262 680 AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK------LDDL 752 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~l 752 (814)
.....++..|+|||.+.+. .++.++||||+||+++||++|+.||......+ .+.. ......... ....
T Consensus 157 --~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~-i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 157 --YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMR-IFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGGS
T ss_pred --cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHH-HHHhhCCCChhhccchhhh
Confidence 2344589999999999765 57999999999999999999999997543211 1111 111110000 0000
Q ss_pred ---------ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 753 ---------VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 753 ---------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.............+.++.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000011122345678899999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=359.25 Aligned_cols=259 Identities=24% Similarity=0.322 Sum_probs=197.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.++||+|+||+||+|.+.. .++.||||+++... ....+++.+|++++++++|||||++++++.++++.+|||
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CEeccEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 3456789999999999999864 56789999996432 233567899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccccc
Q 042262 600 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 678 (814)
Q Consensus 600 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 678 (814)
||+.++.+...... ...+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++.......
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 99976555544333 4568999999999999999999995 5999999999999999999999999999987654332
Q ss_pred ccccccccCCCCccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCccccccCc-
Q 042262 679 KAIKTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD- 756 (814)
Q Consensus 679 ~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~- 756 (814)
. .....||..|+|||.+.... .+.++||||+||++|||++|+.||......+ .+.. ..... +...+...+.
T Consensus 158 ~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~-i~~~~--~~~~~~~~~~~ 230 (298)
T d1gz8a_ 158 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFR-IFRTL--GTPDEVVWPGV 230 (298)
T ss_dssp C--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHH--CCCCTTTSTTG
T ss_pred c--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHH-HHHhc--CCCchhhcccc
Confidence 2 34457999999999887665 5789999999999999999999997543221 1111 11111 1111100000
Q ss_pred ---------cc-------ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 757 ---------TE-------AMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 757 ---------~~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.. .......++++.+++.+||+.||.+|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 00112345788999999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-41 Score=357.11 Aligned_cols=266 Identities=23% Similarity=0.328 Sum_probs=199.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeec---cccceeeeeeeec-----
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQT---HHKNLVRLLGFCD----- 590 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~----- 590 (814)
.+++.++||+|+||+||+|.+... .++.||||+++... .....++.+|+++++.+ +||||+++++++.
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CEEEEEEEecccCeEEEEEEEECC--CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 456678899999999999998542 35789999986532 22234567788887766 7999999999984
Q ss_pred cCCceehhhhhccCCchhhhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCC
Q 042262 591 EGQNRLLVYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 669 (814)
Q Consensus 591 ~~~~~~lV~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl 669 (814)
.....++++||+.++.+..... ....+++...+.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhh
Confidence 3456899999999988765543 44678999999999999999999995 5999999999999999999999999999
Q ss_pred cccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhc-CC
Q 042262 670 AKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-GK 748 (814)
Q Consensus 670 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~ 748 (814)
++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+.. ....... ..
T Consensus 163 ~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~-i~~~~~~~~~ 236 (305)
T d1blxa_ 163 ARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGK-ILDVIGLPGE 236 (305)
T ss_dssp CCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCG
T ss_pred hhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HHHH-HHHhhCCCch
Confidence 987554332 345679999999999999999999999999999999999999997543221 1111 1111110 00
Q ss_pred --ccc-------cc---cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HcCC
Q 042262 749 --LDD-------LV---EGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEGV 797 (814)
Q Consensus 749 --~~~-------l~---~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~--L~~~ 797 (814)
... .. ............++.+.+|+.+||+.||++|||+.|+++. ++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 000 00 0000111123456788999999999999999999999873 5444
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-40 Score=358.06 Aligned_cols=256 Identities=24% Similarity=0.291 Sum_probs=193.8
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeeeeeeecc------CCce
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------GQNR 595 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~~ 595 (814)
|...++||+|+||+||+|++.. .++.||||++... ...+.+|++++++++|+||+++++++.. ..+.
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC----SSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred cEeeeEEeeCcCeEEEEEEECC---CCCEEEEEEECcc----chHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 4455789999999999999874 5789999998643 2345679999999999999999999843 2346
Q ss_pred ehhhhhccCCchhhhh---cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-CeEEeecCCcc
Q 042262 596 LLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAK 671 (814)
Q Consensus 596 ~lV~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~ 671 (814)
+|||||++++.+..+. .....+++.+++.++.||++||+||| +.+|+||||||+|||++.++ .+||+|||+++
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 8999999876544433 34567999999999999999999999 56999999999999999765 89999999998
Q ss_pred cccccccccccccccCCCCccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHH---------
Q 042262 672 LLTLNQSKAIKTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------- 741 (814)
Q Consensus 672 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------- 741 (814)
.+..... .....||..|+|||.+.+ ..++.++||||+||+++||++|+.||......+. +.....
T Consensus 172 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 172 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQ 246 (350)
T ss_dssp ECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred hccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHh
Confidence 7754432 234568999999998875 4689999999999999999999999975543211 111100
Q ss_pred -HHHh----cCCccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 742 -DCYR----NGKLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 742 -~~~~----~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.... ....................++++.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 01111111111111223345678999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-40 Score=350.50 Aligned_cols=254 Identities=21% Similarity=0.253 Sum_probs=207.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc----ccchhhhhceeeEEeeccc-cceeeeeeeeccCCcee
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEGQNRL 596 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~ 596 (814)
+.+.++||+|+||+||+|.....+..++.||||+++... ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 667789999999999999987666678899999986432 2234678999999999976 89999999999999999
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
+|+||+.+|+|.+++.....++......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 999999999999999988888999999999999999999995 59999999999999999999999999999877544
Q ss_pred ccccccccccCCCCccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccccc
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 754 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 754 (814)
.... .....|+..|+|||.+.+. .++.++|||||||+||||++|+.||.......... . .........
T Consensus 183 ~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~-i~~~~~~~~------ 252 (322)
T d1vzoa_ 183 ETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--E-ISRRILKSE------ 252 (322)
T ss_dssp GGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--H-HHHHHHHCC------
T ss_pred cccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHhcccCC------
Confidence 3332 3445699999999999765 47889999999999999999999997654332111 1 111111111
Q ss_pred CcccccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042262 755 GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 792 (814)
Q Consensus 755 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----m~eV~~ 792 (814)
...+...+.++.+++.+||+.||.+||| ++|+++
T Consensus 253 ----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1123356789999999999999999994 788876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-40 Score=348.51 Aligned_cols=260 Identities=18% Similarity=0.180 Sum_probs=196.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccceeee-eeeeccCCceehhhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL-LGFCDEGQNRLLVYE 600 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l-~g~~~~~~~~~lV~e 600 (814)
+.+.+.||+|+||+||+|.+.. +++.||||++... ...+++..|+++++.++|+|++.. .++..+++..++|||
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred EEEeEEEeeCCCcEEEEEEECC---CCCEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 5677899999999999999864 5678999988653 234578899999999987765555 455577788899999
Q ss_pred hccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC---CCCCeEEeecCCcccccccc
Q 042262 601 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD---DYYNARISDFGLAKLLTLNQ 677 (814)
Q Consensus 601 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DfGla~~~~~~~ 677 (814)
|+.++.+..+......+++..+..++.|+++||+|||+ .+|+||||||+|||++ .+..+||+|||+++.+....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 98554444444556789999999999999999999995 5999999999999986 45679999999999875443
Q ss_pred cc-----cccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCCcccc
Q 042262 678 SK-----AIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 752 (814)
Q Consensus 678 ~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 752 (814)
.. .......||+.|+|||.+.+..++.++|||||||+++||++|+.||.........................
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-- 238 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-- 238 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH--
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh--
Confidence 22 11234579999999999999999999999999999999999999997654322111110000000000000
Q ss_pred ccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 753 VEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 753 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
.....+++++.+++..||+.+|++||++.++.+.|+.+.
T Consensus 239 -------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 239 -------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp -------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred -------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 112245688999999999999999999999999887653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-40 Score=352.66 Aligned_cols=264 Identities=18% Similarity=0.215 Sum_probs=196.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccc--cccchhhhhceeeEEeeccccceeeeeeeecc-------
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------- 591 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------- 591 (814)
.+.+.++||+|+||+||+|.+.. +++.||||++... .....+++.+|++++++++|+||+++++++..
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CEEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 45566889999999999999864 5789999998543 23345678899999999999999999999854
Q ss_pred -CCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCc
Q 042262 592 -GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 670 (814)
Q Consensus 592 -~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla 670 (814)
+.+.++||||+.++.+.........++....+.|+.||++||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeeccee
Confidence 34678999999998888777777888999999999999999999995 59999999999999999999999999999
Q ss_pred ccccccccc--cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC
Q 042262 671 KLLTLNQSK--AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 747 (814)
Q Consensus 671 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 747 (814)
+........ .......||..|+|||.+.+. .++.++||||+||+++||++|+.||.......... ........-
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~---~i~~~~~~~ 241 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA---LISQLCGSI 241 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHH---HHHHhcCCC
Confidence 876543221 112335699999999999765 68999999999999999999999997543322111 111111100
Q ss_pred --Cc-cc--------cccCcccccC-------ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 748 --KL-DD--------LVEGDTEAMN-------DIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 748 --~~-~~--------l~~~~~~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
.. .. .......... .......+.+|+.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00 00 0000000000 01124567789999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-39 Score=345.23 Aligned_cols=260 Identities=18% Similarity=0.212 Sum_probs=205.7
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccc-cceeeeeeeeccCCceehhh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 599 (814)
.+.+.++||+|+||+||+|++.. .++.||||++... ....++.+|++++..++| +|++.+++++.++...++||
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 35677899999999999999864 5789999988543 234567888899999865 89999999999999999999
Q ss_pred hhccCCchhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-----CCCeEEeecCCcccc
Q 042262 600 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-----YYNARISDFGLAKLL 673 (814)
Q Consensus 600 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DfGla~~~ 673 (814)
||+ +++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++.+
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 998 68998888654 57899999999999999999999 569999999999999974 567999999999987
Q ss_pred ccccccc-----ccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC
Q 042262 674 TLNQSKA-----IKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 748 (814)
Q Consensus 674 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 748 (814)
....... ......||+.|+|||.+.+..++.++||||||++++||++|+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 5432211 12345799999999999999999999999999999999999999976544322211111111111111
Q ss_pred ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHcCCc
Q 042262 749 LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQMLEGVV 798 (814)
Q Consensus 749 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~L~~~~ 798 (814)
..++ ...+++++.+++..|++.+|++||+++.+.+.|++++
T Consensus 237 ~~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 237 LREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred hHHh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1111 1235678999999999999999999999999887654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=351.60 Aligned_cols=271 Identities=25% Similarity=0.292 Sum_probs=194.3
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCC-----
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----- 593 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 593 (814)
.+.+.++||+|+||+||+|.+.. .++.||||+++... ....+.+.+|+.+|+.++|||||++++++...+
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp SEEEEEEC------CEEEEEETT---TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 35566789999999999999864 57889999997532 223457889999999999999999999997654
Q ss_pred -ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 594 -NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 594 -~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
+.+|||||+ +.+|..++. ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence 569999999 556766654 4578999999999999999999995 5999999999999999999999999999987
Q ss_pred ccccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHH-----HHHhc
Q 042262 673 LTLNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-----DCYRN 746 (814)
Q Consensus 673 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~ 746 (814)
.... .+...||..|+|||.+.+. .++.++||||+||+++||++|+.||................ +.+..
T Consensus 171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 6433 3445689999999998764 57899999999999999999999997543211110000000 00000
Q ss_pred C----------CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HcCCcCCCCCCC
Q 042262 747 G----------KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEGVVEVDVPPN 805 (814)
Q Consensus 747 ~----------~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~--L~~~~~~~~pp~ 805 (814)
. .+.+....... ......+.++.+|+.+||+.||.+|||+.|+++. ++++.+.+.+|.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~ 315 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 315 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------C
T ss_pred hcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccccc
Confidence 0 00001011111 1122445788899999999999999999999984 776655444433
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-39 Score=342.67 Aligned_cols=261 Identities=20% Similarity=0.257 Sum_probs=204.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeeccCCceehhh
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 599 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 599 (814)
+.+.++||+|+||+||+|++.. +++.||||+++... ....+++++|+.+++.++||||+++++++.+....++|+
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CEeeeEEecCcCeEEEEEEECC---CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 4556889999999999999864 56789999986432 233567899999999999999999999999999999999
Q ss_pred hhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccccccccc
Q 042262 600 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 679 (814)
Q Consensus 600 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 679 (814)
|++.+++|..++.....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||.++........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 999999999999888889999999999999999999995 59999999999999999999999999999876544322
Q ss_pred cccccccCCCCccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC---Cccc----
Q 042262 680 AIKTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLDD---- 751 (814)
Q Consensus 680 ~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~---- 751 (814)
.....++..|+|||.+.+.. ++.++||||+||+++||++|+.||........ .+ ..+....... ....
T Consensus 158 --~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp --CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HH-HHHHHHHCCCCTTTCTTGGGS
T ss_pred --ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH-HH-HHHHhhcCCCChhhhhhhhhc
Confidence 23345778899999987665 69999999999999999999999754332211 11 1111111100 0000
Q ss_pred --------cccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 752 --------LVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 752 --------l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
..............++.+.+|+.+||+.||.+|||++||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000111122345678899999999999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=350.00 Aligned_cols=261 Identities=22% Similarity=0.273 Sum_probs=194.1
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc-ccchhhhhceeeEEeeccccceeeeeeeeccCC----cee
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----NRL 596 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~ 596 (814)
+.+.++||+|+||+||+|.... +++.||||+++... ....+++++|+.+|+.++||||+++++++.... ..+
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNV---NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp EEEEEECC---CCCEEEEEETT---TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred eEEEEEEeeccCeEEEEEEECC---CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4556889999999999999764 57789999997543 233467899999999999999999999996653 234
Q ss_pred hhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccccc
Q 042262 597 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 676 (814)
Q Consensus 597 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 676 (814)
++++|+.+|+|.+++... .+++..++.++.||+.||+|||+ .+||||||||+||||++++.+||+|||+++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 455677899999998654 68999999999999999999995 59999999999999999999999999999876554
Q ss_pred ccc-cccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcCC------
Q 042262 677 QSK-AIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK------ 748 (814)
Q Consensus 677 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------ 748 (814)
... .......||..|+|||.+... .++.++||||+||+++||++|+.||......+.... .........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGSPSQEDLNC 239 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHHHT
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH---HhhhccCCChhhhhh
Confidence 332 123446689999999998554 678899999999999999999999975432211111 000000000
Q ss_pred ------------ccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 749 ------------LDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 749 ------------~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
......... .......+.++.+++.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPW-NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCH-HHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCH-HHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 00111334678999999999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-38 Score=341.66 Aligned_cols=257 Identities=20% Similarity=0.305 Sum_probs=196.9
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-ccceeeeeeeecc--CCceeh
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDE--GQNRLL 597 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~l 597 (814)
.+.+.++||+|+||+||+|+... .++.||||+++.. ..+++.+|+.+++.++ ||||+++++++.. ....++
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 45667899999999999999864 5789999998653 3567889999999995 9999999999864 456899
Q ss_pred hhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-CeEEeecCCccccccc
Q 042262 598 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLTLN 676 (814)
Q Consensus 598 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~ 676 (814)
||||+.+++|..+. +.+++..+..++.||++||+|||+ .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999998764 468999999999999999999995 5999999999999998655 6999999999876544
Q ss_pred ccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHH-------HHHHHHhcCC
Q 042262 677 QSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD-------WAFDCYRNGK 748 (814)
Q Consensus 677 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~-------~~~~~~~~~~ 748 (814)
.. .....+|..|+|||.+.+. .++.++||||+|++++|+++|+.||............. ..........
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 32 3345689999999998765 47999999999999999999999997654422111000 0000111000
Q ss_pred cc------cccc--------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042262 749 LD------DLVE--------GDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ 792 (814)
Q Consensus 749 ~~------~l~~--------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~ 792 (814)
.. .... ...........+.++.+|+.+||+.||.+|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000 00111112345678899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-38 Score=340.67 Aligned_cols=260 Identities=24% Similarity=0.265 Sum_probs=186.7
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeecccc--ccchhhhhceeeEEeeccccceeeeeeeecc------CC
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------GQ 593 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~ 593 (814)
+.+.++||+|+||+||+|.+.. +++.||||++.... ....+++.+|+.++++++||||+++++++.. .+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~---t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETT---TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred eEEEEEeecCcCeEEEEEEECC---CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 4556789999999999999864 57899999996532 2334568899999999999999999999853 46
Q ss_pred ceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCcccc
Q 042262 594 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 673 (814)
Q Consensus 594 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~ 673 (814)
+.++||||+.++.+..+ . ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+++..
T Consensus 96 ~~~iv~Ey~~~~l~~~~-~--~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVI-Q--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSEEHHHHH-T--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccchHHHHhh-h--cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence 78999999977655544 2 457899999999999999999995 59999999999999999999999999998876
Q ss_pred cccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhH----------------H
Q 042262 674 TLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL----------------T 737 (814)
Q Consensus 674 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l----------------~ 737 (814)
..... .+...+|..|+|||.+.+..+++++||||+||+++||++|+.||........... .
T Consensus 170 ~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 54332 3445689999999999999999999999999999999999999964421110000 0
Q ss_pred HHHHHHHhcCC-c-----cccccC---cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042262 738 DWAFDCYRNGK-L-----DDLVEG---DTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQM 793 (814)
Q Consensus 738 ~~~~~~~~~~~-~-----~~l~~~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~~ 793 (814)
........... . ...... ..........+.++.+|+.+||+.||++|||++||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000111100 0 000000 00111123457789999999999999999999999863
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-38 Score=343.16 Aligned_cols=267 Identities=25% Similarity=0.289 Sum_probs=197.4
Q ss_pred hhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccc--cchhhhhceeeEEeeccccceeeeeeeecc-----CCc
Q 042262 522 DNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-----GQN 594 (814)
Q Consensus 522 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~ 594 (814)
|.+.++||+|+||+||+|.+.. +++.||||+++.... ...+++.+|+.+++.++|||||++++++.. ...
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETT---TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred eEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5566889999999999999864 578999999975422 234568899999999999999999999853 334
Q ss_pred eehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEEeecCCccccc
Q 042262 595 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 674 (814)
Q Consensus 595 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~ 674 (814)
.++++||+.+|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccC
Confidence 5677788899999999865 468999999999999999999995 599999999999999999999999999997654
Q ss_pred ccccccccccccCCCCccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHHHHHHHHhcC------
Q 042262 675 LNQSKAIKTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG------ 747 (814)
Q Consensus 675 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------ 747 (814)
.. .....|+..|+|||.+.+. .++.++||||+||+++||++|+.||......... ..........
T Consensus 173 ~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~---~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 173 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVGTPGAELLK 244 (348)
T ss_dssp GG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCHHHHT
T ss_pred cc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCChHHhh
Confidence 32 2345688999999987765 4689999999999999999999999754321111 1111110000
Q ss_pred ------------CccccccCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHcCCcCCCCCC
Q 042262 748 ------------KLDDLVEGDTEAMNDIKCTEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEGVVEVDVPP 804 (814)
Q Consensus 748 ------------~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm~eV~~--~L~~~~~~~~pp 804 (814)
........... ......+.++.+|+.+||+.||.+|||++|+++ .+++..+....|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~ 314 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 314 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC
T ss_pred hccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC
Confidence 00000000000 001234577899999999999999999999998 466554444333
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-34 Score=311.81 Aligned_cols=277 Identities=21% Similarity=0.239 Sum_probs=193.5
Q ss_pred HhhhhccccccceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-----------ccceeeeeeee
Q 042262 521 TDNFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-----------HKNLVRLLGFC 589 (814)
Q Consensus 521 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~ 589 (814)
+|.+.++||+|+||+||+|+... +++.||||+++... ...+.+.+|+.++++++ |+||+++++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~---~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 46778999999999999999864 57899999997532 22356677887777765 57899999988
Q ss_pred ccC--CceehhhhhccCCchhhh---hcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCC---
Q 042262 590 DEG--QNRLLVYEFLNNGTLASF---LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN--- 661 (814)
Q Consensus 590 ~~~--~~~~lV~e~~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~--- 661 (814)
... ...+++++++..+..... ......++...+..++.||++||+|||+ ..+|+||||||+||||+.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccc
Confidence 553 445566665544432222 2334678899999999999999999996 358999999999999986553
Q ss_pred ---eEEeecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCcccCCcchhhHHH
Q 042262 662 ---ARISDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 738 (814)
Q Consensus 662 ---~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~ 738 (814)
+||+|||.+...... .....||..|+|||.+.+..++.++||||+||+++||++|+.||............+
T Consensus 168 ~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 999999999865432 234568999999999999999999999999999999999999997654321111111
Q ss_pred HHHHHH-hcCCc---------------------ccccc---Cc------ccccCChhHHHHHHHHHHHccccCCCCCCCH
Q 042262 739 WAFDCY-RNGKL---------------------DDLVE---GD------TEAMNDIKCTEKLVMVSIWCIQEDPSLRPTM 787 (814)
Q Consensus 739 ~~~~~~-~~~~~---------------------~~l~~---~~------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPtm 787 (814)
.....+ .-|.. ..... .. .........+.++.+|+.+||+.||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 111000 00000 00000 00 0111234677899999999999999999999
Q ss_pred HHHHHH--HcC---CcCCCCCCCCCC
Q 042262 788 RKVSQM--LEG---VVEVDVPPNPSP 808 (814)
Q Consensus 788 ~eV~~~--L~~---~~~~~~pp~p~~ 808 (814)
+|+++. +++ ..++..|+.|..
T Consensus 323 ~e~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 323 GGLVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp HHHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred HHHhcCcccCCCCCcccCCCCCcccC
Confidence 999884 543 334555655544
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.80 E-value=6.7e-20 Score=162.38 Aligned_cols=111 Identities=20% Similarity=0.397 Sum_probs=92.0
Q ss_pred CCCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEee
Q 042262 27 NGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTA 106 (814)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~ 106 (814)
+|+|.+||.|.+|+. |+ +|.|.|.|+.+| .|.|+.. .++||.||++ .+ ...+.|.|+.
T Consensus 1 tDtL~~gq~L~~g~~---l~--~g~~~l~~q~DG---------NLvly~~----~~~vW~s~~~---~~-~~~~~l~l~~ 58 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGS---LA--EGGYLFIIQNDC---------NLVLYDN----NRAVWASGTN---GK-ASGCVLKMQN 58 (112)
T ss_dssp CCEEETTEEECTTCE---EE--ETTEEEEECTTS---------CEEEEET----TEEEEECCCT---TS-CSSEEEEECT
T ss_pred CCEecCCCEecCCCE---EE--ECCEEEEEcCCC---------CEEEEcC----CcEEEEccCc---cC-CCCcEEEEec
Confidence 489999999999995 76 599999999776 3677653 5899999987 22 3457899999
Q ss_pred cccEEEeCCCCCeEeeeccCCC-ceeEEEEccCcCEEEEecCCcccccccccccC
Q 042262 107 DRGLVLNDPQGKQVWSSKIDIG-TVAIGVMNDTGNFVLASSSSSKLWDSFTNPSD 160 (814)
Q Consensus 107 ~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtD 160 (814)
||+|+|+|. +.++|++++... +..+|+|+|+|||||++.+++++|||+.+|+|
T Consensus 59 dGnLvl~~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 59 DGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp TSCEEEEET-TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred cccEEEEec-CCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 999999996 567787776544 44689999999999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.79 E-value=7.5e-21 Score=186.78 Aligned_cols=169 Identities=14% Similarity=0.126 Sum_probs=116.7
Q ss_pred hhhccccccceeEEEEEEEeccCCcceEEEEEeecccccc------------------chhhhhceeeEEeeccccceee
Q 042262 523 NFEEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVFQD------------------GEKEFKNEVVVIGQTHHKNLVR 584 (814)
Q Consensus 523 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~------------------~~~~~~~Ei~~l~~l~H~niv~ 584 (814)
.+.++||+|+||+||+|.+. ++..||||+++..... .......|...+.++.|.+++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~----~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~ 78 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK 78 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC
T ss_pred hhCCEeeeCcceEEEEEECC----CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcce
Confidence 35678999999999999875 4678999987532110 0122345677778888999988
Q ss_pred eeeeeccCCceehhhhhccCCchhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCCeEE
Q 042262 585 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 664 (814)
Q Consensus 585 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl 664 (814)
.+++.. .+|+|||+++..+.. ++......++.|++++|+|||+ .+|+||||||+|||++++ .++|
T Consensus 79 ~~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 79 VYAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EEEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEE
T ss_pred EEEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEE
Confidence 886643 379999998866544 3344467899999999999995 599999999999999965 5899
Q ss_pred eecCCcccccccccccccccccCCCCccCcccccCCCCCCccchhhHHHHH
Q 042262 665 SDFGLAKLLTLNQSKAIKTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 715 (814)
Q Consensus 665 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~Gvvl 715 (814)
+|||+++............. +... -.|.+ ...+..++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~~~l~r---d~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILER---DVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHH---HHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHHH---HHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 99999986643321110000 0000 01111 34678889999975433
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.77 E-value=4.3e-19 Score=155.55 Aligned_cols=106 Identities=21% Similarity=0.375 Sum_probs=88.2
Q ss_pred CCCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEee
Q 042262 27 NGTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTA 106 (814)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~ 106 (814)
+++|.+||.|.+|+. |. +|.|.|.|+.+| .|.|+.. .++||.||++ .+ ...+.|.|+.
T Consensus 1 ~~~L~~g~~L~~G~~---l~--ng~~~l~~q~DG---------NLvly~~----~~~vW~s~~~---~~-~~~~~l~l~~ 58 (108)
T d1jpca_ 1 DNILYSGETLSTGEF---LN--YGSFVFIMQEDC---------NLVLYDV----DKPIWATNTG---GL-SRSCFLSMQT 58 (108)
T ss_dssp CCEEETTEEECTTCE---EE--ETTEEEEECTTS---------CEEEEET----TEEEEECCCT---TS-CSSCEEEECT
T ss_pred CCCccCCCEecCCCE---EE--cCCEEEEECCCC---------eEEEEeC----CceeeEeCCC---CC-CCccEEEEec
Confidence 478999999999985 64 699999999876 4777653 5899999988 22 3456899999
Q ss_pred cccEEEeCCCCCeEeeeccCCCce-eEEEEccCcCEEEEecCCccccccccc
Q 042262 107 DRGLVLNDPQGKQVWSSKIDIGTV-AIGVMNDTGNFVLASSSSSKLWDSFTN 157 (814)
Q Consensus 107 ~g~l~l~~~~~~~~wst~~~~~~~-~~~~l~~~GNlvl~~~~~~~~WQSFD~ 157 (814)
||+|+|++++|.+||+|++..... .+|+|+|+|||||++. .+||||+|
T Consensus 59 ~Gnlvl~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 59 DGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp TSCEEEECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred cceEEEECCCccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 999999999999999999765443 5789999999999964 59999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.77 E-value=6.1e-19 Score=154.57 Aligned_cols=106 Identities=23% Similarity=0.382 Sum_probs=88.3
Q ss_pred CCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEeec
Q 042262 28 GTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTAD 107 (814)
Q Consensus 28 ~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~~ 107 (814)
|+|.+||.|.+|+. |+ +|.|.|+|...| .|.++. ..++||+||++ .+....+.|.|+.|
T Consensus 2 ~~L~~g~~L~~g~~---l~--~g~~~l~~q~dg---------nLvl~~----~~~~vW~ant~---~~~~~~~~l~l~~d 60 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQS---LD--VEPYHFIMQEDC---------NLVLYD----HSTSVWASNTG---ILGKKGCKAVLQSD 60 (109)
T ss_dssp CEEETTCEEETTCE---EE--ETTEEEEECTTS---------CEEEEE----TTEEEEECCCC---CTTCCCCEEEECTT
T ss_pred CCccCCCEEeCCCE---EE--eCCEEEEecCCC---------eEEEEe----CCEEEEEeCCC---CCCceeEEEEEcCC
Confidence 68899999999985 75 589999998765 366654 35899999998 45556788999999
Q ss_pred ccEEEeCCCCCeEeeeccCC-CceeEEEEccCcCEEEEecCCccccccccc
Q 042262 108 RGLVLNDPQGKQVWSSKIDI-GTVAIGVMNDTGNFVLASSSSSKLWDSFTN 157 (814)
Q Consensus 108 g~l~l~~~~~~~~wst~~~~-~~~~~~~l~~~GNlvl~~~~~~~~WQSFD~ 157 (814)
|+|||+|++|++||+|+++. .+..+|+|+|+|||||+++ .+|||+-|
T Consensus 61 GnLvl~~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 61 GNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp SCEEEECSSSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred ceEEEEeCCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 99999999999999999864 3456899999999999964 59999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.68 E-value=2.7e-17 Score=146.34 Aligned_cols=102 Identities=22% Similarity=0.303 Sum_probs=85.8
Q ss_pred EEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEeecccEEEeCCCCCeEeeeccCCCc-eeEEEEccCcCEEEEecCCcc
Q 042262 72 SIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSK 150 (814)
Q Consensus 72 giw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~~~GNlvl~~~~~~~ 150 (814)
-|||.++++++++|++|++. +......+|.|+.||||+|++. +.++|++++.+.+ ...+.|+++|||||++.++++
T Consensus 11 ~il~~~~~~~~~~~~l~~~q--~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~ 87 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQ--SLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIA 87 (120)
T ss_dssp EECCCC--CCCCCCEECSSC--CCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEE
T ss_pred eEEEcCCCCCCcccEEcCCC--eeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCE
Confidence 38999999999999999993 4445567899999999999985 6789999987654 468999999999999999999
Q ss_pred cccccccccCccCCCCcccCCceeeecCCCCCCCCCceEEEEecCCceeee
Q 042262 151 LWDSFTNPSDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDGDLVLN 201 (814)
Q Consensus 151 ~WQSFD~PtDTlLpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~ 201 (814)
|||||. +.++|.|.+.|++||+++++
T Consensus 88 lW~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 88 VWTSGN-------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp EEECCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EEEeCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence 999984 34678899999999999886
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.59 E-value=1.7e-16 Score=139.51 Aligned_cols=111 Identities=22% Similarity=0.276 Sum_probs=91.5
Q ss_pred EEEeccCCCeEEEEecCCCCCCCCCCCcEEEEeecccEEEeCCCCCeEeeeccCCCceeEEEEccCcCEEEEecCCcccc
Q 042262 73 IFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDIGTVAIGVMNDTGNFVLASSSSSKLW 152 (814)
Q Consensus 73 iw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~l~~~GNlvl~~~~~~~~W 152 (814)
|||.-.++.+..|+.+.+. +......+|.|+.||||||++ .+.++|++++.+.....+.|+++|||||++.++.+||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~--~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vW 79 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQ--SLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRW 79 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTC--EECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSC
T ss_pred EEEecCCCCCCcceecCCC--cEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEE
Confidence 6777667777788888873 445567789999999999998 5689999998877778899999999999999999999
Q ss_pred cccccccCccCCCCcccCCceeeecCCCCCCCCCceEEEEecCCceeeeeccCCcccccccceecccc
Q 042262 153 DSFTNPSDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTY 220 (814)
Q Consensus 153 QSFD~PtDTlLpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~ 220 (814)
||+. +.++|.|.+.|++||+++++ . .++|.+++-
T Consensus 80 sS~t-------------------------~~~~g~y~l~Lq~DGNlvlY--~-------~~~Wssgt~ 113 (115)
T d1dlpa1 80 SSGT-------------------------KGSIGNYVLVLQPDRTVTIY--G-------PGLWDSGTS 113 (115)
T ss_dssp CCCC-------------------------CCCSSCCEEEECSSSCEEEE--C-------SEEEECSCC
T ss_pred EcCC-------------------------CCCCCCEEEEECCCCcEEEe--C-------CCeecCCCC
Confidence 9873 34689999999999998876 1 357887654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.49 E-value=4.8e-14 Score=124.58 Aligned_cols=102 Identities=20% Similarity=0.297 Sum_probs=79.2
Q ss_pred CCCCCCceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEeec
Q 042262 28 GTVPVGATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTAD 107 (814)
Q Consensus 28 ~~~~~~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~~ 107 (814)
.+|.++|+| .+.+..|.|.|.|..+| -|.+ |. ..++||.+|+.. + ...+.|.|+.|
T Consensus 15 ~~l~~~q~l-------~~~~~~~~y~l~mQ~DG---------NLVL-y~---~~~~vWssnt~~---~-~~~~~l~l~~d 70 (119)
T d1b2pa_ 15 QILHATESL-------EILFGTHVYRFIMQTDC---------NLVL-YD---NNNPIWATNTGG---L-GNGCRAVLQPD 70 (119)
T ss_dssp CEEETTCEE-------EEEETTEEEEEEECTTS---------CEEE-EE---TTEEEEECCCTT---S-CSSCEEEECTT
T ss_pred CEEeCCCeE-------EEecCCceEEEEECCCC---------cEEE-EE---CCeEEEEecCCC---C-CcceEEEEEeC
Confidence 345555555 25678999999999876 2555 43 368999999872 2 33578999999
Q ss_pred ccEEEeCCCCCeEeeeccCCCc-eeEEEEccCcCEEEEecCCcccccccc
Q 042262 108 RGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSFT 156 (814)
Q Consensus 108 g~l~l~~~~~~~~wst~~~~~~-~~~~~l~~~GNlvl~~~~~~~~WQSFD 156 (814)
|+|+|+|.+|.+||++++.+.. ..+++|+|+|||||++ ..+|||-.
T Consensus 71 GnLvL~d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 71 GVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp SCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred CCEEEECCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 9999999999999999986543 3578999999999995 46999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.23 E-value=4.4e-12 Score=110.97 Aligned_cols=88 Identities=24% Similarity=0.310 Sum_probs=69.3
Q ss_pred CCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEeecccEEEeCCCCCeEeeeccCC
Q 042262 48 PSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVLNDPQGKQVWSSKIDI 127 (814)
Q Consensus 48 ~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~ 127 (814)
.+|.|.|.|..+| -|.|+. ..++||.+|.. ....+.+.|..||||||+|.++++||++.+..
T Consensus 24 ~~g~~~l~~q~DG---------NLvL~~----~~~~vW~s~t~-----~~~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~ 85 (115)
T d1dlpa1 24 ELSSFRFTMQSDC---------NLVLFD----SDVRVWASNTA-----GATGCRAVLQSDGLLVILTAQNTIRWSSGTKG 85 (115)
T ss_dssp CSTTEEEEECTTS---------CEEEEE----SSSEEECCCCC-----SCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCC
T ss_pred EcCCEEEEECCCC---------eEEEEc----CCeeEEEcccC-----CCCceEEEEeccCCEEEEccCCCEEEEcCCCC
Confidence 3677999998776 367754 25789988755 23457889999999999999999999999864
Q ss_pred Cc-eeEEEEccCcCEEEEecCCcccccccc
Q 042262 128 GT-VAIGVMNDTGNFVLASSSSSKLWDSFT 156 (814)
Q Consensus 128 ~~-~~~~~l~~~GNlvl~~~~~~~~WQSFD 156 (814)
.. .-+++|+++|||||++ ..+|+|-.
T Consensus 86 ~~g~y~l~Lq~DGNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 86 SIGNYVLVLQPDRTVTIYG---PGLWDSGT 112 (115)
T ss_dssp CSSCCEEEECSSSCEEEEC---SEEEECSC
T ss_pred CCCCEEEEECCCCcEEEeC---CCeecCCC
Confidence 43 3479999999999995 46898853
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.06 E-value=2.5e-10 Score=98.88 Aligned_cols=76 Identities=25% Similarity=0.399 Sum_probs=63.6
Q ss_pred cEEEEeecccEEEeCCCCCeEeeeccCCCc-eeEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCceeeecC
Q 042262 100 SQVKLTADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRK 178 (814)
Q Consensus 100 ~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L~S~~ 178 (814)
-+|.|..||||||++ .+.+||++++.+.+ ...++|+++|||||++.++++||+|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS------------------------ 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS------------------------ 75 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC------------------------
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc------------------------
Confidence 578999999999997 45799999987654 3589999999999999999999976
Q ss_pred CCCCCCCCceEEEEecCCceeee
Q 042262 179 SDTNFSRGRFQFRLLEDGDLVLN 201 (814)
Q Consensus 179 s~~dps~G~~~~~~~~~g~~~~~ 201 (814)
.+.-..+.|.+.|+++|+++++
T Consensus 76 -~t~~~~~~~~l~L~ddGNlVly 97 (108)
T d1jpca_ 76 -NTGGQNGNYVCILQKDRNVVIY 97 (108)
T ss_dssp -CCCCSCSCEEEEECTTSCEEEE
T ss_pred -cccCCCCcEEEEEcCCCCEEEe
Confidence 1222467889999999999887
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.05 E-value=2.8e-10 Score=100.00 Aligned_cols=84 Identities=21% Similarity=0.365 Sum_probs=67.5
Q ss_pred EEEEeecccEEEeCCCCCeEeeeccCCCc-eeEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCceeeecCC
Q 042262 101 QVKLTADRGLVLNDPQGKQVWSSKIDIGT-VAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFSRKS 179 (814)
Q Consensus 101 ~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L~S~~s 179 (814)
.|.|..||||||++. +.++|++++.+.. .+.+.|.++|||||++.++.+||+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t----------------------- 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV----------------------- 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC-----------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCC-----------------------
Confidence 688999999999975 5689999987553 468999999999999999999997531
Q ss_pred CCCCCCCceEEEEecCCceeeeeccCCcccccccceeccc
Q 042262 180 DTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGT 219 (814)
Q Consensus 180 ~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~ 219 (814)
.-+.|.|.+.|++||+++++- .+.|.+++
T Consensus 89 --~~~~~~~~l~Lq~DGNlvlYg---------~~~W~S~T 117 (119)
T d1b2pa_ 89 --AGKAGHYVLVLQPDRNVVIYG---------DALWATQT 117 (119)
T ss_dssp --CCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred --cCCCCceEEEEcCCCCEEEEC---------CCEeccCC
Confidence 114578999999999998861 34687765
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.01 E-value=4.8e-10 Score=97.10 Aligned_cols=87 Identities=30% Similarity=0.546 Sum_probs=68.1
Q ss_pred CcEEEEeecccEEEeCCCCCeEeeeccCCC--ceeEEEEccCcCEEEEecCCcccccccccccCccCCCCcccCCceeee
Q 042262 99 GSQVKLTADRGLVLNDPQGKQVWSSKIDIG--TVAIGVMNDTGNFVLASSSSSKLWDSFTNPSDTLLPGQMMETEQGLFS 176 (814)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~--~~~~~~l~~~GNlvl~~~~~~~~WQSFD~PtDTlLpg~~l~~~~~L~S 176 (814)
.-.|.|..||||||++ .+.+||++++... ....+.|.++|||||+++++.+||+|
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s---------------------- 76 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS---------------------- 76 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEEC----------------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEE----------------------
Confidence 3578899999999987 5679999998643 34679999999999999999999986
Q ss_pred cCCCCCCCCCceEEEEecCCceeeeeccCCcccccccceecccc
Q 042262 177 RKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTY 220 (814)
Q Consensus 177 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~ 220 (814)
.+.-+.|.|.+.|+++|+++++ . .+.|.++++
T Consensus 77 ---~t~~~~~~~~l~L~ddGNlvly--~-------~~~W~S~t~ 108 (109)
T d1kj1a_ 77 ---HSVRGNGNYVLVLQEDGNVVIY--G-------SDIWSTGTY 108 (109)
T ss_dssp ---CCCCCSSCCEEEECTTSCEEEE--C-------CEEEECCCC
T ss_pred ---eeECCCCCEEEEEeCCCcEEEE--C-------CCEecCCCc
Confidence 1112357789999999999886 1 236877654
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.98 E-value=6.7e-10 Score=97.82 Aligned_cols=97 Identities=19% Similarity=0.271 Sum_probs=71.5
Q ss_pred CceeecCCCCCceecCCCcEEEEEeeccCCCCCCCceEEEEEEeccCCCeEEEEecCCCCCCCCCCCcEEEEeecccEEE
Q 042262 33 GATLTAGTNSSPWVSPSGDFAFGFHQLDEENNSNGLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADRGLVL 112 (814)
Q Consensus 33 ~~~l~~~~~~~~lvs~~g~f~lgf~~~~~~~~~~~~~ylgiw~~~~~~~t~vW~an~~~~~~~~~~~~~l~~~~~g~l~l 112 (814)
.+.|.++++ | ..|.|.|.|...| .|.|+. ...+||.++.. .....+.+.|..+|||||
T Consensus 23 ~~~l~~~q~---l--~~g~y~L~~q~DG---------NLvL~~----~~~~vW~s~t~----~~~~~~~~~l~~~GnLvl 80 (120)
T d1dlpa2 23 PQTLHATQS---L--QLSPYRLSMETDC---------NLVLFD----RDDRVWSTNTA----GKGTGCRAVLQPNGRMDV 80 (120)
T ss_dssp CCEECSSCC---C--BCSSCEEEEETTT---------EEEEEB----TTBCCSCCCCC----SSCSSCEEEEETTTEEEE
T ss_pred ccEEcCCCe---e--EcCCEEEEEcCCC---------cEEEec----CCcEEEEEccc----cCCCcEEEEEeCCeeEEE
Confidence 345555543 3 3577888887655 577753 24678977643 234567899999999999
Q ss_pred eCCCCCeEeeeccCCC-ceeEEEEccCcCEEEEecCCcccccc
Q 042262 113 NDPQGKQVWSSKIDIG-TVAIGVMNDTGNFVLASSSSSKLWDS 154 (814)
Q Consensus 113 ~~~~~~~~wst~~~~~-~~~~~~l~~~GNlvl~~~~~~~~WQS 154 (814)
+|.+++++|+|++... +...+.|+++|||||++ ..+|.|
T Consensus 81 ~d~~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~---~~~W~t 120 (120)
T d1dlpa2 81 LTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG---GALWTT 120 (120)
T ss_dssp EETTTEEEEECCCCCSSSCCEEEECSSSCEEEEC---CCCCBC
T ss_pred EcCCCCEEEEeCCCCCCCcEEEEECCCCcEEEeC---CCcccC
Confidence 9999999999998654 34578999999999995 368976
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.90 E-value=4.6e-09 Score=91.55 Aligned_cols=111 Identities=24% Similarity=0.324 Sum_probs=79.3
Q ss_pred cCccCCCCcccCCceeeecCCCCCCCCCceEEEEecCCceeeeeccCCcccccccceeccccCCCCCCCCcceeeecccc
Q 042262 159 SDTLLPGQMMETEQGLFSRKSDTNFSRGRFQFRLLEDGDLVLNVANLPTDFAYDAYYTSGTYDSTNSSNSGYRVMFNESG 238 (814)
Q Consensus 159 tDTlLpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~ 238 (814)
||||+|||.|..++.|++ |.|+|.++.||+++++... .++|.++.... ..+..+.+..+|
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~~~-------~~vW~s~~~~~----~~~~~l~l~~dG 60 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNN-------RAVWASGTNGK----ASGCVLKMQNDG 60 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEETT-------EEEEECCCTTS----CSSEEEEECTTS
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEcCC-------cEEEEccCccC----CCCcEEEEeccc
Confidence 899999999999999964 9999999999999987532 56787765432 234567888889
Q ss_pred cEEEEeccceeeeeeccccccCCccEEEEEEeeCceEEEEEecCCCCCCceEEecCCCCcC
Q 042262 239 YMYILRRNSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYFYPKNGNGNWSAVWSQPENIC 299 (814)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~lr~y~~~~~~~~~W~~~~~~p~~~C 299 (814)
.+.++..+..... +.. .......+++|+.||+|++|.- .....|+...+.|
T Consensus 61 nLvl~~~~~~~w~--s~t--~~~~~~~~l~L~ddGNlvly~~------~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 61 NLVIYSGSRAIWA--SNT--NRQNGNYYLILQRDRNVVIYDN------SNNAIWATHTNVG 111 (112)
T ss_dssp CEEEEETTEEEEE--CCC--CCSCCCCEEEECTTSCEEEECT------TSCEEEECCCCCC
T ss_pred cEEEEecCCeEEE--Eee--ccCCCceEEEEcCCCCEEEECC------CCcEEecCCCccC
Confidence 8877765433222 111 1122346899999999999831 2356788877765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.67 E-value=2e-05 Score=78.79 Aligned_cols=131 Identities=16% Similarity=0.072 Sum_probs=91.0
Q ss_pred ceeEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeecc-ccceeeeeeeeccCCceehhhhhccCCchhhh
Q 042262 532 SFGIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 610 (814)
Q Consensus 532 ~fG~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 610 (814)
....||+... ++..+.||+...........+.+|...+..+. +--+.+++.+..+++..++||+++++..+.+.
T Consensus 26 s~~~v~rv~~-----~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 26 SPAKVYKLVG-----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp SSSEEEEEEC-----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CCCcEEEEEe-----CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 3468998753 34567788876655445556777877776663 43466778888888889999999999887654
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------------------------------
Q 042262 611 LFGNLKPSWNLRTNIAFQIARGLLYLHEDC-------------------------------------------------- 640 (814)
Q Consensus 611 l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------------- 640 (814)
.... .....++.++++.|+.||+..
T Consensus 101 ~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 101 YEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp TTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred cccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 4222 123345666666666666421
Q ss_pred ------CCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 641 ------SAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 641 ------~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
...++|+|+.|.|||++++...-|.||+.+..
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11379999999999999876677999987764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.03 E-value=0.00018 Score=71.15 Aligned_cols=124 Identities=16% Similarity=0.114 Sum_probs=80.0
Q ss_pred eEEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccc--cceeeeeeeeccCCceehhhhhccCCchhhhh
Q 042262 534 GIVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL 611 (814)
Q Consensus 534 G~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 611 (814)
..||+.... .+..+.+|..... ...++..|...++.+.. -.+.+++.++.+++..++|||++++.++.+..
T Consensus 25 ~~v~r~~~~----~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~ 97 (255)
T d1nd4a_ 25 AAVFRLSAQ----GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH 97 (255)
T ss_dssp CEEEEEECT----TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC
T ss_pred CeEEEEEeC----CCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc
Confidence 678987754 3445777875432 23456777777776643 33567788888888899999999887664421
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------------------------c-
Q 042262 612 FGNLKPSWNLRTNIAFQIARGLLYLHE---------------------------------------------------D- 639 (814)
Q Consensus 612 ~~~~~l~~~~~~~i~~~ia~gL~yLH~---------------------------------------------------~- 639 (814)
. . ...++.++++.|+-||. .
T Consensus 98 ~-----~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 98 L-----A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp C-----C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred c-----c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 0 1 11122233333333332 1
Q ss_pred ---CCCCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 640 ---CSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 640 ---~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
....++|+|+.|.|||++++..+-|.||+.+..
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 012479999999999999877678999987754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.83 E-value=0.00045 Score=73.17 Aligned_cols=76 Identities=17% Similarity=0.106 Sum_probs=45.5
Q ss_pred ccccccceeEEEEEEEeccCCcceEEEEEeecccc-------ccchhhhhceeeEEeecc-c--cceeeeeeeeccCCce
Q 042262 526 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDRVF-------QDGEKEFKNEVVVIGQTH-H--KNLVRLLGFCDEGQNR 595 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~~~~~~vaVK~l~~~~-------~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~ 595 (814)
+.||.|..-.||+..... .+..++||.-.... .....+...|.+.++.+. + ..+.+++.+. ....
T Consensus 32 ~eig~G~~N~vfrV~~~~---~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~ 106 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMA 106 (392)
T ss_dssp EECCSSSSEEEEEEEC-------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTT
T ss_pred EEeCCCceEeEEEEEeCC---CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCC
Confidence 468999999999987653 35678888754311 111223445666666552 2 3455666554 4456
Q ss_pred ehhhhhccCCc
Q 042262 596 LLVYEFLNNGT 606 (814)
Q Consensus 596 ~lV~e~~~~gs 606 (814)
++|||++.+..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 88999987654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.87 E-value=0.006 Score=62.27 Aligned_cols=131 Identities=15% Similarity=0.076 Sum_probs=70.7
Q ss_pred EEEEEEEeccCCcceEEEEEeeccccccchhhhhceeeEEeeccccce--eeeeee-----eccCCceehhhhhccCCch
Q 042262 535 IVYKGVIQTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL--VRLLGF-----CDEGQNRLLVYEFLNNGTL 607 (814)
Q Consensus 535 ~Vykg~~~~~~~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~-----~~~~~~~~lV~e~~~~gsL 607 (814)
.||++.+. ++..+++|..+.. ....+++..|...+..|....+ +..+.. ...+...+.+++++++..+
T Consensus 37 ~vy~v~~~----dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 37 RVYQFQDE----DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp EEEEECCT----TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred eeEEEEcC----CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 69988875 5677999987643 2234567777777766643322 111111 1223445677777765433
Q ss_pred hhh--------------hc----CC-----CCCC-------------------HHHHHHHHHHHHHHHHHhh----hcCC
Q 042262 608 ASF--------------LF----GN-----LKPS-------------------WNLRTNIAFQIARGLLYLH----EDCS 641 (814)
Q Consensus 608 ~~~--------------l~----~~-----~~l~-------------------~~~~~~i~~~ia~gL~yLH----~~~~ 641 (814)
... ++ .. ..++ ...+..+...+.+.++.+. +...
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 210 00 00 0111 1111112222222333332 2234
Q ss_pred CCeeecCCCCCcEEECCCCCeEEeecCCccc
Q 042262 642 AQIIHCDIKPQNILLDDYYNARISDFGLAKL 672 (814)
Q Consensus 642 ~~iiH~Dikp~NIll~~~~~~kl~DfGla~~ 672 (814)
.++||+|+.+.|||++++ ..+.||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 578999999999999754 45899987754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.12 E-value=0.036 Score=57.90 Aligned_cols=76 Identities=13% Similarity=0.215 Sum_probs=47.2
Q ss_pred ccccccceeEEEEEEEeccC----CcceEEEEEeeccccccchhhhhceeeEEeeccccce-eeeeeeeccCCceehhhh
Q 042262 526 EEVGRGSFGIVYKGVIQTTR----TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYE 600 (814)
Q Consensus 526 ~~LG~G~fG~Vykg~~~~~~----~~~~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e 600 (814)
+.|+.|--=.+|++...... .....+.+++.-. ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 35666777789998876432 2234566666542 2223455678888887753444 477887754 57888
Q ss_pred hccCCch
Q 042262 601 FLNNGTL 607 (814)
Q Consensus 601 ~~~~gsL 607 (814)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 8876544
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.90 E-value=0.05 Score=34.01 Aligned_cols=32 Identities=25% Similarity=0.569 Sum_probs=24.3
Q ss_pred CcCCCccCCCCcCCCCCCcccccCCCCCCccccCCCCccc
Q 042262 297 NICDNISGEFGSGACGFNSICTLDGDRRPMCECPKGYSLL 336 (814)
Q Consensus 297 ~~Cd~y~~~~~~g~CG~~giC~~~~~~~~~C~Cl~GF~~~ 336 (814)
|.|.+ -..|| +|-|+. ....-.|.|-.||+|.
T Consensus 2 dECsi------gnpCG-nGTCtN-viGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSV------GNPCG-NGTCKN-VIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGT------TCSSS-SSCEEE-CSSSEEECCSSSSCCC
T ss_pred Ccccc------CCccC-Cceeee-cccceEEeecCCcCCC
Confidence 56777 47888 678974 3456689999999985
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.20 E-value=0.083 Score=35.43 Aligned_cols=26 Identities=23% Similarity=0.590 Sum_probs=21.7
Q ss_pred cCCCCCCcccccCCCCCCccccCCCCc
Q 042262 308 SGACGFNSICTLDGDRRPMCECPKGYS 334 (814)
Q Consensus 308 ~g~CG~~giC~~~~~~~~~C~Cl~GF~ 334 (814)
+..|..+|.|.. ...+-.|.|++||+
T Consensus 10 ~~pC~n~g~C~n-~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 10 ANPCEHAGKCIN-TLGSFECQCLQGYT 35 (42)
T ss_dssp SCSSSTTCEEEE-CSSSEEEECCTTEE
T ss_pred CCCCCCCcEeEC-CCCCEEeECCCCCc
Confidence 468999999974 45567999999996
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.32 E-value=0.2 Score=32.84 Aligned_cols=25 Identities=24% Similarity=0.623 Sum_probs=21.0
Q ss_pred CCCCCCcccccCCCCCCccccCCCCc
Q 042262 309 GACGFNSICTLDGDRRPMCECPKGYS 334 (814)
Q Consensus 309 g~CG~~giC~~~~~~~~~C~Cl~GF~ 334 (814)
..|...|.|.. ....-.|.|++||+
T Consensus 6 ~PC~ngg~C~~-~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 6 SPCQNQGKCKD-GLGEYTCTCLEGFE 30 (39)
T ss_dssp CCCCSSCEECC-CSSSCCEECCTTEE
T ss_pred CCCCCCcEEEC-CCCCEEEECCCCCC
Confidence 78999999974 45578999999996
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.25 E-value=0.23 Score=33.29 Aligned_cols=31 Identities=32% Similarity=0.679 Sum_probs=23.7
Q ss_pred CcCCCccCCCCcCCCCCCcccccCCCCCCccccCCCCcc
Q 042262 297 NICDNISGEFGSGACGFNSICTLDGDRRPMCECPKGYSL 335 (814)
Q Consensus 297 ~~Cd~y~~~~~~g~CG~~giC~~~~~~~~~C~Cl~GF~~ 335 (814)
|.|.. +.|+.++.|. |...+-.|.|++||+.
T Consensus 6 dEC~~-------~~~~~~~~C~-Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 6 DECKE-------PDVCKHGQCI-NTDGSYRCECPFGYIL 36 (43)
T ss_dssp CSSSS-------TTSCSSSCCC-CCSSCCCCCCCTTEEE
T ss_pred eccCC-------cCCCCCCEeE-CCCCCeEeECCCCccc
Confidence 56765 4566789997 4556789999999986
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=84.66 E-value=0.27 Score=48.89 Aligned_cols=32 Identities=25% Similarity=0.290 Sum_probs=28.2
Q ss_pred CCCCeeecCCCCCcEEECCCCCeEEeecCCcc
Q 042262 640 CSAQIIHCDIKPQNILLDDYYNARISDFGLAK 671 (814)
Q Consensus 640 ~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~ 671 (814)
...++||+|+.+.||+++.+...-|.||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 45689999999999999988777899999875
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.59 E-value=0.15 Score=33.41 Aligned_cols=25 Identities=24% Similarity=0.517 Sum_probs=21.2
Q ss_pred CCCCCCcccccCCCCCCccccCCCCc
Q 042262 309 GACGFNSICTLDGDRRPMCECPKGYS 334 (814)
Q Consensus 309 g~CG~~giC~~~~~~~~~C~Cl~GF~ 334 (814)
..|...|.|.. ...+-.|.|++||+
T Consensus 7 ~PC~n~g~C~~-~~~~y~C~C~~G~~ 31 (39)
T d2vj3a2 7 NPCQNDATCLD-QIGEFQCICMPGYE 31 (39)
T ss_dssp CCCCSSCEEEE-CSSCEEEECCTTEE
T ss_pred CCCCCCCEEEC-CCCCEEEeCCCCCc
Confidence 78999999984 45678999999996
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.25 E-value=0.068 Score=35.87 Aligned_cols=27 Identities=30% Similarity=0.656 Sum_probs=21.4
Q ss_pred cCCCCCCcccccCCCCCCccccCCCCccc
Q 042262 308 SGACGFNSICTLDGDRRPMCECPKGYSLL 336 (814)
Q Consensus 308 ~g~CG~~giC~~~~~~~~~C~Cl~GF~~~ 336 (814)
++.|. +++|.. +..+-.|.|++||++.
T Consensus 9 ~~~C~-~~~C~N-t~Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 9 PLLCR-GGVCHN-TEGSYRCECPPGHQLS 35 (42)
T ss_dssp SSTTT-TSEEEE-ETTEEEEESCTTSCCC
T ss_pred CCCCC-CCEeEC-CCCCeEEeCCCCCeEC
Confidence 57885 789974 4567799999999964
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.56 E-value=0.25 Score=31.50 Aligned_cols=26 Identities=35% Similarity=0.723 Sum_probs=21.5
Q ss_pred cCCCCCCcccccCCCCCCccccCCCCc
Q 042262 308 SGACGFNSICTLDGDRRPMCECPKGYS 334 (814)
Q Consensus 308 ~g~CG~~giC~~~~~~~~~C~Cl~GF~ 334 (814)
+..|-..|.|.. ...+-.|.|++||+
T Consensus 5 ~~PC~ngg~C~~-~~~~y~C~C~~g~~ 30 (35)
T d2vj3a3 5 SSPCLHNGRCLD-KINEFQCECPTGFT 30 (35)
T ss_dssp TCCSTTTCEEEE-CSSCEEEECCTTEE
T ss_pred CCCCCCCcEEEC-CCCCeEEECCCCCC
Confidence 378999999974 45578999999996
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.20 E-value=0.26 Score=32.26 Aligned_cols=31 Identities=23% Similarity=0.561 Sum_probs=24.8
Q ss_pred CCcCCCccCCCCcCCCCCCcccccCCCCCCccccCCCCc
Q 042262 296 ENICDNISGEFGSGACGFNSICTLDGDRRPMCECPKGYS 334 (814)
Q Consensus 296 ~~~Cd~y~~~~~~g~CG~~giC~~~~~~~~~C~Cl~GF~ 334 (814)
.|+|.. ..|-..|.|.. ......|.|++||+
T Consensus 3 ~d~C~~-------~PC~ngg~C~~-~~~~y~C~C~~g~~ 33 (39)
T d1edmb_ 3 GDQCES-------NPCLNGGSCKD-DINSYECWCPFGFE 33 (39)
T ss_dssp CCTTTT-------CCCCTTCEEEE-ETTEEEEECCTTCC
T ss_pred cccCCC-------CCCCCCcEEEc-CCCCEEEECCCCCC
Confidence 356775 78999999974 34577999999996
|